Name,MOA,Target,Disease Area,Indication,Vendor,Purity,Id,SMILES,InChIKey,Phase,Deprecated ID
abacavir,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),"Tocris, Selleck, MicroSource",98.81,"BRD-K17443395-065-03-0, BRD-K17443395-065-01-4, BRD-K17443395-065-02-2","Nc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](CO)C=C3)c2n1, Nc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](CO)C=C3)c2n1, Nc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](CO)C=C3)c2n1","MCGSCOLBFJQGHM-SCZZXKLOSA-N, MCGSCOLBFJQGHM-SCZZXKLOSA-N, MCGSCOLBFJQGHM-SCZZXKLOSA-N",Launched,"BRD-M55852627-065-01-7, BRD-M42309903-065-03-5, BRD-A95032015-065-01-2"
abamectin,benzodiazepine receptor agonist,"GABBR1, GABBR2",infectious disease,gastrointestinal parasites,MicroSource,61,BRD-A25579302-001-04-8,CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C,RRZXIRBKKLTSOM-ONDMGMIHSA-N,Launched,
abemaciclib,CDK inhibitor,"CDK4, CDK6",oncology,breast cancer,Selleck,94.43,BRD-K33622447-066-01-9,CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)-c3cc(F)c4nc(C)n(C(C)C)c4c3)nc2)CC1,UZWDCWONPYILKI-UHFFFAOYSA-N,Launched,
abiraterone,androgen biosynthesis inhibitor,"CYP11B1, CYP17A1",oncology,prostate cancer,Selleck,92.23,BRD-K50071428-001-03-3,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c1cccnc1,GZOSMCIZMLWJML-VJLLXTKPSA-N,Launched,BRD-K00111504-001-01-9
abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1,oncology,prostate cancer,"Selleck, Selleck",98.65,"BRD-K24048528-001-01-7, BRD-K24048528-001-02-5","CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c4cccnc4)[C@@H]3CC=C2C1, CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c4cccnc4)[C@@H]3CC=C2C1","UVIQSJCZCSLXRZ-UBUQANBQSA-N, UVIQSJCZCSLXRZ-UBUQANBQSA-N",Launched,BRD-K16133773-001-01-9
acamprosate,glutamate receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5",neurology/psychiatry,abstinence from alcohol,"MicroSource, Sigma",89.21,"BRD-K26262077-238-01-5, BRD-K26262077-001-01-7","CC(=O)NCCCS(O)(=O)=O, CC(=O)NCCCS(O)(=O)=O","AFCGFAGUEYAMAO-UHFFFAOYSA-N, AFCGFAGUEYAMAO-UHFFFAOYSA-N",Launched,BRD-M41783010-238-03-5
acarbose,glucosidase inhibitor,"AMY2A, GAA, MGAM, SI",endocrinology,diabetes mellitus,"Tocris, Tocris, MicroSource, Selleck",100,"BRD-K44276885-001-06-6, BRD-K44276885-001-05-8, BRD-K44276885-001-08-2, BRD-K44276885-001-07-4","C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O, C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O, C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O, C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","XUFXOAAUWZOOIT-SXARVLRPSA-N, XUFXOAAUWZOOIT-SXARVLRPSA-N, XUFXOAAUWZOOIT-SXARVLRPSA-N, XUFXOAAUWZOOIT-SXARVLRPSA-N",Launched,"BRD-A16444946-001-09-7, BRD-K01621533-001-01-1"
acebutolol,adrenergic receptor antagonist,"ADRB1, ADRB2",cardiology,"hypertension, ventricular arrhythmias","MicroSource, Selleck",98.29,"BRD-A29260609-003-26-0, BRD-A29260609-003-25-2","CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O, CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O","GOEMGAFJFRBGGG-UHFFFAOYSA-N, GOEMGAFJFRBGGG-UHFFFAOYSA-N",Launched,
aceclidine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ophthalmology,glaucoma,"Selleck, MicroSource, Selleck",100,"BRD-A32673558-003-03-9, BRD-A32673558-001-02-5, BRD-A32673558-003-04-7","CC(=O)OC1CN2CCC1CC2, CC(=O)OC1CN2CCC1CC2, CC(=O)OC1CN2CCC1CC2","WRJPSSPFHGNBMG-UHFFFAOYSA-N, WRJPSSPFHGNBMG-UHFFFAOYSA-N, WRJPSSPFHGNBMG-UHFFFAOYSA-N",Launched,BRD-A80567352-003-02-4
aceclofenac,prostanoid receptor antagonist,PTGS2,rheumatology,"rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, periarthritis, lumbago, ischiadynia",MicroSource,98.5,BRD-K68538666-001-12-3,OC(=O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,Launched,
acedapsone,,,infectious disease,leprosy,MicroSource,77.47,BRD-K97417064-001-02-4,CC(=O)Nc1ccc(cc1)S(=O)(=O)c1ccc(NC(C)=O)cc1,AMTPYFGPPVFBBI-UHFFFAOYSA-N,Launched,
acefylline,adenosine receptor agonist,ADORA1,pulmonary,asthma,Prestwick,97.34,BRD-K44004064-001-07-3,Cn1c2ncn(CC(O)=O)c2c(=O)n(C)c1=O,HCYFGRCYSCXKNQ-UHFFFAOYSA-N,Launched,
aceglutamide,,,gastroenterology,peptic ulcer disease (PUD),MicroSource,100,BRD-K13619941-213-01-8,CC(=O)N[C@@H](CCC(N)=O)C(O)=O,KSMRODHGGIIXDV-YFKPBYRVSA-N,Launched,
acemetacin,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,osteoarthritis,"MicroSource, Selleck",98.86,"BRD-K67563174-001-17-6, BRD-K67563174-001-16-8","COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1, COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(O)=O)c2c1","FSQKKOOTNAMONP-UHFFFAOYSA-N, FSQKKOOTNAMONP-UHFFFAOYSA-N",Launched,
acenocoumarol,vitamin K antagonist,VKORC1,hematology,deep vein thrombosis (DVT),MicroSource,99.56,BRD-A65051990-001-12-9,CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)c1c(O)c2ccccc2oc1=O,VABCILAOYCMVPS-UHFFFAOYSA-N,Launched,
acepromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A",neurology/psychiatry,sedative,MicroSource,90.02,BRD-K37814297-050-09-6,CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(C)=O,NOSIYYJFMPDDSA-UHFFFAOYSA-N,Launched,
acetarsol,,,gastroenterology,diarrhea,"MicroSource, Selleck",100,"BRD-K99048103-001-19-2, BRD-K99048103-001-18-4","CC(=O)Nc1cc(ccc1O)[As](O)(O)=O, CC(=O)Nc1cc(ccc1O)[As](O)(O)=O","ODFJOVXVLFUVNQ-UHFFFAOYSA-N, ODFJOVXVLFUVNQ-UHFFFAOYSA-N",Launched,
acetazolamide,carbonic anhydrase inhibitor,"AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7",ophthalmology,glaucoma,MicroSource,97.61,BRD-K43457670-001-27-8,CC(=O)Nc1nnc(s1)S(N)(=O)=O,BZKPWHYZMXOIDC-UHFFFAOYSA-N,Launched,
acetohexamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ10, KCNJ11",endocrinology,diabetes mellitus,"MicroSource, MedChemEx",92.87,"BRD-K52960356-001-13-0, BRD-K52960356-001-15-5","CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1, CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1","VGZSUPCWNCWDAN-UHFFFAOYSA-N, VGZSUPCWNCWDAN-UHFFFAOYSA-N",Launched,
acetohydroxamic-acid,urease inhibitor,MMP12,infectious disease,urinary tract infections,MicroSource,0,BRD-K21615095-001-08-4,CC(=O)NO,RRUDCFGSUDOHDG-UHFFFAOYSA-N,Launched,
acetophenazine,dopamine receptor antagonist,"DRD1, DRD2",neurology/psychiatry,psychosis,MicroSource,85.87,BRD-K42938903-332-01-1,CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(CCO)CC3)c2c1,WNTYBHLDCKXEOT-UHFFFAOYSA-N,Launched,BRD-K92986184-050-01-7
acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG,dermatology,acne vulgaris (AV),"Cayman, Enzo",81.86,"BRD-K79437791-001-06-5, BRD-K79437791-001-05-7","CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O, CC(=O)N[C@@H](CSC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=O","XTURYZYJYQRJDO-BNAHBJSTSA-N, XTURYZYJYQRJDO-BNAHBJSTSA-N",Launched,
acetyl-l-leucine,,,neurology/psychiatry,vertigo,MicroSource,100,BRD-K27406233-001-07-7,CC(C)C[C@H](NC(C)=O)C(O)=O,WXNXCEHXYPACJF-ZETCQYMHSA-N,Launched,
acetylcholine,acetylcholine receptor agonist,"ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2","neurology/psychiatry, gastroenterology, pulmonary","drowsiness, fatigue, headache, indigestion, chest congestion","MicroSource, Selleck",100,"BRD-K82381502-003-24-9, BRD-K82381502-003-23-1","CC(=O)OCC[N+](C)(C)C, CC(=O)OCC[N+](C)(C)C","OIPILFWXSMYKGL-UHFFFAOYSA-N, OIPILFWXSMYKGL-UHFFFAOYSA-N",Launched,
acetylcysteine,mucolytic agent,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11",gastroenterology,"acetaminophen overdose, hepatic injury","Selleck, MicroSource, Selleck",88.97,"BRD-K59058747-001-19-1, BRD-K59058747-001-20-9, BRD-K59058747-001-18-3","CC(=O)N[C@@H](CS)C(O)=O, CC(=O)N[C@@H](CS)C(O)=O, CC(=O)N[C@@H](CS)C(O)=O","PWKSKIMOESPYIA-BYPYZUCNSA-N, PWKSKIMOESPYIA-BYPYZUCNSA-N, PWKSKIMOESPYIA-BYPYZUCNSA-N",Launched,BRD-K67174965-001-02-7
acexamic-acid,5 alpha reductase inhibitor,GAST,dermatology,wound healing,MicroSource,100,BRD-K72215350-001-06-5,CC(=O)NCCCCCC(O)=O,WDSCBUNMANHPFH-UHFFFAOYSA-N,Launched,
acipimox,cholesterol inhibitor,HCAR2,endocrinology,hyperlipidemia,"Tocris, MicroSource, Selleck",98.26,"BRD-K63736853-001-06-3, BRD-K63736853-001-04-8, BRD-K63736853-001-03-0","Cc1cnc(c[n+]1[O-])C(O)=O, Cc1cnc(c[n+]1[O-])C(O)=O, Cc1cnc(c[n+]1[O-])C(O)=O","DJQOOSBJCLSSEY-UHFFFAOYSA-N, DJQOOSBJCLSSEY-UHFFFAOYSA-N, DJQOOSBJCLSSEY-UHFFFAOYSA-N",Launched,
acitazanolast,mediator release inhibitor,,allergy,allergic rhinitis,"LifeChem, LifeChem",96.68,"BRD-K74236708-001-01-9, BRD-K74236708-001-02-7","OC(=O)C(=O)Nc1cccc(c1)-c1nnn[nH]1, OC(=O)C(=O)Nc1cccc(c1)-c1nnn[nH]1","VWQZJJZGISNFOE-UHFFFAOYSA-N, VWQZJJZGISNFOE-UHFFFAOYSA-N",Launched,
acitretin,retinoid receptor agonist,"RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3",dermatology,psoriasis,"Selleck, Selleck",96.4,"BRD-K62012036-001-14-4, BRD-K62012036-001-13-6","COc1cc(C)c(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)c(C)c1C, COc1cc(C)c(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)c(C)c1C","IHUNBGSDBOWDMA-AQFIFDHZSA-N, IHUNBGSDBOWDMA-AQFIFDHZSA-N",Launched,
aclarubicin,topoisomerase inhibitor,"TOP1, TOP2A",hematologic malignancy,acute myeloid leukemia (AML),"Vitas-M, Vitas-M",24.47,"BRD-A80805100-001-02-7, BRD-A80805100-001-01-9","CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)N(C)C)c2c(cc3C(=O)c4cccc(O)c4C(=O)c3c2O)C1C(=O)OC, CCC1(O)CC(OC2CC(C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)N(C)C)c2c(cc3C(=O)c4cccc(O)c4C(=O)c3c2O)C1C(=O)OC","USZYSDMBJDPRIF-UHFFFAOYSA-N, USZYSDMBJDPRIF-UHFFFAOYSA-N",Launched,
aclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",pulmonary,"bronchitis, emphysema, chronic obstructive pulmonary disease (COPD)",Selleck,95.22,BRD-K74363950-004-01-0,OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1,ASMXXROZKSBQIH-VITNCHFBSA-N,Launched,
acriflavine,hypoxia inducible factor inhibitor,HIF1A,infectious disease,fungal infection,Sigma,32.92,BRD-M87138257-003-01-1,Nc1ccc2cc3ccc(N)cc3nc2c1.C[n+]1c2cc(N)ccc2cc2ccc(N)cc12,BCBIBQWDFMQRSJ-UHFFFAOYSA-O,Launched,
acriflavinium,hypoxia inducible factor inhibitor,HIF1A,infectious disease,fungal infection,MicroSource,37.65,BRD-K97874492-003-12-3,C[n+]1c2cc(N)ccc2cc2ccc(N)cc12,XSIOKTWDEOJMGG-UHFFFAOYSA-O,Launched,
acrisorcin,other antifungal,,infectious disease,fungal infection,MicroSource,61.47,BRD-M49658242-001-04-1,CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc2ccccc12,YZODJQFXMFEJRM-UHFFFAOYSA-N,Launched,
acrivastine,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,Enzo,89.65,BRD-K50163129-001-01-4,Cc1ccc(cc1)C(=C/CN1CCCC1)\c1cccc(\C=C\C(O)=O)n1,PWACSDKDOHSSQD-IUTFFREVSA-N,Launched,
ACT-132577,endothelin receptor antagonist,"EDNRA, EDNRB",pulmonary,pulmonary arterial hypertension (PAH),"MedChemEx, MedChemEx, MedChemEx",80.39,"BRD-K34843150-001-03-0, BRD-K34843150-001-02-2, BRD-K34843150-001-01-4","NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1, NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1, NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1","DKULOVKANLVDEA-UHFFFAOYSA-N, DKULOVKANLVDEA-UHFFFAOYSA-N, DKULOVKANLVDEA-UHFFFAOYSA-N",Launched,
actarit,interleukin receptor agonist,,rheumatology,rheumatoid arthritis,MicroSource,96.94,BRD-K33483813-001-10-0,CC(=O)Nc1ccc(CC(O)=O)cc1,MROJXXOCABQVEF-UHFFFAOYSA-N,Launched,
actinomycin-d,RNA polymerase inhibitor,,oncology,"Wilm's tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular carcinoma","MedChemEx, MedChemEx",81.15,"BRD-K16547679-001-01-5, BRD-A42383464-001-06-3","CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O, CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C1=O","RJURFGZVJUQBHK-DCUCITLNSA-N, RJURFGZVJUQBHK-UHFFFAOYSA-N",Launched,
acyclovir,DNA polymerase inhibitor,PNP,infectious disease,"genitial herpes, shingles, chicken pox","Tocris, MicroSource, Tocris, Selleck, Selleck",100,"BRD-K32318651-001-26-0, BRD-K32318651-001-23-7, BRD-K32318651-001-22-9, BRD-K32318651-001-21-1, BRD-K32318651-001-24-5","Nc1nc2n(COCCO)cnc2c(=O)[nH]1, Nc1nc2n(COCCO)cnc2c(=O)[nH]1, Nc1nc2n(COCCO)cnc2c(=O)[nH]1, Nc1nc2n(COCCO)cnc2c(=O)[nH]1, Nc1nc2n(COCCO)cnc2c(=O)[nH]1","MKUXAQIIEYXACX-UHFFFAOYSA-N, MKUXAQIIEYXACX-UHFFFAOYSA-N, MKUXAQIIEYXACX-UHFFFAOYSA-N, MKUXAQIIEYXACX-UHFFFAOYSA-N, MKUXAQIIEYXACX-UHFFFAOYSA-N",Launched,
adapalene,retinoid receptor agonist,"RARA, RARB, RARG, RXRA, RXRB, RXRG",dermatology,acne vulgaris (AV),"Tocris, Selleck, MicroSource",99.81,"BRD-K33127281-001-06-4, BRD-K33127281-001-04-9, BRD-K33127281-001-05-6","COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O, COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O, COc1ccc(cc1C12CC3CC(CC(C3)C1)C2)-c1ccc2cc(ccc2c1)C(O)=O","LZCDAPDGXCYOEH-UHFFFAOYSA-N, LZCDAPDGXCYOEH-UHFFFAOYSA-N, LZCDAPDGXCYOEH-UHFFFAOYSA-N",Launched,
adefovir,DNA polymerase inhibitor,,infectious disease,hepatitis B,"AKSci, Sigma",99.1,"BRD-K77484724-001-02-0, BRD-K77484724-001-03-8","Nc1ncnc2n(CCOCP(O)(O)=O)cnc12, Nc1ncnc2n(CCOCP(O)(O)=O)cnc12","SUPKOOSCJHTBAH-UHFFFAOYSA-N, SUPKOOSCJHTBAH-UHFFFAOYSA-N",Launched,
adefovir-dipivoxil,DNA polymerase inhibitor,,infectious disease,hepatitis B,"Selleck, Selleck",86.36,"BRD-K96159438-001-07-1, BRD-K96159438-001-06-3","CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C, CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C","WOZSCQDILHKSGG-UHFFFAOYSA-N, WOZSCQDILHKSGG-UHFFFAOYSA-N",Launched,
ademetionine,"methyltransferase stimulant, phosphodiesterase inhibitor","AMD1, CBS, COMT, GNMT, MAT1A, MAT2A",neurology/psychiatry,"depression, attention-deficit/hyperactivity disorder (ADHD)","MedChemEx, MedChemEx",0,"BRD-K78185697-001-02-5, BRD-K78185697-001-01-7","C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12, C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12","MEFKEPWMEQBLKI-AIRLBKTGSA-O, MEFKEPWMEQBLKI-AIRLBKTGSA-O",Launched,
adenosine,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4",cardiology,Wolff-Parkinson-White Syndrome (WPW),"MicroSource, Selleck",96.7,"BRD-K01577834-001-15-1, BRD-K01577834-001-16-9","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O, Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","OIRDTQYFTABQOQ-KQYNXXCUSA-N, OIRDTQYFTABQOQ-KQYNXXCUSA-N",Launched,BRD-K63038995-001-01-4
adenosine-phosphate,adenosine receptor agonist,"ACSL1, ACSS1, ACSS2, ADCY1, ADK, CREB1, FBP1, HINT1, PDE4B, PDE4D, PIM1, PRKAA1, PRKAB1, PRKAB2, PYGL, TRPM4",,,MicroSource,100,BRD-A10111329-001-04-6,Nc1ncnc2n(cnc12)C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,UDMBCSSLTHHNCD-VTHZCTBJSA-N,Launched,
adiphenine,acetylcholine receptor antagonist,CHRNA1,neurology/psychiatry,spasms,"MicroSource, Selleck",94.95,"BRD-K60907894-003-23-5, BRD-K60907894-003-22-7","CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1, CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1","JGOAIQNSOGZNBX-UHFFFAOYSA-N, JGOAIQNSOGZNBX-UHFFFAOYSA-N",Launched,
adrafinil,adrenergic receptor agonist,,neurology/psychiatry,fatigue,"MedChemEx, MedChemEx",96.69,"BRD-A90926615-001-02-7, BRD-A90926615-001-01-9","ONC(=O)CS(=O)C(c1ccccc1)c1ccccc1, ONC(=O)CS(=O)C(c1ccccc1)c1ccccc1","CGNMLOKEMNBUAI-UHFFFAOYSA-N, CGNMLOKEMNBUAI-UHFFFAOYSA-N",Launched,
adrenalone,adrenergic receptor agonist,ADRA1A,hematology,hemorrhage,"Selleck, MicroSource",91.31,"BRD-K82343404-003-02-4, BRD-K82343404-003-03-2","CNCC(=O)c1ccc(O)c(O)c1, CNCC(=O)c1ccc(O)c(O)c1","PZMVOUYYNKPMSI-UHFFFAOYSA-N, PZMVOUYYNKPMSI-UHFFFAOYSA-N",Launched,
afatinib,EGFR inhibitor,"EGFR, ERBB2, ERBB4",oncology,non-small cell lung cancer (NSCLC),"MedChemEx, Selleck, Selleck",99.28,"BRD-K66175015-332-01-6, BRD-K66175015-001-13-2, BRD-K66175015-001-09-0","CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1, CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1, CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1","ULXXDDBFHOBEHA-CWDCEQMOSA-N, ULXXDDBFHOBEHA-CWDCEQMOSA-N, ULXXDDBFHOBEHA-CWDCEQMOSA-N",Launched,
afloqualone,acetylcholine receptor antagonist,,neurology/psychiatry,sedative,AKSci,97.87,BRD-K69247067-001-01-8,Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O,VDOSWXIDETXFET-UHFFFAOYSA-N,Launched,
afobazole,anxiolytic,,neurology/psychiatry,anxiety,MedChemEx,98.16,BRD-K37793595-003-01-7,CCOc1ccc2[nH]c(SCCN3CCOCC3)nc2c1,WWNUCVSRRUDYPP-UHFFFAOYSA-N,Launched,
agomelatine,"melatonin receptor agonist, serotonin receptor antagonist","HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B",neurology/psychiatry,depression,Selleck,98.23,BRD-K84698278-001-03-4,COc1ccc2cccc(CCNC(C)=O)c2c1,YJYPHIXNFHFHND-UHFFFAOYSA-N,Launched,
AGP-103,membrane permeability inhibitor,,,,Enzo,91.5,BRD-K91495480-001-02-2,CCCCCCCCCCCCCCCCCCCCCC(O)=O,UKMSUNONTOPOIO-UHFFFAOYSA-N,Launched,
ajmaline,sodium channel blocker,SCN5A,cardiology,Wolff-Parkinson-White Syndrome (WPW),MicroSource,81.81,BRD-A48300215-001-04-8,CC[C@H]1C2CC3[C@@H]4N(C)c5ccccc5[C@]44C[C@@H](C2C4O)N3[C@@H]1O,CJDRUOGAGYHKKD-FYGXBCQKSA-N,Launched,
aklomide,,,infectious disease,coccidiosis,MicroSource,98.9,BRD-K26807903-001-04-3,NC(=O)c1ccc(cc1Cl)[N+]([O-])=O,GFGSZUNNBQXGMK-UHFFFAOYSA-N,Launched,
alacepril,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,Key,98.51,BRD-K51784806-001-01-6,C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O,FHHHOYXPRDYHEZ-COXVUDFISA-N,Launched,
alanine,,"AARS, AARS2, ABAT, AGXT, AGXT2, GPRC6A, GPT, GPT2, KYNU, NFS1, PHYKPL, SLC1A4, SLC36A1, SLC7A8",,,Sigma,69.19,BRD-A33317514-001-01-3,CC(N)C(O)=O,QNAYBMKLOCPYGJ-UHFFFAOYSA-N,Launched,
alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1,,,MedChemEx,96.08,BRD-K42140276-402-01-4,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,QLGKMLRGKPKGKI-QWQCQAQZSA-N,Launched,
albendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B",infectious disease,"cystic hydatid disease, parenchymal neurocysticercosis","MicroSource, Selleck",93.82,"BRD-K79131256-001-18-7, BRD-K79131256-001-17-9","CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1, CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1","HXHWSAZORRCQMX-UHFFFAOYSA-N, HXHWSAZORRCQMX-UHFFFAOYSA-N",Launched,
albendazole-oxide,anthelmintic agent,,infectious disease,"cystic hydatid disease, parenchymal neurocysticercosis",Selleck,97.13,BRD-A67060370-001-02-9,CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1,VXTGHWHFYNYFFV-UHFFFAOYSA-N,Launched,
albuterol,adrenergic receptor agonist,"ADRB1, ADRB2",pulmonary,asthma,"MicroSource, Selleck",94.73,"BRD-A88254928-001-07-9, BRD-A88254928-065-04-1","CC(C)(C)NCC(O)c1ccc(O)c(CO)c1, CC(C)(C)NCC(O)c1ccc(O)c(CO)c1","NDAUXUAQIAJITI-UHFFFAOYSA-N, NDAUXUAQIAJITI-UHFFFAOYSA-N",Launched,
alcaftadine,histamine receptor antagonist,HRH1,allergy,allergic conjunctivitis,MedChemEx,99.28,BRD-K55991142-001-01-6,CN1CCC(CC1)=C1c2ncc(C=O)n2CCc2ccccc12,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Launched,
alclofenac,cyclooxygenase inhibitor,PTGS1,rheumatology,rheumatoid arthritis,Sigma,96.73,BRD-K47492008-001-02-7,OC(=O)Cc1ccc(OCC=C)c(Cl)c1,ARHWPKZXBHOEEE-UHFFFAOYSA-N,Launched,
alclometasone-dipropionate,glucocorticoid receptor agonist,"CYP3A4, NR3C1, SERPINA6",dermatology,corticosteroid-responsive dermatoses,Prestwick,97.41,BRD-A17407635-001-04-0,CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2C3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,DJHCCTTVDRAMEH-VBIVFILRSA-N,Launched,
alcuronium,muscle relaxant,"CHRM1, CHRM2, CHRM3, CHRM4, CHRNA7",neurology/psychiatry,muscle relaxant,Prestwick,89.64,BRD-A84907376-300-03-8,OC\C=C1/C[N@+]2(CC=C)CC[C@@]34[C@@H]2C[C@@H]1\C1=C\N2C5[C@]6(CC[N@@+]7(CC=C)C\C(=C/CO)[C@H](C[C@@H]67)\C5=C\N(C31)c1ccccc41)c1ccccc21,MUQUYTSLDVKIOF-CNCPGNHZSA-N,Launched,
alectinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET",oncology,non-small cell lung cancer (NSCLC),"Selleck, Selleck",98.17,"BRD-K11267252-001-06-9, BRD-K11267252-001-04-4","CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1, CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1","KDGFLJKFZUIJMX-UHFFFAOYSA-N, KDGFLJKFZUIJMX-UHFFFAOYSA-N",Launched,
alendronate,bone resorption inhibitor,"ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS",orthopedics,osteoporosis,"Selleck, MicroSource, Selleck",0,"BRD-K75527158-360-06-4, BRD-K75527158-360-05-6, BRD-K75527158-360-04-9","NCCCC(O)(P(O)(O)=O)P(O)(O)=O, NCCCC(O)(P(O)(O)=O)P(O)(O)=O, NCCCC(O)(P(O)(O)=O)P(O)(O)=O","OGSPWJRAVKPPFI-UHFFFAOYSA-N, OGSPWJRAVKPPFI-UHFFFAOYSA-N, OGSPWJRAVKPPFI-UHFFFAOYSA-N",Launched,
alfacalcidol,vitamin D receptor agonist,"CYP27B1, VDR",endocrinology,vitamin D deficiency,"Selleck, MedChemEx, Selleck",91.26,"BRD-K49522529-001-02-9, BRD-K49522529-001-01-1, BRD-K49522529-001-03-7","CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C","OFHCOWSQAMBJIW-AVJTYSNKSA-N, OFHCOWSQAMBJIW-AVJTYSNKSA-N, OFHCOWSQAMBJIW-AVJTYSNKSA-N",Launched,"BRD-K92644009-001-02-6, BRD-K84280765-001-01-5"
alfaxalone,"chloride channel agonist, benzodiazepine receptor agonist",GABBR1,neurology/psychiatry,general anaesthetic,Prestwick,98.88,BRD-K41445866-001-18-8,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,DUHUCHOQIDJXAT-OLVMNOGESA-N,Launched,
alfuzosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2",urology,benign prostatic hyperplasia (BPH),"MicroSource, Selleck",93.3,"BRD-A09056319-003-08-5, BRD-A09056319-003-07-7","COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1, COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1","WNMJYKCGWZFFKR-UHFFFAOYSA-N, WNMJYKCGWZFFKR-UHFFFAOYSA-N",Launched,
algestone-acetophenide,,,endocrinology,contraceptive,Prestwick,96.88,BRD-A41774846-001-01-4,CC(=O)[C@@]12OC(C)(O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]21C)c1ccccc1,AHBKIEXBQNRDNL-BXXPAUNWSA-N,Launched,
alibendol,antispasmodic,,gastroenterology,bile stimulation,Selleck,97.28,BRD-K60102752-001-02-2,COc1cc(CC=C)cc(C(=O)NCCO)c1O,UMJHTFHIQDEGKB-UHFFFAOYSA-N,Launched,
alimemazine,histamine receptor agonist,HRH1,neurology/psychiatry,sedative,MicroSource,80.57,BRD-A49225603-045-10-0,CC(CN(C)C)CN1c2ccccc2Sc2ccccc12,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,Launched,
aliskiren-hemifumarate,renin inhibitor,REN,cardiology,hypertension,"Tocris, MicroSource, Selleck",95.42,"BRD-K30020243-051-04-1, BRD-K30020243-051-02-5, BRD-K30020243-051-03-3","COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC, COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC, COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC","UXOWGYHJODZGMF-QORCZRPOSA-N, UXOWGYHJODZGMF-QORCZRPOSA-N, UXOWGYHJODZGMF-QORCZRPOSA-N",Launched,"BRD-M18497616-051-03-6, BRD-K30020243-001-01-2,BRD-M18497616-051-02-8"
alizapride,dopamine receptor antagonist,DRD2,gastroenterology,nausea,Selleck,97.32,BRD-A03061970-003-07-3,COc1cc2[nH]nnc2cc1C(=O)NCC1CCCN1CC=C,KSEYRUGYKHXGFW-UHFFFAOYSA-N,Launched,
allantoin,cosmetic,,dermatology,skin protectant,MicroSource,97.81,BRD-A96407378-001-15-1,NC(=O)NC1NC(=O)NC1=O,POJWUDADGALRAB-UHFFFAOYSA-N,Launched,
allopurinol,xanthine oxidase inhibitor,XDH,"rheumatology, urology","gout, kidney stones","Selleck, MicroSource, Selleck",100,"BRD-K86307448-001-19-1, BRD-K86307448-001-17-5, BRD-K86307448-001-16-7","O=c1[nH]cnc2[nH]ncc12, O=c1[nH]cnc2[nH]ncc12, O=c1[nH]cnc2[nH]ncc12","OFCNXPDARWKPPY-UHFFFAOYSA-N, OFCNXPDARWKPPY-UHFFFAOYSA-N, OFCNXPDARWKPPY-UHFFFAOYSA-N",Launched,
allylestrenol,steroidal progestin,"ESR1, PGR, SLC6A9",obstetrics/gynecology,premature labor,ChemImpex,0,BRD-K12872829-001-01-0,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)CC=C,ATXHVCQZZJYMCF-XUDSTZEESA-N,Launched,
almitrine,neurotransmitter agonist,ATP1A1,pulmonary,chronic obstructive pulmonary disease (COPD),AKSci,99.06,BRD-K82677201-001-01-6,Fc1ccc(cc1)C(N1CCN(CC1)c1nc(NCC=C)nc(NCC=C)n1)c1ccc(F)cc1,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Launched,
almotriptan,serotonin receptor agonist,"HTR1B, HTR1D",neurology/psychiatry,migraine headache,"MicroSource, Selleck",93.42,"BRD-K67601717-001-03-8, BRD-K67601717-037-02-4","CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12, CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12","WKEMJKQOLOHJLZ-UHFFFAOYSA-N, WKEMJKQOLOHJLZ-UHFFFAOYSA-N",Launched,
alogliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,"MicroSource, Selleck, Selleck",93.62,"BRD-A27084604-057-01-0, BRD-K83003151-057-02-4, BRD-K83003151-057-01-6","Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O, Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O, Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O","ZSBOMTDTBDDKMP-UHFFFAOYSA-N, ZSBOMTDTBDDKMP-OAHLLOKOSA-N, ZSBOMTDTBDDKMP-OAHLLOKOSA-N",Launched,"BRD-K83003151-001-03-0, BRD-K83003151-001-02-2"
alpha-tochopherol,antioxidant,,endocrinology,vitamin E deficiency,MicroSource,65.25,BRD-A82892199-001-04-1,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(O)c(C)c(C)c2O1,GVJHHUAWPYXKBD-UHFFFAOYSA-N,Launched,
alpha-tochopheryl-acetate,antioxidant,,endocrinology,vitamin E deficiency,MicroSource,93.36,BRD-A61850409-001-10-7,CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(C)=O)c(C)c(C)c2O1,ZAKOWWREFLAJOT-UHFFFAOYSA-N,Launched,
alprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A",cardiology,angina pectoris,MicroSource,98.73,BRD-A00993607-003-24-6,CC(C)NCC(O)COc1ccccc1CC=C,PAZJSJFMUHDSTF-UHFFFAOYSA-N,Launched,
alprostadil,prostanoid receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR",cardiology,congenital heart defects,"Tocris, Selleck",100,"BRD-K52459643-001-15-1, BRD-K52459643-001-17-7","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O, CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O","GMVPRGQOIOIIMI-DWKJAMRDSA-N, GMVPRGQOIOIIMI-DWKJAMRDSA-N",Launched,BRD-K73691377-001-01-6
althiazide,diuretic,,cardiology,hypertension,MicroSource,99.56,BRD-A56675431-001-12-3,NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl,VGLGVJVUHYTIIU-UHFFFAOYSA-N,Launched,
altrenogest,progestogen hormone,PGR,endocrinology,estrus,"MicroSource, Selleck",100,"BRD-K14619660-001-02-3, BRD-K14619660-001-01-5","C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C, C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C","VWAUPFMBXBWEQY-IVAOSVALSA-N, VWAUPFMBXBWEQY-IVAOSVALSA-N",Launched,BRD-A27554692-001-02-1
altretamine,DNA synthesis inhibitor,,oncology,ovarian cancer,"MicroSource, Selleck",99.9,"BRD-K67043667-001-26-4, BRD-K67043667-001-25-6","CN(C)c1nc(nc(n1)N(C)C)N(C)C, CN(C)c1nc(nc(n1)N(C)C)N(C)C","UUVWYPNAQBNQJQ-UHFFFAOYSA-N, UUVWYPNAQBNQJQ-UHFFFAOYSA-N",Launched,
alverine,muscle relaxant,HTR1A,gastroenterology,"irritable bowel syndrome, diverticular disease","MicroSource, Selleck",94.35,"BRD-K89055274-048-23-5, BRD-K89055274-048-22-7","CCN(CCCc1ccccc1)CCCc1ccccc1, CCN(CCCc1ccccc1)CCCc1ccccc1","ZPFXAOWNKLFJDN-UHFFFAOYSA-N, ZPFXAOWNKLFJDN-UHFFFAOYSA-N",Launched,
alvimopan,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1",gastroenterology,postoperative ileus,MedChemEx,97.74,BRD-K07857022-002-01-1,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Launched,
amantadine,glutamate receptor antagonist,"DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A","infectious disease, neurology/psychiatry","influenza A virus infection, Parkinson's Disease","MicroSource, Selleck",100,"BRD-K70330367-003-08-7, BRD-K70330367-003-07-9","NC12CC3CC(CC(C3)C1)C2, NC12CC3CC(CC(C3)C1)C2","DKNWSYNQZKUICI-UHFFFAOYSA-N, DKNWSYNQZKUICI-UHFFFAOYSA-N",Launched,
ambenonium,cholinesterase inhibitor,ACHE,neurology/psychiatry,myasthenia gravis,Tocris,93.62,BRD-K11292736-300-02-8,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl,OMHBPUNFVFNHJK-UHFFFAOYSA-P,Launched,
ambrisentan,endothelin receptor antagonist,"EDNRA, EDNRB",pulmonary,pulmonary arterial hypertension (PAH),Selleck,97.47,BRD-K41185545-001-02-3,COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1,OUJTZYPIHDYQMC-LJQANCHMSA-N,Launched,
ambroxol,sodium channel blocker,CYP3A4,pulmonary,bronchitis,"Tocris, MicroSource, Tocris, Selleck",97.34,"BRD-K56558538-003-12-7, BRD-K56558538-003-14-3, BRD-K56558538-003-13-5, BRD-K56558538-003-11-9","Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1, Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1, Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1, Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1","JBDGDEWWOUBZPM-XYPYZODXSA-N, JBDGDEWWOUBZPM-XYPYZODXSA-N, JBDGDEWWOUBZPM-XYPYZODXSA-N, JBDGDEWWOUBZPM-XYPYZODXSA-N",Launched,BRD-K11223672-003-05-2
amcinonide,glucocorticoid receptor agonist,"ANXA1, NR3C1",dermatology,corticosteroid-responsive dermatoses,MicroSource,96.95,BRD-A36010170-001-04-0,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,ILKJAFIWWBXGDU-ZYDCGBIBSA-N,Launched,
amdinocillin,bacterial cell wall synthesis inhibitor,,infectious disease,"urinary tract infections, gram-negative bacterial infections",Sigma,61.16,BRD-K41051431-001-02-4,CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(O)=O,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,Launched,
amezinium,adrenergic receptor agonist,ADRB2,,,CombiBlocks,74.42,BRD-K51387999-067-01-6,COc1cc(N)cn[n+]1-c1ccccc1,VXROHTDSRBRJLN-UHFFFAOYSA-O,Launched,
amfenac,cyclooxygenase inhibitor,"PTGS1, PTGS2",neurology/psychiatry,pain relief,Selleck,96.17,BRD-K82122102-323-01-1,Nc1c(CC(O)=O)cccc1C(=O)c1ccccc1,SOYCMDCMZDHQFP-UHFFFAOYSA-N,Launched,
amfepramone,adrenergic receptor agonist,"SLC6A2, SLC6A3",endocrinology,obesity,Prestwick,97.41,BRD-A37288617-003-02-2,CCN(CC)C(C)C(=O)c1ccccc1,XXEPPPIWZFICOJ-UHFFFAOYSA-N,Launched,
amidopyrine,analgesic agent,,dermatology,dermatitis herpetiformis (DH),"MicroSource, Selleck, Selleck",94.77,"BRD-K12568846-001-15-3, BRD-K12568846-001-14-6, BRD-K12568846-001-16-1","CN(C)c1c(C)n(C)n(-c2ccccc2)c1=O, CN(C)c1c(C)n(C)n(-c2ccccc2)c1=O, CN(C)c1c(C)n(C)n(-c2ccccc2)c1=O","RMMXTBMQSGEXHJ-UHFFFAOYSA-N, RMMXTBMQSGEXHJ-UHFFFAOYSA-N, RMMXTBMQSGEXHJ-UHFFFAOYSA-N",Launched,
amifampridine,potassium channel blocker,,neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS),MedChemEx,89.6,BRD-K80262108-001-07-0,Nc1ccncc1N,OYTKINVCDFNREN-UHFFFAOYSA-N,Launched,
amifostine,reducing agent,"ALPPL2, ENPP1",nephrology,renal toxicity,MicroSource,0,BRD-K73947551-001-04-4,NCCCNCCSP(O)(O)=O,JKOQGQFVAUAYPM-UHFFFAOYSA-N,Launched,
amikacin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,"Selleck, MicroSource, Selleck, Selleck, Selleck",100,"BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2","NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O, NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)C1O, NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O, NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O, NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1OC1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O","LKCWBDHBTVXHDL-MRUMTBQISA-N, LKCWBDHBTVXHDL-CJMFXXNZSA-N, LKCWBDHBTVXHDL-RMDFUYIESA-N, LKCWBDHBTVXHDL-RMDFUYIESA-N, LKCWBDHBTVXHDL-MRUMTBQISA-N",Launched,"BRD-U46375448-000-01-5, BRD-K50698959-315-01-8, BRD-U73512331-000-01-9"
amiloride,sodium channel blocker,"AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2",cardiology,"hypertension, congestive heart failure","MicroSource, Selleck, Selleck, Tocris",99.74,"BRD-K97181089-003-24-7, BRD-K97181089-310-06-3, BRD-K97181089-003-22-1, BRD-K97181089-003-23-9","NC(=N)NC(=O)c1nc(Cl)c(N)nc1N, NC(=N)NC(=O)c1nc(Cl)c(N)nc1N, NC(=N)NC(=O)c1nc(Cl)c(N)nc1N, NC(=N)NC(=O)c1nc(Cl)c(N)nc1N","XSDQTOBWRPYKKA-UHFFFAOYSA-N, XSDQTOBWRPYKKA-UHFFFAOYSA-N, XSDQTOBWRPYKKA-UHFFFAOYSA-N, XSDQTOBWRPYKKA-UHFFFAOYSA-N",Launched,
aminocaproic-acid,plasminogen activator inhibitor,"LPA, PLAT, PLG",hematology,fibrinolytic bleeding,"Selleck, MicroSource, Selleck",100,"BRD-K64931368-001-14-1, BRD-K64931368-003-01-4, BRD-K64931368-001-13-3","NCCCCCC(O)=O, NCCCCCC(O)=O, NCCCCCC(O)=O","SLXKOJJOQWFEFD-UHFFFAOYSA-N, SLXKOJJOQWFEFD-UHFFFAOYSA-N, SLXKOJJOQWFEFD-UHFFFAOYSA-N",Launched,
aminoglutethimide,glucocorticoid receptor antagonist,"CYP11A1, CYP19A1","endocrinology, oncology","Cushing's syndrome, breast cancer","MicroSource, Selleck, Selleck",93.51,"BRD-A25234499-001-18-3, BRD-A25234499-001-19-1, BRD-A25234499-001-17-5","CCC1(CCC(=O)NC1=O)c1ccc(N)cc1, CCC1(CCC(=O)NC1=O)c1ccc(N)cc1, CCC1(CCC(=O)NC1=O)c1ccc(N)cc1","ROBVIMPUHSLWNV-UHFFFAOYSA-N, ROBVIMPUHSLWNV-UHFFFAOYSA-N, ROBVIMPUHSLWNV-UHFFFAOYSA-N",Launched,
aminohydroxybutyric-acid,,,neurology/psychiatry,epilepsy,MicroSource,78.63,BRD-A40777960-001-04-2,NCC(O)CC(O)=O,YQGDEPYYFWUPGO-UHFFFAOYSA-N,Launched,
aminopentamide,acetylcholine receptor antagonist,CHRM1,gastroenterology,"acute abdominal visceral spasm, hypertrophic gastritis (GHG), nausea",MicroSource,97.37,BRD-A69917777-065-02-2,CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C,NARHAGIVSFTMIG-UHFFFAOYSA-N,Launched,
aminophylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D",pulmonary,"asthma, bronchitis, emphysema","Key, Selleck",97.33,"BRD-K97799481-205-02-7, BRD-K97799481-230-01-7","Cn1c2nc[nH]c2c(=O)n(C)c1=O, Cn1c2nc[nH]c2c(=O)n(C)c1=O","ZFXYFBGIUFBOJW-UHFFFAOYSA-N, ZFXYFBGIUFBOJW-UHFFFAOYSA-N",Launched,BRD-M53001068-230-06-8
aminosalicylate,cyclooxygenase inhibitor,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",gastroenterology,"inflammatory bowel disease, ulcerative colitis","MicroSource, Selleck, Selleck",97.87,"BRD-K80267133-001-17-7, BRD-K80267133-001-18-5, BRD-K80267133-001-19-3","Nc1ccc(C(O)=O)c(O)c1, Nc1ccc(C(O)=O)c(O)c1, Nc1ccc(C(O)=O)c(O)c1","WUBBRNOQWQTFEX-UHFFFAOYSA-N, WUBBRNOQWQTFEX-UHFFFAOYSA-N, WUBBRNOQWQTFEX-UHFFFAOYSA-N",Launched,"BRD-M65097687-001-19-1, BRD-M65097687-001-18-3, BRD-M65097687-001-20-9"
amiodarone,potassium channel blocker,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2",cardiology,ventricular arrhythmias,"MicroSource, Selleck, Selleck",91.22,"BRD-K17561142-003-33-3, BRD-K17561142-003-35-8, BRD-K17561142-003-32-5","CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1, CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1, CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1","IYIKLHRQXLHMJQ-UHFFFAOYSA-N, IYIKLHRQXLHMJQ-UHFFFAOYSA-N, IYIKLHRQXLHMJQ-UHFFFAOYSA-N",Launched,
amisulpride,dopamine receptor antagonist,"DRD2, DRD3, HTR2A, HTR7",neurology/psychiatry,"psychosis, bipolar disorder, schizophrenia","Selleck, Tocris",94.44,"BRD-A60197193-001-13-8, BRD-A60197193-001-14-6","CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC, CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC","NTJOBXMMWNYJFB-UHFFFAOYSA-N, NTJOBXMMWNYJFB-UHFFFAOYSA-N",Launched,
amitraz,adrenergic receptor agonist,"ADRA1A, ADRA2A",infectious disease,generalized demodicosis,MicroSource,0.09,BRD-K33335792-001-04-0,CN(\C=N\c1ccc(C)cc1C)\C=N\c1ccc(C)cc1C,QXAITBQSYVNQDR-ZIOPAAQOSA-N,Launched,
amitriptyline,"norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4",neurology/psychiatry,depression,"MicroSource, Selleck",98.47,"BRD-K53737926-003-27-8, BRD-K53737926-003-25-2","CN(C)CCC=C1c2ccccc2CCc2ccccc12, CN(C)CCC=C1c2ccccc2CCc2ccccc12","KRMDCWKBEZIMAB-UHFFFAOYSA-N, KRMDCWKBEZIMAB-UHFFFAOYSA-N",Launched,
amlexanox,histamine receptor modulator,"FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13","dental, pulmonary, ophthalmology, allergy","aphthous ulcers, asthma, conjunctivitis, allergic rhinitis","MicroSource, Tocris",99.58,"BRD-K29530284-001-06-2, BRD-K29530284-001-07-0","CC(C)c1ccc2oc3nc(N)c(cc3c(=O)c2c1)C(O)=O, CC(C)c1ccc2oc3nc(N)c(cc3c(=O)c2c1)C(O)=O","SGRYPYWGNKJSDL-UHFFFAOYSA-N, SGRYPYWGNKJSDL-UHFFFAOYSA-N",Launched,
amlodipine,calcium channel blocker,"CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1",cardiology,"hypertension, chronic stable angina, vasospastic angina, coronary artery disease (CAD)","MicroSource, Tocris, Selleck, Tocris, Selleck, Selleck",92.46,"BRD-A22032524-074-09-9, BRD-A22032524-074-07-3, BRD-A22032524-001-03-5, BRD-A22032524-074-10-7, BRD-A22032524-074-06-5, BRD-A22032524-001-05-0","CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC, CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC","HTIQEAQVCYTUBX-UHFFFAOYSA-N, HTIQEAQVCYTUBX-UHFFFAOYSA-N, HTIQEAQVCYTUBX-UHFFFAOYSA-N, HTIQEAQVCYTUBX-UHFFFAOYSA-N, HTIQEAQVCYTUBX-UHFFFAOYSA-N, HTIQEAQVCYTUBX-UHFFFAOYSA-N",Launched,
ammonium-glycyrrhizinate,thrombin inhibitor,"HSD11B1, HSD11B2, SLCO1B1, SLCO1B3",dermatology,cosmetic,"Selleck, Selleck",97.01,"BRD-K15318383-201-01-5, BRD-K15318383-001-01-9","C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O, C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@]4(C)CC[C@H](O[C@H]5O[C@@H]([C@@H](O)[C@H](O)[C@@H]5O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C(O)=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O","LPLVUJXQOOQHMX-FKSWRZCVSA-N, LPLVUJXQOOQHMX-FKSWRZCVSA-N",Launched,BRD-K70038931-001-01-2
ammonium-lactate,,HCAR1,dermatology,"xerosis cutis, ichthyosis vulgaris",MicroSource,0,BRD-M29182745-001-01-4,N.CC(O)C(O)=O,RZOBLYBZQXQGFY-UHFFFAOYSA-N,Launched,
amodiaquine,histamine receptor agonist,HNMT,infectious disease,malaria,"Prestwick, MicroSource",98.24,"BRD-K91290917-336-05-3, BRD-K91290917-300-01-8","CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O, CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O","OVCDSSHSILBFBN-UHFFFAOYSA-N, OVCDSSHSILBFBN-UHFFFAOYSA-N",Launched,BRD-K73443792-300-04-9
amorolfine,membrane integrity inhibitor,,infectious disease,onychomycosis,"Selleck, MicroSource",96.04,"BRD-A37390343-003-02-7, BRD-A37390343-003-03-5","CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1, CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1","MQHLMHIZUIDKOO-AYHJJNSGSA-N, MQHLMHIZUIDKOO-AYHJJNSGSA-N",Launched,
amoxapine,norepinephrine reputake inhibitor,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,depression,"MicroSource, Selleck, Selleck",96.84,"BRD-K02265150-001-26-5, BRD-K02265150-001-25-7, BRD-K02265150-001-27-3","Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1, Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1, Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1","QWGDMFLQWFTERH-UHFFFAOYSA-N, QWGDMFLQWFTERH-UHFFFAOYSA-N, QWGDMFLQWFTERH-UHFFFAOYSA-N",Launched,
amoxicillin,penicillin binding protein inhibitor,"CYP2C19, SLC15A1, SLC15A2, SLC22A6","infectious disease, gastroenterology","skin infections, duodenal ulcer disease, gonorrhea, ear infections, throat infections, genitourinary tract infections, respiratory tract infections","MedChemEx, MicroSource, Selleck, Selleck, Selleck, Selleck",96.19,"BRD-K55044200-236-03-1, BRD-K55044200-001-16-1, BRD-K55044200-236-02-3, BRD-K55044200-236-04-9, BRD-K55044200-001-15-3, BRD-K55044200-001-14-6","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O","LSQZJLSUYDQPKJ-NJBDSQKTSA-N, LSQZJLSUYDQPKJ-NJBDSQKTSA-N, LSQZJLSUYDQPKJ-NJBDSQKTSA-N, LSQZJLSUYDQPKJ-NJBDSQKTSA-N, LSQZJLSUYDQPKJ-NJBDSQKTSA-N, LSQZJLSUYDQPKJ-NJBDSQKTSA-N",Launched,"BRD-K08635111-001-04-8, BRD-K39234907-236-01-9, BRD-K58632460-001-01-7"
amperozide,dopamine receptor antagonist,"FAAH, HTR2A",neurology/psychiatry,psychosis,Enzo,98.96,BRD-K52397688-003-06-4,CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Launched,
amphotericin-b,membrane permeability enhancer,,infectious disease,fungal infection,"Selleck, MicroSource, MedChemEx, Selleck",74.84,"BRD-K27352494-001-03-6, BRD-K27352494-001-04-4, BRD-K27352494-001-05-1, BRD-K27352494-001-06-9","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O","APKFDSVGJQXUKY-INPOYWNPSA-N, APKFDSVGJQXUKY-INPOYWNPSA-N, APKFDSVGJQXUKY-INPOYWNPSA-N, APKFDSVGJQXUKY-INPOYWNPSA-N",Launched,"BRD-A75647097-001-03-3, BRD-K94561406-001-01-1, BRD-K82702594-001-02-5,BRD-K69849489-001-01-1"
ampicillin,bacterial cell wall synthesis inhibitor,,infectious disease,"respiratory tract infections, meningitis, bacterial septicemia, endocarditis, urinary tract infections, gastrointestinal infections","MedChemEx, Selleck, MicroSource, Selleck, MedChemEx, Sigma, Selleck, Selleck",84.41,"BRD-K68432770-236-24-9, BRD-K68432770-236-21-5, BRD-K68432770-236-20-7, BRD-K68432770-236-19-9, BRD-K68432770-236-23-1, BRD-K68432770-236-22-3, BRD-K68432770-341-07-2, BRD-K68432770-341-05-6","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(O)=O","AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N, AVKUERGKIZMTKX-NJBDSQKTSA-N",Launched,BRD-K94927753-341-01-3
ampiroxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2",neurology/psychiatry,pain relief,"MedChemEx, MedChemEx, MicroSource, Selleck, Selleck",78.57,"BRD-A39172021-001-14-5, BRD-A39172021-001-13-7, BRD-A39172021-001-10-3, BRD-A39172021-001-09-5, BRD-A39172021-001-11-1","CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1, CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1, CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1, CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1, CCOC(=O)OC(C)OC1=C(N(C)S(=O)(=O)c2ccccc12)C(=O)Nc1ccccn1","LSNWBKACGXCGAJ-UHFFFAOYSA-N, LSNWBKACGXCGAJ-UHFFFAOYSA-N, LSNWBKACGXCGAJ-UHFFFAOYSA-N, LSNWBKACGXCGAJ-UHFFFAOYSA-N, LSNWBKACGXCGAJ-UHFFFAOYSA-N",Launched,
amprenavir,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),Selleck,95.63,BRD-K47827687-001-02-2,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,YMARZQAQMVYCKC-OEMFJLHTSA-N,Launched,
amprolium,thiamine uptake blocker,,infectious disease,coccidiosis,"Selleck, MicroSource",95.82,"BRD-K90027121-300-13-2, BRD-K90027121-003-01-7","CCCc1ncc(C[n+]2ccccc2C)c(N)n1, CCCc1ncc(C[n+]2ccccc2C)c(N)n1","IPZFPROOBOUEIG-UHFFFAOYSA-N, IPZFPROOBOUEIG-UHFFFAOYSA-N",Launched,
amrinone,phosphodiesterase inhibitor,"PDE3A, PDE3B, PDE4B, TNF",cardiology,congestive heart failure,MicroSource,92.25,BRD-K45924332-001-16-8,Nc1cc(c[nH]c1=O)-c1ccncc1,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,Launched,
amrubicin,topoisomerase inhibitor,"TOP2A, TOP2B",oncology,"small cell lung cancer, small cell lung cancer","MedChemEx, MedChemEx",74.78,"BRD-K13843533-001-02-5, BRD-K13843533-001-01-7","CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)c2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c2C1, CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)c2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c2C1","VJZITPJGSQKZMX-XDPRQOKASA-N, VJZITPJGSQKZMX-XDPRQOKASA-N",Launched,
amsacrine,topoisomerase inhibitor,"KCNH2, TOP2A",hematologic malignancy,"acute lymphoblastic leukemia (ALL), acute lymphoblastic leukemia (ALL)","MicroSource, Enzo",95.69,"BRD-K68346641-001-02-2, BRD-K68346641-001-01-4","COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12, COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12","XCPGHVQEEXUHNC-UHFFFAOYSA-N, XCPGHVQEEXUHNC-UHFFFAOYSA-N",Launched,BRD-K98490050-001-02-6
amtolmetin-guacil,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"rheumatoid arthritis, osteoarthritis",OxChem,94.69,BRD-K70924353-001-01-2,COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C,CWJNMKKMGIAGDK-UHFFFAOYSA-N,Launched,
anagliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,"MedChemEx, MedChemEx",82.68,"BRD-K05355328-001-02-9, BRD-K05355328-001-01-1","Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N, Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N","LDXYBEHACFJIEL-HNNXBMFYSA-N, LDXYBEHACFJIEL-HNNXBMFYSA-N",Launched,
anagrelide,phosphodiesterase inhibitor,PDE3A,"hematology, hematologic malignancy","thrombocythemia, myeloproliferative neoplasms","MicroSource, Selleck, Selleck",98.12,"BRD-K62200014-003-11-3, BRD-K62200014-001-02-6, BRD-K62200014-003-10-5","Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl, Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl, Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl","OTBXOEAOVRKTNQ-UHFFFAOYSA-N, OTBXOEAOVRKTNQ-UHFFFAOYSA-N, OTBXOEAOVRKTNQ-UHFFFAOYSA-N",Launched,
anastrozole,aromatase inhibitor,CYP19A1,oncology,breast cancer,"Tocris, MicroSource, Selleck",99.51,"BRD-K52172416-001-14-8, BRD-K52172416-001-11-4, BRD-K52172416-001-10-6","CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N, CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N, CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N","YBBLVLTVTVSKRW-UHFFFAOYSA-N, YBBLVLTVTVSKRW-UHFFFAOYSA-N, YBBLVLTVTVSKRW-UHFFFAOYSA-N",Launched,
anecortave-acetate,angiogenesis inhibitor,,ophthalmology,macular degeneration,InterBioScreen,96.76,BRD-A53566267-001-01-9,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@]12C,YUWPMEXLKGOSBF-SQIVGGFUSA-N,Launched,
anethole,glutathione transferase stimulant,,,,"MedChemEx, MicroSource, MedChemEx",0,"BRD-K49060658-001-08-0, BRD-K49060658-001-05-6, BRD-K49060658-001-07-2","COc1ccc(cc1)\C=C\C, COc1ccc(cc1)\C=C\C, COc1ccc(cc1)\C=C\C","RUVINXPYWBROJD-ONEGZZNKSA-N, RUVINXPYWBROJD-ONEGZZNKSA-N, RUVINXPYWBROJD-ONEGZZNKSA-N",Launched,
anethole-trithione,glutathione transferase stimulant,,,,"MedChemEx, Enzo",97.57,"BRD-K92490248-001-06-6, BRD-K92490248-001-04-1","COc1ccc(cc1)-c1cc(=S)ss1, COc1ccc(cc1)-c1cc(=S)ss1","KYLIZBIRMBGUOP-UHFFFAOYSA-N, KYLIZBIRMBGUOP-UHFFFAOYSA-N",Launched,
anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,infectious disease,"candidemia, fungal infection, esophageal candidiasis",MedChemEx,98.03,BRD-A75305484-001-01-3,CCCCCOc1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(C)CN2C(=O)C(NC(=O)C(NC(=O)C2CC(O)CN2C(=O)C(NC1=O)C(C)O)C(O)C(O)c1ccc(O)cc1)C(C)O,JHVAMHSQVVQIOT-UHFFFAOYSA-N,Launched,
aniracetam,glutamate receptor agonist,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A",,,"Tocris, Tocris, Selleck",97.89,"BRD-K88611939-001-25-7, BRD-K88611939-001-23-2, BRD-K88611939-001-22-4","COc1ccc(cc1)C(=O)N1CCCC1=O, COc1ccc(cc1)C(=O)N1CCCC1=O, COc1ccc(cc1)C(=O)N1CCCC1=O","ZXNRTKGTQJPIJK-UHFFFAOYSA-N, ZXNRTKGTQJPIJK-UHFFFAOYSA-N, ZXNRTKGTQJPIJK-UHFFFAOYSA-N",Launched,
anisindione,vitamin K antagonist,GGCX,hematology,deep vein thrombosis (DVT),"MedChemEx, Selleck, Vitas-M, MedChemEx, MicroSource, Selleck",89.62,"BRD-K47458712-001-22-3, BRD-K47458712-001-17-3, BRD-K47458712-001-20-7, BRD-K47458712-001-21-5, BRD-K47458712-001-18-1, BRD-K47458712-001-19-9","COc1ccc(cc1)C1C(=O)c2ccccc2C1=O, COc1ccc(cc1)C1C(=O)c2ccccc2C1=O, COc1ccc(cc1)C1C(=O)c2ccccc2C1=O, COc1ccc(cc1)C1C(=O)c2ccccc2C1=O, COc1ccc(cc1)C1C(=O)c2ccccc2C1=O, COc1ccc(cc1)C1C(=O)c2ccccc2C1=O","XRCFXMGQEVUZFC-UHFFFAOYSA-N, XRCFXMGQEVUZFC-UHFFFAOYSA-N, XRCFXMGQEVUZFC-UHFFFAOYSA-N, XRCFXMGQEVUZFC-UHFFFAOYSA-N, XRCFXMGQEVUZFC-UHFFFAOYSA-N, XRCFXMGQEVUZFC-UHFFFAOYSA-N",Launched,
anisotropine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3",gastroenterology,peptic ulcer disease (PUD),Selleck,96.04,BRD-A06771424-004-01-7,CCCC(CCC)C(=O)OC1C[C@@H]2CC[C@H](C1)[N+]2(C)C,XGGHHHBGPSNXFE-XYPWUTKMSA-N,Launched,
antazoline,antihistamine,HRH1,"ophthalmology, otolaryngology","conjunctivitis, nasal congestion","MicroSource, Tocris, Selleck",92.85,"BRD-K99300445-001-01-2, BRD-K99300445-003-21-6, BRD-K99300445-003-20-8","C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1, C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1, C(N(Cc1ccccc1)c1ccccc1)C1=NCCN1","REYFJDPCWQRWAA-UHFFFAOYSA-N, REYFJDPCWQRWAA-UHFFFAOYSA-N, REYFJDPCWQRWAA-UHFFFAOYSA-N",Launched,
anthralin,DNA synthesis inhibitor,,dermatology,psoriasis,"MedChemEx, MicroSource, MedChemEx",0,"BRD-K04725460-001-12-1, BRD-K04725460-001-10-5, BRD-K04725460-001-11-3","Oc1cccc2Cc3cccc(O)c3C(=O)c12, Oc1cccc2Cc3cccc(O)c3C(=O)c12, Oc1cccc2Cc3cccc(O)c3C(=O)c12","NUZWLKWWNNJHPT-UHFFFAOYSA-N, NUZWLKWWNNJHPT-UHFFFAOYSA-N, NUZWLKWWNNJHPT-UHFFFAOYSA-N",Launched,
antioxine,,,,,"Enamine, Sigma",0,"BRD-K15541734-001-01-2, BRD-K15541734-001-02-0","CC(C)c1ccc(C)c(O)c1, CC(C)c1ccc(C)c(O)c1","RECUKUPTGUEGMW-UHFFFAOYSA-N, RECUKUPTGUEGMW-UHFFFAOYSA-N",Launched,
apalutamide,androgen receptor antagonist,,oncology,prostate cancer,Selleck,97.61,BRD-K91308639-001-02-7,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C11CCC1)c1cnc(C#N)c(c1)C(F)(F)F,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Launched,
apixaban,coagulation factor inhibitor,F10,"neurology/psychiatry, hematology, cardiology","stroke, systemic embolism, pulmonary embolism (PE), atrial fibrillation (AF), deep vein thrombosis (DVT)","Selleck, MicroSource",99.06,"BRD-K67121414-001-02-5, BRD-K67121414-001-03-3","COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O, COc1ccc(cc1)-n1nc(C(N)=O)c2CCN(C(=O)c12)c1ccc(cc1)N1CCCCC1=O","QNZCBYKSOIHPEH-UHFFFAOYSA-N, QNZCBYKSOIHPEH-UHFFFAOYSA-N",Launched,
apraclonidine,adrenergic receptor agonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C",ophthalmology,"glaucoma, intraocular pressure",Ark,85.91,BRD-K38911213-003-01-6,Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1,IEJXVRYNEISIKR-UHFFFAOYSA-N,Launched,
apramycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,0,BRD-K36062294-001-04-0,CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O,XZNUGFQTQHRASN-XYPKRARZSA-N,Launched,
apremilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D","dermatology, rheumatology","psoriasis, psoriatic arthritis",Selleck,93.31,BRD-K93208532-001-02-5,CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Launched,
aprepitant,tachykinin antagonist,TACR1,gastroenterology,"nausea, vomiting",Selleck,96.84,BRD-K65170927-001-01-6,C[C@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,ATALOFNDEOCMKK-OCCQLPPTSA-N,Launched,
aprindine,voltage-gated sodium channel blocker,"CALM1, SCN5A",cardiology,cardiac arrythmia,Sigma,82.34,BRD-K53236343-003-03-7,CCN(CC)CCCN(C1Cc2ccccc2C1)c1ccccc1,NZLBHDRPUJLHCE-UHFFFAOYSA-N,Launched,
arbidol,cytochrome P450 inhibitor,CYP3A4,infectious disease,influenza A virus infection,"MedChemEx, Selleck, MedChemEx, Selleck",80.95,"BRD-K73881242-003-06-1, BRD-K73881242-003-02-0, BRD-K73881242-003-04-6, BRD-K73881242-003-03-8","CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12, CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12, CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12, CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12","KCFYEAOKVJSACF-UHFFFAOYSA-N, KCFYEAOKVJSACF-UHFFFAOYSA-N, KCFYEAOKVJSACF-UHFFFAOYSA-N, KCFYEAOKVJSACF-UHFFFAOYSA-N",Launched,
argatroban,thrombin inhibitor,F2,hematology,heparin-induced thrombocytopenia (HIT),"Tocris, Selleck",97.13,"BRD-A48261811-001-07-3, BRD-A48261811-001-08-1","C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)c1cccc2CC(C)CNc12, C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)c1cccc2CC(C)CNc12","KXNPVXPOPUZYGB-IOVMHBDKSA-N, KXNPVXPOPUZYGB-IOVMHBDKSA-N",Launched,BRD-A10012892-001-01-9
arglabin,farnesyltransferase inhibitor,"FNTA, NFKB1",,,MedChemEx,97.88,BRD-K62734952-001-01-0,CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13,UVJYAKBJSGRTHA-CUZKYEQNSA-N,Launched,
aripiprazole,"serotonin receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7",neurology/psychiatry,"depression, schizophrenia, bipolar disorder","Tocris, MicroSource, Selleck",98.35,"BRD-K70358946-001-17-3, BRD-K70358946-001-15-7, BRD-K70358946-001-14-0","Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl, Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl, Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl","CEUORZQYGODEFX-UHFFFAOYSA-N, CEUORZQYGODEFX-UHFFFAOYSA-N, CEUORZQYGODEFX-UHFFFAOYSA-N",Launched,
armodafinil,adrenergic receptor agonist,SLC6A3,"pulmonary, neurology/psychiatry","obstructive sleep apnea, narcolepsy, shift work disorder (SWD)",MicroSource,93.1,BRD-K87278688-001-01-0,NC(=O)C[S@@](=O)C(c1ccccc1)c1ccccc1,YFGHCGITMMYXAQ-LJQANCHMSA-N,Launched,
arotinolol,adrenergic receptor antagonist,ADRB3,"cardiology, neurology/psychiatry","hypertension, tremors",AKSci,96.65,BRD-A28044053-001-01-7,CC(C)(C)NCC(O)CSc1nc(cs1)-c1ccc(s1)C(N)=O,BHIAIPWSVYSKJS-UHFFFAOYSA-N,Launched,
arsenic-trioxide,apoptosis stimulant,"AKT1, CCND1, IKBKB, JUN, MAPK1, MAPK3, TXNRD1",gastroenterology,diarrhea,MicroSource,0,BRD-K47190141-396-01-1,O[AsH]O[AsH]O,NWBBZCLIZUATJF-UHFFFAOYSA-N,Launched,
artemether,antimalarial agent,ATP1A1,infectious disease,malaria,"MicroSource, Selleck, MedChemEx, MedChemEx, Selleck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aunched,"BRD-A45966947-001-02-8, BRD-K17916327-001-02-5, BRD-K12393844-001-01-8"
artemisinin,DNA synthesis inhibitor,CYP2B6,infectious disease,malaria,"Tocris, MicroSource, Tocris, Selleck",100,"BRD-K13112821-001-14-1, BRD-K13112821-001-18-2, BRD-K13112821-001-16-6, BRD-K13112821-001-17-4","C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","BLUAFEHZUWYNDE-NNWCWBAJSA-N, BLUAFEHZUWYNDE-NNWCWBAJSA-N, BLUAFEHZUWYNDE-NNWCWBAJSA-N, BLUAFEHZUWYNDE-NNWCWBAJSA-N",Launched,"BRD-K27678847-001-06-1, BRD-K01715490-001-01-2"
artemotil,,,infectious disease,malaria,"MedChemEx, AKSci, MedChemEx",0,"BRD-K96006160-001-03-7, BRD-K96006160-001-01-1, BRD-K96006160-001-02-9","CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3, CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3, CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3","NLYNIRQVMRLPIQ-XQLAAWPRSA-N, NLYNIRQVMRLPIQ-XQLAAWPRSA-N, NLYNIRQVMRLPIQ-XQLAAWPRSA-N",Launched,
artesunate,DNA synthesis inhibitor,,infectious disease,malaria,"MicroSource, Selleck",100,"BRD-K54634444-001-05-9, BRD-K54634444-001-04-2","C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","FIHJKUPKCHIPAT-AHIGJZGOSA-N, FIHJKUPKCHIPAT-AHIGJZGOSA-N",Launched,"BRD-K17944737-001-02-1, BRD-K65768634-001-01-1"
articaine,local anesthetic,,neurology/psychiatry,local anesthetic,Selleck,90.48,BRD-A70514680-003-11-2,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,QTGIAADRBBLJGA-UHFFFAOYSA-N,Launched,
ascorbic-acid,antioxidant,"ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE",endocrinology,scurvy,"MedChemEx, MedChemEx, Selleck, Sigma, Selleck, MicroSource",100,"BRD-A85242401-001-11-5, BRD-A85242401-001-10-7, BRD-A85242401-001-05-7, BRD-A85242401-001-09-9, BRD-A85242401-001-07-3, BRD-A85242401-001-12-3","OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O, OC[C@H](O)[C@H]1OC(=O)C(=O)C1O","KRGQEOSDQHTZMX-IGCYCDGOSA-N, KRGQEOSDQHTZMX-IGCYCDGOSA-N, KRGQEOSDQHTZMX-IGCYCDGOSA-N, KRGQEOSDQHTZMX-IGCYCDGOSA-N, KRGQEOSDQHTZMX-IGCYCDGOSA-N, KRGQEOSDQHTZMX-IGCYCDGOSA-N",Launched,BRD-A08112603-001-04-5
asenapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",neurology/psychiatry,"schizophrenia, bipolar disorder","Tocris, Tocris, Selleck",95.05,"BRD-K95260951-050-03-1, BRD-M82363962-001-02-8, BRD-K95260951-050-02-3","CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21, CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21.CN1C[C@@H]2[C@@H](C1)c1cc(Cl)ccc1Oc1ccccc21, CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21","VSWBSWWIRNCQIJ-HUUCEWRRSA-N, QGBIWSABMNWWNB-FGYPTBLJSA-N, VSWBSWWIRNCQIJ-HUUCEWRRSA-N",Launched,BRD-M82363962-001-01-0
aspartame,,"TAS1R2, TRPV1",,,"MicroSource, Selleck, Sigma, Selleck",85.8,"BRD-K78841970-001-12-0, BRD-K78841970-001-13-8, BRD-K78841970-001-14-6, BRD-K78841970-001-11-2","COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O, COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O, COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O, COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O","IAOZJIPTCAWIRG-QWRGUYRKSA-N, IAOZJIPTCAWIRG-QWRGUYRKSA-N, IAOZJIPTCAWIRG-QWRGUYRKSA-N, IAOZJIPTCAWIRG-QWRGUYRKSA-N",Launched,
aspirin,cyclooxygenase inhibitor,"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53","neurology/psychiatry, endocrinology, dental","headache, fever, toothache, muscle pain","Tocris, MicroSource, Selleck, Selleck",99.34,"BRD-K11433652-001-23-8, BRD-K11433652-001-17-0, BRD-K11433652-001-16-2, BRD-K11433652-001-18-8","CC(=O)Oc1ccccc1C(O)=O, CC(=O)Oc1ccccc1C(O)=O, CC(=O)Oc1ccccc1C(O)=O, CC(=O)Oc1ccccc1C(O)=O","BSYNRYMUTXBXSQ-UHFFFAOYSA-N, BSYNRYMUTXBXSQ-UHFFFAOYSA-N, BSYNRYMUTXBXSQ-UHFFFAOYSA-N, BSYNRYMUTXBXSQ-UHFFFAOYSA-N",Launched,
astaxanthin,antioxidant,,,,Cayman,26.68,BRD-K51832961-001-01-4,CC(\C=C\C=C(C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Launched,
ataluren,"CFTR channel agonist, dystrophin stimulant",DMD,"genetics, pulmonary","duchenne muscular dystrophy (DMD), cystic fibrosis",Selleck,97.28,BRD-K94830329-001-03-0,OC(=O)c1cccc(c1)-c1noc(n1)-c1ccccc1F,OOUGLTULBSNHNF-UHFFFAOYSA-N,Launched,
atazanavir,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),Selleck,97.57,BRD-K09757388-065-04-0,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,AXRYRYVKAWYZBR-GASGPIRDSA-N,Launched,
atenolol-(+/-),adrenergic receptor antagonist,"ADRB1, ADRB2",cardiology,"hypertension, angina pectoris","Tocris, MicroSource",85.31,"BRD-A20239487-001-24-9, BRD-A20239487-001-25-6","CC(C)NCC(O)COc1ccc(CC(N)=O)cc1, CC(C)NCC(O)COc1ccc(CC(N)=O)cc1","METKIMKYRPQLGS-UHFFFAOYSA-N, METKIMKYRPQLGS-UHFFFAOYSA-N",Launched,
atipamezole,adrenergic receptor antagonist,,neurology/psychiatry,reverse sedative,"Tocris, MedChemEx",99.36,"BRD-K39252998-003-02-3, BRD-K39252998-003-01-5","CCC1(Cc2ccccc2C1)c1cnc[nH]1, CCC1(Cc2ccccc2C1)c1cnc[nH]1","HSWPZIDYAHLZDD-UHFFFAOYSA-N, HSWPZIDYAHLZDD-UHFFFAOYSA-N",Launched,
atomoxetine,norepinephrine transporter inhibitor,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,attention-deficit/hyperactivity disorder (ADHD),"Selleck, Tocris, MicroSource",97.04,"BRD-K20141153-003-12-9, BRD-K20141153-003-13-7, BRD-K20141153-001-01-6","CNCC[C@@H](Oc1ccccc1C)c1ccccc1, CNCC[C@@H](Oc1ccccc1C)c1ccccc1, CNCC[C@@H](Oc1ccccc1C)c1ccccc1","VHGCDTVCOLNTBX-QGZVFWFLSA-N, VHGCDTVCOLNTBX-QGZVFWFLSA-N, VHGCDTVCOLNTBX-QGZVFWFLSA-N",Launched,
atorvastatin,HMGCR inhibitor,"AHR, DPP4, HMGCR","neurology/psychiatry, cardiology","stroke, heart attack","Tocris, MicroSource, Selleck",97.04,"BRD-K69726342-238-03-2, BRD-K69726342-001-03-4, BRD-K69726342-238-02-4","CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1, CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1, CC(C)c1c(C(=O)Nc2ccccc2)c(c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O)-c1ccccc1","XUKUURHRXDUEBC-KAYWLYCHSA-N, XUKUURHRXDUEBC-KAYWLYCHSA-N, XUKUURHRXDUEBC-KAYWLYCHSA-N",Launched,"BRD-M94983326-238-03-6, BRD-M94983326-238-02-8"
atosiban,oxytocin receptor antagonist,"AVPR1A, AVPR1B, AVPR2, OXTR","neurology/psychiatry, cardiology, endocrinology","stroke, angina pectoris, myocardial infarction, hyperlipidemia","MedChemEx, MedChemEx, MedChemEx",75.28,"BRD-A85261566-001-02-5, BRD-A85261566-001-03-3, BRD-A85261566-001-01-7","CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1, CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1, CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1","VWXRQYYUEIYXCZ-AVTFEHRISA-N, VWXRQYYUEIYXCZ-AVTFEHRISA-N, VWXRQYYUEIYXCZ-AVTFEHRISA-N",Launched,
atovaquone,mitochondrial electron transport inhibitor,DHODH,infectious disease,pneumonia,"MicroSource, Selleck",97.44,"BRD-A19795905-001-08-0, BRD-A19795905-001-07-2","Clc1ccc(cc1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)c2ccccc2C1=O, Clc1ccc(cc1)[C@H]1CC[C@@H](CC1)C1C(=O)C(=O)c2ccccc2C1=O","UYFLKEIEOREOFC-KWRXGGKWSA-N, UYFLKEIEOREOFC-KWRXGGKWSA-N",Launched,
atracurium,acetylcholine receptor antagonist,CHRNA2,"critical care, neurology/psychiatry","endotracheal intubation, muscle relaxant","MicroSource, Selleck, Selleck",87.09,"BRD-A75935363-344-06-6, BRD-A75935363-344-07-4, BRD-A75935363-344-05-8","COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC, COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC, COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC","YXSLJKQTIDHPOT-UHFFFAOYSA-N, YXSLJKQTIDHPOT-UHFFFAOYSA-N, YXSLJKQTIDHPOT-UHFFFAOYSA-N",Launched,
atropine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ophthalmology,"cycloplegia, mydriasis, amblyopia","MicroSource, Selleck",97.48,"BRD-A27290375-330-01-1, BRD-A27290375-330-02-9","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1","RKUNBYITZUJHSG-SPUOUPEWSA-N, RKUNBYITZUJHSG-SPUOUPEWSA-N",Launched,"BRD-A93739713-065-04-3, BRD-A27290375-065-01-3,BRD-M93222215-330-02-1"
auranofin,NFkB pathway inhibitor,"IKBKB, PRDX5, TRPA1",rheumatology,rheumatoid arthritis,"MedChemEx, Selleck, MedChemEx",73.57,"BRD-K73841932-001-01-5, BRD-K45995181-001-04-6, BRD-K45995181-001-05-3","CCP(CC)(CC)[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O, CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O, CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O","IRPYFWIZKIOHQN-XTZHGVARSA-N, AUJRCFUBUPVWSZ-XTZHGVARSA-M, AUJRCFUBUPVWSZ-XTZHGVARSA-M",Launched,"BRD-U68276368-000-01-4, BRD-A28431708-001-01-5, BRD-K63171558-001-01-2"
aurothioglucose,PKC inhibitor,PRKCI,rheumatology,rheumatoid arthritis,MicroSource,0,BRD-A89825407-001-01-8,OC[C@H]1OC(S[Au])[C@H](O)[C@@H](O)[C@@H]1O,XHVAWZZCDCWGBK-BMZZJELJSA-M,Launched,
avanafil,phosphodiesterase inhibitor,PDE5A,urology,erectile dysfunction,"Selleck, MicroSource",92.35,"BRD-K65781196-001-03-0, BRD-K65781196-001-04-8","COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl, COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl","WEAJZXNPAWBCOA-INIZCTEOSA-N, WEAJZXNPAWBCOA-INIZCTEOSA-N",Launched,
avatrombopag,thrombopoietin receptor agonist,MPL,hematology,thrombocytopenia,MedChemEx,95.01,BRD-K68544925-001-01-1,OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1,OFZJKCQENFPZBH-UHFFFAOYSA-N,Launched,
avibactam,beta lactamase inhibitor,,infectious disease,"intra-abdominal infections, urinary tract infections, pyelonephritis, intra-abdominal infections, urinary tract infections, pyelonephritis, intra-abdominal infections, urinary tract infections, pyelonephritis","MedChemEx, MedChemEx, MedChemEx",100,"BRD-K85882401-323-01-5, BRD-K85882401-236-01-9, BRD-K85882401-236-02-7","NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O, NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O, NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(O)(=O)=O","NDCUAPJVLWFHHB-UHNVWZDZSA-N, NDCUAPJVLWFHHB-UHNVWZDZSA-N, NDCUAPJVLWFHHB-UHNVWZDZSA-N",Launched,
avobenzone,UV blocker,TYR,dermatology,"cosmetic, sunscreen lotion","MicroSource, Selleck",90.89,"BRD-K14401183-001-11-5, BRD-K14401183-001-10-7","COc1ccc(cc1)C(=O)CC(=O)c1ccc(cc1)C(C)(C)C, COc1ccc(cc1)C(=O)CC(=O)c1ccc(cc1)C(C)(C)C","XNEFYCZVKIDDMS-UHFFFAOYSA-N, XNEFYCZVKIDDMS-UHFFFAOYSA-N",Launched,
axitinib,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1, FLT1, FLT4, KDR, PLK4",oncology,renal cell carcinoma (RCC),"Selleck, Selleck, Selleck, Adooq, Tocris",96.08,"BRD-K29905972-001-10-5, BRD-K29905972-001-08-9, BRD-K29905972-001-06-3, BRD-K29905972-001-11-3, BRD-K29905972-001-12-1","CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1, CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1, CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1, CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1, CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1","RITAVMQDGBJQJZ-FMIVXFBMSA-N, RITAVMQDGBJQJZ-FMIVXFBMSA-N, RITAVMQDGBJQJZ-FMIVXFBMSA-N, RITAVMQDGBJQJZ-FMIVXFBMSA-N, RITAVMQDGBJQJZ-FMIVXFBMSA-N",Launched,
azacitidine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A","hematologic malignancy, hematology","myelodysplastic diseases (MDS), anemia, chronic myelomonocytic leukemia (CMMoL)","MicroSource, Selleck, Tocris",100,"BRD-K03406345-001-21-1, BRD-K03406345-001-27-8, BRD-K03406345-001-24-5","Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1","NMUSYJAQQFHJEW-KVTDHHQDSA-N, NMUSYJAQQFHJEW-KVTDHHQDSA-N, NMUSYJAQQFHJEW-KVTDHHQDSA-N",Launched,BRD-K55026842-001-01-4
azaperone,dopamine receptor antagonist,"DRD2, DRD3",neurology/psychiatry,sedative,"MicroSource, Selleck, Selleck",98.29,"BRD-K45861246-001-14-2, BRD-K45861246-001-13-4, BRD-K45861246-001-15-9","Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1, Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1, Fc1ccc(cc1)C(=O)CCCN1CCN(CC1)c1ccccn1","XTKDAFGWCDAMPY-UHFFFAOYSA-N, XTKDAFGWCDAMPY-UHFFFAOYSA-N, XTKDAFGWCDAMPY-UHFFFAOYSA-N",Launched,
azasetron,serotonin receptor antagonist,"HTR3A, HTR3B",infectious disease,genitial herpes,Selleck,98.4,BRD-A44133049-003-07-8,CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC1CN2CCC1CC2,WUKZPHOXUVCQOR-UHFFFAOYSA-N,Launched,
azatadine,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,"MicroSource, Selleck",91.41,"BRD-K77821588-050-01-7, BRD-K77821588-364-01-2","CN1CCC(CC1)=C1c2ccccc2CCc2cccnc12, CN1CCC(CC1)=C1c2ccccc2CCc2cccnc12","SEBMTIQKRHYNIT-UHFFFAOYSA-N, SEBMTIQKRHYNIT-UHFFFAOYSA-N",Launched,
azathioprine,dehydrogenase inhibitor,"HPRT1, IMPDH1, PPAT","transplant, rheumatology","renal homotransplantation, rheumatoid arthritis","Tocris, MicroSource, Selleck",98.13,"BRD-K32821942-001-22-1, BRD-K32821942-001-21-3, BRD-K32821942-001-20-5","Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O, Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O, Cn1cnc(c1Sc1[nH]cnc2ncnc12)[N+]([O-])=O","LMEKQMALGUDUQG-UHFFFAOYSA-N, LMEKQMALGUDUQG-UHFFFAOYSA-N, LMEKQMALGUDUQG-UHFFFAOYSA-N",Launched,
azelaic-acid,tyrosinase inhibitor,"AKR1D1, SRD5A2, TYR",dermatology,rosacea,MicroSource,97.8,BRD-K08976401-001-18-5,OC(=O)CCCCCCCC(O)=O,BDJRBEYXGGNYIS-UHFFFAOYSA-N,Launched,
azelastine,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,"MicroSource, Selleck",96.67,"BRD-A68888262-003-16-9, BRD-A68888262-003-15-1","CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O, CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O","MBUVEWMHONZEQD-UHFFFAOYSA-N, MBUVEWMHONZEQD-UHFFFAOYSA-N",Launched,
azelnidipine,calcium channel blocker,CACNA1C,cardiology,hypertension,"MedChemEx, Selleck, Selleck",91.33,"BRD-A01098288-001-06-0, BRD-A01098288-001-04-5, BRD-A01098288-001-02-9","CC(C)OC(=O)C1=C(C)NC(N)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC1CN(C1)C(c1ccccc1)c1ccccc1, CC(C)OC(=O)C1=C(C)NC(N)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC1CN(C1)C(c1ccccc1)c1ccccc1, CC(C)OC(=O)C1=C(C)NC(N)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC1CN(C1)C(c1ccccc1)c1ccccc1","ZKFQEACEUNWPMT-UHFFFAOYSA-N, ZKFQEACEUNWPMT-UHFFFAOYSA-N, ZKFQEACEUNWPMT-UHFFFAOYSA-N",Launched,
azilsartan,angiotensin receptor antagonist,"AGTR1, AGTR2",cardiology,hypertension,"Tocris, Selleck",97.15,"BRD-K81074237-001-03-1, BRD-K81074237-001-02-3","CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1, CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1","KGSXMPPBFPAXLY-UHFFFAOYSA-N, KGSXMPPBFPAXLY-UHFFFAOYSA-N",Launched,
azilsartan-medoxomil,angiotensin receptor antagonist,"AGTR1, AGTR2",cardiology,hypertension,"Selleck, MicroSource, Selleck",92.61,"BRD-K25723200-001-03-5, BRD-K25723200-237-01-9, BRD-K25723200-001-02-7","CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1, CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1, CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1","QJFSABGVXDWMIW-UHFFFAOYSA-N, QJFSABGVXDWMIW-UHFFFAOYSA-N, QJFSABGVXDWMIW-UHFFFAOYSA-N",Launched,
azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR,infectious disease,"pelvic inflammatory disease, pneumonia","Tocris, MicroSource, Selleck, Selleck",100,"BRD-K74501079-001-17-3, BRD-K74501079-001-15-7, BRD-K74501079-335-01-9, BRD-K74501079-001-18-1","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O","MQTOSJVFKKJCRP-BICOPXKESA-N, MQTOSJVFKKJCRP-BICOPXKESA-N, MQTOSJVFKKJCRP-BICOPXKESA-N, MQTOSJVFKKJCRP-BICOPXKESA-N",Launched,"BRD-A37438244-335-01-2, BRD-K73794685-001-01-5"
azlocillin,bacterial cell wall synthesis inhibitor,,infectious disease,"gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Selleck, MicroSource, Selleck",85.42,"BRD-K60663764-236-04-7, BRD-A46717658-236-02-5, BRD-K60663764-236-05-4, BRD-K60663764-236-03-9","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)SC2C(NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2C1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O","JTWOMNBEOCYFNV-NFFDBFGFSA-N, JTWOMNBEOCYFNV-MPXNVAGNSA-N, JTWOMNBEOCYFNV-NFFDBFGFSA-N, JTWOMNBEOCYFNV-NFFDBFGFSA-N",Launched,"BRD-A95218818-236-05-4, BRD-A95218818-001-01-1, BRD-A46717658-236-03-3"
azosemide,electrolyte reabsorption inhibitor,"SLC12A1, SLC12A2",cardiology,edema,AKSci,81.77,BRD-K68770713-001-01-8,NS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2cccs2)cc1Cl,HMEDEBAJARCKCT-UHFFFAOYSA-N,Launched,
aztreonam,bacterial cell wall synthesis inhibitor,,infectious disease,"urinary tract infections, respiratory tract infections, bacterial septicemia, skin infections, intra-abdominal infections, gynecologic infections","MicroSource, Selleck, Selleck",90.6,"BRD-K62607865-236-02-4, BRD-K62607865-001-09-7, BRD-K62607865-236-01-6","C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O, C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O, C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O","WZPBZJONDBGPKJ-VEHQQRBSSA-N, WZPBZJONDBGPKJ-VEHQQRBSSA-N, WZPBZJONDBGPKJ-VEHQQRBSSA-N",Launched,"BRD-K36547807-001-03-2, BRD-K41270709-001-01-7"
bacampicillin,bacterial cell wall synthesis inhibitor,,infectious disease,"gram-positive bacterial infections, gram-negative bacterial infections","MicroSource, Sigma, MedChemEx",81.26,"BRD-A41698174-003-13-8, BRD-A41698174-003-11-2, BRD-A41698174-003-12-0","CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O, CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O, CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O","PFOLLRNADZZWEX-FFGRCDKISA-N, PFOLLRNADZZWEX-FFGRCDKISA-N, PFOLLRNADZZWEX-FFGRCDKISA-N",Launched,BRD-A10481343-003-03-3
bacitracin,bacterial cell wall synthesis inhibitor,"A2M, IDE",infectious disease,first-aid antibiotic,"MicroSource, Selleck, Selleck",13.46,"BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1","CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)NCCCCC1NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(Cc2c[nH]cn2)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C(CCCN)NC1=O)C(C)CC, CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC, CCC(C)[C@H](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)C1CN=C(S1)[C@H](N)C(C)C)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)C(C)CC","VRKHYMXTJQCIND-UHFFFAOYSA-N, CLKOFPXJLQSYAH-RNHDWVCBSA-N, RHKCFWGPEDXSNT-IGRZHKPHSA-N",Launched,BRD-A21002158-001-01-6
bacitracin-zinc,bacterial cell wall synthesis inhibitor,,infectious disease,first-aid antibiotic,"Selleck, MedChemEx, Selleck",37.33,"BRD-A06016120-001-02-8, BRD-M45010341-001-01-5, BRD-A06016120-001-01-0","CC[C@H](C)[C@H](N)C1=NCC(S1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1CCC(=O)O[Zn]OC(=O)C[C@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(N)=O)NC2=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)[C@H](C)CC, [Zn++].CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@@H](CCCN)NC1=O)[C@H](C)CC, CC[C@H](C)[C@H](N)C1=NCC(S1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1CCC(=O)O[Zn]OC(=O)C[C@H]2NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC(N)=O)NC2=O)NC(=O)[C@@H](NC1=O)[C@H](C)CC)[C@H](C)CC","NKULICGUDKGGRL-SVBGOZHZSA-L, UCRLQOPRDMGYOA-BWBYNRQYSA-N, NKULICGUDKGGRL-SVBGOZHZSA-L",Launched,"BRD-M97113494-001-02-7, BRD-M36533492-001-01-4"
baclofen,benzodiazepine receptor agonist,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",neurology/psychiatry,"multiple sclerosis, spasms",MicroSource,0,BRD-A84174873-003-07-4,NCC(CC(O)=O)c1ccc(Cl)cc1,KPYSYYIEGFHWSV-UHFFFAOYSA-N,Launched,
baicalin,beta glucuronidase inhibitor,PREP,,,"Selleck, Selleck",87.7,"BRD-K49962337-001-02-9, BRD-K49962337-001-01-1","O[C@H]1[C@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O, O[C@H]1[C@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O","IKIIZLYTISPENI-ZFORQUDYSA-N, IKIIZLYTISPENI-ZFORQUDYSA-N",Launched,"BRD-K99455969-001-02-8, BRD-K98733875-001-01-4"
balofloxacin,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections,"Selleck, Selleck",97.5,"BRD-A47790386-001-02-8, BRD-A47790386-001-03-6","CNC1CCCN(C1)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1, CNC1CCCN(C1)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1","MGQLHRYJBWGORO-UHFFFAOYSA-N, MGQLHRYJBWGORO-UHFFFAOYSA-N",Launched,
balsalazide,cyclooxygenase inhibitor,"ALOX5, PPARG, PTGS1, PTGS2",gastroenterology,ulcerative colitis,MicroSource,97.52,BRD-K41410256-304-02-2,OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(O)c(c1)C(O)=O,IPOKCKJONYRRHP-UHFFFAOYSA-N,Launched,
bambuterol,adrenergic receptor agonist,"ADRB2, BCHE",pulmonary,asthma,MicroSource,97.14,BRD-A17462676-003-11-6,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C,ANZXOIAKUNOVQU-UHFFFAOYSA-N,Launched,
barbital,sedative,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2",neurology/psychiatry,"sedative, seizures",MicroSource,98.75,BRD-K83359602-001-02-3,CCC1(CC)C(=O)NC(=O)NC1=O,FTOAOBMCPZCFFF-UHFFFAOYSA-N,Launched,
barnidipine,calcium channel blocker,,cardiology,hypertension,AKSci,92.07,BRD-K78781788-003-01-9,COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@H]1CCN(Cc2ccccc2)C1,VXMOONUMYLCFJD-DHLKQENFSA-N,Launched,
bazedoxifene,selective estrogen receptor modulator (SERM),"ESR1, ESR2","orthopedics, endocrinology","osteoporosis, menopause","Selleck, Selleck, Tocris",92.53,"BRD-K90195324-003-02-5, BRD-K90195324-003-03-3, BRD-K90195324-015-01-1","Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12, Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12, Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12","UCJGJABZCDBEDK-UHFFFAOYSA-N, UCJGJABZCDBEDK-UHFFFAOYSA-N, UCJGJABZCDBEDK-UHFFFAOYSA-N",Launched,
beclamide,anticonvulsant,,neurology/psychiatry,"sedative, seizures",MicroSource,96.76,BRD-K44824027-001-02-1,ClCCC(=O)NCc1ccccc1,JPYQFYIEOUVJDU-UHFFFAOYSA-N,Launched,
beclomethasone,glucocorticoid receptor agonist,"NR3C1, SERPINA6",allergy,allergic rhinitis,AvaChem,90.36,BRD-A73385064-001-01-5,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO,NBMKJKDGKREAPL-UHFFFAOYSA-N,Launched,
beclomethasone-dipropionate,glucocorticoid receptor agonist,"GPR97, NR3C1",allergy,allergic rhinitis,"MicroSource, Selleck, Selleck",98.04,"BRD-K97810537-001-13-6, BRD-K97810537-001-12-8, BRD-K97810537-001-14-4","CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C, CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C, CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C","KUVIULQEHSCUHY-XYWKZLDCSA-N, KUVIULQEHSCUHY-XYWKZLDCSA-N, KUVIULQEHSCUHY-XYWKZLDCSA-N",Launched,"BRD-A11319535-001-03-6, BRD-K97429934-001-01-9,BRD-K76747609-001-02-1"
bedaquiline,ATPase inhibitor,,infectious disease,tuberculosis,"MedChemEx, MedChemEx, MedChemEx",92.56,"BRD-K90817094-001-05-9, BRD-K90817094-001-02-6, BRD-K90817094-001-03-4","COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12, COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12, COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12","QUIJNHUBAXPXFS-XLJNKUFUSA-N, QUIJNHUBAXPXFS-XLJNKUFUSA-N, QUIJNHUBAXPXFS-XLJNKUFUSA-N",Launched,
bekanamycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,"Selleck, MicroSource",100,"BRD-K73425385-001-01-9, BRD-K73425385-065-04-8","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","SKKLOUVUUNMCJE-FQSMHNGLSA-N, SKKLOUVUUNMCJE-FQSMHNGLSA-N",Launched,BRD-K47908102-001-01-9
belinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",hematologic malignancy,peripheral T-cell lymphoma (PTCL),Selleck,94.73,BRD-K17743125-001-08-4,ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc1ccccc1,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Launched,
bemegride,chemoreceptor agonist,GABRA1,critical care,poison antidote,Selleck,90.86,BRD-K14993104-001-05-9,CCC1(C)CC(=O)NC(=O)C1,ORRZGUBHBVWWOP-UHFFFAOYSA-N,Launched,
bemotrizinol,,,dermatology,sunscreen lotion,MicroSource,0,BRD-A92974210-396-01-0,CCCCC(CC)COc1ccc(c(O)c1)-c1nc(nc(n1)-c1ccc(OCC(CC)CCCC)cc1O)-c1ccc(OC)cc1,XVAMCHGMPYWHNL-UHFFFAOYSA-N,Launched,
benazepril,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,"MicroSource, Tocris, Tocris, Selleck",98.78,"BRD-K49807096-003-16-3, BRD-K49807096-003-15-5, BRD-K49807096-003-17-1, BRD-K49807096-003-14-8","CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O","XPCFTKFZXHTYIP-PMACEKPBSA-N, XPCFTKFZXHTYIP-PMACEKPBSA-N, XPCFTKFZXHTYIP-PMACEKPBSA-N, XPCFTKFZXHTYIP-PMACEKPBSA-N",Launched,
bendamustine,DNA inhibitor,,hematologic malignancy,"chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL)","Selleck, Selleck",88.19,"BRD-K17068645-003-05-9, BRD-K17068645-003-04-2","Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl, Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl","YTKUWDBFDASYHO-UHFFFAOYSA-N, YTKUWDBFDASYHO-UHFFFAOYSA-N",Launched,
bendazac,cyclooxygenase inhibitor,"PTGS1, PTGS2","neurology/psychiatry, rheumatology","muscle pain, joint pain",Key,97.29,BRD-K19515365-001-02-6,OC(=O)COc1nn(Cc2ccccc2)c2ccccc12,BYFMCKSPFYVMOU-UHFFFAOYSA-N,Launched,
bendroflumethiazide,sodium/potassium/chloride transporter inhibitor,"CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3",cardiology,hypertension,"MicroSource, Selleck",98.28,"BRD-A80017228-001-25-7, BRD-A80017228-001-24-0","NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F, NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F","HDWIHXWEUNVBIY-UHFFFAOYSA-N, HDWIHXWEUNVBIY-UHFFFAOYSA-N",Launched,
benfotiamine,antioxidant,AGER,rheumatology,lumbago,"MicroSource, Selleck, Selleck",93.58,"BRD-K07359318-396-01-7, BRD-K05319475-001-04-2, BRD-K07359318-001-03-9","C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)c1ccccc1, C\C(N(Cc1cnc(C)nc1N)C=O)=C(/CCOP(O)(O)=O)SC(=O)c1ccccc1, C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCOP(O)(O)=O)SC(=O)c1ccccc1","BTNNPSLJPBRMLZ-GHRIWEEISA-N, BTNNPSLJPBRMLZ-LGMDPLHJSA-N, BTNNPSLJPBRMLZ-GHRIWEEISA-N",Launched,
benidipine,calcium channel blocker,"CACNA1C, CACNA1G",cardiology,hypertension,"Selleck, Selleck",97.05,"BRD-K97181463-003-02-9, BRD-K97181463-003-01-1","COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(Cc2ccccc2)C1, COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(Cc2ccccc2)C1","QZVNQOLPLYWLHQ-ZEQKJWHPSA-N, QZVNQOLPLYWLHQ-ZEQKJWHPSA-N",Launched,
benperidol,dopamine receptor antagonist,DRD2,neurology/psychiatry,schizophrenia,Prestwick,88.46,BRD-K79425933-001-09-3,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Launched,
benproperine,antitussive,SCN5A,pulmonary,cough suppressant,AvaChem,97.04,BRD-A42423104-001-01-4,CC(COc1ccccc1Cc1ccccc1)N1CCCCC1,JTUQXGZRVLWBCR-UHFFFAOYSA-N,Launched,
benserazide,DOPA decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease,"MicroSource, Selleck",93.52,"BRD-A61194565-003-28-8, BRD-A61194565-003-27-0","NC(CO)C(=O)NNCc1ccc(O)c(O)c1O, NC(CO)C(=O)NNCc1ccc(O)c(O)c1O","BNQDCRGUHNALGH-UHFFFAOYSA-N, BNQDCRGUHNALGH-UHFFFAOYSA-N",Launched,
bentazepam,benzodiazepine receptor agonist,,neurology/psychiatry,"anxiety, sedative, muscle relaxant",Asinex,98.21,BRD-K89490285-001-08-1,O=C1CN=C(c2c3CCCCc3sc2N1)c1ccccc1,AIZFEOPQVZBNGH-UHFFFAOYSA-N,Launched,
bentiromide,,HPN,gastroenterology,pancreas diagnostic agent,"Selleck, Selleck",93.46,"BRD-K58794715-001-01-8, BRD-K58794715-001-02-6","OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1, OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1","SPPTWHFVYKCNNK-FQEVSTJZSA-N, SPPTWHFVYKCNNK-FQEVSTJZSA-N",Launched,
benzalkonium,Cationic surfactant,,dermatology,"abrasions, superficial cuts",MicroSource,0,BRD-K34234316-003-04-7,CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1,VVZBFOKBSDGVGZ-UHFFFAOYSA-N,Launched,
benzbromarone,chloride channel blocker,ABCC1,rheumatology,gout,"MicroSource, Selleck",96.2,"BRD-K11717138-001-30-3, BRD-K11717138-001-29-5","CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1, CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1","WHQCHUCQKNIQEC-UHFFFAOYSA-N, WHQCHUCQKNIQEC-UHFFFAOYSA-N",Launched,
benzethonium,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic,"MicroSource, Selleck",99.48,"BRD-K72723676-003-17-8, BRD-K72723676-003-16-0","CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1, CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1","SIYLLGKDQZGJHK-UHFFFAOYSA-N, SIYLLGKDQZGJHK-UHFFFAOYSA-N",Launched,
benznidazole,DNA synthesis inhibitor,,infectious disease,Chagas disease,Toronto,86.94,BRD-K56156805-001-09-6,[O-][N+](=O)c1nccn1CC(=O)NCc1ccccc1,CULUWZNBISUWAS-UHFFFAOYSA-N,Launched,
benzocaine,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic,"MicroSource, Selleck",99.51,"BRD-K75466013-001-14-4, BRD-K75466013-001-13-6","CCOC(=O)c1ccc(N)cc1, CCOC(=O)c1ccc(N)cc1","BLFLLBZGZJTVJG-UHFFFAOYSA-N, BLFLLBZGZJTVJG-UHFFFAOYSA-N",Launched,
benzoic-acid,food preservative,"DAO, HRSP12, PRDX5, RAB9A",infectious disease,tinea pedis,"MicroSource, Selleck, Selleck",98.16,"BRD-K53397409-001-12-3, BRD-K53397409-001-11-5, BRD-K53397409-001-13-1","OC(=O)c1ccccc1, OC(=O)c1ccccc1, OC(=O)c1ccccc1","WPYMKLBDIGXBTP-UHFFFAOYSA-N, WPYMKLBDIGXBTP-UHFFFAOYSA-N, WPYMKLBDIGXBTP-UHFFFAOYSA-N",Launched,
benzonatate,local anesthetic,SCN5A,pulmonary,cough suppressant,MicroSource,99.74,BRD-K91699951-001-10-2,CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,MAFMQEKGGFWBAB-UHFFFAOYSA-N,Launched,
benzoyl-peroxide,oxidizing agent,,dermatology,acne vulgaris (AV),"MicroSource, Sigma",0,"BRD-K59986511-001-04-9, BRD-K59986511-001-06-4","O=C(OOC(=O)c1ccccc1)c1ccccc1, O=C(OOC(=O)c1ccccc1)c1ccccc1","OMPJBNCRMGITSC-UHFFFAOYSA-N, OMPJBNCRMGITSC-UHFFFAOYSA-N",Launched,
benzthiazide,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA4, CA9, SLC12A3",cardiology,"hypertension, edema","MicroSource, Selleck",99.29,"BRD-K21450440-001-14-6, BRD-K21450440-001-13-8","NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O, NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O","NDTSRXAMMQDVSW-UHFFFAOYSA-N, NDTSRXAMMQDVSW-UHFFFAOYSA-N",Launched,
benztropine-mesylate,acetylcholine receptor antagonist,"CHRM1, HRH1, SLC6A3",neurology/psychiatry,"extrapyramidal symptoms (EPS), Parkinson's Disease",Selleck,97.24,BRD-K48061146-066-01-7,CN1[C@@H]2CC[C@@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1,GIJXKZJWITVLHI-RTBURBONSA-N,Launched,
benzydamine,prostanoid receptor antagonist,,"dental, otolaryngology","mouth inflammation, throat inflammation","MicroSource, Selleck",98.35,"BRD-K28542495-003-13-5, BRD-K28542495-003-12-7","CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12, CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12","CNBGNNVCVSKAQZ-UHFFFAOYSA-N, CNBGNNVCVSKAQZ-UHFFFAOYSA-N",Launched,
benzyl-alcohol,local anesthetic,,infectious disease,virus herpes simplex (HSV),"MicroSource, Sigma",0,"BRD-K98494274-001-03-6, BRD-K98494274-001-05-1","OCc1ccccc1, OCc1ccccc1","WVDDGKGOMKODPV-UHFFFAOYSA-N, WVDDGKGOMKODPV-UHFFFAOYSA-N",Launched,
benzyl-benzoate,lipase inhibitor,LIPE,allergy,sweet itch,"MicroSource, MedChemEx, Sigma",0,"BRD-K52072429-001-10-3, BRD-K52072429-001-12-9, BRD-K52072429-001-11-1","O=C(OCc1ccccc1)c1ccccc1, O=C(OCc1ccccc1)c1ccccc1, O=C(OCc1ccccc1)c1ccccc1","SESFRYSPDFLNCH-UHFFFAOYSA-N, SESFRYSPDFLNCH-UHFFFAOYSA-N, SESFRYSPDFLNCH-UHFFFAOYSA-N",Launched,
benzylpenicillin,penicillin binding protein inhibitor,,infectious disease,"celluitis, meningitis, endocarditis, syphilis, pneumonia, bacterial septicemia","Selleck, MicroSource, Selleck",97.54,"BRD-K55191674-236-06-0, BRD-K55191674-237-18-3, BRD-K55191674-236-07-8","CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O","JGSARLDLIJGVTE-MBNYWOFBSA-N, JGSARLDLIJGVTE-MBNYWOFBSA-N, JGSARLDLIJGVTE-MBNYWOFBSA-N",Launched,
bephenium-hydroxynaphthoate,anthelmintic agent,,infectious disease,ascariasis,"MicroSource, Selleck, Selleck",97.09,"BRD-K47878171-086-06-0, BRD-K47878171-086-05-2, BRD-K47878171-086-07-8","C[N+](C)(CCOc1ccccc1)Cc1ccccc1, C[N+](C)(CCOc1ccccc1)Cc1ccccc1, C[N+](C)(CCOc1ccccc1)Cc1ccccc1","AVWWVJUMXRXPNF-UHFFFAOYSA-N, AVWWVJUMXRXPNF-UHFFFAOYSA-N, AVWWVJUMXRXPNF-UHFFFAOYSA-N",Launched,
bepotastine,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,Selleck,90.86,BRD-K98624455-074-02-8,OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1,YWGDOWXRIALTES-NRFANRHFSA-N,Launched,
bepridil,calcium channel blocker,"ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1",cardiology,angina pectoris,"MicroSource, Tocris, Sigma",96.17,"BRD-A91008255-003-24-8, BRD-A91008255-003-26-3, BRD-A91008255-003-25-5","CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1, CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1, CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1","UIEATEWHFDRYRU-UHFFFAOYSA-N, UIEATEWHFDRYRU-UHFFFAOYSA-N, UIEATEWHFDRYRU-UHFFFAOYSA-N",Launched,
besifloxacin,bacterial DNA gyrase inhibitor,,ophthalmology,conjunctivitis,Selleck,93.81,BRD-K10196357-003-02-0,N[C@@H]1CCCCN(C1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)C1CC1,QFFGVLORLPOAEC-SNVBAGLBSA-N,Launched,
beta-carotene,,,,,"Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K74225533-001-10-4, BRD-K74225533-001-08-8, BRD-K74225533-001-12-0, BRD-K74225533-001-09-6","CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C, CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C, CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C, CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C","OENHQHLEOONYIE-JLTXGRSLSA-N, OENHQHLEOONYIE-JLTXGRSLSA-N, OENHQHLEOONYIE-JLTXGRSLSA-N, OENHQHLEOONYIE-JLTXGRSLSA-N",Launched,BRD-K34538779-001-01-1
beta-CCB,benzodiazepine receptor ligand,"GABRA1, GABRG2",,,Tocris,98.04,BRD-K87349602-001-03-8,CCCCOC(=O)c1cc2c(cn1)[nH]c1ccccc21,WGNGIELOOKACSB-UHFFFAOYSA-N,Launched,
beta-elemene,apoptosis stimulant,"MMP2, MMP9",,,Sigma,0,BRD-K21045639-001-01-2,CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C,OPFTUNCRGUEPRZ-QLFBSQMISA-N,Launched,
betahistine,"histamine receptor agonist, histamine receptor antagonist","HRH1, HRH3",neurology/psychiatry,Meniere's disease,"MicroSource, Selleck",100,"BRD-K91315211-300-06-5, BRD-K91315211-300-05-7","CNCCc1ccccn1, CNCCc1ccccn1","UUQMNUMQCIQDMZ-UHFFFAOYSA-N, UUQMNUMQCIQDMZ-UHFFFAOYSA-N",Launched,
betaine,nitric oxide donor,,metabolism,homocystinuria,MicroSource,0,BRD-K12014493-001-02-2,C[N+](C)(C)CC(O)=O,KWIUHFFTVRNATP-UHFFFAOYSA-O,Launched,BRD-M80997309-001-09-2
betamethasone,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,"MicroSource, Selleck",97.06,"BRD-A02180903-001-04-5, BRD-K12955147-001-01-8","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]2(C)[C@]1(O)C(=O)CO","UREBDLICKHMUKA-REKGUKDCSA-N, UREBDLICKHMUKA-AMDXKQBSSA-N",Launched,
betamethasone-acetate,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,MicroSource,93.5,BRD-A92177080-001-02-1,C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,AKUJBENLRBOFTD-DKNQJTFPSA-N,Launched,
betamethasone-dipropionate,anti-inflammatory agent,,dermatology,corticosteroid-responsive dermatoses,"MicroSource, Selleck",96.86,"BRD-K58148589-001-03-6, BRD-K58148589-001-02-8","CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C, CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C","CIWBQSYVNNPZIQ-XYWKZLDCSA-N, CIWBQSYVNNPZIQ-XYWKZLDCSA-N",Launched,"BRD-A66861218-001-04-3, BRD-K95691366-001-01-3"
betamethasone-valerate,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,"Selleck, MicroSource, Selleck",86.11,"BRD-K34032314-001-02-5, BRD-K34032314-001-04-1, BRD-K34032314-001-03-3","CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO, CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO, CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO","SNHRLVCMMWUAJD-SUYDQAKGSA-N, SNHRLVCMMWUAJD-SUYDQAKGSA-N, SNHRLVCMMWUAJD-SUYDQAKGSA-N",Launched,"BRD-A80594172-001-04-6, BRD-K57769959-001-01-6"
betamipron,panipenem uptake inhibitor,,nephrology,renal toxicity,"MicroSource, Selleck",96.24,"BRD-K82142815-001-19-1, BRD-K82142815-001-18-3","OC(=O)CCNC(=O)c1ccccc1, OC(=O)CCNC(=O)c1ccccc1","CWXYHOHYCJXYFQ-UHFFFAOYSA-N, CWXYHOHYCJXYFQ-UHFFFAOYSA-N",Launched,
betaxolol,adrenergic receptor antagonist,"ADRB1, ADRB2",ophthalmology,"intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Tocris, Selleck, Selleck, Selleck",96.12,"BRD-A02759312-003-25-2, BRD-A02759312-001-02-5, BRD-A02759312-003-24-5, BRD-A02759312-001-03-3, BRD-A02759312-003-23-7, BRD-K17498618-344-02-6","CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1, CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1, CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1, CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1, CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1, COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC","NWIUTZDMDHAVTP-UHFFFAOYSA-N, NWIUTZDMDHAVTP-UHFFFAOYSA-N, NWIUTZDMDHAVTP-UHFFFAOYSA-N, NWIUTZDMDHAVTP-UHFFFAOYSA-N, NWIUTZDMDHAVTP-UHFFFAOYSA-N, YXSLJKQTIDHPOT-LJCJQEJUSA-N",Launched,
betazole,histamine receptor agonist,HRH2,gastroenterology,gastric hypersecretion diagnostic,Prestwick,97.19,BRD-K20075662-300-04-0,NCCc1cc[nH]n1,JXDFEQONERDKSS-UHFFFAOYSA-N,Launched,
bethanechol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4",urology,urinary retention,"MicroSource, Selleck, Selleck",100,"BRD-A99833829-003-26-3, BRD-A99833829-003-27-1, BRD-A99833829-003-25-5","CC(C[N+](C)(C)C)OC(N)=O, CC(C[N+](C)(C)C)OC(N)=O, CC(C[N+](C)(C)C)OC(N)=O","NZUPCNDJBJXXRF-UHFFFAOYSA-O, NZUPCNDJBJXXRF-UHFFFAOYSA-O, NZUPCNDJBJXXRF-UHFFFAOYSA-O",Launched,
betrixaban,coagulation factor inhibitor,KCNH2,hematology,deep vein thrombosis (DVT),MedChemEx,85.59,BRD-K45275534-001-01-3,COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc1ccc(Cl)cn1,XHOLNRLADUSQLD-UHFFFAOYSA-N,Launched,
bevantolol,adrenergic receptor antagonist,"ADRA1A, ADRB1, ADRB2",cardiology,"angina pectoris, hypertension",AKSci,94.05,BRD-A18233884-003-02-7,COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC,HXLAFSUPPDYFEO-UHFFFAOYSA-N,Launched,
bexarotene,retinoid receptor agonist,"RXRA, RXRB, RXRG",hematologic malignancy,cutaneous T-cell lymphoma (CTCL),Selleck,98.35,BRD-K92441787-001-04-1,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Launched,
bezafibrate,PPAR receptor agonist,"PPARA, PPARD, PPARG",cardiology,cholesterol,"MicroSource, Selleck",99.25,"BRD-K46018455-001-27-6, BRD-K46018455-001-26-8","CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O, CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O","IIBYAHWJQTYFKB-UHFFFAOYSA-N, IIBYAHWJQTYFKB-UHFFFAOYSA-N",Launched,
biapenem,bacterial cell wall synthesis inhibitor,,infectious disease,"bacterial septicemia, pneumonia, urinary tract infections","MedChemEx, MedChemEx, Sigma, MedChemEx, Selleck, Selleck",74.7,"BRD-A80321291-001-01-6, BRD-A80321291-001-05-7, BRD-A80321291-001-04-0, BRD-A80321291-001-06-5, BRD-A80321291-001-02-4, BRD-A80321291-001-03-2","C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O","MRMBZHPJVKCOMA-YJFSRANCSA-O, MRMBZHPJVKCOMA-YJFSRANCSA-O, MRMBZHPJVKCOMA-YJFSRANCSA-O, MRMBZHPJVKCOMA-YJFSRANCSA-O, MRMBZHPJVKCOMA-YJFSRANCSA-O, MRMBZHPJVKCOMA-YJFSRANCSA-O",Launched,BRD-A66479836-001-03-8
bicalutamide,androgen receptor antagonist,AR,oncology,prostate cancer,"Tocris, MicroSource, Selleck",98.74,"BRD-A29485665-001-14-4, BRD-A29485665-001-12-8, BRD-A29485665-001-11-0","CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F, CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F, CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F","LKJPYSCBVHEWIU-UHFFFAOYSA-N, LKJPYSCBVHEWIU-UHFFFAOYSA-N, LKJPYSCBVHEWIU-UHFFFAOYSA-N",Launched,
bicyclol,NFkB pathway inhibitor,"HSPA1A, HSPB1",,,Sigma,98.42,BRD-K16546375-001-01-4,COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1CO,KXMTXZACPVCDMH-UHFFFAOYSA-N,Launched,
bifemelane,acetylcholine release enhancer,"MAOA, MAOB","ophthalmology, neurology/psychiatry","glaucoma, senile dementia","Tocris, Tocris",95.87,"BRD-K18779551-003-08-6, BRD-K18779551-003-07-8","CNCCCCOc1ccccc1Cc1ccccc1, CNCCCCOc1ccccc1Cc1ccccc1","QSQQPMHPCBLLGX-UHFFFAOYSA-N, QSQQPMHPCBLLGX-UHFFFAOYSA-N",Launched,
bifendate,,,,,AKSci,99.86,BRD-K26581543-001-01-6,COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1C(=O)OC,JMZOMFYRADAWOG-UHFFFAOYSA-N,Launched,
bifonazole,sterol demethylase inhibitor,CYP2B6,infectious disease,"tinea pedis, tinea cruris","MicroSource, Selleck",98.98,"BRD-A94543220-001-24-7, BRD-A94543220-001-23-9","c1cn(cn1)C(c1ccccc1)c1ccc(cc1)-c1ccccc1, c1cn(cn1)C(c1ccccc1)c1ccc(cc1)-c1ccccc1","OCAPBUJLXMYKEJ-UHFFFAOYSA-N, OCAPBUJLXMYKEJ-UHFFFAOYSA-N",Launched,
bilastine,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,MedChemEx,99.77,BRD-K51937257-001-01-4,CCOCCn1c(nc2ccccc12)C1CCN(CCc2ccc(cc2)C(C)(C)C(O)=O)CC1,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Launched,
bimatoprost,prostanoid receptor agonist,"AKR1C3, PTGER1, PTGER3, PTGFR",ophthalmology,"intraocular pressure, glaucoma, ocular hypertension",Selleck,95.82,BRD-A45153512-001-01-0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(O)CCc1ccccc1,AQOKCDNYWBIDND-GCYMYIANSA-N,Launched,
biotin,vitamin B,"ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6",,,"MicroSource, Selleck",100,"BRD-K89210380-001-14-5, BRD-K89210380-001-13-7","OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12, OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12","YBJHBAHKTGYVGT-ZKWXMUAHSA-N, YBJHBAHKTGYVGT-ZKWXMUAHSA-N",Launched,"BRD-A36603537-001-13-1, BRD-K95496960-001-01-7"
biperiden,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",neurology/psychiatry,Parkinson's Disease,"MicroSource, Selleck",97.94,"BRD-A00546892-001-02-6, BRD-A00546892-003-05-5","OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1, OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1","YSXKPIUOCJLQIE-UHFFFAOYSA-N, YSXKPIUOCJLQIE-UHFFFAOYSA-N",Launched,
bisacodyl,laxative,,gastroenterology,constipation,"MicroSource, Selleck",96.97,"BRD-K39987650-001-24-1, BRD-K39987650-001-23-3","CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1, CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1","KHOITXIGCFIULA-UHFFFAOYSA-N, KHOITXIGCFIULA-UHFFFAOYSA-N",Launched,
bismuth-subcitrate-potassium,,,gastroenterology,duodenal ulcer disease,"Selleck, Selleck",0,"BRD-A03880619-001-01-0, BRD-A03880619-001-02-8","OC(=O)CC(O)(CC(=O)O[Bi]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O, OC(=O)CC(O)(CC(=O)O[Bi]1OC(=O)CC(O)(CC(O)=O)C(=O)O1)C(O)=O","KNOSZBQOKCZXTI-UHFFFAOYSA-K, KNOSZBQOKCZXTI-UHFFFAOYSA-K",Launched,"BRD-M47372415-001-01-8, BRD-M47372415-001-02-6"
bismuth-subgallate,nitric oxide synthase inhibitor,NOS1,,,Sigma,0,BRD-K65978409-001-01-9,O[Bi]1Oc2cc(cc(O)c2O1)C(O)=O,JAONZGLTYYUPCT-UHFFFAOYSA-K,Launched,
bismuth-subsalicylate,antacid,,gastroenterology,diarrhea,"MicroSource, MedChemEx, Selleck, MedChemEx, Selleck",5.83,"BRD-K80528473-001-03-0, BRD-K80528473-001-08-9, BRD-K80528473-001-04-8, BRD-K80528473-001-07-1, BRD-K80528473-001-05-5","O[Bi]1OC(=O)c2ccccc2O1, O[Bi]1OC(=O)c2ccccc2O1, O[Bi]1OC(=O)c2ccccc2O1, O[Bi]1OC(=O)c2ccccc2O1, O[Bi]1OC(=O)c2ccccc2O1","ZREIPSZUJIFJNP-UHFFFAOYSA-K, ZREIPSZUJIFJNP-UHFFFAOYSA-K, ZREIPSZUJIFJNP-UHFFFAOYSA-K, ZREIPSZUJIFJNP-UHFFFAOYSA-K, ZREIPSZUJIFJNP-UHFFFAOYSA-K",Launched,"BRD-M10663475-001-02-8, BRD-M10663475-001-03-6"
bisoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2",cardiology,hypertension,"MicroSource, Tocris, Selleck, Selleck",95.41,"BRD-A89175223-051-14-8, BRD-A89175223-051-15-5, BRD-A89175223-051-13-0, BRD-A89175223-051-16-3","CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1, CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1, CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1, CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1","VHYCDWMUTMEGQY-UHFFFAOYSA-N, VHYCDWMUTMEGQY-UHFFFAOYSA-N, VHYCDWMUTMEGQY-UHFFFAOYSA-N, VHYCDWMUTMEGQY-UHFFFAOYSA-N",Launched,BRD-M21493215-051-04-3
bivalirudin,thrombin inhibitor,F2,cardiology,angina pectoris,"MedChemEx, Key, MedChemEx",93.05,"BRD-K28054654-019-01-9, BRD-K73504359-001-01-3, BRD-K73504359-019-01-5","[2H]N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O, CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O, CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O","OIRCOABEOLEUMC-CPNFJSNPSA-N, OIRCOABEOLEUMC-GEJPAHFPSA-N, OIRCOABEOLEUMC-GEJPAHFPSA-N",Launched,BRD-A64231665-019-01-7
bleomycin,DNA synthesis inhibitor,"LIG1, LIG3","hematologic malignancy, pulmonary, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, pleural effusion, testicular carcinoma, squamous cell carcinoma","Selleck, Selleck, MedChemEx, MicroSource",51.47,"BRD-A42083487-065-06-7, BRD-A42083487-065-05-9, BRD-A12918100-065-01-8, BRD-A42083487-001-01-3","C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C, C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C, CC(O)C(NC(=O)C(C)C(O)C(C)NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(N)=O)NCC(N)C(N)=O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C, C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C","OYVAGSVQBOHSSS-NHOVFDEISA-O, OYVAGSVQBOHSSS-NHOVFDEISA-O, OYVAGSVQBOHSSS-UHFFFAOYSA-O, OYVAGSVQBOHSSS-NHOVFDEISA-O",Launched,
blonanserin,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A",neurology/psychiatry,schizophrenia,Selleck,90.29,BRD-K25943794-001-02-3,CCN1CCN(CC1)c1cc(-c2ccc(F)cc2)c2CCCCCCc2n1,XVGOZDAJGBALKS-UHFFFAOYSA-N,Launched,
boceprevir,HCV inhibitor,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS",infectious disease,hepatitis C,"MedChemEx, MedChemEx, MedChemEx",82.09,"BRD-A09735281-001-03-3, BRD-A09735281-001-02-5, BRD-A09735281-001-04-1","CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C, CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C, CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C","LHHCSNFAOIFYRV-DOVBMPENSA-N, LHHCSNFAOIFYRV-DOVBMPENSA-N, LHHCSNFAOIFYRV-DOVBMPENSA-N",Launched,
bopindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B",cardiology,"hypertension, coronary artery disease (CAD)",Enzo,91.96,BRD-A07563059-035-01-3,Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1,UUOJIACWOAYWEZ-UHFFFAOYSA-N,Launched,
bortezomib,"NFkB pathway inhibitor, proteasome inhibitor","PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA",hematologic malignancy,"multiple myeloma, mantle cell lymphoma (MCL)","MedChemEx, Selleck, Selleck, Selleck, Selleck",97.62,"BRD-K88510285-001-18-6, BRD-K88510285-001-17-8, BRD-K88510285-001-25-1, BRD-K88510285-001-22-8, BRD-K88510285-001-11-1","CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O, CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O","GXJABQQUPOEUTA-RDJZCZTQSA-N, GXJABQQUPOEUTA-RDJZCZTQSA-N, GXJABQQUPOEUTA-RDJZCZTQSA-N, GXJABQQUPOEUTA-RDJZCZTQSA-N, GXJABQQUPOEUTA-RDJZCZTQSA-N",Launched,"BRD-K50691590-001-05-5, BRD-K50691590-001-02-2"
bosentan,endothelin receptor antagonist,"EDNRA, EDNRB",pulmonary,pulmonary arterial hypertension (PAH),Selleck,97.9,BRD-K74763371-002-04-0,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1,GJPICJJJRGTNOD-UHFFFAOYSA-N,Launched,
bosutinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor","ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK",hematologic malignancy,chronic myeloid leukemia (CML),"Selleck, Tocris",99.19,"BRD-K99964838-001-11-9, BRD-K99964838-001-12-7","COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl, COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl","UBPYILGKFZZVDX-UHFFFAOYSA-N, UBPYILGKFZZVDX-UHFFFAOYSA-N",Launched,
bretylium,norepinephrine inhibitor,ATP1A1,cardiology,"ventricular arrhythmias, ventricular fibrillation (VF), ventricular tachycardia (VT)","Sigma, MicroSource",49.99,"BRD-K49669424-075-19-2, BRD-K49669424-001-01-6","CC[N+](C)(C)Cc1ccccc1Br, CC[N+](C)(C)Cc1ccccc1Br","AAQOQKQBGPPFNS-UHFFFAOYSA-N, AAQOQKQBGPPFNS-UHFFFAOYSA-N",Launched,
brexpiprazole,dopamine receptor partial agonist,DRD2,neurology/psychiatry,"depression, schizophrenia",MedChemEx,94.37,BRD-K00911143-001-01-9,O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Launched,
brigatinib,"ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","ALK, EGFR",oncology,non-small cell lung cancer (NSCLC),"MedChemEx, MedChemEx",93.49,"BRD-K56981171-001-02-8, BRD-K56981171-001-01-0","COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1, COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1","AILRADAXUVEEIR-UHFFFAOYSA-N, AILRADAXUVEEIR-UHFFFAOYSA-N",Launched,
brilliant-green,,,,,Acros,90.42,BRD-K60348325-065-09-9,CCN(CC)c1ccc(cc1)C(c1ccccc1)=C1C=CC(C=C1)=[N+](CC)CC,HXCILVUBKWANLN-UHFFFAOYSA-N,Launched,
brimonidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C",ophthalmology,"intraocular pressure, glaucoma, ocular hypertension","Tocris, Tocris, Tocris, Selleck, Selleck",99,"BRD-K68264559-001-14-2, BRD-K68264559-045-02-4, BRD-K68264559-001-13-4, BRD-K68264559-045-03-2, BRD-K68264559-045-04-0","Brc1c(NC2=NCCN2)ccc2nccnc12, Brc1c(NC2=NCCN2)ccc2nccnc12, Brc1c(NC2=NCCN2)ccc2nccnc12, Brc1c(NC2=NCCN2)ccc2nccnc12, Brc1c(NC2=NCCN2)ccc2nccnc12","XYLJNLCSTIOKRM-UHFFFAOYSA-N, XYLJNLCSTIOKRM-UHFFFAOYSA-N, XYLJNLCSTIOKRM-UHFFFAOYSA-N, XYLJNLCSTIOKRM-UHFFFAOYSA-N, XYLJNLCSTIOKRM-UHFFFAOYSA-N",Launched,"BRD-M06829359-001-01-4, BRD-M06829359-001-02-2"
brinzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7",ophthalmology,"intraocular pressure, glaucoma, ocular hypertension","MicroSource, Selleck, Selleck",99.04,"BRD-K74913225-001-14-0, BRD-K74913225-001-12-4, BRD-K74913225-001-13-2","CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O, CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O, CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O","HCRKCZRJWPKOAR-JTQLQIEISA-N, HCRKCZRJWPKOAR-JTQLQIEISA-N, HCRKCZRJWPKOAR-JTQLQIEISA-N",Launched,BRD-A82599487-001-01-9
brivaracetam,voltage-gated sodium channel blocker,SV2A,neurology/psychiatry,seizures,"MedChemEx, MedChemEx",94.2,"BRD-K00634421-001-02-8, BRD-K00634421-001-01-0","CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1, CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1","MSYKRHVOOPPJKU-BDAKNGLRSA-N, MSYKRHVOOPPJKU-BDAKNGLRSA-N",Launched,
brivudine,DNA directed DNA polymerase inhibitor,,infectious disease,shingles,TCI,95.52,BRD-A63675168-001-01-6,OC[C@H]1O[C@H](CC1O)n1cc(\C=C\Br)c(=O)[nH]c1=O,ODZBBRURCPAEIQ-GIANCMQGSA-N,Launched,
brolitene,muscle relaxant,RYR1,,,"ChemBridge, Vitas-M",0,"BRD-K76021681-001-01-4, BRD-K76021681-001-02-2","OCCNC(=O)\C=C\c1ccccc1, OCCNC(=O)\C=C\c1ccccc1","OSCTXCOERRNGLW-VOTSOKGWSA-N, OSCTXCOERRNGLW-VOTSOKGWSA-N",Launched,
bromantan,"dopamine reuptake inhibitor, serotonin reuptake inhibitor",,neurology/psychiatry,neurasthenia,"Enamine, Enamine",86.43,"BRD-K86358349-001-01-2, BRD-K86358349-001-02-0","Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1, Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1","LWJALJDRFBXHKX-UHFFFAOYSA-N, LWJALJDRFBXHKX-UHFFFAOYSA-N",Launched,
bromhexine,mucolytic agent,,pulmonary,chest congestion,"MicroSource, Selleck",93.96,"BRD-K47631482-003-07-0, BRD-K47631482-003-06-2","CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1, CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1","OJGDCBLYJGHCIH-UHFFFAOYSA-N, OJGDCBLYJGHCIH-UHFFFAOYSA-N",Launched,
bromocriptine,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7","endocrinology, neurology/psychiatry","hyperprolactinemia, Parkinson's Disease, acromegaly","Tocris, MicroSource, Tocris",93.48,"BRD-K14496212-066-03-0, BRD-K14496212-066-04-8, BRD-K14496212-066-02-2","CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C, CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C, CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C","OZVBMTJYIDMWIL-AYFBDAFISA-N, OZVBMTJYIDMWIL-AYFBDAFISA-N, OZVBMTJYIDMWIL-AYFBDAFISA-N",Launched,BRD-A80151636-066-04-8
bromopride,dopamine receptor antagonist,DRD2,gastroenterology,"nausea, vomiting, gastroesophageal reflux disease (GERD)",MicroSource,96.6,BRD-K73642618-001-13-3,CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC,GIYAQDDTCWHPPL-UHFFFAOYSA-N,Launched,
bromperidol,dopamine receptor antagonist,DRD2,neurology/psychiatry,schizophrenia,MicroSource,98.85,BRD-K78643075-001-11-6,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Br)cc1,RKLNONIVDFXQRX-UHFFFAOYSA-N,Launched,
brompheniramine,histamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1","allergy, otolaryngology","allergic rhinitis, common cold","MicroSource, Selleck",92.64,"BRD-A68723818-050-32-5, BRD-A68723818-050-31-7","CN(C)CCC(c1ccc(Br)cc1)c1ccccn1, CN(C)CCC(c1ccc(Br)cc1)c1ccccn1","ZDIGNSYAACHWNL-UHFFFAOYSA-N, ZDIGNSYAACHWNL-UHFFFAOYSA-N",Launched,
bronopol,,,,,MicroSource,0,BRD-K33457401-001-01-1,OCC(Br)(CO)[N+]([O-])=O,LVDKZNITIUWNER-UHFFFAOYSA-N,Launched,
bucillamine,immunosuppressant,,rheumatology,rheumatoid arthritis,"Kemprotec, AKSci",96.91,"BRD-K24697665-001-02-2, BRD-K24697665-001-01-4","CC(C)(S)C(=O)N[C@@H](CS)C(O)=O, CC(C)(S)C(=O)N[C@@H](CS)C(O)=O","VUAFHZCUKUDDBC-BYPYZUCNSA-N, VUAFHZCUKUDDBC-BYPYZUCNSA-N",Launched,
bucladesine,"adenosine receptor agonist, cAMP stimulant",PRKACA,dermatology,skin ulcer,"Tocris, MicroSource, Tocris",98.02,"BRD-A94624445-236-18-8, BRD-A15931911-001-03-8, BRD-A94624445-236-17-0","CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC, CCCC(=O)Nc1ncnc2n(cnc12)C1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC, CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]1O[C@@H]2COP(O)(=O)O[C@H]2[C@H]1OC(=O)CCC","CJGYSWNGNKCJSB-YVLZZHOMSA-N, CJGYSWNGNKCJSB-ZBSNKJFMSA-N, CJGYSWNGNKCJSB-YVLZZHOMSA-N",Launched,
buclizine,histamine receptor antagonist,"CHRM1, HRH1",neurology/psychiatry,migraine headache,Key,99.32,BRD-A91444184-300-01-9,CC(C)(C)c1ccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)cc1,MOYGZHXDRJNJEP-UHFFFAOYSA-N,Launched,
budesonide,glucocorticoid receptor agonist,NR3C1,gastroenterology,Crohn's disease,"Sigma, Selleck, Tocris, MedChemEx, Tocris, MedChemEx, MicroSource, Selleck",54.98,"BRD-A34299591-001-25-7, BRD-K90758956-001-02-9, BRD-A34299591-001-27-3, BRD-A34299591-001-28-1, BRD-A34299591-001-22-4, BRD-A34299591-001-26-5, BRD-A34299591-001-29-9, BRD-K90758956-001-03-7","CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO","VOVIALXJUBGFJZ-KWVAZRHASA-N, VOVIALXJUBGFJZ-VXKMTNQYSA-N, VOVIALXJUBGFJZ-KWVAZRHASA-N, VOVIALXJUBGFJZ-KWVAZRHASA-N, VOVIALXJUBGFJZ-KWVAZRHASA-N, VOVIALXJUBGFJZ-KWVAZRHASA-N, VOVIALXJUBGFJZ-KWVAZRHASA-N, VOVIALXJUBGFJZ-VXKMTNQYSA-N",Launched,"BRD-A60571864-001-04-1, BRD-K17742695-001-01-1"
budipine,glutamate receptor antagonist,GRIN1,neurology/psychiatry,Parkinson's Disease,AQBioPharma,94.36,BRD-K18324993-001-01-6,CC(C)(C)N1CCC(CC1)(c1ccccc1)c1ccccc1,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,Launched,
buflomedil,"adrenergic receptor antagonist, calcium channel blocker",ADRA1A,cardiology,peripheral artery disease (PAD),"Selleck, MicroSource",98.69,"BRD-K19462402-003-23-8, BRD-K19462402-003-24-6","COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1, COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1","OWYLAEYXIQKAOL-UHFFFAOYSA-N, OWYLAEYXIQKAOL-UHFFFAOYSA-N",Launched,
bumetanide,solute carrier family member inhibitor,"CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5",cardiology,"edema, congestive heart failure","Tocris, MicroSource, Selleck",99.54,"BRD-K38197229-001-31-5, BRD-K38197229-001-29-9, BRD-K38197229-001-28-1","CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O, CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O, CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O","MAEIEVLCKWDQJH-UHFFFAOYSA-N, MAEIEVLCKWDQJH-UHFFFAOYSA-N, MAEIEVLCKWDQJH-UHFFFAOYSA-N",Launched,
bunazosin,adrenergic receptor antagonist,ADRA1A,ophthalmology,"glaucoma, intraocular pressure",Enamine,97.77,BRD-K35034482-001-01-8,CCCC(=O)N1CCCN(CC1)c1nc(N)c2cc(OC)c(OC)cc2n1,RHLJLALHBZGAFM-UHFFFAOYSA-N,Launched,
buparvaquone,antiprotozoal agent,,,,MedChemEx,96.77,BRD-A07947329-001-01-4,CC(C)(C)C1CCC(CC2C(=O)C(=O)c3ccccc3C2=O)CC1,OMMKCJLAGTXGLC-UHFFFAOYSA-N,Launched,
buphenine,adrenergic receptor agonist,ADRB2,rheumatology,Raynaud's disease,"MedChemEx, MicroSource",89.35,"BRD-A36267905-003-19-2, BRD-A36267905-003-18-4","CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1, CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1","PTGXAUBQBSGPKF-UHFFFAOYSA-N, PTGXAUBQBSGPKF-UHFFFAOYSA-N",Launched,
bupivacaine,sodium channel blocker,"KCNA5, PTGER1, SCN10A, SCN4A",neurology/psychiatry,"peripheral nerve block, caudal epidural block, lumbar epidural block","MicroSource, Selleck",98.95,"BRD-A01636364-003-15-1, BRD-A01636364-003-14-4","CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C, CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C","LEBVLXFERQHONN-UHFFFAOYSA-N, LEBVLXFERQHONN-UHFFFAOYSA-N",Launched,
bupranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3","cardiology, ophthalmology","hypertension, glaucoma","Enamine, Enamine",96.59,"BRD-A48420483-001-01-5, BRD-A48420483-001-02-3","Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1, Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1","HQIRNZOQPUAHHV-UHFFFAOYSA-N, HQIRNZOQPUAHHV-UHFFFAOYSA-N",Launched,
bupropion,dopamine uptake inhibitor,"CHRNA3, SLC6A2, SLC6A3",neurology/psychiatry,depression,"MicroSource, Tocris, Selleck",97.76,"BRD-A05186015-003-20-6, BRD-A05186015-003-21-4, BRD-A05186015-003-19-8","CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1, CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1, CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1","SNPPWIUOZRMYNY-UHFFFAOYSA-N, SNPPWIUOZRMYNY-UHFFFAOYSA-N, SNPPWIUOZRMYNY-UHFFFAOYSA-N",Launched,
buspirone,serotonin receptor agonist,"DRD2, HTR1A",neurology/psychiatry,generalized anxiety disorder (GAD),"Tocris, MicroSource, Selleck",99.45,"BRD-K93461745-003-24-3, BRD-K93461745-003-25-0, BRD-K93461745-003-23-5","O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1, O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1, O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1","QWCRAEMEVRGPNT-UHFFFAOYSA-N, QWCRAEMEVRGPNT-UHFFFAOYSA-N, QWCRAEMEVRGPNT-UHFFFAOYSA-N",Launched,
busulfan,DNA inhibitor,,hematologic malignancy,chronic myeloid leukemia (CML),"Selleck, MicroSource, Selleck",89.78,"BRD-K23204545-001-18-0, BRD-K23204545-001-16-4, BRD-K23204545-001-15-6","CS(=O)(=O)OCCCCOS(C)(=O)=O, CS(=O)(=O)OCCCCOS(C)(=O)=O, CS(=O)(=O)OCCCCOS(C)(=O)=O","COVZYZSDYWQREU-UHFFFAOYSA-N, COVZYZSDYWQREU-UHFFFAOYSA-N, COVZYZSDYWQREU-UHFFFAOYSA-N",Launched,
butacaine,local anesthetic,,neurology/psychiatry,local anesthetic,"MicroSource, Selleck",95.48,"BRD-K99622919-001-23-0, BRD-K99622919-001-22-2","CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1, CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1","HQFWVSGBVLEQGA-UHFFFAOYSA-N, HQFWVSGBVLEQGA-UHFFFAOYSA-N",Launched,
butalbital,GABA receptor antagonist,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2",neurology/psychiatry,"headache, muscle relaxant",Prestwick,98.11,BRD-K71350836-001-02-4,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,Launched,
butenafine,fungal squalene epoxidase inhibitor,SQLE,infectious disease,"tinea pedis, tinea cruris, tinea corporis",Selleck,97.73,BRD-K90630139-003-05-9,CN(Cc1ccc(cc1)C(C)(C)C)Cc1cccc2ccccc12,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Launched,
butoconazole,bacterial cell wall synthesis inhibitor,,infectious disease,vulvovaginal candidiasis,"MicroSource, Selleck",99.34,"BRD-A16665823-001-02-0, BRD-A16665823-008-12-4","Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1, Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1","SWLMUYACZKCSHZ-UHFFFAOYSA-N, SWLMUYACZKCSHZ-UHFFFAOYSA-N",Launched,
butorphanol-(+)-tartrate,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1","neurology/psychiatry, gastroenterology","muscle pain, headache, abdominal pain",Enzo,97.38,BRD-K42417338-045-01-9,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,IFKLAQQSCNILHL-QHAWAJNXSA-N,Launched,BRD-M74255273-001-01-2
butylphthalide,potassium channel antagonist,KCNK2,neurology/psychiatry,stroke,MedChemEx,94.43,BRD-A59378440-001-01-3,CCCCC1OC(=O)c2ccccc12,HJXMNVQARNZTEE-UHFFFAOYSA-N,Launched,
butylscopolamine-bromide,cholinergic receptor antagonist,,gastroenterology,abdominal pain,Selleck,94.79,BRD-A53951045-004-01-6,CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@@H](CO)c1ccccc1,YBCNXCRZPWQOBR-NQNPYAFXSA-N,Launched,
cabagin,,,gastroenterology,dyspepsia,AlfaAesar,0,BRD-K41504985-005-01-5,C[S+](C)CC[C@H](N)C(O)=O,YDBYJHTYSHBBAU-YFKPBYRVSA-O,Launched,
cabazitaxel,microtubule inhibitor,"TUBA4A, TUBB, TUBB1",oncology,prostate cancer,Selleck,96.88,BRD-K06858286-001-01-3,CO[C@@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@@H](OC(=O)c3ccccc3)[C@@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C,BMQGVNUXMIRLCK-VCPXPHFHSA-N,Launched,
cabergoline,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7",endocrinology,hyperprolactinemia,"Tocris, Enzo",94.48,"BRD-K86882815-001-05-7, BRD-K86882815-001-03-2","CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1, CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1","KORNTPPJEAJQIU-KJXAQDMKSA-N, KORNTPPJEAJQIU-KJXAQDMKSA-N",Launched,BRD-K34586087-001-01-7
cabozantinib,"RET tyrosine kinase inhibitor, VEGFR inhibitor","KDR, MET",oncology,medullary thyroid cancer (MTC),"Selleck, Tocris",99.07,"BRD-K51544265-001-04-2, BRD-K51544265-001-06-7","COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC, COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC","ONIQOQHATWINJY-UHFFFAOYSA-N, ONIQOQHATWINJY-UHFFFAOYSA-N",Launched,
cadralazine,adrenergic receptor antagonist,,cardiology,hypertension,Key,57.47,BRD-A78134170-001-01-3,CCOC(=O)NNc1ccc(nn1)N(CC)CC(C)O,QLTVVOATEHFXLT-UHFFFAOYSA-N,Launched,
cafestol,pregnane X receptor agonist,,,,Enzo,95.32,BRD-K46741531-001-02-4,C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@@H]21)[C@@](O)(CO)C3,DNJVYWXIDISQRD-HWUKTEKMSA-N,Launched,
caffeine,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3",neurology/psychiatry,"fatigue, drowsiness, fatigue, drowsiness",MicroSource,99.15,BRD-K02404261-001-16-7,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Launched,
calcifediol,vitamin D receptor agonist,VDR,,,"Adooq, MedChemEx, Selleck, Selleck",93.33,"BRD-K77175907-001-08-0, BRD-K77175907-002-01-3, BRD-K77175907-001-06-4, BRD-K77175907-001-10-6","C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C","JWUBBDSIWDLEOM-DTOXIADCSA-N, JWUBBDSIWDLEOM-DTOXIADCSA-N, JWUBBDSIWDLEOM-DTOXIADCSA-N, JWUBBDSIWDLEOM-DTOXIADCSA-N",Launched,BRD-K34907920-001-01-6
calcipotriol,vitamin D receptor agonist,VDR,dermatology,psoriasis,"Tocris, MedChemEx, MedChemEx",92.24,"BRD-K56429665-001-07-0, BRD-K56429665-001-09-6, BRD-K56429665-002-01-1","C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C","LWQQLNNNIPYSNX-UROSTWAQSA-N, LWQQLNNNIPYSNX-UROSTWAQSA-N, LWQQLNNNIPYSNX-UROSTWAQSA-N",Launched,
calcitriol,vitamin D receptor agonist,VDR,"endocrinology, orthopedics","hypocalcemia, hypoparathyroidism, osteoporosis","Selleck, Selleck, Selleck",96.4,"BRD-K27316855-001-13-3, BRD-K27316855-001-15-8, BRD-K27316855-001-19-0","C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C","GMRQFYUYWCNGIN-NKMMMXOESA-N, GMRQFYUYWCNGIN-NKMMMXOESA-N, GMRQFYUYWCNGIN-NKMMMXOESA-N",Launched,BRD-K28731095-001-01-7
calcium-gluceptate,,,,,"MicroSource, Selleck",100,"BRD-K35952844-238-02-0, BRD-K35952844-238-01-2","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O, OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O","KWMLJOLKUYYJFJ-VFUOTHLCSA-N, KWMLJOLKUYYJFJ-VFUOTHLCSA-N",Launched,"BRD-M41172429-238-02-8, BRD-K74392481-001-01-3"
calcium-levofolinate,,,,,"Selleck, Selleck",100,"BRD-K97009491-238-03-8, BRD-K97009491-238-02-0","Nc1nc(=O)c2N(C=O)[C@@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1, Nc1nc(=O)c2N(C=O)[C@@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1","VVIAGPKUTFNRDU-STQMWFEESA-N, VVIAGPKUTFNRDU-STQMWFEESA-N",Launched,
camostat-mesilate,protease inhibitor,PRSS1,gastroenterology,pancreatitis,"Tocris, Selleck",96.31,"BRD-K43806473-066-03-9, BRD-K43806473-066-02-1","CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1, CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(N)=N)cc2)cc1","XASIMHXSUQUHLV-UHFFFAOYSA-N, XASIMHXSUQUHLV-UHFFFAOYSA-N",Launched,
camylofine-chlorhydrate,,,gastroenterology,abdominal pain,"Selleck, MicroSource, Selleck",96.03,"BRD-A91733352-300-03-7, BRD-A91733352-300-04-5, BRD-A91733352-300-05-2","CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1, CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1, CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1","RYOOHIUJEJZCFT-UHFFFAOYSA-N, RYOOHIUJEJZCFT-UHFFFAOYSA-N, RYOOHIUJEJZCFT-UHFFFAOYSA-N",Launched,
canagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2",endocrinology,diabetes mellitus,"MicroSource, Selleck",98.9,"BRD-K90868879-001-03-8, BRD-K90868879-001-02-0","Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O, Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","XTNGUQKDFGDXSJ-ZXGKGEBGSA-N, XTNGUQKDFGDXSJ-ZXGKGEBGSA-N",Launched,
candesartan,angiotensin receptor antagonist,AGTR1,cardiology,"hypertension, congestive heart failure","Tocris, Selleck, MicroSource",98.75,"BRD-K84091759-001-10-5, BRD-K84091759-001-07-1, BRD-K84091759-001-08-9","CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1","HTQMVQVXFRQIKW-UHFFFAOYSA-N, HTQMVQVXFRQIKW-UHFFFAOYSA-N, HTQMVQVXFRQIKW-UHFFFAOYSA-N",Launched,
candesartan-cilextil,angiotensin receptor antagonist,"AGTR1, AGTR2",cardiology,"hypertension, congestive heart failure","MicroSource, Selleck",98.51,"BRD-A65671304-001-08-3, BRD-A65671304-001-07-5","CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1","GHOSNRCGJFBJIB-UHFFFAOYSA-N, GHOSNRCGJFBJIB-UHFFFAOYSA-N",Launched,
candicidin,fungal ergosterol inhibitor,,infectious disease,vulvovaginal candidiasis,MicroSource,0,BRD-A37348498-015-01-4,CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(O[C@@H]2O[C@H](C)[C@H](O)[C@@H](O)[C@@H]2N)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(O)=O)C(O)CC(=O)c1ccc(N)cc1,HYIZCDMXFDRDFE-RTQJASBYSA-N,Launched,
cantharidin,protein phosphatase inhibitor,,dermatology,blisters,"MedChemEx, MedChemEx, Sigma, Tocris",47.3,"BRD-K80684056-001-09-3, BRD-K80684056-001-06-9, BRD-K80684056-001-05-1, BRD-K80684056-001-04-4","C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O, C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O, C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O, C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O","DHZBEENLJMYSHQ-XCVPVQRUSA-N, DHZBEENLJMYSHQ-XCVPVQRUSA-N, DHZBEENLJMYSHQ-XCVPVQRUSA-N, DHZBEENLJMYSHQ-XCVPVQRUSA-N",Launched,
capecitabine,"DNA synthesis inhibitor, thymidylate synthase inhibitor",TYMS,oncology,"breast cancer, colorectal cancer","Selleck, Tocris, Selleck, MicroSource",97.88,"BRD-K61192372-001-05-5, BRD-K61192372-001-06-3, BRD-K61192372-001-07-1, BRD-K61192372-001-08-9","CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O, CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O, CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O, CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O","GAGWJHPBXLXJQN-UORFTKCHSA-N, GAGWJHPBXLXJQN-UORFTKCHSA-N, GAGWJHPBXLXJQN-UORFTKCHSA-N, GAGWJHPBXLXJQN-UORFTKCHSA-N",Launched,"BRD-K15574380-001-01-0, BRD-A91877226-001-01-4"
capreomycin,protein synthesis inhibitor,,infectious disease,tuberculosis,"MicroSource, MedChemEx",100,"BRD-A33801468-065-04-1, BRD-A31362467-065-01-3","NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC1=O)=C/NC(N)=O)C1CCNC(=N)N1, CC1NC(=O)C(N)CNC(=O)C(NC(=O)\C(NC(=O)C(CNC(=O)CC(N)CCCN)NC1=O)=C/NC(N)=O)C1CCNC(=N)N1","JNIIDKODPGHQSS-OQLLNIDSSA-N, FRXNXDHFQYZYNA-MHWRWJLKSA-N",Launched,
caprylic-acid,,,,,"Enamine, Enamine",8.98,"BRD-K35170555-001-09-5, BRD-K35170555-001-12-9","CCCCCCCC(O)=O, CCCCCCCC(O)=O","WWZKQHOCKIZLMA-UHFFFAOYSA-N, WWZKQHOCKIZLMA-UHFFFAOYSA-N",Launched,
capsaicin,TRPV agonist,"CFTR, TRPV1","neurology/psychiatry, rheumatology","muscle pain, rheumatoid arthritis","Tocris, MicroSource",95.04,"BRD-K50590187-001-19-9, BRD-K50590187-001-20-7","COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O, COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O","YKPUWZUDDOIDPM-SOFGYWHQSA-N, YKPUWZUDDOIDPM-SOFGYWHQSA-N",Launched,
captopril,angiotensin converting enzyme inhibitor,"ACE, LTA4H, MMP2, MMP9","cardiology, endocrinology, nephrology","hypertension, congestive heart failure, myocardial infarction, diabetes mellitus, diabetic nephropathy","MicroSource, Selleck, Selleck",100,"BRD-K54529596-001-25-5, BRD-K54529596-001-26-3, BRD-K54529596-001-28-9","C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O","FAKRSMQSSFJEIM-RQJHMYQMSA-N, FAKRSMQSSFJEIM-RQJHMYQMSA-N, FAKRSMQSSFJEIM-RQJHMYQMSA-N",Launched,BRD-K96855766-001-01-9
caramiphen,cholinergic receptor antagonist,"CHRM1, CHRM2",neurology/psychiatry,Parkinson's Disease,ChemDiv,87.71,BRD-K59895502-001-01-9,CCN(CC)CCOC(=O)C1(CCCC1)c1ccccc1,OFAIGZWCDGNZGT-UHFFFAOYSA-N,Launched,
carazolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3",cardiology,"angina pectoris, cardiac arrythmia, hypertension, myocardial infarction",Cayman,95.74,BRD-A50675490-001-01-0,CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12,BQXQGZPYHWWCEB-UHFFFAOYSA-N,Launched,
carbachol,cholinergic receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",ophthalmology,intraocular pressure,"MicroSource, Selleck",100,"BRD-K75037734-003-14-7, BRD-K75037734-003-13-9","C[N+](C)(C)CCOC(N)=O, C[N+](C)(C)CCOC(N)=O","VPJXQGSRWJZDOB-UHFFFAOYSA-O, VPJXQGSRWJZDOB-UHFFFAOYSA-O",Launched,
carbadox,other antibiotic,,"infectious disease, gastroenterology","dysentry, enteritis","MicroSource, Selleck, Selleck",99.18,"BRD-K56735750-001-06-8, BRD-K56735750-001-09-2, BRD-K56735750-001-07-6","COC(=O)N\N=C\c1c[n+]([O-])c2ccccc2[n+]1[O-], COC(=O)N\N=C\c1c[n+]([O-])c2ccccc2[n+]1[O-], COC(=O)N\N=C\c1c[n+]([O-])c2ccccc2[n+]1[O-]","OVGGLBAWFMIPPY-WUXMJOGZSA-N, OVGGLBAWFMIPPY-WUXMJOGZSA-N, OVGGLBAWFMIPPY-WUXMJOGZSA-N",Launched,BRD-K06386100-001-01-9
carbamazepine,carboxamide antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,"Tocris, MicroSource, Selleck",99.2,"BRD-K71799949-001-38-0, BRD-K71799949-001-36-4, BRD-K71799949-001-35-6","NC(=O)N1c2ccccc2C=Cc2ccccc12, NC(=O)N1c2ccccc2C=Cc2ccccc12, NC(=O)N1c2ccccc2C=Cc2ccccc12","FFGPTBGBLSHEPO-UHFFFAOYSA-N, FFGPTBGBLSHEPO-UHFFFAOYSA-N, FFGPTBGBLSHEPO-UHFFFAOYSA-N",Launched,
carbaril,acetylcholinesterase inhibitor,,,,MicroSource,54.75,BRD-K54208592-001-09-4,CNC(=O)Oc1cccc2ccccc12,CVXBEEMKQHEXEN-UHFFFAOYSA-N,Launched,
carbarsone,antiprotozoal agent,,infectious disease,amebiasis,MicroSource,69.44,BRD-K94848716-001-11-6,NC(=O)Nc1ccc(cc1)[As](O)(O)=O,WWXBHTZSYYGCSG-UHFFFAOYSA-N,Launched,
carbazochrome,,,hematology,hemorrhage,Selleck,93.38,BRD-A11070335-236-02-1,CN1C(CC2=C\C(=N\NC(N)=O)C(=O)C=C12)S(O)(=O)=O,OZCACMPSTYQSMM-SDQBBNPISA-N,Launched,
carbendazim,"microtubule inhibitor, tubulin polymerization inhibitor","TP53, TUBB",infectious disease,fungicide,Sigma,98.32,BRD-K12906202-001-06-2,COC(=O)Nc1nc2ccccc2[nH]1,TWFZGCMQGLPBSX-UHFFFAOYSA-N,Launched,
carbenicillin,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,"MedChemEx, MicroSource, Selleck, MedChemEx, Selleck",0,"BRD-A13078313-304-09-9, BRD-A13078313-304-06-5, BRD-A13078313-304-05-7, BRD-A13078313-304-08-1, BRD-A13078313-304-07-3","CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O","FPPNZSSZRUTDAP-UWFZAAFLSA-N, FPPNZSSZRUTDAP-UWFZAAFLSA-N, FPPNZSSZRUTDAP-UWFZAAFLSA-N, FPPNZSSZRUTDAP-UWFZAAFLSA-N, FPPNZSSZRUTDAP-UWFZAAFLSA-N",Launched,
carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3","gastroenterology, dental","peptic ulcer disease (PUD), mouth inflammation","Selleck, MicroSource, Selleck",94.39,"BRD-A29700858-304-03-4, BRD-A29700858-304-02-6, BRD-A29700858-304-01-8","CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O, CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O, CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C(O)=O)OC(=O)CCC(O)=O","OBZHEBDUNPOCJG-SOJSWMKXSA-N, OBZHEBDUNPOCJG-SOJSWMKXSA-N, OBZHEBDUNPOCJG-SOJSWMKXSA-N",Launched,"BRD-A25216804-304-01-4, BRD-A98702003-304-04-8, BRD-A25216804-304-02-2"
carbetapentane,acetylcholine receptor antagonist,CHRM2,"otolaryngology, pulmonary","common cold, nasal congestion, bronchitis","Tocris, MicroSource",93.21,"BRD-K06181161-048-15-1, BRD-K06181161-048-16-9","CCN(CC)CCOCCOC(=O)C1(CCCC1)c1ccccc1, CCN(CC)CCOCCOC(=O)C1(CCCC1)c1ccccc1","CFJMRBQWBDQYMK-UHFFFAOYSA-N, CFJMRBQWBDQYMK-UHFFFAOYSA-N",Launched,
carbetocin,oxytocin receptor agonist,OXTR,hematology,hemorrhage,MedChemEx,93.12,BRD-K56107812-001-01-7,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,NSTRIRCPWQHTIA-DTRKZRJBSA-N,Launched,
carbidopa,aromatic L-amino acid decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease,"Selleck, MedChemEx, Selleck, MedChemEx, Tocris, MicroSource",63.9,"BRD-K78712176-001-14-1, BRD-A69512159-001-07-3, BRD-K78712176-001-11-7, BRD-K78712176-001-15-8, BRD-K78712176-001-12-5, BRD-K78712176-001-13-3","C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O, CC(Cc1ccc(O)c(O)c1)(NN)C(O)=O, C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O, C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O, C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O, C[C@@](Cc1ccc(O)c(O)c1)(NN)C(O)=O","TZFNLOMSOLWIDK-JTQLQIEISA-N, TZFNLOMSOLWIDK-UHFFFAOYSA-N, TZFNLOMSOLWIDK-JTQLQIEISA-N, TZFNLOMSOLWIDK-JTQLQIEISA-N, TZFNLOMSOLWIDK-JTQLQIEISA-N, TZFNLOMSOLWIDK-JTQLQIEISA-N",Launched,BRD-A69512159-001-06-5
carbimazole,antithyroid agent,TPO,endocrinology,hyperthyroidism,"Selleck, MicroSource, Selleck",86.2,"BRD-K87156652-001-11-9, BRD-K87156652-001-12-7, BRD-K87156652-001-13-5","CCOC(=O)n1ccn(C)c1=S, CCOC(=O)n1ccn(C)c1=S, CCOC(=O)n1ccn(C)c1=S","CFOYWRHIYXMDOT-UHFFFAOYSA-N, CFOYWRHIYXMDOT-UHFFFAOYSA-N, CFOYWRHIYXMDOT-UHFFFAOYSA-N",Launched,
carbinoxamine,histamine receptor antagonist,HRH1,"allergy, ophthalmology, otolaryngology, dermatology","allergic rhinitis, conjunctivitis, vasomotor rhinitis, dermatographism",MicroSource,98.35,BRD-A29426959-050-13-2,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,OJFSXZCBGQGRNV-UHFFFAOYSA-N,Launched,
carboplatin,"DNA alkylating agent, DNA inhibitor",,oncology,ovarian cancer,"Selleck, Tocris, MicroSource, Selleck",0,"BRD-K90947825-001-05-0, BRD-K90947825-001-02-7, BRD-K90947825-001-03-5, BRD-K90947825-001-04-3","N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1, N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1, N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1, N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1","YAYRGNWWLMLWJE-UHFFFAOYSA-L, YAYRGNWWLMLWJE-UHFFFAOYSA-L, YAYRGNWWLMLWJE-UHFFFAOYSA-L, YAYRGNWWLMLWJE-UHFFFAOYSA-L",Launched,"BRD-M80278122-318-03-3, BRD-K64763651-001-01-1, BRD-K11626735-318-08-7, BRD-M80278122-318-02-5"
carfilzomib,proteasome inhibitor,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9",hematologic malignancy,multiple myeloma,Selleck,95.76,BRD-K15179879-001-03-2,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,BLMPQMFVWMYDKT-NZTKNTHTSA-N,Launched,
carglumic-acid,carbamoyl phosphate synthase activator,CPS1,metabolism,hyperammonemia,MicroSource,100,BRD-K60240222-001-01-4,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,LCQLHJZYVOQKHU-VKHMYHEASA-N,Launched,
cariprazine,dopamine receptor antagonist,"DRD2, DRD3",neurology/psychiatry,schizophrenia,MedChemEx,97.64,BRD-K57764956-001-02-8,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1,KPWSJANDNDDRMB-QAQDUYKDSA-N,Launched,
carisoprodol,acetylcholine receptor antagonist,CYP2C19,neurology/psychiatry,muscle relaxant,MicroSource,100,BRD-A99939097-001-24-2,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,Launched,
carmofur,thymidylate synthase inhibitor,TYMS,oncology,"breast cancer, colorectal cancer","Selleck, MicroSource, Selleck",86.52,"BRD-K11630072-001-13-2, BRD-K11630072-001-12-4, BRD-K11630072-001-11-6","CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O, CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O, CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O","AOCCBINRVIKJHY-UHFFFAOYSA-N, AOCCBINRVIKJHY-UHFFFAOYSA-N, AOCCBINRVIKJHY-UHFFFAOYSA-N",Launched,
carmustine,"DNA alkylating agent, DNA inhibitor",GSR,"hematologic malignancy, oncology","non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, multiple myeloma, glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma",MicroSource,0,BRD-K36234266-001-09-8,[O-][N+]N(CCCl)C(=O)NCCCl,DLGOEMSEDOSKAD-UHFFFAOYSA-N,Launched,
caroverine,"glutamate receptor antagonist, calcium channel blocker",,neurology/psychiatry,tinnitus,Sigma,86.74,BRD-K65900713-003-01-0,CCN(CC)CCN1C(=O)C(Nc2ccccc12)=Cc1ccc(OC)cc1,GVZONAHBJMFJOW-UHFFFAOYSA-N,Launched,
carprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,osteoarthritis,"Selleck, MicroSource",98.54,"BRD-A17411484-001-10-1, BRD-A17411484-001-11-9","CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21, CC(C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21","PUXBGTOOZJQSKH-UHFFFAOYSA-N, PUXBGTOOZJQSKH-UHFFFAOYSA-N",Launched,
carteolol,adrenergic receptor antagonist,"ADRB1, ADRB2",ophthalmology,"intraocular pressure, glaucoma, ocular hypertension",MedChemEx,98.62,BRD-A42167015-003-10-2,CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12,LWAFSWPYPHEXKX-UHFFFAOYSA-N,Launched,
carumonam,bacterial cell wall synthesis inhibitor,,infectious disease,"urinary tract infections, gram-negative bacterial infections",Sigma,97.4,BRD-K71026158-304-01-0,NC(=O)OC[C@@H]1[C@H](NC(=O)C(=N/OCC(O)=O)\c2csc(N)n2)C(=O)N1S(O)(=O)=O,UIMOJFJSJSIGLV-JNHMLNOCSA-N,Launched,
carvedilol,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA",cardiology,"myocardial infarction, hypertension","Tocris, MicroSource, MicroSource, Tocris, Selleck",93.97,"BRD-A10977446-001-17-0, BRD-A10977446-001-14-7, BRD-A10977446-011-01-3, BRD-A10977446-001-13-9, BRD-A10977446-001-12-1","COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12, COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12, COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12, COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12, COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12","OGHNVEJMJSYVRP-UHFFFAOYSA-N, OGHNVEJMJSYVRP-UHFFFAOYSA-N, OGHNVEJMJSYVRP-UHFFFAOYSA-N, OGHNVEJMJSYVRP-UHFFFAOYSA-N, OGHNVEJMJSYVRP-UHFFFAOYSA-N",Launched,
casanthranol-variant,,,,,MicroSource,0,BRD-K12413266-001-01-3,OC[C@H]1O[C@@H](O[C@@H]2c3cccc(O)c3C(=O)c3c(O)cc(CO)cc23)[C@H](O)[C@H](O)[C@H]1O,CPUHNROBVJNNPW-VVBPCJSVSA-N,Launched,
caspofungin,"fungal 1,3-beta-D-glucan synthase inhibitor, bacterial cell wall synthesis inhibitor",,infectious disease,"candidemia, esophageal candidiasis, aspergillosis, fungal infection","MedChemEx, MedChemEx",51.17,"BRD-A31685486-402-01-9, BRD-A31685486-402-02-7","CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)c1ccc(O)cc1)[C@H](O)CCN, CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)c1ccc(O)cc1)[C@H](O)CCN","JYIKNQVWKBUSNH-QPUODBGRSA-N, JYIKNQVWKBUSNH-QPUODBGRSA-N",Launched,
caspofungin-acetate,"fungal 1,3-beta-D-glucan synthase inhibitor",,infectious disease,"candidemia, esophageal candidiasis, aspergillosis, peritonitis","Selleck, Selleck",79.25,"BRD-K49793107-402-03-4, BRD-K49793107-402-02-6","CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@H](O)CCN, CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@H](O)CCN","JYIKNQVWKBUSNH-JYEVSGHCSA-N, JYIKNQVWKBUSNH-JYEVSGHCSA-N",Launched,"BRD-K49793107-001-01-8,BRD-K33838583-402-01-2"
cefaclor,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology","pneumonia, skin infections, urinary tract infections, respiratory tract infections, tonsillitis, pharyngitis","Selleck, MicroSource, Selleck",89.07,"BRD-K20338176-001-18-5, BRD-K20338176-001-17-7, BRD-K20338176-001-16-9","N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1, N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1, N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1","QYIYFLOTGYLRGG-GPCCPHFNSA-N, QYIYFLOTGYLRGG-GPCCPHFNSA-N, QYIYFLOTGYLRGG-GPCCPHFNSA-N",Launched,
cefadroxil,bacterial cell wall synthesis inhibitor,"SLC15A1, SLC15A2, SLC22A6, SLC22A8","infectious disease, otolaryngology","urinary tract infections, skin infections, tonsillitis, pharyngitis",MicroSource,87.28,BRD-A56858165-001-04-4,CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c1ccc(O)cc1)C2=O)C(O)=O,BOEGTKLJZSQCCD-HUFXEGEASA-N,Launched,
cefalonium,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,MicroSource,0,BRD-K15514357-001-05-6,NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc2cccs2)C3=O)C(O)=O)cc1,FMZXNVLFJHCSAF-DNVCBOLYSA-O,Launched,
cefamandole,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, urinary tract infections, respiratory tract infections","Sigma, MicroSource",32.02,"BRD-K27130738-236-14-1, BRD-K27130738-236-15-8","Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](O)c1ccccc1)C2=O)C(O)=O, Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](O)c1ccccc1)C2=O)C(O)=O","OLVCFLKTBJRLHI-AXAPSJFSSA-N, OLVCFLKTBJRLHI-AXAPSJFSSA-N",Launched,BRD-A23933379-236-04-9
cefamandole-nafate,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, urinary tract infections, respiratory tract infections","MedChemEx, MedChemEx, MicroSource",43.32,"BRD-K17903788-236-01-9, BRD-K17903788-236-02-7, BRD-K17903788-236-03-5","Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](OC=O)c1ccccc1)C2=O)C(O)=O, Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](OC=O)c1ccccc1)C2=O)C(O)=O, Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](OC=O)c1ccccc1)C2=O)C(O)=O","RRJHESVQVSRQEX-SUYBPPKGSA-N, RRJHESVQVSRQEX-SUYBPPKGSA-N, RRJHESVQVSRQEX-SUYBPPKGSA-N",Launched,BRD-A02439449-236-04-8
cefathiamidine,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,AKSci,68.39,BRD-K63835048-001-01-0,CC(C)N\C(SCC(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)=N/C(C)C,JYXACOFERDBGGQ-RHSMWYFYSA-N,Launched,
cefazolin,bacterial cell wall synthesis inhibitor,PON1,infectious disease,"urinary tract infections, skin infections, bacterial septicemia, endocarditis, surgical prophylaxis, bone and joint infections","MedChemEx, MicroSource, MedChemEx",87.37,"BRD-K99750640-236-20-3, BRD-K99750640-236-18-7, BRD-K99750640-236-19-5","Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn2cnnn2)C3=O)C(O)=O)s1, Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn2cnnn2)C3=O)C(O)=O)s1, Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn2cnnn2)C3=O)C(O)=O)s1","MLYYVTUWGNIJIB-BXKDBHETSA-N, MLYYVTUWGNIJIB-BXKDBHETSA-N, MLYYVTUWGNIJIB-BXKDBHETSA-N",Launched,
cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, pneumonia, urinary tract infections","Sigma, AKSci, Astatech",90.61,"BRD-K27515606-311-02-8, BRD-K27515606-311-01-0, BRD-K27515606-003-01-3","CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1, CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1, CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1","WVPAABNYMHNFJG-QDVBXLKVSA-N, WVPAABNYMHNFJG-QDVBXLKVSA-N, WVPAABNYMHNFJG-QDVBXLKVSA-N",Launched,
cefdinir,bacterial cell wall synthesis inhibitor,MPO,"infectious disease, otolaryngology, pulmonary","pneumonia, tonsillitis, pharyngitis, bronchitis, skin infections, otitis, sinusitis","MicroSource, Selleck, Selleck",87.42,"BRD-K15766189-001-09-8, BRD-K15766189-001-10-6, BRD-K15766189-001-08-0","Nc1nc(cs1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=N\O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O","RTXOFQZKPXMALH-GHXIOONMSA-N, RTXOFQZKPXMALH-GHXIOONMSA-N, RTXOFQZKPXMALH-GHXIOONMSA-N",Launched,
cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,,"infectious disease, pulmonary, otolaryngology","pneumonia, bronchitis, skin infections, tonsillitis, pharyngitis","MicroSource, Selleck, Selleck",88.24,"BRD-K72167406-001-04-7, BRD-K72167406-001-02-1, BRD-K72167406-001-03-9","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(\C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1","AFZFFLVORLEPPO-UVYJNCLZSA-N, AFZFFLVORLEPPO-UVYJNCLZSA-N, AFZFFLVORLEPPO-UVYJNCLZSA-N",Launched,"BRD-A39056513-001-04-6, BRD-K05878591-001-01-2"
cefepime,bacterial cell wall synthesis inhibitor,,infectious disease,"pneumonia, urinary tract infections, skin infections, intra-abdominal infections",MicroSource,96.32,BRD-A12077521-003-01-5,CO\N=C(\C(=O)NC1C2SCC(C[N+]3(C)CCCC3)=C(N2C1=O)C(O)=O)c1csc(N)n1,HVFLCNVBZFFHBT-FSJBWODESA-O,Launched,
cefetamet,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology, pulmonary","ear infections, pneumonia, otitis, sinusitis, bronchitis, urinary tract infections",Sigma,91.04,BRD-K27798832-001-01-5,CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(O)=O)c1csc(N)n1,MQLRYUCJDNBWMV-GHXIOONMSA-N,Launched,
cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,"AvaChem, AKSci, MedChemEx",87.11,"BRD-K21372554-001-01-1, BRD-K21372554-003-01-7, BRD-K21372554-003-02-5","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1","DASYMCLQENWCJG-XUKDPADISA-N, DASYMCLQENWCJG-XUKDPADISA-N, DASYMCLQENWCJG-XUKDPADISA-N",Launched,
cefixime,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology, pulmonary","urinary tract infections, otitis, pharyngitis, tonsillitis, gonorrhea, bronchitis","Sigma, MedChemEx, Enzo",93.65,"BRD-K71059170-341-02-5, BRD-K71059170-001-12-4, BRD-K71059170-001-11-6","Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O","OKBVVJOGVLARMR-QSWIMTSFSA-N, OKBVVJOGVLARMR-QSWIMTSFSA-N, OKBVVJOGVLARMR-QSWIMTSFSA-N",Launched,
cefmenoxime,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,85.33,BRD-A20839672-003-01-5,CO\N=C(\C(=O)NC1C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1,HJJDBAOLQAWBMH-ODCIPOBUSA-N,Launched,
cefmetazole,bacterial cell wall synthesis inhibitor,,infectious disease,"urinary tract infections, skin infections","MedChemEx, MedChemEx, MicroSource",89.48,"BRD-K48470486-236-11-6, BRD-K48470486-236-10-8, BRD-K48470486-236-12-4","CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O","SNBUBQHDYVFSQF-HIFRSBDPSA-N, SNBUBQHDYVFSQF-HIFRSBDPSA-N, SNBUBQHDYVFSQF-HIFRSBDPSA-N",Launched,BRD-A97040294-236-04-6
cefminox,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,Key,83.7,BRD-K77073709-435-01-2,CO[C@]1(NC(=O)CSC[C@@H](N)C(O)=O)[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O,JSDXOWVAHXDYCU-VXSYNFHWSA-N,Launched,
cefodizime,bacterial cell wall synthesis inhibitor,,infectious disease,"respiratory tract infections, skin infections, gonorrhea","AKSci, Kemprotec",73.75,"BRD-K22641081-001-01-0, BRD-K22641081-304-01-8","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(C)c(CC(O)=O)s3)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(C)c(CC(O)=O)s3)=C(N2C1=O)C(O)=O)c1csc(N)n1","XDZKBRJLTGRPSS-BGZQYGJUSA-N, XDZKBRJLTGRPSS-BGZQYGJUSA-N",Launched,"BRD-A42969929-001-01-9, BRD-K72150952-304-01-5"
cefonicid,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,"MicroSource, MedChemEx, MedChemEx",83.1,"BRD-K34058848-304-03-1, BRD-K34058848-304-02-3, BRD-K34058848-304-01-5","O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1, O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1, O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1","DYAIAHUQIPBDIP-AXAPSJFSSA-N, DYAIAHUQIPBDIP-AXAPSJFSSA-N, DYAIAHUQIPBDIP-AXAPSJFSSA-N",Launched,BRD-A65872513-304-01-7
cefoperazone,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,"MicroSource, Selleck",95.7,"BRD-K02292852-001-04-7, BRD-K02292852-001-02-1","CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSc4nnnn4C)=C(N3C2=O)C(O)=O)c2ccc(O)cc2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSc4nnnn4C)=C(N3C2=O)C(O)=O)c2ccc(O)cc2)C(=O)C1=O","GCFBRXLSHGKWDP-XCGNWRKASA-N, GCFBRXLSHGKWDP-XCGNWRKASA-N",Launched,BRD-A73079885-001-01-1
ceforanide,penicillin binding protein inhibitor,,infectious disease,gram-negative bacterial infections,"MicroSource, AvaChem",90.8,"BRD-K37848908-001-06-4, BRD-K37848908-001-05-6","NCc1ccccc1CC(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CC(O)=O)=C(N2C1=O)C(O)=O, NCc1ccccc1CC(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CC(O)=O)=C(N2C1=O)C(O)=O","SLAYUXIURFNXPG-CRAIPNDOSA-N, SLAYUXIURFNXPG-CRAIPNDOSA-N",Launched,BRD-A38738672-001-01-3
cefoselis,bacterial cell wall synthesis inhibitor,,,,"Selleck, MedChemEx, AKSci, Selleck",99.54,"BRD-K72339976-065-03-9, BRD-K72339976-065-01-3, BRD-K72339976-065-04-7, BRD-K72339976-065-02-1","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(Cn3ccc(=N)n3CCO)=C(N2C1=O)C(O)=O)c1csc(N)n1","ZINFAXPQMLDEEJ-GFVOIPPFSA-N, ZINFAXPQMLDEEJ-GFVOIPPFSA-N, ZINFAXPQMLDEEJ-GFVOIPPFSA-N, ZINFAXPQMLDEEJ-GFVOIPPFSA-N",Launched,"BRD-K37910175-065-03-0, BRD-K20284063-065-01-8, BRD-K02689172-065-01-8"
cefotaxime,bacterial cell wall synthesis inhibitor,,infectious disease,"respiratory tract infections, bone and joint infections, pelvic inflammatory disease, intra-abdominal infections, skin infections, bone and joint infections, meningitis, urinary tract infections, bacterial septicemia, gynecologic infections","MedChemEx, MicroSource, MedChemEx, Sigma",95.77,"BRD-K78364995-236-18-3, BRD-K78364995-236-19-1, BRD-K78364995-236-17-5, BRD-K78364995-236-16-7","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1","GPRBEKHLDVQUJE-QSWIMTSFSA-N, GPRBEKHLDVQUJE-QSWIMTSFSA-N, GPRBEKHLDVQUJE-QSWIMTSFSA-N, GPRBEKHLDVQUJE-QSWIMTSFSA-N",Launched,BRD-K99586414-236-04-9
cefotetan,bacterial cell wall synthesis inhibitor,,infectious disease,"urinary tract infections, respiratory tract infections, skin infections, gynecologic infections, chlamydia, intra-abdominal infections, bone and joint infections, surgical prophylaxis",MicroSource,88.4,BRD-A78723049-001-01-2,CO[C@]1(NC(=O)C2SC(S2)=C(C(N)=O)C(O)=O)C2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O,SRZNHPXWXCNNDU-PGEKIEPBSA-N,Launched,
cefotiam,bacterial cell wall synthesis inhibitor,,infectious disease,"bacterial septicemia, bone and joint infections, respiratory tract infections, skin infections, urinary tract infections","Prestwick, MedChemEx",88.63,"BRD-K02275692-300-01-8, BRD-K02275692-300-02-6","CN(C)CCn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1csc(N)n1)C2=O)C(O)=O, CN(C)CCn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1csc(N)n1)C2=O)C(O)=O","QYQDKDWGWDOFFU-IUODEOHRSA-N, QYQDKDWGWDOFFU-IUODEOHRSA-N",Launched,
cefotiam-cilexetil,bacterial cell wall synthesis inhibitor,,,,"SantaCruz, SantaCruz",23.99,"BRD-A76661185-300-02-4, BRD-A76661185-300-01-6","CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CSC2C(NC(=O)Cc3csc(N)n3)C(=O)N12, CC(OC(=O)OC1CCCCC1)OC(=O)C1=C(CSc2nnnn2CCN(C)C)CSC2C(NC(=O)Cc3csc(N)n3)C(=O)N12","VVFDMWZLBPUKTD-UHFFFAOYSA-N, VVFDMWZLBPUKTD-UHFFFAOYSA-N",Launched,
cefoxitin,bacterial cell wall synthesis inhibitor,,infectious disease,"respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections","MedChemEx, MedChemEx, MicroSource",98.36,"BRD-K70976396-236-27-8, BRD-K70976396-236-26-0, BRD-K70976396-236-25-2","CO[C@]1(NC(=O)Cc2cccs2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)Cc2cccs2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)Cc2cccs2)[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O","WZOZEZRFJCJXNZ-ZBFHGGJFSA-N, WZOZEZRFJCJXNZ-ZBFHGGJFSA-N, WZOZEZRFJCJXNZ-ZBFHGGJFSA-N",Launched,
cefozopran,bacterial cell wall synthesis inhibitor,,,,MedChemEx,90.83,BRD-K46970505-003-01-9,CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccn4ncccc34)=C(N2C1=O)C(O)=O)c1nsc(N)n1,QDUIJCOKQCCXQY-WHJQOFBOSA-O,Launched,
cefpiramide,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,"MicroSource, Sigma, MedChemEx",86.38,"BRD-K92872987-001-02-9, BRD-K92872987-001-01-1, BRD-K92872987-236-03-9","Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1ccc(O)cc1, Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1ccc(O)cc1, Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O)c1ccc(O)cc1","PWAUCHMQEXVFJR-PMAPCBKXSA-N, PWAUCHMQEXVFJR-PMAPCBKXSA-N, PWAUCHMQEXVFJR-PMAPCBKXSA-N",Launched,BRD-A39975020-001-01-9
cefpirome,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,ChemImpex,91.01,BRD-K56542719-065-01-4,CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3cccc4CCCc34)=C(N2C1=O)C(O)=O)c1csc(N)n1,DKOQGJHPHLTOJR-PUIFZAHNSA-O,Launched,
cefpodoxime,bacterial cell wall synthesis inhibitor,,"otolaryngology, infectious disease, pulmonary","pharyngitis, pneumonia, bronchitis, gonorrhea, skin infections, urinary tract infections, sinusitis, tonsillitis","Key, MicroSource",49.13,"BRD-A34205213-001-03-9, BRD-A34205213-001-04-7","COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)\c1csc(N)n1)C2=O)C(=O)OC(C)OC(=O)OC(C)C, COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)\c1csc(N)n1)C2=O)C(=O)OC(C)OC(=O)OC(C)C","LTINZAODLRIQIX-FBXRGJNPSA-N, LTINZAODLRIQIX-FBXRGJNPSA-N",Launched,BRD-A87387433-001-03-5
cefprozil,bacterial cell wall synthesis inhibitor,,"otolaryngology, infectious disease, pulmonary","pharyngitis, tonsillitis, otitis, sinusitis, respiratory tract infections, skin infections, bronchitis","MicroSource, Selleck, MedChemEx, Selleck",76.4,"BRD-K24871708-001-01-4, BRD-K24871708-002-03-8, BRD-K24871708-002-04-6, BRD-K24871708-002-02-0","C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O, C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O, C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O, C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O","WDLWHQDACQUCJR-ZAMMOSSLSA-N, WDLWHQDACQUCJR-ZAMMOSSLSA-N, WDLWHQDACQUCJR-ZAMMOSSLSA-N, WDLWHQDACQUCJR-ZAMMOSSLSA-N",Launched,BRD-A85137183-001-03-8
cefradine,bacterial cell wall synthesis inhibitor,CYP3A4,"infectious disease, otolaryngology","respiratory tract infections, otitis, skin infections, urinary tract infections, tonsillitis, pharyngitis, pneumonia","MedChemEx, MedChemEx",65.46,"BRD-K13797099-001-02-9, BRD-K13797099-001-01-1","CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O, CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O","RDLPVSKMFDYCOR-UEKVPHQBSA-N, RDLPVSKMFDYCOR-UEKVPHQBSA-N",Launched,
cefsulodin,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,"MedChemEx, MedChemEx, Sigma, MicroSource",29.68,"BRD-K03907181-236-06-8, BRD-K03907181-236-05-0, BRD-K03907181-236-04-3, BRD-K03907181-236-07-6","NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1, NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1, NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1, NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c2ccccc2)S(O)(=O)=O)C3=O)C(O)=O)cc1","SYLKGLMBLAAGSC-QLVMHMETSA-O, SYLKGLMBLAAGSC-QLVMHMETSA-O, SYLKGLMBLAAGSC-QLVMHMETSA-O, SYLKGLMBLAAGSC-QLVMHMETSA-O",Launched,BRD-A86462796-236-04-8
ceftaroline-fosamil,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, pneumonia",GLSyntech,63.93,BRD-K37252028-349-01-8,CCO\N=C(\C(=O)N[C@H]1[C@H]2SCC(Sc3nc(cs3)-c3cc[n+](C)cc3)=C(N2C1=O)C(O)=O)c1nsc(NP(O)(O)=O)n1,ZCCUWMICIWSJIX-XHNDKCDBSA-O,Launched,
ceftazidime,bacterial cell wall synthesis inhibitor,,infectious disease,"respiratory tract infections, skin infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, meningitis","Sigma, MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",74,"BRD-K52117081-345-03-1, BRD-K52117081-001-03-0, BRD-K52117081-396-01-8, BRD-K52117081-001-02-2, BRD-K57502136-345-02-6, BRD-K57502136-345-03-4","CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O, CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O, CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O, CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O, CC(C)(O\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O, CC(C)(O\N=C(\C(=O)N[C@H]1[C@H]2SCC(C[n+]3ccccc3)=C(N2C1=O)C(O)=O)c1csc(N)n1)C(O)=O","ORFOPKXBNMVMKC-DWVKKRMSSA-O, ORFOPKXBNMVMKC-DWVKKRMSSA-O, ORFOPKXBNMVMKC-DWVKKRMSSA-O, ORFOPKXBNMVMKC-DWVKKRMSSA-O, ORFOPKXBNMVMKC-KZBLUZIOSA-O, ORFOPKXBNMVMKC-KZBLUZIOSA-O",Launched,BRD-A73933229-396-01-8
ceftibuten,bacterial cell wall synthesis inhibitor,,"pulmonary, otolaryngology","bronchitis, otitis, pharyngitis, tonsillitis","MicroSource, MedChemEx, MedChemEx, MedChemEx, Sigma",95.4,"BRD-K11124378-001-04-6, BRD-K11124378-335-03-0, BRD-K11124378-335-01-4, BRD-K11124378-335-02-2, BRD-K11124378-002-01-0","Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O, Nc1nc(cs1)C(=C\CC(O)=O)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O","UNJFKXSSGBWRBZ-BJCIPQKHSA-N, UNJFKXSSGBWRBZ-BJCIPQKHSA-N, UNJFKXSSGBWRBZ-BJCIPQKHSA-N, UNJFKXSSGBWRBZ-BJCIPQKHSA-N, UNJFKXSSGBWRBZ-BJCIPQKHSA-N",Launched,
ceftiofur,bacterial cell wall synthesis inhibitor,,infectious disease,"pneumonia, respiratory tract infections","MicroSource, Selleck, Selleck",93.8,"BRD-K82960980-003-01-9, BRD-K82960980-003-03-5, BRD-K82960980-003-02-7","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c1csc(N)n1","ZBHXIWJRIFEVQY-IHMPYVIRSA-N, ZBHXIWJRIFEVQY-IHMPYVIRSA-N, ZBHXIWJRIFEVQY-IHMPYVIRSA-N",Launched,"BRD-K75097379-003-01-8, BRD-K15436267-003-01-6, BRD-K21017401-003-02-1"
ceftizoxim,bacterial cell wall synthesis inhibitor,,infectious disease,"respiratory tract infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, intra-abdominal infections, bacterial septicemia, skin infections, bone and joint infections, meningitis","MedChemEx, MedChemEx, Enzo",88.85,"BRD-K04301924-236-03-2, BRD-K04301924-236-02-4, BRD-K04301924-236-01-6","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(O)=O)c1csc(N)n1","NNULBSISHYWZJU-LLKWHZGFSA-N, NNULBSISHYWZJU-LLKWHZGFSA-N, NNULBSISHYWZJU-LLKWHZGFSA-N",Launched,
ceftriaxone,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology","gonorrhea, pneumonia, otitis, skin infections, urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, surgical prophylaxis","MicroSource, MedChemEx",85.48,"BRD-K96734425-324-01-5, BRD-K96734425-304-01-7","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(=O)c(O)nn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(=O)c(O)nn3C)=C(N2C1=O)C(O)=O)c1csc(N)n1","VAAUVRVFOQPIGI-SPQHTLEESA-N, VAAUVRVFOQPIGI-SPQHTLEESA-N",Launched,BRD-K38010979-324-03-7
cefuroxime,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections,"MedChemEx, MedChemEx, MicroSource",86.53,"BRD-K02733959-236-06-9, BRD-K02733959-236-05-1, BRD-K02733959-236-07-7","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1","JFPVXVDWJQMJEE-IZRZKJBUSA-N, JFPVXVDWJQMJEE-IZRZKJBUSA-N, JFPVXVDWJQMJEE-IZRZKJBUSA-N",Launched,BRD-A76746748-236-04-5
cefuroxime-axetil,bacterial cell wall synthesis inhibitor,,otolaryngology,"pharyngitis, tonsillitis, otitis, sinusitis","Sigma, MicroSource",56.52,"BRD-A22303829-001-01-6, BRD-A22303829-001-02-4","CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(C)=O)c1ccco1, CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(C)=O)c1ccco1","KEJCWVGMRLCZQQ-YJBYXUATSA-N, KEJCWVGMRLCZQQ-YJBYXUATSA-N",Launched,BRD-A36322567-001-02-4
celecoxib,cyclooxygenase inhibitor,"CA12, PDPK1, PTGS2","rheumatology, endocrinology","osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, primary dysmenorrhea (PD)","Tocris, MicroSource, Selleck",99.47,"BRD-K02637541-001-22-2, BRD-K02637541-001-18-0, BRD-K02637541-001-17-2","Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F, Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F, Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F","RZEKVGVHFLEQIL-UHFFFAOYSA-N, RZEKVGVHFLEQIL-UHFFFAOYSA-N, RZEKVGVHFLEQIL-UHFFFAOYSA-N",Launched,
celiprolol,adrenergic receptor antagonist,"ADRA2A, ADRB1, ADRB2",genetics,Ehlers-Danlos syndrome (EDS),Prestwick,97.27,BRD-A95602221-003-02-1,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O,JOATXPAWOHTVSZ-UHFFFAOYSA-N,Launched,
cephalexin,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology","respiratory tract infections, otitis, skin infections, bone and joint infections, genitourinary tract infections","MedChemEx, MedChemEx, Sigma, Selleck, MicroSource, Selleck",75.26,"BRD-K90733503-001-08-7, BRD-K90733503-001-07-9, BRD-K90733503-001-06-1, BRD-K90733503-001-09-5, BRD-K90733503-001-10-3, BRD-K90733503-001-05-3","CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O, CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O, CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O, CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O, CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O, CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O)C(O)=O","ZAIPMKNFIOOWCQ-UEKVPHQBSA-N, ZAIPMKNFIOOWCQ-UEKVPHQBSA-N, ZAIPMKNFIOOWCQ-UEKVPHQBSA-N, ZAIPMKNFIOOWCQ-UEKVPHQBSA-N, ZAIPMKNFIOOWCQ-UEKVPHQBSA-N, ZAIPMKNFIOOWCQ-UEKVPHQBSA-N",Launched,"BRD-K64997193-001-01-0, BRD-A37536726-001-04-2"
cephalothin,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, surgical prophylaxis",MicroSource,92.86,BRD-K28210218-236-08-1,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc1cccs1)C2=O)C(O)=O,XIURVHNZVLADCM-IUODEOHRSA-N,Launched,
cephapirin,bacterial cell wall synthesis inhibitor,,obstetrics/gynecology,mastitis,"MicroSource, Selleck",85.45,"BRD-K49880111-236-09-2, BRD-K49880111-236-10-0","CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc1ccncc1)C2=O)C(O)=O, CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc1ccncc1)C2=O)C(O)=O","UQLLWWBDSUHNEB-CZUORRHYSA-N, UQLLWWBDSUHNEB-CZUORRHYSA-N",Launched,BRD-K25085912-236-01-4
cephradine,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, respiratory tract infections, urinary tract infections",MicroSource,5.47,BRD-A90807417-001-04-5,CC1=C(N2C(SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O,RDLPVSKMFDYCOR-MHSSMOFYSA-N,Launched,
ceramide,"phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator",,dermatology,cosmetic,Tocris,100,BRD-K41707108-001-05-6,CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O,BLTCBVOJNNKFKC-QUDYQQOWSA-N,Launched,
ceritinib,ALK tyrosine kinase receptor inhibitor,"ALK, FLT3, IGF1R, INSR, TSSK1B",oncology,non-small cell lung cancer (NSCLC),"MedChemEx, MedChemEx, Selleck, Selleck",95.07,"BRD-K22149900-001-06-2, BRD-K22149900-001-05-4, BRD-K22149900-001-03-9, BRD-K22149900-001-01-3","CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1, CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1, CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1, CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1","VERWOWGGCGHDQE-UHFFFAOYSA-N, VERWOWGGCGHDQE-UHFFFAOYSA-N, VERWOWGGCGHDQE-UHFFFAOYSA-N, VERWOWGGCGHDQE-UHFFFAOYSA-N",Launched,
cerulenin,fatty acid synthase inhibitor,FASN,infectious disease,fungal infection,Enzo,41.25,BRD-K52075040-001-09-7,C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O,GVEZIHKRYBHEFX-NQQPLRFYSA-N,Launched,
cetirizine,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,"MicroSource, Tocris, Selleck",98.06,"BRD-A42571354-300-13-8, BRD-A42571354-300-12-0, BRD-A42571354-300-11-2","OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1, OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1, OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1","ZKLPARSLTMPFCP-UHFFFAOYSA-N, ZKLPARSLTMPFCP-UHFFFAOYSA-N, ZKLPARSLTMPFCP-UHFFFAOYSA-N",Launched,
cetrimonium,,,dermatology,cosmetic,"Selleck, MicroSource",100,"BRD-K47079459-004-04-6, BRD-K47079459-004-05-3","CCCCCCCCCCCCCCCC[N+](C)(C)C, CCCCCCCCCCCCCCCC[N+](C)(C)C","RLGQACBPNDBWTB-UHFFFAOYSA-N, RLGQACBPNDBWTB-UHFFFAOYSA-N",Launched,
cetrorelix,gonadotropin releasing factor hormone receptor antagonist,"GNRHR, LHCGR",endocrinology,premature luteinizing hormone surges,Sigma,97.29,BRD-K76315403-015-02-5,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,SBNPWPIBESPSIF-MHWMIDJBSA-N,Launched,
cetylpyridinium,,,dental,"gingivitis, mouth inflammation","MicroSource, Selleck, Selleck",98.97,"BRD-K87700323-003-05-1, BRD-K87700323-003-04-4, BRD-K87700323-003-06-9","CCCCCCCCCCCCCCCC[n+]1ccccc1, CCCCCCCCCCCCCCCC[n+]1ccccc1, CCCCCCCCCCCCCCCC[n+]1ccccc1","NEUSVAOJNUQRTM-UHFFFAOYSA-N, NEUSVAOJNUQRTM-UHFFFAOYSA-N, NEUSVAOJNUQRTM-UHFFFAOYSA-N",Launched,
cevimeline,acetylcholine receptor agonist,"CHRM1, CHRM3",rheumatology,sjogren's syndrome,Tocris,97.85,BRD-M98279124-300-01-1,C[C@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1,YMMKDPCCYMGDHD-JWGPUQBJSA-N,Launched,
chenodeoxycholic-acid,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","HSD11B1, NR1H4","cardiology, gastroenterology","cerebral cholesterosis, gallstones","MicroSource, Selleck",100,"BRD-K18135438-001-14-2, BRD-K18135438-001-16-7","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C, C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","RUDATBOHQWOJDD-BSWAIDMHSA-N, RUDATBOHQWOJDD-BSWAIDMHSA-N",Launched,BRD-K43723251-001-01-5
chidamide,HDAC inhibitor,"HDAC10, HDAC3",,,MedChemEx,91.41,BRD-K28537285-001-01-8,Nc1ccc(F)cc1NC(=O)c1ccc(CNC(=O)\C=C\c2cccnc2)cc1,WXHHICFWKXDFOW-BJMVGYQFSA-N,Launched,
chiniofon,antiprotozoal agent,,infectious disease,amebiasis,MicroSource,95.18,BRD-K52284881-236-02-4,Oc1c(I)cc(c2cccnc12)S(O)(=O)=O,ZBJWWKFMHOAPNS-UHFFFAOYSA-N,Launched,
chlorambucil,DNA inhibitor,,hematologic malignancy,"chronic lymphocytic leukemia (CLL), Hodgkin's lymphoma",MicroSource,94.93,BRD-K29458283-001-29-9,OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl,JCKYGMPEJWAADB-UHFFFAOYSA-N,Launched,
chloramine-t,,,infectious disease,bacterial gill disease,MicroSource,69.13,BRD-K93546328-236-02-8,Cc1ccc(cc1)S(=O)(=O)NCl,NXTVQNIVUKXOIL-UHFFFAOYSA-N,Launched,
chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55,"infectious disease, endocrinology","meningitis, fever, cholera","MicroSource, Selleck",99.59,"BRD-K08111712-001-16-7, BRD-K08111712-001-14-2","OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O, OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O","WIIZWVCIJKGZOK-RKDXNWHRSA-N, WIIZWVCIJKGZOK-RKDXNWHRSA-N",Launched,BRD-K22969690-001-04-2
chloramphenicol-palmitate,protein synthesis inhibitor,,"infectious disease, endocrinology","meningitis, fever, cholera",MicroSource,89.74,BRD-K96424892-001-02-9,CCCCCCCCCCCCCCCC(=O)OC[C@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+]([O-])=O,PXKHGMGELZGJQE-UKILVPOCSA-N,Launched,
chloramphenicol-sodium-succinate,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,31.43,BRD-K25209357-236-01-2,O[C@@H]([C@@H](COC(=O)CCC(O)=O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+]([O-])=O,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,Launched,
chlorcyclizine,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,Enzo,97.82,BRD-A57133233-003-11-0,CN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,WFNAKBGANONZEQ-UHFFFAOYSA-N,Launched,
chlorhexidine,membrane integrity inhibitor,,"dermatology, infectious disease, dental","cosmetic, skin infections, gingivitis",MicroSource,97.77,BRD-K52256627-300-06-6,Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Launched,
chlormadinone-acetate,5 alpha reductase inhibitor,PGR,endocrinology,"hypermenorrhea, amenorrhea, oligomenorrhea, polymenorrhea",MicroSource,99.74,BRD-A01593789-001-03-1,CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O,QMBJSIBWORFWQT-GDMUWPLKSA-N,Launched,
chlormidazole,fungal lanosterol demethylase inhibitor,,infectious disease,fungal infection,MicroSource,94.26,BRD-K60443845-001-08-6,Cc1nc2ccccc2n1Cc1ccc(Cl)cc1,WNAQOLSMVPFGTE-UHFFFAOYSA-N,Launched,
chlorobutanol,,,neurology/psychiatry,"anesthetic, sedative","MicroSource, Enamine",0,"BRD-K39495750-001-01-2, BRD-K39495750-001-02-0","CC(C)(O)C(Cl)(Cl)Cl, CC(C)(O)C(Cl)(Cl)Cl","OSASVXMJTNOKOY-UHFFFAOYSA-N, OSASVXMJTNOKOY-UHFFFAOYSA-N",Launched,
chlorocresol,ryanodine receptor activator,,infectious disease,first-aid antiseptic,"MicroSource, Selleck, Selleck",94.58,"BRD-K89056082-001-07-7, BRD-K89056082-001-06-9, BRD-K89056082-001-08-5","Cc1cc(O)ccc1Cl, Cc1cc(O)ccc1Cl, Cc1cc(O)ccc1Cl","CFKMVGJGLGKFKI-UHFFFAOYSA-N, CFKMVGJGLGKFKI-UHFFFAOYSA-N, CFKMVGJGLGKFKI-UHFFFAOYSA-N",Launched,
chlorogenic-acid,antioxidant,SLC37A4,"neurology/psychiatry, pulmonary, allergy","headache, chest congestion, allergic rhinitis","Selleck, Selleck",95.33,"BRD-K47114202-001-14-6, BRD-K47114202-001-15-3","O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)C(O)=O, O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)C(O)=O","CWVRJTMFETXNAD-JUHZACGLSA-N, CWVRJTMFETXNAD-JUHZACGLSA-N",Launched,BRD-K46579573-001-01-9
chloroprocaine,sodium channel blocker,"ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3",neurology/psychiatry,local anesthetic,Enamine,88.33,BRD-K86864073-001-01-1,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,VDANGULDQQJODZ-UHFFFAOYSA-N,Launched,
chloropyramine,histamine receptor antagonist,HRH1,"cardiology, ophthalmology, allergy, pulmonary","edema, conjunctivitis, allergic rhinitis, asthma",MicroSource,95.27,BRD-K83257731-003-23-5,CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1,ICKFFNBDFNZJSX-UHFFFAOYSA-N,Launched,
chloroquine,antimalarial agent,"GSTA2, MRGPRX1, TLR9, TNF",infectious disease,"malaria, amebiasis","MicroSource, Selleck, Selleck",96.54,"BRD-A91699651-316-10-9, BRD-A91699651-316-09-1, BRD-A91699651-316-11-7","CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12, CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12, CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12","WHTVZRBIWZFKQO-UHFFFAOYSA-N, WHTVZRBIWZFKQO-UHFFFAOYSA-N, WHTVZRBIWZFKQO-UHFFFAOYSA-N",Launched,
chlorothiazide,diuretic,"CA1, CA2, CA4, SLC12A3",cardiology,hypertension,"MicroSource, Selleck",95.43,"BRD-K88682005-001-16-6, BRD-K88682005-001-15-8","NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O, NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O","JBMKAUGHUNFTOL-UHFFFAOYSA-N, JBMKAUGHUNFTOL-UHFFFAOYSA-N",Launched,
chlorothymol,,,,,Enamine,0,BRD-K04358951-001-01-0,CC(C)c1cc(Cl)c(C)cc1O,KFZXVMNBUMVKLN-UHFFFAOYSA-N,Launched,
chlorotrianisene,estrogenic hormone,"ESR1, ESR2","endocrinology, oncology","menopause, prostate cancer",Prestwick,98.18,BRD-K27062708-001-23-1,COc1ccc(cc1)C(Cl)=C(c1ccc(OC)cc1)c1ccc(OC)cc1,BFPSDSIWYFKGBC-UHFFFAOYSA-N,Launched,
chloroxine,opioid receptor antagonist,OPRK1,"gastroenterology, infectious disease, dermatology","diarrhea, inflammatory bowel disease, giardiasis, dandruff","MicroSource, Selleck, Selleck",99.48,"BRD-K17075857-001-17-6, BRD-K17075857-001-18-4, BRD-K17075857-001-16-8","Oc1c(Cl)cc(Cl)c2cccnc12, Oc1c(Cl)cc(Cl)c2cccnc12, Oc1c(Cl)cc(Cl)c2cccnc12","WDFKMLRRRCGAKS-UHFFFAOYSA-N, WDFKMLRRRCGAKS-UHFFFAOYSA-N, WDFKMLRRRCGAKS-UHFFFAOYSA-N",Launched,
chloroxoquinoline,,,,,Alinda,97.87,BRD-K83335125-001-07-0,Oc1ccnc2cc(Cl)ccc12,XMFXTXKSWIDMER-UHFFFAOYSA-N,Launched,
chloroxylenol,ATP synthase inhibitor,,infectious disease,skin infections,MicroSource,95.32,BRD-K17223896-001-10-0,Cc1cc(O)cc(C)c1Cl,OSDLLIBGSJNGJE-UHFFFAOYSA-N,Launched,
chlorphenamine,histamine receptor antagonist,"HRH1, SLC6A2, SLC6A3, SLC6A4",allergy,"allergic rhinitis, urticaria",Selleck,96.29,BRD-A04553218-050-16-2,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,SOYKEARSMXGVTM-UHFFFAOYSA-N,Launched,
chlorphenesin,muscle relaxant,,neurology/psychiatry,"muscle relaxant, sedative","Enamine, Sigma",98.16,"BRD-A92262698-001-01-7, BRD-A92262698-001-02-5","OCC(O)COc1ccc(Cl)cc1, OCC(O)COc1ccc(Cl)cc1","MXOAEAUPQDYUQM-UHFFFAOYSA-N, MXOAEAUPQDYUQM-UHFFFAOYSA-N",Launched,
chlorproguanil,dihydrofolate reductase inhibitor,DHFR,infectious disease,malaria,AMS,97.75,BRD-K25494650-003-01-8,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1,ISZNZKHCRKXXAU-UHFFFAOYSA-N,Launched,
chlorpromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5","neurology/psychiatry, gastroenterology, hematology, infectious disease","schizophrenia, nausea, vomiting, acute intermittent porphyria (AIP), tetanus","MicroSource, Selleck, Selleck",97.33,"BRD-K89997465-001-10-3, BRD-K89997465-003-43-0, BRD-K89997465-003-44-8","CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12, CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12, CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12","ZPEIMTDSQAKGNT-UHFFFAOYSA-N, ZPEIMTDSQAKGNT-UHFFFAOYSA-N, ZPEIMTDSQAKGNT-UHFFFAOYSA-N",Launched,
chlorpropamide,ATP channel blocker,"ABCC8, KCNJ10, KCNJ11",endocrinology,diabetes mellitus,"MicroSource, Selleck",98.37,"BRD-K97746869-001-27-0, BRD-K97746869-001-26-2","CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1, CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1","RKWGIWYCVPQPMF-UHFFFAOYSA-N, RKWGIWYCVPQPMF-UHFFFAOYSA-N",Launched,
chlorprothixene,dopamine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C",neurology/psychiatry,"schizophrenia, bipolar disorder","Selleck, MicroSource, Selleck",97.83,"BRD-K36207157-001-07-0, BRD-K36207157-001-09-6, BRD-K36207157-001-08-8","CN(C)CC\C=C1\c2ccccc2Sc2ccc(Cl)cc12, CN(C)CC\C=C1\c2ccccc2Sc2ccc(Cl)cc12, CN(C)CC\C=C1\c2ccccc2Sc2ccc(Cl)cc12","WSPOMRSOLSGNFJ-AUWJEWJLSA-N, WSPOMRSOLSGNFJ-AUWJEWJLSA-N, WSPOMRSOLSGNFJ-AUWJEWJLSA-N",Launched,"BRD-K59058766-003-21-9, BRD-K59058766-001-01-5"
chlorpyrifos,acetylcholinesterase inhibitor,ACHE,,,MicroSource,79.39,BRD-K08303368-001-10-0,CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl,SBPBAQFWLVIOKP-UHFFFAOYSA-N,Launched,
chlorquinaldol,other antibiotic,,infectious disease,fungal infection,"Selleck, MicroSource",96.93,"BRD-K90374350-001-09-2, BRD-K90374350-001-10-0","Cc1ccc2c(Cl)cc(Cl)c(O)c2n1, Cc1ccc2c(Cl)cc(Cl)c(O)c2n1","GPTXWRGISTZRIO-UHFFFAOYSA-N, GPTXWRGISTZRIO-UHFFFAOYSA-N",Launched,
chlortetracycline,protein synthesis inhibitor,,ophthalmology,conjunctivitis,"MicroSource, Selleck, Selleck",76.26,"BRD-A25492003-003-13-3, BRD-A25492003-003-15-8, BRD-A25492003-003-14-1","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O","RNPLSXLZRGPQCU-WYOUFOJNSA-N, RNPLSXLZRGPQCU-WYOUFOJNSA-N, RNPLSXLZRGPQCU-WYOUFOJNSA-N",Launched,"BRD-A41555725-003-08-4, BRD-A25492003-001-02-0,BRD-A41555725-003-09-2"
chlorthalidone,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3","cardiology, gastroenterology, rheumatology, nephrology","hypertension, edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis (AGN), chronic renal failure",MicroSource,98.01,BRD-A26384407-001-25-1,NS(=O)(=O)c1cc(ccc1Cl)C1(O)NC(=O)c2ccccc12,JIVPVXMEBJLZRO-UHFFFAOYSA-N,Launched,
chlorzoxazone,bacterial 30S ribosomal subunit inhibitor,"KCNMA1, KCNN4",neurology/psychiatry,muscle relaxant,"MicroSource, Selleck",100,"BRD-K98174813-001-18-0, BRD-K98174813-001-17-2","Clc1ccc2oc(=O)[nH]c2c1, Clc1ccc2oc(=O)[nH]c2c1","TZFWDZFKRBELIQ-UHFFFAOYSA-N, TZFWDZFKRBELIQ-UHFFFAOYSA-N",Launched,
cholecalciferol,,VDR,endocrinology,vitamin D deficiency,"MicroSource, Selleck, Selleck",92.35,"BRD-K62779383-001-08-9, BRD-K62779383-001-07-1, BRD-K62779383-001-05-5","CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C, CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C","QYSXJUFSXHHAJI-YRZJJWOYSA-N, QYSXJUFSXHHAJI-YRZJJWOYSA-N, QYSXJUFSXHHAJI-YRZJJWOYSA-N",Launched,"BRD-A56749456-001-04-3, BRD-K32793810-001-01-5"
cholic-acid,bile acid,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B","gastroenterology, neurology/psychiatry, genetics","bile acid synthesis disorders, peroxisomal disorders, Zellweger syndrome",Enzo,100,BRD-K43164539-001-11-5,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Launched,
choline-alfoscerate,acetylcholine precursor,GM2A,,,MedChemEx,100,BRD-A72390365-001-15-2,C[N+](C)(C)CCOP(O)(=O)OC[C@H](O)CO,SUHOQUVVVLNYQR-MRVPVSSYSA-O,Launched,
chromocarb,antispasmodic,,,,"MicroSource, Selleck",97.77,"BRD-K94720315-001-10-4, BRD-K94720315-001-09-6","OC(=O)c1cc(=O)c2ccccc2o1, OC(=O)c1cc(=O)c2ccccc2o1","RVMGXWBCQGAWBR-UHFFFAOYSA-N, RVMGXWBCQGAWBR-UHFFFAOYSA-N",Launched,
cibenzoline,sodium channel blocker,,,,Sigma,98.93,BRD-K34251960-036-01-6,C1C(=C2NCCN2)C1(c1ccccc1)c1ccccc1,AMRFVEMXRRPNJH-UHFFFAOYSA-N,Launched,
ciclesonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6",allergy,allergic rhinitis,Enzo,98.53,BRD-K35245662-001-01-2,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1,LUKZNWIVRBCLON-GXOBDPJESA-N,Launched,
ciclopirox,membrane integrity inhibitor,ATP1A1,infectious disease,onychomycosis,"MicroSource, Selleck, Selleck, Sigma, Selleck, Selleck",84.85,"BRD-K13044802-213-21-5, BRD-K13044802-001-02-4, BRD-K13044802-001-03-2, BRD-K13044802-213-25-6, BRD-K13044802-213-24-9, BRD-K13044802-213-20-7","Cc1cc(C2CCCCC2)n(O)c(=O)c1, Cc1cc(C2CCCCC2)n(O)c(=O)c1, Cc1cc(C2CCCCC2)n(O)c(=O)c1, Cc1cc(C2CCCCC2)n(O)c(=O)c1, Cc1cc(C2CCCCC2)n(O)c(=O)c1, Cc1cc(C2CCCCC2)n(O)c(=O)c1","SCKYRAXSEDYPSA-UHFFFAOYSA-N, SCKYRAXSEDYPSA-UHFFFAOYSA-N, SCKYRAXSEDYPSA-UHFFFAOYSA-N, SCKYRAXSEDYPSA-UHFFFAOYSA-N, SCKYRAXSEDYPSA-UHFFFAOYSA-N, SCKYRAXSEDYPSA-UHFFFAOYSA-N",Launched,
cidofovir,DNA polymerase inhibitor,,infectious disease,"acquired immunodeficiency syndrome (AIDS), cytomegalovirus retinitis","Selleck, Selleck",100,"BRD-K96153583-001-05-1, BRD-K96153583-001-04-4","Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1, Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1","VWFCHDSQECPREK-LURJTMIESA-N, VWFCHDSQECPREK-LURJTMIESA-N",Launched,
cilastatin,dehydropeptidase inhibitor,DPEP1,,,"AvaChem, Tocris",0,"BRD-K85518562-236-08-9, BRD-K85518562-236-09-7","CC1(C)C[C@@H]1C(=O)N\C(C(O)=O)=C/CCCCSC[C@H](N)C(O)=O, CC1(C)C[C@@H]1C(=O)N\C(C(O)=O)=C/CCCCSC[C@H](N)C(O)=O","DHSUYTOATWAVLW-WFVMDLQDSA-N, DHSUYTOATWAVLW-WFVMDLQDSA-N",Launched,"BRD-K62370608-001-02-9, BRD-K26556168-236-01-4"
cilazapril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, congestive heart failure",Selleck,97,BRD-K65518078-002-01-1,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](N2C1=O)C(O)=O,HHHKFGXWKKUNCY-GBESFXJTSA-N,Launched,
cilnidipine,calcium channel blocker,CACNA1B,cardiology,hypertension,"Selleck, Tocris, Tocris, Selleck",95.59,"BRD-A02743701-001-04-4, BRD-A02743701-001-03-6, BRD-A02743701-001-06-9, BRD-A02743701-001-02-8","COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1, COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1, COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1, COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1","KJEBULYHNRNJTE-DHZHZOJOSA-N, KJEBULYHNRNJTE-DHZHZOJOSA-N, KJEBULYHNRNJTE-DHZHZOJOSA-N, KJEBULYHNRNJTE-DHZHZOJOSA-N",Launched,BRD-A07875874-001-03-2
cilostazol,phosphodiesterase inhibitor,"PDE3A, PDE3B",cardiology,claudication,"MicroSource, Tocris, Selleck, Tocris",98.71,"BRD-K67017579-001-28-1, BRD-K67017579-001-29-9, BRD-K67017579-001-26-5, BRD-K67017579-001-27-3","O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1, O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1, O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1, O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1","RRGUKTPIGVIEKM-UHFFFAOYSA-N, RRGUKTPIGVIEKM-UHFFFAOYSA-N, RRGUKTPIGVIEKM-UHFFFAOYSA-N, RRGUKTPIGVIEKM-UHFFFAOYSA-N",Launched,
cimetidine,histamine receptor antagonist,"HRH2, SLC29A4, SLC47A1, SLC47A2","gastroenterology, hematologic malignancy, endocrinology","duodenal ulcer disease, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), aggressive systemic mastocytosis (ASM), Zollinger-Ellison syndrome, endocrine adenoma","Tocris, Tocris, Selleck, MicroSource",99.16,"BRD-K34157611-001-21-0, BRD-K34157611-001-15-2, BRD-K34157611-001-14-5, BRD-K34157611-001-16-0","CN\C(NCCSCc1nc[nH]c1C)=N/C#N, CN\C(NCCSCc1nc[nH]c1C)=N/C#N, CN\C(NCCSCc1nc[nH]c1C)=N/C#N, CN\C(NCCSCc1nc[nH]c1C)=N/C#N","AQIXAKUUQRKLND-UHFFFAOYSA-N, AQIXAKUUQRKLND-UHFFFAOYSA-N, AQIXAKUUQRKLND-UHFFFAOYSA-N, AQIXAKUUQRKLND-UHFFFAOYSA-N",Launched,
cimetropium,acetylcholine receptor antagonist,CHRM1,gastroenterology,irritable bowel syndrome,Sigma,93.27,BRD-A99899486-004-01-9,C[N+]1(CC2CC2)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,QVVOZYKELHAIPX-WVHCHWADSA-N,Launched,
cinacalcet,calcium channel activator,CASR,"endocrinology, nephrology, oncology","hyperparathyroidism, chronic kidney disease (CKD), parathyroid carcinoma, hypercalcemia",Selleck,98.6,BRD-K73838513-003-05-5,C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12,VDHAWDNDOKGFTD-MRXNPFEDSA-N,Launched,
cinchocaine,sodium channel blocker,"CALM1, SCN10A, SCN5A",neurology/psychiatry,local anesthetic,"MicroSource, Selleck",96.87,"BRD-K99121711-003-20-5, BRD-K99121711-003-19-7","CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1, CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1","PUFQVTATUTYEAL-UHFFFAOYSA-N, PUFQVTATUTYEAL-UHFFFAOYSA-N",Launched,
cinchophen,analgesic agent,,rheumatology,gout,"Selleck, MicroSource",99.45,"BRD-K72915123-001-17-3, BRD-K72915123-001-18-1","OC(=O)c1cc(nc2ccccc12)-c1ccccc1, OC(=O)c1cc(nc2ccccc12)-c1ccccc1","YTRMTPPVNRALON-UHFFFAOYSA-N, YTRMTPPVNRALON-UHFFFAOYSA-N",Launched,
cinepazet,vasodilator,,,,Sigma,95.1,BRD-K00531707-001-01-3,CCOC(=O)CN1CCN(CC1)C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1,XDUOTWNXVDBCDY-VOTSOKGWSA-N,Launched,
cinnarazine,calcium channel blocker,,"neurology/psychiatry, gastroenterology, ophthalmology","Meniere's disease, nausea, vomiting, Cogan's syndrome","MicroSource, ChemDiv",98.16,"BRD-K07220430-001-19-2, BRD-K07220430-001-18-4","C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1, C(\C=C\c1ccccc1)N1CCN(CC1)C(c1ccccc1)c1ccccc1","DERZBLKQOCDDDZ-JLHYYAGUSA-N, DERZBLKQOCDDDZ-JLHYYAGUSA-N",Launched,BRD-K32256916-001-04-0
cinoxacin,topoisomerase inhibitor,,infectious disease,urinary tract infections,"MicroSource, Selleck",93.53,"BRD-K14704277-001-23-4, BRD-K14704277-001-22-6","CCn1nc(C(O)=O)c(=O)c2cc3OCOc3cc12, CCn1nc(C(O)=O)c(=O)c2cc3OCOc3cc12","VDUWPHTZYNWKRN-UHFFFAOYSA-N, VDUWPHTZYNWKRN-UHFFFAOYSA-N",Launched,
cinoxate,,,dermatology,sunscreen lotion,Enamine,95.2,BRD-K17828029-001-01-5,CCOCCOC(=O)\C=C\c1ccc(OC)cc1,CMDKPGRTAQVGFQ-RMKNXTFCSA-N,Launched,
ciprofibrate,PPAR receptor agonist,PPARA,endocrinology,hyperlipidemia,"MicroSource, Selleck",96.78,"BRD-A49358627-001-14-6, BRD-A49358627-001-13-8","CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O, CC(C)(Oc1ccc(cc1)C1CC1(Cl)Cl)C(O)=O","KPSRODZRAIWAKH-UHFFFAOYSA-N, KPSRODZRAIWAKH-UHFFFAOYSA-N",Launched,
ciprofloxacin,bacterial DNA gyrase inhibitor,TOP2A,otolaryngology,otitis,"MicroSource, Selleck, Selleck",98.2,"BRD-K04804440-001-09-5, BRD-K04804440-001-13-7, BRD-K04804440-001-08-7","OC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O, OC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O, OC(=O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O","MYSWGUAQZAJSOK-UHFFFAOYSA-N, MYSWGUAQZAJSOK-UHFFFAOYSA-N, MYSWGUAQZAJSOK-UHFFFAOYSA-N",Launched,
"cis-9,trans-11-Conjugated-linoleic-acid",,,,,Enzo,96.02,BRD-K80025777-001-01-4,CCCCCC\C=C\C=C/CCCCCCCC(O)=O,JBYXPOFIGCOSSB-GOJKSUSPSA-N,Launched,
cisatracurium,acetylcholine receptor antagonist,CHRNA2,"neurology/psychiatry, critical care","muscle relaxant, endotracheal intubation",Selleck,64.92,BRD-K17498618-344-03-4,COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC,YXSLJKQTIDHPOT-LJCJQEJUSA-N,Launched,
cisplatin,"DNA alkylating agent, DNA synthesis inhibitor",XIAP,oncology,"testicular carcinoma, ovarian cancer, bladder cancer","Selleck, Tocris, MicroSource, Selleck",0,"BRD-K69172251-001-11-3, BRD-K69172251-001-09-7, BRD-K69172251-001-10-5, BRD-K69172251-001-08-9","N[Pt](N)(Cl)Cl, N[Pt](N)(Cl)Cl, N[Pt](N)(Cl)Cl, N[Pt](N)(Cl)Cl","DQLATGHUWYMOKM-UHFFFAOYSA-L, DQLATGHUWYMOKM-UHFFFAOYSA-L, DQLATGHUWYMOKM-UHFFFAOYSA-L, DQLATGHUWYMOKM-UHFFFAOYSA-L",Launched,"BRD-K33494261-407-01-2, BRD-K01228321-318-04-3"
citalopram,selective serotonin reuptake inhibitor (SSRI),"SLC6A2, SLC6A4",neurology/psychiatry,depression,"MicroSource, Enamine, Tocris, Selleck",97.27,"BRD-A47598013-004-17-8, BRD-A47598013-004-18-6, BRD-A47598013-004-16-0, BRD-A47598013-034-02-7","CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1, CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1, CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1, CN(C)CCCC1(OCc2cc(ccc12)C#N)c1ccc(F)cc1","WSEQXVZVJXJVFP-UHFFFAOYSA-N, WSEQXVZVJXJVFP-UHFFFAOYSA-N, WSEQXVZVJXJVFP-UHFFFAOYSA-N, WSEQXVZVJXJVFP-UHFFFAOYSA-N",Launched,
citicoline,"membrane permeability enhancer, glutathione transferase stimulant","ACHE, SLC1A2","neurology/psychiatry, ophthalmology","stroke, Alzheimer's disease, senile dementia, Parkinson's Disease, attention-deficit/hyperactivity disorder (ADHD), glaucoma","TargetMol, MicroSource, Cayman",99.5,"BRD-A91728607-001-01-8, BRD-A91728607-396-01-2, BRD-A91728607-236-11-9","C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(N)nc1=O, C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(N)nc1=O, C[N+](C)(C)CCOP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc(N)nc1=O","RZZPDXZPRHQOCG-OJAKKHQRSA-O, RZZPDXZPRHQOCG-OJAKKHQRSA-O, RZZPDXZPRHQOCG-OJAKKHQRSA-O",Launched,BRD-A74441166-396-01-6
cladribine,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B",hematologic malignancy,hairy cell leukemia,Selleck,98.23,BRD-K93034159-001-25-8,Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1,PTOAARAWEBMLNO-KVQBGUIXSA-N,Launched,
clarithromycin,bacterial 50S ribosomal subunit inhibitor,CYP3A4,"otolaryngology, pulmonary, infectious disease","pharyngitis, tonsillitis, sinusitis, bronchitis, pneumonia, skin infections, otitis","MicroSource, Selleck",100,"BRD-K49668410-001-16-2, BRD-K49668410-001-18-8","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC","AGOYDEPGAOXOCK-KCBOHYOISA-N, AGOYDEPGAOXOCK-KCBOHYOISA-N",Launched,BRD-K16762525-001-01-6
clavulanate,beta lactamase inhibitor,,otolaryngology,otitis,"MicroSource, AvaChem",0,"BRD-K94250879-235-03-9, BRD-K94250879-001-01-9","OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O, OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O","HZZVJAQRINQKSD-PBFISZAISA-N, HZZVJAQRINQKSD-PBFISZAISA-N",Launched,
clebopride,dopamine receptor antagonist,"ACHE, DRD2",gastroenterology,nausea,Prestwick,99.18,BRD-K17294426-050-12-3,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,BVPWJMCABCPUQY-UHFFFAOYSA-N,Launched,
clemastine,histamine receptor antagonist,HRH1,allergy,"allergic rhinitis, urticaria","Tocris, MicroSource, Selleck, Tocris",96.36,"BRD-K30240666-051-16-7, BRD-K30240666-051-15-9, BRD-K30240666-051-13-4, BRD-K30240666-051-14-2","CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1, CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1, CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1, CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1","YNNUSGIPVFPVBX-NHCUHLMSSA-N, YNNUSGIPVFPVBX-NHCUHLMSSA-N, YNNUSGIPVFPVBX-NHCUHLMSSA-N, YNNUSGIPVFPVBX-NHCUHLMSSA-N",Launched,
clemizole,HCV inhibitor,,allergy,allergic rhinitis,"Tocris, MicroSource",97.9,"BRD-K04704168-003-15-0, BRD-K04704168-003-14-3","Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc23)cc1, Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc23)cc1","CJXAEXPPLWQRFR-UHFFFAOYSA-N, CJXAEXPPLWQRFR-UHFFFAOYSA-N",Launched,
clenbuterol,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3, NGF, TNF",pulmonary,"chronic obstructive pulmonary disease (COPD), asthma",MicroSource,99.02,BRD-A75726477-003-21-3,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,STJMRWALKKWQGH-UHFFFAOYSA-N,Launched,
cleviprex,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1S",cardiology,hypertension,Selleck,96.26,BRD-A01563671-001-02-7,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,KPBZROQVTHLCDU-UHFFFAOYSA-N,Launched,
clevudine,DNA polymerase inhibitor,,infectious disease,hepatitis B,Selleck,94.05,BRD-K18948558-001-01-9,Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@@H]2F)c(=O)[nH]c1=O,GBBJCSTXCAQSSJ-AZRUVXNYSA-N,Launched,
clidinium,acetylcholine receptor antagonist,"CHRM1, CHRM3",gastroenterology,"peptic ulcer disease (PUD), irritable bowel syndrome, enterocolitis",MicroSource,99.37,BRD-A46066006-004-22-6,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c1ccccc1)c1ccccc1,HOOSGZJRQIVJSZ-UHFFFAOYSA-N,Launched,
climbazole,enzyme inducer,,dermatology,"dandruff, eczema","Selleck, MicroSource",99.56,"BRD-A61676498-001-05-8, BRD-A61676498-001-06-6","CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1, CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1","OWEGWHBOCFMBLP-UHFFFAOYSA-N, OWEGWHBOCFMBLP-UHFFFAOYSA-N",Launched,
clindamycin,protein synthesis inhibitor,,infectious disease,"respiratory tract infections, pneumonia, skin infections, gynecologic infections, intra-abdominal infections, bacterial septicemia, bone and joint infections","MicroSource, Selleck, Selleck",100,"BRD-K23586533-003-01-6, BRD-K23586533-001-03-6, BRD-K23586533-003-02-4","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O","KDLRVYVGXIQJDK-AWPVFWJPSA-N, KDLRVYVGXIQJDK-AWPVFWJPSA-N, KDLRVYVGXIQJDK-AWPVFWJPSA-N",Launched,"BRD-A23034328-003-09-1, BRD-A43673346-001-01-1,BRD-A52252998-001-01-3, BRD-A43673346-003-01-7,BRD-A52252998-003-01-9"
clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,,infectious disease,"intra-abdominal infections, skin infections, pneumonia, peritonitis, gynecologic infections",Selleck,100,BRD-A76672327-003-02-0,CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C1CC(CCC)CN1C)C(C)Cl,OYSKUZDIHNKWLV-UHFFFAOYSA-N,Launched,
clindamycin-phosphate,protein synthesis inhibitor,,obstetrics/gynecology,bacterial vaginosis,Selleck,100,BRD-K27771035-001-02-5,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1O,UFUVLHLTWXBHGZ-MGZQPHGTSA-N,Launched,BRD-K52542745-001-01-1
clinofibrate,lipase clearing factor inhibitor,LPL,endocrinology,hypertriglyceridemia,Selleck,94.72,BRD-A90625545-001-02-0,CCC(C)(Oc1ccc(cc1)C1(CCCCC1)c1ccc(OC(C)(CC)C(O)=O)cc1)C(O)=O,BMOVQUBVGICXQN-UHFFFAOYSA-N,Launched,
clobazam,GABA benzodiazepine site receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",neurology/psychiatry,seizures,Enzo,98.93,BRD-K52408781-001-02-8,CN1c2ccc(Cl)cc2N(c2ccccc2)C(=O)CC1=O,CXOXHMZGEKVPMT-UHFFFAOYSA-N,Launched,
clobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B",dermatology,corticosteroid-responsive dermatoses,"Sigma, MicroSource, Selleck",98.73,"BRD-K10799896-001-24-7, BRD-K10799896-001-26-2, BRD-K10799896-001-25-4","CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl, CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl, CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl","CBGUOGMQLZIXBE-XGQKBEPLSA-N, CBGUOGMQLZIXBE-XGQKBEPLSA-N, CBGUOGMQLZIXBE-XGQKBEPLSA-N",Launched,"BRD-A26095496-001-04-0, BRD-K91981767-001-01-7,BRD-K84443303-001-02-6"
clobetasone-butyrate,corticosteroid agonist,NR3C1,dermatology,"eczema, psoriasis, dermatitis",Sigma,93.44,BRD-K58810291-001-16-2,CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCl,FBRAWBYQGRLCEK-AVVSTMBFSA-N,Launched,
clocortolone-pivalate,steroid,"NR3C1, PLA2G1B",dermatology,corticosteroid-responsive dermatoses,Prestwick,98.68,BRD-K38003476-001-09-1,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,SXYZQZLHAIHKKY-GSTUPEFVSA-N,Launched,
clodronic-acid,bone resorption inhibitor,"SLC25A4, SLC25A5, SLC25A6","orthopedics, endocrinology, hematologic malignancy","osteoporosis, hyperparathyroidism, hypercalcemia, multiple myeloma","Selleck, Selleck",0,"BRD-K72542090-304-02-4, BRD-K72542090-304-03-2","OP(O)(=O)C(Cl)(Cl)P(O)(O)=O, OP(O)(=O)C(Cl)(Cl)P(O)(O)=O","ACSIXWWBWUQEHA-UHFFFAOYSA-N, ACSIXWWBWUQEHA-UHFFFAOYSA-N",Launched,
clofarabine,ribonucleotide reductase inhibitor,"POLA1, POLD1, POLE, RRM1, RRM2, RRM2B",hematologic malignancy,acute lymphoblastic leukemia (ALL),"Tocris, Tocris, Selleck",98.71,"BRD-K34022604-001-09-0, BRD-K34022604-001-06-6, BRD-K34022604-001-05-8","Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F, Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F, Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F","WDDPHFBMKLOVOX-AYQXTPAHSA-N, WDDPHFBMKLOVOX-AYQXTPAHSA-N, WDDPHFBMKLOVOX-AYQXTPAHSA-N",Launched,
clofazimine,GK0582 inhibitor,,infectious disease,leprosy,"MicroSource, Selleck, Selleck",86.22,"BRD-K56614220-001-19-0, BRD-K56614220-001-18-2, BRD-K56614220-001-21-6","CC(C)\N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1, CC(C)\N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1, CC(C)\N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc2cc1Nc1ccc(Cl)cc1","WDQPAMHFFCXSNU-BGABXYSRSA-N, WDQPAMHFFCXSNU-BGABXYSRSA-N, WDQPAMHFFCXSNU-BGABXYSRSA-N",Launched,
clofedanol,histamine receptor antagonist,HRH1,pulmonary,cough suppressant,Sigma,97.05,BRD-A15687940-001-05-6,CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl,WRCHFMBCVFFYEQ-UHFFFAOYSA-N,Launched,
clofibrate,PPAR receptor agonist,"LPL, PPARA","endocrinology, cardiology","hyperlipidemia, cholesterol","MicroSource, Selleck, Selleck",99.05,"BRD-K45252063-001-13-6, BRD-K45252063-001-14-4, BRD-K45252063-001-12-8","CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1, CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1, CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1","KNHUKKLJHYUCFP-UHFFFAOYSA-N, KNHUKKLJHYUCFP-UHFFFAOYSA-N, KNHUKKLJHYUCFP-UHFFFAOYSA-N",Launched,
clofibric-acid,PPAR receptor agonist,PPARA,,,"MicroSource, Tocris, Selleck",98.95,"BRD-K19111024-001-20-9, BRD-K19111024-001-19-1, BRD-K19111024-001-18-3","CC(C)(Oc1ccc(Cl)cc1)C(O)=O, CC(C)(Oc1ccc(Cl)cc1)C(O)=O, CC(C)(Oc1ccc(Cl)cc1)C(O)=O","TXCGAZHTZHNUAI-UHFFFAOYSA-N, TXCGAZHTZHNUAI-UHFFFAOYSA-N, TXCGAZHTZHNUAI-UHFFFAOYSA-N",Launched,
clofoctol,protein synthesis inhibitor,,infectious disease,gram-positive bacterial infections,"Selleck, MicroSource",97.9,"BRD-K02900412-001-11-3, BRD-K02900412-001-12-1","CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1, CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1","HQVZOORKDNCGCK-UHFFFAOYSA-N, HQVZOORKDNCGCK-UHFFFAOYSA-N",Launched,
clomethiazole,"GABA receptor antagonist, GABA receptor modulator",GABRA1,neurology/psychiatry,"Parkinson's Disease, sedative, muscle relaxant","Tocris, Enamine",94.39,"BRD-K50422030-003-02-6, BRD-K50422030-001-05-3","Cc1ncsc1CCCl, Cc1ncsc1CCCl","PCLITLDOTJTVDJ-UHFFFAOYSA-N, PCLITLDOTJTVDJ-UHFFFAOYSA-N",Launched,
clomifene,estrogen receptor antagonist,ESR1,obstetrics/gynecology,infertility,"MicroSource, Selleck, Selleck",94.27,"BRD-K29950728-048-17-4, BRD-K29950728-048-16-6, BRD-K29950728-048-18-2","CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1, CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1, CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1","GKIRPKYJQBWNGO-QPLCGJKRSA-N, GKIRPKYJQBWNGO-QPLCGJKRSA-N, GKIRPKYJQBWNGO-QPLCGJKRSA-N",Launched,
clomipramine,serotonin transporter (SERT) inhibitor,"GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,obsessive compulsive disorder (OCD),"MicroSource, Tocris, Selleck",92.56,"BRD-K52989797-003-28-0, BRD-K52989797-003-27-2, BRD-K52989797-003-26-4","CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12, CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12, CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12","GDLIGKIOYRNHDA-UHFFFAOYSA-N, GDLIGKIOYRNHDA-UHFFFAOYSA-N, GDLIGKIOYRNHDA-UHFFFAOYSA-N",Launched,
clonazepam,GABA benzodiazepine site receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",neurology/psychiatry,"seizures, panic disorders",MicroSource,96.01,BRD-K38183498-001-02-0,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,DGBIGWXXNGSACT-UHFFFAOYSA-N,Launched,
clonidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","cardiology, neurology/psychiatry","hypertension, attention-deficit/hyperactivity disorder (ADHD)","MicroSource, Tocris, Selleck",99.61,"BRD-K98530306-003-18-3, BRD-K98530306-003-17-5, BRD-K98530306-003-16-7","Clc1cccc(Cl)c1N=C1NCCN1, Clc1cccc(Cl)c1N=C1NCCN1, Clc1cccc(Cl)c1N=C1NCCN1","GJSURZIOUXUGAL-UHFFFAOYSA-N, GJSURZIOUXUGAL-UHFFFAOYSA-N, GJSURZIOUXUGAL-UHFFFAOYSA-N",Launched,
clonixin-lysinate,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief,"Prestwick, Sigma",86.5,"BRD-M63173034-001-02-8, BRD-M63173034-001-03-6","NCCCC[C@H](N)C(O)=O.Cc1c(Cl)cccc1Nc1ncccc1C(O)=O, NCCCC[C@H](N)C(O)=O.Cc1c(Cl)cccc1Nc1ncccc1C(O)=O","CVNFYQCHAWFYQI-ZSCHJXSPSA-N, CVNFYQCHAWFYQI-ZSCHJXSPSA-N",Launched,
clopamide,sodium/chloride cotransporter inhibitor,,cardiology,hypertension,Selleck,98.21,BRD-A85651701-001-19-7,CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O,LBXHRAWDUMTPSE-UHFFFAOYSA-N,Launched,
cloperastine,antitussive,,pulmonary,cough suppressant,MicroSource,97.64,BRD-A80908310-003-13-8,Clc1ccc(cc1)C(OCCN1CCCCC1)c1ccccc1,FLNXBVJLPJNOSI-UHFFFAOYSA-N,Launched,
clopidogrel,purinergic receptor antagonist,P2RY12,"cardiology, neurology/psychiatry","myocardial infarction, stroke, peripheral artery disease (PAD), acute coronary syndrome (ACS)","Selleck, MicroSource, Selleck",99.2,"BRD-K27721098-065-10-2, BRD-K27721098-065-09-4, BRD-K27721098-065-08-6","COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl, COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl, COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl","GKTWGGQPFAXNFI-HNNXBMFYSA-N, GKTWGGQPFAXNFI-HNNXBMFYSA-N, GKTWGGQPFAXNFI-HNNXBMFYSA-N",Launched,
clopidol,,,infectious disease,coccidiosis,MicroSource,95.89,BRD-K80036624-001-04-0,Cc1nc(C)c(Cl)c(O)c1Cl,ZDPIZLCVJAAHHR-UHFFFAOYSA-N,Launched,
cloprostenol-(+/-),prostaglandin receptor agonist,"PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R",,,Tocris,93.34,BRD-K17850764-236-11-9,O[C@@H](COc1cccc(Cl)c1)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,Launched,
cloranolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3",,,Sigma,97.23,BRD-A04971881-003-01-3,CC(C)(C)NCC(O)COc1cc(Cl)ccc1Cl,XYCMOTOFHFTUIU-UHFFFAOYSA-N,Launched,
clorotepine,"dopamine receptor antagonist, adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6",neurology/psychiatry,psychosis,Sigma,99.23,BRD-A19053834-050-09-5,CN1CCN(CC1)C1Cc2ccccc2Sc2ccc(Cl)cc12,XRYLGRGAWQSVQW-UHFFFAOYSA-N,Launched,
clorprenaline,adrenergic receptor agonist,"ADRB1, ADRB2",pulmonary,asthma,Selleck,95.94,BRD-A29281099-003-03-2,CC(C)NCC(O)c1ccccc1Cl,SSMSBSWKLKKXGG-UHFFFAOYSA-N,Launched,
clorsulon,glycolysis inhibitor,,infectious disease,"gastrointestinal roundworms, lungworms, liver flukes, lice, mites","MicroSource, Selleck",99.05,"BRD-K97521363-001-16-1, BRD-K97521363-001-15-3","Nc1cc(C(Cl)=C(Cl)Cl)c(cc1S(N)(=O)=O)S(N)(=O)=O, Nc1cc(C(Cl)=C(Cl)Cl)c(cc1S(N)(=O)=O)S(N)(=O)=O","QOVTVIYTBRHADL-UHFFFAOYSA-N, QOVTVIYTBRHADL-UHFFFAOYSA-N",Launched,
closantel,"chitinase inhibitor, NFkB pathway inhibitor",,infectious disease,liver flukes,"MicroSource, Selleck, Selleck, Selleck",99.14,"BRD-A19952358-001-11-3, BRD-A19952358-236-01-6, BRD-A19952358-001-10-5, BRD-A19952358-001-12-1","Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O, Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O, Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O, Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O","JMPFSEBWVLAJKM-UHFFFAOYSA-N, JMPFSEBWVLAJKM-UHFFFAOYSA-N, JMPFSEBWVLAJKM-UHFFFAOYSA-N, JMPFSEBWVLAJKM-UHFFFAOYSA-N",Launched,
clotiapine,,,neurology/psychiatry,psychosis,Enzo,98.82,BRD-K10990317-001-04-5,CN1CCN(CC1)C1=Nc2ccccc2Sc2ccc(Cl)cc12,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Launched,
clotrimazole,"cytochrome P450 inhibitor, imidazoline receptor ligand","CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8",infectious disease,"vulvovaginal candidiasis, oropharyngeal candidiasis","Tocris, MicroSource, Selleck",98.93,"BRD-K15916496-001-29-5, BRD-K15916496-001-27-9, BRD-K15916496-001-26-1","Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1, Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1, Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1","VNFPBHJOKIVQEB-UHFFFAOYSA-N, VNFPBHJOKIVQEB-UHFFFAOYSA-N, VNFPBHJOKIVQEB-UHFFFAOYSA-N",Launched,
cloxacillin,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,"MicroSource, Selleck, Selleck",94.98,"BRD-K01244426-236-12-1, BRD-K01244426-323-07-7, BRD-K01244426-323-08-5","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1Cl, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1Cl, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1Cl","LQOLIRLGBULYKD-JKIFEVAISA-N, LQOLIRLGBULYKD-JKIFEVAISA-N, LQOLIRLGBULYKD-JKIFEVAISA-N",Launched,BRD-K23933163-323-01-9
clozapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7",neurology/psychiatry,schizophrenia,"MicroSource, Selleck, Tocris, Selleck",95.42,"BRD-K37289225-001-36-4, BRD-K37289225-001-34-9, BRD-K37289225-001-35-6, BRD-K37289225-001-37-2","CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12, CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12, CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12, CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12","QZUDBNBUXVUHMW-UHFFFAOYSA-N, QZUDBNBUXVUHMW-UHFFFAOYSA-N, QZUDBNBUXVUHMW-UHFFFAOYSA-N, QZUDBNBUXVUHMW-UHFFFAOYSA-N",Launched,
cobicistat,cytochrome P450 inhibitor,"CYP3A4, CYP3A43, CYP3A5, CYP3A7",infectious disease,human immunodeficiency virus (HIV-1),Selleck,95.36,BRD-K51040301-001-02-1,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,Launched,
cobimetinib,MEK inhibitor,,oncology,melanoma,MedChemEx,91.15,BRD-K03390685-001-01-7,OC1(CN(C1)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F)[C@@H]1CCCCN1,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Launched,
coenzyme-a,,"ACAT2, CRAT, CS, DBI, HMGCR, KAT2A, KAT2B, KAT5",,,ChemImpex,0,BRD-A67956599-002-01-3,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12)[C@@H](O)C(=O)NCCC(=O)NCCS,RGJOEKWQDUBAIZ-IBOSZNHHSA-N,Launched,
coenzyme-q10,,,,,"Sigma, Selleck, Selleck",0,"BRD-K75043328-001-05-9, BRD-K75043328-001-04-2, BRD-K75043328-001-03-4","COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O, COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O, COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O","ACTIUHUUMQJHFO-UPTCCGCDSA-N, ACTIUHUUMQJHFO-UPTCCGCDSA-N, ACTIUHUUMQJHFO-UPTCCGCDSA-N",Launched,
colchicine,microtubule inhibitor,"GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8","rheumatology, endocrinology","gout, fever","MicroSource, Tocris",96.57,"BRD-K00259736-001-16-4, BRD-K00259736-001-18-0","COc1cc2CC[C@H](NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC, COc1cc2CC[C@H](NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC","IAKHMKGGTNLKSZ-INIZCTEOSA-N, IAKHMKGGTNLKSZ-INIZCTEOSA-N",Launched,BRD-A46684810-001-12-9
colforsin-daproate,adenylyl cyclase activator,,,,EMDBio,100,BRD-K19388745-003-01-7,CN(C)CCC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C,RSOZZQTUMVBTMR-XGUNBQNXSA-N,Launched,
colfosceril-palmitate,pulmonary surfactant,,pulmonary,respiratory distress syndrome (RDS),"Sigma, Acros",0,"BRD-A95886749-001-04-3, BRD-A95886749-001-03-5","CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC, CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC","KILNVBDSWZSGLL-KXQOOQHDSA-O, KILNVBDSWZSGLL-KXQOOQHDSA-O",Launched,
colistimethate,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections,"MicroSource, Selleck",0,"BRD-A13668387-319-04-7, BRD-A44942307-405-01-9","CCC(C)C1NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(CCNCS(O)(=O)=O)NC1=O)C(C)O)NC(=O)C(CCNCS(O)(=O)=O)NC(=O)C(NC(=O)C(CCNCS(O)(=O)=O)NC(=O)CCCCC(C)C)C(C)O)C(C)CC, CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O","JGZYUDARLHNRKM-UHFFFAOYSA-N, XDJYMJULXQKGMM-KFZDXBANSA-N",Launched,
colistin,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections,"MedChemEx, MedChemEx",65.4,"BRD-A18924964-065-01-5, BRD-A18924964-065-02-3","CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O, CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O","YKQOSKADJPQZHB-QNPLFGSASA-N, YKQOSKADJPQZHB-QNPLFGSASA-N",Launched,
colistin-b-sulfate,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections,Enzo,46.42,BRD-A36456202-001-01-3,CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)C(CCN)NC1=O)C(C)O,KNIWPHSUTGNZST-INRBSFJCSA-N,Launched,
colistin-sulfate,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections,"MicroSource, Selleck, Selleck",55.02,"BRD-A45201156-315-02-0, BRD-K57773246-001-01-1, BRD-K57773246-001-02-9","CCC(C)C1NC(=O)C(NC(=O)C(CCN)NC(=O)C(CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC1=O)C(C)O)NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC(=O)CCCCC(C)C)C(C)O)C(C)CC, CC(C)CCCCC(=O)N[C@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)C(C)C)[C@@H](C)O, CC(C)CCCCC(=O)N[C@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)C(C)C)[C@@H](C)O","VCRYFUBRFYUNTM-UHFFFAOYSA-N, MEOTUCBFWIQPRL-UPDVJOSMSA-N, MEOTUCBFWIQPRL-UPDVJOSMSA-N",Launched,"BRD-M52026403-001-01-6,BRD-U87151157-000-01-1, BRD-M52026403-001-02-4,BRD-M87664656-343-01-3"
conivaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2",endocrinology,hyponatremia,Selleck,98.26,BRD-K37385792-003-02-1,Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1,IKENVDNFQMCRTR-UHFFFAOYSA-N,Launched,
copanlisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",hematologic malignancy,follicular lymphoma,"MedChemEx, MedChemEx",97.22,"BRD-K24666289-001-02-3, BRD-K24666289-001-04-9","COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12, COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12","PZBCKZWLPGJMAO-UHFFFAOYSA-N, PZBCKZWLPGJMAO-UHFFFAOYSA-N",Launched,
cortisone,glucocorticoid receptor agonist,NR3C1,"gastroenterology, rheumatology, dermatology","ulcerative colitis, rheumatoid arthritis, psoriasis, joint inflammation, eczema",MicroSource,93.59,BRD-A62731508-001-05-8,C[C@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO,MFYSYFVPBJMHGN-BDQMTFAOSA-N,Launched,
cortisone-acetate,glucocorticoid receptor agonist,NR3C1,"pulmonary, rheumatology, allergy, dermatology, ophthalmology, gastroenterology, infectious disease","asthma, rheumatoid arthritis, urticaria, osteoarthritis, psoriasis, allergic rhinitis, conjunctivitis, ulcerative colitis, meningitis","MicroSource, Selleck, Selleck",87.13,"BRD-K86161929-001-13-3, BRD-K86161929-001-11-7, BRD-K86161929-001-12-5","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C","ITRJWOMZKQRYTA-RFZYENFJSA-N, ITRJWOMZKQRYTA-RFZYENFJSA-N, ITRJWOMZKQRYTA-RFZYENFJSA-N",Launched,"BRD-A54487287-001-04-7, BRD-K83872210-001-01-1"
coumarin,vitamin K antagonist,"CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6","gastroenterology, pulmonary","ulcerative colitis, asthma, celiac disease","MicroSource, Selleck",99.45,"BRD-K23913458-001-20-7, BRD-K23913458-001-19-9","O=c1ccc2ccccc2o1, O=c1ccc2ccccc2o1","ZYGHJZDHTFUPRJ-UHFFFAOYSA-N, ZYGHJZDHTFUPRJ-UHFFFAOYSA-N",Launched,
creatine,,"CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8",,,Vitas-M,100,BRD-K19615002-001-02-3,CN(CC(O)=O)C(N)=N,CVSVTCORWBXHQV-UHFFFAOYSA-N,Launched,
creatinol-phosphate,,,,,"CombiBlocks, CombiBlocks",100,"BRD-K42991124-001-04-8, BRD-K42991124-001-03-0","CN(CCOP(O)(O)=O)C(N)=N, CN(CCOP(O)(O)=O)C(N)=N","FOIPWTMKYXWFGC-UHFFFAOYSA-N, FOIPWTMKYXWFGC-UHFFFAOYSA-N",Launched,
cresol,,,,,MicroSource,78.99,BRD-K56940914-001-04-2,Cc1ccc(O)cc1,IWDCLRJOBJJRNH-UHFFFAOYSA-N,Launched,
cridanimod,progesterone receptor agonist,PGR,,,"ChemDiv, Sigma",98.36,"BRD-K97939847-001-11-2, BRD-K97939847-001-12-0","OC(=O)Cn1c2ccccc2c(=O)c2ccccc12, OC(=O)Cn1c2ccccc2c(=O)c2ccccc12","UOMKBIIXHQIERR-UHFFFAOYSA-N, UOMKBIIXHQIERR-UHFFFAOYSA-N",Launched,
crizotinib,ALK tyrosine kinase receptor inhibitor,"ALK, MET",oncology,non-small cell lung cancer (NSCLC),"MedChemEx, Selleck, Selleck",89.1,"BRD-K78431006-001-15-1, BRD-K78431006-001-10-2, BRD-K78431006-001-11-0","C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl, C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl, C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl","KTEIFNKAUNYNJU-GFCCVEGCSA-N, KTEIFNKAUNYNJU-GFCCVEGCSA-N, KTEIFNKAUNYNJU-GFCCVEGCSA-N",Launched,
croconazole,bacterial cell wall synthesis inhibitor,,,,AKSci,0,BRD-K73701464-003-01-3,Clc1cccc(COc2ccccc2C(=C)n2ccnc2)c1,WHPAGCJNPTUGGD-UHFFFAOYSA-N,Launched,
cromoglicic-acid,immunosuppressant,"KCNMA1, S100P","pulmonary, ophthalmology, allergy, gastroenterology","asthma, conjunctivitis, urticaria, ulcerative colitis","MicroSource, Selleck",100,"BRD-K20920669-304-10-9, BRD-K20920669-304-09-1","OC(COc1cccc2oc(cc(=O)c12)C(O)=O)COc1cccc2oc(cc(=O)c12)C(O)=O, OC(COc1cccc2oc(cc(=O)c12)C(O)=O)COc1cccc2oc(cc(=O)c12)C(O)=O","IMZMKUWMOSJXDT-UHFFFAOYSA-N, IMZMKUWMOSJXDT-UHFFFAOYSA-N",Launched,
crotamiton,antipruritic,,infectious disease,scabies,MicroSource,85.06,BRD-K57179821-001-15-4,CCN(C(=O)\C=C\C)c1ccccc1C,DNTGGZPQPQTDQF-XBXARRHUSA-N,Launched,
crystal-violet,other antibiotic,,,,"Selleck, Selleck, MicroSource",86.06,"BRD-K60025295-003-07-4, BRD-K60025295-003-05-8, BRD-K60025295-003-06-6","CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)=C1C=CC(C=C1)=[N+](C)C, CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)=C1C=CC(C=C1)=[N+](C)C, CN(C)c1ccc(cc1)C(c1ccc(cc1)N(C)C)=C1C=CC(C=C1)=[N+](C)C","LGLFFNDHMLKUMI-UHFFFAOYSA-N, LGLFFNDHMLKUMI-UHFFFAOYSA-N, LGLFFNDHMLKUMI-UHFFFAOYSA-N",Launched,
curcumin,"cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor","APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH",,,"Selleck, Selleck, Enzo",91.77,"BRD-K07572174-001-39-4, BRD-K07572174-001-38-6, BRD-K07572174-001-43-6","COc1cc(ccc1O)\C=C\C(=O)CC(=O)\C=C\c1ccc(O)c(OC)c1, COc1cc(ccc1O)\C=C\C(=O)CC(=O)\C=C\c1ccc(O)c(OC)c1, COc1cc(ccc1O)\C=C\C(=O)CC(=O)\C=C\c1ccc(O)c(OC)c1","VFLDPWHFBUODDF-FCXRPNKRSA-N, VFLDPWHFBUODDF-FCXRPNKRSA-N, VFLDPWHFBUODDF-FCXRPNKRSA-N",Launched,BRD-K69690935-001-03-5
cyamemazine,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C, HTR7",neurology/psychiatry,"schizophrenia, anxiety",Sigma,87.23,BRD-A42881122-001-01-1,CC(CN(C)C)CN1c2ccccc2Sc2ccc(cc12)C#N,SLFGIOIONGJGRT-UHFFFAOYSA-N,Launched,
cyanocobalamin,"methylmalonyl CoA mutase stimulant, vitamin B","MMAA, MMACHC, MTHFR, MTR, MTRR, MUT","hematology, infectious disease, gastroenterology","anemia, fish tapeworm infestation, celiac disease","MicroSource, Selleck",97.22,"BRD-A18627414-001-05-6, BRD-A18627414-001-04-9","C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12, C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12","RMRCNWBMXRMIRW-WZHZPDAFSA-M, RMRCNWBMXRMIRW-WZHZPDAFSA-M",Launched,"BRD-A59561452-001-01-9, BRD-M14495474-001-01-4,BRD-A97502381-001-01-3|BRD-M38660727-001-01-0"
cyclandelate,calcium channel blocker,"CACNA2D1, CES1","cardiology, rheumatology","claudication, arteriosclerosis, Raynaud's disease","MicroSource, Selleck, Selleck",96.1,"BRD-A27370296-001-03-0, BRD-A27370296-001-02-2, BRD-A27370296-001-04-8","CC1CC(CC(C)(C)C1)OC(=O)C(O)c1ccccc1, CC1CC(CC(C)(C)C1)OC(=O)C(O)c1ccccc1, CC1CC(CC(C)(C)C1)OC(=O)C(O)c1ccccc1","WZHCOOQXZCIUNC-UHFFFAOYSA-N, WZHCOOQXZCIUNC-UHFFFAOYSA-N, WZHCOOQXZCIUNC-UHFFFAOYSA-N",Launched,
cyclizine,histamine receptor modulator,"HRH1, SULT1E1","gastroenterology, neurology/psychiatry","nausea, vomiting, vertigo, motion sickness","MicroSource, Selleck",99.27,"BRD-K79501723-001-04-6, BRD-K79501723-300-01-8","CN1CCN(CC1)C(c1ccccc1)c1ccccc1, CN1CCN(CC1)C(c1ccccc1)c1ccccc1","UVKZSORBKUEBAZ-UHFFFAOYSA-N, UVKZSORBKUEBAZ-UHFFFAOYSA-N",Launched,
cyclobenzaprine,"adrenergic receptor agonist, serotonin receptor agonist",HTR2A,neurology/psychiatry,spasms,MicroSource,97.11,BRD-K42348709-003-13-1,CN(C)CCC=C1c2ccccc2C=Cc2ccccc12,JURKNVYFZMSNLP-UHFFFAOYSA-N,Launched,
cyclopenthiazide,thiazide diuretic,,cardiology,"hypertension, congestive heart failure",Prestwick,99.7,BRD-A41250306-001-11-7,NS(=O)(=O)c1cc2c(NC(CC3CCCC3)NS2(=O)=O)cc1Cl,BKYKPTRYDKTTJY-UHFFFAOYSA-N,Launched,
cyclopentolate,acetylcholine receptor antagonist,CHRM1,ophthalmology,"mydriasis, cycloplegia",MicroSource,94.68,BRD-A77291778-003-22-0,CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,Launched,
cyclophosphamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7","hematologic malignancy, oncology","Hodgkin's lymphoma, small lymphocytic lymphoma (SLL), breast cancer, neuroblastoma, Burkitt's lymphoma, multiple myeloma, chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), true histiocytic lymphoma (THL), retinoblastoma, ovarian cancer","MicroSource, Selleck, Selleck",93.6,"BRD-A09722536-002-18-0, BRD-A09722536-002-19-8, BRD-A09722536-002-17-2","ClCCN(CCCl)P1(=O)NCCCO1, ClCCN(CCCl)P1(=O)NCCCO1, ClCCN(CCCl)P1(=O)NCCCO1","CMSMOCZEIVJLDB-UHFFFAOYSA-N, CMSMOCZEIVJLDB-UHFFFAOYSA-N, CMSMOCZEIVJLDB-UHFFFAOYSA-N",Launched,
cycloserine-(d),bacterial cell wall synthesis inhibitor,GRIN1,infectious disease,tuberculosis,"MedChemEx, MicroSource, Selleck, MedChemEx, Selleck",0,"BRD-K87226815-001-21-3, BRD-K87226815-001-17-1, BRD-K87226815-001-18-9, BRD-K87226815-001-20-5, BRD-K87226815-001-19-7","N[C@@H]1CONC1=O, N[C@@H]1CONC1=O, N[C@@H]1CONC1=O, N[C@@H]1CONC1=O, N[C@@H]1CONC1=O","DYDCUQKUCUHJBH-UWTATZPHSA-N, DYDCUQKUCUHJBH-UWTATZPHSA-N, DYDCUQKUCUHJBH-UWTATZPHSA-N, DYDCUQKUCUHJBH-UWTATZPHSA-N, DYDCUQKUCUHJBH-UWTATZPHSA-N",Launched,BRD-K53226837-001-08-4
cyclosporin-a,calcineurin inhibitor,PPP3CA,"rheumatology, dermatology","rheumatoid arthritis, psoriasis","Tocris, MicroSource",99.52,"BRD-A69815203-001-07-6, BRD-A69815203-001-08-4","CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C, CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C","PMATZTZNYRCHOR-IMVLJIQESA-N, PMATZTZNYRCHOR-IMVLJIQESA-N",Launched,
cyclosporine,calcineurin inhibitor,"ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3","transplant, rheumatology, dermatology","organ rejection, rheumatoid arthritis, psoriasis","Selleck, Selleck",98.93,"BRD-K13533483-001-16-2, BRD-K13533483-001-17-0","CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C, CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C","PMATZTZNYRCHOR-CGLBZJNRSA-N, PMATZTZNYRCHOR-CGLBZJNRSA-N",Launched,"BRD-K03152136-001-01-6, BRD-A11864475-001-02-5"
cyclothiazide,glutamate receptor modulator,"CA1, CA2, CA4, FXYD2, GRIA1, GRIA2, GRIA3, GRIA4, SLC12A3",cardiology,hypertension,"Tocris, MicroSource, Sigma, DuPont, Tocris",65.61,"BRD-A38675539-001-13-5, BRD-A38675539-001-11-9, BRD-A38675539-001-14-3, BRD-A38675539-001-12-7, BRD-A38675539-001-10-1","NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl, NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl, NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl, NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl, NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C2CC3CC2C=C3)cc1Cl","BOCUKUHCLICSIY-UHFFFAOYSA-N, BOCUKUHCLICSIY-UHFFFAOYSA-N, BOCUKUHCLICSIY-UHFFFAOYSA-N, BOCUKUHCLICSIY-UHFFFAOYSA-N, BOCUKUHCLICSIY-UHFFFAOYSA-N",Launched,BRD-A38639147-001-17-6
cyclovalone,breast cancer resistance protein inhibitor,ABCG2,gastroenterology,bile stimulation,"Enamine, Sigma",97.7,"BRD-K59866480-001-08-1, BRD-K59866480-001-07-3","COc1cc(ccc1O)\C=C1/CCC\C(C1=O)=C/c1ccc(O)c(OC)c1, COc1cc(ccc1O)\C=C1/CCC\C(C1=O)=C/c1ccc(O)c(OC)c1","DHKKONBXGAAFTB-OTYYAQKOSA-N, DHKKONBXGAAFTB-OTYYAQKOSA-N",Launched,BRD-K84397942-001-01-3
cypermethrin,,,,,MicroSource,42.23,BRD-A62798249-001-04-4,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1,KAATUXNTWXVJKI-UHFFFAOYSA-N,Launched,
cyproheptadine,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7","allergy, otolaryngology, ophthalmology, dermatology","allergic rhinitis, vasomotor rhinitis, conjunctivitis, urticaria, dermatographism","MicroSource, Tocris, MicroSource, Selleck",98.68,"BRD-K28143534-001-02-2, BRD-K28143534-003-25-9, BRD-K28143534-003-26-7, BRD-K28143534-003-24-2","CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12, CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12, CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12, CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12","JJCFRYNCJDLXIK-UHFFFAOYSA-N, JJCFRYNCJDLXIK-UHFFFAOYSA-N, JJCFRYNCJDLXIK-UHFFFAOYSA-N, JJCFRYNCJDLXIK-UHFFFAOYSA-N",Launched,
cyproterone,androgen receptor antagonist,AR,oncology,prostate cancer,MicroSource,54.15,BRD-A48103086-001-04-2,CC(=O)[C@@]1(O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@]12C,DUSHUSLJJMDGTE-AVWUXPBGSA-N,Launched,
cyproterone-acetate,androgen receptor antagonist,"ADORA1, AR",oncology,prostate cancer,"MicroSource, Sigma, Selleck",94.11,"BRD-K41141507-001-17-0, BRD-K41141507-001-15-4, BRD-K41141507-001-16-2","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O","UWFYSQMTEOIJJG-FDTZYFLXSA-N, UWFYSQMTEOIJJG-FDTZYFLXSA-N, UWFYSQMTEOIJJG-FDTZYFLXSA-N",Launched,"BRD-A95207036-001-04-4, BRD-K59573506-001-01-8"
cyromazine,,,,,"Selleck, MicroSource",99.31,"BRD-K36711084-001-01-2, BRD-K36711084-001-02-0","Nc1nc(N)nc(NC2CC2)n1, Nc1nc(N)nc(NC2CC2)n1","LVQDKIWDGQRHTE-UHFFFAOYSA-N, LVQDKIWDGQRHTE-UHFFFAOYSA-N",Launched,
cysteamine,tissue transglutaminase inhibitor,"NPY2R, SST",metabolism,cystinosis,"MicroSource, Selleck, Selleck",0,"BRD-K92611362-001-02-6, BRD-M77687198-001-10-6, BRD-M77687198-001-12-2","NCCS, Cl.NCCS, Cl.NCCS","UFULAYFCSOUIOV-UHFFFAOYSA-N, OGMADIBCHLQMIP-UHFFFAOYSA-N, OGMADIBCHLQMIP-UHFFFAOYSA-N",Launched,BRD-M77687198-001-11-4
cytarabine,ribonucleotide reductase inhibitor,"POLA1, POLB, POLD1, POLE",hematologic malignancy,"acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL)","MicroSource, Selleck, Selleck",100,"BRD-K71847383-001-13-3, BRD-K71847383-001-12-5, BRD-K71847383-001-07-5","Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1","UHDGCWIWMRVCDJ-XVFCMESISA-N, UHDGCWIWMRVCDJ-XVFCMESISA-N, UHDGCWIWMRVCDJ-XVFCMESISA-N",Launched,"BRD-A57371185-001-04-3, BRD-K33106058-001-16-8"
cytisine,acetylcholine receptor agonist,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4",neurology/psychiatry,nicotinism,"MicroSource, Tocris, Selleck, Selleck",98.23,"BRD-K74186897-001-13-2, BRD-K74186897-001-11-6, BRD-K74186897-001-10-8, BRD-K74186897-001-12-4","O=c1cccc2[C@H]3CNC[C@H](C3)Cn12, O=c1cccc2[C@H]3CNC[C@H](C3)Cn12, O=c1cccc2[C@H]3CNC[C@H](C3)Cn12, O=c1cccc2[C@H]3CNC[C@H](C3)Cn12","ANJTVLIZGCUXLD-DTWKUNHWSA-N, ANJTVLIZGCUXLD-DTWKUNHWSA-N, ANJTVLIZGCUXLD-DTWKUNHWSA-N, ANJTVLIZGCUXLD-DTWKUNHWSA-N",Launched,BRD-A55579717-001-04-0
D-alpha-tocopheryl-succinate,,,,,SantaCruz,93.52,BRD-K64636206-001-02-7,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(O)=O)c(C)c(C)c2O1,IELOKBJPULMYRW-NJQVLOCASA-N,Launched,
D-delta-Tocopherol,,,,,Acros,91.79,BRD-K04657451-001-01-0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1,GZIFEOYASATJEH-VHFRWLAGSA-N,Launched,
D-Serine,glutamate receptor agonist,"GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3",,,Enzo,100,BRD-K71822263-001-03-2,N[C@H](CO)C(O)=O,MTCFGRXMJLQNBG-UWTATZPHSA-N,Launched,
dabigatran,thrombin inhibitor,F2,"neurology/psychiatry, hematology","stroke, systemic embolism, pulmonary embolism (PE), deep vein thrombosis (DVT)","MedChemEx, Selleck, MedChemEx, Selleck",77.34,"BRD-K38168441-001-04-5, BRD-K38168441-001-02-9, BRD-K38168441-001-05-2, BRD-K38168441-001-03-7","Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1, Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1, Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1, Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1","YBSJFWOBGCMAKL-UHFFFAOYSA-N, YBSJFWOBGCMAKL-UHFFFAOYSA-N, YBSJFWOBGCMAKL-UHFFFAOYSA-N, YBSJFWOBGCMAKL-UHFFFAOYSA-N",Launched,
dabigatran-etexilate,thrombin inhibitor,F2,"neurology/psychiatry, hematology","stroke, systemic embolism, pulmonary embolism (PE), deep vein thrombosis (DVT)","MicroSource, Selleck",92.78,"BRD-K57041787-066-01-1, BRD-K57041787-001-02-6","CCCCCCOC(=O)\N=C(\N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1, CCCCCCOC(=O)\N=C(\N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1","KSGXQBZTULBEEQ-UHFFFAOYSA-N, KSGXQBZTULBEEQ-UHFFFAOYSA-N",Launched,
dabrafenib,RAF inhibitor,"BRAF, LIMK1, NEK11, RAF1, SIK1",oncology,melanoma,"Selleck, MedChemEx, Selleck",98.14,"BRD-K09951645-001-11-8, BRD-K09951645-001-08-4, BRD-K09951645-001-06-8","CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F, CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F, CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F","BFSMGDJOXZAERB-UHFFFAOYSA-N, BFSMGDJOXZAERB-UHFFFAOYSA-N, BFSMGDJOXZAERB-UHFFFAOYSA-N",Launched,
dacarbazine,DNA alkylating agent,"PGD, POLA2","oncology, hematologic malignancy","melanoma, Hodgkin's lymphoma","MicroSource, Selleck",98.92,"BRD-K35520305-001-17-7, BRD-K35520305-001-16-9","CN(C)\N=N\c1[nH]cnc1C(N)=O, CN(C)\N=N\c1[nH]cnc1C(N)=O","FDKXTQMXEQVLRF-ZHACJKMWSA-N, FDKXTQMXEQVLRF-ZHACJKMWSA-N",Launched,
daclatasvir,HCV inhibitor,,infectious disease,hepatitis C,Selleck,94.53,BRD-K82861010-001-02-5,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,FKRSSPOQAMALKA-CUPIEXAXSA-N,Launched,
dactinomycin,RNA polymerase inhibitor,POLR2A,oncology,"testicular carcinoma, Wilm's tumor, rhabdomyosarcoma, Ewing's sarcoma, gestational trophoblastic disease (GTD)",MicroSource,77.87,BRD-K70578146-001-06-7,CC(C)[C@H]1NC(=O)[C@@H](NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4nc23)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O,RJURFGZVJUQBHK-IIXSONLDSA-N,Launched,
dalbavancin,bacterial cell wall synthesis inhibitor,PNLIP,infectious disease,skin infections,MedChemEx,68.91,BRD-K30177383-001-01-0,CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2,KGPGQDLTDHGEGT-SZUNQUCBSA-N,Launched,
dalfampridine,potassium channel blocker,"KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2",neurology/psychiatry,multiple sclerosis,"Tocris, MicroSource",97.14,"BRD-K22482860-001-20-6, BRD-K22482860-001-21-4","Nc1ccncc1, Nc1ccncc1","NUKYPUAOHBNCPY-UHFFFAOYSA-N, NUKYPUAOHBNCPY-UHFFFAOYSA-N",Launched,
danazol,"estrogen receptor antagonist, progesterone receptor agonist","AR, CCL2, ESR1, GNRHR, GNRHR2, PGR","obstetrics/gynecology, cardiology","endometriosis, angioedema",MicroSource,98.72,BRD-A92537424-001-04-7,C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C,POZRVZJJTULAOH-GSQPBCFPSA-N,Launched,
danofloxacin,bacterial DNA gyrase inhibitor,,pulmonary,bovine respiratory disease (BRD),Selleck,95.15,BRD-K45916615-066-02-5,CN1C[C@@H]2C[C@H]1CN2c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1,QMLVECGLEOSESV-RYUDHWBXSA-N,Launched,
dantrolene,calcium channel blocker,"RYR1, RYR3","neurology/psychiatry, endocrinology","spasms, malignant hyperthermia (MH)","MicroSource, Tocris",97.08,"BRD-K81272440-236-13-5, BRD-K81272440-236-12-7","[O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1, [O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1","OZOMQRBLCMDCEG-VIZOYTHASA-N, OZOMQRBLCMDCEG-VIZOYTHASA-N",Launched,
dapagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2",endocrinology,diabetes mellitus,"Selleck, MicroSource",98,"BRD-K58160573-001-05-4, BRD-K58160573-001-04-7","CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1, CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1","JVHXJTBJCFBINQ-ADAARDCZSA-N, JVHXJTBJCFBINQ-ADAARDCZSA-N",Launched,BRD-K46604138-001-01-3
dapiprazole,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D",ophthalmology,mydriasis,AvaChem,99.76,BRD-K33133047-001-01-8,Cc1ccccc1N1CCN(CCc2nnc3CCCCn23)CC1,RFWZESUMWJKKRN-UHFFFAOYSA-N,Launched,
dapoxetine,selective serotonin reuptake inhibitor (SSRI),"HTR1A, HTR1B, HTR2C, SLC6A4",urology,premature ejaculation (PE),Selleck,98.79,BRD-K51579475-003-02-4,CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1,USRHYDPUVLEVMC-FQEVSTJZSA-N,Launched,
dapsone,bacterial antifolate,DHFR,"dermatology, infectious disease","dermatitis herpetiformis (DH), leprosy",MicroSource,98.4,BRD-K62363391-001-24-9,Nc1ccc(cc1)S(=O)(=O)c1ccc(N)cc1,MQJKPEGWNLWLTK-UHFFFAOYSA-N,Launched,
daptomycin,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, endocarditis","Selleck, Selleck",89.99,"BRD-K94358652-001-03-9, BRD-K94358652-001-02-1","CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)c2ccccc2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O, CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)c2ccccc2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@@H](C)CC(O)=O","DOAKLVKFURWEDJ-QAMDLYIKSA-N, DOAKLVKFURWEDJ-QAMDLYIKSA-N",Launched,BRD-K25021320-001-01-3
darifenacin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",urology,urinary incontinence,"MicroSource, Selleck",95.96,"BRD-K95773607-004-04-6, BRD-K95773607-004-03-8","NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1, NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1","HXGBXQDTNZMWGS-RUZDIDTESA-N, HXGBXQDTNZMWGS-RUZDIDTESA-N",Launched,"BRD-K95773607-001-03-4,BRD-A01118042-004-01-8"
darunavir,HIV protease inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),Selleck,98.7,BRD-K84986517-001-01-8,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Launched,BRD-M22677129-001-01-6
dasabuvir,HCV inhibitor,,infectious disease,hepatitis C,MedChemEx,91.31,BRD-K02943813-001-01-9,COc1c(cc(cc1C(C)(C)C)-n1ccc(=O)[nH]c1=O)-c1ccc2cc(NS(C)(=O)=O)ccc2c1,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Launched,
dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor","ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1",hematologic malignancy,"chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)","Selleck, Selleck",88.41,"BRD-K49328571-001-19-2, BRD-K49328571-001-15-0","Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1, Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1","ZBNZXTGUTAYRHI-UHFFFAOYSA-N, ZBNZXTGUTAYRHI-UHFFFAOYSA-N",Launched,
daunorubicin,"RNA synthesis inhibitor, topoisomerase inhibitor","TOP2A, TOP2B",hematologic malignancy,"acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL)","MicroSource, Tocris, Selleck, Selleck",90.48,"BRD-K43389675-001-02-1, BRD-K43389675-003-20-9, BRD-K43389675-003-19-1, BRD-K43389675-003-16-7","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O","STQGQHZAVUOBTE-VGBVRHCVSA-N, STQGQHZAVUOBTE-VGBVRHCVSA-N, STQGQHZAVUOBTE-VGBVRHCVSA-N, STQGQHZAVUOBTE-VGBVRHCVSA-N",Launched,"BRD-K79347022-003-01-4,BRD-A68009927-003-03-7, BRD-K91966436-003-02-3"
debrisoquin,adrenergic neuron blocker,SLC6A2,cardiology,hypertension,"PrincetonBio, MicroSource",80.31,"BRD-K80419150-001-02-4, BRD-K80419150-065-03-7","NC(=N)N1CCc2ccccc2C1, NC(=N)N1CCc2ccccc2C1","JWPGJSVJDAJRLW-UHFFFAOYSA-N, JWPGJSVJDAJRLW-UHFFFAOYSA-N",Launched,
decamethonium,acetylcholine receptor agonist,"ACHE, CHRNA2",neurology/psychiatry,muscle relaxant,"MicroSource, Selleck",99.47,"BRD-K49783248-303-08-4, BRD-K49783248-303-07-6","C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C, C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C","MTCUAOILFDZKCO-UHFFFAOYSA-N, MTCUAOILFDZKCO-UHFFFAOYSA-N",Launched,
decitabine,DNA methyltransferase inhibitor,"DNMT1, DNMT3A","hematologic malignancy, hematology","myelodysplastic diseases (MDS), anemia, chronic myeloid leukemia (CML)","Tocris, Tocris, Selleck",100,"BRD-K79254416-001-24-2, BRD-K79254416-001-22-6, BRD-K79254416-001-21-8","Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1, Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1, Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1","XAUDJQYHKZQPEU-KVQBGUIXSA-N, XAUDJQYHKZQPEU-KVQBGUIXSA-N, XAUDJQYHKZQPEU-KVQBGUIXSA-N",Launched,
decoquinate,antiprotozoal agent,,infectious disease,coccidiosis,"MicroSource, MedChemEx, Selleck, Selleck",100,"BRD-K17641316-213-01-5, BRD-K17641316-001-04-8, BRD-K17641316-001-02-2, BRD-K17641316-001-03-0","CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC, CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC, CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC, CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC","JHAYEQICABJSTP-UHFFFAOYSA-N, JHAYEQICABJSTP-UHFFFAOYSA-N, JHAYEQICABJSTP-UHFFFAOYSA-N, JHAYEQICABJSTP-UHFFFAOYSA-N",Launched,
deferasirox,chelating agent,CYP3A4,hematology,"transfusional hemosiderosis, thalassemia, iron overload",Selleck,97.73,BRD-K97010173-001-04-1,OC(=O)c1ccc(cc1)-n1nc(nc1-c1ccccc1O)-c1ccccc1O,BOFQWVMAQOTZIW-UHFFFAOYSA-N,Launched,
deferiprone,chelating agent,UGT1A6,hematology,"transfusional hemosiderosis, thalassemia, iron overload","MicroSource, Selleck",95.65,"BRD-K06878038-001-18-6, BRD-K06878038-001-17-8","Cc1c(O)c(=O)ccn1C, Cc1c(O)c(=O)ccn1C","TZXKOCQBRNJULO-UHFFFAOYSA-N, TZXKOCQBRNJULO-UHFFFAOYSA-N",Launched,
deferoxamine-mesylate,chelating agent,,hematology,"acute iron intoxication, iron overload","Sigma, MicroSource, MedChemEx",95.48,"BRD-K09821361-066-24-1, BRD-K09821361-066-23-3, BRD-K09821361-066-25-8","CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN, CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN, CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN","UBQYURCVBFRUQT-UHFFFAOYSA-N, UBQYURCVBFRUQT-UHFFFAOYSA-N, UBQYURCVBFRUQT-UHFFFAOYSA-N",Launched,
deflazacort,glucocorticoid receptor agonist,NR3C1,rheumatology,joint inflammation,Selleck,91.86,BRD-K96006502-001-02-6,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C,FBHSPRKOSMHSIF-NADGHRDBSA-N,Launched,BRD-K94177716-001-01-1
degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,oncology,prostate cancer,MedChemEx,96.07,BRD-A88562598-001-01-7,CC(C)CC(NC(=O)C(Cc1ccc(NC(N)=O)cc1)NC(=O)C(Cc1ccc(NC(=O)C2CC(=O)NC(=O)N2)cc1)NC(=O)C(CO)NC(=O)C(Cc1cccnc1)NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(N)=O,MEUCPCLKGZSHTA-UHFFFAOYSA-N,Launched,
dehydroepiandrosterone,protein synthesis stimulant,"ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1",,,"MicroSource, Selleck",100,"BRD-K41256143-001-13-5, BRD-K41256143-001-12-7","C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O","FMGSKLZLMKYGDP-USOAJAOKSA-N, FMGSKLZLMKYGDP-USOAJAOKSA-N",Launched,"BRD-A79445307-001-01-8, BRD-K85833139-001-01-9"
dehydroepiandrosterone-sulfate,"androgen receptor agonist, estrogen receptor agonist","AR, ESR1, ESR2",endocrinology,menopause,Sigma,99.5,BRD-K15360631-325-01-4,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@H](CC[C@]34C)OS(O)(=O)=O)[C@@H]1CCC2=O,CZWCKYRVOZZJNM-USOAJAOKSA-N,Launched,
delamanid,bacterial cell wall synthesis inhibitor,,infectious disease,tuberculosis,Adooq,97.31,BRD-K17480742-001-01-1,C[C@]1(COc2ccc(cc2)N2CCC(CC2)Oc2ccc(OC(F)(F)F)cc2)Cn2cc(nc2O1)[N+]([O-])=O,XDAOLTSRNUSPPH-XMMPIXPASA-N,Launched,
delapril,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,AKSci,94.88,BRD-K00573984-003-01-5,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(O)=O)C1Cc2ccccc2C1,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,Launched,
delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),"Tocris, Sigma, MedChemEx, Enzo",95.35,"BRD-K34068325-066-04-5, BRD-K34068325-066-02-9, BRD-K34068325-066-03-7, BRD-K34068325-066-01-1","CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1, CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1, CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1, CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(NS(C)(=O)=O)ccc2[nH]1","WHBIGIKBNXZKFE-UHFFFAOYSA-N, WHBIGIKBNXZKFE-UHFFFAOYSA-N, WHBIGIKBNXZKFE-UHFFFAOYSA-N, WHBIGIKBNXZKFE-UHFFFAOYSA-N",Launched,
delivert,angiotensin receptor agonist,"AGTR1, AGTR2",,,MedChemEx,88.91,BRD-K45503887-001-01-1,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O,CZGUSIXMZVURDU-FCWOTDAASA-N,Launched,
demecarium,acetylcholinesterase inhibitor,"ACHE, BCHE",ophthalmology,"intraocular pressure, glaucoma",Prestwick,94.41,BRD-K51471001-303-04-7,CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc1cccc(c1)[N+](C)(C)C,RWZVPVOZTJJMNU-UHFFFAOYSA-N,Launched,
demeclocycline,bacterial 30S ribosomal subunit inhibitor,,"endocrinology, infectious disease, ophthalmology, urology","fever, respiratory tract infections, psittacosis, trachoma, conjunctivitis, urethritis, chancroid, cholera, syphilis, listeria, anthrax, actinomycosis, tularemia, brucellosis","MicroSource, MedChemEx, MedChemEx, Selleck",63.01,"BRD-A34145622-003-22-8, BRD-A34145622-003-23-6, BRD-A34145622-003-24-4, BRD-A34145622-003-25-1","CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O","JHOHXJYRVSLQCB-AMESULRKSA-N, JHOHXJYRVSLQCB-AMESULRKSA-N, JHOHXJYRVSLQCB-AMESULRKSA-N, JHOHXJYRVSLQCB-AMESULRKSA-N",Launched,BRD-A50207110-003-01-8
denotivir,antiviral,,infectious disease,"virus herpes simplex (HSV), skin infections",Vitas-M,98.5,BRD-K01773083-001-01-4,Cc1nsc(NC(=O)c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1,ZPBLNADJHWHOEP-UHFFFAOYSA-N,Launched,
deoxycholic-acid,"biliverdin reductase A activator, G protein-coupled receptor agonist","EFTUD1, FPR1, GPBAR1",endocrinology,submental fat,Enzo,100,BRD-K41170226-001-13-8,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,KXGVEGMKQFWNSR-LLQZFEROSA-N,Launched,
dequalinium,PKC inhibitor,"KCNN1, KCNN3",,,"MicroSource, Selleck",95.31,"BRD-K77685957-300-09-1, BRD-K77685957-300-08-3","Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc12, Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc12","PCSWXVJAIHCTMO-UHFFFAOYSA-P, PCSWXVJAIHCTMO-UHFFFAOYSA-P",Launched,
deracoxib,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis,MicroSource,99.74,BRD-K68558722-001-04-0,COc1ccc(cc1F)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)F,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Launched,
deserpidine,angiotensin converting enzyme inhibitor,"ACE, SLC18A2",cardiology,hypertension,"Key, AKSci",96.99,"BRD-K29462201-001-02-7, BRD-K29462201-001-01-9","CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1, CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1","CVBMAZKKCSYWQR-WCGOZPBSSA-N, CVBMAZKKCSYWQR-WCGOZPBSSA-N",Launched,
desipramine,tricyclic antidepressant,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1",neurology/psychiatry,depression,"MicroSource, Sigma",94.4,"BRD-K60762818-003-25-2, BRD-K60762818-003-26-0","CNCCCN1c2ccccc2CCc2ccccc12, CNCCCN1c2ccccc2CCc2ccccc12","HCYAFALTSJYZDH-UHFFFAOYSA-N, HCYAFALTSJYZDH-UHFFFAOYSA-N",Launched,
deslanoside,Na/K-ATPase inhibitor,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2",cardiology,"congestive heart failure, cardiac arrythmia",AvaChem,98.38,BRD-K99919177-001-01-3,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,OBATZBGFDSVCJD-LALPQLPRSA-N,Launched,
desloratadine,histamine receptor antagonist,HRH1,allergy,"allergic rhinitis, urticaria","MicroSource, Selleck, Selleck",91.35,"BRD-K82357231-001-18-3, BRD-K82357231-001-19-1, BRD-K82357231-001-17-5","Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1, Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1, Clc1ccc2c(CCc3cccnc3C2=C2CCNCC2)c1","JAUOIFJMECXRGI-UHFFFAOYSA-N, JAUOIFJMECXRGI-UHFFFAOYSA-N, JAUOIFJMECXRGI-UHFFFAOYSA-N",Launched,
desmopressin-acetate,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR","endocrinology, urology","central diabetes insipidus, nocturnal enuresis",MedChemEx,90.07,BRD-A49399758-015-01-8,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O,NFLWUMRGJYTJIN-UHFFFAOYSA-N,Launched,
desogestrel,progesterone receptor agonist,"ESR1, PGR",endocrinology,contraceptive,Enzo,97.27,BRD-K46061689-001-01-9,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Launched,
desonide,glucocorticoid receptor agonist,"NR3C1, PLA2G1B",gastroenterology,Crohn's disease,"MicroSource, Selleck, Selleck",97.37,"BRD-K21528677-001-04-4, BRD-K21528677-001-02-8, BRD-K21528677-001-03-6","CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO","WBGKWQHBNHJJPZ-LECWWXJVSA-N, WBGKWQHBNHJJPZ-LECWWXJVSA-N, WBGKWQHBNHJJPZ-LECWWXJVSA-N",Launched,"BRD-A26858303-001-02-8, BRD-K30131328-001-01-5"
desoximetasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B",dermatology,corticosteroid-responsive dermatoses,MicroSource,98.83,BRD-A49447682-001-02-4,C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,VWVSBHGCDBMOOT-ZIKVJHDZSA-N,Launched,
desoxycorticosterone-pivalate,corticosteroid agonist,NR3C2,endocrinology,Addison's disease,InterBioScreen,98.85,BRD-K26024145-001-01-9,CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,VVOIQBFMTVCINR-WWMZEODYSA-N,Launched,
desvenlafaxine,serotoninâ€“norepinephrine reuptake inhibitor (SNRI),"SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,depression,"MicroSource, Tocris, Selleck, Selleck, Selleck, Selleck",97.16,"BRD-A98845662-036-03-7, BRD-A98845662-036-05-2, BRD-A98845662-001-02-3, BRD-A98845662-036-02-9, BRD-A98845662-001-03-1, BRD-A98845662-036-04-5","CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1, CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1, CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1, CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1, CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1, CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1","KYYIDSXMWOZKMP-UHFFFAOYSA-N, KYYIDSXMWOZKMP-UHFFFAOYSA-N, KYYIDSXMWOZKMP-UHFFFAOYSA-N, KYYIDSXMWOZKMP-UHFFFAOYSA-N, KYYIDSXMWOZKMP-UHFFFAOYSA-N, KYYIDSXMWOZKMP-UHFFFAOYSA-N",Launched,
detomidine,adrenergic receptor agonist,ADRA2A,neurology/psychiatry,sedative,Selleck,98.34,BRD-K77597856-003-02-5,Cc1cccc(Cc2c[nH]cn2)c1C,RHDJRPPFURBGLQ-UHFFFAOYSA-N,Launched,
dexamethasone,glucocorticoid receptor agonist,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2","endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Tocris, Selleck, Tocris",96.19,"BRD-A10188456-001-04-9, BRD-K38775274-001-22-1, BRD-K38775274-001-23-9, BRD-K38775274-001-24-7","C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","UREBDLICKHMUKA-QCYOSJOCSA-N, UREBDLICKHMUKA-CXSFZGCWSA-N, UREBDLICKHMUKA-CXSFZGCWSA-N, UREBDLICKHMUKA-CXSFZGCWSA-N",Launched,"BRD-A27572786-001-01-2, BRD-K45192137-001-01-1, BRD-A27572786-001-02-0"
dexamethasone-acetate,glucocorticoid receptor agonist,,"endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, Selleck",97.02,"BRD-K47635719-001-21-1, BRD-K47635719-001-20-3","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O","AKUJBENLRBOFTD-RPRRAYFGSA-N, AKUJBENLRBOFTD-RPRRAYFGSA-N",Launched,"BRD-A93424738-001-04-8, BRD-K40063336-001-01-8"
dexamethasone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,"endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology","hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis","MicroSource, MicroSource",95.47,"BRD-A79380603-304-02-4, BRD-A83802939-304-04-2","C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O, C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O","VQODGRNSFPNSQE-REKGUKDCSA-N, VQODGRNSFPNSQE-QCYOSJOCSA-N",Launched,
dexchlorpheniramine,histamine receptor antagonist,,"allergy, cardiology","allergic conjunctivitis, allergic rhinitis, urticaria, angioedema",MicroSource,95.84,BRD-K39462424-050-09-8,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,SOYKEARSMXGVTM-HNNXBMFYSA-N,Launched,
dexlansoprazole,ATPase inhibitor,"ATP4A, ATP4B",gastroenterology,"gastroesophageal reflux disease (GERD), erosive esophagitis (EE)","MicroSource, Selleck, Selleck",95.4,"BRD-K05900209-001-02-6, BRD-K05900209-001-01-8, BRD-K05900209-001-03-4","Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1, Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1, Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1","MJIHNNLFOKEZEW-RUZDIDTESA-N, MJIHNNLFOKEZEW-RUZDIDTESA-N, MJIHNNLFOKEZEW-RUZDIDTESA-N",Launched,
dexmedetomidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C",,,"Tocris, Selleck, Selleck",98.01,"BRD-K18423410-003-03-3, BRD-K18423410-003-02-5, BRD-K18423410-001-02-9","C[C@H](c1cnc[nH]1)c1cccc(C)c1C, C[C@H](c1cnc[nH]1)c1cccc(C)c1C, C[C@H](c1cnc[nH]1)c1cccc(C)c1C","CUHVIMMYOGQXCV-NSHDSACASA-N, CUHVIMMYOGQXCV-NSHDSACASA-N, CUHVIMMYOGQXCV-NSHDSACASA-N",Launched,
dexpanthenol,,,gastroenterology,paralytic ileus,"MicroSource, MicroSource",89.9,"BRD-K71210479-001-05-5, BRD-A59413292-001-08-2","CC(C)(CO)[C@@H](O)C(=O)NCCCO, CC(C)(CO)C(O)C(=O)NCCCO","SNPLKNRPJHDVJA-ZETCQYMHSA-N, SNPLKNRPJHDVJA-UHFFFAOYSA-N",Launched,
dexrazoxane,"chelating agent, topoisomerase inhibitor","TOP2A, TOP2B",cardiology,cardiomyopathy,"Selleck, Selleck, Tocris",94.57,"BRD-K07265709-003-05-6, BRD-K07265709-003-03-1, BRD-K07265709-003-04-9","C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1, C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1, C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1","BMKDZUISNHGIBY-ZETCQYMHSA-N, BMKDZUISNHGIBY-ZETCQYMHSA-N, BMKDZUISNHGIBY-ZETCQYMHSA-N",Launched,
dextran,,,"hematology, critical care","thrombosis, hypovolemia",ANpharma,100,BRD-K67117832-001-01-9,OC[C@H]1O[C@H](OC[C@H]2O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,FZWBNHMXJMCXLU-BLAUPYHCSA-N,Launched,
dextroamphetamine,monoamine oxidase inhibitor,"ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1",neurology/psychiatry,"attention-deficit/hyperactivity disorder (ADHD), narcolepsy",MicroSource,85.01,BRD-K21160401-065-01-0,C[C@H](N)Cc1ccccc1,KWTSXDURSIMDCE-QMMMGPOBSA-N,Launched,
dextromethorphan,"glutamate receptor antagonist, sigma receptor agonist","CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4",pulmonary,cough suppressant,MicroSource,99.02,BRD-K33211335-004-01-7,COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1,MKXZASYAUGDDCJ-NJAFHUGGSA-N,Launched,
dextrose,,,endocrinology,hypoglycemia,Selleck,96.3,BRD-K51431759-001-02-9,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O,GZCGUPFRVQAUEE-SLPGGIOYSA-N,Launched,
diacerein,interleukin inhibitor,IL1B,rheumatology,osteoarthritis,"MicroSource, Selleck, Selleck",95.35,"BRD-K69122748-001-10-1, BRD-K69122748-001-09-3, BRD-K69122748-001-11-9","CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O, CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O, CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(C)=O)c3C(=O)c12)C(O)=O","TYNLGDBUJLVSMA-UHFFFAOYSA-N, TYNLGDBUJLVSMA-UHFFFAOYSA-N, TYNLGDBUJLVSMA-UHFFFAOYSA-N",Launched,
diatrizoic-acid,,,radiology,contrast agent,MicroSource,97.75,BRD-K48247567-001-01-9,CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I,YVPYQUNUQOZFHG-UHFFFAOYSA-N,Launched,
diaveridine,dihydrofolate reductase inhibitor,,,,MicroSource,99.41,BRD-K97464279-001-03-5,COc1ccc(Cc2cnc(N)nc2N)cc1OC,LDBTVAXGKYIFHO-UHFFFAOYSA-N,Launched,
diazepam,benzodiazepine receptor agonist,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",neurology/psychiatry,"generalized anxiety disorder (GAD), abstinence from alcohol, hallucinosis, tremors",Enzo,99.35,BRD-K16508793-001-05-9,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,AAOVKJBEBIDNHE-UHFFFAOYSA-N,Launched,
diazoxide,potassium channel activator,"ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3",endocrinology,hypoglycemia,"Tocris, MicroSource, Tocris",99.38,"BRD-K73109821-001-22-7, BRD-K73109821-001-20-1, BRD-K73109821-001-19-3","CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1, CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1, CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1","GDLBFKVLRPITMI-UHFFFAOYSA-N, GDLBFKVLRPITMI-UHFFFAOYSA-N, GDLBFKVLRPITMI-UHFFFAOYSA-N",Launched,
dibekacin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,0,BRD-K48427910-001-01-1,NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1,JJCQSGDBDPYCEO-XVZSLQNASA-N,Launched,
dichlorophen,anticestodal agent,,,,"Sigma, MicroSource",92.97,"BRD-K62326629-001-20-8, BRD-K62326629-001-19-0","Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O, Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O","MDNWOSOZYLHTCG-UHFFFAOYSA-N, MDNWOSOZYLHTCG-UHFFFAOYSA-N",Launched,
dichlorvos,acetylcholinesterase inhibitor,,,,MicroSource,0,BRD-K23779958-001-05-8,COP(=O)(OC)OC=C(Cl)Cl,OEBRKCOSUFCWJD-UHFFFAOYSA-N,Launched,
diclazuril,antiprotozoal agent,,infectious disease,equine protozoal myeloencephalitis (EPM),"MicroSource, Selleck",98.14,"BRD-A06426627-001-04-3, BRD-A06426627-001-03-5","Clc1ccc(cc1)C(C#N)c1c(Cl)cc(cc1Cl)-n1ncc(=O)[nH]c1=O, Clc1ccc(cc1)C(C#N)c1c(Cl)cc(cc1Cl)-n1ncc(=O)[nH]c1=O","ZSZFUDFOPOMEET-UHFFFAOYSA-N, ZSZFUDFOPOMEET-UHFFFAOYSA-N",Launched,
diclofenac,cyclooxygenase inhibitor,"AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A","rheumatology, neurology/psychiatry","rheumatoid arthritis, osteoarthritis, migraine headache","MicroSource, Selleck, Selleck, Selleck",99.61,"BRD-K08252256-236-33-8, BRD-K08252256-237-02-1, BRD-K08252256-224-02-9, BRD-K08252256-236-32-0","OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl, OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl, OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl, OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl","DCOPUUMXTXDBNB-UHFFFAOYSA-N, DCOPUUMXTXDBNB-UHFFFAOYSA-N, DCOPUUMXTXDBNB-UHFFFAOYSA-N, DCOPUUMXTXDBNB-UHFFFAOYSA-N",Launched,
diclofenamide,carbonic anhydrase inhibitor,"CA1, CA12, CA2, CA4, CA7","ophthalmology, neurology/psychiatry","glaucoma, epilepsy",Selleck,98.21,BRD-K71499074-001-12-9,NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(N)(=O)=O,GJQPMPFPNINLKP-UHFFFAOYSA-N,Launched,
dicloxacillin,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,"MicroSource, Selleck, Selleck",87.83,"BRD-K05673000-236-12-1, BRD-K05673000-323-13-5, BRD-K05673000-323-12-7","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(Cl)cccc1Cl, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(Cl)cccc1Cl, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(Cl)cccc1Cl","YFAGHNZHGGCZAX-JKIFEVAISA-N, YFAGHNZHGGCZAX-JKIFEVAISA-N, YFAGHNZHGGCZAX-JKIFEVAISA-N",Launched,BRD-K59843513-323-01-4
dicoumarol,NADPH inhibitor,"CRYZ, NQO1, VKORC1",hematology,deep vein thrombosis (DVT),MicroSource,99.51,BRD-K82236179-213-01-0,Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Launched,
dicycloverine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3",gastroenterology,irritable bowel syndrome,"MicroSource, Selleck",100,"BRD-K68507560-003-25-3, BRD-K68507560-003-24-6","CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1, CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1","CURUTKGFNZGFSE-UHFFFAOYSA-N, CURUTKGFNZGFSE-UHFFFAOYSA-N",Launched,
didanosine,nucleoside reverse transcriptase inhibitor,PNP,infectious disease,human immunodeficiency virus (HIV-1),"Selleck, Selleck",99.4,"BRD-K99063460-001-13-1, BRD-K99063460-001-12-3","OC[C@@H]1CC[C@@H](O1)n1cnc2c(O)ncnc12, OC[C@@H]1CC[C@@H](O1)n1cnc2c(O)ncnc12","BXZVVICBKDXVGW-NKWVEPMBSA-N, BXZVVICBKDXVGW-NKWVEPMBSA-N",Launched,
didox,ribonucleotide reductase inhibitor,RRM1,oncology,breast cancer,MedChemEx,95.72,BRD-K94146583-001-01-6,ONC(=O)c1ccc(O)c(O)c1,QJMCKEPOKRERLN-UHFFFAOYSA-N,Launched,
dienestrol,estrogen receptor agonist,ESR1,endocrinology,menopause,MicroSource,90.26,BRD-K95309561-001-24-7,C\C=C(c1ccc(O)cc1)\C(c1ccc(O)cc1)=C\C,NFDFQCUYFHCNBW-SCGPFSFSSA-N,Launched,
dienogest,progesterone receptor agonist,PGR,"endocrinology, obstetrics/gynecology","contraceptive, endometriosis",Selleck,92.69,BRD-K50853363-001-02-3,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,AZFLJNIPTRTECV-FUMNGEBKSA-N,Launched,BRD-K64504314-001-01-8
diethylcarbamazine,lipoxygenase inhibitor,"ALOX5, PTGS1",infectious disease,filariasis,MicroSource,99.23,BRD-K45542189-048-22-1,CCN(CC)C(=O)N1CCN(C)CC1,RCKMWOKWVGPNJF-UHFFFAOYSA-N,Launched,
diethyltoluamide,ionotropic receptor IR40a activator,,dermatology,sunscreen lotion,MicroSource,98.89,BRD-K94080537-001-09-7,CCN(CC)C(=O)c1cccc(C)c1,MMOXZBCLCQITDF-UHFFFAOYSA-N,Launched,
difenpiramide,"cyclooxygenase inhibitor, prostaglandin inhibitor",,,,Enamine,85.55,BRD-K96206066-001-07-9,O=C(Cc1ccc(cc1)-c1ccccc1)Nc1ccccn1,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Launched,
diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,MicroSource,97.55,BRD-A66869276-001-02-9,C[C@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O,BOBLHFUVNSFZPJ-LIRARCAYSA-N,Launched,
difloxacin,bacterial DNA gyrase inhibitor,,infectious disease,"skin infections, urinary tract infections","Selleck, MicroSource",97.01,"BRD-K73923631-003-01-1, BRD-K73923631-003-02-9","CN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1, CN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1","NOCJXYPHIIZEHN-UHFFFAOYSA-N, NOCJXYPHIIZEHN-UHFFFAOYSA-N",Launched,
diflunisal,prostanoid receptor antagonist,"PTGS1, PTGS2",rheumatology,"rheumatoid arthritis, osteoarthritis",MicroSource,98.97,BRD-K22031190-001-23-6,OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F,HUPFGZXOMWLGNK-UHFFFAOYSA-N,Launched,
difluprednate,glucocorticoid receptor agonist,NR3C1,ophthalmology,endogenous uveitis,Selleck,95.46,BRD-K33720171-001-01-0,CCCC(=O)O[C@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)COC(C)=O,WYQPLTPSGFELIB-QXNOXDERSA-N,Launched,
diftalone,cyclooxygenase inhibitor,,endocrinology,thyroiditis,Vitas-M,98.16,BRD-K80076813-001-08-8,O=C1N2Cc3ccccc3C(=O)N2Cc2ccccc12,CXSJGNHRBWJXEA-UHFFFAOYSA-N,Launched,
digitoxin,ATPase inhibitor,ATP1A1,,,MicroSource,97.65,BRD-A93236127-001-04-5,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,WDJUZGPOPHTGOT-KSVSUYAUSA-N,Launched,
digoxin,ATPase inhibitor,ATP1A1,cardiology,"congestive heart failure, atrial fibrillation (AF)",MicroSource,96.49,BRD-A94756469-001-04-7,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CCC5C4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,LTMHDMANZUZIPE-QVYPYPLASA-N,Launched,
dihydroartemisinin,antimalarial agent,,infectious disease,malaria,"Selleck, MicroSource",94.91,"BRD-K62213621-001-01-6, BRD-K62213621-001-02-4","C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4, C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","BJDCWCLMFKKGEE-ISOSDAIHSA-N, BJDCWCLMFKKGEE-ISOSDAIHSA-N",Launched,"BRD-K45089490-001-02-8,BRD-K11421397-001-01-9, BRD-A82452087-001-02-3"
dihydroergocristine,"adrenergic receptor antagonist, prolactin inhibitor","ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7",,,"Tocris, Tocris",96.31,"BRD-K97440753-066-19-9, BRD-K97440753-066-18-1","CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O, CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O","DEQITUUQPICUMR-HJPBWRTMSA-N, DEQITUUQPICUMR-HJPBWRTMSA-N",Launched,
dihydroergotamine,serotonin receptor agonist,"ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7",neurology/psychiatry,migraine headache,"Tocris, MicroSource, Tocris",97.15,"BRD-K72166146-066-06-2, BRD-K72166146-066-05-4, BRD-K72166146-066-04-7","CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O, CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O, CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O","LUZRJRNZXALNLM-JGRZULCMSA-N, LUZRJRNZXALNLM-JGRZULCMSA-N, LUZRJRNZXALNLM-JGRZULCMSA-N",Launched,
dihydrotachysterol,vitamin analog,VDR,"orthopedics, endocrinology","rickets, hypocalcemia, osteomalacia",Sigma,0,BRD-A34455052-001-01-8,CC(C)C(C)\C=C\C(C)C1CCC2C1(C)CCC\C2=C/C=C1\CC(O)CCC1C,ILYCWAKSDCYMBB-ZJGOHBTISA-N,Launched,
dihydrotestosterone,androgen receptor agonist,"AR, HSD17B1","neurology/psychiatry, endocrinology","tetany, hypoparathyroidism",MedChemEx,99.31,BRD-K22525962-001-05-0,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,Launched,
dihydroxyacetone,,,dermatology,skin protectant,Sigma,0,BRD-K18637542-001-01-7,OCC(=O)CO,RXKJFZQQPQGTFL-UHFFFAOYSA-N,Launched,
dilazep,adenosine reuptake inhibitor,SLC29A1,,,"MicroSource, Tocris",92.84,"BRD-K48722258-300-11-0, BRD-K48722258-300-10-2","COc1cc(cc(OC)c1OC)C(=O)OCCCN1CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC1, COc1cc(cc(OC)c1OC)C(=O)OCCCN1CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC1","QVZCXCJXTMIDME-UHFFFAOYSA-N, QVZCXCJXTMIDME-UHFFFAOYSA-N",Launched,
diloxanide,protein synthesis inhibitor,,infectious disease,amebiasis,MicroSource,98.59,BRD-K10974103-001-21-1,CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1,BDYYDXJSHYEDGB-UHFFFAOYSA-N,Launched,
diltiazem,calcium channel blocker,"CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5",cardiology,"hypertension, angina pectoris","Tocris, MicroSource, Selleck, Tocris",99.25,"BRD-K24023109-003-28-6, BRD-A69636825-003-04-7, BRD-K24023109-003-25-2, BRD-K24023109-003-26-0","COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O, COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O, COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O, COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O","HSUGRBWQSSZJOP-RTWAWAEBSA-N, HSUGRBWQSSZJOP-UHFFFAOYSA-N, HSUGRBWQSSZJOP-RTWAWAEBSA-N, HSUGRBWQSSZJOP-RTWAWAEBSA-N",Launched,
dimemorfan,sigma receptor agonist,SIGMAR1,pulmonary,cough suppressant,Key,98.52,BRD-K29812331-011-01-7,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C)cc31,KBEZZLAAKIIPFK-NJAFHUGGSA-N,Launched,
dimenhydrinate,histamine receptor antagonist,HRH1,"neurology/psychiatry, gastroenterology","motion sickness, nausea, vomiting","MicroSource, MedChemEx, MedChemEx",59.15,"BRD-M98649031-001-08-6, BRD-M98649031-001-10-2, BRD-M98649031-001-09-4","Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1, Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1, Cn1c2nc(Cl)[nH]c2c(=O)n(C)c1=O.CN(C)CCOC(c1ccccc1)c1ccccc1","NFLLKCVHYJRNRH-UHFFFAOYSA-N, NFLLKCVHYJRNRH-UHFFFAOYSA-N, NFLLKCVHYJRNRH-UHFFFAOYSA-N",Launched,
dimercaprol,chelating agent,,neurology/psychiatry,metal toxicity,"Sigma, MicroSource",0,"BRD-A56152450-001-03-8, BRD-A56152450-001-02-0","OCC(S)CS, OCC(S)CS","WQABCVAJNWAXTE-UHFFFAOYSA-N, WQABCVAJNWAXTE-UHFFFAOYSA-N",Launched,
dimercaptosuccinic-acid,chelating agent,DNMT1,neurology/psychiatry,metal toxicity,"AlfaAesar, AlfaAesar",0,"BRD-K88701661-001-03-7, BRD-K88701661-001-02-9","OC(=O)[C@@H](S)[C@@H](S)C(O)=O, OC(=O)[C@@H](S)[C@@H](S)C(O)=O","ACTRVOBWPAIOHC-XIXRPRMCSA-N, ACTRVOBWPAIOHC-XIXRPRMCSA-N",Launched,
dimethicone,,,dermatology,cosmetic,Sigma,0,BRD-K26674746-001-01-4,C[Si](C)(C)O[Si](C)(C)C,UQEAIHBTYFGYIE-UHFFFAOYSA-N,Launched,
dimethisoquin,local anesthetic,,neurology/psychiatry,local anesthetic,Prestwick,95.73,BRD-K73391359-003-10-2,CCCCc1cc2ccccc2c(OCCN(C)C)n1,XNMYNYSCEJBRPZ-UHFFFAOYSA-N,Launched,
dimethyl-fumarate,"nuclear factor erythroid derived, like (NRF2) activator",KEAP1,neurology/psychiatry,multiple sclerosis,"MicroSource, Selleck, Selleck",97.66,"BRD-K31111078-001-04-2, BRD-K31111078-001-05-9, BRD-K31111078-001-03-4","COC(=O)\C=C\C(=O)OC, COC(=O)\C=C\C(=O)OC, COC(=O)\C=C\C(=O)OC","LDCRTTXIJACKKU-ONEGZZNKSA-N, LDCRTTXIJACKKU-ONEGZZNKSA-N, LDCRTTXIJACKKU-ONEGZZNKSA-N",Launched,
dimetindene,"histamine receptor antagonist, cholinergic receptor antagonist","CHRM2, HRH1",allergy,allergic rhinitis,AMS,52.79,BRD-A54141700-001-01-5,CC(C1=C(CCN(C)C)Cc2ccccc12)c1ccccn1,MVMQESMQSYOVGV-UHFFFAOYSA-N,Launched,
dimetridazole,bacterial DNA inhibitor,,,,MicroSource,96.89,BRD-K72728560-001-01-4,Cc1ncc(n1C)[N+]([O-])=O,IBXPYPUJPLLOIN-UHFFFAOYSA-N,Launched,BRD-U80626937-000-01-6
dimpylate,acetylcholinesterase inhibitor,ACHE,,,MicroSource,89.72,BRD-K60567437-001-10-2,CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C,FHIVAFMUCKRCQO-UHFFFAOYSA-N,Launched,
dinitolmide,,,infectious disease,coccidiosis,MicroSource,98.55,BRD-K93240442-001-08-4,Cc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(N)=O,ZEFNOZRLAWVAQF-UHFFFAOYSA-N,Launched,
dinoprost,prostacyclin analog,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R",obstetrics/gynecology,labor induction,Enzo,100,BRD-K81672972-001-03-1,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,PXGPLTODNUVGFL-YNNPMVKQSA-N,Launched,
diosmetin,aryl hydrocarbon receptor agonist,CYP1B1,dermatology,cosmetic,Selleck,96.23,BRD-K26862302-001-05-2,COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O)cc2o1,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Launched,
diosmin,"aryl hydrocarbon receptor agonist, capillary stabilizing agent",AHR,"cardiology, hematology, dermatology","chronic venous insufficiency (CVI), edema, deep vein thrombosis (DVT), statis dermatitis, heavy leg syndrome","MicroSource, Selleck, Selleck",89.84,"BRD-K94436377-001-10-2, BRD-K94436377-001-11-0, BRD-K94436377-001-12-8","COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1, COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1, COc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2o1","GZSOSUNBTXMUFQ-YFAPSIMESA-N, GZSOSUNBTXMUFQ-YFAPSIMESA-N, GZSOSUNBTXMUFQ-YFAPSIMESA-N",Launched,"BRD-K22902927-001-01-4,BRD-A35279169-001-07-8"
dipeptamin,,,,,"ChemImpex, ChemImpex",0,"BRD-K11595419-001-02-2, BRD-K11595419-001-01-4","C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O, C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O","HJCMDXDYPOUFDY-WHFBIAKZSA-N, HJCMDXDYPOUFDY-WHFBIAKZSA-N",Launched,
diphemanil,acetylcholine receptor antagonist,CHRM3,neurology/psychiatry,spasms,Selleck,96.64,BRD-K93441486-067-12-8,C[N+]1(C)CCC(CC1)=C(c1ccccc1)c1ccccc1,LCTZPQRFOZKZNK-UHFFFAOYSA-N,Launched,
diphenhydramine,histamine receptor antagonist,HRH1,neurology/psychiatry,headache,"MicroSource, Selleck",98.11,"BRD-K47278471-003-26-3, BRD-K47278471-003-25-5","CN(C)CCOC(c1ccccc1)c1ccccc1, CN(C)CCOC(c1ccccc1)c1ccccc1","ZZVUWRFHKOJYTH-UHFFFAOYSA-N, ZZVUWRFHKOJYTH-UHFFFAOYSA-N",Launched,
diphenidol,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4",neurology/psychiatry,vertigo,Enamine,99.63,BRD-K01663662-003-20-2,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,OGAKLTJNUQRZJU-UHFFFAOYSA-N,Launched,
diphenylpyraline,dopamine uptake inhibitor,"HRH1, SLC6A3",allergy,allergic rhinitis,"MicroSource, Selleck",97.93,"BRD-K22936972-003-23-6, BRD-K22936972-003-22-8","CN1CCC(CC1)OC(c1ccccc1)c1ccccc1, CN1CCC(CC1)OC(c1ccccc1)c1ccccc1","OWQUZNMMYNAXSL-UHFFFAOYSA-N, OWQUZNMMYNAXSL-UHFFFAOYSA-N",Launched,
dipivefrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRA2A, ADRB2, BCHE",ophthalmology,"glaucoma, intraocular pressure",Prestwick,94.37,BRD-A47494775-003-11-3,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,OCUJLLGVOUDECM-UHFFFAOYSA-N,Launched,
DIPT,"dopamine reuptake inhibitor, serotonin reuptake inhibitor","HTR1A, HTR2A, HTR2C",,,Cayman,88.49,BRD-K75385383-001-01-5,CC(C)N(CCc1c[nH]c2ccccc12)C(C)C,ZRVAAGAZUWXRIP-UHFFFAOYSA-N,Launched,
dipyridamole,phosphodiesterase inhibitor,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1",cardiology,"coronary artery disease (CAD), peripheral artery disease (PAD), hypertension","Selleck, Tocris, MicroSource, Selleck, Tocris",91.41,"BRD-K86301799-001-37-1, BRD-K86301799-001-39-7, BRD-K86301799-001-36-3, BRD-K86301799-001-34-8, BRD-K86301799-001-35-5","OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO, OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO, OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO, OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO, OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO","IZEKFCXSFNUWAM-UHFFFAOYSA-N, IZEKFCXSFNUWAM-UHFFFAOYSA-N, IZEKFCXSFNUWAM-UHFFFAOYSA-N, IZEKFCXSFNUWAM-UHFFFAOYSA-N, IZEKFCXSFNUWAM-UHFFFAOYSA-N",Launched,
dipyrocetyl,chelating agent,,"endocrinology, neurology/psychiatry","fever, pain relief",MicroSource,46.15,BRD-K47608922-001-04-7,CC(=O)Oc1cccc(C(O)=O)c1OC(C)=O,NYIZXMGNIUSNKL-UHFFFAOYSA-N,Launched,
dirithromycin,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bronchitis,"AvaChem, MicroSource, Sigma, MedChemEx, MedChemEx, Selleck, Selleck",95.4,"BRD-K52756523-001-27-0, BRD-K52756523-001-24-7, BRD-K52756523-001-28-8, BRD-A77786295-001-02-9, BRD-K52756523-001-25-4, BRD-K52756523-001-26-2, BRD-K52756523-001-29-6","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H](C2C)C1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O","WLOHNSSYAXHWNR-DWIOZXRMSA-N, WLOHNSSYAXHWNR-DWIOZXRMSA-N, WLOHNSSYAXHWNR-DWIOZXRMSA-N, WLOHNSSYAXHWNR-GHZCURSSSA-N, WLOHNSSYAXHWNR-DWIOZXRMSA-N, WLOHNSSYAXHWNR-DWIOZXRMSA-N, WLOHNSSYAXHWNR-DWIOZXRMSA-N",Launched,"BRD-K15706428-001-01-2, BRD-A77786295-001-01-1, BRD-A83603976-001-01-6, BRD-A44120870-001-01-6"
disopyramide,sodium channel blocker,"CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A",cardiology,"ventricular tachycardia (VT), ventricular arrhythmias","MicroSource, Selleck",97.94,"BRD-A29734509-011-13-6, BRD-A29734509-011-12-8","CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C, CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C","UVTNFZQICZKOEM-UHFFFAOYSA-N, UVTNFZQICZKOEM-UHFFFAOYSA-N",Launched,
disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist","ALDH2, DBH",neurology/psychiatry,abstinence from alcohol,"MicroSource, Selleck, Selleck",99.04,"BRD-K32744045-001-31-2, BRD-K32744045-001-30-4, BRD-K32744045-001-34-6","CCN(CC)C(=S)SSC(=S)N(CC)CC, CCN(CC)C(=S)SSC(=S)N(CC)CC, CCN(CC)C(=S)SSC(=S)N(CC)CC","AUZONCFQVSMFAP-UHFFFAOYSA-N, AUZONCFQVSMFAP-UHFFFAOYSA-N, AUZONCFQVSMFAP-UHFFFAOYSA-N",Launched,
dithranol,DNA synthesis inhibitor,,dermatology,psoriasis,Sigma,0,BRD-K51807679-001-06-8,Oc1cccc2cc3cccc(O)c3c(O)c12,YUTJCNNFTOIOGT-UHFFFAOYSA-N,Launched,
divalproex-sodium,benzodiazepine receptor agonist,ALDH5A1,neurology/psychiatry,"epilepsy, seizures","Selleck, Selleck, Sigma",65.88,"BRD-K41260949-236-20-0, BRD-K41260949-236-19-2, BRD-K41260949-001-18-2","CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O","NIJJYAXOARWZEE-UHFFFAOYSA-N, NIJJYAXOARWZEE-UHFFFAOYSA-N, NIJJYAXOARWZEE-UHFFFAOYSA-N",Launched,"BRD-M19962486-236-03-2, BRD-M19962486-236-02-4"
dobutamine,adrenergic receptor agonist,"ADRB1, ADRB2",cardiology,congestive heart failure,"Tocris, MedChemEx, Tocris, MedChemEx, Tocris",81.27,"BRD-A78322124-003-16-5, BRD-A78322124-003-18-1, BRD-A78322124-003-17-3, BRD-A78322124-003-15-7, BRD-A78322124-003-14-0","CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1, CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1, CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1, CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1, CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1","JRWZLRBJNMZMFE-UHFFFAOYSA-N, JRWZLRBJNMZMFE-UHFFFAOYSA-N, JRWZLRBJNMZMFE-UHFFFAOYSA-N, JRWZLRBJNMZMFE-UHFFFAOYSA-N, JRWZLRBJNMZMFE-UHFFFAOYSA-N",Launched,
docetaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1",oncology,"breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric adenocarcinoma, head and neck squamous cell carcinoma (HNSCC)","Selleck, MicroSource, Selleck",99.62,"BRD-K30577245-001-04-3, BRD-K30577245-341-01-9, BRD-K30577245-001-05-0","CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C, CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C, CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C","ZDZOTLJHXYCWBA-VCVYQWHSSA-N, ZDZOTLJHXYCWBA-VCVYQWHSSA-N, ZDZOTLJHXYCWBA-VCVYQWHSSA-N",Launched,"BRD-A05821830-001-05-6, BRD-A05821830-341-01-5, BRD-K63265447-001-07-4,BRD-A28612473-001-01-3"
doconexent,PPAR receptor agonist,"FFAR1, PTGS1, PTGS2",,,"Sigma, MicroSource",56.12,"BRD-K39965020-001-12-5, BRD-K39965020-001-09-1","CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O, CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O","MBMBGCFOFBJSGT-KUBAVDMBSA-N, MBMBGCFOFBJSGT-KUBAVDMBSA-N",Launched,
doconexent-ethyl-ester,omega 3 fatty acid stimulant,,,,Cayman,0,BRD-K61937613-001-01-1,CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,ITNKVODZACVXDS-YNUSHXQLSA-N,Launched,
docosanol,lipase clearing factor inhibitor,TLR7,dental,cold sore,"Selleck, Selleck, MicroSource",0,"BRD-K50050533-001-04-7, BRD-K50050533-001-02-1, BRD-K50050533-001-03-9","CCCCCCCCCCCCCCCCCCCCCCO, CCCCCCCCCCCCCCCCCCCCCCO, CCCCCCCCCCCCCCCCCCCCCCO","NOPFSRXAKWQILS-UHFFFAOYSA-N, NOPFSRXAKWQILS-UHFFFAOYSA-N, NOPFSRXAKWQILS-UHFFFAOYSA-N",Launched,
docusate,laxative,,gastroenterology,constipation,MicroSource,60.87,BRD-A00092689-236-03-8,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(O)(=O)=O,HNSDLXPSAYFUHK-UHFFFAOYSA-N,Launched,
dolasetron,serotonin receptor antagonist,HTR3A,gastroenterology,"nausea, vomiting","Tocris, Enzo",99.45,"BRD-K28029915-066-03-3, BRD-K28029915-001-02-2","O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12, O=C(O[C@H]1C[C@H]2C[C@H]3C[C@@H](C1)N2CC3=O)c1c[nH]c2ccccc12","UKTAZPQNNNJVKR-YXSUXZIUSA-N, UKTAZPQNNNJVKR-YXSUXZIUSA-N",Launched,"BRD-K37792492-066-01-0,BRD-A03259768-066-01-9, BRD-K34008116-001-01-7"
dolutegravir,HIV integrase inhibitor,"CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1",infectious disease,human immunodeficiency virus (HIV-1),Selleck,91.66,BRD-K36386086-001-01-1,C[C@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,RHWKPHLQXYSBKR-BONVTDFDSA-N,Launched,
domperidone,dopamine receptor antagonist,"DRD2, DRD3",infectious disease,fescue toxicosis,"Tocris, MicroSource, Selleck",97.24,"BRD-K38305202-001-17-4, BRD-K38305202-001-18-2, BRD-K38305202-001-16-6","Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1, Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1, Clc1ccc2n(C3CCN(CCCn4c5ccccc5[nH]c4=O)CC3)c(=O)[nH]c2c1","FGXWKSZFVQUSTL-UHFFFAOYSA-N, FGXWKSZFVQUSTL-UHFFFAOYSA-N, FGXWKSZFVQUSTL-UHFFFAOYSA-N",Launched,
donepezil,acetylcholinesterase inhibitor,"ACHE, HTR2A",neurology/psychiatry,Alzheimer's disease,"MicroSource, Selleck",97.71,"BRD-A49160188-003-12-7, BRD-A49160188-003-11-9","COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC, COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC","ADEBPBSSDYVVLD-UHFFFAOYSA-N, ADEBPBSSDYVVLD-UHFFFAOYSA-N",Launched,
dopamine,dopamine receptor agonist,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4","cardiology, neurology/psychiatry","ventricular arrhythmias, depression, headache, tremors","MicroSource, Selleck, Selleck",100,"BRD-K43887077-003-26-3, BRD-K43887077-003-27-1, BRD-K43887077-003-25-5","NCCc1ccc(O)c(O)c1, NCCc1ccc(O)c(O)c1, NCCc1ccc(O)c(O)c1","VYFYYTLLBUKUHU-UHFFFAOYSA-N, VYFYYTLLBUKUHU-UHFFFAOYSA-N, VYFYYTLLBUKUHU-UHFFFAOYSA-N",Launched,
doramectin,,,infectious disease,gastrointestinal roundworms,MicroSource,96.39,BRD-A16350940-001-01-9,CO[C@H]1C[C@H](OC2[C@H](C)OC(C[C@@H]2OC)O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(C5)O[C@H](C5CCCCC5)[C@@H](C)C=C2)[C@]34O)O[C@@H](C)[C@@H]1O,QLFZZSKTJWDQOS-CYHFSSRLSA-N,Launched,
doripenem,bacterial cell wall synthesis inhibitor,DPEP1,infectious disease,"intra-abdominal infections, urinary tract infections, pyelonephritis","Sigma, MedChemEx, MedChemEx, Selleck, Selleck",42.28,"BRD-K45319714-002-02-7, BRD-K45319714-002-04-3, BRD-K45319714-002-03-5, BRD-K45319714-002-05-0, BRD-K45319714-002-01-9","C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N2C1=O)C(O)=O","AVAACINZEOAHHE-VFZPANTDSA-N, AVAACINZEOAHHE-VFZPANTDSA-N, AVAACINZEOAHHE-VFZPANTDSA-N, AVAACINZEOAHHE-VFZPANTDSA-N, AVAACINZEOAHHE-VFZPANTDSA-N",Launched,BRD-K20901660-002-03-3
dorzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7",ophthalmology,"intraocular pressure, glaucoma",Selleck,90.38,BRD-K71075609-003-01-0,CCN[C@@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,IAVUPMFITXYVAF-POYBYMJQSA-N,Launched,
dosulepin,"norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4",neurology/psychiatry,depression,Prestwick,96.47,BRD-K54759182-003-08-0,CN(C)CC\C=C1/c2ccccc2CSc2ccccc12,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,Launched,
doxapram,potassium channel blocker,"KCNK3, KCNK9","pulmonary, neurology/psychiatry","respiratory depression, central nervous system depression, acute hypercapnia (AHC)","MicroSource, Selleck",97.8,"BRD-A46179541-311-03-8, BRD-A46179541-311-02-0","CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1, CCN1CC(CCN2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1","XFDJYSQDBULQSI-UHFFFAOYSA-N, XFDJYSQDBULQSI-UHFFFAOYSA-N",Launched,BRD-A47978079-003-01-9
doxazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7","urology, cardiology","benign prostatic hyperplasia (BPH), hypertension","Tocris, MicroSource, Selleck",97.75,"BRD-A13188892-066-23-1, BRD-A13188892-066-22-3, BRD-A13188892-066-21-5","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1, COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1, COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1","RUZYUOTYCVRMRZ-UHFFFAOYSA-N, RUZYUOTYCVRMRZ-UHFFFAOYSA-N, RUZYUOTYCVRMRZ-UHFFFAOYSA-N",Launched,
doxepin,histamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4",neurology/psychiatry,"depression, anxiety","MicroSource, Tocris",98.99,"BRD-K37694030-003-12-7, BRD-K37694030-003-11-9","CN(C)CC\C=C1\c2ccccc2COc2ccccc12, CN(C)CC\C=C1\c2ccccc2COc2ccccc12","ODQWQRRAPPTVAG-BOPFTXTBSA-N, ODQWQRRAPPTVAG-BOPFTXTBSA-N",Launched,
doxercalciferol,vitamin D receptor agonist,VDR,"nephrology, endocrinology","chronic kidney disease (CKD), hyperparathyroidism","Selleck, Selleck",85.38,"BRD-K82928892-001-02-5, BRD-K82928892-001-03-3","CC(C)[C@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)C[C@H](O)C1=C, CC(C)[C@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1\C[C@@H](O)C[C@H](O)C1=C","HKXBNHCUPKIYDM-ZKVKAWQFSA-N, HKXBNHCUPKIYDM-ZKVKAWQFSA-N",Launched,BRD-K07234650-001-01-4
doxifluridine,thymidylate synthase inhibitor,TYMS,oncology,colorectal cancer,"MicroSource, Selleck",96.4,"BRD-K58262659-001-10-5, BRD-K58262659-001-09-7","C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O, C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(F)c(=O)[nH]c1=O","ZWAOHEXOSAUJHY-ZIYNGMLESA-N, ZWAOHEXOSAUJHY-ZIYNGMLESA-N",Launched,"BRD-A68537732-001-03-6, BRD-K83057217-001-01-2"
doxofylline,adenosine receptor antagonist,"ADORA1, PDE4A, PDE4B, PDE4C, PDE4D",pulmonary,asthma,"Selleck, MicroSource",99.7,"BRD-K70507123-001-08-9, BRD-K70507123-001-09-7","Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O, Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O","HWXIGFIVGWUZAO-UHFFFAOYSA-N, HWXIGFIVGWUZAO-UHFFFAOYSA-N",Launched,
doxorubicin,topoisomerase inhibitor,TOP2A,"hematologic malignancy, oncology","acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Wilm's tumor, breast cancer, ovarian cancer, Hodgkin's lymphoma, bladder cancer, multiple myeloma","Selleck, Selleck, MicroSource, Tocris, Tocris, Selleck",96.83,"BRD-K92093830-003-33-2, BRD-K92093830-003-31-6, BRD-K92093830-001-05-4, BRD-K92093830-003-30-8, BRD-K92093830-003-34-0, BRD-K92093830-003-35-7","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO","AOJJSUZBOXZQNB-TZSSRYMLSA-N, AOJJSUZBOXZQNB-TZSSRYMLSA-N, AOJJSUZBOXZQNB-TZSSRYMLSA-N, AOJJSUZBOXZQNB-TZSSRYMLSA-N, AOJJSUZBOXZQNB-TZSSRYMLSA-N, AOJJSUZBOXZQNB-TZSSRYMLSA-N",Launched,"BRD-A52530684-001-02-9, BRD-K61468417-003-01-1"
doxycycline,metalloproteinase inhibitor,MMP8,dental,periodontitis,"MicroSource, Selleck, Selleck, Selleck, Selleck",99,"BRD-A08545410-003-06-0, BRD-A08545410-003-08-6, BRD-A08545410-311-01-8, BRD-A08545410-311-03-4, BRD-A08545410-003-07-8","C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12, C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12","VXVNYCRICCVPTD-MULYGRJNSA-N, VXVNYCRICCVPTD-MULYGRJNSA-N, VXVNYCRICCVPTD-MULYGRJNSA-N, VXVNYCRICCVPTD-MULYGRJNSA-N, VXVNYCRICCVPTD-MULYGRJNSA-N",Launched,"BRD-A36632888-003-01-6, BRD-M28128163-312-01-2,BRD-M68646745-311-09-6, BRD-M28128163-312-03-8"
doxycycline-hyclate,bacterial 30S ribosomal subunit inhibitor,,dental,periodontitis,MedChemEx,0,BRD-M28128163-003-01-7,CCO.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12.C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C2C(=O)c2c(O)cccc12,OQQMRKYWJNJBBI-AIDNFEPSSA-N,Launched,
doxylamine,histamine receptor antagonist,"CHRM1, HRH1",neurology/psychiatry,sedative,"MicroSource, Selleck",98.3,"BRD-A44008656-036-25-8, BRD-A44008656-036-24-1","CN(C)CCOC(C)(c1ccccc1)c1ccccn1, CN(C)CCOC(C)(c1ccccc1)c1ccccn1","HCFDWZZGGLSKEP-UHFFFAOYSA-N, HCFDWZZGGLSKEP-UHFFFAOYSA-N",Launched,
drofenine,,,neurology/psychiatry,spasms,MicroSource,93.04,BRD-A22267103-003-13-1,CCN(CC)CCOC(=O)C(C1CCCCC1)c1ccccc1,AGJBLWCLQCKRJP-UHFFFAOYSA-N,Launched,
dromostanolone-propionate,androgen receptor modulator,AR,oncology,breast cancer,ANpharma,99.15,BRD-A38706605-001-01-2,CCC(=O)OC1CCC2C3CCC4CC(=O)C(C)CC4(C)C3CCC12C,NOTIQUSPUUHHEH-UHFFFAOYSA-N,Launched,
dronedarone,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A",cardiology,atrial fibrillation (AF),Selleck,96.35,BRD-K05524748-003-04-4,CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c1c(CCCC)oc2ccc(NS(C)(=O)=O)cc12,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,Launched,
droperidol,dopamine receptor antagonist,"ADRA1A, DRD2, DRD3, DRD4, HTR2A",gastroenterology,"nausea, vomiting","MicroSource, Selleck",94.72,"BRD-K97158071-001-18-1, BRD-K97158071-001-17-3","Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O, Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O","RMEDXOLNCUSCGS-UHFFFAOYSA-N, RMEDXOLNCUSCGS-UHFFFAOYSA-N",Launched,
dropropizine,antitussive,,pulmonary,cough suppressant,"MicroSource, Selleck, Selleck",95.27,"BRD-A29349577-001-23-0, BRD-A29349577-001-22-2, BRD-A29349577-001-24-8","OCC(O)CN1CCN(CC1)c1ccccc1, OCC(O)CN1CCN(CC1)c1ccccc1, OCC(O)CN1CCN(CC1)c1ccccc1","PTVWPYVOOKLBCG-UHFFFAOYSA-N, PTVWPYVOOKLBCG-UHFFFAOYSA-N, PTVWPYVOOKLBCG-UHFFFAOYSA-N",Launched,
drospirenone,mineralocorticoid receptor antagonist,"AR, NR3C2, PGR",endocrinology,contraceptive,"Selleck, Selleck, MicroSource, Selleck",99.66,"BRD-K04394237-001-03-7, BRD-K04394237-001-04-5, BRD-K04394237-001-06-0, BRD-K04394237-001-05-2","C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1, C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1, C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1, C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1","METQSPRSQINEEU-HXCATZOESA-N, METQSPRSQINEEU-HXCATZOESA-N, METQSPRSQINEEU-HXCATZOESA-N, METQSPRSQINEEU-HXCATZOESA-N",Launched,"BRD-A00938334-001-01-3, BRD-K70875526-001-01-8"
drotaverine,phosphodiesterase inhibitor,"CACNA1C, PDE4A",obstetrics/gynecology,labor induction,"Vitas-M, Enamine",88.7,"BRD-K14658796-001-01-0, BRD-K14658796-003-01-6","CCOc1ccc(\C=C2\NCCc3cc(OCC)c(OCC)cc23)cc1OCC, CCOc1ccc(\C=C2\NCCc3cc(OCC)c(OCC)cc23)cc1OCC","OMFNSKIUKYOYRG-DEDYPNTBSA-N, OMFNSKIUKYOYRG-DEDYPNTBSA-N",Launched,
droxicam,cyclooxygenase inhibitor,PTGS1,rheumatology,"rheumatoid arthritis, osteoarthritis","Ark, Sigma",0,"BRD-K17219082-001-01-1, BRD-K17219082-001-02-9","CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O, CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O","OEHFRZLKGRKFAS-UHFFFAOYSA-N, OEHFRZLKGRKFAS-UHFFFAOYSA-N",Launched,
droxidopa,norepinephrine precursor,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH","cardiology, neurology/psychiatry","hypertension, Parkinson's Disease","Selleck, Selleck",100,"BRD-K20372197-001-02-3, BRD-K20372197-001-03-1","N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O, N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O","QXWYKJLNLSIPIN-JGVFFNPUSA-N, QXWYKJLNLSIPIN-JGVFFNPUSA-N",Launched,
duloxetine,"norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)","HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,"depression, generalized anxiety disorder (GAD), muscle pain, peripheral neuropathy","Tocris, MicroSource, Selleck",98.43,"BRD-K71103788-003-13-8, BRD-K71103788-003-12-0, BRD-K71103788-003-11-2","CNCC[C@H](Oc1cccc2ccccc12)c1cccs1, CNCC[C@H](Oc1cccc2ccccc12)c1cccs1, CNCC[C@H](Oc1cccc2ccccc12)c1cccs1","ZEUITGRIYCTCEM-KRWDZBQOSA-N, ZEUITGRIYCTCEM-KRWDZBQOSA-N, ZEUITGRIYCTCEM-KRWDZBQOSA-N",Launched,
dutasteride,5 alpha reductase inhibitor,"SRD5A1, SRD5A2",urology,benign prostatic hyperplasia (BPH),Selleck,97.58,BRD-K30373883-001-02-8,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F,JWJOTENAMICLJG-QWBYCMEYSA-N,Launched,BRD-K28984613-001-01-5
dyclonine,sodium channel blocker,"SCN10A, SCN5A",neurology/psychiatry,local anesthetic,"Selleck, MedChemEx, MicroSource, Selleck, MedChemEx",93.29,"BRD-K72259270-003-25-6, BRD-K72259270-003-27-2, BRD-K72259270-003-24-9, BRD-K72259270-003-23-1, BRD-K72259270-003-26-4","CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1, CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1, CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1, CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1, CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1","BZEWSEKUUPWQDQ-UHFFFAOYSA-N, BZEWSEKUUPWQDQ-UHFFFAOYSA-N, BZEWSEKUUPWQDQ-UHFFFAOYSA-N, BZEWSEKUUPWQDQ-UHFFFAOYSA-N, BZEWSEKUUPWQDQ-UHFFFAOYSA-N",Launched,
dydrogesterone,progesterone receptor agonist,PGR,obstetrics/gynecology,infertility,"MicroSource, Selleck, Selleck",98.97,"BRD-K68620903-001-11-4, BRD-K68620903-001-10-6, BRD-K68620903-001-09-8","CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C","JGMOKGBVKVMRFX-HQZYFCCVSA-N, JGMOKGBVKVMRFX-HQZYFCCVSA-N, JGMOKGBVKVMRFX-HQZYFCCVSA-N",Launched,"BRD-A86597857-001-01-1, BRD-K27038879-001-01-0"
dyphylline,"adenosine receptor antagonist, phosphodiesterase inhibitor","ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B",pulmonary,"asthma, bronchitis, emphysema","MicroSource, Selleck",99.68,"BRD-A00827783-001-24-6, BRD-A00827783-001-23-8","Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O, Cn1c2ncn(CC(O)CO)c2c(=O)n(C)c1=O","KSCFJBIXMNOVSH-UHFFFAOYSA-N, KSCFJBIXMNOVSH-UHFFFAOYSA-N",Launched,
ebastine,histamine receptor antagonist,"CYP3A4, HRH1",allergy,"allergic rhinitis, urticaria",Selleck,92.12,BRD-K13314656-001-01-0,CC(C)(C)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1,MJJALKDDGIKVBE-UHFFFAOYSA-N,Launched,
ecabet,"gastrin inhibitor, urease inhibitor",NOXO1,ophthalmology,dry eye syndrome,OxChem,98.28,BRD-K03353589-236-01-4,CC(C)c1cc2CC[C@H]3[C@@](C)(CCC[C@]3(C)c2cc1S(O)(=O)=O)C(O)=O,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Launched,
ecamsule-triethanolamine,,,dermatology,"skin protectant, sunscreen lotion",MicroSource,92.57,BRD-A47953250-001-01-7,CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/c1ccc(cc1)\C=C1\C2CCC(CS(O)(=O)=O)(C1=O)C2(C)C,HEAHZSUCFKFERC-AXPXABNXSA-N,Launched,
econazole,"lanosterol demethylase inhibitor, sterol demethylase inhibitor","CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5",infectious disease,"tinea pedis, tinea cruris, tinea corporis, tinea versicolor, cutaneous candidiasis","Selleck, MicroSource",99.93,"BRD-A51820102-008-27-1, BRD-A51820102-008-28-9","Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1, Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1","LEZWWPYKPKIXLL-UHFFFAOYSA-N, LEZWWPYKPKIXLL-UHFFFAOYSA-N",Launched,
edaravone,nootropic agent,BCL2,neurology/psychiatry,stroke,"MedChemEx, MedChemEx, MicroSource, Selleck, Tocris, Selleck",65.37,"BRD-K35458079-001-34-9, BRD-K35458079-001-33-1, BRD-K35458079-001-29-9, BRD-K35458079-001-31-5, BRD-K35458079-001-28-1, BRD-K35458079-001-27-3","CC1=NN(C(=O)C1)c1ccccc1, CC1=NN(C(=O)C1)c1ccccc1, CC1=NN(C(=O)C1)c1ccccc1, CC1=NN(C(=O)C1)c1ccccc1, CC1=NN(C(=O)C1)c1ccccc1, CC1=NN(C(=O)C1)c1ccccc1","QELUYTUMUWHWMC-UHFFFAOYSA-N, QELUYTUMUWHWMC-UHFFFAOYSA-N, QELUYTUMUWHWMC-UHFFFAOYSA-N, QELUYTUMUWHWMC-UHFFFAOYSA-N, QELUYTUMUWHWMC-UHFFFAOYSA-N, QELUYTUMUWHWMC-UHFFFAOYSA-N",Launched,
edoxaban,coagulation factor inhibitor,F10,"neurology/psychiatry, hematology, cardiology","stroke, pulmonary embolism (PE), systemic embolism, deep vein thrombosis (DVT), atrial fibrillation (AF)",Selleck,95.16,BRD-K29322660-001-01-9,CN(C)C(=O)[C@@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@H](C1)NC(=O)c1nc2CCN(C)Cc2s1,HGVDHZBSSITLCT-KMFMINBZSA-N,Launched,
edoxudine,DNA directed DNA polymerase inhibitor,,infectious disease,virus herpes simplex (HSV),MicroSource,98.02,BRD-K86892782-001-17-0,CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,XACKNLSZYYIACO-DJLDLDEBSA-N,Launched,BRD-A62505706-001-04-9
edrophonium,acetylcholinesterase inhibitor,"ACHE, BCHE",neurology/psychiatry,myasthenia gravis,MicroSource,98.99,BRD-K81128206-003-24-4,CC[N+](C)(C)c1cccc(O)c1,VWLHWLSRQJQWRG-UHFFFAOYSA-O,Launched,
efavirenz,HIV protease inhibitor,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4",infectious disease,human immunodeficiency virus (HIV-1),Enzo,98.9,BRD-K40758068-001-08-2,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,XPOQHMRABVBWPR-ZDUSSCGKSA-N,Launched,
efinaconazole,lanosterol demethylase inhibitor,CYP51A1,infectious disease,onychomycosis,MedChemEx,92.45,BRD-A30774155-001-01-2,C[C@@H](N1CCC(=C)CC1)C(O)(Cn1cncn1)c1ccc(F)cc1F,NFEZZTICAUWDHU-IKJXHCRLSA-N,Launched,
eflornithine,ornithine decarboxylase inhibitor,"ARG2, ODC1",dermatology,facial hair reduction,Enzo,100,BRD-A96292436-003-16-1,NCCCC(N)(C(F)F)C(O)=O,VLCYCQAOQCDTCN-UHFFFAOYSA-N,Launched,
efonidipine-monoethanolate,"L-type calcium channel blocker, T-type calcium channel blocker","CACNA1C, CACNA1G",,,"Tocris, Tocris, Tocris",95.91,"BRD-M92675308-003-06-3, BRD-M92675308-003-07-1, BRD-M92675308-003-05-5","CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1, CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1, CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(Cc1ccccc1)c1ccccc1","DUUFLTUTPZFOAH-UHFFFAOYSA-N, DUUFLTUTPZFOAH-UHFFFAOYSA-N, DUUFLTUTPZFOAH-UHFFFAOYSA-N",Launched,"BRD-A39845846-003-01-2,BRD-M92675308-003-03-0"
elbasvir,HCV inhibitor,,infectious disease,hepatitis C,MedChemEx,95.63,BRD-K09735259-001-01-3,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc2-c3cc4cc(ccc4n3[C@@H](Oc2c1)c1ccccc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,BVAZQCUMNICBAQ-PZHYSIFUSA-N,Launched,
eletriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7",neurology/psychiatry,migraine headache,"Tocris, Selleck, MicroSource, Tocris",97.64,"BRD-K30652337-004-03-9, BRD-K30652337-004-01-3, BRD-K30652337-001-01-9, BRD-K30652337-004-02-1","CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12, CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12, CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12, CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12","PWVXXGRKLHYWKM-LJQANCHMSA-N, PWVXXGRKLHYWKM-LJQANCHMSA-N, PWVXXGRKLHYWKM-LJQANCHMSA-N, PWVXXGRKLHYWKM-LJQANCHMSA-N",Launched,
eliglustat,Glycosyl transferase inhibitor,UGCG,hematology,"Gaucher disease, Gaucher disease","MedChemEx, MedChemEx",93.73,"BRD-K86410485-001-01-5, BRD-K86410485-046-01-0","CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1, CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2OCCOc2c1","FJZZPCZKBUKGGU-AUSIDOKSSA-N, FJZZPCZKBUKGGU-AUSIDOKSSA-N",Launched,BRD-M75840137-046-01-1
eltrombopag,thrombopoietin receptor agonist,MPL,"hematology, infectious disease","anemia, hepatitis C, thrombocytopenia","Selleck, Selleck, Selleck",97.73,"BRD-K40496271-396-01-1, BRD-K40496271-001-02-5, BRD-K40496271-001-03-3","CC1=NN(C(=O)C\1=N\Nc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1, CC1=NN(C(=O)C\1=N\Nc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1, CC1=NN(C(=O)C\1=N\Nc1cccc(-c2cccc(c2)C(O)=O)c1O)c1ccc(C)c(C)c1","XDXWLKQMMKQXPV-HPNDGRJYSA-N, XDXWLKQMMKQXPV-HPNDGRJYSA-N, XDXWLKQMMKQXPV-HPNDGRJYSA-N",Launched,
eluxadoline,opioid receptor modulator,"OPRD1, OPRK1, OPRM1",gastroenterology,irritable bowel syndrome,MedChemEx,94.62,BRD-K39560679-001-01-1,COc1ccc(CN([C@@H](C)c2ncc([nH]2)-c2ccccc2)C(=O)[C@@H](N)Cc2c(C)cc(cc2C)C(N)=O)cc1C(O)=O,QFNHIDANIVGXPE-FNZWTVRRSA-N,Launched,
elvitegravir,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),Selleck,94.69,BRD-K54472332-001-03-4,COc1cc2n(cc(C(O)=O)c(=O)c2cc1Cc1cccc(Cl)c1F)[C@H](CO)C(C)C,JUZYLCPPVHEVSV-LJQANCHMSA-N,Launched,
emedastine,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis,"Prestwick, TCI",86.56,"BRD-K15010214-364-01-9, BRD-K15010214-364-02-7","CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1, CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1","KBUZBQVCBVDWKX-UHFFFAOYSA-N, KBUZBQVCBVDWKX-UHFFFAOYSA-N",Launched,
emorfazone,"antiinflammatory agent, cyclooxygenase inhibitor",,dental,mouth inflammation,Sigma,99.42,BRD-K90629600-001-01-4,CCOc1c(cnn(C)c1=O)N1CCOCC1,URJQOOISAKEBKW-UHFFFAOYSA-N,Launched,
empagliflozin,sodium/glucose cotransporter inhibitor,"SLC5A1, SLC5A2",endocrinology,diabetes mellitus,Selleck,96.18,BRD-K53765467-001-02-1,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1,OBWASQILIWPZMG-QZMOQZSNSA-N,Launched,
emtricitabine,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),Selleck,96.41,BRD-K61452026-001-04-6,Nc1nc(=O)n(cc1F)[C@@H]1CS[C@H](CO)O1,XQSPYNMVSIKCOC-NTSWFWBYSA-N,Launched,
enalapril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, congestive heart failure, left ventricular systolic dysfunction (LVSD)","Selleck, MicroSource",94.83,"BRD-K57545991-050-23-1, BRD-K57545991-050-24-9","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O","GBXSMTUPTTWBMN-XIRDDKMYSA-N, GBXSMTUPTTWBMN-XIRDDKMYSA-N",Launched,
enalaprilat,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,"MicroSource, MedChemEx, Selleck, MedChemEx, Selleck",83.84,"BRD-K99447003-335-03-3, BRD-K99447003-335-05-8, BRD-K99447003-335-02-5, BRD-K99447003-335-06-6, BRD-K99447003-335-04-1","C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O","LZFZMUMEGBBDTC-QEJZJMRPSA-N, LZFZMUMEGBBDTC-QEJZJMRPSA-N, LZFZMUMEGBBDTC-QEJZJMRPSA-N, LZFZMUMEGBBDTC-QEJZJMRPSA-N, LZFZMUMEGBBDTC-QEJZJMRPSA-N",Launched,
enasidenib,isocitrate dehydrogenase inhibitor,IDH1,hematologic malignancy,acute myeloid leukemia (AML),MedChemEx,97.55,BRD-K70601687-001-01-3,CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)-c1cccc(n1)C(F)(F)F,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Launched,
enbucrilate,,,dermatology,"skin lacerations, tissue adhesive",Ark,0,BRD-K66918327-001-01-3,CCCCOC(=O)C(=C)C#N,JJJFUHOGVZWXNQ-UHFFFAOYSA-N,Launched,
enflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4",,,Apollo,0,BRD-A51831848-001-01-7,FC(F)OC(F)(F)C(F)Cl,JPGQOUSTVILISH-UHFFFAOYSA-N,Launched,
enilconazole,sterol demethylase inhibitor,"CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2",infectious disease,skin infections,MicroSource,98.23,BRD-A11776908-065-01-5,Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1,PZBPKYOVPCNPJY-UHFFFAOYSA-N,Launched,
enisamium-iodide,,,,,Vitas-M,96.66,BRD-K10029415-005-06-9,C[n+]1ccc(cc1)C(=O)NCc1ccccc1,QOEJDHLJOKRPJG-UHFFFAOYSA-O,Launched,
enocitabine,DNA synthesis inhibitor,"CMPK1, RRM1, TYMS",,,"AKSci, Carbosynth",97.2,"BRD-K32007074-001-02-9, BRD-K32007074-001-01-1","CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1, CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1","SAMRUMKYXPVKPA-VFKOLLTISA-N, SAMRUMKYXPVKPA-VFKOLLTISA-N",Launched,BRD-A77582494-001-01-3
enoxacin,topoisomerase inhibitor,TOP2A,infectious disease,"urinary tract infections, gonorrhea","MicroSource, Selleck, Selleck",89.69,"BRD-K78113049-001-16-2, BRD-K78113049-001-15-4, BRD-K78113049-001-17-0","CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1, CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1, CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1","IDYZIJYBMGIQMJ-UHFFFAOYSA-N, IDYZIJYBMGIQMJ-UHFFFAOYSA-N, IDYZIJYBMGIQMJ-UHFFFAOYSA-N",Launched,
enoximone,phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure,Sigma,92.01,BRD-K21152241-001-07-3,CSc1ccc(cc1)C(=O)c1[nH]c(O)nc1C,ZJKNESGOIKRXQY-UHFFFAOYSA-N,Launched,
enoxolone,gap junction modulator,HSD11B1,"gastroenterology, otolaryngology","peptic ulcer disease (PUD), common cold","MicroSource, Selleck",99.76,"BRD-K96137854-001-18-9, BRD-K96137854-001-17-1","C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O, C[C@]12CC[C@@](C)(C[C@H]1C1=CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2)C(O)=O","MPDGHEJMBKOTSU-YKLVYJNSSA-N, MPDGHEJMBKOTSU-YKLVYJNSSA-N",Launched,"BRD-A20200672-001-05-5, BRD-K80535353-001-01-4"
enrofloxacin,bacterial DNA gyrase inhibitor,,infectious disease,"gram-negative bacterial infections, gram-negative bacterial infections","MicroSource, Selleck",96.46,"BRD-K76534306-001-22-7, BRD-K76534306-001-21-9","CCN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1, CCN1CCN(CC1)c1cc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1","SPFYMRJSYKOXGV-UHFFFAOYSA-N, SPFYMRJSYKOXGV-UHFFFAOYSA-N",Launched,
entacapone,catechol O methyltransferase inhibitor,COMT,neurology/psychiatry,Parkinson's Disease,"MicroSource, Selleck, Selleck",97.02,"BRD-K83636919-001-04-8, BRD-K83636919-001-05-5, BRD-K83636919-001-03-0","CCN(CC)C(=O)C(\C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O, CCN(CC)C(=O)C(\C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O, CCN(CC)C(=O)C(\C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O","JRURYQJSLYLRLN-BJMVGYQFSA-N, JRURYQJSLYLRLN-BJMVGYQFSA-N, JRURYQJSLYLRLN-BJMVGYQFSA-N",Launched,
entecavir,"DNA replication inhibitor, nucleoside reverse transcriptase inhibitor",,infectious disease,hepatitis B,Selleck,99.22,BRD-K08206212-002-01-0,Nc1nc(=O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)C3=C)c2[nH]1,QDGZDCVAUDNJFG-FXQIFTODSA-N,Launched,
enzalutamide,androgen receptor antagonist,AR,oncology,prostate cancer,Selleck,95.96,BRD-K56851771-001-06-8,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Launched,
epalrestat,aldose reductase inhibitor,AKR1B1,nephrology,diabetic nephropathy,"MedChemEx, MedChemEx, Selleck, Selleck",81.25,"BRD-K98054437-001-11-5, BRD-K98054437-001-12-3, BRD-K98054437-001-09-9, BRD-K98054437-001-08-1","CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1, CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1, CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1, CC(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1","CHNUOJQWGUIOLD-NFZZJPOKSA-N, CHNUOJQWGUIOLD-NFZZJPOKSA-N, CHNUOJQWGUIOLD-NFZZJPOKSA-N, CHNUOJQWGUIOLD-NFZZJPOKSA-N",Launched,
eperisone,acetylcholine receptor antagonist,CYP2J2,neurology/psychiatry,"amyotrophic lateral sclerosis (ALS), spasms, head injury, spinal injury",CombiBlocks,99,BRD-A04252265-003-01-4,CCc1ccc(cc1)C(=O)C(C)CN1CCCCC1,SQUNAWUMZGQQJD-UHFFFAOYSA-N,Launched,
ephedrine,adrenergic receptor agonist,"ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2","cardiology, pulmonary, neurology/psychiatry, endocrinology","hypotension, asthma, narcolepsy, obesity",MicroSource,97.68,BRD-K45014108-003-01-8,CN[C@@H](C)[C@H](O)c1ccccc1,KWGRBVOPPLSCSI-WPRPVWTQSA-N,Launched,
ephedrine-(racemic),adrenergic receptor agonist,"ADRA1A, ADRA2A","cardiology, pulmonary, neurology/psychiatry, endocrinology","hypotension, asthma, narcolepsy, obesity",MicroSource,97.69,BRD-A54236247-003-04-3,CNC(C)C(O)c1ccccc1,KWGRBVOPPLSCSI-UHFFFAOYSA-N,Launched,
epinastine,histamine receptor antagonist,"ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7",ophthalmology,conjunctivitis,Selleck,95.95,BRD-A98990573-003-01-3,NC1=NCC2N1c1ccccc1Cc1ccccc21,WHWZLSFABNNENI-UHFFFAOYSA-N,Launched,
epinephrine,"adrenergic receptor agonist, neurotransmitter","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF","cardiology, allergy, pulmonary","cardiac arrest, anaphylactic shock, asthma","Selleck, Selleck, Selleck, Selleck, Selleck, MicroSource",100,"BRD-K63126190-046-03-1, BRD-K63126190-001-05-1, BRD-K63126190-046-02-3, BRD-K63126190-001-03-6, BRD-K63126190-003-01-6, BRD-K63126190-001-04-4","CNC[C@H](O)c1ccc(O)c(O)c1, CNC[C@H](O)c1ccc(O)c(O)c1, CNC[C@H](O)c1ccc(O)c(O)c1, CNC[C@H](O)c1ccc(O)c(O)c1, CNC[C@H](O)c1ccc(O)c(O)c1, CNC[C@H](O)c1ccc(O)c(O)c1","UCTWMZQNUQWSLP-VIFPVBQESA-N, UCTWMZQNUQWSLP-VIFPVBQESA-N, UCTWMZQNUQWSLP-VIFPVBQESA-N, UCTWMZQNUQWSLP-VIFPVBQESA-N, UCTWMZQNUQWSLP-VIFPVBQESA-N, UCTWMZQNUQWSLP-VIFPVBQESA-N",Launched,
epinephrine-(racemic),carbonic anhydrase activator,,"cardiology, allergy, pulmonary","cardiac arrest, anaphylactic shock, asthma","Selleck, Selleck",0,"BRD-A07765530-001-06-4, BRD-A07765530-001-05-6","CNCC(O)c1ccc(O)c(O)c1, CNCC(O)c1ccc(O)c(O)c1","UCTWMZQNUQWSLP-UHFFFAOYSA-N, UCTWMZQNUQWSLP-UHFFFAOYSA-N",Launched,
epirizole,cyclooxygenase inhibitor,"PTGS1, PTGS2",neurology/psychiatry,pain relief,Prestwick,98.14,BRD-K39339537-001-21-0,COc1cc(C)nn1-c1nc(C)cc(OC)n1,RHAXSHUQNIEUEY-UHFFFAOYSA-N,Launched,
epirubicin,topoisomerase inhibitor,"CHD1, TOP2A",oncology,breast cancer,"MicroSource, Selleck",90.55,"BRD-K04548931-003-13-2, BRD-K04548931-003-16-5","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO","AOJJSUZBOXZQNB-VTZDEGQISA-N, AOJJSUZBOXZQNB-VTZDEGQISA-N",Launched,BRD-K56844688-003-01-2
epitiostanol,androgen receptor agonist,AR,,,Prestwick,90.16,BRD-K02314383-001-01-3,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O,OBMLHUPNRURLOK-XGRAFVIBSA-N,Launched,
eplerenone,cytochrome P450 inhibitor,NR3C2,cardiology,"congestive heart failure, hypertension","Selleck, Tocris, Selleck",99.75,"BRD-K19761926-001-03-6, BRD-K19761926-001-02-8, BRD-K19761926-001-04-4","COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13, COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13, COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13","JUKPWJGBANNWMW-VWBFHTRKSA-N, JUKPWJGBANNWMW-VWBFHTRKSA-N, JUKPWJGBANNWMW-VWBFHTRKSA-N",Launched,BRD-K82139003-001-01-7
epomediol,cholesterol inhibitor,CYP7A1,,,TimTec,0,BRD-A59329714-001-01-5,CC1(C)OC2(C)C(O)CC1CC2O,JSNQSLSBBZFGBM-UHFFFAOYSA-N,Launched,
epoprostenol,prostacyclin analog,"P2RY12, PTGER1, PTGER4, PTGIR, PTGIS",cardiology,hypertension,Enzo,36.41,BRD-K64054020-001-03-5,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O,KAQKFAOMNZTLHT-OZUDYXHBSA-N,Launched,
eprazinone,mucolytic agent,,pulmonary,bronchospasm,"Selleck, Selleck",94.62,"BRD-A72212290-300-01-4, BRD-A72212290-300-02-2","CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1, CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1","BSHWLCACYCVCJE-UHFFFAOYSA-N, BSHWLCACYCVCJE-UHFFFAOYSA-N",Launched,
eprinomectin,benzodiazepine receptor agonist,,infectious disease,"gastrointestinal roundworms, lungworms",MicroSource,92.46,BRD-A91366704-001-01-9,CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C\C=C(C)\[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)C=C[C@@H]1C,ZKWQQXZUCOBISE-WIDYHQJMSA-N,Launched,
eprobemide,monoamine oxidase inhibitor,MAOA,neurology/psychiatry,depression,MicroSource,96.11,BRD-K17979676-001-01-2,Clc1ccc(cc1)C(=O)NCCCN1CCOCC1,YYFGRAGNYHYWEZ-UHFFFAOYSA-N,Launched,
eprosartan,angiotensin receptor antagonist,AGTR1,cardiology,hypertension,"Selleck, Selleck",99.15,"BRD-K67977190-066-02-3, BRD-K67977190-066-03-1","CCCCc1ncc(\C=C(/Cc2cccs2)C(O)=O)n1Cc1ccc(cc1)C(O)=O, CCCCc1ncc(\C=C(/Cc2cccs2)C(O)=O)n1Cc1ccc(cc1)C(O)=O","OROAFUQRIXKEMV-LDADJPATSA-N, OROAFUQRIXKEMV-LDADJPATSA-N",Launched,
eptifibatide,platelet aggregation inhibitor,"ITGA2B, ITGB3",cardiology,"acute coronary syndrome (ACS), percutaneous coronary intervention (PCI)",Enzo,98.5,BRD-A90547603-001-02-5,NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,CZKPOZZJODAYPZ-UHFFFAOYSA-N,Launched,
equol,estrogen receptor agonist,"ESR1, ESR2",,,"Selleck, Selleck",94.51,"BRD-K54847683-001-04-0, BRD-K54847683-001-03-2","Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1, Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1","ADFCQWZHKCXPAJ-GFCCVEGCSA-N, ADFCQWZHKCXPAJ-GFCCVEGCSA-N",Launched,
erdosteine,mucolytic agent,,"pulmonary, infectious disease","bronchitis, cough suppressant, chronic obstructive pulmonary disease (COPD), respiratory tract infections","MicroSource, Selleck, Selleck",99.06,"BRD-A05515753-001-03-2, BRD-A05515753-001-02-4, BRD-A05515753-001-04-0","OC(=O)CSCC(=O)NC1CCSC1=O, OC(=O)CSCC(=O)NC1CCSC1=O, OC(=O)CSCC(=O)NC1CCSC1=O","QGFORSXNKQLDNO-UHFFFAOYSA-N, QGFORSXNKQLDNO-UHFFFAOYSA-N, QGFORSXNKQLDNO-UHFFFAOYSA-N",Launched,
ergocalciferol,vitamin analog,VDR,"endocrinology, orthopedics","hypoparathyroidism, rickets, hypophosphatemia","MicroSource, Sigma, Selleck, Selleck",79.58,"BRD-K56155962-001-15-4, BRD-K56155962-001-12-1, BRD-K56155962-001-16-2, BRD-K56155962-001-11-3","CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C, CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C","MECHNRXZTMCUDQ-RKHKHRCZSA-N, MECHNRXZTMCUDQ-RKHKHRCZSA-N, MECHNRXZTMCUDQ-RKHKHRCZSA-N, MECHNRXZTMCUDQ-RKHKHRCZSA-N",Launched,"BRD-A87199639-001-04-4, BRD-K05243578-001-01-6"
ergonovine,"adrenergic receptor agonist, serotonin receptor agonist","ADRA1A, HTR1E",hematology,postpartum hemorrhage (PPH),MicroSource,95.17,BRD-A26387268-050-04-4,CC(CO)NC(=O)C1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,WVVSZNPYNCNODU-FWXSHLFISA-N,Launched,
ergotamine,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, DRD1, DRD2, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, SLC6A2",neurology/psychiatry,migraine headache,MicroSource,25.51,BRD-A43227343-046-01-4,CN1C[C@@H](C=C2[C@H]1Cc1c[nH]c3cccc2c13)C(=O)N[C@]1(C)O[C@@]2(O)C3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O,XCGSFFUVFURLIX-WSHJXIHDSA-N,Launched,
erlotinib,EGFR inhibitor,"EGFR, NR1I2",oncology,"non-small cell lung cancer (NSCLC), pancreatic cancer","Selleck, Selleck",99.27,"BRD-K70401845-001-15-7, BRD-K70401845-003-09-6","COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC, COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC","AAKJLRGGTJKAMG-UHFFFAOYSA-N, AAKJLRGGTJKAMG-UHFFFAOYSA-N",Launched,
ertapenem,bacterial cell wall synthesis inhibitor,,infectious disease,"intra-abdominal infections, skin infections, pneumonia, urinary tract infections, gynecologic infections, postpartum endomyometritis","SantaCruz, SantaCruz",0,"BRD-A40472231-304-01-7, BRD-A40472231-304-02-5","C[C@@H](O)C1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)Nc3cccc(c3)C(O)=O)=C(N2C1=O)C(O)=O, C[C@@H](O)C1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)Nc3cccc(c3)C(O)=O)=C(N2C1=O)C(O)=O","JUZNIMUFDBIJCM-YZLSNGRKSA-N, JUZNIMUFDBIJCM-YZLSNGRKSA-N",Launched,
ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2,endocrinology,diabetes mellitus,MedChemEx,99.59,BRD-K10071630-001-01-0,CCOc1ccc(Cc2cc(ccc2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1,MCIACXAZCBVDEE-VNXMGFANSA-N,Launched,
erythritol,,,,,"Selleck, Selleck",92.41,"BRD-K79315489-001-07-8, BRD-K79315489-001-08-6","OC[C@H](O)[C@H](O)CO, OC[C@H](O)[C@H](O)CO","UNXHWFMMPAWVPI-ZXZARUISSA-N, UNXHWFMMPAWVPI-ZXZARUISSA-N",Launched,
erythromycin,NFkB pathway inhibitor,MLNR,infectious disease,"listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma","MicroSource, MicroSource, Selleck, Selleck",88.23,"BRD-K63550407-001-12-7, BRD-K63550407-028-04-7, BRD-K63550407-001-13-5, BRD-K63550407-001-14-3","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","ULGZDMOVFRHVEP-RWJQBGPGSA-N, ULGZDMOVFRHVEP-RWJQBGPGSA-N, ULGZDMOVFRHVEP-RWJQBGPGSA-N, ULGZDMOVFRHVEP-RWJQBGPGSA-N",Launched,"BRD-K05127550-001-02-1, BRD-K05127550-001-03-9,BRD-A20485507-001-01-2"
erythromycin-estolate,bacterial 50S ribosomal subunit inhibitor,"ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1",infectious disease,"listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma",MicroSource,0,BRD-K39746403-084-04-9,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,TYQXKHPOXXXCTP-CSLYCKPJSA-N,Launched,
erythromycin-ethylsuccinate,"cytochrome P450 inhibitor, protein synthesis inhibitor","ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1",infectious disease,"listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma","MicroSource, Selleck, Selleck",93.05,"BRD-K51677086-001-12-0, BRD-K51677086-001-13-8, BRD-K51677086-001-14-6","CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C, CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C, CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C","NSYZCCDSJNWWJL-YXOIYICCSA-N, NSYZCCDSJNWWJL-YXOIYICCSA-N, NSYZCCDSJNWWJL-YXOIYICCSA-N",Launched,BRD-K13846766-001-01-8
escin,nitric oxide synthase stimulant,,dermatology,varicose veins,MicroSource,34.56,BRD-A90796352-001-04-7,C\C=C(\C)C(=O)O[C@@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)[C@](C)(CO)C5CC[C@@]34C)C2CC1(C)C,AXNVHPCVMSNXNP-LGWBRZJHSA-N,Launched,
escitalopram,selective serotonin reuptake inhibitor (SSRI),"ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,"depression, generalized anxiety disorder (GAD)","MicroSource, Tocris",98.5,"BRD-K70301876-034-13-7, BRD-K70301876-034-14-5","CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c1ccc(F)cc1, CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c1ccc(F)cc1","WSEQXVZVJXJVFP-FQEVSTJZSA-N, WSEQXVZVJXJVFP-FQEVSTJZSA-N",Launched,
eslicarbazepine-acetate,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,MedChemEx,99.86,BRD-K61237927-001-01-7,CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc12,QIALRBLEEWJACW-INIZCTEOSA-N,Launched,
esmolol,adrenergic receptor antagonist,ADRB1,cardiology,"ventricular tachycardia (VT), hypertension",Selleck,95.59,BRD-A07395371-003-10-0,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,AQNDDEOPVVGCPG-UHFFFAOYSA-N,Launched,
esomeprazole,ATPase inhibitor,ATP4A,gastroenterology,"gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, peptic ulcer disease (PUD)","Selleck, Selleck, MicroSource",98.67,"BRD-K61443506-236-02-0, BRD-K61443506-239-01-6, BRD-K61443506-237-01-0","COc1ccc2[nH]c(nc2c1)[S@@](=O)Cc1ncc(C)c(OC)c1C, COc1ccc2[nH]c(nc2c1)[S@@](=O)Cc1ncc(C)c(OC)c1C, COc1ccc2[nH]c(nc2c1)[S@@](=O)Cc1ncc(C)c(OC)c1C","SUBDBMMJDZJVOS-DEOSSOPVSA-N, SUBDBMMJDZJVOS-DEOSSOPVSA-N, SUBDBMMJDZJVOS-DEOSSOPVSA-N",Launched,"BRD-A55962179-236-02-5, BRD-M04732511-239-09-6,BRD-A55962179-239-02-9, BRD-A55962179-239-01-1"
estradiol,estrogen receptor agonist,"ESR1, ESR2, GPER1, KCNMA1, NR1I2",endocrinology,contraceptive,"Selleck, MicroSource, Selleck",92.44,"BRD-K18910433-001-36-6, BRD-K18910433-001-43-2, BRD-K18910433-001-42-4","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O","VOXZDWNPVJITMN-ZBRFXRBCSA-N, VOXZDWNPVJITMN-ZBRFXRBCSA-N, VOXZDWNPVJITMN-ZBRFXRBCSA-N",Launched,"BRD-A18917088-001-04-9, BRD-K60633875-001-01-0"
estradiol-acetate,estrogen receptor agonist,ESR1,"endocrinology, obstetrics/gynecology","menopause, vaginal atrophy",Sigma,96.27,BRD-K53319039-001-01-8,CC(=O)Oc1ccc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2c1,FHXBMXJMKMWVRG-SLHNCBLASA-N,Launched,
estradiol-cypionate,estrogen receptor agonist,ESR1,endocrinology,"hypoestrogenism, menopause",MicroSource,92.4,BRD-A91452556-001-04-0,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1,UOACKFBJUYNSLK-OCTSOESTSA-N,Launched,
estradiol-valerate,estrogen receptor agonist,ESR1,"oncology, endocrinology, obstetrics/gynecology","prostate cancer, hypoestrogenism, menopause, vaginal atrophy","MicroSource, Selleck",96.27,"BRD-K66766661-001-19-2, BRD-K66766661-001-20-0","CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C, CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C","RSEPBGGWRJCQGY-RBRWEJTLSA-N, RSEPBGGWRJCQGY-RBRWEJTLSA-N",Launched,"BRD-A39747742-001-04-3, BRD-K12790232-001-01-5"
estramustine,DNA alkylating agent,"ESR1, ESR2, MAP1A, MAP2",oncology,prostate cancer,MicroSource,94.83,BRD-A70858459-001-01-7,C[C@]12CCC3C(CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)C1CC[C@@H]2O,FRPJXPJMRWBBIH-ZZSVNSIZSA-N,Launched,
estramustine-phosphate,"DNA synthesis inhibitor, microtubule inhibitor","ESR1, ESR2, MAP1A, MAP2",oncology,prostate cancer,Enzo,93.37,BRD-K00077635-304-01-2,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(O)(O)=O,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Launched,
estriol,estrogen receptor agonist,"ESR1, ESR2","endocrinology, obstetrics/gynecology, infectious disease","menopause, vaginal atrophy, urinary tract infections","MicroSource, Selleck, MicroSource, Selleck",88.19,"BRD-K17016787-001-16-7, BRD-K17016787-001-13-4, BRD-A63433173-001-02-1, BRD-K17016787-001-15-9","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O, CC12CCC3C(CCc4cc(O)ccc34)C1C[C@H](O)[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O","PROQIPRRNZUXQM-ZXXIGWHRSA-N, PROQIPRRNZUXQM-ZXXIGWHRSA-N, PROQIPRRNZUXQM-WRECPOHLSA-N, PROQIPRRNZUXQM-ZXXIGWHRSA-N",Launched,"BRD-A18620900-001-05-2, BRD-K03411175-001-01-8"
estrone,"estrogen receptor agonist, estrogenic hormone","ESR1, ESR2",,,"Selleck, MicroSource, Selleck",91.87,"BRD-K81839095-001-25-1, BRD-K81839095-001-30-1, BRD-K81839095-001-29-3","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O","DNXHEGUUPJUMQT-CBZIJGRNSA-N, DNXHEGUUPJUMQT-CBZIJGRNSA-N, DNXHEGUUPJUMQT-CBZIJGRNSA-N",Launched,"BRD-A37959677-001-04-5, BRD-K15236393-001-01-1"
estropipate,estrogen receptor agonist,"ESR1, ESR2","orthopedics, endocrinology, obstetrics/gynecology","osteoporosis, menopause, vaginal atrophy, hypoestrogenism",MicroSource,97.6,BRD-A22143024-231-03-8,C[C@]12CCC3C(CCc4cc(OS(O)(=O)=O)ccc34)C1CCC2=O,JKKFKPJIXZFSSB-GUZDXLFXSA-N,Launched,
eszopiclone,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",neurology/psychiatry,insomnia,MicroSource,98.3,BRD-K29220403-001-10-8,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,GBBSUAFBMRNDJC-INIZCTEOSA-N,Launched,
etacrynic-acid,sodium/potassium/chloride transporter inhibitor,"ATP1A1, SLC12A1","cardiology, gastroenterology, nephrology, rheumatology","hypertension, congestive heart failure, edema, hepatic cirrhosis, chronic renal failure, nephrotic syndrome",MicroSource,98.7,BRD-K63630713-001-25-8,CCC(=C)C(=O)c1ccc(OCC(O)=O)c(Cl)c1Cl,AVOLMBLBETYQHX-UHFFFAOYSA-N,Launched,
etafenone,calcium channel blocker,,,,Vitas-M,98.74,BRD-K84971356-001-01-4,CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1,OEGDFSLNGABBKJ-UHFFFAOYSA-N,Launched,
etamsylate,haemostatic agent,,hematology,hemorrhage,"Selleck, Selleck",98.66,"BRD-K71055333-224-05-8, BRD-K71055333-224-06-6","Oc1ccc(O)c(c1)S(O)(=O)=O, Oc1ccc(O)c(c1)S(O)(=O)=O","IKQCSJBQLWJEPU-UHFFFAOYSA-N, IKQCSJBQLWJEPU-UHFFFAOYSA-N",Launched,
ethacizin,anticonvulsant,,cardiology,"ventricular tachycardia (VT), Wolff-Parkinson-White Syndrome (WPW)",Vitas-M,97.41,BRD-K10667240-001-01-7,CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN(CC)CC)c2c1,PQXGNJKJMFUPPM-UHFFFAOYSA-N,Launched,
ethambutol,bacterial cell wall synthesis inhibitor,,infectious disease,tuberculosis,"MicroSource, Selleck",100,"BRD-K93231391-300-06-4, BRD-K93231391-300-05-6","CC[C@@H](CO)NCCN[C@@H](CC)CO, CC[C@@H](CO)NCCN[C@@H](CC)CO","AEUTYOVWOVBAKS-UWVGGRQHSA-N, AEUTYOVWOVBAKS-UWVGGRQHSA-N",Launched,
ethanolamine-oleate,immunostimulant,"F12, FABP4, FFAR1, FFAR4, PLD2",gastroenterology,esophageal varices,MicroSource,0,BRD-M75061779-001-01-2,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,KGWDUNBJIMUFAP-KVVVOXFISA-N,Launched,
ethaverine,calcium channel blocker,,neurology/psychiatry,"muscle relaxant, spasms",MicroSource,99.19,BRD-K36756879-003-08-7,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC,ZOWYFYXTIWQBEP-UHFFFAOYSA-N,Launched,
ethenzamide,analgesic agent,,"neurology/psychiatry, endocrinology, otolaryngology","headache, fever, common cold",MicroSource,99.07,BRD-K88308881-001-06-8,CCOc1ccccc1C(N)=O,SBNKFTQSBPKMBZ-UHFFFAOYSA-N,Launched,
ethinyl-estradiol,"estrogen receptor agonist, estrogenic hormone","ESR1, ESR2, NR1I2",endocrinology,contraceptive,"Selleck, MicroSource, Selleck",91.77,"BRD-K48195008-001-17-3, BRD-K48195008-001-19-9, BRD-K48195008-001-18-1","C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C","BFPYWIDHMRZLRN-SLHNCBLASA-N, BFPYWIDHMRZLRN-SLHNCBLASA-N, BFPYWIDHMRZLRN-SLHNCBLASA-N",Launched,"BRD-A02367930-001-04-5, BRD-K42555202-001-01-2"
ethionamide,mycolic synthesis inhibitor,,infectious disease,tuberculosis,"MicroSource, Selleck",98.1,"BRD-K51207550-001-23-0, BRD-K51207550-001-22-2","CCc1cc(ccn1)C(S)=N, CCc1cc(ccn1)C(S)=N","AEOCXXJPGCBFJA-UHFFFAOYSA-N, AEOCXXJPGCBFJA-UHFFFAOYSA-N",Launched,
ethisterone,progestogen hormone,TYR,,,"MicroSource, Selleck, Selleck",97.2,"BRD-A29111201-001-04-8, BRD-K03981224-001-19-3, BRD-K03981224-001-21-9","CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C","CHNXZKVNWQUJIB-UHFFFAOYSA-N, CHNXZKVNWQUJIB-CEGNMAFCSA-N, CHNXZKVNWQUJIB-CEGNMAFCSA-N",Launched,BRD-K00456604-001-01-7
ethopabate,antiprotozoal agent,,infectious disease,coccidiosis,MicroSource,97.78,BRD-K02475039-001-01-0,CCOc1cc(NC(C)=O)ccc1C(=O)OC,GOVWOKSKFSBNGD-UHFFFAOYSA-N,Launched,
ethosuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I",neurology/psychiatry,epilepsy,"Sigma, MicroSource",99.47,"BRD-A99633051-001-08-8, BRD-A99633051-001-07-0","CCC1(C)CC(=O)NC1=O, CCC1(C)CC(=O)NC1=O","HAPOVYFOVVWLRS-UHFFFAOYSA-N, HAPOVYFOVVWLRS-UHFFFAOYSA-N",Launched,
ethotoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,"MicroSource, AMS",97.23,"BRD-A30205217-001-11-2, BRD-A30205217-001-12-0","CCN1C(=O)NC(C1=O)c1ccccc1, CCN1C(=O)NC(C1=O)c1ccccc1","SZQIFWWUIBRPBZ-UHFFFAOYSA-N, SZQIFWWUIBRPBZ-UHFFFAOYSA-N",Launched,
ethoxzolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9","ophthalmology, gastroenterology","glaucoma, duodenal ulcer disease","MicroSource, Selleck",96.7,"BRD-K18131774-001-18-4, BRD-K18131774-001-17-6","CCOc1ccc2nc(sc2c1)S(N)(=O)=O, CCOc1ccc2nc(sc2c1)S(N)(=O)=O","OUZWUKMCLIBBOG-UHFFFAOYSA-N, OUZWUKMCLIBBOG-UHFFFAOYSA-N",Launched,
ethylenediaminetetraacetic-acid,PKC inhibitor,,neurology/psychiatry,metal toxicity,MicroSource,100,BRD-K82603084-408-01-1,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O,KCXVZYZYPLLWCC-UHFFFAOYSA-N,Launched,
ethynodiol-diacetate,,"ESR1, PGR",endocrinology,contraceptive,"Selleck, MicroSource, Selleck",99.51,"BRD-K46331928-001-06-6, BRD-K46331928-001-05-8, BRD-K46331928-001-08-2","CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1, CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1, CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1","ONKUMRGIYFNPJW-KIEAKMPYSA-N, ONKUMRGIYFNPJW-KIEAKMPYSA-N, ONKUMRGIYFNPJW-KIEAKMPYSA-N",Launched,BRD-K06056310-001-01-4
etidronic-acid,bone resorption inhibitor,"ATP6V1A, PTPRS","endocrinology, orthopedics","Paget's disease, heterotopic ossification","MicroSource, Selleck, Selleck",0,"BRD-K37949327-304-06-1, BRD-K37949327-001-07-1, BRD-K37949327-001-06-3","CC(O)(P(O)(O)=O)P(O)(O)=O, CC(O)(P(O)(O)=O)P(O)(O)=O, CC(O)(P(O)(O)=O)P(O)(O)=O","DBVJJBKOTRCVKF-UHFFFAOYSA-N, DBVJJBKOTRCVKF-UHFFFAOYSA-N, DBVJJBKOTRCVKF-UHFFFAOYSA-N",Launched,
etifoxine,GABA receptor modulator,"GABRA1, GABRA2, GABRA3, GABRA5",neurology/psychiatry,anxiety,"MedChemEx, MedChemEx, MedChemEx",98.68,"BRD-A60821666-003-01-2, BRD-A60821666-003-02-0, BRD-A60821666-001-01-6","CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c1ccccc1, CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c1ccccc1, CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c1ccccc1","IBYCYJFUEJQSMK-UHFFFAOYSA-N, IBYCYJFUEJQSMK-UHFFFAOYSA-N, IBYCYJFUEJQSMK-UHFFFAOYSA-N",Launched,
etilefrine,adrenergic receptor agonist,"ADRA1A, ADRB1","neurology/psychiatry, otolaryngology, endocrinology, pulmonary","headache, nasal congestion, fever, cough suppressant, common cold",Prestwick,88.17,BRD-A09925278-003-05-6,CCNCC(O)c1cccc(O)c1,SQVIAVUSQAWMKL-UHFFFAOYSA-N,Launched,
etizolam,benzodiazepine receptor agonist,GABRA1,neurology/psychiatry,"insomnia, anxiety",MedChemEx,99.78,BRD-K68232413-001-01-2,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Launched,
etodolac,cyclooxygenase inhibitor,"PTGS1, PTGS2, RXRA",rheumatology,"osteoarthritis, rheumatoid arthritis","Selleck, MicroSource",99.16,"BRD-A74667430-001-25-1, BRD-A74667430-001-23-6","CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12, CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12","NNYBQONXHNTVIJ-UHFFFAOYSA-N, NNYBQONXHNTVIJ-UHFFFAOYSA-N",Launched,BRD-K36911961-001-01-6
etofenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2","neurology/psychiatry, rheumatology","muscle pain, joint pain",MedChemEx,97.04,BRD-K73541271-001-03-6,OCCOCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,XILVEPYQJIOVNB-UHFFFAOYSA-N,Launched,
etofibrate,PPAR receptor agonist,PPARA,endocrinology,hypertriglyceridemia,Selleck,95.38,BRD-K49338325-001-03-4,CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1,XXRVYAFBUDSLJX-UHFFFAOYSA-N,Launched,
etofylline,adenosine receptor antagonist,ADORA1,pulmonary,"asthma, bronchitis",Enzo,98.82,BRD-K83064458-001-23-0,Cn1c2ncn(CCO)c2c(=O)n(C)c1=O,NWPRCRWQMGIBOT-UHFFFAOYSA-N,Launched,
etofylline-clofibrate,platelet aggregation inhibitor,PPARA,,,Enamine,99.43,BRD-K49840922-001-05-1,Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O,KYAKGJDISSNVPZ-UHFFFAOYSA-N,Launched,
etomidate,GABA receptor modulator,"ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",neurology/psychiatry,general anaesthetic,"MicroSource, Selleck, Tocris",95.99,"BRD-K55055802-001-09-4, BRD-K55055802-001-10-2, BRD-K55055802-001-08-6","CCOC(=O)c1cncn1[C@H](C)c1ccccc1, CCOC(=O)c1cncn1[C@H](C)c1ccccc1, CCOC(=O)c1cncn1[C@H](C)c1ccccc1","NPUKDXXFDDZOKR-LLVKDONJSA-N, NPUKDXXFDDZOKR-LLVKDONJSA-N, NPUKDXXFDDZOKR-LLVKDONJSA-N",Launched,BRD-A54880345-001-20-9
etonogestrel,progesterone receptor agonist,"ESR1, PGR",endocrinology,contraceptive,Enzo,97.58,BRD-A08302182-001-01-7,CCC12CC(=C)C3C(CCC4=CC(=O)CCC34)C1CC[C@@]2(O)C#C,GCKFUYQCUCGESZ-KIIRVTSASA-N,Launched,
etoposide,topoisomerase inhibitor,"TOP2A, TOP2B",oncology,non-small cell lung cancer (NSCLC),"Selleck, Tocris, MedChemEx, MicroSource, Selleck, Tocris",99.86,"BRD-K37798499-001-18-1, BRD-K37798499-001-24-9, BRD-K37798499-001-25-6, BRD-K37798499-001-27-2, BRD-K37798499-001-22-3, BRD-K37798499-001-21-5","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12","VJJPUSNTGOMMGY-MRVIYFEKSA-N, VJJPUSNTGOMMGY-MRVIYFEKSA-N, VJJPUSNTGOMMGY-MRVIYFEKSA-N, VJJPUSNTGOMMGY-MRVIYFEKSA-N, VJJPUSNTGOMMGY-MRVIYFEKSA-N, VJJPUSNTGOMMGY-MRVIYFEKSA-N",Launched,"BRD-A33280134-001-04-7, BRD-K36186323-001-01-8, BRD-A26175277-001-02-9,BRD-A35357953-001-01-5"
etoposide-phosphate,topoisomerase inhibitor,TOP2A,oncology,"testicular carcinoma, small cell lung cancer",ChemImpex,94.37,BRD-K72533376-001-01-2,COc1cc(cc(OC)c1OP(O)(O)=O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,LIQODXNTTZAGID-OCBXBXKTSA-N,Launched,
etoricoxib,cyclooxygenase inhibitor,PTGS2,rheumatology,"rheumatoid arthritis, psoriatic arthritis, osteoarthritis, gout, ankylosing spondylitis",MedChemEx,99.25,BRD-K54770957-001-04-3,Cc1ccc(cn1)-c1ncc(Cl)cc1-c1ccc(cc1)S(C)(=O)=O,MNJVRJDLRVPLFE-UHFFFAOYSA-N,Launched,
etravirine,non-nucleoside reverse transcriptase inhibitor,"CYP2C19, CYP2C9, CYP3A4",infectious disease,human immunodeficiency virus (HIV-1),Selleck,92.21,BRD-K74717603-001-02-2,Cc1cc(cc(C)c1Oc1nc(Nc2ccc(cc2)C#N)nc(N)c1Br)C#N,PYGWGZALEOIKDF-UHFFFAOYSA-N,Launched,
eucalyptol,acetylcholinesterase inhibitor,ACHE,dental,gingivitis,"MicroSource, AMS",0,"BRD-K29996876-001-10-1, BRD-K29996876-001-09-3","CC12CCC(CC1)C(C)(C)O2, CC12CCC(CC1)C(C)(C)O2","WEEGYLXZBRQIMU-UHFFFAOYSA-N, WEEGYLXZBRQIMU-UHFFFAOYSA-N",Launched,BRD-K15671046-001-03-6
eugenol,androgen receptor antagonist,AR,dental,toothache,MicroSource,92.11,BRD-K32977963-001-05-0,COc1cc(CC=C)ccc1O,RRAFCDWBNXTKKO-UHFFFAOYSA-N,Launched,
eupatilin,mucus protecting agent,,,,"MedChemEx, Astatech",94.26,"BRD-K47031502-001-02-4, BRD-K47031502-001-01-6","COc1ccc(cc1OC)-c1cc(=O)c2c(O)c(OC)c(O)cc2o1, COc1ccc(cc1OC)-c1cc(=O)c2c(O)c(OC)c(O)cc2o1","DRRWBCNQOKKKOL-UHFFFAOYSA-N, DRRWBCNQOKKKOL-UHFFFAOYSA-N",Launched,
evans-blue,glutamate receptor negative allosteric modulator,"GRIA1, PTPN1",,,MicroSource,92.8,BRD-K24548560-342-02-1,Cc1cc(ccc1\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O)-c1ccc(c(C)c1)\N=N\c1ccc2c(cc(c(N)c2c1O)S(O)(=O)=O)S(O)(=O)=O,COXVTLYNGOIATD-HVMBLDELSA-N,Launched,
everolimus,mTOR inhibitor,MTOR,"oncology, neurology/psychiatry, genetics, urology","breast cancer, neuroendocrine tumors of pancreatic origin (PNET), renal cell carcinoma (RCC), subependymal giant cell astrocytoma (SEGA), tuberous sclerosis complex (TSC), renal angiomyolipoma","Selleck, Selleck",95.59,"BRD-K13514097-001-04-6, BRD-K13514097-001-05-3","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO","HKVAMNSJSFKALM-GKUWKFKPSA-N, HKVAMNSJSFKALM-GKUWKFKPSA-N",Launched,"BRD-K13154216-001-03-9, BRD-K13154216-001-01-3"
exalamide,membrane permeability inhibitor,,,,MicroSource,98.99,BRD-K12609457-001-03-1,CCCCCCOc1ccccc1C(N)=O,CKSJXOVLXUMMFF-UHFFFAOYSA-N,Launched,
exemestane,aromatase inhibitor,CYP19A1,oncology,breast cancer,"Tocris, MicroSource, Selleck",98.07,"BRD-K33425534-001-10-9, BRD-K33425534-001-12-5, BRD-K33425534-001-11-7","C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O","BFYIZQONLCFLEV-DAELLWKTSA-N, BFYIZQONLCFLEV-DAELLWKTSA-N, BFYIZQONLCFLEV-DAELLWKTSA-N",Launched,"BRD-A73741725-001-02-8, BRD-K93923542-001-02-7,BRD-K35247444-001-01-3"
exenatide,GLP receptor agonist,GLP1R,endocrinology,diabetes mellitus,MedChemEx,59.57,BRD-K05505104-001-01-1,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O,HRPOQXWQRXFQTM-XWLPCZSASA-N,Launched,BRD-U88413610-000-01-5
ezetimibe,"cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist","ANPEP, NPC1L1, SOAT1","endocrinology, metabolism","hyperlipidemia, hypercholesterolemia, sitosterolemia","MicroSource, Adooq, Selleck, Selleck",96.2,"BRD-A41519720-001-04-8, BRD-K42260897-001-08-4, BRD-K42260897-001-07-6, BRD-K42260897-001-09-2","OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1, O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1, O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1, O[C@@H](CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1","OLNTVTPDXPETLC-OJVMETQDSA-N, OLNTVTPDXPETLC-XPWALMASSA-N, OLNTVTPDXPETLC-XPWALMASSA-N, OLNTVTPDXPETLC-XPWALMASSA-N",Launched,BRD-K32180660-001-01-6
fadrozole,aromatase inhibitor,"CYP11B1, CYP19A1",oncology,breast cancer,SantaCruz,98.89,BRD-A25619068-003-03-4,N#Cc1ccc(cc1)C1CCCc2cncn12,CLPFFLWZZBQMAO-UHFFFAOYSA-N,Launched,
falecalcitriol,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism,"MedChemEx, MedChemEx",89.51,"BRD-K08251020-001-02-8, BRD-K08251020-001-01-0","C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C, C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C","XPYGGHVSFMUHLH-UUSULHAXSA-N, XPYGGHVSFMUHLH-UUSULHAXSA-N",Launched,
famciclovir,DNA polymerase inhibitor,,"dental, infectious disease","cold sore, genitial herpes, shingles","MicroSource, Selleck",99.1,"BRD-K45033733-001-12-2, BRD-K45033733-001-11-4","CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O, CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O","GGXKWVWZWMLJEH-UHFFFAOYSA-N, GGXKWVWZWMLJEH-UHFFFAOYSA-N",Launched,
famotidine,histamine receptor antagonist,HRH2,gastroenterology,heartburn,"Selleck, MicroSource",99.08,"BRD-K00673382-001-17-1, BRD-K00673382-001-18-9","NC(N)=Nc1nc(CSCC\C(N)=N/S(N)(=O)=O)cs1, NC(N)=Nc1nc(CSCC\C(N)=N/S(N)(=O)=O)cs1","XUFQPHANEAPEMJ-UHFFFAOYSA-N, XUFQPHANEAPEMJ-UHFFFAOYSA-N",Launched,
faropenem,lactamase inhibitor,,"infectious disease, pulmonary, otolaryngology","pneumonia, bronchitis, skin infections, urinary tract infections, sinusitis",Astatech,98.06,BRD-A49622760-001-01-9,CC(O)C1C2SC(C3CCCO3)=C(N2C1=O)C(O)=O,HGGAKXAHAYOLDJ-UHFFFAOYSA-N,Launched,
faropenem-medoxomil,lactamase inhibitor,,"otolaryngology, infectious disease, pulmonary","sinusitis, pneumonia, bronchitis, skin infections, urinary tract infections","MedChemEx, MedChemEx, MedChemEx",82.42,"BRD-K59045783-001-03-7, BRD-K59045783-001-02-9, BRD-K59045783-001-01-1","C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCc1oc(=O)oc1C, C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCc1oc(=O)oc1C, C[C@@H](O)[C@@H]1[C@H]2SC([C@H]3CCCO3)=C(N2C1=O)C(=O)OCc1oc(=O)oc1C","JQBKWZPHJOEQAO-DVPVEWDBSA-N, JQBKWZPHJOEQAO-DVPVEWDBSA-N, JQBKWZPHJOEQAO-DVPVEWDBSA-N",Launched,
fasudil,rho associated kinase inhibitor,"PKIA, PRKACA, ROCK1, ROCK2",neurology/psychiatry,cerebral vasospasm,"MicroSource, Selleck, Tocris, Tocris",98.59,"BRD-K76617868-001-05-5, BRD-K76617868-003-10-1, BRD-K76617868-003-14-3, BRD-K76617868-003-11-9","O=S(=O)(N1CCCNCC1)c1cccc2cnccc12, O=S(=O)(N1CCCNCC1)c1cccc2cnccc12, O=S(=O)(N1CCCNCC1)c1cccc2cnccc12, O=S(=O)(N1CCCNCC1)c1cccc2cnccc12","NGOGFTYYXHNFQH-UHFFFAOYSA-N, NGOGFTYYXHNFQH-UHFFFAOYSA-N, NGOGFTYYXHNFQH-UHFFFAOYSA-N, NGOGFTYYXHNFQH-UHFFFAOYSA-N",Launched,
febuxostat,xanthine oxidase inhibitor,XDH,nephrology,hyperuricemia,"Tocris, MicroSource, Selleck",98.36,"BRD-K48367671-001-07-5, BRD-K48367671-001-06-7, BRD-K48367671-001-05-9","CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O, CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O, CC(C)COc1ccc(cc1C#N)-c1nc(C)c(s1)C(O)=O","BQSJTQLCZDPROO-UHFFFAOYSA-N, BQSJTQLCZDPROO-UHFFFAOYSA-N, BQSJTQLCZDPROO-UHFFFAOYSA-N",Launched,
felbamate,glutamate receptor antagonist,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",neurology/psychiatry,epilepsy,"Tocris, Tocris, Selleck, Selleck",94.7,"BRD-K99107520-001-27-4, BRD-K99107520-001-24-1, BRD-K99107520-001-25-8, BRD-K99107520-001-23-3","NC(=O)OCC(COC(N)=O)c1ccccc1, NC(=O)OCC(COC(N)=O)c1ccccc1, NC(=O)OCC(COC(N)=O)c1ccccc1, NC(=O)OCC(COC(N)=O)c1ccccc1","WKGXYQFOCVYPAC-UHFFFAOYSA-N, WKGXYQFOCVYPAC-UHFFFAOYSA-N, WKGXYQFOCVYPAC-UHFFFAOYSA-N, WKGXYQFOCVYPAC-UHFFFAOYSA-N",Launched,
felbinac,cyclooxygenase inhibitor,CTSL,"rheumatology, neurology/psychiatry","rheumatoid arthritis, muscle pain",MicroSource,99.79,BRD-K91740057-001-19-8,OC(=O)Cc1ccc(cc1)-c1ccccc1,QRZAKQDHEVVFRX-UHFFFAOYSA-N,Launched,
felbinac-ethyl,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,AMS,47.98,BRD-K26404903-001-01-5,CCOC(=O)Cc1ccc(cc1)-c1ccccc1,NPPJLSILDPVHCM-UHFFFAOYSA-N,Launched,
felodipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2",cardiology,hypertension,"Tocris, MicroSource, Selleck",98.85,"BRD-A30815329-001-12-1, BRD-A30815329-001-10-5, BRD-A30815329-001-08-9","CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC","RZTAMFZIAATZDJ-UHFFFAOYSA-N, RZTAMFZIAATZDJ-UHFFFAOYSA-N, RZTAMFZIAATZDJ-UHFFFAOYSA-N",Launched,
fenbendazole,tubulin polymerization inhibitor,TUBB,infectious disease,"gastrointestinal parasites, gastrointestinal roundworms","Selleck, MicroSource",98.69,"BRD-K51318897-001-14-6, BRD-K51318897-001-15-3","COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1, COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1","HDDSHPAODJUKPD-UHFFFAOYSA-N, HDDSHPAODJUKPD-UHFFFAOYSA-N",Launched,
fenbufen,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,MicroSource,99.5,BRD-K12513978-001-24-1,OC(=O)CCC(=O)c1ccc(cc1)-c1ccccc1,ZPAKPRAICRBAOD-UHFFFAOYSA-N,Launched,
fenigam,benzodiazepine receptor agonist,"GABBR1, GABBR2",neurology/psychiatry,"posttraumatic stress disorder, anxiety, depression",Enamine,92.36,BRD-A66920069-001-01-3,NCC(CC(O)=O)c1ccccc1,DAFOCGYVTAOKAJ-UHFFFAOYSA-N,Launched,
fenipentol,choleretic agent,,gastroenterology,bile stimulation,MicroSource,0,BRD-A66284731-001-02-0,CCCCC(O)c1ccccc1,OVGORFFCBUIFIA-UHFFFAOYSA-N,Launched,
fenofibrate,PPAR receptor agonist,"MMP25, PPARA",endocrinology,"hypercholesterolemia, hypertriglyceridemia","Tocris, MicroSource, Selleck",99.56,"BRD-K50388907-001-32-0, BRD-K50388907-001-30-4, BRD-K50388907-001-29-6","CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1, CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1, CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1","YMTINGFKWWXKFG-UHFFFAOYSA-N, YMTINGFKWWXKFG-UHFFFAOYSA-N, YMTINGFKWWXKFG-UHFFFAOYSA-N",Launched,
fenofibric-acid,cytochrome P450 inhibitor,"CLCN1, PPARA",cardiology,dyslipidemia,MicroSource,94.36,BRD-K30213273-001-01-6,CC(C)(Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1)C(O)=O,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Launched,
fenoldopam,dopamine receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5",cardiology,hypertension,"MicroSource, Tocris",94.55,"BRD-A50684349-066-11-7, BRD-A50684349-003-02-9","Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12, Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12","TVURRHSHRRELCG-UHFFFAOYSA-N, TVURRHSHRRELCG-UHFFFAOYSA-N",Launched,
fenoprofen,prostaglandin inhibitor,"PTGS1, PTGS2, SLC5A8",rheumatology,"rheumatoid arthritis, osteoarthritis","Selleck, MicroSource, Selleck",99.05,"BRD-A81129465-001-04-6, BRD-A81129465-001-03-8, BRD-A81129465-238-01-0","CC(C(O)=O)c1cccc(Oc2ccccc2)c1, CC(C(O)=O)c1cccc(Oc2ccccc2)c1, CC(C(O)=O)c1cccc(Oc2ccccc2)c1","RDJGLLICXDHJDY-UHFFFAOYSA-N, RDJGLLICXDHJDY-UHFFFAOYSA-N, RDJGLLICXDHJDY-UHFFFAOYSA-N",Launched,"BRD-U45213318-000-01-6, BRD-M61246020-238-04-4"
fenoverine,acetylcholine receptor antagonist,,neurology/psychiatry,spasms,Vitas-M,94.91,BRD-K77564118-001-03-1,O=C(CN1CCN(Cc2ccc3OCOc3c2)CC1)N1c2ccccc2Sc2ccccc12,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Launched,
fenspiride,bronchodilator,,"pulmonary, otolaryngology","asthma, otitis, sinusitis, rhinopharyngitis, laryngitis","Selleck, MicroSource",98.6,"BRD-K26739552-003-14-7, BRD-K26739552-003-15-4","O=C1NCC2(CCN(CCc3ccccc3)CC2)O1, O=C1NCC2(CCN(CCc3ccccc3)CC2)O1","FVNFBBAOMBJTST-UHFFFAOYSA-N, FVNFBBAOMBJTST-UHFFFAOYSA-N",Launched,
fenthion,cholinesterase inhibitor,,,,MicroSource,78.04,BRD-K67217586-001-08-0,COP(=S)(OC)Oc1ccc(SC)c(C)c1,PNVJTZOFSHSLTO-UHFFFAOYSA-N,Launched,
fentiazac,cyclooxygenase inhibitor,"PTGS1, PTGS2","neurology/psychiatry, rheumatology","muscle pain, joint pain",Prestwick,92.65,BRD-K16077845-001-06-1,OC(=O)Cc1sc(nc1-c1ccc(Cl)cc1)-c1ccccc1,JIEKMACRVQTPRC-UHFFFAOYSA-N,Launched,
fenticonazole,bacterial cell wall synthesis inhibitor,,infectious disease,vulvovaginal candidiasis,Selleck,98.76,BRD-A33697453-008-02-4,Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1,ZCJYUTQZBAIHBS-UHFFFAOYSA-N,Launched,
fesoterodine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",urology,urinary incontinence,"Selleck, Selleck",88.03,"BRD-K46731503-050-01-8, BRD-K46731503-051-04-0","CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1OC(=O)C(C)C)C(C)C, CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1OC(=O)C(C)C)C(C)C","DCCSDBARQIPTGU-HSZRJFAPSA-N, DCCSDBARQIPTGU-HSZRJFAPSA-N",Launched,
fexofenadine,histamine receptor antagonist,HRH1,allergy,"allergic rhinitis, urticaria","MicroSource, Tocris, Tocris, Selleck",98.09,"BRD-A73368467-003-18-4, BRD-A73368467-003-17-6, BRD-A73368467-003-19-2, BRD-A73368467-003-16-8","CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1, CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1, CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1, CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1","RWTNPBWLLIMQHL-UHFFFAOYSA-N, RWTNPBWLLIMQHL-UHFFFAOYSA-N, RWTNPBWLLIMQHL-UHFFFAOYSA-N, RWTNPBWLLIMQHL-UHFFFAOYSA-N",Launched,
fidaxomicin,RNA polymerase inhibitor,,gastroenterology,diarrhea,Selleck,91.8,BRD-K57371763-001-01-7,CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@H](C\C=C(C)\C=C(C)[C@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@H]1O)[C@@H](C)O,ZVGNESXIJDCBKN-MHDOWYNASA-N,Launched,
fimasartan,angiotensin receptor antagonist,AGTR1,cardiology,"hypertension, congestive heart failure, hypertension, congestive heart failure","MedChemEx, MedChemEx",89.33,"BRD-K21586122-001-02-7, BRD-K21586122-001-01-9","CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1","AMEROGPZOLAFBN-UHFFFAOYSA-N, AMEROGPZOLAFBN-UHFFFAOYSA-N",Launched,BRD-K76786967-001-01-7
finafloxacin,bacterial DNA gyrase inhibitor,,"infectious disease, pulmonary","intra-abdominal infections, chronic obstructive pulmonary disease (COPD), cystic fibrosis",SantaCruz,93.21,BRD-K98384930-003-01-5,OC(=O)c1cn(C2CC2)c2c(C#N)c(N3C[C@@H]4NCCO[C@H]4C3)c(F)cc2c1=O,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Launched,
finasteride,5 alpha reductase inhibitor,"AKR1D1, SRD5A1, SRD5A2",endocrinology,androgenetic alopecia,"MicroSource, Selleck",98.24,"BRD-K01095011-001-15-9, BRD-K01095011-001-14-2","CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C, CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C","DBEPLOCGEIEOCV-WSBQPABSSA-N, DBEPLOCGEIEOCV-WSBQPABSSA-N",Launched,"BRD-A83081521-001-02-3, BRD-K37882277-001-01-7"
fingolimod,"immunosuppressant, sphingosine phosphate receptor agonist","S1PR1, S1PR5",neurology/psychiatry,multiple sclerosis,"Selleck, Selleck",95.28,"BRD-K88025533-003-04-1, BRD-K88025533-003-03-3","CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1, CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1","KKGQTZUTZRNORY-UHFFFAOYSA-N, KKGQTZUTZRNORY-UHFFFAOYSA-N",Launched,
fipronil,"chloride channel blocker, GABA gated chloride channel blocker",,,,MicroSource,96.39,BRD-A50675702-001-07-1,Nc1c(c(nn1-c1c(Cl)cc(cc1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F,ZOCSXAVNDGMNBV-UHFFFAOYSA-N,Launched,
firocoxib,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis,MicroSource,99.46,BRD-K09090523-001-02-1,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(cc1)S(C)(=O)=O,FULAPETWGIGNMT-UHFFFAOYSA-N,Launched,
flavoxate,acetylcholine receptor antagonist,"CHRM1, CHRM2",urology,"urinary incontinence, interstitial cystitis (IC), urethritis, prostatitis",Selleck,96.85,BRD-K47639036-003-06-6,Cc1c(oc2c(cccc2c1=O)C(=O)OCCN1CCCCC1)-c1ccccc1,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Launched,
flecainide,sodium channel blocker,"KCNA5, KCNA7, SCN4A, SCN5A",cardiology,"ventricular tachycardia (VT), atrial fibrillation (AF), ventricular arrhythmias","Tocris, MicroSource, Tocris",96.6,"BRD-A09472452-015-26-7, BRD-A09472452-015-23-4, BRD-A09472452-015-22-6","FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1, FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1, FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1","DJBNUMBKLMJRSA-UHFFFAOYSA-N, DJBNUMBKLMJRSA-UHFFFAOYSA-N, DJBNUMBKLMJRSA-UHFFFAOYSA-N",Launched,
fleroxacin,topoisomerase inhibitor,,"infectious disease, gastroenterology","gonorrhea, enteritis, diarrhea, respiratory tract infections","Selleck, Selleck",99.55,"BRD-K61717546-001-04-3, BRD-K61717546-001-05-0","CN1CCN(CC1)c1c(F)cc2c(c1F)n(CCF)cc(C(O)=O)c2=O, CN1CCN(CC1)c1c(F)cc2c(c1F)n(CCF)cc(C(O)=O)c2=O","XBJBPGROQZJDOJ-UHFFFAOYSA-N, XBJBPGROQZJDOJ-UHFFFAOYSA-N",Launched,
flibanserin,serotonin receptor agonist,"DRD4, HTR1A, HTR2A",neurology/psychiatry,hypoactive sexual desire disorder,MedChemEx,96.14,BRD-K33637378-001-01-7,FC(F)(F)c1cccc(c1)N1CCN(CCn2c3ccccc3[nH]c2=O)CC1,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Launched,
floctafenine,cyclooxygenase inhibitor,"PTGS1, PTGS2",neurology/psychiatry,pain relief,Carbosynth,99.43,BRD-A23418262-001-01-5,OCC(O)COC(=O)c1ccccc1Nc1ccnc2c(cccc12)C(F)(F)F,APQPGQGAWABJLN-UHFFFAOYSA-N,Launched,
flopropione,serotonin receptor antagonist,HTR1A,neurology/psychiatry,spasms,"MicroSource, Selleck",98.95,"BRD-K43383936-001-05-2, BRD-K43383936-001-04-5","CCC(=O)c1c(O)cc(O)cc1O, CCC(=O)c1c(O)cc(O)cc1O","PTHLEKANMPKYDB-UHFFFAOYSA-N, PTHLEKANMPKYDB-UHFFFAOYSA-N",Launched,
florfenicol,protein synthesis inhibitor,,pulmonary,bovine respiratory disease (BRD),"MicroSource, Selleck",97.38,"BRD-A30886737-001-02-9, BRD-K11298197-001-12-0","CS(=O)(=O)c1ccc(cc1)C(O)[C@H](CF)NC(=O)C(Cl)Cl, CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl","AYIRNRDRBQJXIF-RGURZIINSA-N, AYIRNRDRBQJXIF-NXEZZACHSA-N",Launched,
floxuridine,DNA synthesis inhibitor,TYMS,oncology,colorectal cancer,"MicroSource, Selleck",100,"BRD-A03757454-001-03-4, BRD-K47832606-001-30-1","OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O","ODKNJVUHOIMIIZ-CQMSUOBXSA-N, ODKNJVUHOIMIIZ-RRKCRQDMSA-N",Launched,BRD-K73088654-001-01-9
flubendazole,tubulin polymerization inhibitor,TUBB,infectious disease,gastrointestinal parasites,"MicroSource, Selleck",97.49,"BRD-K86003836-001-10-5, BRD-K86003836-001-09-7","COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccc(F)cc1, COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccc(F)cc1","CPEUVMUXAHMANV-UHFFFAOYSA-N, CPEUVMUXAHMANV-UHFFFAOYSA-N",Launched,BRD-K99928247-001-01-0
flucloxacillin,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology, dermatology, gastroenterology","gram-positive bacterial infections, tonsillitis, sinusitis, pneumonia, eczema, endocarditis, meningitis, enteritis, bacterial septicemia","Prestwick, Sigma",78.07,"BRD-K27871792-001-01-8, BRD-K27871792-236-01-0","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(F)cccc1Cl, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1c(F)cccc1Cl","UIOFUWFRIANQPC-JKIFEVAISA-N, UIOFUWFRIANQPC-JKIFEVAISA-N",Launched,BRD-A13650332-236-09-6
fluconazole,sterol demethylase inhibitor,CYP51A1,infectious disease,"esophageal candidiasis, meningitis","MicroSource, Sigma, Selleck",97.95,"BRD-K05977355-001-19-0, BRD-K05977355-001-23-2, BRD-K05977355-001-18-2","OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F, OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F, OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F","RFHAOTPXVQNOHP-UHFFFAOYSA-N, RFHAOTPXVQNOHP-UHFFFAOYSA-N, RFHAOTPXVQNOHP-UHFFFAOYSA-N",Launched,
flucytosine,other antifungal,DNMT1,infectious disease,"bacterial septicemia, endocarditis, urinary tract infections, meningitis","MicroSource, Selleck",100,"BRD-K82143716-001-20-7, BRD-K82143716-001-19-9","Nc1nc(=O)[nH]cc1F, Nc1nc(=O)[nH]cc1F","XRECTZIEBJDKEO-UHFFFAOYSA-N, XRECTZIEBJDKEO-UHFFFAOYSA-N",Launched,
fludarabine,ribonucleotide reductase inhibitor,"ADA, RRM1, RRM2",hematologic malignancy,chronic lymphocytic leukemia (CLL),"Tocris, Selleck, Tocris",98.32,"BRD-K66788707-001-14-3, BRD-K66788707-001-17-6, BRD-K66788707-001-15-0","Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O, Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O, Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","HBUBKKRHXORPQB-FJFJXFQQSA-N, HBUBKKRHXORPQB-FJFJXFQQSA-N, HBUBKKRHXORPQB-FJFJXFQQSA-N",Launched,BRD-K51927012-001-02-9
fludarabine-phosphate,ribonucleotide reductase inhibitor,"DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B",hematologic malignancy,chronic lymphocytic leukemia (CLL),"Selleck, MicroSource, Selleck",96.99,"BRD-K71106091-001-09-5, BRD-K71106091-001-06-1, BRD-K71106091-001-05-3","Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O, Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O, Nc1nc(F)nc2n(cnc12)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O","GIUYCYHIANZCFB-FJFJXFQQSA-N, GIUYCYHIANZCFB-FJFJXFQQSA-N, GIUYCYHIANZCFB-FJFJXFQQSA-N",Launched,
fludrocortisone-acetate,,"AR, NR3C1, NR3C2",endocrinology,"Addison's disease, adrenogenital syndrome","MicroSource, Sigma",92.71,"BRD-K06408664-001-03-5, BRD-K06408664-001-02-7","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C","SYWHXTATXSMDSB-GSLJADNHSA-N, SYWHXTATXSMDSB-GSLJADNHSA-N",Launched,BRD-A38749782-001-04-1
fludroxycortide,glucocorticoid receptor agonist,"NR3C1, SERPINA6","infectious disease, dermatology","skin infections, psoriasis",MicroSource,97.06,BRD-A49765801-001-04-1,CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,POPFMWWJOGLOIF-KYSSJFEUSA-N,Launched,
flumazenil,benzodiazepine receptor antagonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",neurology/psychiatry,sedative,"Tocris, MicroSource, Selleck, Tocris",99.3,"BRD-K98769987-001-25-2, BRD-K98769987-001-23-7, BRD-K98769987-001-21-1, BRD-K98769987-001-22-9","CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21, CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21, CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21, CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21","OFBIFZUFASYYRE-UHFFFAOYSA-N, OFBIFZUFASYYRE-UHFFFAOYSA-N, OFBIFZUFASYYRE-UHFFFAOYSA-N, OFBIFZUFASYYRE-UHFFFAOYSA-N",Launched,
flumecinol,,,,,Enamine,97.8,BRD-A44181516-001-01-8,CCC(O)(c1ccccc1)c1cccc(c1)C(F)(F)F,DVASNQYQOZHAJN-UHFFFAOYSA-N,Launched,
flumequine,topoisomerase inhibitor,,infectious disease,urinary tract infections,"MicroSource, Selleck",98.1,"BRD-A69777949-001-25-9, BRD-A69777949-001-24-2","CC1CCc2cc(F)cc3c2n1cc(C(O)=O)c3=O, CC1CCc2cc(F)cc3c2n1cc(C(O)=O)c3=O","DPSPPJIUMHPXMA-UHFFFAOYSA-N, DPSPPJIUMHPXMA-UHFFFAOYSA-N",Launched,
flumethasone,glucocorticoid receptor agonist,"NR3C1, PLA2G1B",dermatology,corticosteroid-responsive dermatoses,"Selleck, MicroSource",97.76,"BRD-K61496577-001-19-4, BRD-K61496577-001-20-2","C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","WXURHACBFYSXBI-GQKYHHCASA-N, WXURHACBFYSXBI-GQKYHHCASA-N",Launched,"BRD-K09237689-001-01-0, BRD-A01346607-001-04-2"
flumethasone-pivalate,glucocorticoid receptor agonist,"NR3C1, SERPINA6",,,MicroSource,96.12,BRD-A50064262-001-04-7,C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C,JWRMHDSINXPDHB-DCPWPRNHSA-N,Launched,
flunarizine,calcium channel blocker,"CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1","neurology/psychiatry, cardiology","migraine headache, vertigo, peripheral artery disease (PAD)","Tocris, Selleck, MicroSource, Tocris",97.81,"BRD-K29582677-300-11-4, BRD-K29582677-300-08-0, BRD-K29582677-300-10-6, BRD-K29582677-300-09-8","Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1, Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1, Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1, Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1","SMANXXCATUTDDT-QPJJXVBHSA-N, SMANXXCATUTDDT-QPJJXVBHSA-N, SMANXXCATUTDDT-QPJJXVBHSA-N, SMANXXCATUTDDT-QPJJXVBHSA-N",Launched,
flunisolide,cytochrome P450 inhibitor,NR3C1,allergy,allergic rhinitis,MicroSource,93.61,BRD-A65449987-001-10-4,CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO,XSFJVAJPIHIPKU-CCRGDLLISA-N,Launched,
flunixin-meglumin,prostanoid receptor antagonist,,,,"MicroSource, Selleck",99.53,"BRD-K99984802-100-13-5, BRD-K99984802-100-12-7","Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F, Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F","NOOCSNJCXJYGPE-UHFFFAOYSA-N, NOOCSNJCXJYGPE-UHFFFAOYSA-N",Launched,
fluocinolone-acetonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6",dermatology,seborrheic dermatitis,"MicroSource, MicroSource, Selleck",97.54,"BRD-K94353609-001-21-6, BRD-A15297126-001-04-3, BRD-K94353609-001-20-8","CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C, CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO","FEBLZLNTKCEFIT-VSXGLTOVSA-N, WJOHZNCJWYWUJD-UUTDCOIBSA-N, FEBLZLNTKCEFIT-VSXGLTOVSA-N",Launched,"BRD-A77824596-001-04-0, BRD-K95627890-001-01-2"
fluocinonide,glucocorticoid receptor agonist,"NR3C1, SERPINA6, SMO",dermatology,"seborrheic dermatitis, eczema",Selleck,93.28,BRD-K57886322-001-16-6,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Launched,BRD-K68865937-001-01-6
fluorescein,,SLC22A6,ophthalmology,ophthalmology diagnostic,MicroSource,95.86,BRD-K21913543-001-02-4,Oc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3ccccc23)c1,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Launched,
fluorometholone,glucocorticoid receptor agonist,NR3C1,ophthalmology,eye inflammation,MicroSource,98.58,BRD-A13133631-001-04-0,C[C@H]1CC2C3CC[C@](O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)C2(C)C=CC(=O)C=C12,FAOZLTXFLGPHNG-KXWDGVDDSA-N,Launched,
fluorometholone-acetate,,NR3C1,ophthalmology,eye inflammation,"Selleck, Selleck",97.54,"BRD-K02528732-001-01-6, BRD-K02528732-001-02-4","C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12","YRFXGQHBPBMFHW-SBTZIJSASA-N, YRFXGQHBPBMFHW-SBTZIJSASA-N",Launched,
fluoromethylcholine,,,,,MatrixSci,100,BRD-K51199656-003-01-4,C[N+](C)(CF)CCO,PBVFROWIWWGIFK-UHFFFAOYSA-N,Launched,
fluoxetine,selective serotonin reuptake inhibitor (SSRI),"ANO1, HTR2B, SLC6A4",neurology/psychiatry,"depression, obsessive compulsive disorder (OCD), bulimia nervosa, panic disorders, bipolar disorder","MicroSource, Selleck, Tocris, Tocris",98.86,"BRD-A31159102-003-30-4, BRD-A31159102-003-28-8, BRD-A31159102-003-29-6, BRD-A31159102-003-31-2","CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1, CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1, CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1, CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1","RTHCYVBBDHJXIQ-UHFFFAOYSA-N, RTHCYVBBDHJXIQ-UHFFFAOYSA-N, RTHCYVBBDHJXIQ-UHFFFAOYSA-N, RTHCYVBBDHJXIQ-UHFFFAOYSA-N",Launched,
fluoxymesterone,androgen receptor modulator,"AR, ESR1, NR3C1, PRLR",endocrinology,hypogonadism,Enzo,96.41,BRD-K24255045-001-05-3,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,YLRFCQOZQXIBAB-RBZZARIASA-N,Launched,
flupentixol,dopamine receptor antagonist,"ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A",neurology/psychiatry,"schizophrenia, depression",Enzo,93.69,BRD-K70487031-001-02-8,OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,NJMYODHXAKYRHW-DVZOWYKESA-N,Launched,
fluphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7",neurology/psychiatry,schizophrenia,MicroSource,95.33,BRD-K55127134-300-11-2,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Launched,
fluphenazine-decanoate,dopamine receptor antagonist,"DRD2, HTR1B, HTR4",neurology/psychiatry,schizophrenia,AKSci,59.41,BRD-K27898013-001-01-4,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,VIQCGTZFEYDQMR-UHFFFAOYSA-N,Launched,
flupirtine,glutamate receptor antagonist,"ADRA2A, KCNQ1, KCNQ2",neurology/psychiatry,pain relief,"Selleck, Tocris, MedChemEx, MedChemEx, Selleck",85.76,"BRD-K50720187-051-03-1, BRD-K50720187-001-02-8, BRD-K50720187-050-09-0, BRD-K50720187-050-08-2, BRD-K50720187-051-02-3","CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N, CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N, CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N, CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N, CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N","JUUFBMODXQKSTD-UHFFFAOYSA-N, JUUFBMODXQKSTD-UHFFFAOYSA-N, JUUFBMODXQKSTD-UHFFFAOYSA-N, JUUFBMODXQKSTD-UHFFFAOYSA-N, JUUFBMODXQKSTD-UHFFFAOYSA-N",Launched,
flurbiprofen-(+/-),cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"rheumatoid arthritis, osteoarthritis","Tocris, MicroSource",98.21,"BRD-A86044036-001-26-5, BRD-A86044036-001-27-3","CC(C(O)=O)c1ccc(c(F)c1)-c1ccccc1, CC(C(O)=O)c1ccc(c(F)c1)-c1ccccc1","SYTBZMRGLBWNTM-UHFFFAOYSA-N, SYTBZMRGLBWNTM-UHFFFAOYSA-N",Launched,
flurbiprofen-(S)-(+),cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"rheumatoid arthritis, osteoarthritis","Selleck, Selleck",99.2,"BRD-K69907333-001-07-2, BRD-K69907333-001-10-6","C[C@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1, C[C@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1","SYTBZMRGLBWNTM-JTQLQIEISA-N, SYTBZMRGLBWNTM-JTQLQIEISA-N",Launched,
fluspirilene,dopamine receptor antagonist,"CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A",neurology/psychiatry,schizophrenia,Enzo,91.79,BRD-K77947974-001-16-3,Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1,QOYHHIBFXOOADH-UHFFFAOYSA-N,Launched,
flutamide,androgen receptor antagonist,"AHR, AR",oncology,prostate cancer,"Tocris, MicroSource, Selleck",99.28,"BRD-K28307902-001-23-3, BRD-K28307902-001-21-7, BRD-K28307902-001-20-9","CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O, CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O, CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O","MKXKFYHWDHIYRV-UHFFFAOYSA-N, MKXKFYHWDHIYRV-UHFFFAOYSA-N, MKXKFYHWDHIYRV-UHFFFAOYSA-N",Launched,
fluticasone-propionate,glucocorticoid receptor agonist,"NR3C1, NR3C2, PGR, PLA2G4A",dermatology,corticosteroid-responsive dermatoses,"Tocris, MicroSource, Selleck, Tocris",96.66,"BRD-K62310379-001-12-1, BRD-A45538101-001-01-9, BRD-K62310379-001-13-9, BRD-K62310379-001-10-5","CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF, CCC(=O)O[C@@]1([C@H](C)CC2C3CC(F)C4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@]12C)C(=O)SCF, CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF, CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF","WMWTYOKRWGGJOA-CENSZEJFSA-N, WMWTYOKRWGGJOA-HLJZTEGPSA-N, WMWTYOKRWGGJOA-CENSZEJFSA-N, WMWTYOKRWGGJOA-CENSZEJFSA-N",Launched,BRD-K40517875-001-01-0
flutrimazole,sterol demethylase inhibitor,,infectious disease,mycosis,SantaCruz,99.39,BRD-A00218260-001-03-4,Fc1ccc(cc1)C(c1ccccc1)(c1ccccc1F)n1ccnc1,QHMWCHQXCUNUAK-UHFFFAOYSA-N,Launched,
fluvastatin,HMGCR inhibitor,HMGCR,"endocrinology, cardiology","hypercholesterolemia, congenital heart defects","Selleck, MicroSource, Tocris, Selleck",97.47,"BRD-K66296774-236-11-3, BRD-K66296774-001-07-9, BRD-K66296774-236-12-1, BRD-K66296774-236-10-5","CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12, CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12, CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12, CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)c(-c2ccc(F)cc2)c2ccccc12","FJLGEFLZQAZZCD-MCBHFWOFSA-N, FJLGEFLZQAZZCD-MCBHFWOFSA-N, FJLGEFLZQAZZCD-MCBHFWOFSA-N, FJLGEFLZQAZZCD-MCBHFWOFSA-N",Launched,BRD-M74726084-304-01-9
fluvoxamine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,neurology/psychiatry,obsessive compulsive disorder (OCD),"MicroSource, Tocris, Selleck",93.31,"BRD-K53517854-050-21-4, BRD-K53517854-050-20-6, BRD-K53517854-051-01-4","COCCCC\C(c1ccc(cc1)C(F)(F)F)=N/OCCN, COCCCC\C(c1ccc(cc1)C(F)(F)F)=N/OCCN, COCCCC\C(c1ccc(cc1)C(F)(F)F)=N/OCCN","CJOFXWAVKWHTFT-XSFVSMFZSA-N, CJOFXWAVKWHTFT-XSFVSMFZSA-N, CJOFXWAVKWHTFT-XSFVSMFZSA-N",Launched,
folic-acid,folate receptor ligand,"FOLR2, FOLR3, SLC19A1, SLC46A1",hematology,megaloblastic anemia,MicroSource,89.21,BRD-K18673820-001-15-5,Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2[nH]1,OVBPIULPVIDEAO-LBPRGKRZSA-N,Launched,
fomepizole,alcohol dehydrogenase inhibitor,"ADH1A, ADH1B, ADH1C, AKR1A1, CAT",critical care,poison antidote,"MicroSource, MicroSource",98.99,"BRD-K56810756-003-07-7, BRD-K56810756-001-03-0","Cc1cn[nH]c1, Cc1cn[nH]c1","RIKMMFOAQPJVMX-UHFFFAOYSA-N, RIKMMFOAQPJVMX-UHFFFAOYSA-N",Launched,
fomocaine,voltage-gated sodium channel modulator,,neurology/psychiatry,local anesthetic,ChemDiv,96.22,BRD-K44942188-001-09-1,C(CN1CCOCC1)Cc1ccc(COc2ccccc2)cc1,CVHGCWVMTZWGAY-UHFFFAOYSA-N,Launched,
formestane,aromatase inhibitor,CYP19A1,oncology,breast cancer,"Selleck, MicroSource",100,"BRD-A26503646-001-18-2, BRD-A26503646-001-16-6","C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O, C[C@]12CC[C@H]3[C@@H](CCC4C(=O)C(=O)CC[C@]34C)[C@@H]1CCC2=O","ZMEULISFKSVRLQ-AZXRADLDSA-N, ZMEULISFKSVRLQ-AZXRADLDSA-N",Launched,BRD-A87468186-001-01-6
formoterol,adrenergic receptor agonist,ADRB2,pulmonary,"asthma, chronic obstructive pulmonary disease (COPD), bronchospasm","Tocris, Selleck, Selleck, Tocris",98.09,"BRD-K54006094-051-06-6, BRD-K54006094-051-01-7, BRD-K54006094-051-03-3, BRD-K54006094-051-02-5","COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1, COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1, COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1, COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1","BPZSYCZIITTYBL-ORAYPTAESA-N, BPZSYCZIITTYBL-ORAYPTAESA-N, BPZSYCZIITTYBL-ORAYPTAESA-N, BPZSYCZIITTYBL-ORAYPTAESA-N",Launched,"BRD-M00539986-051-06-0, BRD-M00539986-051-03-7, BRD-M00539986-051-05-2, BRD-M00539986-051-04-5"
forskolin,adenylyl cyclase activator,"ADCY2, ADCY5, GNAS",,,"Tocris, Selleck, Tocris",100,"BRD-K09602097-001-13-6, BRD-K09602097-001-23-5, BRD-K09602097-001-20-1","CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C, CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C, CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C","OHCQJHSOBUTRHG-KGGHGJDLSA-N, OHCQJHSOBUTRHG-KGGHGJDLSA-N, OHCQJHSOBUTRHG-KGGHGJDLSA-N",Launched,"BRD-K77830450-001-05-7,BRD-K62498766-001-01-8"
fosamprenavir,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),MedChemEx,93.28,BRD-K59110290-238-01-7,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,MLBVMOWEQCZNCC-OEMFJLHTSA-N,Launched,
fosaprepitant-dimeglumine,tachykinin antagonist,TACR1,gastroenterology,"nausea, vomiting","MedChemEx, MedChemEx, Selleck, Selleck",78.2,"BRD-K23848629-401-05-2, BRD-K23848629-401-04-5, BRD-K23848629-401-02-9, BRD-K23848629-401-03-7","C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F, C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F, C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F, C[C@@H](O[C@H]1OCCN(Cc2nn(c(=O)[nH]2)P(O)(O)=O)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F","BARDROPHSZEBKC-OITMNORJSA-N, BARDROPHSZEBKC-OITMNORJSA-N, BARDROPHSZEBKC-OITMNORJSA-N, BARDROPHSZEBKC-OITMNORJSA-N",Launched,
foscarnet,DNA polymerase inhibitor,,infectious disease,"cytomegalovirus retinitis, acquired immunodeficiency syndrome (AIDS), virus herpes simplex (HSV)","Selleck, Selleck, MicroSource",0,"BRD-K85146014-314-05-4, BRD-K85146014-314-07-0, BRD-K85146014-314-06-2","OC(=O)P(O)(O)=O, OC(=O)P(O)(O)=O, OC(=O)P(O)(O)=O","ZJAOAACCNHFJAH-UHFFFAOYSA-N, ZJAOAACCNHFJAH-UHFFFAOYSA-N, ZJAOAACCNHFJAH-UHFFFAOYSA-N",Launched,
fosfestrol,synthetic estrogen,"ESR1, ESR2",oncology,prostate cancer,MatrixSci,0,BRD-K20801936-001-01-9,CC\C(c1ccc(OP(O)(O)=O)cc1)=C(\CC)c1ccc(OP(O)(O)=O)cc1,NLORYLAYLIXTID-ISLYRVAYSA-N,Launched,
fosfomycin,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections,"Selleck, MicroSource",100,"BRD-K81101512-234-01-9, BRD-A10652366-238-04-1","C[C@@H]1O[C@@H]1P(O)(O)=O, CC1OC1P(O)(O)=O","YMDXZJFXQJVXBF-STHAYSLISA-N, YMDXZJFXQJVXBF-UHFFFAOYSA-N",Launched,BRD-K48461310-234-01-3
fosfosal,phosphodiesterase inhibitor,"PTGS1, PTGS2",,,"MicroSource, Sigma",84.64,"BRD-K28687144-001-07-9, BRD-K28687144-001-08-7","OC(=O)c1ccccc1OP(O)(O)=O, OC(=O)c1ccccc1OP(O)(O)=O","FFKUDWZICMJVPA-UHFFFAOYSA-N, FFKUDWZICMJVPA-UHFFFAOYSA-N",Launched,
fosinopril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, congestive heart failure","Selleck, Selleck",97.48,"BRD-A51382177-236-03-0, BRD-A51382177-236-04-8","CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C, CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C","BIDNLKIUORFRQP-AJTMIRJTSA-N, BIDNLKIUORFRQP-AJTMIRJTSA-N",Launched,
fosinoprilat,angiotensin converting enzyme inhibitor,ACE,,,AvaChem,61.88,BRD-A33506612-001-01-2,OC(=O)[C@@H]1C[C@H](CN1C(=O)CP(O)(=O)CCCCc1ccccc1)C1CCCCC1,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Launched,
fosphenytoin,sodium channel blocker,SCN5A,neurology/psychiatry,"epilepsy, seizures","AKSci, CombiBlocks",94.91,"BRD-K53809807-304-01-6, BRD-K53809807-304-02-4","OP(O)(=O)OCN1C(=O)NC(C1=O)(c1ccccc1)c1ccccc1, OP(O)(=O)OCN1C(=O)NC(C1=O)(c1ccccc1)c1ccccc1","XWLUWCNOOVRFPX-UHFFFAOYSA-N, XWLUWCNOOVRFPX-UHFFFAOYSA-N",Launched,
fostamatinib,SYK inhibitor,SYK,hematology,chronic immune thrombocytopenia (ITP),"Selleck, Selleck",92.92,"BRD-K85178109-001-03-1, BRD-K85178109-001-02-3","COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(O)(O)=O)c4n3)n2)cc(OC)c1OC, COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(O)(O)=O)c4n3)n2)cc(OC)c1OC","GKDRMWXFWHEQQT-UHFFFAOYSA-N, GKDRMWXFWHEQQT-UHFFFAOYSA-N",Launched,
fotemustine,thioredoxin inhibitor,TXNRD1,oncology,melanoma,"MedChemEx, MedChemEx",36.92,"BRD-A62893078-001-02-3, BRD-A62893078-001-01-5","CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)[N+][O-], CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)[N+][O-]","YAKWPXVTIGTRJH-UHFFFAOYSA-N, YAKWPXVTIGTRJH-UHFFFAOYSA-N",Launched,
frovatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D",neurology/psychiatry,migraine headache,Sigma,91.96,BRD-K08255599-365-01-1,CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O,XPSQPHWEGNHMSK-SECBINFHSA-N,Launched,
ftorafur,thymidylate synthase inhibitor,TYMS,oncology,colorectal cancer,"Selleck, Selleck",100,"BRD-K99383816-001-03-5, BRD-K99383816-001-02-7","Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O, Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O","WFWLQNSHRPWKFK-ZCFIWIBFSA-N, WFWLQNSHRPWKFK-ZCFIWIBFSA-N",Launched,
fudosteine,mucolytic agent,,pulmonary,chest congestion,"Selleck, Selleck",100,"BRD-K54838207-001-03-8, BRD-K54838207-001-02-0","N[C@@H](CSCCCO)C(O)=O, N[C@@H](CSCCCO)C(O)=O","KINWYTAUPKOPCQ-YFKPBYRVSA-N, KINWYTAUPKOPCQ-YFKPBYRVSA-N",Launched,
fulvestrant,estrogen receptor antagonist,"ESR1, ESR2, GPER1",oncology,breast cancer,"Tocris, MicroSource, Tocris, Selleck",97.7,"BRD-A85667082-001-10-1, BRD-A85667082-001-11-9, BRD-A85667082-001-12-7, BRD-A85667082-001-13-5","C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31, C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31, C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31, C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31","VWUXBMIQPBEWFH-WCCTWKNTSA-N, VWUXBMIQPBEWFH-WCCTWKNTSA-N, VWUXBMIQPBEWFH-WCCTWKNTSA-N, VWUXBMIQPBEWFH-WCCTWKNTSA-N",Launched,"BRD-A03249105-001-02-7, BRD-A50947932-001-01-9, BRD-A03249105-001-01-9, BRD-A17828570-001-02-8,BRD-A52958897-001-01-7"
fumagillin,methionine aminopeptidase inhibitor,METAP2,infectious disease,microsporidiosis,"MedChemEx, MedChemEx, Enzo",86.8,"BRD-A99367815-001-04-9, BRD-A99367815-001-03-1, BRD-A99367815-001-01-5","CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O, CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O, CO[C@@H]1[C@@H](CC[C@]2(CO2)C1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O","NGGMYCMLYOUNGM-ZVVCMXCESA-N, NGGMYCMLYOUNGM-ZVVCMXCESA-N, NGGMYCMLYOUNGM-ZVVCMXCESA-N",Launched,
furaltadone,bacterial DNA inhibitor,,,,"MicroSource, Selleck, Selleck",99.01,"BRD-A67514145-001-02-9, BRD-A67514145-003-05-8, BRD-A67514145-003-06-6","[O-][N+](=O)c1ccc(\C=N\N2CC(CN3CCOCC3)OC2=O)o1, [O-][N+](=O)c1ccc(\C=N\N2CC(CN3CCOCC3)OC2=O)o1, [O-][N+](=O)c1ccc(\C=N\N2CC(CN3CCOCC3)OC2=O)o1","YVQVOQKFMFRVGR-VGOFMYFVSA-N, YVQVOQKFMFRVGR-VGOFMYFVSA-N, YVQVOQKFMFRVGR-VGOFMYFVSA-N",Launched,
furazolidone,bacterial DNA inhibitor,,"gastroenterology, infectious disease","diarrhea, enteritis, cholera",MicroSource,91.67,BRD-K11756522-001-09-9,[O-][N+](=O)c1ccc(\C=N\N2CCOC2=O)o1,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,Launched,
furosemide,diuretic,"CA2, GPR35, SLC12A1, SLC12A2","cardiology, rheumatology","edema, hypertension, congestive heart failure, nephrotic syndrome","Tocris, Selleck, MicroSource",99.55,"BRD-K78010432-001-24-9, BRD-K78010432-001-20-7, BRD-K78010432-001-21-5","NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl, NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl, NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl","ZZUFCTLCJUWOSV-UHFFFAOYSA-N, ZZUFCTLCJUWOSV-UHFFFAOYSA-N, ZZUFCTLCJUWOSV-UHFFFAOYSA-N",Launched,
fursultiamine,vitamin B,,,,Prestwick,99.61,BRD-A71157293-003-10-0,C\C(N(Cc1cnc(C)nc1N)C=O)=C(\CCO)SSCC1CCCO1,JTLXCMOFVBXEKD-FOWTUZBSSA-N,Launched,
fusidic-acid,bacterial 30S ribosomal subunit inhibitor,,dermatology,acne vulgaris (AV),MicroSource,96.62,BRD-A06935312-001-04-3,C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)C2[C@H](O)C[C@@H]2[C@]1(C)C[C@H](OC(C)=O)\C2=C(/CCC=C(C)C)C(O)=O,IECPWNUMDGFDKC-FRVBXGIOSA-N,Launched,
gabapentin,calcium channel blocker,"ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B","infectious disease, neurology/psychiatry","virus herpes simplex (HSV), shingles, seizures, restless leg syndrome","Selleck, MicroSource, Selleck",100,"BRD-K62737565-001-09-5, BRD-K62737565-001-10-3, BRD-K62737565-003-02-6","NCC1(CC(O)=O)CCCCC1, NCC1(CC(O)=O)CCCCC1, NCC1(CC(O)=O)CCCCC1","UGJMXCAKCUNAIE-UHFFFAOYSA-N, UGJMXCAKCUNAIE-UHFFFAOYSA-N, UGJMXCAKCUNAIE-UHFFFAOYSA-N",Launched,
gabapentin-enacarbil,adrenergic receptor agonist,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8",neurology/psychiatry,"restless leg syndrome, postherpetic neuralgia",AdvChemBlocks,89.16,BRD-A86665761-001-01-1,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1,TZDUHAJSIBHXDL-UHFFFAOYSA-N,Launched,
gabexate,serine protease inhibitor,"PRSS1, TPSAB1",gastroenterology,pancreatitis,"MedChemEx, Selleck, MedChemEx, Selleck, Tocris",85.7,"BRD-K59256312-066-17-3, BRD-K59256312-066-13-2, BRD-K59256312-066-16-5, BRD-K59256312-066-15-7, BRD-K59256312-066-14-0","CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1, CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1, CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1, CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1, CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1","YKGYIDJEEQRWQH-UHFFFAOYSA-N, YKGYIDJEEQRWQH-UHFFFAOYSA-N, YKGYIDJEEQRWQH-UHFFFAOYSA-N, YKGYIDJEEQRWQH-UHFFFAOYSA-N, YKGYIDJEEQRWQH-UHFFFAOYSA-N",Launched,
gadobutrol,radiopaque medium,,radiology,MRI contrast agent,MedChemEx,100,BRD-A67181951-001-01-2,OCC(O)[C@@H](CO)N1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C3)OC(=O)C2,ZPDFIIGFYAHNSK-FUISWZMFSA-K,Launched,BRD-M08398761-001-01-0
gadodiamide,radiopaque medium,,radiology,MRI contrast agent,Selleck,100,BRD-K38140108-002-01-2,CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2,HZHFFEYYPYZMNU-UHFFFAOYSA-K,Launched,BRD-M27076668-002-02-9
gadopentetic-acid,contrast agent,,radiology,contrast agent,Sigma,0,BRD-K25106841-001-01-2,OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2,IZOOGPBRAOKZFK-UHFFFAOYSA-K,Launched,BRD-M44547596-002-01-7
gadoterate-meglumine,radiopaque medium,,radiology,MRI contrast agent,"Sigma, TCI",97.1,"BRD-K11099631-001-08-4, BRD-K11099631-001-07-6","OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1, OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1","WDLRUFUQRNWCPK-UHFFFAOYSA-N, WDLRUFUQRNWCPK-UHFFFAOYSA-N",Launched,
gadoteridol,radiopaque medium,,radiology,MRI contrast agent,"Kemprotec, MicroSource",86.8,"BRD-A72401848-001-02-2, BRD-A72401848-001-01-4","CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C2)OC(=O)C3, CC(O)CN1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C2)OC(=O)C3","DPNNNPAKRZOSMO-UHFFFAOYSA-K, DPNNNPAKRZOSMO-UHFFFAOYSA-K",Launched,"BRD-M87846614-001-02-9, BRD-M87846614-001-01-1"
galantamine,acetylcholinesterase inhibitor,"ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG",neurology/psychiatry,senile dementia,"Tocris, MicroSource",98.59,"BRD-K49481516-004-18-3, BRD-K49481516-001-01-5","COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24, COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24","ASUTZQLVASHGKV-JDFRZJQESA-N, ASUTZQLVASHGKV-JDFRZJQESA-N",Launched,
gallamine-triethiodide,acetylcholine receptor antagonist,"ACHE, CHRM2, CHRNA1, CHRNA2",neurology/psychiatry,muscle relaxant,"Selleck, MicroSource, Selleck",98.46,"BRD-K43106192-320-09-2, BRD-K43106192-320-10-0, BRD-K43106192-320-11-8","CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC, CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC, CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC","OZLPUNFFCJDMJD-UHFFFAOYSA-N, OZLPUNFFCJDMJD-UHFFFAOYSA-N, OZLPUNFFCJDMJD-UHFFFAOYSA-N",Launched,
gallopamil,L-type calcium channel blocker,ATP2A2,cardiology,"hypertension, cardiac arrythmia",Enzo,97.61,BRD-A52922642-001-03-7,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)c(OC)c2)cc1OC,XQLWNAFCTODIRK-UHFFFAOYSA-N,Launched,
ganciclovir,DNA polymerase inhibitor,,infectious disease,cytomegalovirus (CMV),"Selleck, Selleck, MicroSource",100,"BRD-K22662435-001-17-5, BRD-K22662435-001-19-1, BRD-K22662435-001-18-3","Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1, Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1, Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1","IRSCQMHQWWYFCW-UHFFFAOYSA-N, IRSCQMHQWWYFCW-UHFFFAOYSA-N, IRSCQMHQWWYFCW-UHFFFAOYSA-N",Launched,
garenoxacin,topoisomerase inhibitor,TOP2A,infectious disease,respiratory tract infections,MedChemEx,96.9,BRD-K77038618-356-01-3,C[C@H]1NCc2cc(ccc12)-c1ccc2c(c1OC(F)F)n(cc(C(O)=O)c2=O)C1CC1,NJDRXTDGYFKORP-LLVKDONJSA-N,Launched,
gefitinib,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),"Selleck, Tocris, Selleck, Tocris",99.54,"BRD-K64052750-001-22-5, BRD-K64052750-001-17-5, BRD-K64052750-001-16-7, BRD-K64052750-001-23-3","COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1, COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1, COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1, COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1","XGALLCVXEZPNRQ-UHFFFAOYSA-N, XGALLCVXEZPNRQ-UHFFFAOYSA-N, XGALLCVXEZPNRQ-UHFFFAOYSA-N, XGALLCVXEZPNRQ-UHFFFAOYSA-N",Launched,
gemcitabine,ribonucleotide reductase inhibitor,"CMPK1, RRM1, RRM2, TYMS",oncology,"ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC), pancreatic cancer","MedChemEx, Selleck, Tocris, Selleck",100,"BRD-K15108141-001-08-2, BRD-K15108141-001-06-6, BRD-K15108141-003-04-7, BRD-K15108141-003-05-4","Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","SDUQYLNIPVEERB-QPPQHZFASA-N, SDUQYLNIPVEERB-QPPQHZFASA-N, SDUQYLNIPVEERB-QPPQHZFASA-N, SDUQYLNIPVEERB-QPPQHZFASA-N",Launched,"BRD-K67681739-003-01-4, BRD-K11238904-003-01-9"
gemfibrozil,lipoprotein lipase activator,"LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1","endocrinology, cardiology","hyperlipidemia, coronary heart disease","Selleck, MicroSource",97.18,"BRD-K11129031-001-26-7, BRD-K11129031-001-27-5","Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1, Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1","HEMJJKBWTPKOJG-UHFFFAOYSA-N, HEMJJKBWTPKOJG-UHFFFAOYSA-N",Launched,
gemifloxacin,bacterial DNA gyrase inhibitor,,"pulmonary, infectious disease","bronchitis, pneumonia",MicroSource,94.6,BRD-A40787240-066-04-6,CO\N=C1/CN(CC1CN)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1,ZRCVYEYHRGVLOC-HYARGMPZSA-N,Launched,
gentamycin,bacterial 50S ribosomal subunit inhibitor,"HSPA8, LRP2","infectious disease, critical care","bone and joint infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis","MicroSource, Sigma",0,"BRD-A89445950-001-01-6, BRD-M10279501-065-05-9","CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1, CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@H](CC[C@H]3N)[C@@H](C)N)[C@@H]2O)OC[C@]1(C)O.CN[C@H](C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1","CEAZRRDELHUEMR-VVSHQIECSA-N, NPEFREDMMVQEPL-YJSGWBGLSA-N",Launched,
gepefrine,adrenergic receptor agonist,,cardiology,hypotension,Sigma,84.77,BRD-A04447196-001-01-8,CC(N)Cc1cccc(O)c1,WTDGMHYYGNJEKQ-UHFFFAOYSA-N,Launched,
gestodene,contraceptive agent,,endocrinology,contraceptive,Selleck,95.03,BRD-K97197005-001-03-2,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C,SIGSPDASOTUPFS-XUDSTZEESA-N,Launched,BRD-K81077266-001-01-2
gestrinone,progesterone receptor antagonist,"AR, ESR1, PGR",obstetrics/gynecology,endometriosis,Prestwick,95.29,BRD-K97472745-001-01-8,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C,BJJXHLWLUDYTGC-ANULTFPQSA-N,Launched,
gidazepam,GABA benzodiazepine site receptor agonist,,,,Enamine,88.96,BRD-K22588750-001-07-0,NNC(=O)CN1c2ccc(Br)cc2C(=NCC1=O)c1ccccc1,XLGCMZLSEXRBSG-UHFFFAOYSA-N,Launched,
gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD,oncology,gastric adenocarcinoma,"Selleck, Selleck",98.28,"BRD-K35687421-001-02-5, BRD-K35687421-001-03-3","Oc1cc(=O)[nH]cc1Cl, Oc1cc(=O)[nH]cc1Cl","ZPLQIPFOCGIIHV-UHFFFAOYSA-N, ZPLQIPFOCGIIHV-UHFFFAOYSA-N",Launched,
ginsenoside-rg3,"angiogenesis inhibitor, apoptosis stimulant",KCNH2,,,MedChemEx,99.4,BRD-A44511856-001-01-4,CC(C)=CCCC(C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C,RWXIFXNRCLMQCD-QIRRTGJGSA-N,Launched,
gliclazide,"ATP channel blocker, insulin secretagogue","ABCC8, VEGFA",endocrinology,diabetes mellitus,"MicroSource, Selleck, Selleck",88.04,"BRD-A61154809-001-15-9, BRD-A61154809-001-16-7, BRD-A61154809-001-14-2","Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1, Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1, Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1","BOVGTQGAOIONJV-UHFFFAOYSA-N, BOVGTQGAOIONJV-UHFFFAOYSA-N, BOVGTQGAOIONJV-UHFFFAOYSA-N",Launched,
glimepiride,insulin secretagogue,"ABCC8, KCNJ1, KCNJ11",endocrinology,diabetes mellitus,"MicroSource, Tocris, Selleck",96.93,"BRD-K34776109-001-16-6, BRD-K34776109-001-15-8, BRD-K34776109-001-14-1","CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O, CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O, CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O","WIGIZIANZCJQQY-RUCARUNLSA-N, WIGIZIANZCJQQY-RUCARUNLSA-N, WIGIZIANZCJQQY-RUCARUNLSA-N",Launched,
glipizide,sulfonylurea,"ABCC8, KCNJ10, KCNJ11, PPARG",endocrinology,"diabetes mellitus, hyperglycemia","MicroSource, Selleck",98.53,"BRD-K12219985-001-26-1, BRD-K12219985-001-25-3","Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1, Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1","ZJJXGWJIGJFDTL-UHFFFAOYSA-N, ZJJXGWJIGJFDTL-UHFFFAOYSA-N",Launched,
gliquidone,sulfonylurea,"ABCC8, KCNJ10, KCNJ8",endocrinology,diabetes mellitus,Selleck,94.47,BRD-K80396088-001-12-0,COc1ccc2c(c1)C(=O)N(CCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Launched,
gluconolactone,,LCT,,,MicroSource,0,BRD-K04288422-001-04-4,OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O,PHOQVHQSTUBQQK-KLVWXMOXSA-N,Launched,
glucosamine,glycosylated protein precursor,"IFNG, IL1B, MMP9, NFKB2, TNF","neurology/psychiatry, rheumatology","muscle pain, rheumatoid arthritis, joint pain, backache",MicroSource,100,BRD-K29918010-003-04-1,N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,MSWZFWKMSRAUBD-QZABAPFNSA-N,Launched,
glutamine-(l),,"CTPS1, GLUL, GPRC6A, PPAT","gastroenterology, dental, neurology/psychiatry, rheumatology","diarrhea, mucositis, muscle pain, joint pain, peptic ulcer disease (PUD), ulcerative colitis, Crohn's disease, anxiety, insomnia","Selleck, Selleck",93.22,"BRD-K83896451-001-06-7, BRD-K83896451-001-07-5","N[C@@H](CCC(N)=O)C(O)=O, N[C@@H](CCC(N)=O)C(O)=O","ZDXPYRJPNDTMRX-VKHMYHEASA-N, ZDXPYRJPNDTMRX-VKHMYHEASA-N",Launched,
glyburide,"ATP channel blocker, insulin secretagogue, sulfonylurea","ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1",endocrinology,"diabetes mellitus, hyperglycemia","Tocris, Selleck, MicroSource, Tocris",97.94,"BRD-K36927236-001-36-7, BRD-K36927236-001-30-0, BRD-K36927236-001-32-6, BRD-K36927236-001-31-8","COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1, COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1, COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1, COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1","ZNNLBTZKUZBEKO-UHFFFAOYSA-N, ZNNLBTZKUZBEKO-UHFFFAOYSA-N, ZNNLBTZKUZBEKO-UHFFFAOYSA-N, ZNNLBTZKUZBEKO-UHFFFAOYSA-N",Launched,
glycerol-monolaurate,beta lactamase inhibitor,,,,Sigma,98.1,BRD-A10773072-001-03-4,CCCCCCCCCCCC(=O)OCC(O)CO,ARIWANIATODDMH-UHFFFAOYSA-N,Launched,
glycopyrrolate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",gastroenterology,peptic ulcer disease (PUD),MicroSource,98.36,BRD-A81233518-004-16-1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1,ANGKOCUUWGHLCE-UHFFFAOYSA-N,Launched,
gonadorelin,gonadotropin releasing factor hormone receptor agonist,"GNRHR, GNRHR2",obstetrics/gynecology,"cystic ovaries, reproductive synchrony",MedChemEx,95.93,BRD-K96874295-015-01-0,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,XLXSAKCOAKORKW-AQJXLSMYSA-N,Launched,
goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,"GNRHR, LHCGR","oncology, obstetrics/gynecology","prostate cancer, breast cancer, endometriosis",Enzo,97.19,BRD-K99504665-001-01-2,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,BLCLNMBMMGCOAS-URPVMXJPSA-N,Launched,
GR-235,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist",NR1H4,,,Tocris,55.9,BRD-K26674531-001-02-1,C\C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,WDXRGPWQVHZTQJ-OSJVMJFVSA-N,Launched,
gramicidin,bacterial permeability inducer,,infectious disease,first-aid antibiotic,MicroSource,65.47,BRD-A52977603-001-01-2,CC(C)CC(NC(=O)C(C)NC(=O)CNC(=O)C(NC=O)C(C)C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCCO,ZWCXYZRRTRDGQE-UHFFFAOYSA-N,Launched,
granisetron,serotonin receptor antagonist,HTR3A,gastroenterology,"nausea, vomiting","MicroSource, Selleck",97.08,"BRD-A10967948-003-06-3, BRD-A10967948-003-05-5","CN1C2CCCC1CC(C2)NC(=O)c1nn(C)c2ccccc12, CN1C2CCCC1CC(C2)NC(=O)c1nn(C)c2ccccc12","MFWNKCLOYSRHCJ-UHFFFAOYSA-N, MFWNKCLOYSRHCJ-UHFFFAOYSA-N",Launched,
grapiprant,prostaglandin inhibitor,PTGER4,rheumatology,osteoarthritis,MedChemEx,96.45,BRD-K62050508-001-01-0,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Launched,
grazoprevir,HCV inhibitor,,,,"MedChemEx, MedChemEx",98.76,"BRD-K24943235-237-01-3, BRD-K24943235-001-01-3","COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)Oc3nc2c1)C(C)(C)C, COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)Oc3nc2c1)C(C)(C)C","OBMNJSNZOWALQB-NCQNOWPTSA-N, OBMNJSNZOWALQB-NCQNOWPTSA-N",Launched,
griseofulvin,tubulin polymerization inhibitor,KRT12,infectious disease,"ringworm, tinea pedis","MicroSource, Selleck",95.44,"BRD-K08273968-001-16-6, BRD-K08273968-001-19-0","COc1cc(OC)c(Cl)c2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)c12, COc1cc(OC)c(Cl)c2O[C@]3([C@H](C)CC(=O)C=C3OC)C(=O)c12","DDUHZTYCFQRHIY-RBHXEPJQSA-N, DDUHZTYCFQRHIY-RBHXEPJQSA-N",Launched,BRD-K12423485-001-01-7
guacetisal,immunosuppressant,,,,AvaChem,96.88,BRD-K00739965-001-01-9,COc1ccccc1OC(=O)c1ccccc1OC(C)=O,HSJFYRYGGKLQBT-UHFFFAOYSA-N,Launched,
guaiacol,local anesthetic,CA2,,,MicroSource,0,BRD-K96282009-001-08-8,COc1ccccc1O,LHGVFZTZFXWLCP-UHFFFAOYSA-N,Launched,
guaifenesin,expectorant,,pulmonary,cough suppressant,"MicroSource, Selleck",98.9,"BRD-A90515964-001-16-5, BRD-A90515964-001-15-7","COc1ccccc1OCC(O)CO, COc1ccccc1OCC(O)CO","HSRJKNPTNIJEKV-UHFFFAOYSA-N, HSRJKNPTNIJEKV-UHFFFAOYSA-N",Launched,
guanaben-acetate,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C",cardiology,hypertension,"Tocris, Selleck, MicroSource, Selleck",95.27,"BRD-K62736196-015-10-2, BRD-K62736196-015-09-4, BRD-K62736196-015-13-6, BRD-K62736196-015-11-0","NC(=N)N\N=C\c1c(Cl)cccc1Cl, NC(=N)N\N=C\c1c(Cl)cccc1Cl, NC(=N)N\N=C\c1c(Cl)cccc1Cl, NC(=N)N\N=C\c1c(Cl)cccc1Cl","WDZVGELJXXEGPV-YIXHJXPBSA-N, WDZVGELJXXEGPV-YIXHJXPBSA-N, WDZVGELJXXEGPV-YIXHJXPBSA-N, WDZVGELJXXEGPV-YIXHJXPBSA-N",Launched,BRD-K56800335-015-04-9
guanadrel,adrenergic inhibitor,SLC6A2,cardiology,hypertension,MicroSource,100,BRD-A14262390-065-01-8,NC(=N)NCC1COC2(CCCCC2)O1,HPBNRIOWIXYZFK-UHFFFAOYSA-N,Launched,
guanethidine,adrenergic inhibitor,SLC6A2,cardiology,hypertension,"MicroSource, Selleck",100,"BRD-K62676709-001-01-9, BRD-K62676709-065-05-5","NC(=N)NCCN1CCCCCCC1, NC(=N)NCCN1CCCCCCC1","ACGDKVXYNVEAGU-UHFFFAOYSA-N, ACGDKVXYNVEAGU-UHFFFAOYSA-N",Launched,BRD-M18219129-065-04-2
guanfacine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C",cardiology,hypertension,"MicroSource, MicroSource, Tocris",100,"BRD-K32830106-003-21-2, BRD-K32830106-001-02-6, BRD-K32830106-003-20-4","NC(=N)NC(=O)Cc1c(Cl)cccc1Cl, NC(=N)NC(=O)Cc1c(Cl)cccc1Cl, NC(=N)NC(=O)Cc1c(Cl)cccc1Cl","INJOMKTZOLKMBF-UHFFFAOYSA-N, INJOMKTZOLKMBF-UHFFFAOYSA-N, INJOMKTZOLKMBF-UHFFFAOYSA-N",Launched,
guanidine,HSP inhibitor,"ALDH2, DLG4, GAMT, RNASE1",neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS),"Selleck, MicroSource",98.46,"BRD-K76037122-001-02-5, BRD-K76037122-001-01-7","NC(N)=N, NC(N)=N","ZRALSGWEFCBTJO-UHFFFAOYSA-N, ZRALSGWEFCBTJO-UHFFFAOYSA-N",Launched,"BRD-M47712611-001-03-3, BRD-M47712611-001-04-1,BRD-M29095938-001-02-3"
halazone,,,,,MicroSource,0,BRD-K68091065-001-04-7,OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl,XPDVQPODLRGWPL-UHFFFAOYSA-N,Launched,
halcinonide,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,"MicroSource, Selleck",97.7,"BRD-A88138582-001-04-8, BRD-K81709173-001-09-5","CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl, CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl","MUQNGPZZQDCDFT-RLDTZFIDSA-N, MUQNGPZZQDCDFT-JNQJZLCISA-N",Launched,BRD-K64408465-001-01-9
halobetasol-propionate,glucocorticoid receptor agonist,"NR3C1, PLA2G1B",dermatology,corticosteroid-responsive dermatoses,Selleck,96.13,BRD-K65877271-001-01-8,CCC(=O)O[C@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@H](O)C[C@]12C)C(=O)CCl,BDSYKGHYMJNPAB-MUYQOBDSSA-N,Launched,
halofantrine,antimalarial agent,"KCNH2, KCNN4",infectious disease,malaria,Enzo,89.55,BRD-A51964809-003-12-6,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(ccc12)C(F)(F)F,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,Launched,
halofuginone,collagenase inhibitor,"COL1A1, MMP2",rheumatology,scleroderma,EMDBio,95.58,BRD-K54247840-004-01-3,O[C@H]1CCCN[C@@H]1CC(=O)Cn1cnc2cc(Br)c(Cl)cc2c1=O,LVASCWIMLIKXLA-CABCVRRESA-N,Launched,
haloperidol,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1",neurology/psychiatry,"schizophrenia, Tourette's disorder","Tocris, Selleck, MicroSource",99.67,"BRD-K67783091-003-07-7, BRD-K67783091-001-25-3, BRD-K67783091-001-26-1","OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1, OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1, OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1","LNEPOXFFQSENCJ-UHFFFAOYSA-N, LNEPOXFFQSENCJ-UHFFFAOYSA-N, LNEPOXFFQSENCJ-UHFFFAOYSA-N",Launched,
haloperidol-decanoate,psychoactive drug,"DRD2, DRD3, DRD4, HTR2A",neurology/psychiatry,schizophrenia,Key,99.05,BRD-K80859331-001-01-5,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,GUTXTARXLVFHDK-UHFFFAOYSA-N,Launched,
haloprogin,other antifungal,,infectious disease,tinea pedis,Prestwick,98.19,BRD-K13238168-001-02-0,Clc1cc(Cl)c(OCC#CI)cc1Cl,CTETYYAZBPJBHE-UHFFFAOYSA-N,Launched,
halothane,glutamate receptor antagonist,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO",neurology/psychiatry,general anaesthetic,"MicroSource, MedChemEx",0,"BRD-A20550616-001-02-9, BRD-A20550616-001-03-7","FC(F)(F)C(Cl)Br, FC(F)(F)C(Cl)Br","BCQZXOMGPXTTIC-UHFFFAOYSA-N, BCQZXOMGPXTTIC-UHFFFAOYSA-N",Launched,
hematoporphyrin,,,neurology/psychiatry,"depression, psychosis, psychosis, depression","MedChemEx, Sigma",16.61,"BRD-A44995766-300-03-0, BRD-A44995766-001-02-6","CC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(O)=O)c(CCC(O)=O)c4C)c(C)c3C(C)O, CC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(O)=O)c(CCC(O)=O)c4C)c(C)c3C(C)O","UJKPHYRXOLRVJJ-UHFFFAOYSA-N, UJKPHYRXOLRVJJ-UHFFFAOYSA-N",Launched,
hemin,enzyme inducer,,"hematology, cardiology","acute intermittent porphyria (AIP), hypertension, ventricular tachycardia (VT)",InterBioScreen,0,BRD-M75036822-003-01-7,[Fe+3].Cc1c(CCC(O)=O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C=C)c5C)c(C=C)c4C)c(C)c3CCC(O)=O,VSTBFMUUCAUPAF-UHFFFAOYSA-N,Launched,
hemomex-s,,PPARG,,,MedChemEx,90.75,BRD-K15231341-001-01-5,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O)C[C@@]21C,SHCBCKBYTHZQGZ-CJPZEJHVSA-N,Launched,
heptaminol,vasoconstrictor,,cardiology,hypotension,MicroSource,100,BRD-A32988684-003-08-7,CC(N)CCCC(C)(C)O,LREQLEBVOXIEOM-UHFFFAOYSA-N,Launched,
hesperetin,ACAT inhibitor,"DGAT1, MTTP, SOAT1, SOAT2",,,Selleck,98.16,BRD-K30553453-001-13-2,COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O)cc2O1,AIONOLUJZLIMTK-AWEZNQCLSA-N,Launched,
hesperidin,flavanone glycoside,CACNA1B,,,"Selleck, Selleck, Selleck",90.46,"BRD-K38903228-001-11-9, BRD-K38903228-001-13-5, BRD-K38903228-001-12-7","COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1, COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1, COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1","QUQPHWDTPGMPEX-QJBIFVCTSA-N, QUQPHWDTPGMPEX-QJBIFVCTSA-N, QUQPHWDTPGMPEX-QJBIFVCTSA-N",Launched,"BRD-K43382661-001-02-2,BRD-M12718521-001-02-2, BRD-K53229386-001-04-2,BRD-K93633846-001-01-7, BRD-K43382661-001-01-4,BRD-M45990714-001-01-7"
hetacillin,bacterial cell wall synthesis inhibitor,,obstetrics/gynecology,mastitis,MicroSource,26.47,BRD-A27828834-237-04-4,CC1(C)S[C@@H]2C(N3C(=O)[C@H](NC3(C)C)c3ccccc3)C(=O)N2[C@H]1C(O)=O,DXVUYOAEDJXBPY-HCYBMXRASA-N,Launched,
hexachlorophene,potassium channel activator,"GLUD1, SDHD",infectious disease,gram-positive bacterial infections,MicroSource,98.49,BRD-K99792991-001-34-9,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,ACGUYXCXAPNIKK-UHFFFAOYSA-N,Launched,
hexaminolevulinate,,,radiology,diagnostic agent,MedChemEx,100,BRD-K73753850-003-01-6,CCCCCCOC(=O)CCC(=O)CN,RYQOILLJDKPETL-UHFFFAOYSA-N,Launched,
hexestrol,synthetic estrogen,"AKR1C1, ESR1, ESR2",,,"MicroSource, Selleck, Selleck",88.97,"BRD-A01078468-001-14-8, BRD-K69253806-001-02-0, BRD-K69253806-001-03-8","CCC(C(CC)c1ccc(O)cc1)c1ccc(O)cc1, CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c1ccc(O)cc1, CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c1ccc(O)cc1","PBBGSZCBWVPOOL-UHFFFAOYSA-N, PBBGSZCBWVPOOL-HDICACEKSA-N, PBBGSZCBWVPOOL-HDICACEKSA-N",Launched,
hexetidine,local anesthetic,,"otolaryngology, infectious disease, dental, gastroenterology","pharyngitis, meningitis, laryngitis, gingivitis, ulcerative colitis","MicroSource, MedChemEx, MedChemEx",25.25,"BRD-A18605525-001-12-4, BRD-A18605525-001-13-2, BRD-A18605525-001-14-0","CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1, CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1, CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1","DTOUUUZOYKYHEP-UHFFFAOYSA-N, DTOUUUZOYKYHEP-UHFFFAOYSA-N, DTOUUUZOYKYHEP-UHFFFAOYSA-N",Launched,
hexoprenaline,adrenergic receptor agonist,ADRB2,pulmonary,asthma,Carbosynth,79.95,BRD-A33894669-065-01-9,OC(CNCCCCCCNCC(O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,OXLZNBCNGJWPRV-UHFFFAOYSA-N,Launched,
hexylcaine,sodium channel blocker,"SCN10A, SCN5A",neurology/psychiatry,local anesthetic,Prestwick,96.16,BRD-A97730597-003-11-5,CC(CNC1CCCCC1)OC(=O)c1ccccc1,DKLKMKYDWHYZTD-UHFFFAOYSA-N,Launched,
hexylresorcinol,local anesthetic,TYR,infectious disease,"skin infections, first-aid antiseptic",MicroSource,98.8,BRD-K99946902-001-07-5,CCCCCCc1ccc(O)cc1O,WFJIVOKAWHGMBH-UHFFFAOYSA-N,Launched,
histamine,histamine receptor agonist,"HRH1, HRH2, HRH3, HRH4",allergy,allergic rhinitis,"Tocris, Tocris, Selleck, MicroSource, Selleck, Selleck",100,"BRD-K01674964-300-07-1, BRD-K01674964-300-10-5, BRD-K01674964-001-19-0, BRD-K01674964-300-08-9, BRD-K01674964-316-01-0, BRD-K01674964-300-06-3","NCCc1c[nH]cn1, NCCc1c[nH]cn1, NCCc1c[nH]cn1, NCCc1c[nH]cn1, NCCc1c[nH]cn1, NCCc1c[nH]cn1","NTYJJOPFIAHURM-UHFFFAOYSA-N, NTYJJOPFIAHURM-UHFFFAOYSA-N, NTYJJOPFIAHURM-UHFFFAOYSA-N, NTYJJOPFIAHURM-UHFFFAOYSA-N, NTYJJOPFIAHURM-UHFFFAOYSA-N, NTYJJOPFIAHURM-UHFFFAOYSA-N",Launched,BRD-U61402069-000-01-5
homatropine,acetylcholine receptor antagonist,"CES1, CHRM1",ophthalmology,pupil dilation,"MicroSource, Selleck",93.54,"BRD-A74975734-004-10-7, BRD-A74975734-004-09-9","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c1ccccc1, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c1ccccc1","ZTVIKZXZYLEVOL-MCOXGKPRSA-N, ZTVIKZXZYLEVOL-MCOXGKPRSA-N",Launched,"BRD-A09539288-004-04-4, BRD-A35196708-004-01-9"
homatropine-methylbromide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ophthalmology,uveal tract inflammation,MicroSource,96.2,BRD-A43999749-004-04-1,C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c1ccccc1,WKWOJBUWWZTUQV-JWMHWRSXSA-N,Launched,
homochlorcyclizine,antihistamine,HRH1,allergy,allergic rhinitis,Enzo,96.11,BRD-A22769835-300-05-7,CN1CCCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,WEUCDJCFJHYFRL-UHFFFAOYSA-N,Launched,
homoharringtonine,protein synthesis inhibitor,RPL3,hematologic malignancy,chronic myeloid leukemia (CML),Tocris,87.85,BRD-K76674262-001-03-3,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC,HYFHYPWGAURHIV-JFIAXGOJSA-N,Launched,
hyaluronic-acid,,"C1QBP, CD44, HABP2, HAPLN1, HAPLN3, HAPLN4, HMMR, ICAM1, NCAN, VCAN","rheumatology, urology","osteoarthritis, interstitial cystitis (IC)",Sigma,0,BRD-K59788572-236-01-3,CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1C(O)=O,WCDDVEOXEIYWFB-VXORFPGASA-N,Launched,
hycanthone,RNA synthesis inhibitor,,infectious disease,schistosomiasis,MicroSource,86.83,BRD-K50406511-001-26-0,CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12,MFZWMTSUNYWVBU-UHFFFAOYSA-N,Launched,
hydralazine,vasodilator,"AOC3, P4HA1",cardiology,hypertension,"MicroSource, MedChemEx, Selleck, Selleck",87.04,"BRD-K82103381-003-07-8, BRD-K82103381-003-09-4, BRD-K82103381-003-06-0, BRD-K82103381-003-08-6","NNc1nncc2ccccc12, NNc1nncc2ccccc12, NNc1nncc2ccccc12, NNc1nncc2ccccc12","RPTUSVTUFVMDQK-UHFFFAOYSA-N, RPTUSVTUFVMDQK-UHFFFAOYSA-N, RPTUSVTUFVMDQK-UHFFFAOYSA-N, RPTUSVTUFVMDQK-UHFFFAOYSA-N",Launched,
hydrochlorothiazide,thiazide diuretic,"CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3",cardiology,"hypertension, congestive heart failure","Selleck, MicroSource",98.34,"BRD-K13078532-001-27-6, BRD-K13078532-001-28-4","NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl, NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl","JZUFKLXOESDKRF-UHFFFAOYSA-N, JZUFKLXOESDKRF-UHFFFAOYSA-N",Launched,
hydrocortisone,glucocorticoid receptor agonist,,"dermatology, neurology/psychiatry","eczema, psoriasis, seborrheic dermatitis, itching","Tocris, MicroSource, Selleck",97.33,"BRD-K93568044-001-30-4, BRD-K93568044-001-32-0, BRD-K93568044-001-31-2","C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO","JYGXADMDTFJGBT-VWUMJDOOSA-N, JYGXADMDTFJGBT-VWUMJDOOSA-N, JYGXADMDTFJGBT-VWUMJDOOSA-N",Launched,"BRD-A75172220-001-04-0, BRD-K97571677-001-01-9"
hydrocortisone-acetate,glucocorticoid receptor agonist,"NR3C1, NR3C2",dermatology,corticosteroid-responsive dermatoses,MicroSource,88.6,BRD-A65767837-001-04-4,CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C,ALEXXDVDDISNDU-KPYZGQEZSA-N,Launched,
hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1,dermatology,"corticosteroid-responsive dermatoses, eczema","MicroSource, Sigma",85.87,"BRD-K99199077-001-17-9, BRD-K99199077-001-16-1","CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO, CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO","BMCQMVFGOVHVNG-TUFAYURCSA-N, BMCQMVFGOVHVNG-TUFAYURCSA-N",Launched,BRD-A34508879-001-04-9
hydrocortisone-phosphate,,"ANXA1, NOS2, NR3C1","pulmonary, gastroenterology, hematologic malignancy, ophthalmology","asthma, nausea, vomiting, multiple myeloma, contact dermatitis, enteritis, colitis",MicroSource,79.61,BRD-A46186775-369-02-0,CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O,BGSOJVFOEQLVMH-QVABZINDSA-N,Launched,
hydrocortisone-valerate,glucocorticoid receptor agonist,,dermatology,corticosteroid-responsive dermatoses,MicroSource,88.16,BRD-A25143711-001-02-2,CCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)CO,FZCHYNWYXKICIO-BXLKFAEVSA-N,Launched,
hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,"ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3","cardiology, gastroenterology, rheumatology, nephrology","edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, chronic renal failure, acute glomerulonephritis (AGN), hypertension",MicroSource,97.64,BRD-K36862742-001-25-6,NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F,DMDGGSIALPNSEE-UHFFFAOYSA-N,Launched,
hydroquinidine,antiarrhythmic,,cardiology,cardiac arrythmia,MicroSource,98.92,BRD-A06390036-001-04-6,CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,LJOQGZACKSYWCH-NBGVHYBESA-N,Launched,
hydroquinone,melanin inhibitor,TYR,dermatology,dyschromia,"MicroSource, MedChemEx",49.83,"BRD-K11227669-001-07-8, BRD-K11227669-001-08-6","Oc1ccc(O)cc1, Oc1ccc(O)cc1","QIGBRXMKCJKVMJ-UHFFFAOYSA-N, QIGBRXMKCJKVMJ-UHFFFAOYSA-N",Launched,
hydroxyamphetamine,trace amine associated receptor agonist,TAAR1,ophthalmology,mydriasis,MicroSource,97.66,BRD-A80871782-004-06-9,CC(N)Cc1ccc(O)cc1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,Launched,
hydroxychloroquine,antimalarial agent,"TLR7, TLR9",infectious disease,malaria,"MicroSource, Sigma",98.39,"BRD-A99117172-065-04-0, BRD-A99117172-065-05-7","CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12, CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12","XXSMGPRMXLTPCZ-UHFFFAOYSA-N, XXSMGPRMXLTPCZ-UHFFFAOYSA-N",Launched,
hydroxyprogesterone,progesterone receptor agonist,PGR,obstetrics/gynecology,spontaneous preterm birth,MicroSource,95.14,BRD-A39791822-001-05-1,CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,DBPWSSGDRRHUNT-AYUYWISESA-N,Launched,
hydroxyprogesterone-acetate,progesterone receptor agonist,PGR,,,Sigma,94,BRD-K92902018-001-01-9,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,VTHUYJIXSMGYOQ-KOORYGTMSA-N,Launched,
hydroxystilbamidine,,,,,Enzo,93.1,BRD-K62186992-334-02-8,NC(=N)c1ccc(cc1)\C=C\c1ccc(cc1O)C(N)=N,TUESWZZJYCLFNL-DAFODLJHSA-N,Launched,
hydroxyurea,ribonucleotide reductase inhibitor,"RRM1, RRM2, RRM2B","hematologic malignancy, oncology","chronic myeloid leukemia (CML), head and neck squamous cell carcinoma (HNSCC)","Selleck, Selleck, MicroSource",98.2,"BRD-K51747290-001-15-6, BRD-K51747290-001-12-3, BRD-K51747290-001-13-1","NC(=O)NO, NC(=O)NO, NC(=O)NO","VSNHCAURESNICA-UHFFFAOYSA-N, VSNHCAURESNICA-UHFFFAOYSA-N, VSNHCAURESNICA-UHFFFAOYSA-N",Launched,
hydroxyzine,antihistamine,HRH1,"neurology/psychiatry, allergy, dermatology","anxiety, urticaria, itching, dermatosis, anxiety, urticaria, itching, dermatosis","Selleck, MicroSource",96.59,"BRD-A62428732-300-06-3, BRD-A62428732-096-10-9","OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1, OCCOCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1","ZQDWXGKKHFNSQK-UHFFFAOYSA-N, ZQDWXGKKHFNSQK-UHFFFAOYSA-N",Launched,
hyoscyamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology, urology, neurology/psychiatry, allergy","peptic ulcer disease (PUD), acute abdominal visceral spasm, ulcerative colitis, interstitial cystitis (IC), enterocolitis, irritable bowel syndrome, tremors, allergic rhinitis","MicroSource, Selleck",97.93,"BRD-K40530731-001-11-6, BRD-K40530731-001-10-8","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)c1ccccc1, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)c1ccccc1","RKUNBYITZUJHSG-FXUDXRNXSA-N, RKUNBYITZUJHSG-FXUDXRNXSA-N",Launched,"BRD-A78303415-001-04-3, BRD-A97674763-001-01-8"
ibandronate,bone resorption inhibitor,FDPS,orthopedics,osteoporosis,"MicroSource, Selleck, Selleck",0,"BRD-K08681769-323-04-5, BRD-K08681769-323-05-2, BRD-K08681769-323-03-7","CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O, CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O, CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O","MPBVHIBUJCELCL-UHFFFAOYSA-N, MPBVHIBUJCELCL-UHFFFAOYSA-N, MPBVHIBUJCELCL-UHFFFAOYSA-N",Launched,
ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,"BLK, BMX, BTK",hematologic malignancy,"chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenstrom's macroglobulinemia (WM)","Selleck, Selleck",99.58,"BRD-K70301465-001-05-9, BRD-K70301465-001-02-6","Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C, Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C","XYFPWWZEPKGCCK-GOSISDBHSA-N, XYFPWWZEPKGCCK-GOSISDBHSA-N",Launched,
ibudilast,"leukotriene receptor antagonist, phosphodiesterase inhibitor","IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A","pulmonary, neurology/psychiatry","asthma, stroke","Tocris, Tocris",96.95,"BRD-K16444452-001-11-7, BRD-K16444452-001-09-1","CC(C)C(=O)c1c(nn2ccccc12)C(C)C, CC(C)C(=O)c1c(nn2ccccc12)C(C)C","ZJVFLBOZORBYFE-UHFFFAOYSA-N, ZJVFLBOZORBYFE-UHFFFAOYSA-N",Launched,
ibuprofen,cyclooxygenase inhibitor,"PTGS1, PTGS2","neurology/psychiatry, rheumatology, otolaryngology, obstetrics/gynecology, endocrinology, dental","headache, muscle pain, rheumatoid arthritis, backache, common cold, menstrual pain, fever, toothache","MicroSource, Selleck",99.41,"BRD-A17655518-001-24-4, BRD-A17655518-001-23-6","CC(C)Cc1ccc(cc1)C(C)C(O)=O, CC(C)Cc1ccc(cc1)C(C)C(O)=O","HEFNNWSXXWATRW-UHFFFAOYSA-N, HEFNNWSXXWATRW-UHFFFAOYSA-N",Launched,
ibuprofen-lysine,cyclooxygenase inhibitor,"PTGS1, PTGS2",cardiology,patent ductus arteriosus (PDA),"Selleck, Selleck",0,"BRD-M64062803-001-03-9, BRD-M64062803-001-02-1","NCCCC[C@H](N)C(O)=O.CC(C)Cc1ccc(cc1)C(C)C(O)=O, NCCCC[C@H](N)C(O)=O.CC(C)Cc1ccc(cc1)C(C)C(O)=O","IHHXIUAEPKVVII-ZSCHJXSPSA-N, IHHXIUAEPKVVII-ZSCHJXSPSA-N",Launched,
ibuprofen-piconol,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,"Enamine, Enamine",95.32,"BRD-A75224450-001-01-6, BRD-A75224450-001-02-4","CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1, CC(C)Cc1ccc(cc1)C(C)C(=O)OCc1ccccn1","ACEWLPOYLGNNHV-UHFFFAOYSA-N, ACEWLPOYLGNNHV-UHFFFAOYSA-N",Launched,
ibuproxam,"cyclooxygenase inhibitor, prostaglandin inhibitor",ALOX5,"endocrinology, rheumatology, neurology/psychiatry","fever, joint inflammation, pain relief",Enzo,80.93,BRD-A40940854-001-01-1,CC(C)Cc1ccc(cc1)C(C)C(=O)NO,BYPIURIATSUHDW-UHFFFAOYSA-N,Launched,
ibutilide,potassium channel blocker,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6",cardiology,atrial fibrillation (AF),"Tocris, Selleck, Selleck",96.32,"BRD-A74391928-051-03-9, BRD-A74391928-051-01-3, BRD-A74391928-051-02-1","CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1, CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1, CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1","ALOBUEHUHMBRLE-UHFFFAOYSA-N, ALOBUEHUHMBRLE-UHFFFAOYSA-N, ALOBUEHUHMBRLE-UHFFFAOYSA-N",Launched,"BRD-M56587789-051-04-6, BRD-M56587789-051-02-0, BRD-M56587789-051-03-8"
icatibant-acetate,bradykinin receptor antagonist,"ANPEP, BDKRB2",cardiology,angioedema,"MedChemEx, MedChemEx, MedChemEx",93.99,"BRD-K63772874-001-03-0, BRD-K63772874-001-01-4, BRD-K63772874-001-02-2","N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O, N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O, N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O","QURWXBZNHXJZBE-SKXRKSCCSA-N, QURWXBZNHXJZBE-SKXRKSCCSA-N, QURWXBZNHXJZBE-SKXRKSCCSA-N",Launched,
icosapent,platelet aggregation inhibitor,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1",endocrinology,hypertriglyceridemia,Enzo,87.46,BRD-K47192521-001-05-4,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,JAZBEHYOTPTENJ-JLNKQSITSA-N,Launched,
icotinib,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),Selleck,96.95,BRD-K31698212-001-02-9,C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1,QQLKULDARVNMAL-UHFFFAOYSA-N,Launched,
idarubicin,topoisomerase inhibitor,TOP2A,hematologic malignancy,acute myeloid leukemia (AML),"Selleck, Selleck",98.01,"BRD-K69650333-003-13-2, BRD-K69650333-003-14-0","C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O, C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O","XDXDZDZNSLXDNA-TZNDIEGXSA-N, XDXDZDZNSLXDNA-TZNDIEGXSA-N",Launched,BRD-K63126143-003-01-4
idebenone,calcium channel modulator,,"neurology/psychiatry, ophthalmology","Alzheimer's disease, Friedreich's ataxia, Leber hereditary optic neuropathy (LHON)","Selleck, Selleck, MicroSource",95.71,"BRD-K37516142-001-11-3, BRD-K37516142-001-09-7, BRD-K37516142-001-10-5","COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O, COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O, COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O","JGPMMRGNQUBGND-UHFFFAOYSA-N, JGPMMRGNQUBGND-UHFFFAOYSA-N, JGPMMRGNQUBGND-UHFFFAOYSA-N",Launched,
idelalisib,PI3K inhibitor,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",hematologic malignancy,chronic lymphocytic leukemia (CLL),Selleck,96.97,BRD-K60866521-001-07-1,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Launched,
idoxuridine,DNA directed DNA polymerase inhibitor,,infectious disease,virus herpes simplex (HSV),"Selleck, MicroSource",98.08,"BRD-K76634210-001-12-1, BRD-K76634210-001-14-7","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(I)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(I)c(=O)[nH]c1=O","XQFRJNBWHJMXHO-RRKCRQDMSA-N, XQFRJNBWHJMXHO-RRKCRQDMSA-N",Launched,BRD-A85439007-001-01-6
ifenprodil,"adrenergic receptor antagonist, glutamate receptor antagonist","GRIN1, GRIN2B",,,"MicroSource, Selleck, Tocris, Selleck",99,"BRD-A24191444-046-01-3, BRD-A24191444-046-02-1, BRD-A24191444-045-10-6, BRD-A24191444-046-03-9","CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1, CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1, CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1, CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1","UYNVMODNBIQBMV-UHFFFAOYSA-N, UYNVMODNBIQBMV-UHFFFAOYSA-N, UYNVMODNBIQBMV-UHFFFAOYSA-N, UYNVMODNBIQBMV-UHFFFAOYSA-N",Launched,"BRD-M01603234-046-01-4, BRD-M20547247-322-01-0, BRD-M01603234-046-02-2"
ifosfamide,DNA alkylating agent,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1","oncology, urology","testicular carcinoma, hemorrhagic cystitis","MicroSource, Selleck",100,"BRD-A67097164-001-18-7, BRD-A67097164-001-17-9","ClCCNP1(=O)OCCCN1CCCl, ClCCNP1(=O)OCCCN1CCCl","HOMGKSMUEGBAAB-UHFFFAOYSA-N, HOMGKSMUEGBAAB-UHFFFAOYSA-N",Launched,
iguratimod,"cyclooxygenase inhibitor, NFkB pathway inhibitor",PTGS2,rheumatology,rheumatoid arthritis,MedChemEx,96.01,BRD-K15426076-001-01-2,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,ANMATWQYLIFGOK-UHFFFAOYSA-N,Launched,
iloperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7",neurology/psychiatry,schizophrenia,Selleck,97.56,BRD-K48722833-001-07-6,COc1cc(ccc1OCCCN1CCC(CC1)c1noc2cc(F)ccc12)C(C)=O,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Launched,
iloprost,"platelet aggregation inhibitor, prostanoid receptor agonist","PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R",pulmonary,pulmonary arterial hypertension (PAH),MedChemEx,50.79,BRD-A45664787-001-04-8,CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,Launched,
imatinib,"Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","hematologic malignancy, oncology","chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), myelodysplastic diseases (MDS), aggressive systemic mastocytosis (ASM), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans (DFSP), gastrointestinal stromal tumors (GIST)","Selleck, Selleck, Selleck",99.23,"BRD-K92723993-001-12-5, BRD-K92723993-001-06-7, BRD-K92723993-066-22-7","CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1, CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1, CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1","KTUFNOKKBVMGRW-UHFFFAOYSA-N, KTUFNOKKBVMGRW-UHFFFAOYSA-N, KTUFNOKKBVMGRW-UHFFFAOYSA-N",Launched,
imidacloprid,acetylcholine receptor antagonist,CHRFAM7A,,,SantaCruz,99.22,BRD-K76609936-001-08-4,[O-][N+](=O)NC1=NCCN1Cc1ccc(Cl)nc1,YWTYJOPNNQFBPC-UHFFFAOYSA-N,Launched,
imidafenacin,acetylcholine receptor antagonist,"CHRM1, CHRM3",neurology/psychiatry,"spasms, spasms","MedChemEx, MedChemEx",97.97,"BRD-K29626940-001-01-5, BRD-K29626940-001-02-3","Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1, Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1","SQKXYSGRELMAAU-UHFFFAOYSA-N, SQKXYSGRELMAAU-UHFFFAOYSA-N",Launched,
imidapril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, congestive heart failure",Selleck,97.71,BRD-K34332569-001-01-3,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](CN(C)C1=O)C(O)=O,KLZWOWYOHUKJIG-CWRNSKLLSA-N,Launched,
imipenem,bacterial cell wall synthesis inhibitor,,infectious disease,"pneumonia, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections, endocarditis","MicroSource, Sigma",0,"BRD-K23200955-002-01-5, BRD-K23200955-002-02-3","C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O","ZSKVGTPCRGIANV-ZXFLCMHBSA-N, ZSKVGTPCRGIANV-ZXFLCMHBSA-N",Launched,
imipramine,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor","ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry, urology","depression, nocturnal enuresis","Selleck, MicroSource, Selleck",92.52,"BRD-K38436528-003-25-3, BRD-K38436528-003-26-1, BRD-K38436528-003-27-9","CN(C)CCCN1c2ccccc2CCc2ccccc12, CN(C)CCCN1c2ccccc2CCc2ccccc12, CN(C)CCCN1c2ccccc2CCc2ccccc12","BCGWQEUPMDMJNV-UHFFFAOYSA-N, BCGWQEUPMDMJNV-UHFFFAOYSA-N, BCGWQEUPMDMJNV-UHFFFAOYSA-N",Launched,
imiquimod,"interferon inducer, toll-like receptor agonist","TLR7, TLR8","dermatology, infectious disease, oncology","actinic keratosis (AK), genital warts, basal cell carcinoma (BCC)","Selleck, MicroSource, Selleck",98.69,"BRD-K26657438-001-17-8, BRD-K26657438-003-01-8, BRD-K26657438-001-15-2","CC(C)Cn1cnc2c(N)nc3ccccc3c12, CC(C)Cn1cnc2c(N)nc3ccccc3c12, CC(C)Cn1cnc2c(N)nc3ccccc3c12","DOUYETYNHWVLEO-UHFFFAOYSA-N, DOUYETYNHWVLEO-UHFFFAOYSA-N, DOUYETYNHWVLEO-UHFFFAOYSA-N",Launched,
indacaterol,adrenergic receptor agonist,"ADRB1, ADRB2",pulmonary,chronic obstructive pulmonary disease (COPD),Selleck,95.34,BRD-K89208535-051-01-5,CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Launched,
indapamide,thiazide diuretic,"KCNE1, KCNQ1, SLC12A3",cardiology,"hypertension, congestive heart failure","MicroSource, Selleck",96.25,"BRD-A95869247-001-26-9, BRD-A95869247-001-25-1","CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O, CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(c1)S(N)(=O)=O","NDDAHWYSQHTHNT-UHFFFAOYSA-N, NDDAHWYSQHTHNT-UHFFFAOYSA-N",Launched,
indinavir,HIV protease inhibitor,"CYP3A4, CYP3A5, CYP3A7",infectious disease,human immunodeficiency virus (HIV-1),Enzo,97.93,BRD-K33226500-001-01-0,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12,CBVCZFGXHXORBI-PXQQMZJSSA-N,Launched,
indobufen,"cyclooxygenase inhibitor, platelet aggregation inhibitor","PTGS1, PTGS2",hematology,thrombosis,AKSci,99.21,BRD-A16296925-001-01-3,CCC(C(O)=O)c1ccc(cc1)N1Cc2ccccc2C1=O,AYDXAULLCROVIT-UHFFFAOYSA-N,Launched,
indocyanine-green,contrast agent,SLCO1B1,,,"MedChemEx, Sigma, MedChemEx",92.75,"BRD-K80762071-236-01-7, BRD-K80762071-236-02-5, BRD-K80762071-236-03-3","CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(O)(=O)=O)c2ccc3ccccc3c12, CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(O)(=O)=O)c2ccc3ccccc3c12, CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS(O)(=O)=O)c3ccc4ccccc4c3C2(C)C)N(CCCCS(O)(=O)=O)c2ccc3ccccc3c12","BDBMLMBYCXNVMC-UHFFFAOYSA-O, BDBMLMBYCXNVMC-UHFFFAOYSA-O, BDBMLMBYCXNVMC-UHFFFAOYSA-O",Launched,
indomethacin,cyclooxygenase inhibitor,"GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1","rheumatology, orthopedics","rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, bursitis, tendinitis","Tocris, MicroSource, Selleck",99.45,"BRD-K57222227-001-29-3, BRD-K57222227-001-30-1, BRD-K57222227-001-28-5","COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1, COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1, COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1","CGIGDMFJXJATDK-UHFFFAOYSA-N, CGIGDMFJXJATDK-UHFFFAOYSA-N, CGIGDMFJXJATDK-UHFFFAOYSA-N",Launched,
indoramin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C","urology, cardiology","benign prostatic hyperplasia (BPH), hypertension",Maybridge,92.44,BRD-K76953762-001-08-5,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Launched,
ingenol-mebutate,PKC activator,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCG",dermatology,actinic keratosis (AK),MedChemEx,97.23,BRD-K93779381-001-01-9,C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,VDJHFHXMUKFKET-WDUFCVPESA-N,Launched,
inimur,other antifungal,,,,"MedChemEx, MedChemEx",86.95,"BRD-A71407503-001-01-8, BRD-A71407503-001-02-6","CSCC1CN(\N=C\c2ccc(o2)[N+]([O-])=O)C(=O)O1, CSCC1CN(\N=C\c2ccc(o2)[N+]([O-])=O)C(=O)O1","SRQKTCXJCCHINN-NYYWCZLTSA-N, SRQKTCXJCCHINN-NYYWCZLTSA-N",Launched,
inosine,neurotrophic agent,"PARP1, PNP",,,"Selleck, Selleck, MicroSource",94.71,"BRD-K79612754-001-20-9, BRD-K79612754-001-19-1, BRD-K79612754-001-21-7","OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(O)ncnc12, OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(O)ncnc12, OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(O)ncnc12","UGQMRVRMYYASKQ-KQYNXXCUSA-N, UGQMRVRMYYASKQ-KQYNXXCUSA-N, UGQMRVRMYYASKQ-KQYNXXCUSA-N",Launched,"BRD-K14210676-001-01-5, BRD-A28787076-001-04-8"
inositol,insulin sensitizer,"CDIPT, GBA",,,MicroSource,98.26,BRD-K52618540-001-09-9,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O,CDAISMWEOUEBRE-GPIVLXJGSA-N,Launched,
inositol-hexanicotinate,,,"dermatology, cardiology, rheumatology, neurology/psychiatry","statis dermatitis, claudication, Raynaud's disease, hypertension, insomnia, atherosclerosis, restless leg syndrome, schizophrenia, psoriasis, acne vulgaris (AV)",AKSci,89.29,BRD-K82800842-001-01-9,O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,MFZCIDXOLLEMOO-GYSGTQPESA-N,Launched,
iobenguane,antineoplastic agent,,"oncology, cardiology, endocrinology","neuroblastoma, congestive heart failure, pheochromocytoma","Prestwick, Axon",98.26,"BRD-K43860855-065-10-1, BRD-K43860855-065-11-9","NC(=N)NCc1cccc(I)c1, NC(=N)NCc1cccc(I)c1","PDWUPXJEEYOOTR-UHFFFAOYSA-N, PDWUPXJEEYOOTR-UHFFFAOYSA-N",Launched,
iocetamic-acid,radiopaque medium,,radiology,contrast agent,Prestwick,85.31,BRD-A37492983-001-10-3,CC(CN(C(C)=O)c1c(I)cc(I)c(N)c1I)C(O)=O,GSVQIUGOUKJHRC-UHFFFAOYSA-N,Launched,
iodipamide,radiopaque medium,ALB,radiology,contrast agent,MicroSource,99.2,BRD-K67261995-001-11-7,OC(=O)c1c(I)cc(I)c(NC(=O)CCCCC(=O)Nc2c(I)cc(I)c(C(O)=O)c2I)c1I,FFINMCNLQNTKLU-UHFFFAOYSA-N,Launched,
iodixanol,radiopaque medium,,radiology,contrast agent,"Sigma, MicroSource",79.95,"BRD-A08660406-001-06-7, BRD-A08660406-001-05-9","CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I, CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","NBQNWMBBSKPBAY-UHFFFAOYSA-N, NBQNWMBBSKPBAY-UHFFFAOYSA-N",Launched,
iodoquinol,antiseptic,,infectious disease,amebiasis,MicroSource,88.89,BRD-K75855670-001-14-2,Oc1c(I)cc(I)c2cccnc12,UXZFQZANDVDGMM-UHFFFAOYSA-N,Launched,
iohexol,radiopaque medium,,radiology,contrast agent,MicroSource,98.79,BRD-A60217728-001-11-2,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,NTHXOOBQLCIOLC-UHFFFAOYSA-N,Launched,
iopamidol,radiopaque medium,,radiology,contrast agent,MedChemEx,100,BRD-K75868704-001-05-3,C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I,XQZXYNRDCRIARQ-LURJTMIESA-N,Launched,
iopodic-acid,,,radiology,contrast agent,Vitas-M,98.86,BRD-K51956333-001-03-8,CN(C)\C=N\c1c(I)cc(I)c(CCC(O)=O)c1I,YQNFBOJPTAXAKV-OMCISZLKSA-N,Launched,
iopromide,radiopaque medium,,radiology,contrast agent,"Prestwick, Sigma",64.8,"BRD-A72075775-001-10-4, BRD-A72075775-001-11-2","COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I, COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I","DGAIEPBNLOQYER-UHFFFAOYSA-N, DGAIEPBNLOQYER-UHFFFAOYSA-N",Launched,
ioversol,radiopaque medium,,radiology,contrast agent,MicroSource,97.06,BRD-A65818372-001-05-3,OCCN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,AMDBBAQNWSUWGN-UHFFFAOYSA-N,Launched,
ioxaglic-acid,radiopaque medium,,radiology,contrast agent,Prestwick,92.49,BRD-K79124250-001-08-9,CNC(=O)c1c(I)c(N(C)C(C)=O)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c2I)c1I,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Launched,
ioxilan,radiopaque medium,,radiology,angiography,MicroSource,85.72,BRD-A09370961-001-01-0,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I,UUMLTINZBQPNGF-UHFFFAOYSA-N,Launched,
ipragliflozin-l-proline,sodium/glucose cotransporter inhibitor,SLC5A2,endocrinology,diabetes mellitus,MedChemEx,98.3,BRD-K51247865-001-01-2,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(F)c(Cc2cc3ccccc3s2)c1,AHFWIQIYAXSLBA-RQXATKFSSA-N,Launched,
ipratropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",pulmonary,"bronchospasm, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema","Tocris, MicroSource, Selleck",93.93,"BRD-A47449001-004-12-9, BRD-A47449001-004-13-7, BRD-A47449001-004-14-5","CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1, CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1, CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c1ccccc1","OEXHQOGQTVQTAT-BHIXFJMTSA-N, OEXHQOGQTVQTAT-BHIXFJMTSA-N, OEXHQOGQTVQTAT-BHIXFJMTSA-N",Launched,"BRD-A65721754-004-02-8, BRD-A96060515-004-01-6, BRD-A05352148-004-03-8"
ipriflavone,bone resorption inhibitor,,orthopedics,osteoporosis,"MicroSource, Selleck",98.07,"BRD-K93618743-001-21-0, BRD-K93618743-001-20-2","CC(C)Oc1ccc2c(c1)occ(-c1ccccc1)c2=O, CC(C)Oc1ccc2c(c1)occ(-c1ccccc1)c2=O","SFBODOKJTYAUCM-UHFFFAOYSA-N, SFBODOKJTYAUCM-UHFFFAOYSA-N",Launched,
irbesartan,angiotensin receptor antagonist,"AGTR1, JUN, SLC10A1","cardiology, nephrology","hypertension, diabetic nephropathy","MicroSource, Selleck",98.6,"BRD-K60038276-001-09-0, BRD-K60038276-001-08-2","CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1","YOSHYTLCDANDAN-UHFFFAOYSA-N, YOSHYTLCDANDAN-UHFFFAOYSA-N",Launched,
irinotecan,topoisomerase inhibitor,"TOP1, TOP1MT",oncology,colorectal cancer,"Selleck, Tocris, MedChemEx, Tocris, MicroSource, Selleck, Selleck",98.48,"BRD-K08547377-001-04-4, BRD-K08547377-003-06-5, BRD-K08547377-003-07-3, BRD-K08547377-003-04-0, BRD-K08547377-003-05-7, BRD-K08547377-001-06-9, BRD-K08547377-394-03-5","CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(OC(=O)N3CCC(CC3)N3CCCCC3)cc12","UWKQSNNFCGGAFS-XIFFEERXSA-N, UWKQSNNFCGGAFS-XIFFEERXSA-N, UWKQSNNFCGGAFS-XIFFEERXSA-N, UWKQSNNFCGGAFS-XIFFEERXSA-N, UWKQSNNFCGGAFS-XIFFEERXSA-N, UWKQSNNFCGGAFS-XIFFEERXSA-N, UWKQSNNFCGGAFS-XIFFEERXSA-N",Launched,BRD-K72035773-001-01-7
irsogladine,phosphodiesterase inhibitor,PDE4A,gastroenterology,peptic ulcer disease (PUD),"Tocris, Tocris, Selleck",99.31,"BRD-K74195153-050-12-1, BRD-K74195153-050-13-9, BRD-K74195153-001-04-1","Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl, Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl, Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl","ATCGGEJZONJOCL-UHFFFAOYSA-N, ATCGGEJZONJOCL-UHFFFAOYSA-N, ATCGGEJZONJOCL-UHFFFAOYSA-N",Launched,
isepamicin,protein synthesis inhibitor,,infectious disease,"pneumonia, peritonitis","Carbosynth, Sigma",95.5,"BRD-K74759733-001-01-9, BRD-K74759733-065-01-4","CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O, CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)NC(=O)[C@@H](O)CN)OC[C@]1(C)O","UDIIBEDMEYAVNG-ZKFPOVNWSA-N, UDIIBEDMEYAVNG-ZKFPOVNWSA-N",Launched,
isocarboxazid,monoamine oxidase inhibitor,"MAOA, MAOB",neurology/psychiatry,depression,"Sigma, Enzo",64.59,"BRD-K93332168-001-11-5, BRD-K93332168-001-10-7","Cc1cc(no1)C(=O)NNCc1ccccc1, Cc1cc(no1)C(=O)NNCc1ccccc1","XKFPYPQQHFEXRZ-UHFFFAOYSA-N, XKFPYPQQHFEXRZ-UHFFFAOYSA-N",Launched,
isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1,infectious disease,gram-positive bacterial infections,Selleck,98.55,BRD-A93353767-008-02-2,Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1,MPIPASJGOJYODL-UHFFFAOYSA-N,Launched,
isoetharine,adrenergic receptor agonist,"ADRB1, ADRB2",pulmonary,"bronchospasm, asthma","Selleck, MicroSource, Selleck",94.7,"BRD-A24587114-066-21-7, BRD-A24587114-066-22-5, BRD-A24587114-066-23-3","CCC(NC(C)C)C(O)c1ccc(O)c(O)c1, CCC(NC(C)C)C(O)c1ccc(O)c(O)c1, CCC(NC(C)C)C(O)c1ccc(O)c(O)c1","HUYWAWARQUIQLE-UHFFFAOYSA-N, HUYWAWARQUIQLE-UHFFFAOYSA-N, HUYWAWARQUIQLE-UHFFFAOYSA-N",Launched,
isoflurane,inhaled anaesthetic,"ATP2C1, ATP5D, CALM1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9",neurology/psychiatry,general anaesthetic,"Sigma, Enamine",0,"BRD-A31564021-001-02-6, BRD-A31564021-001-01-8","FC(F)OC(Cl)C(F)(F)F, FC(F)OC(Cl)C(F)(F)F","PIWKPBJCKXDKJR-UHFFFAOYSA-N, PIWKPBJCKXDKJR-UHFFFAOYSA-N",Launched,
isoflurophate,cholinesterase inhibitor,"ACHE, BCHE",ophthalmology,glaucoma,"Sigma, Sigma",0,"BRD-K56575995-001-03-0, BRD-K56575995-001-02-2","CC(C)OP(F)(=O)OC(C)C, CC(C)OP(F)(=O)OC(C)C","MUCZHBLJLSDCSD-UHFFFAOYSA-N, MUCZHBLJLSDCSD-UHFFFAOYSA-N",Launched,
isoleucine,,"ACADSB, BCAT1, BCAT2, IARS, IARS2",,,Enamine,89.82,BRD-A02232681-001-01-8,CCC(C)C(N)C(O)=O,AGPKZVBTJJNPAG-UHFFFAOYSA-N,Launched,
isometheptene-mucate,,"ADRA1A, SLC18A2",neurology/psychiatry,headache,Prestwick,81.13,BRD-A64743628-001-01-5,CNC(C)CCC=C(C)C,XVQUOJBERHHONY-UHFFFAOYSA-N,Launched,"BRD-M48029916-001-06-6,BRD-M59543297-001-05-3"
isoniazid,FABI inhibitor,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4",infectious disease,tuberculosis,"Selleck, MicroSource",100,"BRD-K87202646-001-32-6, BRD-K87202646-001-33-4","NNC(=O)c1ccncc1, NNC(=O)c1ccncc1","QRXWMOHMRWLFEY-UHFFFAOYSA-N, QRXWMOHMRWLFEY-UHFFFAOYSA-N",Launched,
isopentyl-4-methoxycinnamate,,,dermatology,sunscreen lotion,Enamine,0,BRD-K37851352-001-01-0,COc1ccc(cc1)\C=C\C(=O)OCCC(C)C,UBNYRXMKIIGMKK-RMKNXTFCSA-N,Launched,
isoprenaline,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3","cardiology, pulmonary","bradycardia, heart block, asthma","Selleck, Selleck, MicroSource, Tocris",94.79,"BRD-A04322457-003-18-7, BRD-A04322457-003-15-3, BRD-A04322457-003-17-9, BRD-A04322457-003-16-1","CC(C)NCC(O)c1ccc(O)c(O)c1, CC(C)NCC(O)c1ccc(O)c(O)c1, CC(C)NCC(O)c1ccc(O)c(O)c1, CC(C)NCC(O)c1ccc(O)c(O)c1","JWZZKOKVBUJMES-UHFFFAOYSA-N, JWZZKOKVBUJMES-UHFFFAOYSA-N, JWZZKOKVBUJMES-UHFFFAOYSA-N, JWZZKOKVBUJMES-UHFFFAOYSA-N",Launched,
isopropamide-iodide,acetylcholine receptor antagonist,"CHRM3, CHRM4",gastroenterology,"peptic ulcer disease (PUD), gastrointestinal acidosis",MicroSource,97.23,BRD-K14127446-005-22-7,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,JTPUMZTWMWIVPA-UHFFFAOYSA-O,Launched,
isopropyl-myristate,,,dermatology,cosmetic,"Sigma, Acros",0,"BRD-K13409143-001-02-7, BRD-K13409143-001-01-9","CCCCCCCCCCCCCC(=O)OC(C)C, CCCCCCCCCCCCCC(=O)OC(C)C","AXISYYRBXTVTFY-UHFFFAOYSA-N, AXISYYRBXTVTFY-UHFFFAOYSA-N",Launched,
isopropyl-palmitate,cosmetic moisturizer,,dermatology,cosmetic,"Sigma, TCI",0,"BRD-K30758549-001-02-6, BRD-K30758549-001-01-8","CCCCCCCCCCCCCCCC(=O)OC(C)C, CCCCCCCCCCCCCCCC(=O)OC(C)C","XUGNVMKQXJXZCD-UHFFFAOYSA-N, XUGNVMKQXJXZCD-UHFFFAOYSA-N",Launched,
isosorbide,nitric oxide stimulant,,cardiology,"angina pectoris, coronary artery disease (CAD)","MedChemEx, MedChemEx, Selleck, Selleck",0,"BRD-K47178855-001-03-4, BRD-K47178855-001-02-6, BRD-K47178855-001-04-2, BRD-K47178855-001-01-8","O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12, O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12, O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12, O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12","KLDXJTOLSGUMSJ-JGWLITMVSA-N, KLDXJTOLSGUMSJ-JGWLITMVSA-N, KLDXJTOLSGUMSJ-JGWLITMVSA-N, KLDXJTOLSGUMSJ-JGWLITMVSA-N",Launched,BRD-K57344138-001-01-2
isosorbide-dinitrate,nitric oxide stimulant,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, NPR1",cardiology,"angina pectoris, coronary artery disease (CAD)","Enamine, MicroSource",0,"BRD-K55853390-001-13-2, BRD-K55853390-001-12-4","[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O, [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O","MOYKHGMNXAOIAT-JGWLITMVSA-N, MOYKHGMNXAOIAT-JGWLITMVSA-N",Launched,
isosorbide-mononitrate,nitric oxide stimulant,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3",cardiology,"angina pectoris, coronary artery disease (CAD)",MicroSource,97.02,BRD-K82225283-001-03-1,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O,YWXYYJSYQOXTPL-SLPGGIOYSA-N,Launched,
isotretinoin,retinoid receptor agonist,"RARA, RARB, RARG",dermatology,acne vulgaris (AV),"Selleck, MedChemEx, Selleck, MicroSource",51.38,"BRD-K76723084-001-25-7, BRD-K76723084-001-24-0, BRD-K76723084-001-22-4, BRD-K76723084-001-23-2","CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O","SHGAZHPCJJPHSC-XFYACQKRSA-N, SHGAZHPCJJPHSC-XFYACQKRSA-N, SHGAZHPCJJPHSC-XFYACQKRSA-N, SHGAZHPCJJPHSC-XFYACQKRSA-N",Launched,BRD-K95366153-001-02-7
isoxsuprine,adrenergic receptor agonist,ADRB2,"rheumatology, cardiology","Raynaud's disease, arteriosclerosis, Buerger's disease",MicroSource,93.61,BRD-A16700644-003-04-4,CC(COc1ccccc1)NC(C)[C@H](O)c1ccc(O)cc1,BMUKKTUHUDJSNZ-JRSKDTKFSA-N,Launched,
isradipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2",cardiology,hypertension,"Tocris, MicroSource, Selleck, Tocris",97.4,"BRD-A90799790-001-20-7, BRD-A90799790-001-19-9, BRD-A90799790-001-16-5, BRD-A90799790-001-17-3","COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1cccc2nonc12)C(=O)OC(C)C","HMJIYCCIJYRONP-UHFFFAOYSA-N, HMJIYCCIJYRONP-UHFFFAOYSA-N, HMJIYCCIJYRONP-UHFFFAOYSA-N, HMJIYCCIJYRONP-UHFFFAOYSA-N",Launched,
istradefylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3",neurology/psychiatry,"Parkinson's Disease, dyskinesia","MedChemEx, MedChemEx, MedChemEx, Selleck, Selleck",95.36,"BRD-K87774949-001-06-2, BRD-K87774949-001-05-4, BRD-K87774949-001-07-0, BRD-K87774949-001-03-9, BRD-K87774949-001-04-7","CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O, CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O, CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O, CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O, CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O","IQVRBWUUXZMOPW-PKNBQFBNSA-N, IQVRBWUUXZMOPW-PKNBQFBNSA-N, IQVRBWUUXZMOPW-PKNBQFBNSA-N, IQVRBWUUXZMOPW-PKNBQFBNSA-N, IQVRBWUUXZMOPW-PKNBQFBNSA-N",Launched,
itopride,dopamine receptor antagonist,"CHRM3, DRD2","gastroenterology, neurology/psychiatry","dyspepsia, gastroparesis, heartburn, nausea, vomiting, anorexia",MicroSource,96.72,BRD-K96740444-001-02-1,COc1ccc(cc1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,QQQIECGTIMUVDS-UHFFFAOYSA-N,Launched,
itraconazole,cytochrome P450 inhibitor,CYP51A1,infectious disease,"onychomycosis, histoplasmosis, blastomycosis, aspergillosis","MicroSource, Selleck, Selleck",89.77,"BRD-A23067620-300-01-3, BRD-A23067620-001-04-1, BRD-A23067620-001-03-3","CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O, CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O, CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O","VHVPQPYKVGDNFY-ZPGVKDDISA-N, VHVPQPYKVGDNFY-ZPGVKDDISA-N, VHVPQPYKVGDNFY-ZPGVKDDISA-N",Launched,
ivabradine,"HCN channel antagonist, potassium channel blocker, sodium channel blocker","HCN1, HCN3, HCN4",cardiology,angina pectoris,Selleck,96.65,BRD-K31385749-003-01-3,COc1cc2C[C@@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,ACRHBAYQBXXRTO-NRFANRHFSA-N,Launched,
ivacaftor,CFTR channel potentiator,CFTR,pulmonary,cystic fibrosis,Selleck,98.82,BRD-K52818472-001-02-2,CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C,PURKAOJPTOLRMP-UHFFFAOYSA-N,Launched,
ivermectin,benzodiazepine receptor agonist,"CHRNA7, GABRB3, GLRA3, P2RX7",infectious disease,"gastrointestinal roundworms, lungworms, cattle grubs, mites, lice, horn flies","Tocris, MicroSource, Selleck, Selleck",94.01,"BRD-K85554912-001-05-5, BRD-K85554912-001-08-9, BRD-K85554912-001-06-3, BRD-K85554912-001-07-1","CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2, CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2, CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2, CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C\C=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2","AZSNMRSAGSSBNP-XPNPUAGNSA-N, AZSNMRSAGSSBNP-XPNPUAGNSA-N, AZSNMRSAGSSBNP-XPNPUAGNSA-N, AZSNMRSAGSSBNP-XPNPUAGNSA-N",Launched,"BRD-M44211600-001-01-6, BRD-A48570745-001-02-9, BRD-K71544586-001-01-6"
ivosidenib,isocitrate dehydrogenase inhibitor,IDH1,hematologic malignancy,acute myeloid leukemia (AML),MedChemEx,96.63,BRD-K93073858-001-01-1,Fc1cncc(c1)N([C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl)C(=O)[C@@H]1CCC(=O)N1c1cc(ccn1)C#N,WIJZXSAJMHAVGX-DHLKQENFSA-N,Launched,
ixabepilone,microtubule stabilizing agent,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",oncology,breast cancer,MedChemEx,98.98,BRD-K03601870-001-01-2,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1,FABUFPQFXZVHFB-PVYNADRNSA-N,Launched,
ixazomib,proteasome inhibitor,,hematologic malignancy,multiple myeloma,Selleck,93.99,BRD-K78659596-001-03-9,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,MXAYKZJJDUDWDS-LBPRGKRZSA-N,Launched,
ixazomib-citrate,proteasome inhibitor,,hematologic malignancy,multiple myeloma,Selleck,92.47,BRD-A66419424-001-02-4,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(O)=O)(O1)C(O)=O,YTXSYWAKVMZICI-PVCZSOGJSA-N,Launched,
josamycin,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bronchitis,Prestwick,90.23,BRD-K25837718-001-03-8,CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O,UKNSBNVKSFTZOJ-NGVXBBESSA-N,Launched,
kanamycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,"MedChemEx, MedChemEx, MicroSource",0,"BRD-K08327065-065-05-0, BRD-K08327065-065-04-3, BRD-K08327065-065-06-8","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O, NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O, NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","SBUJHOSQTJFQJX-NOAMYHISSA-N, SBUJHOSQTJFQJX-NOAMYHISSA-N, SBUJHOSQTJFQJX-NOAMYHISSA-N",Launched,BRD-A53533407-065-04-9
ketanserin,serotonin receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2",cardiology,hypertension,"MicroSource, Tocris, Selleck",98.5,"BRD-K49671696-046-01-8, BRD-K49671696-045-08-5, BRD-K49671696-001-05-4","Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1, Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1, Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1","FPCCSQOGAWCVBH-UHFFFAOYSA-N, FPCCSQOGAWCVBH-UHFFFAOYSA-N, FPCCSQOGAWCVBH-UHFFFAOYSA-N",Launched,
ketoconazole,sterol demethylase inhibitor,"AR, CYP19A1, CYP21A2, KCNA10",dermatology,seborrheic dermatitis,"Selleck, Tocris, Selleck, MicroSource",95.89,"BRD-K29113274-001-28-3, BRD-K29113274-001-27-5, BRD-K29113274-001-26-7, BRD-A38350138-001-04-9","CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1, CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1, CC(=O)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1, CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1","XMAYWYJOQHXEEK-OZXSUGGESA-N, XMAYWYJOQHXEEK-OZXSUGGESA-N, XMAYWYJOQHXEEK-OZXSUGGESA-N, XMAYWYJOQHXEEK-NASUQTAISA-N",Launched,
ketoprofen,cyclooxygenase inhibitor,"CXCR1, PTGS1, PTGS2, SLC5A8",rheumatology,"rheumatoid arthritis, osteoarthritis","Selleck, MicroSource",99.39,"BRD-A97739905-001-25-7, BRD-A97739905-001-26-5","CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1, CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1","DKYWVDODHFEZIM-UHFFFAOYSA-N, DKYWVDODHFEZIM-UHFFFAOYSA-N",Launched,
ketorolac,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,"MicroSource, Selleck, Selleck",95.72,"BRD-A40639672-234-18-0, BRD-A40639672-234-17-2, BRD-A40639672-001-01-9","OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1, OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1, OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1","OZWKMVRBQXNZKK-UHFFFAOYSA-N, OZWKMVRBQXNZKK-UHFFFAOYSA-N, OZWKMVRBQXNZKK-UHFFFAOYSA-N",Launched,
ketotifen,"histamine receptor agonist, leukotriene receptor antagonist, phosphodiesterase inhibitor","HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD",neurology/psychiatry,itching,"Tocris, MicroSource, Selleck",98.24,"BRD-K28936863-051-32-2, BRD-K28936863-051-33-0, BRD-K28936863-051-31-4","CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12, CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12, CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12","ZCVMWBYGMWKGHF-UHFFFAOYSA-N, ZCVMWBYGMWKGHF-UHFFFAOYSA-N, ZCVMWBYGMWKGHF-UHFFFAOYSA-N",Launched,
kinetin,cell division inducer,,dermatology,sunburn,Selleck,97.88,BRD-K65667145-001-14-0,C(Nc1ncnc2[nH]cnc12)c1ccco1,QANMHLXAZMSUEX-UHFFFAOYSA-N,Launched,
L-alanine,,,,,Sigma,0,BRD-K25125382-001-02-5,C[C@H](N)C(O)=O,QNAYBMKLOCPYGJ-REOHCLBHSA-N,Launched,
L-Arginine,nitric oxide precursor,"ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4","cardiology, neurology/psychiatry, urology, obstetrics/gynecology, otolaryngology","congestive heart failure, hypertension, coronary artery disease (CAD), claudication, senile dementia, erectile dysfunction, infertility, common cold",Selleck,100,BRD-K76811153-003-01-3,N[C@H](CCCNC(N)=N)C(O)=O,ODKSFYDXXFIFQN-SCSAIBSYSA-N,Launched,
L-Aspartic-Acid,metallic radical formation stimulant,"ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13",,,"Sigma, Enzo",98.1,"BRD-K97163964-001-04-1, BRD-K97163964-001-03-3","N[C@@H](CC(O)=O)C(O)=O, N[C@@H](CC(O)=O)C(O)=O","CKLJMWTZIZZHCS-REOHCLBHSA-N, CKLJMWTZIZZHCS-REOHCLBHSA-N",Launched,
L-Citrulline,nitric oxide stimulant,"ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6","cardiology, urology","hypertension, erectile dysfunction",Vitas-M,100,BRD-A12237696-001-04-2,NC(CCCNC(N)=O)C(O)=O,RHGKLRLOHDJJDR-UHFFFAOYSA-N,Launched,
L-cysteine,,"CARS, CARS2, CBS, CDO-1, CDO1, CSAD, CTH, GCLC, GCLM, GOT1, GSS, MGMT, NFS1, SLC19A3",,,Sigma,0,BRD-K00795468-001-02-1,N[C@@H](CS)C(O)=O,XUJNEKJLAYXESH-REOHCLBHSA-N,Launched,
L-Cystine,,"CTNS, SLC3A1, SLC7A11, SLC7A9",,,"Enamine, Enamine, Sigma",0,"BRD-A15397381-001-02-5, BRD-A15397381-001-03-3, BRD-K99679910-001-02-3","NC(CSSCC(N)C(O)=O)C(O)=O, NC(CSSCC(N)C(O)=O)C(O)=O, N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O","LEVWYRKDKASIDU-UHFFFAOYSA-N, LEVWYRKDKASIDU-UHFFFAOYSA-N, LEVWYRKDKASIDU-IMJSIDKUSA-N",Launched,
L-glutamic-acid,glutamate receptor agonist,"AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT",,,Sigma,98.26,BRD-K62309135-001-05-2,N[C@@H](CCC(O)=O)C(O)=O,WHUUTDBJXJRKMK-VKHMYHEASA-N,Launched,BRD-M12235055-001-06-2
L-Hydroxyproline,,,,,Enamine,0,BRD-A12454076-001-01-9,OC1CNC(C1)C(O)=O,PMMYEEVYMWASQN-UHFFFAOYSA-N,Launched,
L-methionine,voltage-gated calcium channel ligand,,,,Sigma,97.7,BRD-K06502269-001-02-6,CSCC[C@H](N)C(O)=O,FFEARJCKVFRZRR-BYPYZUCNSA-N,Launched,
L-proline,glutamate receptor agonist,"EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7",,,Sigma,99.2,BRD-K01666412-001-02-0,OC(=O)[C@@H]1CCCN1,ONIBWKKTOPOVIA-BYPYZUCNSA-N,Launched,
L-Theanine,glutamate receptor antagonist,,,,Enzo,100,BRD-A08715367-001-01-7,CCNC(=O)CCC(N)C(O)=O,DATAGRPVKZEWHA-UHFFFAOYSA-N,Launched,
labetalol,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2",cardiology,hypertension,MicroSource,95.95,BRD-A07440155-003-25-4,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,SGUAFYQXFOLMHL-UHFFFAOYSA-N,Launched,
lacidipine,calcium channel blocker,CACNA1C,cardiology,hypertension,Selleck,95.57,BRD-K43586850-001-02-9,CCOC(=O)C1=C(C)NC(C)=C(C1c1ccccc1\C=C\C(=O)OC(C)(C)C)C(=O)OCC,GKQPCPXONLDCMU-CCEZHUSRSA-N,Launched,
lacitol,osmosis stimulant,,gastroenterology,constipation,"MicroSource, MicroSource",100,"BRD-K40787673-001-02-1, BRD-K40787673-001-01-3","OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO, OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO","VQHSOMBJVWLPSR-JVCRWLNRSA-N, VQHSOMBJVWLPSR-JVCRWLNRSA-N",Launched,BRD-A34513497-002-02-3
lacosamide,"collapsin response mediator protein inhibitor, collapsin response mediator protein stimulant, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,Enzo,98.58,BRD-K68232650-001-02-2,COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,Launched,
lactulose,laxative,,gastroenterology,portal-systemic encephalopathy (PSE),MicroSource,100,BRD-K77258318-001-04-6,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,JCQLYHFGKNRPGE-FCVZTGTOSA-N,Launched,
lafutidine,histamine receptor antagonist,HRH2,gastroenterology,"duodenal ulcer disease, peptic ulcer disease (PUD)",Selleck,96.82,BRD-A67516570-001-02-8,O=C(CS(=O)Cc1ccco1)NC\C=C/COc1cc(CN2CCCCC2)ccn1,KMZQAVXSMUKBPD-DJWKRKHSSA-N,Launched,
lamivudine,nucleoside reverse transcriptase inhibitor,,infectious disease,"human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS), hepatitis B","MicroSource, Selleck",96.67,"BRD-A02309928-001-04-1, BRD-K02992638-001-11-8","Nc1ccn(C2CSC(CO)O2)c(=O)n1, Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1","JTEGQNOMFQHVDC-UHFFFAOYSA-N, JTEGQNOMFQHVDC-NKWVEPMBSA-N",Launched,
lamotrigine,"serotonin receptor antagonist, sodium channel blocker","SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,"epilepsy, bipolar disorder","MicroSource, Selleck",99.52,"BRD-K93460210-001-23-7, BRD-K93460210-001-22-9","Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl, Nc1nnc(c(N)n1)-c1cccc(Cl)c1Cl","PYZRQGJRPPTADH-UHFFFAOYSA-N, PYZRQGJRPPTADH-UHFFFAOYSA-N",Launched,
landiolol,adrenergic receptor antagonist,ADRB1,cardiology,cardiac arrythmia,AKSci,98.94,BRD-K86436199-003-01-3,CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1,WMDSZGFJQKSLLH-RBBKRZOGSA-N,Launched,
lanoconazole,sterol demethylase inhibitor,,infectious disease,fungal infection,AKSci,96.68,BRD-A54275602-001-01-0,Clc1ccccc1C1CS\C(S1)=C(\C#N)n1ccnc1,ZRTQSJFIDWNVJW-WYMLVPIESA-N,Launched,
lansoprazole,ATPase inhibitor,"ATP4A, ATP4B",gastroenterology,heartburn,"MicroSource, Tocris, Selleck",98.97,"BRD-A49172652-001-28-9, BRD-A49172652-001-27-1, BRD-A49172652-001-26-3","Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1, Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1, Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1","MJIHNNLFOKEZEW-UHFFFAOYSA-N, MJIHNNLFOKEZEW-UHFFFAOYSA-N, MJIHNNLFOKEZEW-UHFFFAOYSA-N",Launched,
lapatinib,EGFR inhibitor,"EGFR, ERBB2",oncology,breast cancer,"Selleck, Selleck, Selleck",97.32,"BRD-K19687926-001-10-8, BRD-K19687926-379-07-4, BRD-K19687926-001-04-1","CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1, CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1, CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1","BCFGMOOMADDAQU-UHFFFAOYSA-N, BCFGMOOMADDAQU-UHFFFAOYSA-N, BCFGMOOMADDAQU-UHFFFAOYSA-N",Launched,
laropiprant,prostanoid receptor antagonist,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R",cardiology,cholesterol,MedChemEx,98.78,BRD-K48894757-001-01-8,CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12,NXFFJDQHYLNEJK-CYBMUJFWSA-N,Launched,
lasalocid,bacterial permeability inducer,,infectious disease,coccidiosis,MicroSource,91.23,BRD-A72711497-236-03-8,CC[C@H](C1OC(CC)(C[C@@H]1C)C1CC[C@](O)(CC)[C@H](C)O1)C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(O)=O,BBMULGJBVDDDNI-YFGMYPSKSA-N,Launched,
lasofoxifene,selective estrogen receptor modulator (SERM),"ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","MedChemEx, MedChemEx",98.71,"BRD-M93148412-001-02-6, BRD-M93148412-001-01-8","O[C@@H]([C@H](O)C(O)=O)C(O)=O.Oc1ccc2[C@H]([C@H](CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1, O[C@@H]([C@H](O)C(O)=O)C(O)=O.Oc1ccc2[C@H]([C@H](CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1","INEHJXCWEVNEDZ-LUDNRVPPSA-N, INEHJXCWEVNEDZ-LUDNRVPPSA-N",Launched,
latanoprost,prostanoid receptor agonist,PTGFR,ophthalmology,"ocular hypertension, glaucoma",Enzo,98.27,BRD-K10961822-001-05-1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,GGXICVAJURFBLW-CEYXHVGTSA-N,Launched,
LCZ696,angiotensin receptor antagonist,,cardiology,"angioedema, hypotension","MedChemEx, MedChemEx, MedChemEx, Selleck",61.98,"BRD-M31057929-314-01-9, BRD-M31057929-001-01-2, BRD-M31057929-385-01-9, BRD-M31057929-447-01-7","CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O, CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O, CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O, CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)[C@@H](C(C)C)C(O)=O","XTKIDERFOUYBDE-QEPKIHTBSA-N, XTKIDERFOUYBDE-QEPKIHTBSA-N, XTKIDERFOUYBDE-QEPKIHTBSA-N, XTKIDERFOUYBDE-QEPKIHTBSA-N",Launched,"BRD-M75836831-385-01-0, BRD-M42331949-431-01-3"
ledipasvir,HCV inhibitor,,infectious disease,hepatitis C,MedChemEx,94.99,BRD-K05446112-001-01-8,COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1ncc([nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2nc([nH]c2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C,VRTWBAAJJOHBQU-KMWAZVGDSA-N,Launched,
leflunomide,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor","AHR, DHODH, PTK2B",rheumatology,rheumatoid arthritis,"MicroSource, Tocris, Selleck",94.48,"BRD-K78692225-001-24-5, BRD-K78692225-001-23-7, BRD-K78692225-001-22-9","Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F, Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F, Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F","VHOGYURTWQBHIL-UHFFFAOYSA-N, VHOGYURTWQBHIL-UHFFFAOYSA-N, VHOGYURTWQBHIL-UHFFFAOYSA-N",Launched,
lenalidomide,anticancer agent,"CDH5, CRBN, PTGS2, TNF, TNFSF11",hematologic malignancy,"multiple myeloma, mantle cell lymphoma (MCL), myelodysplastic diseases (MDS)",Selleck,98.9,BRD-A17883755-001-06-1,Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O,GOTYRUGSSMKFNF-UHFFFAOYSA-N,Launched,
lenvatinib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FLT4, KDR",oncology,thyroid cancer,Selleck,98.78,BRD-K39974922-001-04-3,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Launched,
lercanidipine,calcium channel blocker,"CACNA2D1, CACNG1",cardiology,hypertension,Sigma,98.03,BRD-A18992208-003-02-7,COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c1ccccc1,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,Launched,
lesinurad,uric acid diuretic,SLC22A12,rheumatology,gout,MedChemEx,85.07,BRD-K75024268-001-01-0,OC(=O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12,FGQFOYHRJSUHMR-UHFFFAOYSA-N,Launched,
letosteine,mucolytic agent,,"pulmonary, infectious disease","bronchitis, pneumonia",AKSci,96.97,BRD-A32597168-001-03-6,CCOC(=O)CSCCC1NC(CS1)C(O)=O,IKOCLISPVJZJEA-UHFFFAOYSA-N,Launched,
letrozole,aromatase inhibitor,CYP19A1,oncology,breast cancer,"Tocris, Selleck",96.85,"BRD-K88789588-001-16-4, BRD-K88789588-001-14-9","N#Cc1ccc(cc1)C(c1ccc(cc1)C#N)n1cncn1, N#Cc1ccc(cc1)C(c1ccc(cc1)C#N)n1cncn1","HPJKCIUCZWXJDR-UHFFFAOYSA-N, HPJKCIUCZWXJDR-UHFFFAOYSA-N",Launched,
leucovorin,folate receptor ligand,TYMS,oncology,osteosarcoma,"Selleck, Selleck, MicroSource",97.3,"BRD-A75919782-399-02-6, BRD-A75919782-399-03-4, BRD-A75919782-238-08-3","Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1, Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1, Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2[nH]1","VVIAGPKUTFNRDU-ABLWVSNPSA-N, VVIAGPKUTFNRDU-ABLWVSNPSA-N, VVIAGPKUTFNRDU-ABLWVSNPSA-N",Launched,
leuprolide,gonadotropin releasing factor hormone receptor agonist,GNRHR,oncology,prostate cancer,Sigma,93.87,BRD-K26323068-001-01-8,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,GFIJNRVAKGFPGQ-LIJARHBVSA-N,Launched,
levalbuterol,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm,MicroSource,97.04,BRD-K34469523-003-03-0,CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1,NDAUXUAQIAJITI-LBPRGKRZSA-N,Launched,
levallorphan,opioid antagonist,"CHRNA2, OPRM1",pulmonary,respiratory depression,Enzo,93.45,BRD-K30634073-046-01-0,Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1,OZYUPQUCAUTOBP-QXAKKESOSA-N,Launched,
levetiracetam,calcium channel blocker,"CACNA1B, SCN1A, SV2A",neurology/psychiatry,seizures,"Selleck, Tocris, MicroSource, Selleck",95.46,"BRD-K49404994-001-11-7, BRD-K49404994-001-13-3, BRD-K49404994-001-10-9, BRD-K49404994-001-09-1","CC[C@H](N1CCCC1=O)C(N)=O, CC[C@H](N1CCCC1=O)C(N)=O, CC[C@H](N1CCCC1=O)C(N)=O, CC[C@H](N1CCCC1=O)C(N)=O","HPHUVLMMVZITSG-LURJTMIESA-N, HPHUVLMMVZITSG-LURJTMIESA-N, HPHUVLMMVZITSG-LURJTMIESA-N, HPHUVLMMVZITSG-LURJTMIESA-N",Launched,
levo-phencynonate,acetylcholine receptor antagonist,CHRM1,,,ChemPacific,87.3,BRD-A64698388-003-01-7,CN1CC2CCCC(C1)C2OC(=O)C(O)(C1CCCC1)c1ccccc1,ROZOEEGFKDFEFP-UHFFFAOYSA-N,Launched,
levobetaxolol,adrenergic receptor antagonist,"ADRB1, ADRB2",ophthalmology,"intraocular pressure, glaucoma",Selleck,94.07,BRD-K43883465-003-01-5,CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,NWIUTZDMDHAVTP-KRWDZBQOSA-N,Launched,
levobunolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3",ophthalmology,"glaucoma, ocular hypertension","Prestwick, Enzo",99.36,"BRD-K31812033-003-11-0, BRD-K31812033-003-10-2","CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12, CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12","IXHBTMCLRNMKHZ-LBPRGKRZSA-N, IXHBTMCLRNMKHZ-LBPRGKRZSA-N",Launched,
levocabastine,histamine receptor antagonist,"HRH1, NTSR2",ophthalmology,conjunctivitis,Prestwick,98.8,BRD-K33453211-003-11-5,C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1,ZCGOMHNNNFPNMX-KYTRFIICSA-N,Launched,
levocarnitine,,,endocrinology,carnitine deficiency,"MicroSource, Selleck",100,"BRD-K59647213-001-10-5, BRD-K59647213-001-09-7","C[N+](C)(C)C[C@H](O)CC(O)=O, C[N+](C)(C)C[C@H](O)CC(O)=O","PHIQHXFUZVPYII-ZCFIWIBFSA-O, PHIQHXFUZVPYII-ZCFIWIBFSA-O",Launched,
levocarnitine-propionate,carnitine palmitoyltransferase inhibitor,CRAT,"neurology/psychiatry, endocrinology","peripheral neuropathy, carnitine deficiency",MedChemEx,61.9,BRD-K84366268-003-01-0,CCC(=O)O[C@H](CC(O)=O)C[N+](C)(C)C,UFAHZIUFPNSHSL-MRVPVSSYSA-O,Launched,
levocetirizine,histamine receptor antagonist,HRH1,allergy,"allergic rhinitis, urticaria",MicroSource,94.6,BRD-K27184429-300-01-3,OC(=O)COCCN1CCN(CC1)[C@H](c1ccccc1)c1ccc(Cl)cc1,ZKLPARSLTMPFCP-OAQYLSRUSA-N,Launched,BRD-K18097163-300-02-6
levodopa,dopamine precursor,"DRD1, DRD2, DRD3, DRD4, DRD5, GPR143",neurology/psychiatry,Parkinson's Disease,"Selleck, MicroSource, Selleck",92.55,"BRD-K34730807-001-17-6, BRD-K34730807-001-16-8, BRD-K34730807-001-15-0","N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O, N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O, N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O","WTDRDQBEARUVNC-LURJTMIESA-N, WTDRDQBEARUVNC-LURJTMIESA-N, WTDRDQBEARUVNC-LURJTMIESA-N",Launched,
levodropropizine,antitussive,,pulmonary,cough suppressant,"Selleck, Selleck",95.16,"BRD-K83551379-001-02-6, BRD-K83551379-001-01-8","OC[C@@H](O)CN1CCN(CC1)c1ccccc1, OC[C@@H](O)CN1CCN(CC1)c1ccccc1","PTVWPYVOOKLBCG-ZDUSSCGKSA-N, PTVWPYVOOKLBCG-ZDUSSCGKSA-N",Launched,BRD-K60537263-001-01-3
levofloxacin,bacterial DNA gyrase inhibitor,TOP2A,"infectious disease, otolaryngology, pulmonary, urology","pneumonia, sinusitis, bronchitis, skin infections, prostatitis, urinary tract infections, pyelonephritis, anthrax, plague","MicroSource, Selleck",97.7,"BRD-K09471561-001-18-2, BRD-K09471561-001-20-8","C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O, C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O","GSDSWSVVBLHKDQ-JTQLQIEISA-N, GSDSWSVVBLHKDQ-JTQLQIEISA-N",Launched,BRD-K88565300-001-01-7
levomenol,,,"neurology/psychiatry, infectious disease","spasms, skin infections",Sigma,0,BRD-K62751771-001-01-3,CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1,RGZSQWQPBWRIAQ-CABCVRRESA-N,Launched,
levomenthol,,"OPRK1, TRPA1, TRPM8, TRPV3",neurology/psychiatry,pain relief,"MicroSource, Sigma, Sigma",32.51,"BRD-K50329370-001-08-2, BRD-A54393207-001-03-6, BRD-K50329370-001-09-0","CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O, CC(C)C1CCC(C)CC1O, CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O","NOOLISFMXDJSKH-KXUCPTDWSA-N, NOOLISFMXDJSKH-UHFFFAOYSA-N, NOOLISFMXDJSKH-KXUCPTDWSA-N",Launched,
levomepromazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C","neurology/psychiatry, gastroenterology","psychosis, schizophrenia, bipolar disorder, nausea, insomnia","Prestwick, Sigma",96.44,"BRD-K35559145-050-08-5, BRD-K35559145-001-01-3","COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1, COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1","VRQVVMDWGGWHTJ-CQSZACIVSA-N, VRQVVMDWGGWHTJ-CQSZACIVSA-N",Launched,
levonordefrin,vasodilator,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, SLC6A2",hematology,hemorrhage,"Sigma, MicroSource",0,"BRD-K02976377-001-08-2, BRD-K02976377-001-07-4","C[C@H](N)[C@H](O)c1ccc(O)c(O)c1, C[C@H](N)[C@H](O)c1ccc(O)c(O)c1","GEFQWZLICWMTKF-CDUCUWFYSA-N, GEFQWZLICWMTKF-CDUCUWFYSA-N",Launched,
levonorgestrel,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","AR, ESR1, PGR, SRD5A1",endocrinology,contraceptive,"Tocris, Selleck, Selleck, MicroSource",98.56,"BRD-K35189033-001-28-7, BRD-K35189033-001-30-3, BRD-K35189033-001-29-5, BRD-K35189033-001-26-1","CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C","WWYNJERNGUHSAO-XUDSTZEESA-N, WWYNJERNGUHSAO-XUDSTZEESA-N, WWYNJERNGUHSAO-XUDSTZEESA-N, WWYNJERNGUHSAO-XUDSTZEESA-N",Launched,"BRD-K10086084-001-02-7, BRD-K10086084-001-01-9"
levopropoxyphene,antitussive,"OPRD1, OPRK1, OPRM1",pulmonary,cough suppressant,Prestwick,28.74,BRD-A54635441-078-09-1,CCC(=O)OC(Cc1ccccc1)(C(C)CN(C)C)c1ccccc1,XLMALTXPSGQGBX-UHFFFAOYSA-N,Launched,
levosimendan,calcium sensitizer,"KCNJ11, KCNJ8, PDE3A, TNNC1",cardiology,congestive heart failure,"Selleck, MicroSource",99.1,"BRD-K03095347-001-05-3, BRD-K03095347-001-06-1","C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1, C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1","WHXMKTBCFHIYNQ-SECBINFHSA-N, WHXMKTBCFHIYNQ-SECBINFHSA-N",Launched,
levosulpiride,dopamine receptor antagonist,"CA1, CA12, CA7, DRD2, DRD3","neurology/psychiatry, gastroenterology, urology","schizophrenia, psychosis, anxiety, vertigo, dyspepsia, irritable bowel syndrome, premature ejaculation (PE)","Tocris, Selleck, Tocris",98.1,"BRD-K51671335-001-12-2, BRD-K51671335-001-09-8, BRD-K51671335-001-10-6","CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O, CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O, CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O","BGRJTUBHPOOWDU-NSHDSACASA-N, BGRJTUBHPOOWDU-NSHDSACASA-N, BGRJTUBHPOOWDU-NSHDSACASA-N",Launched,
levothyroxine,thyroid hormone stimulant,"THRA, THRB",endocrinology,myxedema coma,"Selleck, MicroSource, Selleck, Sigma",96.14,"BRD-K30685142-001-16-2, BRD-K30685142-001-15-4, BRD-K30685142-001-14-7, BRD-K30685142-001-17-0","N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O, N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O, N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O, N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O","XUIIKFGFIJCVMT-LBPRGKRZSA-N, XUIIKFGFIJCVMT-LBPRGKRZSA-N, XUIIKFGFIJCVMT-LBPRGKRZSA-N, XUIIKFGFIJCVMT-LBPRGKRZSA-N",Launched,
lidamidine,adrenergic receptor agonist,,gastroenterology,diarrhea,ChemDiv,93.96,BRD-K68693535-001-03-4,CNC(=N)NC(=O)Nc1c(C)cccc1C,RRHJHSBDJDZUGL-UHFFFAOYSA-N,Launched,
lidocaine,histamine receptor agonist,"EGFR, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","neurology/psychiatry, dermatology, hematology","itching, eczema, hemorrhage","Selleck, MicroSource",99.22,"BRD-K52662033-001-19-0, BRD-K52662033-003-21-2","CCN(CC)CC(=O)Nc1c(C)cccc1C, CCN(CC)CC(=O)Nc1c(C)cccc1C","NNJVILVZKWQKPM-UHFFFAOYSA-N, NNJVILVZKWQKPM-UHFFFAOYSA-N",Launched,
lidoflazine,calcium channel blocker,"SCN1A, SCN3A, SLC29A1",,,Prestwick,97.89,BRD-K62996583-001-10-3,Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Launched,
limaprost-alfadex,prostanoid receptor agonist,PTGER1,cardiology,claudication,"MedChemEx, MedChemEx",93.26,"BRD-K25015158-001-01-2, BRD-K25015158-001-02-0","CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O, CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O","OJZYRQPMEIEQFC-UAWLTFRCSA-N, OJZYRQPMEIEQFC-UAWLTFRCSA-N",Launched,
linaclotide,guanylate cyclase activator,GUCY2C,gastroenterology,"irritable bowel syndrome, constipation",MedChemEx,0,BRD-A55468767-001-01-1,C[C@@H](O)C1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2,KXGCNMMJRFDFNR-IURAOCFRSA-N,Launched,
linagliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,"MicroSource, MicroSource, Selleck, Selleck",88.62,"BRD-K96550715-003-01-4, BRD-K96550715-001-03-4, BRD-K96550715-001-04-2, BRD-K96550715-001-02-6","CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1, CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1, CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1, CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1","LTXREWYXXSTFRX-QGZVFWFLSA-N, LTXREWYXXSTFRX-QGZVFWFLSA-N, LTXREWYXXSTFRX-QGZVFWFLSA-N, LTXREWYXXSTFRX-QGZVFWFLSA-N",Launched,BRD-A23155464-001-01-9
lincomycin,bacterial 30S ribosomal subunit inhibitor,,gastroenterology,enteritis,"Selleck, MicroSource, Selleck",94.94,"BRD-K81447180-003-21-4, BRD-K08033334-003-04-3, BRD-K81447180-001-01-0","CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O, CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]1O","OJMMVQQUTAEWLP-HZUSHKNOSA-N, OJMMVQQUTAEWLP-LPSAIEBYSA-N, OJMMVQQUTAEWLP-HZUSHKNOSA-N",Launched,BRD-K99816398-003-01-0
lindane,,"GABRB1, GLRA1, GLRA2, GLRA3, GLRB",infectious disease,scabies,"MedChemEx, MedChemEx, MicroSource",0,"BRD-K93814253-001-06-8, BRD-K93814253-001-05-0, BRD-K93814253-001-04-3","Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl, Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl, Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl","JLYXXMFPNIAWKQ-GNIYUCBRSA-N, JLYXXMFPNIAWKQ-GNIYUCBRSA-N, JLYXXMFPNIAWKQ-GNIYUCBRSA-N",Launched,
linezolid,bacterial 50S ribosomal subunit inhibitor,"MAOA, MAOB",infectious disease,"pneumonia, skin infections","Tocris, MicroSource, Selleck",98.39,"BRD-K66876909-001-15-9, BRD-K66876909-001-12-6, BRD-K66876909-001-11-8","CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1, CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1, CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1","TYZROVQLWOKYKF-ZDUSSCGKSA-N, TYZROVQLWOKYKF-ZDUSSCGKSA-N, TYZROVQLWOKYKF-ZDUSSCGKSA-N",Launched,
linsidomine,nitric oxide donor,,urology,erectile dysfunction,"EMDBio, Cayman",94.73,"BRD-K86344238-003-04-6, BRD-K86344238-003-03-8","Nc1c[n+](no1)N1CCOCC1, Nc1c[n+](no1)N1CCOCC1","XZYRDNUZENBYFI-UHFFFAOYSA-N, XZYRDNUZENBYFI-UHFFFAOYSA-N",Launched,BRD-K72922393-003-15-2
liothyronine,thyroid hormone stimulant,"THRA, THRB",endocrinology,"hypothyroidism, myxedema coma","MicroSource, Selleck, Selleck",87.3,"BRD-K89152108-236-06-8, BRD-K89152108-236-05-0, BRD-K89152108-236-07-6","N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O, N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O, N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O","AUYYCJSJGJYCDS-LBPRGKRZSA-N, AUYYCJSJGJYCDS-LBPRGKRZSA-N, AUYYCJSJGJYCDS-LBPRGKRZSA-N",Launched,
liraglutide,GLP receptor agonist,GLP1R,endocrinology,"weight-loss aid, diabetes mellitus",MedChemEx,83.15,BRD-A48274390-001-01-8,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O,YSDQQAXHVYUZIW-UHFFFAOYSA-N,Launched,
liranaftate,fungal squalene epoxidase inhibitor,,infectious disease,fungal infection,Selleck,97.22,BRD-K35775715-001-03-1,COc1cccc(n1)N(C)C(=S)Oc1ccc2CCCCc2c1,VPHPQNGOVQYUMG-UHFFFAOYSA-N,Launched,
lisadimate,topical sunscreen agent,,dermatology,sunscreen lotion,Sigma,78.91,BRD-A76533773-001-01-9,Nc1ccc(cc1)C(=O)OCC(O)CO,WHQOKFZWSDOTQP-UHFFFAOYSA-N,Launched,
lisinopril,angiotensin converting enzyme inhibitor,"ACE, ACE2","cardiology, endocrinology","hypertension, congestive heart failure, diabetes mellitus","Selleck, MicroSource, Selleck",100,"BRD-K67966701-001-10-8, BRD-K67966701-001-11-6, BRD-K67966701-001-12-4","NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O, NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O","RLAWWYSOJDYHDC-BZSNNMDCSA-N, RLAWWYSOJDYHDC-BZSNNMDCSA-N, RLAWWYSOJDYHDC-BZSNNMDCSA-N",Launched,
lisuride,dopamine receptor agonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6",neurology/psychiatry,Parkinson's Disease,Enzo,92.31,BRD-K67943528-050-01-4,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Launched,
lithium-citrate,,,neurology/psychiatry,"bipolar disorder, depression","MicroSource, Selleck, Selleck",0,"BRD-M41245765-001-04-2, BRD-M41245765-001-05-9, BRD-M41245765-001-03-4","[Li].[Li].[Li].OC(=O)CC(O)(CC(O)=O)C(O)=O, [Li].[Li].[Li].OC(=O)CC(O)(CC(O)=O)C(O)=O, [Li].[Li].[Li].OC(=O)CC(O)(CC(O)=O)C(O)=O","PTYJGLZVOMGTRG-UHFFFAOYSA-N, PTYJGLZVOMGTRG-UHFFFAOYSA-N, PTYJGLZVOMGTRG-UHFFFAOYSA-N",Launched,BRD-M83658881-001-01-0
lobeline,acetylcholine receptor antagonist,"CHRNA10, CHRNA9, SLC18A2",neurology/psychiatry,smoking cessation,"MedChemEx, MicroSource, Tocris, Sigma, MedChemEx",65.76,"BRD-K66206289-003-22-1, BRD-A65243462-003-04-4, BRD-K66206289-003-20-5, BRD-K66206289-065-01-4, BRD-K66206289-003-21-3","CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1, CN1C(CC(O)c2ccccc2)CCCC1CC(=O)c1ccccc1, CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1, CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1, CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1","MXYUKLILVYORSK-HBMCJLEFSA-N, MXYUKLILVYORSK-UHFFFAOYSA-N, MXYUKLILVYORSK-HBMCJLEFSA-N, MXYUKLILVYORSK-HBMCJLEFSA-N, MXYUKLILVYORSK-HBMCJLEFSA-N",Launched,BRD-M82226456-065-01-7
lobenzarit,immunosuppressant,,rheumatology,rheumatoid arthritis,AKSci,98.34,BRD-K55847762-304-01-7,OC(=O)c1ccccc1Nc1cc(Cl)ccc1C(O)=O,UGDPYGKWIHHBMB-UHFFFAOYSA-N,Launched,
lodoxamide,histamine receptor antagonist,,ophthalmology,vernal keratoconjunctivitis (VKC),Prestwick,94.05,BRD-K66937583-001-01-2,OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N,RVGLGHVJXCETIO-UHFFFAOYSA-N,Launched,
lofepramine,"norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)","HTR1A, SLC6A2, SLC6A4",neurology/psychiatry,depression,"Tocris, Key",46.37,"BRD-K82147103-001-02-7, BRD-K82147103-003-05-6","CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1, CN(CCCN1c2ccccc2CCc2ccccc12)CC(=O)c1ccc(Cl)cc1","SAPNXPWPAUFAJU-UHFFFAOYSA-N, SAPNXPWPAUFAJU-UHFFFAOYSA-N",Launched,
lofexidine,adrenergic receptor agonist,ADRA2A,neurology/psychiatry,opioid withdrawal,"Selleck, MicroSource",97.02,"BRD-A02990301-003-05-8, BRD-A02990301-003-06-6","CC(Oc1c(Cl)cccc1Cl)C1=NCCN1, CC(Oc1c(Cl)cccc1Cl)C1=NCCN1","KSMAGQUYOIHWFS-UHFFFAOYSA-N, KSMAGQUYOIHWFS-UHFFFAOYSA-N",Launched,
lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A,infectious disease,"respiratory tract infections, urinary tract infections","Selleck, MicroSource",98.31,"BRD-A75850590-003-09-8, BRD-A75850590-213-01-0","CCn1cc(C(O)=O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12, CCn1cc(C(O)=O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12","ZEKZLJVOYLTDKK-UHFFFAOYSA-N, ZEKZLJVOYLTDKK-UHFFFAOYSA-N",Launched,
lomerizine,calcium channel blocker,"CACNA1B, SCN5A",neurology/psychiatry,migraine headache,"MicroSource, Selleck",97.88,"BRD-K62858456-001-01-8, BRD-K62858456-300-01-4","COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC, COc1ccc(CN2CCN(CC2)C(c2ccc(F)cc2)c2ccc(F)cc2)c(OC)c1OC","JQSAYKKFZOSZGJ-UHFFFAOYSA-N, JQSAYKKFZOSZGJ-UHFFFAOYSA-N",Launched,
lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP,endocrinology,hypercholesterolemia,MedChemEx,91.88,BRD-K92213669-001-01-3,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c2ccccc2-c2ccc(cc2)C(F)(F)F)c2ccccc2-c2ccccc12,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Launched,
lomustine,DNA synthesis inhibitor,STMN4,"hematologic malignancy, oncology","Hodgkin's lymphoma, brain tumors","MedChemEx, MedChemEx, Selleck, Selleck, MicroSource",0,"BRD-K51768138-001-10-9, BRD-K51768138-001-09-1, BRD-K51768138-001-04-2, BRD-K51768138-001-07-5, BRD-K51768138-001-05-9","[O-][N+]N(CCCl)C(=O)NC1CCCCC1, [O-][N+]N(CCCl)C(=O)NC1CCCCC1, [O-][N+]N(CCCl)C(=O)NC1CCCCC1, [O-][N+]N(CCCl)C(=O)NC1CCCCC1, [O-][N+]N(CCCl)C(=O)NC1CCCCC1","GQYIWUVLTXOXAJ-UHFFFAOYSA-N, GQYIWUVLTXOXAJ-UHFFFAOYSA-N, GQYIWUVLTXOXAJ-UHFFFAOYSA-N, GQYIWUVLTXOXAJ-UHFFFAOYSA-N, GQYIWUVLTXOXAJ-UHFFFAOYSA-N",Launched,
lonidamine,glucokinase inhibitor,GCK,,,"Tocris, MicroSource, Selleck, Tocris",98.47,"BRD-K78513633-001-16-5, BRD-K78513633-001-15-7, BRD-K78513633-001-13-2, BRD-K78513633-001-14-0","OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12, OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12, OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12, OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12","WDRYRZXSPDWGEB-UHFFFAOYSA-N, WDRYRZXSPDWGEB-UHFFFAOYSA-N, WDRYRZXSPDWGEB-UHFFFAOYSA-N, WDRYRZXSPDWGEB-UHFFFAOYSA-N",Launched,
loperamide,opioid receptor agonist,"CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC",gastroenterology,diarrhea,"Tocris, MicroSource, Selleck",98.87,"BRD-K61250553-003-30-6, BRD-K61250553-003-32-2, BRD-K61250553-003-29-8","CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1, CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1, CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1","RDOIQAHITMMDAJ-UHFFFAOYSA-N, RDOIQAHITMMDAJ-UHFFFAOYSA-N, RDOIQAHITMMDAJ-UHFFFAOYSA-N",Launched,
lopinavir,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),Selleck,98.22,BRD-K99451608-001-07-3,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1,KJHKTHWMRKYKJE-SUGCFTRWSA-N,Launched,
loracarbef,bacterial cell wall synthesis inhibitor,,"infectious disease, otolaryngology, pulmonary","ear infections, laryngitis, bronchitis, pneumonia, urinary tract infections, skin infections","Kemprotec, Prestwick",24.5,"BRD-A04915500-002-01-3, BRD-K28935038-001-02-2","N[C@@H](C(=O)NC1C2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1, N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1","JAPHQRWPEGVNBT-MOENNCHZSA-N, JAPHQRWPEGVNBT-UTUOFQBUSA-N",Launched,
loratadine,histamine receptor antagonist,HRH1,"allergy, neurology/psychiatry","allergic rhinitis, itching","Tocris, MicroSource, Selleck, Tocris",99.62,"BRD-K82795137-001-28-8, BRD-K82795137-001-26-2, BRD-K82795137-001-24-7, BRD-K82795137-001-25-4","CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12, CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12, CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12, CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12","JCCNYMKQOSZNPW-UHFFFAOYSA-N, JCCNYMKQOSZNPW-UHFFFAOYSA-N, JCCNYMKQOSZNPW-UHFFFAOYSA-N, JCCNYMKQOSZNPW-UHFFFAOYSA-N",Launched,
lorazepam,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",neurology/psychiatry,status epilepticus,Enzo,98.57,BRD-A11990600-001-03-4,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,DIWRORZWFLOCLC-UHFFFAOYSA-N,Launched,
lorcaserin,serotonin receptor agonist,"HTR2A, HTR2B, HTR2C",endocrinology,obesity,Selleck,95.01,BRD-K55013654-003-02-3,C[C@H]1CNCCc2ccc(Cl)cc12,XTTZERNUQAFMOF-QMMMGPOBSA-N,Launched,
lornoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2","rheumatology, neurology/psychiatry","osteoarthritis, sciata","Selleck, MicroSource",97.64,"BRD-A90551241-001-09-0, BRD-A90551241-001-10-8","CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O, CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O","QOFQTBTZCJVITI-UHFFFAOYSA-N, QOFQTBTZCJVITI-UHFFFAOYSA-N",Launched,
losartan,angiotensin receptor antagonist,AGTR1,"cardiology, nephrology","hypertension, diabetic nephropathy","MicroSource, Tocris, Selleck, Pharmeks",97.85,"BRD-K76205745-001-06-6, BRD-K76205745-237-19-9, BRD-K76205745-237-16-5, BRD-K76205745-237-18-1","CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1, CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1","PSIFNNKUMBGKDQ-UHFFFAOYSA-N, PSIFNNKUMBGKDQ-UHFFFAOYSA-N, PSIFNNKUMBGKDQ-UHFFFAOYSA-N, PSIFNNKUMBGKDQ-UHFFFAOYSA-N",Launched,
loteprednol,"glucocorticoid receptor agonist, phospholipase inhibitor",NR3C1,ophthalmology,conjunctivitis,"Selleck, Selleck",95.55,"BRD-K39983086-001-06-1, BRD-K39983086-001-07-9","CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl, CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl","DMKSVUSAATWOCU-HROMYWEYSA-N, DMKSVUSAATWOCU-HROMYWEYSA-N",Launched,BRD-K43659793-001-01-6
lovastatin,HMGCR inhibitor,"HDAC2, HMGCR, ITGAL, NR1I2","cardiology, endocrinology","coronary heart disease, myocardial infarction, hypercholesterolemia","Tocris, MicroSource, Selleck, Selleck, Tocris",89.65,"BRD-K09416995-001-43-1, BRD-K09416995-001-39-9, BRD-K09416995-001-44-9, BRD-K09416995-001-40-7, BRD-K09416995-001-38-1","CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12","PCZOHLXUXFIOCF-BXMDZJJMSA-N, PCZOHLXUXFIOCF-BXMDZJJMSA-N, PCZOHLXUXFIOCF-BXMDZJJMSA-N, PCZOHLXUXFIOCF-BXMDZJJMSA-N, PCZOHLXUXFIOCF-BXMDZJJMSA-N",Launched,BRD-K74251557-001-01-0
loxapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,schizophrenia,"MicroSource, Selleck",98.55,"BRD-K39915878-036-25-1, BRD-K39915878-036-24-4","CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12, CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12","XJGVXQDUIWGIRW-UHFFFAOYSA-N, XJGVXQDUIWGIRW-UHFFFAOYSA-N",Launched,
loxoprofen,"cyclooxygenase inhibitor, prostanoid receptor antagonist",PTGS2,neurology/psychiatry,pain relief,"MicroSource, MedChemEx",98.61,"BRD-A43082555-001-02-9, BRD-A43082555-001-01-1","CC(C(O)=O)c1ccc(CC2CCCC2=O)cc1, CC(C(O)=O)c1ccc(CC2CCCC2=O)cc1","YMBXTVYHTMGZDW-UHFFFAOYSA-N, YMBXTVYHTMGZDW-UHFFFAOYSA-N",Launched,BRD-A18039798-001-01-9
lubiprostone,chloride channel activator,CLCN2,gastroenterology,"constipation, irritable bowel syndrome","Selleck, Selleck",98.91,"BRD-K33814251-001-01-4, BRD-K33814251-001-02-2","CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O, CCCCC(F)(F)C(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O","DBVFKLAGQHYVGQ-BFYDXBDKSA-N, DBVFKLAGQHYVGQ-BFYDXBDKSA-N",Launched,BRD-K58693165-001-01-7
lufenuron,chitin inhibitor,,infectious disease,flea control,MicroSource,97.07,BRD-A71774530-001-05-9,FC(C(F)(F)F)C(F)(F)Oc1cc(Cl)c(NC(=O)NC(=O)c2c(F)cccc2F)cc1Cl,PWPJGUXAGUPAHP-UHFFFAOYSA-N,Launched,
luliconazole,sterol demethylase inhibitor,,infectious disease,"tinea pedis, tinea cruris, tinea corporis",Selleck,92.75,BRD-K71058253-001-01-9,Clc1ccc([C@@H]2CS\C(S2)=C(\C#N)n2ccnc2)c(Cl)c1,YTAOBBFIOAEMLL-REQDGWNSSA-N,Launched,
lumacaftor,CFTR channel agonist,CFTR,pulmonary,cystic fibrosis,Selleck,98.26,BRD-K69236721-001-02-7,Cc1ccc(NC(=O)C2(CC2)c2ccc3OC(F)(F)Oc3c2)nc1-c1cccc(c1)C(O)=O,UFSKUSARDNFIRC-UHFFFAOYSA-N,Launched,
lumefantrine,antimalarial agent,ATP1A1,infectious disease,malaria,"MedChemEx, Enamine, MedChemEx",58.57,"BRD-A05926236-001-04-6, BRD-A05926236-001-05-3, BRD-A05926236-001-03-8","CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12, CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12, CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12","DYLGFOYVTXJFJP-MYYYXRDXSA-N, DYLGFOYVTXJFJP-MYYYXRDXSA-N, DYLGFOYVTXJFJP-MYYYXRDXSA-N",Launched,BRD-A58804007-001-01-4
lurasidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7",neurology/psychiatry,schizophrenia,Selleck,97.97,BRD-K51143828-003-03-1,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Launched,
lutein,antioxidant,,ophthalmology,"macular degeneration, cataracts, retinitis pigmentosa (RP)","Sigma, AKSci",0,"BRD-K16742848-001-02-6, BRD-K16742848-001-01-8","CC(\C=C\C=C(C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C, CC(\C=C\C=C(C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C","KBPHJBAIARWVSC-RGZFRNHPSA-N, KBPHJBAIARWVSC-RGZFRNHPSA-N",Launched,
lymecycline,bacterial 50S ribosomal subunit inhibitor,,dermatology,acne vulgaris (AV),Prestwick,0,BRD-A15750551-001-01-1,CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)C1=O,DZTKAWPWXGIREW-UINNQTPFSA-N,Launched,BRD-A58731732-001-04-5
lynestrenol,progestogen hormone,,endocrinology,contraceptive,"Prestwick, Sigma",0,"BRD-K39707084-001-04-1, BRD-K39707084-001-05-8","C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C","YNVGQYHLRCDXFQ-XGXHKTLJSA-N, YNVGQYHLRCDXFQ-XGXHKTLJSA-N",Launched,
lypressin,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2",,,Apollo,70.31,BRD-K93331255-001-02-0,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BJFIDCADFRDPIO-DZCXQCEKSA-N,Launched,
mabuprofen,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief,Enamine,91.14,BRD-A93683007-001-01-9,CC(C)Cc1ccc(cc1)C(C)C(=O)NCCO,JVGUNCHERKJFCM-UHFFFAOYSA-N,Launched,
mabuterol,adrenergic receptor agonist,ADRB2,,,Sigma,98.26,BRD-A13116749-003-01-6,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(c1)C(F)(F)F,JSJCTEKTBOKRST-UHFFFAOYSA-N,Launched,
macitentan,endothelin receptor antagonist,"EDNRA, EDNRB",endocrinology,contraceptive,"Selleck, Selleck",90.02,"BRD-K48812570-001-02-3, BRD-K48812570-001-03-1","CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1, CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1","JGCMEBMXRHSZKX-UHFFFAOYSA-N, JGCMEBMXRHSZKX-UHFFFAOYSA-N",Launched,
mafenide,carbonic anhydrase inhibitor,"CA12, CA14, CA2, CA4, CA6, CA9",infectious disease,"first-aid antibiotic, skin infections",MicroSource,100,BRD-K30649484-003-13-7,NCc1ccc(cc1)S(N)(=O)=O,TYMRLRRVMHJFTF-UHFFFAOYSA-N,Launched,
malathion,cholinesterase inhibitor,"ACHE, BCHE",infectious disease,lice,"MedChemEx, MicroSource, MedChemEx",78.47,"BRD-A01976766-001-06-8, BRD-A01976766-001-04-3, BRD-A01976766-001-07-6","CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC, CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC, CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC","JXSJBGJIGXNWCI-UHFFFAOYSA-N, JXSJBGJIGXNWCI-UHFFFAOYSA-N, JXSJBGJIGXNWCI-UHFFFAOYSA-N",Launched,
malic-acid,,"CS, ME2, PKD2L1",,,"Enamine, Enamine",100,"BRD-A18396475-001-16-1, BRD-A18396475-001-15-3","OC(CC(O)=O)C(O)=O, OC(CC(O)=O)C(O)=O","BJEPYKJPYRNKOW-UHFFFAOYSA-N, BJEPYKJPYRNKOW-UHFFFAOYSA-N",Launched,
malotilate,protein synthesis stimulant,,gastroenterology,hepatic cirrhosis,Selleck,96.64,BRD-K97884852-001-05-4,CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1,YPIQVCUJEKAZCP-UHFFFAOYSA-N,Launched,
maltobionic-acid,matrix metalloprotease inhibitor,,dermatology,cosmetic,CombiBlocks,97.5,BRD-K01624185-001-05-7,OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O,JYTUSYBCFIZPBE-AMTLMPIISA-N,Launched,
mandelic-acid,,,,,Enamine,0,BRD-A91448670-001-06-4,OC(C(O)=O)c1ccccc1,IWYDHOAUDWTVEP-UHFFFAOYSA-N,Launched,
mangafodipir,contrast agent,,radiology,contrast agent,"MicroSource, MedChemEx",0,"BRD-K57365211-314-01-4, BRD-K57365211-314-02-2","Cc1nc(COP(O)(O)=O)cc2CN(CC(O)=O)CCN(CC(O)=O)Cc3cc(COP(O)(O)=O)nc(C)c3O[Mn]Oc12, Cc1nc(COP(O)(O)=O)cc2CN(CC(O)=O)CCN(CC(O)=O)Cc3cc(COP(O)(O)=O)nc(C)c3O[Mn]Oc12","CXFKOLCMCRBYPL-UHFFFAOYSA-L, CXFKOLCMCRBYPL-UHFFFAOYSA-L",Launched,"BRD-A81339141-314-01-6,BRD-U27874988-000-01-6"
manidipine,calcium channel blocker,"CACNA1C, CACNA1D",cardiology,hypertension,"MicroSource, Selleck, Selleck, Selleck",98.86,"BRD-A90695733-001-07-4, BRD-A90695733-300-02-1, BRD-A90695733-001-06-6, BRD-A90695733-001-08-2","COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1, COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1, COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1, COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1","ANEBWFXPVPTEET-UHFFFAOYSA-N, ANEBWFXPVPTEET-UHFFFAOYSA-N, ANEBWFXPVPTEET-UHFFFAOYSA-N, ANEBWFXPVPTEET-UHFFFAOYSA-N",Launched,
mannitol-D,diuretic,,"neurology/psychiatry, ophthalmology, gastroenterology","intracranial pressure, intraocular pressure, constipation","MicroSource, Selleck",100,"BRD-K66035042-001-11-9, BRD-K30374899-001-09-3","OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","FBPFZTCFMRRESA-JGWLITMVSA-N, FBPFZTCFMRRESA-KVTDHHQDSA-N",Launched,
maprotiline,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2",neurology/psychiatry,"depression, dysthymic disorder","Selleck, Tocris, MicroSource",96.89,"BRD-K25433859-003-23-9, BRD-K25433859-003-24-7, BRD-K25433859-003-25-4","CNCCCC12CCC(c3ccccc13)c1ccccc21, CNCCCC12CCC(c3ccccc13)c1ccccc21, CNCCCC12CCC(c3ccccc13)c1ccccc21","QSLMDECMDJKHMQ-UHFFFAOYSA-N, QSLMDECMDJKHMQ-UHFFFAOYSA-N, QSLMDECMDJKHMQ-UHFFFAOYSA-N",Launched,
maraviroc,CC chemokine receptor antagonist,CCR5,infectious disease,human immunodeficiency virus (HIV-1),"Tocris, Selleck",95.18,"BRD-A04352665-001-06-1, BRD-A04352665-001-05-3","CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1, CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1","GSNHKUDZZFZSJB-ILVMPNSOSA-N, GSNHKUDZZFZSJB-ILVMPNSOSA-N",Launched,
marbofloxacin,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections,"Selleck, Selleck, MicroSource",99.41,"BRD-K71926323-001-14-6, BRD-K71926323-001-12-0, BRD-K71926323-001-13-8","CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O, CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O, CN1CCN(CC1)c1c(F)cc2c3c1OCN(C)n3cc(C(O)=O)c2=O","BPFYOAJNDMUVBL-UHFFFAOYSA-N, BPFYOAJNDMUVBL-UHFFFAOYSA-N, BPFYOAJNDMUVBL-UHFFFAOYSA-N",Launched,
maropitant,neurokinin receptor antagonist,TACR1,gastroenterology,vomiting,MedChemEx,97.11,BRD-K76594255-001-01-6,COc1ccc(cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1)C(C)(C)C,OMPCVMLFFSQFIX-CONSDPRKSA-N,Launched,
masitinib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor","FGFR3, KIT, PDGFRA, PDGFRB",dermatology,mastocytoma,"Selleck, Selleck",92.11,"BRD-K71035033-001-08-9, BRD-K71035033-001-07-1","CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1, CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1","WJEOLQLKVOPQFV-UHFFFAOYSA-N, WJEOLQLKVOPQFV-UHFFFAOYSA-N",Launched,
masoprocol,lipoxygenase inhibitor,ALOX5,dermatology,actinic keratosis (AK),Enzo,89.52,BRD-A87130939-001-07-9,CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1,HCZKYJDFEPMADG-UHFFFAOYSA-N,Launched,
maxacalcitol,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism,MedChemEx,95.36,BRD-K81332461-001-01-4,[2H]C([2H])([2H])C(O)(CCO[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C)C([2H])([2H])[2H],DTXXSJZBSTYZKE-OXMAATCFSA-N,Launched,
mazindol,"dopamine reuptake inhibitor, selective serotonin reuptake inhibitor (SSRI)","SLC6A2, SLC6A3, SLC6A4",genetics,duchenne muscular dystrophy (DMD),MedChemEx,96.3,BRD-A68464583-001-02-5,OC1(N2CCN=C2c2ccccc12)c1ccc(Cl)cc1,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,Launched,
mebendazole,tubulin polymerization inhibitor,"TUBA1A, TUBB, TUBB4B",infectious disease,"pinworm, whipworm, hookworm, ascariasis",MicroSource,96.72,BRD-K77987382-001-13-2,COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c1ccccc1,OPXLLQIJSORQAM-UHFFFAOYSA-N,Launched,
mebeverine,acetylcholine receptor antagonist,CHRM1,gastroenterology,irritable bowel syndrome,MicroSource,95.24,BRD-A09467419-003-22-4,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,VYVKHNNGDFVQGA-UHFFFAOYSA-N,Launched,
mebhydrolin,antihistamine,,allergy,"allergic rhinitis, urticaria",MicroSource,90.08,BRD-K29713308-001-01-7,CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Launched,
mebicar,anxiolytic,,neurology/psychiatry,anxiety,ChemDiv,94.75,BRD-K76606751-001-01-7,CN1C2C(N(C)C1=O)N(C)C(=O)N2C,XIUUSFJTJXFNGH-UHFFFAOYSA-N,Launched,
mebrofenin,,,radiology,diagnostic agent,Sigma,69.8,BRD-K96691275-001-01-2,Cc1cc(C)c(NC(=O)CN(CC(O)=O)CC(O)=O)c(C)c1Br,MHPZZZZLAQGTHT-UHFFFAOYSA-N,Launched,
mecamylamine,acetylcholine receptor antagonist,"CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7",cardiology,hypertension,MicroSource,100,BRD-A20119038-003-07-8,CNC1(C)C2CCC(C2)C1(C)C,IMYZQPCYWPFTAG-UHFFFAOYSA-N,Launched,
mechlorethamine,DNA inhibitor,,"hematologic malignancy, hematology, infectious disease, oncology","Hodgkin's lymphoma, chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), polycythemia vera, mycosis, bronchogenic carcinoma","MedChemEx, Selleck, MedChemEx, MicroSource, Selleck",21.94,"BRD-K12829205-003-05-1, BRD-K12829205-003-02-8, BRD-K12829205-003-04-4, BRD-K12829205-001-04-8, BRD-K12829205-003-03-6","CN(CCCl)CCCl, CN(CCCl)CCCl, CN(CCCl)CCCl, CN(CCCl)CCCl, CN(CCCl)CCCl","HAWPXGHAZFHHAD-UHFFFAOYSA-N, HAWPXGHAZFHHAD-UHFFFAOYSA-N, HAWPXGHAZFHHAD-UHFFFAOYSA-N, HAWPXGHAZFHHAD-UHFFFAOYSA-N, HAWPXGHAZFHHAD-UHFFFAOYSA-N",Launched,
meclizine,constitutive androstane receptor (CAR) agonist,"HRH1, NR1I3","gastroenterology, neurology/psychiatry","nausea, vomiting, motion sickness","Tocris, Selleck, MicroSource",97.63,"BRD-A50311610-300-11-2, BRD-A50311610-300-09-6, BRD-A50311610-300-10-4","Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1, Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1, Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1","OCJYIGYOJCODJL-UHFFFAOYSA-N, OCJYIGYOJCODJL-UHFFFAOYSA-N, OCJYIGYOJCODJL-UHFFFAOYSA-N",Launched,
meclocycline-sulfosalicylate,bacterial 50S ribosomal subunit inhibitor,,"dermatology, infectious disease","acne vulgaris (AV), skin infections","MicroSource, DuPont, Selleck",82.79,"BRD-A07600638-060-05-2, BRD-A07600638-060-06-0, BRD-A07600638-060-04-5","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)ccc(Cl)c4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O","YKYBWGJKLYMCFI-KCDYASHQSA-N, YKYBWGJKLYMCFI-KCDYASHQSA-N, YKYBWGJKLYMCFI-KCDYASHQSA-N",Launched,
meclofenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2","rheumatology, neurology/psychiatry, endocrinology","joint pain, muscle pain, rheumatoid arthritis, primary dysmenorrhea (PD)",MicroSource,98.55,BRD-K50398167-236-22-7,Cc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl,SBDNJUWAMKYJOX-UHFFFAOYSA-N,Launched,
meclofenoxate,nootropic agent,,neurology/psychiatry,"senile dementia, Alzheimer's disease",MicroSource,87.92,BRD-K10314788-003-12-7,CN(C)CCOC(=O)COc1ccc(Cl)cc1,XZTYGFHCIAKPGJ-UHFFFAOYSA-N,Launched,
mecysteine,analgesic agent,,pulmonary,chest congestion,MicroSource,12.39,BRD-A77473570-003-04-2,COC(=O)C(N)CS,MCYHPZGUONZRGO-UHFFFAOYSA-N,Launched,
medetomidine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",neurology/psychiatry,sedative,"Selleck, Tocris, Tocris",98.61,"BRD-A21607826-003-04-4, BRD-A21607826-003-06-9, BRD-A21607826-003-05-1","CC(c1c[nH]cn1)c1cccc(C)c1C, CC(c1c[nH]cn1)c1cccc(C)c1C, CC(c1c[nH]cn1)c1cccc(C)c1C","CUHVIMMYOGQXCV-UHFFFAOYSA-N, CUHVIMMYOGQXCV-UHFFFAOYSA-N, CUHVIMMYOGQXCV-UHFFFAOYSA-N",Launched,
medronic-acid,bone resorption inhibitor,,radiology,skeletal imaging agent,Sigma,98.4,BRD-K94072573-001-09-9,OP(O)(=O)CP(O)(O)=O,MBKDYNNUVRNNRF-UHFFFAOYSA-N,Launched,
medroxyprogesterone,progesterone receptor agonist,"ESR1, PGR",endocrinology,contraceptive,MedChemEx,95.16,BRD-K99615199-001-18-5,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12,FRQMUZJSZHZSGN-HBNHAYAOSA-N,Launched,
medroxyprogesterone-acetate,progesterone receptor agonist,,endocrinology,contraceptive,"Selleck, MicroSource",95.9,"BRD-A61221616-001-05-0, BRD-A61221616-001-04-3","C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12, C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12","PSGAAPLEWMOORI-GDXVCIIOSA-N, PSGAAPLEWMOORI-GDXVCIIOSA-N",Launched,BRD-K44848460-001-01-6
medrysone,glucocorticoid receptor agonist,NR3C1,ophthalmology,"conjunctivitis, episcleritis","Selleck, MicroSource",95.45,"BRD-A59014912-001-01-3, BRD-K56515112-001-21-6","C[C@H]1CC2C3CCC(C(C)=O)C3(C)CC(O)C2C2(C)CCC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)CCC(=O)C=C12","GZENKSODFLBBHQ-CHMAHDFQSA-N, GZENKSODFLBBHQ-ILSZZQPISA-N",Launched,BRD-A20126139-001-04-2
mefenamic-acid,cyclooxygenase inhibitor,"KCNQ1, PTGS1, PTGS2, TRPM3",endocrinology,primary dysmenorrhea (PD),"MicroSource, Selleck",99.01,"BRD-K92778217-001-32-7, BRD-K92778217-001-31-9","Cc1cccc(Nc2ccccc2C(O)=O)c1C, Cc1cccc(Nc2ccccc2C(O)=O)c1C","HYYBABOKPJLUIN-UHFFFAOYSA-N, HYYBABOKPJLUIN-UHFFFAOYSA-N",Launched,
mefloquine,"adenosine receptor antagonist, hemoglobin antagonist","ADORA2A, HBA1",infectious disease,malaria,MicroSource,88.97,BRD-A89585551-003-16-6,OC(C1CCCCN1)c1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F,XEEQGYMUWCZPDN-UHFFFAOYSA-N,Launched,
megestrol-acetate,progesterone receptor agonist,"NR3C1, PGR","neurology/psychiatry, endocrinology","anorexia, cachexia","Selleck, Selleck, MicroSource",98.58,"BRD-K19507340-001-22-1, BRD-K19507340-001-25-4, BRD-A35989968-001-04-2","CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O, CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C)C(C)=O","RQZAXGRLVPAYTJ-GQFGMJRRSA-N, RQZAXGRLVPAYTJ-GQFGMJRRSA-N, RQZAXGRLVPAYTJ-VSUSFZLSSA-N",Launched,BRD-K29344105-001-01-6
meglumine,excipient,,,,"MicroSource, Selleck, Selleck",100,"BRD-K28595280-001-04-5, BRD-K28595280-001-03-7, BRD-K28595280-001-05-2","CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","MBBZMMPHUWSWHV-BDVNFPICSA-N, MBBZMMPHUWSWHV-BDVNFPICSA-N, MBBZMMPHUWSWHV-BDVNFPICSA-N",Launched,
meglutol,HMGCR inhibitor,HMGCR,,,MicroSource,0,BRD-K00495673-001-05-2,CC(O)(CC(O)=O)CC(O)=O,NPOAOTPXWNWTSH-UHFFFAOYSA-N,Launched,
melatonin,"melatonin receptor agonist, nitric oxide synthase inhibitor","ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB",neurology/psychiatry,sleep cycle support,"Tocris, Tocris, Selleck",95.68,"BRD-K97530723-001-20-9, BRD-K97530723-001-24-1, BRD-K97530723-001-19-1","COc1ccc2[nH]cc(CCNC(C)=O)c2c1, COc1ccc2[nH]cc(CCNC(C)=O)c2c1, COc1ccc2[nH]cc(CCNC(C)=O)c2c1","DRLFMBDRBRZALE-UHFFFAOYSA-N, DRLFMBDRBRZALE-UHFFFAOYSA-N, DRLFMBDRBRZALE-UHFFFAOYSA-N",Launched,
meldonium,gamma butyrobetaine hydroxylase inhibitor,BBOX1,cardiology,coronary artery disease (CAD),LifeChem,60.9,BRD-K79392608-335-01-8,C[N+](C)(C)NCCC(O)=O,PVBQYTCFVWZSJK-UHFFFAOYSA-O,Launched,
melevodopa,"dopamine precursor, dopamine receptor agonist",DDC,neurology/psychiatry,Parkinson's Disease,"Vitas-M, Sigma",88.63,"BRD-A25827085-001-01-0, BRD-K18749874-003-08-9","COC(=O)C(N)Cc1ccc(O)c(O)c1, COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1","XBBDACCLCFWBSI-UHFFFAOYSA-N, XBBDACCLCFWBSI-ZETCQYMHSA-N",Launched,
meloxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"osteoarthritis, rheumatoid arthritis","MicroSource, Sigma, Selleck",99.09,"BRD-A84174393-236-07-1, BRD-A84174393-323-07-7, BRD-A84174393-001-34-3","CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O, CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O, CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O","ZAHQBPYQBHTECE-UHFFFAOYSA-N, ZAHQBPYQBHTECE-UHFFFAOYSA-N, ZAHQBPYQBHTECE-UHFFFAOYSA-N",Launched,
melperone,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A",neurology/psychiatry,psychosis,"Tocris, Tocris",96.46,"BRD-K92984783-003-05-7, BRD-K92984783-003-06-5","CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1, CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1","DKMFBWQBDIGMHM-UHFFFAOYSA-N, DKMFBWQBDIGMHM-UHFFFAOYSA-N",Launched,
melphalan,"DNA alkylating agent, DNA inhibitor",,hematologic malignancy,multiple myeloma,"MicroSource, MicroSource",93.38,"BRD-K87827419-001-16-8, BRD-K87827419-001-14-3","N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O, N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O","SGDBTWWWUNNDEQ-LBPRGKRZSA-N, SGDBTWWWUNNDEQ-LBPRGKRZSA-N",Launched,
memantine,glutamate receptor antagonist,"CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A",neurology/psychiatry,"Alzheimer's disease, senile dementia","Selleck, Tocris, MicroSource",100,"BRD-A79803969-003-16-1, BRD-A79803969-003-17-9, BRD-A79803969-003-18-7","CC12CC3CC(C)(C1)CC(N)(C3)C2, CC12CC3CC(C)(C1)CC(N)(C3)C2, CC12CC3CC(C)(C1)CC(N)(C3)C2","BUGYDGFZZOZRHP-UHFFFAOYSA-N, BUGYDGFZZOZRHP-UHFFFAOYSA-N, BUGYDGFZZOZRHP-UHFFFAOYSA-N",Launched,
menadione,"mitochondrial DNA polymerase inhibitor, phosphatase inhibitor","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1","gastroenterology, neurology/psychiatry, dermatology, rheumatology","ulcerative colitis, diarrhea, headache, varicose veins, rheumatoid arthritis","Selleck, Selleck, MicroSource",98.17,"BRD-K78126613-001-27-7, BRD-K78126613-001-29-3, BRD-K78126613-001-28-5","CC1=CC(=O)c2ccccc2C1=O, CC1=CC(=O)c2ccccc2C1=O, CC1=CC(=O)c2ccccc2C1=O","MJVAVZPDRWSRRC-UHFFFAOYSA-N, MJVAVZPDRWSRRC-UHFFFAOYSA-N, MJVAVZPDRWSRRC-UHFFFAOYSA-N",Launched,
menatetrenone,bone resorption inhibitor,,orthopedics,osteoporosis,Sigma,48.49,BRD-K75864342-001-14-2,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O,DKHGMERMDICWDU-GHDNBGIDSA-N,Launched,
menbutone,,,gastroenterology,bile stimulation,MicroSource,93.68,BRD-K53852914-001-01-8,COc1ccc(C(=O)CCC(O)=O)c2ccccc12,FHGJSJFIQNQBCK-UHFFFAOYSA-N,Launched,
mepacrine,"cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B, PLA2G4A, PLA2G6, PLCL1",infectious disease,giardiasis,"Selleck, MicroSource, Selleck",95.48,"BRD-A45889380-300-06-3, BRD-A45889380-300-07-1, BRD-A45889380-300-08-9","CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12, CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12, CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12","GPKJTRJOBQGKQK-UHFFFAOYSA-N, GPKJTRJOBQGKQK-UHFFFAOYSA-N, GPKJTRJOBQGKQK-UHFFFAOYSA-N",Launched,
mepenzolate,acetylcholine receptor antagonist,"CHRM1, CHRM3",gastroenterology,peptic ulcer disease (PUD),"MicroSource, Selleck",99.17,"BRD-A62421304-004-18-9, BRD-A62421304-004-17-1","C[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1, C[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1","GKNPSSNBBWDAGH-UHFFFAOYSA-N, GKNPSSNBBWDAGH-UHFFFAOYSA-N",Launched,
mephenesin,muscle relaxant,,neurology/psychiatry,muscle relaxant,MicroSource,99.05,BRD-A55469827-001-07-4,Cc1ccccc1OCC(O)CO,JWDYCNIAQWPBHD-UHFFFAOYSA-N,Launched,
mephentermine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3",cardiology,hypotension,MicroSource,93.01,BRD-K18194590-065-08-0,CNC(C)(C)Cc1ccccc1,RXQCGGRTAILOIN-UHFFFAOYSA-N,Launched,
mephenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,MicroSource,98.67,BRD-A83937277-001-10-5,CCC1(NC(=O)N(C)C1=O)c1ccccc1,GMHKMTDVRCWUDX-UHFFFAOYSA-N,Launched,
mepivacaine,"potassium channel blocker, sodium channel blocker",SCN10A,neurology/psychiatry,local anesthetic,"MicroSource, Selleck",97.82,"BRD-A03216249-003-24-3, BRD-A03216249-003-23-5","CN1CCCCC1C(=O)Nc1c(C)cccc1C, CN1CCCCC1C(=O)Nc1c(C)cccc1C","INWLQCZOYSRPNW-UHFFFAOYSA-N, INWLQCZOYSRPNW-UHFFFAOYSA-N",Launched,
meprednisone,,NR3C1,,,"Selleck, Selleck",0.53,"BRD-K18207669-001-02-4, BRD-K81190290-001-01-3","C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO, C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO","PIDANAQULIKBQS-RNUIGHNZSA-N, XTLSVXWJVRKFIP-RNUIGHNZSA-N",Launched,BRD-K79233274-001-01-5
meprobamate,,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",neurology/psychiatry,anxiety,Enzo,91.41,BRD-K19180152-001-02-6,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,Launched,
meptazinol,opioid receptor agonist,BCHE,neurology/psychiatry,pain relief,"Tocris, Selleck, Selleck",94.08,"BRD-A02710418-003-13-4, BRD-A02710418-003-12-6, BRD-A02710418-003-11-8","CCC1(CCCCN(C)C1)c1cccc(O)c1, CCC1(CCCCN(C)C1)c1cccc(O)c1, CCC1(CCCCN(C)C1)c1cccc(O)c1","JLICHNCFTLFZJN-UHFFFAOYSA-N, JLICHNCFTLFZJN-UHFFFAOYSA-N, JLICHNCFTLFZJN-UHFFFAOYSA-N",Launched,
mepyramine,histamine receptor antagonist,HRH1,"otolaryngology, obstetrics/gynecology","common cold, menstrual pain","Selleck, MicroSource, Tocris",99.13,"BRD-K97564742-051-02-8, BRD-K97564742-050-32-7, BRD-K97564742-050-31-9","COc1ccc(cc1)CN(CCN(C)C)c1ccccn1, COc1ccc(cc1)CN(CCN(C)C)c1ccccn1, COc1ccc(cc1)CN(CCN(C)C)c1ccccn1","YECBIJXISLIIDS-UHFFFAOYSA-N, YECBIJXISLIIDS-UHFFFAOYSA-N, YECBIJXISLIIDS-UHFFFAOYSA-N",Launched,
mequinol,,TYR,dermatology,skin depigmentation,"MicroSource, Selleck, Selleck",99.23,"BRD-K45216060-001-10-0, BRD-K45216060-001-09-2, BRD-K45216060-001-11-8","COc1ccc(O)cc1, COc1ccc(O)cc1, COc1ccc(O)cc1","NWVVVBRKAWDGAB-UHFFFAOYSA-N, NWVVVBRKAWDGAB-UHFFFAOYSA-N, NWVVVBRKAWDGAB-UHFFFAOYSA-N",Launched,
merbromin,antiseptic,,infectious disease,first-aid antiseptic,MicroSource,0,BRD-K21771665-304-04-2,O[Hg]c1c(O)c(Br)cc2c(-c3ccccc3C(O)=O)c3cc(Br)c(=O)cc3oc12,OHCFGBLQZMYRTR-UHFFFAOYSA-M,Launched,
mercaptopurine,"immunosuppressant, protein synthesis inhibitor, purine antagonist","HPRT1, IMPDH1, IMPDH2, PPAT",hematologic malignancy,acute lymphoblastic leukemia (ALL),"Selleck, MicroSource",100,"BRD-K91601245-001-12-0, BRD-K91601245-001-13-8","S=c1[nH]cnc2nc[nH]c12, S=c1[nH]cnc2nc[nH]c12","GLVAUDGFNGKCSF-UHFFFAOYSA-N, GLVAUDGFNGKCSF-UHFFFAOYSA-N",Launched,
mercaptosuccinic-acid,,,,,"Enamine, Enamine",100,"BRD-A43435802-001-01-2, BRD-A43435802-001-02-0","OC(=O)CC(S)C(O)=O, OC(=O)CC(S)C(O)=O","NJRXVEJTAYWCQJ-UHFFFAOYSA-N, NJRXVEJTAYWCQJ-UHFFFAOYSA-N",Launched,
meropenem,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, intra-abdominal infections, meningitis","Selleck, Key, Selleck, MicroSource",23.73,"BRD-K01612348-001-12-2, BRD-K01612348-001-11-4, BRD-K01612348-001-13-0, BRD-K01612348-001-14-8","C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O, C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O","DMJNNHOOLUXYBV-PQTSNVLCSA-N, DMJNNHOOLUXYBV-PQTSNVLCSA-N, DMJNNHOOLUXYBV-PQTSNVLCSA-N, DMJNNHOOLUXYBV-PQTSNVLCSA-N",Launched,"BRD-A18115130-001-03-0, BRD-A18115130-001-02-2, BRD-A53925737-001-01-9"
mesalazine,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist","ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2",gastroenterology,"ulcerative colitis, inflammatory bowel disease","Selleck, MicroSource, Selleck",90.1,"BRD-K28849549-001-13-4, BRD-K28849549-001-12-6, BRD-K28849549-001-11-8","Nc1ccc(O)c(c1)C(O)=O, Nc1ccc(O)c(c1)C(O)=O, Nc1ccc(O)c(c1)C(O)=O","KBOPZPXVLCULAV-UHFFFAOYSA-N, KBOPZPXVLCULAV-UHFFFAOYSA-N, KBOPZPXVLCULAV-UHFFFAOYSA-N",Launched,
mesna,antioxidant,,urology,hemorrhagic cystitis,"Selleck, Selleck, MicroSource",92.74,"BRD-K49954789-001-03-7, BRD-K49954789-001-01-1, BRD-K49954789-001-02-9","OS(=O)(=O)CCS, OS(=O)(=O)CCS, OS(=O)(=O)CCS","ZNEWHQLOPFWXOF-UHFFFAOYSA-N, ZNEWHQLOPFWXOF-UHFFFAOYSA-N, ZNEWHQLOPFWXOF-UHFFFAOYSA-N",Launched,"BRD-M40783228-001-16-8, BRD-M40783228-001-14-3, BRD-M40783228-001-15-0"
mesoridazine,dopamine receptor antagonist,"DRD2, HTR2A",neurology/psychiatry,schizophrenia,"MicroSource, Selleck, Selleck",90.35,"BRD-A14395271-074-17-8, BRD-A14395271-074-16-0, BRD-A14395271-074-18-6","CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O, CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O, CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O","SLVMESMUVMCQIY-UHFFFAOYSA-N, SLVMESMUVMCQIY-UHFFFAOYSA-N, SLVMESMUVMCQIY-UHFFFAOYSA-N",Launched,
mestinon,cholinesterase inhibitor,"ACHE, BCHE",neurology/psychiatry,myasthenia gravis,"MicroSource, Selleck",98.82,"BRD-K69688083-004-23-1, BRD-K69688083-004-22-3","CN(C)C(=O)Oc1ccc[n+](C)c1, CN(C)C(=O)Oc1ccc[n+](C)c1","RVOLLAQWKVFTGE-UHFFFAOYSA-N, RVOLLAQWKVFTGE-UHFFFAOYSA-N",Launched,
mestranol,estrogen receptor agonist,ESR1,endocrinology,contraceptive,"Selleck, MicroSource",98.35,"BRD-K31920458-001-22-8, BRD-K31920458-001-23-6","COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1, COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1","IMSSROKUHAOUJS-MJCUULBUSA-N, IMSSROKUHAOUJS-MJCUULBUSA-N",Launched,"BRD-K92042497-001-01-4, BRD-A14798026-001-02-6"
metacresol,,INS,,,MicroSource,96.37,BRD-K22518984-001-01-8,Cc1cccc(O)c1,RLSSMJSEOOYNOY-UHFFFAOYSA-N,Launched,
metafolin,,AMT,,,"MedChemEx, MedChemEx, MedChemEx",67.8,"BRD-K28580965-238-03-9, BRD-K28580965-238-01-3, BRD-K28580965-238-02-1","CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2nc(N)[nH]c(=O)c12, CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2nc(N)[nH]c(=O)c12, CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2nc(N)[nH]c(=O)c12","ZNOVTXRBGFNYRX-STQMWFEESA-N, ZNOVTXRBGFNYRX-STQMWFEESA-N, ZNOVTXRBGFNYRX-STQMWFEESA-N",Launched,
metaproterenol,adrenergic receptor agonist,ADRB2,pulmonary,"bronchospasm, asthma, bronchitis, emphysema","Selleck, MicroSource, Selleck",90.17,"BRD-A07780951-065-09-2, BRD-A07780951-001-08-9, BRD-A07780951-065-10-0","CC(C)NCC(O)c1cc(O)cc(O)c1, CC(C)NCC(O)c1cc(O)cc(O)c1, CC(C)NCC(O)c1cc(O)cc(O)c1","LMOINURANNBYCM-UHFFFAOYSA-N, LMOINURANNBYCM-UHFFFAOYSA-N, LMOINURANNBYCM-UHFFFAOYSA-N",Launched,"BRD-M02190957-065-05-7, BRD-M02190957-065-06-5"
metaraminol,adrenergic receptor agonist,ADRA1A,cardiology,hypotension,"MicroSource, Selleck, Selleck",95.01,"BRD-K96253961-046-04-9, BRD-K96253961-046-05-6, BRD-K96253961-046-03-1","C[C@H](N)[C@H](O)c1cccc(O)c1, C[C@H](N)[C@H](O)c1cccc(O)c1, C[C@H](N)[C@H](O)c1cccc(O)c1","WXFIGDLSSYIKKV-RCOVLWMOSA-N, WXFIGDLSSYIKKV-RCOVLWMOSA-N, WXFIGDLSSYIKKV-RCOVLWMOSA-N",Launched,
metaxalone,muscle relaxant,,neurology/psychiatry,muscle pain,MicroSource,99.54,BRD-A94709349-001-08-3,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,IMWZZHHPURKASS-UHFFFAOYSA-N,Launched,
metergoline,"dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",,,"Tocris, MicroSource, Tocris",94,"BRD-K56699285-001-24-3, BRD-A72309220-001-04-1, BRD-K56699285-001-23-5","CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13, CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13, CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13","WZHJKEUHNJHDLS-QTGUNEKASA-N, WZHJKEUHNJHDLS-STDCAVTESA-N, WZHJKEUHNJHDLS-QTGUNEKASA-N",Launched,
metformin,insulin sensitizer,"ACACB, PRKAB1",endocrinology,diabetes mellitus,"Selleck, MicroSource, Tocris",93.76,"BRD-K79602928-003-18-1, BRD-K79602928-003-19-9, BRD-K79602928-003-21-5","CN(C)C(=N)NC(N)=N, CN(C)C(=N)NC(N)=N, CN(C)C(=N)NC(N)=N","XZWYZXLIPXDOLR-UHFFFAOYSA-N, XZWYZXLIPXDOLR-UHFFFAOYSA-N, XZWYZXLIPXDOLR-UHFFFAOYSA-N",Launched,
methacholine,acetylcholine receptor agonist,"CHRM2, CHRM3, CHRM4",pulmonary,bronchial hyperresponsiveness diagnostic,MicroSource,98.32,BRD-A18056626-003-22-3,CC(C[N+](C)(C)C)OC(C)=O,NZWOPGCLSHLLPA-UHFFFAOYSA-N,Launched,
methacycline,protein synthesis inhibitor,,pulmonary,bronchitis,"MedChemEx, Selleck, Selleck, MicroSource",90.63,"BRD-A49035384-003-29-7, BRD-A49035384-003-28-9, BRD-A49035384-003-30-5, BRD-A49035384-003-27-1","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3=C)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O","QNJKSUYWBCNWFI-KCDYASHQSA-N, QNJKSUYWBCNWFI-KCDYASHQSA-N, QNJKSUYWBCNWFI-KCDYASHQSA-N, QNJKSUYWBCNWFI-KCDYASHQSA-N",Launched,BRD-A27249758-003-01-7
methantheline,acetylcholine receptor antagonist,"CHRM1, HRH2","gastroenterology, neurology/psychiatry, urology","peptic ulcer disease (PUD), irritable bowel syndrome, pancreatitis, dyskinesia, neurogenic bladder",Prestwick,53.05,BRD-K09859624-004-10-4,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc12,GZHFODJQISUKAY-UHFFFAOYSA-N,Launched,
metharbital,GABA receptor modulator,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2",neurology/psychiatry,epilepsy,Enamine,99.64,BRD-K88143662-001-01-5,CCC1(CC)C(=O)NC(=O)N(C)C1=O,FWJKNZONDWOGMI-UHFFFAOYSA-N,Launched,
methazolamide,carbonic anhydrase inhibitor,"CA1, CA12, CA14, CA2, CA4, CA7",ophthalmology,"glaucoma, intraocular pressure","MicroSource, Selleck, Selleck",98.57,"BRD-K13356952-001-26-9, BRD-K13356952-001-25-1, BRD-K13356952-001-27-7","CC(=O)N=c1sc(nn1C)S(N)(=O)=O, CC(=O)N=c1sc(nn1C)S(N)(=O)=O, CC(=O)N=c1sc(nn1C)S(N)(=O)=O","FLOSMHQXBMRNHR-UHFFFAOYSA-N, FLOSMHQXBMRNHR-UHFFFAOYSA-N, FLOSMHQXBMRNHR-UHFFFAOYSA-N",Launched,
methenamine,bacterial DNA inhibitor,,infectious disease,urinary tract infections,"Selleck, MicroSource",100,"BRD-K30114692-001-15-9, BRD-K30114692-001-16-7","C1N2CN3CN1CN(C2)C3, C1N2CN3CN1CN(C2)C3","VKYKSIONXSXAKP-UHFFFAOYSA-N, VKYKSIONXSXAKP-UHFFFAOYSA-N",Launched,
methicillin,bacterial cell wall synthesis inhibitor,,,,"Sigma, MicroSource",85.33,"BRD-K34388247-236-09-0, BRD-K34388247-236-08-2","COc1cccc(OC)c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O, COc1cccc(OC)c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O","RJQXTJLFIWVMTO-TYNCELHUSA-N, RJQXTJLFIWVMTO-TYNCELHUSA-N",Launched,
methimazole,antithyroid agent,TPO,endocrinology,hyperthyroidism,"Selleck, MicroSource",100,"BRD-K54416256-001-18-1, BRD-K54416256-001-19-9","Cn1cc[nH]c1=S, Cn1cc[nH]c1=S","PMRYVIKBURPHAH-UHFFFAOYSA-N, PMRYVIKBURPHAH-UHFFFAOYSA-N",Launched,
methionine,,"BHMT, BHMT2, METAP2, MTR, MTRR",,,Sigma,47.29,BRD-A39515206-001-01-9,CSCCC(N)C(O)=O,FFEARJCKVFRZRR-UHFFFAOYSA-N,Launched,
methocarbamol,muscle relaxant,CA1,neurology/psychiatry,muscle relaxant,"Selleck, MicroSource",99.36,"BRD-A31521121-001-25-6, BRD-A31521121-001-26-4","COc1ccccc1OCC(O)COC(N)=O, COc1ccccc1OCC(O)COC(N)=O","GNXFOGHNGIVQEH-UHFFFAOYSA-N, GNXFOGHNGIVQEH-UHFFFAOYSA-N",Launched,
methotrexate,dihydrofolate reductase inhibitor,DHFR,"oncology, hematologic malignancy, dermatology, rheumatology","gestational choriocarcinoma, hydatidiform mole, acute lymphoblastic leukemia (ALL), psoriasis, rheumatoid arthritis","Selleck, Selleck, Tocris, MicroSource",98.9,"BRD-K59456551-001-22-6, BRD-K59456551-001-19-2, BRD-K59456551-001-20-0, BRD-A55424491-001-19-9","CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)NC(CCC(O)=O)C(O)=O","FBOZXECLQNJBKD-ZDUSSCGKSA-N, FBOZXECLQNJBKD-ZDUSSCGKSA-N, FBOZXECLQNJBKD-ZDUSSCGKSA-N, FBOZXECLQNJBKD-UHFFFAOYSA-N",Launched,
methoxamine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D",cardiology,hypotension,"Selleck, MicroSource",97.81,"BRD-A39189014-003-21-9, BRD-A39189014-003-22-7","COc1ccc(OC)c(c1)C(O)C(C)N, COc1ccc(OC)c(c1)C(O)C(C)N","WJAJPNHVVFWKKL-UHFFFAOYSA-N, WJAJPNHVVFWKKL-UHFFFAOYSA-N",Launched,
methoxsalen,DNA synthesis inhibitor,"CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4",dermatology,psoriasis,"Selleck, MicroSource",99.46,"BRD-K63430059-001-16-4, BRD-K63430059-001-17-2","COc1c2occc2cc2ccc(=O)oc12, COc1c2occc2cc2ccc(=O)oc12","QXKHYNVANLEOEG-UHFFFAOYSA-N, QXKHYNVANLEOEG-UHFFFAOYSA-N",Launched,
methoxyflurane,membrane permeability inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1",neurology/psychiatry,general anaesthetic,"Sigma, MatrixSci",0,"BRD-K06152156-001-02-6, BRD-K06152156-001-01-8","COC(F)(F)C(Cl)Cl, COC(F)(F)C(Cl)Cl","RFKMCNOHBTXSMU-UHFFFAOYSA-N, RFKMCNOHBTXSMU-UHFFFAOYSA-N",Launched,
methoxyphenamine,adrenergic receptor agonist,,pulmonary,asthma,Sigma,98.67,BRD-A21474126-001-01-6,CNC(C)Cc1ccccc1OC,OEHAYUOVELTAPG-UHFFFAOYSA-N,Launched,
methscopolamine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3",gastroenterology,peptic ulcer disease (PUD),"Selleck, MicroSource, Selleck",98.54,"BRD-K48619321-004-16-8, BRD-A03932035-004-04-3, BRD-K48619321-004-17-6","C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1, C[N+]1(C)C2CC(CC1C1OC21)OC(=O)[C@@H](CO)c1ccccc1, C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1","LZCOQTDXKCNBEE-IKIFYQGPSA-N, LZCOQTDXKCNBEE-RUTJIGONSA-N, LZCOQTDXKCNBEE-IKIFYQGPSA-N",Launched,BRD-K05224916-004-01-1
methsuximide,T-type calcium channel binder,"CACNA1G, CACNA1H, CACNA1I",neurology/psychiatry,seizures,MicroSource,99.54,BRD-A57592049-001-01-6,CN1C(=O)CC(C)(C1=O)c1ccccc1,AJXPJJZHWIXJCJ-UHFFFAOYSA-N,Launched,
methyclothiazide,chloride reabsorption inhibitor,"CA1, CA2, CA4, SLC12A1, SLC12A3",cardiology,"hypertension, edema",Selleck,97.93,BRD-A95340155-001-09-7,CN1C(CCl)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O,CESYKOGBSMNBPD-UHFFFAOYSA-N,Launched,
methyl-aminolevulinate,oxidizing agent,"FCGR1A, FECH",dermatology,actinic keratosis (AK),Enzo,0,BRD-K01292611-003-17-8,COC(=O)CCC(=O)CN,YUUAYBAIHCDHHD-UHFFFAOYSA-N,Launched,
methyl-salicylate,,,"endocrinology, neurology/psychiatry","fever, pain relief",Enamine,0,BRD-K10103010-001-01-1,COC(=O)c1ccccc1O,OSWPMRLSEDHDFF-UHFFFAOYSA-N,Launched,
methyldopa,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DDC",cardiology,hypertension,"Selleck, Selleck, Tocris, MicroSource",100,"BRD-K48578705-001-17-6, BRD-K48578705-001-14-3, BRD-K48578705-001-15-0, BRD-K48578705-001-16-8","C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O, C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O, C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O, C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O","CJCSPKMFHVPWAR-JTQLQIEISA-N, CJCSPKMFHVPWAR-JTQLQIEISA-N, CJCSPKMFHVPWAR-JTQLQIEISA-N, CJCSPKMFHVPWAR-JTQLQIEISA-N",Launched,
methyldopate,,,cardiology,hypertension,Prestwick,0,BRD-K82259334-003-02-7,CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1,SVEBYYWCXTVYCR-LBPRGKRZSA-N,Launched,
methylene-blue,"guanylyl cyclase inhibitor, nitric oxide production inhibitor",ACHE,hematology,methemoglobinemia,"MicroSource, MedChemEx",47.14,"BRD-K16406336-311-02-0, BRD-K54770538-003-14-6","CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C, CN(C)c1ccc2nc3ccc(cc3sc2c1)=[N+](C)C","RBTBFTRPCNLSDE-UHFFFAOYSA-N, RBTBFTRPCNLSDE-UHFFFAOYSA-N",Launched,
methylergometrine,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C","hematology, neurology/psychiatry","postpartum hemorrhage (PPH), migraine headache","Tocris, MicroSource",91.71,"BRD-K34685430-050-11-7, BRD-K34685430-050-12-5","CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34, CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34","UNBRKDKAWYKMIV-QWQRMKEZSA-N, UNBRKDKAWYKMIV-QWQRMKEZSA-N",Launched,
methylnaltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1",gastroenterology,constipation,MedChemEx,96.91,BRD-K33732501-004-01-0,C[N@@+]1(CC2CC2)CC[C@@]23[C@H]4Oc5c2c(C[C@@H]1[C@@]3(O)CCC4=O)ccc5O,JVLBPIPGETUEET-RESYIPQXSA-O,Launched,
methylparaben,other antifungal,,dermatology,cosmetic,Enamine,0,BRD-K78321730-001-10-8,COC(=O)c1ccc(O)cc1,LXCFILQKKLGQFO-UHFFFAOYSA-N,Launched,
methylphenidate,dopamine-norepinephrine reuptake inhibitor,"SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,"attention-deficit/hyperactivity disorder (ADHD), narcolepsy",MicroSource,96.03,BRD-A19585813-003-03-3,COC(=O)C(C1CCCCN1)c1ccccc1,DUGOZIWVEXMGBE-UHFFFAOYSA-N,Launched,
methylprednisolone,glucocorticoid receptor agonist,NR3C1,"endocrinology, rheumatology, dermatology, infectious disease, allergy, hematology, neurology/psychiatry, gastroenterology","hypercalcemia, thyroiditis, ankylosing spondylitis, bursitis, osteoarthritis, psoriatic arthritis, seborrheic dermatitis, mycosis, allergic rhinitis, psoriasis, anemia, multiple sclerosis, ulcerative colitis, enteritis","Tocris, Selleck, MicroSource",95.49,"BRD-K35240538-001-24-7, BRD-K35240538-001-25-4, BRD-K35240538-001-26-2","C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12, C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12","VHRSUDSXCMQTMA-PJHHCJLFSA-N, VHRSUDSXCMQTMA-PJHHCJLFSA-N, VHRSUDSXCMQTMA-PJHHCJLFSA-N",Launched,"BRD-K99443616-001-01-3, BRD-A53176877-001-04-3"
methylprednisolone-aceponate,"anti-inflammatory agent, glucocorticoid receptor agonist",NR3C1,"endocrinology, rheumatology, infectious disease, allergy, pulmonary, gastroenterology, dermatology, neurology/psychiatry, hematology","congenital adrenal hyperplasia, thyroiditis, hypercalcemia, rheumatoid arthritis, bursitis, epicondylitis, allergic rhinitis, asthma, ulcerative colitis, enteritis, osteoarthritis, psoriasis, multiple sclerosis, anemia",Alinda,97.13,BRD-K24452555-001-01-7,CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O,DALKLAYLIPSCQL-YPYQNWSCSA-N,Launched,
methylprednisolone-sodium-succinate,glucocorticoid receptor agonist,,"endocrinology, rheumatology, dermatology, pulmonary, allergy, infectious disease, ophthalmology, gastroenterology, hematology, neurology/psychiatry","hypercalcemia, thyroiditis, osteoarthritis, rheumatoid arthritis, seborrheic dermatitis, asthma, allergic rhinitis, shingles, conjunctivitis, ulcerative colitis, enteritis, anemia, multiple sclerosis, mycosis",MicroSource,85.4,BRD-A45044890-236-02-3,C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12,IMBXEJJVJRTNOW-RCSGDJEUSA-N,Launched,
methylthiouracil,,,endocrinology,hyperthyroidism,"MicroSource, Selleck",100,"BRD-K11900042-001-14-4, BRD-K11900042-001-13-6","Cc1cc(=O)[nH]c(=S)[nH]1, Cc1cc(=O)[nH]c(=S)[nH]1","HWGBHCRJGXAGEU-UHFFFAOYSA-N, HWGBHCRJGXAGEU-UHFFFAOYSA-N",Launched,
methysergide,serotonin receptor antagonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",neurology/psychiatry,headache,Tocris,61.35,BRD-K35941380-050-27-9,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,KPJZHOPZRAFDTN-ZRGWGRIASA-N,Launched,
meticrane,diuretic,,cardiology,edema,"Selleck, MicroSource",97.99,"BRD-K58265391-001-11-9, BRD-K58265391-001-12-7","Cc1cc2CCCS(=O)(=O)c2cc1S(N)(=O)=O, Cc1cc2CCCS(=O)(=O)c2cc1S(N)(=O)=O","FNQQBFNIYODEMB-UHFFFAOYSA-N, FNQQBFNIYODEMB-UHFFFAOYSA-N",Launched,
metirosine,tyrosine hydroxylase inhibitor,TH,cardiology,hypertension,Enamine,85.79,BRD-K83766205-001-03-8,C[C@](N)(Cc1ccc(O)cc1)C(O)=O,NHTGHBARYWONDQ-JTQLQIEISA-N,Launched,
metixene,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",neurology/psychiatry,Parkinson's Disease,Prestwick,97.52,BRD-A33711280-003-03-1,CN1CCCC(CC2c3ccccc3Sc3ccccc23)C1,MJFJKKXQDNNUJF-UHFFFAOYSA-N,Launched,
metoclopramide,"dopamine receptor antagonist, serotonin receptor antagonist","CHRM1, DRD2, HTR3A, HTR3B, HTR4",gastroenterology,"gastroparesis, nausea, vomiting",MicroSource,98.56,BRD-K75641298-003-25-0,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,TTWJBBZEZQICBI-UHFFFAOYSA-N,Launched,
metocurine,acetylcholine receptor antagonist,"CHRM2, CHRNA2",neurology/psychiatry,muscle relaxant,Specs,96.67,BRD-K16484091-001-01-1,COc1ccc2C[C@@H]3c4c(CC[N+]3(C)C)cc(OC)c(OC)c4Oc3ccc(C[C@H]4c5cc(Oc1c2)c(OC)cc5CC[N+]4(C)C)cc3,JFXBEKISTKFVAB-AJQTZOPKSA-N,Launched,
metolazone,carbonic anhydrase inhibitor,SLC12A3,cardiology,"edema, hypertension","Selleck, MicroSource, Selleck",97.53,"BRD-A61793559-001-16-4, BRD-A61793559-001-15-6, BRD-A61793559-001-14-9","CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O, CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O, CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O","AQCHWTWZEMGIFD-UHFFFAOYSA-N, AQCHWTWZEMGIFD-UHFFFAOYSA-N, AQCHWTWZEMGIFD-UHFFFAOYSA-N",Launched,
metoprolol,adrenergic receptor antagonist,"ADRB1, ADRB2",cardiology,"hypertension, angina pectoris, myocardial infarction","Tocris, MicroSource, Selleck",98.88,"BRD-A03623303-046-15-0, BRD-A03623303-045-09-5, BRD-A03623303-046-14-3","COCCc1ccc(OCC(O)CNC(C)C)cc1, COCCc1ccc(OCC(O)CNC(C)C)cc1, COCCc1ccc(OCC(O)CNC(C)C)cc1","IUBSYMUCCVWXPE-UHFFFAOYSA-N, IUBSYMUCCVWXPE-UHFFFAOYSA-N, IUBSYMUCCVWXPE-UHFFFAOYSA-N",Launched,"BRD-M45038741-045-02-7, BRD-M45038741-046-05-8"
metoxibutropate,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,Specs,96.65,BRD-A71725768-001-01-3,COc1ccccc1OC(=O)C(C)c1ccc(CC(C)C)cc1,FVRWRGBTEHAPDI-UHFFFAOYSA-N,Launched,
metrizamide,radiopaque medium,,radiology,contrast agent,Selleck,91.39,BRD-A45543382-001-10-0,CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c1I,BAQCROVBDNBEEB-UBYUBLNFSA-N,Launched,
metrizoic-acid,radiopaque medium,,radiology,contrast agent,"Sigma, TCI",89.37,"BRD-K99241550-001-04-3, BRD-K99241550-001-03-5","CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I, CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I","GGGDNPWHMNJRFN-UHFFFAOYSA-N, GGGDNPWHMNJRFN-UHFFFAOYSA-N",Launched,
metronidazole,DNA inhibitor,"CYP2C9, CYP3A4",dermatology,rosacea,"Selleck, MicroSource",99.43,"BRD-K52020312-001-25-0, BRD-K52020312-001-26-8","Cc1ncc(n1CCO)[N+]([O-])=O, Cc1ncc(n1CCO)[N+]([O-])=O","VAOCPAMSLUNLGC-UHFFFAOYSA-N, VAOCPAMSLUNLGC-UHFFFAOYSA-N",Launched,
metyrapone,cytochrome P450 inhibitor,CYP11B1,nephrology,adrenal diagnostic agent,"Tocris, MicroSource, MedChemEx",92.16,"BRD-K46862739-001-15-0, BRD-K46862739-001-13-5, BRD-K46862739-001-14-3","CC(C)(C(=O)c1cccnc1)c1cccnc1, CC(C)(C(=O)c1cccnc1)c1cccnc1, CC(C)(C(=O)c1cccnc1)c1cccnc1","FJLBFSROUSIWMA-UHFFFAOYSA-N, FJLBFSROUSIWMA-UHFFFAOYSA-N, FJLBFSROUSIWMA-UHFFFAOYSA-N",Launched,
mexiletine,sodium channel blocker,"AHR, SCN4A, SCN5A",cardiology,"ventricular arrhythmias, ventricular tachycardia (VT)","MicroSource, Tocris, Tocris, Selleck",98.76,"BRD-A64092382-003-18-3, BRD-A64092382-003-17-5, BRD-A64092382-003-19-1, BRD-A64092382-003-16-7","CC(N)COc1c(C)cccc1C, CC(N)COc1c(C)cccc1C, CC(N)COc1c(C)cccc1C, CC(N)COc1c(C)cccc1C","VLPIATFUUWWMKC-UHFFFAOYSA-N, VLPIATFUUWWMKC-UHFFFAOYSA-N, VLPIATFUUWWMKC-UHFFFAOYSA-N, VLPIATFUUWWMKC-UHFFFAOYSA-N",Launched,
mezlocillin,bacterial cell wall synthesis inhibitor,,infectious disease,"gram-negative bacterial infections, gram-positive bacterial infections","Selleck, Selleck",88.63,"BRD-K45114938-236-02-6, BRD-K45114938-236-01-8","CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)c3ccccc3)C(=O)N2[C@@H]1C(O)=O, CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(C3=O)S(C)(=O)=O)c3ccccc3)C(=O)N2[C@@H]1C(O)=O","YPBATNHYBCGSSN-ZJOBFFGXSA-N, YPBATNHYBCGSSN-ZJOBFFGXSA-N",Launched,BRD-K53064842-236-01-9
mianserin,serotonin receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,depression,"Selleck, MicroSource, Tocris, Selleck",98.04,"BRD-A19661776-003-28-4, BRD-A19661776-003-27-6, BRD-A19661776-003-26-8, BRD-A19661776-003-25-0","CN1CCN2C(C1)c1ccccc1Cc1ccccc21, CN1CCN2C(C1)c1ccccc1Cc1ccccc21, CN1CCN2C(C1)c1ccccc1Cc1ccccc21, CN1CCN2C(C1)c1ccccc1Cc1ccccc21","UEQUQVLFIPOEMF-UHFFFAOYSA-N, UEQUQVLFIPOEMF-UHFFFAOYSA-N, UEQUQVLFIPOEMF-UHFFFAOYSA-N, UEQUQVLFIPOEMF-UHFFFAOYSA-N",Launched,
micafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,infectious disease,"candidemia, peritonitis, esophageal candidiasis","MedChemEx, MedChemEx, MedChemEx, Enzo",83.81,"BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4","CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O, CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)NC1C[C@@H](O)[C@@H](O)NC(=O)C2[C@@H](O)[C@@H](C)CN2C(=O)C(NC(=O)C(NC(=O)C2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O, CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O, CCCCCOc1ccc(cc1)-c1cc(no1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)C(NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)c(OS(O)(=O)=O)c1)[C@H](O)CC(N)=O","PIEUQSKUWLMALL-YABMTYFHSA-N, PIEUQSKUWLMALL-LZQXLXGFSA-N, PIEUQSKUWLMALL-YABMTYFHSA-N, PIEUQSKUWLMALL-SICPAZHLSA-N",Launched,"BRD-A06596811-236-02-5, BRD-A06596811-236-01-7"
miconazole,bacterial cell wall synthesis inhibitor,"KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5","infectious disease, neurology/psychiatry","yeast infection, itching","Tocris, Selleck, Selleck, MicroSource",99.92,"BRD-A82396632-008-30-8, BRD-A82396632-001-16-2, BRD-A82396632-008-28-2, BRD-A82396632-008-29-0","Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1, Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1, Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1, Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1","BYBLEWFAAKGYCD-UHFFFAOYSA-N, BYBLEWFAAKGYCD-UHFFFAOYSA-N, BYBLEWFAAKGYCD-UHFFFAOYSA-N, BYBLEWFAAKGYCD-UHFFFAOYSA-N",Launched,
micronomicin,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections,AvaChem,0,BRD-K18552138-001-01-8,CNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1,DNYGXMICFMACRA-XHEDQWPISA-N,Launched,
midecamycin,protein synthesis inhibitor,,infectious disease,"respiratory tract infections, ear infections, skin infections",AvaChem,0,BRD-K68822425-001-01-6,CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C,DMUAPQTXSSNEDD-QALJCMCCSA-N,Launched,
midodrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D",cardiology,hypotension,MicroSource,96.09,BRD-A79981887-003-16-4,COc1ccc(OC)c(c1)C(O)CNC(=O)CN,PTKSEFOSCHHMPD-UHFFFAOYSA-N,Launched,
midostaurin,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor","FLT3, PRKCG",hematologic malignancy,acute myeloid leukemia (AML),Enzo,95.95,BRD-K13646352-001-03-8,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Launched,
mifepristone,"glucocorticoid receptor antagonist, progesterone receptor antagonist","AR, NR1I2, NR3C1, PGR",endocrinology,"hyperglycemia, diabetes mellitus","Tocris, MicroSource, Selleck, Selleck, Tocris",90.12,"BRD-K37270826-001-29-2, BRD-K37270826-001-31-8, BRD-K37270826-001-27-6, BRD-K37270826-001-30-0, BRD-K37270826-001-26-8","CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C","VKHAHZOOUSRJNA-GCNJZUOMSA-N, VKHAHZOOUSRJNA-GCNJZUOMSA-N, VKHAHZOOUSRJNA-GCNJZUOMSA-N, VKHAHZOOUSRJNA-GCNJZUOMSA-N, VKHAHZOOUSRJNA-GCNJZUOMSA-N",Launched,"BRD-A79939557-001-01-7, BRD-K46504237-001-01-5"
miglitol,glucosidase inhibitor,"GAA, GANAB, GANC, MGAM",endocrinology,diabetes mellitus,"Tocris, MicroSource, Selleck",100,"BRD-K44779798-001-10-7, BRD-A63310107-001-04-8, BRD-K44779798-001-11-5","OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO, OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO, OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO","IBAQFPQHRJAVAV-ULAWRXDQSA-N, IBAQFPQHRJAVAV-WMEPKMGJSA-N, IBAQFPQHRJAVAV-ULAWRXDQSA-N",Launched,BRD-K82665349-001-01-4
miglustat,Glycosyl transferase inhibitor,UGCG,hematology,Gaucher disease,Enzo,100,BRD-K33251802-001-01-3,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,UQRORFVVSGFNRO-UTINFBMNSA-N,Launched,
milnacipran,serotoninâ€“norepinephrine reuptake inhibitor (SNRI),"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4",rheumatology,fibromyalgia,"MicroSource, Selleck",97.86,"BRD-A15202882-003-02-7, BRD-K02227374-003-07-1","CCN(CC)C(=O)C1(CC1CN)c1ccccc1, CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c1ccccc1","GJJFMKBJSRMPLA-UHFFFAOYSA-N, GJJFMKBJSRMPLA-HIFRSBDPSA-N",Launched,
milrinone,phosphodiesterase inhibitor,"PDE2A, PDE3A, PDE3B, PDE5A",cardiology,congestive heart failure,"MicroSource, Selleck",100,"BRD-K67080878-001-16-2, BRD-K67080878-001-15-4","Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N, Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N","PZRHRDRVRGEVNW-UHFFFAOYSA-N, PZRHRDRVRGEVNW-UHFFFAOYSA-N",Launched,
miltefosine,membrane integrity inhibitor,PLA2G1B,infectious disease,leishmaniasis,MicroSource,92.47,BRD-A31811760-001-06-7,CCCCCCCCCCCCCCCCOP(O)(=O)OCC[N+](C)(C)C,PQLXHQMOHUQAKB-UHFFFAOYSA-O,Launched,
minocycline,bacterial 30S ribosomal subunit inhibitor,"ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA","endocrinology, infectious disease, ophthalmology, urology","fever, respiratory tract infections, psittacosis, trachoma, conjunctivitis, urethritis, chancroid, tularemia, cholera, brucellosis","MedChemEx, Sigma, MicroSource, Selleck, Selleck",93.08,"BRD-A69651145-003-11-4, BRD-A69651145-003-10-6, BRD-A69651145-003-07-2, BRD-A69651145-003-08-0, BRD-A69651145-003-09-8","CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C","ZZZRUAITSXLWBH-CSYJEMQYSA-N, ZZZRUAITSXLWBH-CSYJEMQYSA-N, ZZZRUAITSXLWBH-CSYJEMQYSA-N, ZZZRUAITSXLWBH-CSYJEMQYSA-N, ZZZRUAITSXLWBH-CSYJEMQYSA-N",Launched,BRD-A05311824-003-01-1
minodronic-acid,bone resorption inhibitor,"FDPS, GGPS1",orthopedics,osteoporosis,"AKSci, AvaChem",0,"BRD-K89337853-001-01-1, BRD-K89337853-001-02-9","OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O, OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O","VMMKGHQPQIEGSQ-UHFFFAOYSA-N, VMMKGHQPQIEGSQ-UHFFFAOYSA-N",Launched,
minoxidil,"KATP activator, Kir6 channel (KATP) activator, vasodilator","ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1",endocrinology,androgenetic alopecia,"Tocris, MicroSource, Selleck, Sigma, Tocris",96.36,"BRD-K06902185-001-21-9, BRD-K06902185-003-01-7, BRD-K06902185-001-16-9, BRD-K06902185-001-22-7, BRD-K06902185-001-17-7","Nc1cc(nc(N)[n+]1[O-])N1CCCCC1, Nc1cc(nc(N)[n+]1[O-])N1CCCCC1, Nc1cc(nc(N)[n+]1[O-])N1CCCCC1, Nc1cc(nc(N)[n+]1[O-])N1CCCCC1, Nc1cc(nc(N)[n+]1[O-])N1CCCCC1","ZFMITUMMTDLWHR-UHFFFAOYSA-N, ZFMITUMMTDLWHR-UHFFFAOYSA-N, ZFMITUMMTDLWHR-UHFFFAOYSA-N, ZFMITUMMTDLWHR-UHFFFAOYSA-N, ZFMITUMMTDLWHR-UHFFFAOYSA-N",Launched,BRD-K14888893-001-14-8
miocamycin,other antibiotic,,infectious disease,"urinary tract infections, chlamydia",AvaChem,92.27,BRD-K30764557-001-01-5,CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(C)=O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](OC(C)=O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C,GQNZGCARKRHPOH-RQIKCTSVSA-N,Launched,
mirabegron,adrenergic receptor agonist,"ADRB1, ADRB2, ADRB3",urology,urinary incontinence,"Selleck, Selleck",95.25,"BRD-K47949423-001-02-3, BRD-K47949423-001-03-1","Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1, Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1","PBAPPPCECJKMCM-IBGZPJMESA-N, PBAPPPCECJKMCM-IBGZPJMESA-N",Launched,
miriplatin,DNA synthesis inhibitor,,oncology,hepatocellular carcinoma (HCC),"MedChemEx, MedChemEx",0,"BRD-M78068755-001-02-0, BRD-M78068755-001-01-2","[Pt++].NC1CCCCC1N.CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O, [Pt++].NC1CCCCC1N.CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O","BGIHRZPJIYJKAZ-UHFFFAOYSA-N, BGIHRZPJIYJKAZ-UHFFFAOYSA-N",Launched,
mirodenafil,phosphodiesterase inhibitor,PDE5A,urology,erectile dysfunction,MedChemEx,97.2,BRD-K82967685-300-01-2,CCCOc1ccc(cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1)S(=O)(=O)N1CCN(CCO)CC1,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Launched,
mirtazapine,"adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,depression,"Tocris, MicroSource, Selleck, Tocris",98.93,"BRD-A64977602-001-16-7, BRD-A64977602-001-15-9, BRD-A64977602-001-13-4, BRD-A64977602-001-14-2","CN1CCN2C(C1)c1ccccc1Cc1cccnc21, CN1CCN2C(C1)c1ccccc1Cc1cccnc21, CN1CCN2C(C1)c1ccccc1Cc1cccnc21, CN1CCN2C(C1)c1ccccc1Cc1cccnc21","RONZAEMNMFQXRA-UHFFFAOYSA-N, RONZAEMNMFQXRA-UHFFFAOYSA-N, RONZAEMNMFQXRA-UHFFFAOYSA-N, RONZAEMNMFQXRA-UHFFFAOYSA-N",Launched,
misoprostol,prostanoid receptor agonist,"PTGER2, PTGER3, PTGER4, PTGIR",gastroenterology,duodenal ulcer disease,Sigma,99.4,BRD-A72351335-001-04-5,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,OJLOPKGSLYJEMD-URPKTTJQSA-N,Launched,
mitiglinide,insulin secretagogue,"ABCC8, KCNJ10, PPARG",endocrinology,diabetes mellitus,Selleck,98.47,BRD-K52959329-238-01-9,OC(=O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1,WPGGHFDDFPHPOB-BBWFWOEESA-N,Launched,BRD-M71049352-238-02-2
mitomycin-c,"DNA alkylating agent, DNA synthesis inhibitor",,oncology,"pancreatic cancer, gastric adenocarcinoma",MicroSource,99.49,BRD-A48237631-001-04-8,CO[C@@]12[C@@H]3NC3CN1C1=C([C@@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O,NWIBSHFKIJFRCO-CPKMXBGFSA-N,Launched,
mitotane,antineoplastic agent,"CYP11A1, CYP11B1, ESR1, FDX1",oncology,adrenal cortical carcinoma,"MedChemEx, MicroSource, MedChemEx, Selleck, Selleck",0,"BRD-A31204924-001-18-3, BRD-A31204924-001-14-2, BRD-A31204924-001-17-5, BRD-A31204924-001-16-7, BRD-A31204924-001-13-4","ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl, ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl, ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl, ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl, ClC(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl","JWBOIMRXGHLCPP-UHFFFAOYSA-N, JWBOIMRXGHLCPP-UHFFFAOYSA-N, JWBOIMRXGHLCPP-UHFFFAOYSA-N, JWBOIMRXGHLCPP-UHFFFAOYSA-N, JWBOIMRXGHLCPP-UHFFFAOYSA-N",Launched,
mitoxantrone,topoisomerase inhibitor,TOP2A,"neurology/psychiatry, oncology, hematologic malignancy","multiple sclerosis, prostate cancer, acute myeloid leukemia (AML)","MicroSource, Selleck, Selleck",96.64,"BRD-K21680192-300-15-1, BRD-K21680192-300-16-9, BRD-K21680192-300-14-4","OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12, OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12, OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12","KKZJGLLVHKMTCM-UHFFFAOYSA-N, KKZJGLLVHKMTCM-UHFFFAOYSA-N, KKZJGLLVHKMTCM-UHFFFAOYSA-N",Launched,
mivacurium,acetylcholine receptor antagonist,"BCHE, CHRM2, CHRM3, CHRNA2","critical care, neurology/psychiatry","endotracheal intubation, muscle relaxant",AKSci,47.83,BRD-A48465967-300-01-1,COc1cc2CC[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc3cc(OC)c(OC)c(OC)c3)[C@H](Cc3cc(OC)c(OC)c(OC)c3)c2cc1OC,ILVYCEVXHALBSC-OTBYEXOQSA-N,Launched,
mizolastine,histamine receptor antagonist,HRH1,allergy,"urticaria, allergic rhinitis",Selleck,98.43,BRD-K21884483-001-03-7,CN(C1CCN(CC1)c1nc2ccccc2n1Cc1ccc(F)cc1)c1nccc(=O)[nH]1,PVLJETXTTWAYEW-UHFFFAOYSA-N,Launched,
mizoribine,"immunosuppressant, inosine monophosphate dehydrogenase inhibitor",IMPDH1,,,"Selleck, MicroSource, Selleck",100,"BRD-K88061624-001-21-4, BRD-K88061624-001-20-6, BRD-K88061624-001-22-2","NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O, NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O, NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O","HZQDCMWJEBCWBR-UUOKFMHZSA-N, HZQDCMWJEBCWBR-UUOKFMHZSA-N, HZQDCMWJEBCWBR-UUOKFMHZSA-N",Launched,BRD-K05218031-001-01-9
moclobemide,monoamine oxidase inhibitor,"MAOA, MAOB",neurology/psychiatry,"depression, anxiety","Tocris, Selleck",94.41,"BRD-K07237224-001-20-4, BRD-K07237224-001-19-6","Clc1ccc(cc1)C(=O)NCCN1CCOCC1, Clc1ccc(cc1)C(=O)NCCN1CCOCC1","YHXISWVBGDMDLQ-UHFFFAOYSA-N, YHXISWVBGDMDLQ-UHFFFAOYSA-N",Launched,
modafinil,adrenergic receptor agonist,"ADRA1B, SLC6A3","pulmonary, neurology/psychiatry","obstructive sleep apnea, shift work disorder (SWD)",MicroSource,48.32,BRD-A16332958-001-09-9,NC(=O)CS(=O)C(c1ccccc1)c1ccccc1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,Launched,
moexipril,angiotensin converting enzyme inhibitor,"ACE, ACE2",cardiology,hypertension,"Tocris, Selleck, Selleck",93.18,"BRD-K34441861-003-06-2, BRD-K34441861-003-05-4, BRD-K34441861-003-07-0","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O","UWWDHYUMIORJTA-HSQYWUDLSA-N, UWWDHYUMIORJTA-HSQYWUDLSA-N, UWWDHYUMIORJTA-HSQYWUDLSA-N",Launched,
mofezolac,cyclooxygenase inhibitor,PTGS1,"rheumatology, orthopedics","rheumatoid arthritis, osteoporosis",Sigma,99.58,BRD-K49372556-001-04-1,COc1ccc(cc1)-c1noc(CC(O)=O)c1-c1ccc(OC)cc1,DJEIHHYCDCTAAH-UHFFFAOYSA-N,Launched,
molindone,dopamine receptor antagonist,"CHRM1, DRD2, HRH1, HTR1A, HTR2A",neurology/psychiatry,schizophrenia,MicroSource,98.2,BRD-A65280694-003-13-7,CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12,KLPWJLBORRMFGK-UHFFFAOYSA-N,Launched,
molsidomine,guanylate cyclase stimulant,GUCY1A3,cardiology,coronary artery disease (CAD),MicroSource,98.74,BRD-K63861289-001-19-6,CCOC(=O)Nc1c[n+](no1)N1CCOCC1,XLFWDASMENKTKL-UHFFFAOYSA-O,Launched,
mometasone,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,Sigma,0,BRD-K50265942-001-01-2,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Launched,
mometasone-furoate,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses,"MicroSource, Selleck",94.31,"BRD-K60640630-001-11-0, BRD-K60640630-001-10-2","C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl, C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl","WOFMFGQZHJDGCX-ZULDAHANSA-N, WOFMFGQZHJDGCX-ZULDAHANSA-N",Launched,"BRD-A01139232-001-01-0, BRD-K28476963-001-01-8"
monensin,bacterial permeability inducer,,,,"Selleck, MicroSource, Selleck",83.47,"BRD-A06627858-236-01-4, BRD-A06627858-236-03-0, BRD-A06627858-236-02-2","CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C, CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C, CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)C1O[C@H](C[C@@H]1C)C1O[C@@](O)(CO)[C@H](C)C[C@@H]1C","GAOZTHIDHYLHMS-SMJJDZSHSA-N, GAOZTHIDHYLHMS-SMJJDZSHSA-N, GAOZTHIDHYLHMS-SMJJDZSHSA-N",Launched,"BRD-A61543962-236-02-6, BRD-A09919099-236-01-1, BRD-A43972623-236-01-3"
monobenzone,melanin inhibitor,TYR,dermatology,skin depigmentation,"Selleck, MicroSource, Sigma, Selleck",77.12,"BRD-K54262262-001-11-6, BRD-K54262262-001-10-8, BRD-K54262262-001-12-4, BRD-K54262262-001-09-0","Oc1ccc(OCc2ccccc2)cc1, Oc1ccc(OCc2ccccc2)cc1, Oc1ccc(OCc2ccccc2)cc1, Oc1ccc(OCc2ccccc2)cc1","VYQNWZOUAUKGHI-UHFFFAOYSA-N, VYQNWZOUAUKGHI-UHFFFAOYSA-N, VYQNWZOUAUKGHI-UHFFFAOYSA-N, VYQNWZOUAUKGHI-UHFFFAOYSA-N",Launched,
monoctanoin,,,gastroenterology,gallstones,"Sigma, Sigma",84.6,"BRD-A48938994-001-15-8, BRD-A48938994-001-14-1","CCCCCCCC(=O)OCC(O)CO, CCCCCCCC(=O)OCC(O)CO","GHBFNMLVSPCDGN-UHFFFAOYSA-N, GHBFNMLVSPCDGN-UHFFFAOYSA-N",Launched,
monosodium-alpha-luminol,,,,,"Enamine, MedChemEx",97.04,"BRD-K52559566-001-01-1, BRD-K52559566-001-02-9","Nc1cccc2c1c(=O)[nH][nH]c2=O, Nc1cccc2c1c(=O)[nH][nH]c2=O","HWYHZTIRURJOHG-UHFFFAOYSA-N, HWYHZTIRURJOHG-UHFFFAOYSA-N",Launched,
montelukast,leukotriene receptor antagonist,"ALOX5, CYSLTR1","pulmonary, allergy","asthma, allergic rhinitis, exercise-induced bronchoconstriction (EIB)","Selleck, MicroSource, Selleck",98.68,"BRD-K69470111-236-08-9, BRD-K69470111-001-01-2, BRD-K69470111-236-09-7","CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1, CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1, CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(O)=O)CC1)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1","UCHDWCPVSPXUMX-TZIWLTJVSA-N, UCHDWCPVSPXUMX-TZIWLTJVSA-N, UCHDWCPVSPXUMX-TZIWLTJVSA-N",Launched,
moprolol,adrenergic receptor antagonist,,"cardiology, ophthalmology, neurology/psychiatry","hypertension, glaucoma, anxiety",LifeChem,95.27,BRD-A51747092-003-03-0,COc1ccccc1OCC(O)CNC(C)C,LFTFGCDECFPSQD-UHFFFAOYSA-N,Launched,
moracizine,sodium channel blocker,SCN5A,cardiology,ventricular arrhythmias,Prestwick,99.39,BRD-K21548250-003-19-1,CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN3CCOCC3)c2c1,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Launched,
morantel,acetylcholine receptor agonist,,infectious disease,tapeworm,MicroSource,55.48,BRD-K71454870-048-06-3,CN1CCCN=C1\C=C\c1sccc1C,NVEPPWDVLBMNMB-SNAWJCMRSA-N,Launched,
morinidazole,other antibiotic,CYP51A1,,,MedChemEx,85.47,BRD-A40546373-001-01-8,Cc1ncc(n1CC(O)CN1CCOCC1)[N+]([O-])=O,GAZGHCHCYRSPIV-UHFFFAOYSA-N,Launched,
morniflumate,anti-inflammatory agent,,neurology/psychiatry,pain relief,AKSci,97.89,BRD-K38938675-001-01-4,FC(F)(F)c1cccc(Nc2ncccc2C(=O)OCCN2CCOCC2)c1,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Launched,
moroxydine,antiviral,,infectious disease,influenza A virus infection,"MicroSource, Selleck",100,"BRD-K57291914-003-10-2, BRD-K57291914-003-09-4","NC(=N)NC(=N)N1CCOCC1, NC(=N)NC(=N)N1CCOCC1","KJHOZAZQWVKILO-UHFFFAOYSA-N, KJHOZAZQWVKILO-UHFFFAOYSA-N",Launched,
mosapride,serotonin receptor agonist,HTR4,gastroenterology,"hypertrophic gastritis (GHG), gastroesophageal reflux disease (GERD), dyspepsia, irritable bowel syndrome","Tocris, Selleck",98.7,"BRD-A39052811-048-12-8, BRD-A39052811-048-11-0","CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1, CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1","YPELFRMCRYSPKZ-UHFFFAOYSA-N, YPELFRMCRYSPKZ-UHFFFAOYSA-N",Launched,
moxalactam,bacterial cell wall synthesis inhibitor,,infectious disease,"skin infections, bone and joint infections, pneumonia, urinary tract infections, meningitis","MedChemEx, MicroSource, Selleck, Selleck",0,"BRD-K40831222-304-06-2, BRD-A08899266-304-05-0, BRD-K40831222-304-05-4, BRD-K40831222-304-04-7","CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)C(C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O, CO[C@]1(NC(=O)[C@H](C(O)=O)c2ccc(O)cc2)[C@H]2OCC(CSc3nnnn3C)=C(N2C1=O)C(O)=O","JWCSIUVGFCSJCK-LIUKBUMOSA-N, JWCSIUVGFCSJCK-CAVRMKNVSA-N, JWCSIUVGFCSJCK-LIUKBUMOSA-N, JWCSIUVGFCSJCK-LIUKBUMOSA-N",Launched,
moxaverine,phosphodiesterase inhibitor,,neurology/psychiatry,spasms,Innovapharm,99.2,BRD-K12742203-003-01-7,CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1,MYCMTMIGRXJNSO-UHFFFAOYSA-N,Launched,
moxidectin,chloride channel antagonist,,infectious disease,gastrointestinal parasites,MicroSource,92.02,BRD-K61988078-001-01-2,CO\N=C1\C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@@H]([C@H]1C)C(\C)=C\C(C)C,YZBLFMPOMVTDJY-CBYMMZEQSA-N,Launched,
moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A,"otolaryngology, pulmonary, infectious disease","sinusitis, bronchitis, pneumonia, skin infections, intra-abdominal infections","MicroSource, Selleck",92.59,"BRD-K66615216-003-14-8, BRD-K66615216-003-13-0","COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1, COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1","FABPRXSRWADJSP-MEDUHNTESA-N, FABPRXSRWADJSP-MEDUHNTESA-N",Launched,
moxonidine,imidazoline receptor agonist,"ADRA2A, ADRA2B, ADRA2C",cardiology,hypertension,"Tocris, Tocris, Selleck",96.96,"BRD-K77771411-003-10-7, BRD-K77771411-003-12-3, BRD-K77771411-001-12-7","COc1nc(C)nc(Cl)c1NC1=NCCN1, COc1nc(C)nc(Cl)c1NC1=NCCN1, COc1nc(C)nc(Cl)c1NC1=NCCN1","WPNJAUFVNXKLIM-UHFFFAOYSA-N, WPNJAUFVNXKLIM-UHFFFAOYSA-N, WPNJAUFVNXKLIM-UHFFFAOYSA-N",Launched,
mozavaptan,vasopressin receptor antagonist,"AVPR1A, AVPR1B, AVPR2",endocrinology,hyponatremia,Selleck,97.07,BRD-A31095847-001-02-3,CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12,WRNXUQJJCIZICJ-UHFFFAOYSA-N,Launched,
mupirocin,isoleucyl-tRNA synthetase inhibitor,,infectious disease,impetigo,"MicroSource, MedChemEx, Selleck",93.41,"BRD-K15262564-001-14-3, BRD-K15262564-001-15-0, BRD-K15262564-001-16-8","C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O, C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O, C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O","MINDHVHHQZYEEK-HBBNESRFSA-N, MINDHVHHQZYEEK-HBBNESRFSA-N, MINDHVHHQZYEEK-HBBNESRFSA-N",Launched,BRD-K25394084-001-01-0
mycophenolate-mofetil,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2",transplant,organ rejection,"Tocris, MicroSource, Selleck",95.21,"BRD-K92428153-001-07-7, BRD-K92428153-001-05-1, BRD-K92428153-001-04-4","COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(=O)OCCN1CCOCC1, COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(=O)OCCN1CCOCC1, COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(=O)OCCN1CCOCC1","RTGDFNSFWBGLEC-SYZQJQIISA-N, RTGDFNSFWBGLEC-SYZQJQIISA-N, RTGDFNSFWBGLEC-SYZQJQIISA-N",Launched,
mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","IMPDH1, IMPDH2",transplant,organ rejection,"Tocris, MicroSource, Selleck, Tocris",98.39,"BRD-K63750851-001-22-3, BRD-K63750851-001-20-7, BRD-K63750851-001-18-1, BRD-K63750851-001-19-9","COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O, COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O, COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O, COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)CCC(O)=O","HPNSFSBZBAHARI-RUDMXATFSA-N, HPNSFSBZBAHARI-RUDMXATFSA-N, HPNSFSBZBAHARI-RUDMXATFSA-N, HPNSFSBZBAHARI-RUDMXATFSA-N",Launched,
N-acetyl-tyrosine,,,,,Enamine,96.39,BRD-A24857382-001-03-4,CC(=O)NC(Cc1ccc(O)cc1)C(O)=O,CAHKINHBCWCHCF-UHFFFAOYSA-N,Launched,
nabumetone,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"rheumatoid arthritis, osteoarthritis","MicroSource, Selleck",99.57,"BRD-K65146499-001-27-9, BRD-K65146499-001-26-1","COc1ccc2cc(CCC(C)=O)ccc2c1, COc1ccc2cc(CCC(C)=O)ccc2c1","BLXXJMDCKKHMKV-UHFFFAOYSA-N, BLXXJMDCKKHMKV-UHFFFAOYSA-N",Launched,
nadide,electron acceptor,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2",,,MicroSource,86.18,BRD-A11132253-001-08-2,NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O,BAWFJGJZGIEFAR-NNYOXOHSSA-O,Launched,
nadifloxacin,bacterial DNA gyrase inhibitor,,"dermatology, infectious disease","acne vulgaris (AV), skin infections","MicroSource, Selleck",99.02,"BRD-A24397426-001-10-4, BRD-A24397426-001-09-6","CC1CCc2c(N3CCC(O)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O, CC1CCc2c(N3CCC(O)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O","JYJTVFIEFKZWCJ-UHFFFAOYSA-N, JYJTVFIEFKZWCJ-UHFFFAOYSA-N",Launched,
nadolol,adrenergic receptor antagonist,"ADRB1, ADRB2, ADRB3",cardiology,"angina pectoris, hypertension","MicroSource, Sigma",63.89,"BRD-A87606379-001-22-4, BRD-A87606379-001-23-2","CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12, CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12","VWPOSFSPZNDTMJ-UCWKZMIHSA-N, VWPOSFSPZNDTMJ-UCWKZMIHSA-N",Launched,
nafamostat,serine protease inhibitor,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7",,,"Selleck, Tocris, Selleck",89.75,"BRD-K06674495-334-04-0, BRD-K06674495-334-05-7, BRD-K06674495-334-03-2","NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N, NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N, NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N","MQQNFDZXWVTQEH-UHFFFAOYSA-N, MQQNFDZXWVTQEH-UHFFFAOYSA-N, MQQNFDZXWVTQEH-UHFFFAOYSA-N",Launched,
nafcillin,bacterial cell wall synthesis inhibitor,"CYP1A2, CYP3A4, SLC22A6",infectious disease,gram-positive bacterial infections,"Selleck, MicroSource, Selleck",96.54,"BRD-K18574842-323-11-6, BRD-K18574842-236-17-7, BRD-K18574842-323-10-8","CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O, CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O, CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O","GPXLMGHLHQJAGZ-JTDSTZFVSA-N, GPXLMGHLHQJAGZ-JTDSTZFVSA-N, GPXLMGHLHQJAGZ-JTDSTZFVSA-N",Launched,BRD-K96812051-323-01-2
naftidrofuryl,adrenergic receptor antagonist,,cardiology,claudication,MicroSource,92.27,BRD-A67862938-034-14-9,CCN(CC)CCOC(=O)C(CC1CCCO1)Cc1cccc2ccccc12,KBAFPSLPKGSANY-UHFFFAOYSA-N,Launched,
naftifine,fungal squalene epoxidase inhibitor,SQLE,infectious disease,"tinea pedis, tinea cruris, tinea corporis","MicroSource, Selleck",98.83,"BRD-K74141488-003-11-2, BRD-K74141488-003-10-4","CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12, CN(C\C=C\c1ccccc1)Cc1cccc2ccccc12","OZGNYLLQHRPOBR-DHZHZOJOSA-N, OZGNYLLQHRPOBR-DHZHZOJOSA-N",Launched,
naftopidil,adrenergic receptor antagonist,ADRA1A,urology,benign prostatic hyperplasia (BPH),"Selleck, Tocris, Selleck, Selleck, Selleck, Tocris, MicroSource",99.08,"BRD-A01787639-300-09-4, BRD-A01787639-003-17-7, BRD-A01787639-300-08-6, BRD-A01787639-001-06-4, BRD-A01787639-001-08-0, BRD-A01787639-003-16-9, BRD-A01787639-001-07-2","COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1, COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1, COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1, COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1, COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1, COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1, COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1","HRRBJVNMSRJFHQ-UHFFFAOYSA-N, HRRBJVNMSRJFHQ-UHFFFAOYSA-N, HRRBJVNMSRJFHQ-UHFFFAOYSA-N, HRRBJVNMSRJFHQ-UHFFFAOYSA-N, HRRBJVNMSRJFHQ-UHFFFAOYSA-N, HRRBJVNMSRJFHQ-UHFFFAOYSA-N, HRRBJVNMSRJFHQ-UHFFFAOYSA-N",Launched,
nalbuphine,"opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1",neurology/psychiatry,pain relief,"MicroSource, Enzo",91.8,"BRD-K66404838-001-02-4, BRD-K66404838-310-01-1","O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45, O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45","NETZHAKZCGBWSS-CEDHKZHLSA-N, NETZHAKZCGBWSS-CEDHKZHLSA-N",Launched,BRD-A92651262-003-04-7
nalfurafine,opioid receptor agonist,"OPRK1, OPRM1",nephrology,uremic pruritus,MedChemEx,97.5,BRD-K89272869-003-01-8,CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45)C(=O)\C=C\c1ccoc1,XGZZHZMWIXFATA-UEZBDDGYSA-N,Launched,
nalidixic-acid,bacterial DNA gyrase inhibitor,,infectious disease,urinary tract infections,"MicroSource, Selleck",97.94,"BRD-K47886988-001-22-2, BRD-K47886988-001-21-4","CCn1cc(C(O)=O)c(=O)c2ccc(C)nc12, CCn1cc(C(O)=O)c(=O)c2ccc(C)nc12","MHWLWQUZZRMNGJ-UHFFFAOYSA-N, MHWLWQUZZRMNGJ-UHFFFAOYSA-N",Launched,
nalmefene,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1",pulmonary,respiratory depression,"Tocris, Selleck",96.81,"BRD-K68407436-003-02-7, BRD-A72767275-003-01-6","Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=C)CC[C@@]35O, Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=C)CCC35O","WJBLNOPPDWQMCH-MBPVOVBZSA-N, WJBLNOPPDWQMCH-UHFFFAOYSA-N",Launched,
naloxegol,opioid receptor antagonist,OPRM1,gastroenterology,constipation,MedChemEx,88.98,BRD-K41458421-034-01-6,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC=C)c45,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,Launched,
naloxone,opioid receptor antagonist,"CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4",pulmonary,respiratory depression,"Selleck, Selleck, Tocris, MicroSource",87.7,"BRD-K67511046-003-16-9, BRD-K67511046-003-14-4, BRD-K67511046-003-15-1, BRD-K67511046-001-02-3","Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O, Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O, Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O, Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O","UZHSEJADLWPNLE-GRGSLBFTSA-N, UZHSEJADLWPNLE-GRGSLBFTSA-N, UZHSEJADLWPNLE-GRGSLBFTSA-N, UZHSEJADLWPNLE-GRGSLBFTSA-N",Launched,BRD-A23195370-003-01-4
naltrexone,opioid receptor antagonist,"OPRD1, OPRK1, OPRM1, SIGMAR1",neurology/psychiatry,abstinence from alcohol,"MicroSource, Selleck, Selleck",93.54,"BRD-K88172511-003-21-1, BRD-K88172511-003-19-5, BRD-K88172511-003-20-3","Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O, Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O, Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O","DQCKKXVULJGBQN-XFWGSAIBSA-N, DQCKKXVULJGBQN-XFWGSAIBSA-N, DQCKKXVULJGBQN-XFWGSAIBSA-N",Launched,BRD-A66559694-003-01-8
nandrolone,imidazoline receptor agonist,"AR, CYP19A1, MAOA, MAOB",hematology,anemia,"MedChemEx, MedChemEx",95.76,"BRD-K52080565-001-09-2, BRD-K52080565-001-10-0","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O","NPAGDVCDWIYMMC-IZPLOLCNSA-N, NPAGDVCDWIYMMC-IZPLOLCNSA-N",Launched,
naphazoline,adrenergic receptor agonist,"ADRA1A, ADRA2A",ophthalmology,eye irritation,"Selleck, MicroSource",98.84,"BRD-K77641333-003-26-3, BRD-K77641333-003-27-1","C(C1=NCCN1)c1cccc2ccccc12, C(C1=NCCN1)c1cccc2ccccc12","CNIIGCLFLJGOGP-UHFFFAOYSA-N, CNIIGCLFLJGOGP-UHFFFAOYSA-N",Launched,
naphthoquine-phosphate,antimalarial agent,,,,"MedChemEx, MedChemEx, MedChemEx",79.04,"BRD-K13664493-316-02-5, BRD-K13664493-316-01-7, BRD-K13664493-316-03-3","CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O, CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O, CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O","VEVMYTDOWUQLGI-UHFFFAOYSA-N, VEVMYTDOWUQLGI-UHFFFAOYSA-N, VEVMYTDOWUQLGI-UHFFFAOYSA-N",Launched,
naproxen,cyclooxygenase inhibitor,"PTGS1, PTGS2","neurology/psychiatry, rheumatology, dental, otolaryngology, endocrinology","pain relief, rheumatoid arthritis, headache, toothache, backache, muscle pain, common cold, fever","Selleck, Tocris, Selleck, MicroSource",99.66,"BRD-K59197931-236-22-9, BRD-K59197931-236-21-1, BRD-K59197931-236-20-3, BRD-K59197931-001-04-5","COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O, COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O, COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O, COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O","CMWTZPSULFXXJA-VIFPVBQESA-N, CMWTZPSULFXXJA-VIFPVBQESA-N, CMWTZPSULFXXJA-VIFPVBQESA-N, CMWTZPSULFXXJA-VIFPVBQESA-N",Launched,
narasin,antiprotozoal agent,,infectious disease,coccidiosis,MicroSource,100,BRD-A25608658-001-01-1,CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)C4CC[C@](O)(CC)[C@H](C)O4)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(O)=O,VHKXXVVRRDYCIK-HNOFAURLSA-N,Launched,
naratriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",neurology/psychiatry,migraine headache,"Selleck, Selleck",88.86,"BRD-K61337602-003-03-9, BRD-K61337602-003-02-1","CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1, CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1","AMKVXSZCKVJAGH-UHFFFAOYSA-N, AMKVXSZCKVJAGH-UHFFFAOYSA-N",Launched,
natamycin,fungal ergosterol inhibitor,,"ophthalmology, infectious disease","conjunctivitis, fungal keratosis, blepharitis","MicroSource, MedChemEx, MedChemEx, Sigma, Selleck, Selleck",91.43,"BRD-K90563805-213-01-9, BRD-K90563805-001-03-4, BRD-K90563805-001-04-2, BRD-K90563805-001-02-6, BRD-K90563805-001-05-9, BRD-K90563805-001-06-7","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O","NCXMLFZGDNKEPB-FFPOYIOWSA-N, NCXMLFZGDNKEPB-FFPOYIOWSA-N, NCXMLFZGDNKEPB-FFPOYIOWSA-N, NCXMLFZGDNKEPB-FFPOYIOWSA-N, NCXMLFZGDNKEPB-FFPOYIOWSA-N, NCXMLFZGDNKEPB-FFPOYIOWSA-N",Launched,"BRD-A00398769-213-01-5, BRD-K40312300-001-01-1, BRD-A55960065-001-01-6,BRD-A00773244-001-01-3, BRD-A55960065-001-02-4,BRD-K63692151-001-01-8"
nateglinide,insulin secretagogue,"ABCC8, KCNJ10, KCNJ11, PPARG",endocrinology,diabetes mellitus,"Tocris, MicroSource, Tocris, Selleck",98.07,"BRD-K44353683-001-10-9, BRD-K84658672-001-04-8, BRD-K44353683-001-08-3, BRD-K44353683-001-07-5","CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O, CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O, CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O, CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O","OELFLUMRDSZNSF-BRWVUGGUSA-N, OELFLUMRDSZNSF-ULQDDVLXSA-N, OELFLUMRDSZNSF-BRWVUGGUSA-N, OELFLUMRDSZNSF-BRWVUGGUSA-N",Launched,
nebivolol,adrenergic receptor antagonist,"ADRB1, ADRB2",cardiology,hypertension,"Tocris, Tocris, Selleck, MicroSource",94.76,"BRD-K04956647-003-03-3, BRD-K04956647-003-04-1, BRD-K04956647-003-02-5, BRD-A53597562-003-01-2","O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1, O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1, O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1, OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1","KOHIRBRYDXPAMZ-YHBROIRLSA-N, KOHIRBRYDXPAMZ-YHBROIRLSA-N, KOHIRBRYDXPAMZ-YHBROIRLSA-N, KOHIRBRYDXPAMZ-UHFFFAOYSA-N",Launched,
NECA,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1",,,"Tocris, Tocris",98.69,"BRD-K14395568-001-17-1, BRD-K14395568-001-16-3","CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12, CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12","JADDQZYHOWSFJD-FLNNQWSLSA-N, JADDQZYHOWSFJD-FLNNQWSLSA-N",Launched,
nedaplatin,DNA inhibitor,,,,"MedChemEx, MedChemEx",0,"BRD-K38820178-001-01-6, BRD-K73469236-001-01-8","N[Pt++]1(N)OCC(=O)O1, N[Pt]1(N)OCC(=O)O1","DVUJFSXMTBOIKW-UHFFFAOYSA-M, GRHLMSBCOPRFNA-UHFFFAOYSA-M",Launched,"BRD-U66818247-000-01-2, BRD-K34751753-318-01-8,BRD-U48121946-000-01-8"
nedocromil,histamine receptor antagonist,"CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR","neurology/psychiatry, ophthalmology","itching, conjunctivitis","MedChemEx, MedChemEx, MedChemEx",91.97,"BRD-K64716392-001-02-1, BRD-K64716392-001-01-3, BRD-K64716392-001-03-9","CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O, CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O, CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O","RQTOOFIXOKYGAN-UHFFFAOYSA-N, RQTOOFIXOKYGAN-UHFFFAOYSA-N, RQTOOFIXOKYGAN-UHFFFAOYSA-N",Launched,
nefopam,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief,"Selleck, MicroSource",98.6,"BRD-A78877355-003-11-9, BRD-A78877355-001-03-0","CN1CCOC(c2ccccc2)c2ccccc2C1, CN1CCOC(c2ccccc2)c2ccccc2C1","RGPDEAGGEXEMMM-UHFFFAOYSA-N, RGPDEAGGEXEMMM-UHFFFAOYSA-N",Launched,
nelarabine,"DNA synthesis inhibitor, T cell inhibitor",POLA1,hematologic malignancy,"acute lymphoblastic leukemia (ALL), acute lymphoblastic leukemia (ALL)",Selleck,98.35,BRD-K84466663-001-05-4,COc1nc(N)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,Launched,
nelfinavir,HIV protease inhibitor,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7",infectious disease,human immunodeficiency virus (HIV-1),Enzo,98.14,BRD-K74117820-066-10-8,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Launched,
nemonapride,dopamine receptor antagonist,"DRD2, DRD3, DRD4",neurology/psychiatry,schizophrenia,"Tocris, Tocris",96.75,"BRD-M80207679-001-02-3, BRD-M80207679-001-01-5","CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C, CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C","QCYCDKUNJFKYEI-ZVWWNKPMSA-N, QCYCDKUNJFKYEI-ZVWWNKPMSA-N",Launched,
neo-gilurytmal,,,,,InterBioScreen,83.33,BRD-A53539450-004-01-7,CCC[N+]12[C@H]3C[C@]45C(O)C3[C@@H](CC1[C@@H]4N(C)c1ccccc51)[C@H](CC)[C@H]2O,UAUHEPXILIZYCU-CQSZUQOFSA-N,Launched,
neomycin,bacterial 30S ribosomal subunit inhibitor,CXCR4,"gastroenterology, infectious disease","hepatic encephalopathy (HE), intra-abdominal infections","MedChemEx, Sigma, MedChemEx, Selleck",0,"BRD-K71013094-326-02-6, BRD-K71013094-001-02-5, BRD-K71013094-326-01-8, BRD-K71013094-065-04-6","NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","PGBHMTALBVVCIT-VCIWKGPPSA-N, PGBHMTALBVVCIT-VCIWKGPPSA-N, PGBHMTALBVVCIT-VCIWKGPPSA-N, PGBHMTALBVVCIT-VCIWKGPPSA-N",Launched,"BRD-M08953053-001-01-9, BRD-A35132579-065-01-1"
neomycin-sulfate,bacterial 30S ribosomal subunit inhibitor,,infectious disease,first-aid antibiotic,"Selleck, MicroSource",0,"BRD-K71013094-065-05-3, BRD-K71013094-326-03-4","NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","PGBHMTALBVVCIT-VCIWKGPPSA-N, PGBHMTALBVVCIT-VCIWKGPPSA-N",Launched,"BRD-A93778806-065-02-3, BRD-A93490927-326-01-7"
neostigmine,acetylcholinesterase inhibitor,ACHE,neurology/psychiatry,myasthenia gravis,"Selleck, Selleck, MicroSource",95.35,"BRD-K18922609-004-24-9, BRD-K18922609-004-22-3, BRD-K18922609-004-23-1","CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C, CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C, CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C","ALWKGYPQUAPLQC-UHFFFAOYSA-N, ALWKGYPQUAPLQC-UHFFFAOYSA-N, ALWKGYPQUAPLQC-UHFFFAOYSA-N",Launched,
nepafenac,cyclooxygenase inhibitor,"PTGS1, PTGS2",ophthalmology,eye inflammation,Selleck,97.8,BRD-K04112579-001-07-0,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,QEFAQIPZVLVERP-UHFFFAOYSA-N,Launched,
neridronic-acid,bone resorption inhibitor,FDPS,endocrinology,"brittle bone disease, Paget's disease",Toronto,0,BRD-K60212747-236-01-1,NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O,PUUSSSIBPPTKTP-UHFFFAOYSA-N,Launched,
netilmicin,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections,"MicroSource, MedChemEx, Selleck, Selleck",100,"BRD-A59825838-315-02-5, BRD-A59825838-326-01-4, BRD-A59825838-315-03-3, BRD-A59825838-315-04-1","CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O, CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O, CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O, CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1OC1OC[C@](C)(O)[C@H](NC)[C@H]1O","CIDUJQMULVCIBT-OHMMYJSPSA-N, CIDUJQMULVCIBT-OHMMYJSPSA-N, CIDUJQMULVCIBT-OHMMYJSPSA-N, CIDUJQMULVCIBT-OHMMYJSPSA-N",Launched,"BRD-M29626677-343-03-4, BRD-A79774694-315-01-6,BRD-M03948854-343-01-1, BRD-A79774694-315-02-4,BRD-M53946149-343-02-7"
netupitant,tachykinin antagonist,TACR1,gastroenterology,"nausea, vomiting",MedChemEx,97.52,BRD-K97428065-001-01-2,CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Launched,
nevirapine,non-nucleoside reverse transcriptase inhibitor,"CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5",infectious disease,human immunodeficiency virus (HIV-1),"MicroSource, Selleck",99.37,"BRD-K15502390-001-20-9, BRD-K15502390-001-19-1","Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1, Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1","NQDJXKOVJZTUJA-UHFFFAOYSA-N, NQDJXKOVJZTUJA-UHFFFAOYSA-N",Launched,
niacin,"NAD precursor, vitamin B","DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT",endocrinology,hypertriglyceridemia,"Selleck, Selleck, MicroSource",91.85,"BRD-K60237333-001-28-9, BRD-K60237333-001-26-3, BRD-K60237333-001-27-1","OC(=O)c1cccnc1, OC(=O)c1cccnc1, OC(=O)c1cccnc1","PVNIIMVLHYAWGP-UHFFFAOYSA-N, PVNIIMVLHYAWGP-UHFFFAOYSA-N, PVNIIMVLHYAWGP-UHFFFAOYSA-N",Launched,
nicardipine,calcium channel blocker,"ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B",cardiology,"chronic stable angina, hypertension","Selleck, MicroSource",97.24,"BRD-A26711594-003-08-0, BRD-A26711594-003-10-6","COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1, COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1","ZBBHBTPTTSWHBA-UHFFFAOYSA-N, ZBBHBTPTTSWHBA-UHFFFAOYSA-N",Launched,
nicergoline,adrenergic receptor antagonist,ADRA1A,"rheumatology, neurology/psychiatry, cardiology, hematology","Raynaud's disease, migraine headache, atherosclerosis, thrombosis, Raynaud's disease, migraine headache, atherosclerosis, thrombosis","Tocris, MicroSource",96.16,"BRD-K76810206-001-08-1, BRD-K76810206-001-07-3","CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13, CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13","YSEXMKHXIOCEJA-FVFQAYNVSA-N, YSEXMKHXIOCEJA-FVFQAYNVSA-N",Launched,BRD-A58096341-001-01-2
niceritrol,NAD precursor,,endocrinology,hyperlipidemia,Kemprotec,97.86,BRD-K11256763-001-01-5,O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1,KUEUWHJGRZKESU-UHFFFAOYSA-N,Launched,
niclosamide,"DNA replication inhibitor, STAT inhibitor",STAT3,infectious disease,tapeworm,"MicroSource, Selleck",97.63,"BRD-K35960502-001-20-0, BRD-K35960502-001-19-2","Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O, Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O","RJMUSRYZPJIFPJ-UHFFFAOYSA-N, RJMUSRYZPJIFPJ-UHFFFAOYSA-N",Launched,
nicorandil,"nitric oxide donor, potassium channel activator",KCNJ11,cardiology,angina pectoris,"Tocris, MicroSource, Selleck, Selleck",93,"BRD-K97752965-001-14-9, BRD-K97752965-001-15-6, BRD-K97752965-001-13-1, BRD-K97752965-001-16-4","[O-][N+](=O)OCCNC(=O)c1cccnc1, [O-][N+](=O)OCCNC(=O)c1cccnc1, [O-][N+](=O)OCCNC(=O)c1cccnc1, [O-][N+](=O)OCCNC(=O)c1cccnc1","LBHIOVVIQHSOQN-UHFFFAOYSA-N, LBHIOVVIQHSOQN-UHFFFAOYSA-N, LBHIOVVIQHSOQN-UHFFFAOYSA-N, LBHIOVVIQHSOQN-UHFFFAOYSA-N",Launched,
nicotinamide,protein synthesis stimulant,"BST1, LDHA, PARP1, SIRT5",dermatology,acne vulgaris (AV),"MicroSource, Selleck, Selleck",96.39,"BRD-K28912512-001-24-0, BRD-K28912512-001-25-7, BRD-K28912512-001-23-2","NC(=O)c1cccnc1, NC(=O)c1cccnc1, NC(=O)c1cccnc1","DFPAKSUCGFBDDF-UHFFFAOYSA-N, DFPAKSUCGFBDDF-UHFFFAOYSA-N, DFPAKSUCGFBDDF-UHFFFAOYSA-N",Launched,
nicotine,acetylcholine receptor agonist,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1",neurology/psychiatry,smoking cessation,"Selleck, MicroSource, Selleck",98.55,"BRD-A93695607-322-01-7, BRD-K05395900-322-05-4, BRD-A93695607-322-02-5","CN1CCCC1c1cccnc1, CN1CCC[C@H]1c1cccnc1, CN1CCCC1c1cccnc1","SNICXCGAKADSCV-UHFFFAOYSA-N, SNICXCGAKADSCV-JTQLQIEISA-N, SNICXCGAKADSCV-UHFFFAOYSA-N",Launched,
nicotinyl-alcohol-tartrate,,,,,MicroSource,88.02,BRD-K76600340-045-04-9,OCc1cccnc1,MVQVNTPHUGQQHK-UHFFFAOYSA-N,Launched,
nifedipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3",cardiology,"vasospastic angina, chronic stable angina","MedChemEx, MedChemEx, Tocris, Selleck, MicroSource, Selleck",96.3,"BRD-K96354014-001-29-4, BRD-K96354014-001-27-8, BRD-K96354014-001-15-3, BRD-K96354014-001-21-1, BRD-K96354014-001-17-9, BRD-K96354014-001-14-6","COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OC","HYIMSNHJOBLJNT-UHFFFAOYSA-N, HYIMSNHJOBLJNT-UHFFFAOYSA-N, HYIMSNHJOBLJNT-UHFFFAOYSA-N, HYIMSNHJOBLJNT-UHFFFAOYSA-N, HYIMSNHJOBLJNT-UHFFFAOYSA-N, HYIMSNHJOBLJNT-UHFFFAOYSA-N",Launched,
nifekalant,potassium channel blocker,,cardiology,"ventricular arrhythmias, ventricular tachycardia (VT)",Prestwick,94.25,BRD-K32311154-001-01-0,Cn1c(NCCN(CCO)CCCc2ccc(cc2)[N+]([O-])=O)cc(=O)n(C)c1=O,OEBPANQZQGQPHF-UHFFFAOYSA-N,Launched,
nifenalol,adrenergic receptor antagonist,"ADRB1, ADRB2",,,Enamine,87.38,BRD-A21280314-001-06-8,CC(C)NCC(O)c1ccc(cc1)[N+]([O-])=O,UAORFCGRZIGNCI-UHFFFAOYSA-N,Launched,
nifenazone,analgesic agent,,neurology/psychiatry,pain relief,"Selleck, MicroSource",99.25,"BRD-K47407372-001-16-3, BRD-K47407372-001-17-1","Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C, Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C","BRZANEXCSZCZCI-UHFFFAOYSA-N, BRZANEXCSZCZCI-UHFFFAOYSA-N",Launched,
niflumic-acid,cyclooxygenase inhibitor,"ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9","rheumatology, neurology/psychiatry","joint pain, muscle pain","MicroSource, Selleck",97.55,"BRD-K98763141-001-30-8, BRD-K98763141-001-29-0","OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F, OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F","JZFPYUNJRRFVQU-UHFFFAOYSA-N, JZFPYUNJRRFVQU-UHFFFAOYSA-N",Launched,
nifuroxazide,bacterial DNA inhibitor,,gastroenterology,"colitis, diarrhea","MicroSource, Selleck, Selleck",98.14,"BRD-K68188368-001-09-4, BRD-K68188368-001-08-6, BRD-K68188368-001-11-0","Oc1ccc(cc1)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O, Oc1ccc(cc1)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O, Oc1ccc(cc1)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O","YCWSUKQGVSGXJO-NTUHNPAUSA-N, YCWSUKQGVSGXJO-NTUHNPAUSA-N, YCWSUKQGVSGXJO-NTUHNPAUSA-N",Launched,
nifursol,bacterial DNA inhibitor,,,,MicroSource,96.23,BRD-K85757157-001-01-7,Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O,XXUXXCZCUGIGPP-WLRTZDKTSA-N,Launched,
nifurtimox,DNA inhibitor,,infectious disease,"Chagas disease, African trypanosomiasis",Prestwick,95.98,BRD-A00100033-001-08-9,CC1CS(=O)(=O)CCN1N=Cc1ccc(o1)[N+]([O-])=O,ARFHIAQFJWUCFH-UHFFFAOYSA-N,Launched,
nilotinib,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor","ABL1, KIT",hematologic malignancy,chronic myeloid leukemia (CML),Selleck,98.71,BRD-K81528515-001-13-8,Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F,HHZIURLSWUIHRB-UHFFFAOYSA-N,Launched,
nilutamide,androgen receptor antagonist,AR,oncology,prostate cancer,"MicroSource, Tocris",99.22,"BRD-K23566484-001-15-1, BRD-K23566484-001-14-4","CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O, CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O","XWXYUMMDTVBTOU-UHFFFAOYSA-N, XWXYUMMDTVBTOU-UHFFFAOYSA-N",Launched,
nilvadipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2",cardiology,"hypertension, cerebral artery occlusion","Selleck, Selleck",90.2,"BRD-A84687895-001-03-2, BRD-A84687895-001-04-0","COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N, COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N","FAIIFDPAEUKBEP-UHFFFAOYSA-N, FAIIFDPAEUKBEP-UHFFFAOYSA-N",Launched,
nimesulide,cyclooxygenase inhibitor,"LTF, PLA2G2E, PTGS1, PTGS2","rheumatology, obstetrics/gynecology","osteoarthritis, menstrual pain","MicroSource, Tocris, Selleck",99.29,"BRD-K76775527-001-30-2, BRD-K76775527-001-29-4, BRD-K76775527-001-28-6","CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O, CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O, CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O","HYWYRSMBCFDLJT-UHFFFAOYSA-N, HYWYRSMBCFDLJT-UHFFFAOYSA-N, HYWYRSMBCFDLJT-UHFFFAOYSA-N",Launched,
nimodipine,calcium channel blocker,"AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2",hematology,hemorrhage,"MicroSource, Selleck, Tocris",93.03,"BRD-A58048407-001-20-4, BRD-A58048407-001-17-0, BRD-A58048407-001-18-8","COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C, COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C, COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C","UIAGMCDKSXEBJQ-UHFFFAOYSA-N, UIAGMCDKSXEBJQ-UHFFFAOYSA-N, UIAGMCDKSXEBJQ-UHFFFAOYSA-N",Launched,
nimorazole,bacterial DNA inhibitor,,oncology,head and neck squamous cell carcinoma (HNSCC),MedChemEx,96.86,BRD-K79145628-001-05-5,[O-][N+](=O)c1cncn1CCN1CCOCC1,MDJFHRLTPRPZLY-UHFFFAOYSA-N,Launched,
nimustine,DNA alkylating agent,,,,"MicroSource, Sigma",37.86,"BRD-K13240081-001-06-1, BRD-K13240081-003-06-7","Cc1ncc(CNC(=O)N(CCCl)[N+][O-])c(N)n1, Cc1ncc(CNC(=O)N(CCCl)[N+][O-])c(N)n1","VFEDRRNHLBGPNN-UHFFFAOYSA-N, VFEDRRNHLBGPNN-UHFFFAOYSA-N",Launched,
nintedanib,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB",pulmonary,idiopathic pulmonary fibrosis (IPF),"Selleck, Selleck",90.8,"BRD-K49075727-001-09-3, BRD-K49075727-001-08-5","COC(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1, COC(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1","XZXHXSATPCNXJR-ZIADKAODSA-N, XZXHXSATPCNXJR-ZIADKAODSA-N",Launched,
niraparib,PARP inhibitor,PARP1,oncology,primary peritoneal cancer (PPC),"MedChemEx, MedChemEx",95.87,"BRD-K54955827-001-02-2, BRD-K54955827-001-01-4","NC(=O)c1cccc2cn(nc12)-c1ccc(cc1)[C@@H]1CCCNC1, NC(=O)c1cccc2cn(nc12)-c1ccc(cc1)[C@@H]1CCCNC1","PCHKPVIQAHNQLW-CQSZACIVSA-N, PCHKPVIQAHNQLW-CQSZACIVSA-N",Launched,
niridazole,phosphofructokinase inhibitor,,infectious disease,schistosomiasis,Prestwick,94.95,BRD-K53123955-001-10-5,[O-][N+](=O)c1cnc(s1)N1CCNC1=O,RDXLYGJSWZYTFJ-UHFFFAOYSA-N,Launched,
nisoldipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNB2",cardiology,hypertension,"MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",86.15,"BRD-A84465106-001-05-3, BRD-A84465106-001-09-5, BRD-A84465106-001-08-7, BRD-A84465106-001-03-8, BRD-A84465106-001-06-1","COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C, COC(=O)C1=C(C)NC(C)=C(C1c1ccccc1[N+]([O-])=O)C(=O)OCC(C)C","VKQFCGNPDRICFG-UHFFFAOYSA-N, VKQFCGNPDRICFG-UHFFFAOYSA-N, VKQFCGNPDRICFG-UHFFFAOYSA-N, VKQFCGNPDRICFG-UHFFFAOYSA-N, VKQFCGNPDRICFG-UHFFFAOYSA-N",Launched,
nitarsone,,,dermatology,blackhead disease,"MicroSource, Selleck",89.7,"BRD-K56707426-001-02-0, BRD-K56707426-001-01-2","O[As](O)(=O)c1ccc(cc1)[N+]([O-])=O, O[As](O)(=O)c1ccc(cc1)[N+]([O-])=O","FUUFQLXAIUOWML-UHFFFAOYSA-N, FUUFQLXAIUOWML-UHFFFAOYSA-N",Launched,
nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,,gastroenterology,diarrhea,"Selleck, MicroSource, MedChemEx, MedChemEx, Selleck",87.36,"BRD-K96471533-001-09-0, BRD-K96471533-001-08-2, BRD-K96471533-001-10-8, BRD-K96471533-001-11-6, BRD-K96471533-001-07-4","CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O, CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O, CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O, CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O, CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+]([O-])=O","YQNQNVDNTFHQSW-UHFFFAOYSA-N, YQNQNVDNTFHQSW-UHFFFAOYSA-N, YQNQNVDNTFHQSW-UHFFFAOYSA-N, YQNQNVDNTFHQSW-UHFFFAOYSA-N, YQNQNVDNTFHQSW-UHFFFAOYSA-N",Launched,
nitenpyram,,,infectious disease,flea control,Selleck,93.18,BRD-K47887731-001-01-4,CCN(Cc1ccc(Cl)nc1)C(\NC)=C\[N+]([O-])=O,CFRPSFYHXJZSBI-DHZHZOJOSA-N,Launched,
nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD,metabolism,tyrosinemia,"MedChemEx, Enzo",87.67,"BRD-K01109406-001-04-5, BRD-K01109406-001-03-7","[O-][N+](=O)c1cc(ccc1C(=O)C1C(=O)CCCC1=O)C(F)(F)F, [O-][N+](=O)c1cc(ccc1C(=O)C1C(=O)CCCC1=O)C(F)(F)F","OUBCNLGXQFSTLU-UHFFFAOYSA-N, OUBCNLGXQFSTLU-UHFFFAOYSA-N",Launched,
nitrendipine,calcium channel blocker,"CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4",cardiology,hypertension,"Tocris, MicroSource, Selleck, Tocris",97.81,"BRD-A02006392-001-19-8, BRD-A02006392-001-17-2, BRD-A02006392-001-15-6, BRD-A02006392-001-16-4","CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC, CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC","PVHUJELLJLJGLN-UHFFFAOYSA-N, PVHUJELLJLJGLN-UHFFFAOYSA-N, PVHUJELLJLJGLN-UHFFFAOYSA-N, PVHUJELLJLJGLN-UHFFFAOYSA-N",Launched,
nitrofurantoin,DNA inhibitor,,infectious disease,"urinary tract infections, pyelonephritis","MedChemEx, MedChemEx, MicroSource",83.96,"BRD-K76927775-001-13-4, BRD-K76927775-001-11-8, BRD-K76927775-001-10-0","[O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1, [O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1, [O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1","NXFQHRVNIOXGAQ-YCRREMRBSA-N, NXFQHRVNIOXGAQ-YCRREMRBSA-N, NXFQHRVNIOXGAQ-YCRREMRBSA-N",Launched,
nitrofurazone,bacterial DNA inhibitor,,infectious disease,first-aid antibiotic,"Selleck, MicroSource",98.77,"BRD-K79092138-001-10-2, BRD-K79092138-001-11-0","NC(=O)N\N=C\c1ccc(o1)[N+]([O-])=O, NC(=O)N\N=C\c1ccc(o1)[N+]([O-])=O","IAIWVQXQOWNYOU-FPYGCLRLSA-N, IAIWVQXQOWNYOU-FPYGCLRLSA-N",Launched,
nitromide,,,,,MicroSource,99.72,BRD-K76381435-001-08-6,NC(=O)c1cc(cc(c1)[N+]([O-])=O)[N+]([O-])=O,UUKWKUSGGZNXGA-UHFFFAOYSA-N,Launched,
nitroxoline,cathepsin inhibitor,METAP2,infectious disease,urinary tract infections,"MedChemEx, MicroSource",62.54,"BRD-K97534525-001-24-3, BRD-K97534525-001-23-5","Oc1ccc([N+]([O-])=O)c2cccnc12, Oc1ccc([N+]([O-])=O)c2cccnc12","RJIWZDNTCBHXAL-UHFFFAOYSA-N, RJIWZDNTCBHXAL-UHFFFAOYSA-N",Launched,
nizatidine,histamine receptor antagonist,HRH2,gastroenterology,"duodenal ulcer disease, erosive esophagitis (EE), ulcerative esophagitis (UE), gastroesophageal reflux disease (GERD)","Selleck, MicroSource",93.08,"BRD-K73589491-001-12-0, BRD-K73589491-001-11-2","CN\C(NCCSCc1csc(CN(C)C)n1)=C/[N+]([O-])=O, CN\C(NCCSCc1csc(CN(C)C)n1)=C/[N+]([O-])=O","SGXXNSQHWDMGGP-IZZDOVSWSA-N, SGXXNSQHWDMGGP-IZZDOVSWSA-N",Launched,BRD-K46652470-001-09-1
nizofenone,ion channel antagonist,,neurology/psychiatry,stroke,AKSci,99.4,BRD-K84011460-051-01-7,CCN(CC)Cc1nccn1-c1ccc(cc1C(=O)c1ccccc1Cl)[N+]([O-])=O,WZGBZLHGOVJDET-UHFFFAOYSA-N,Launched,
nomegestrol-acetate,progesterone receptor agonist,PGR,endocrinology,contraceptive,Prestwick,96.56,BRD-K27351809-001-09-5,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Launched,
nonivamide,TRPV agonist,TRPV1,"rheumatology, neurology/psychiatry","rheumatoid arthritis, muscle pain",MicroSource,92,BRD-K05907307-001-07-1,CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1,RGOVYLWUIBMPGK-UHFFFAOYSA-N,Launched,
nonoxynol-9,membrane integrity inhibitor,,endocrinology,contraceptive,"MicroSource, LKT, MedChemEx",82.85,"BRD-K88625236-001-04-2, BRD-K88625236-001-07-5, BRD-K88625236-001-05-9","CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1, CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1, CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1","FBWNMEQMRUMQSO-UHFFFAOYSA-N, FBWNMEQMRUMQSO-UHFFFAOYSA-N, FBWNMEQMRUMQSO-UHFFFAOYSA-N",Launched,
norelgestromin,,PGR,endocrinology,contraceptive,MedChemEx,88.48,BRD-K42504537-001-01-6,CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C,ISHXLNHNDMZNMC-VTKCIJPMSA-N,Launched,
norepinephrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2","cardiology, allergy, neurology/psychiatry","hypertension, urticaria, headache, seasonal affective disorder","Selleck, Selleck, MicroSource",100,"BRD-K87349682-347-02-0, BRD-K87349682-347-03-8, BRD-K87349682-001-04-9","NC[C@H](O)c1ccc(O)c(O)c1, NC[C@H](O)c1ccc(O)c(O)c1, NC[C@H](O)c1ccc(O)c(O)c1","SFLSHLFXELFNJZ-QMMMGPOBSA-N, SFLSHLFXELFNJZ-QMMMGPOBSA-N, SFLSHLFXELFNJZ-QMMMGPOBSA-N",Launched,
norethindrone,progesterone receptor agonist,PGR,obstetrics/gynecology,endometriosis,"Selleck, MicroSource, Selleck",98.2,"BRD-K92073408-001-15-7, BRD-K92073408-001-16-5, BRD-K92073408-001-14-0","C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C, C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C","VIKNJXKGJWUCNN-XGXHKTLJSA-N, VIKNJXKGJWUCNN-XGXHKTLJSA-N, VIKNJXKGJWUCNN-XGXHKTLJSA-N",Launched,"BRD-A39415247-001-11-2,BRD-A83260288-001-01-8, BRD-A39415247-001-10-4, BRD-K01123092-001-01-1"
norethindrone-acetate,progesterone receptor agonist,,"endocrinology, orthopedics, obstetrics/gynecology","menopause, osteoporosis, vaginal atrophy",MicroSource,98.25,BRD-A09349126-001-10-7,CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@]12C)C#C,IMONTRJLAWHYGT-FJMAIUEKSA-N,Launched,
norethisterone-enanthate,contraceptive agent,,endocrinology,contraceptive,AvaChem,96.7,BRD-K07625016-001-01-2,CCCCCCC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,APTGJECXMIKIET-WOSSHHRXSA-N,Launched,
noretynodrel,progestogen hormone,PGR,endocrinology,contraceptive,MicroSource,81.73,BRD-A00758722-001-04-9,C[C@]12CCC3C(CCC4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C,ICTXHFFSOAJUMG-OQPPHWFISA-N,Launched,
norfloxacin,bacterial DNA gyrase inhibitor,TOP2A,"infectious disease, urology","urinary tract infections, gonorrhea, prostatitis","Selleck, Selleck, MicroSource",98.57,"BRD-K11196887-001-22-0, BRD-K11196887-001-20-4, BRD-K11196887-001-21-2","CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCNCC1, CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCNCC1, CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCNCC1","OGJPXUAPXNRGGI-UHFFFAOYSA-N, OGJPXUAPXNRGGI-UHFFFAOYSA-N, OGJPXUAPXNRGGI-UHFFFAOYSA-N",Launched,
norgestimate,progesterone receptor agonist,"ESR1, PGR",endocrinology,contraceptive,"MicroSource, Sigma",61.05,"BRD-K38041788-001-02-9, BRD-K38041788-001-01-1","CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(OC(C)=O)C#C, CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(OC(C)=O)C#C","KIQQMECNKUGGKA-NMYWJIRASA-N, KIQQMECNKUGGKA-NMYWJIRASA-N",Launched,"BRD-A04756508-001-02-3, BRD-A75867198-001-01-9"
norgestrel,progesterone receptor agonist,PGR,endocrinology,contraceptive,MicroSource,98.29,BRD-A14886633-001-01-6,CC[C@]12CCC3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,WWYNJERNGUHSAO-NJTPJZBZSA-N,Launched,
nortriptyline,tricyclic antidepressant,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4",neurology/psychiatry,depression,MicroSource,98.98,BRD-K91263825-003-21-4,CNCCC=C1c2ccccc2CCc2ccccc12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Launched,
noscapine,"bradykinin receptor antagonist, tubulin polymerization inhibitor",SIGMAR1,pulmonary,cough suppressant,"Selleck, MicroSource, Tocris",99.38,"BRD-K89237706-003-02-6, BRD-K91301684-003-05-5, BRD-K89237706-003-03-4","COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12, COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12, COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3c(OC)c12","AKNNEGZIBPJZJG-MSOLQXFVSA-N, AKNNEGZIBPJZJG-QZTJIDSGSA-N, AKNNEGZIBPJZJG-MSOLQXFVSA-N",Launched,"BRD-K91301684-003-04-8, BRD-A51393488-003-02-7"
novobiocin,bacterial DNA gyrase inhibitor,,obstetrics/gynecology,mastitis,"Selleck, MicroSource, Selleck",89.03,"BRD-K85307935-236-10-3, BRD-K85307935-236-09-5, BRD-K85307935-236-08-7","CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C, CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C, CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C","YJQPYGGHQPGBLI-KGSXXDOSSA-N, YJQPYGGHQPGBLI-KGSXXDOSSA-N, YJQPYGGHQPGBLI-KGSXXDOSSA-N",Launched,
nystatin,fungal ergosterol inhibitor,,infectious disease,"esophageal candidiasis, skin infections, yeast infection","Sigma, MedChemEx, Selleck, MicroSource, Selleck",61.91,"BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7","C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O, C[C@H]1OC(OC2CC3O[C@@](O)(CC(O)C3C(O)=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O, C[C@@H]1O[C@H](O[C@@H]2C[C@@H]3O[C@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)[C@@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\CC\C=C\C=C\C=C\C=C\2)[C@H](O)[C@H](N)[C@H]1O","VQOXZBDYSJBXMA-NQTDYLQESA-N, VQOXZBDYSJBXMA-NQTDYLQESA-N, VQOXZBDYSJBXMA-VHFLTRTASA-N, VQOXZBDYSJBXMA-VNGPISPUSA-N, VQOXZBDYSJBXMA-NSTZTQKZSA-N",Launched,"BRD-K82677637-001-01-0, BRD-K33243830-001-01-6"
obeticholic-acid,FXR agonist,NR1H4,gastroenterology,primary biliary cholangitis,Selleck,67.62,BRD-A75838038-001-01-4,CCC1C(O)C2C3CCC(C(C)CCC(O)=O)C3(C)CCC2C2(C)CCC(O)CC12,ZXERDUOLZKYMJM-UHFFFAOYSA-N,Launched,
obidoxime,cholinesterase reactivator,ACHE,"critical care, neurology/psychiatry","poison antidote, nerve gas poisoning",Vitas-M,100,BRD-K33588785-001-01-9,O\N=C\c1cc[n+](COC[n+]2ccc(cc2)\C=N\O)cc1,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,Launched,
octenidine,membrane integrity inhibitor,,,,TCI,99.2,BRD-K04568635-300-01-4,CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(cc2)=NCCCCCCCC)cc1,ZVXNYZWXUADSRV-UHFFFAOYSA-N,Launched,
octinoxate,,,dermatology,sunscreen lotion,MicroSource,95.81,BRD-K19972289-001-01-4,CCCC[C@@H](CC)COC(=O)\C=C\c1ccc(OC)cc1,YBGZDTIWKVFICR-NRMKIYEFSA-N,Launched,
octisalate,,,dermatology,sunscreen lotion,MicroSource,98.81,BRD-K95161686-001-02-8,CCCC[C@@H](CC)COC(=O)c1ccccc1O,FMRHJJZUHUTGKE-GFCCVEGCSA-N,Launched,
octocrylene,,,dermatology,sunscreen lotion,MicroSource,98.2,BRD-K39023557-001-01-7,CCCC[C@@H](CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1,FMJSMJQBSVNSBF-LJQANCHMSA-N,Launched,
octreotide,somatostatin receptor agonist,"SSTR1, SSTR2, SSTR3, SSTR5","gastroenterology, endocrinology, oncology","diarrhea, acromegaly, carcinoid tumors","MedChemEx, MedChemEx, MedChemEx",91,"BRD-A64173453-015-03-1, BRD-A64173453-015-02-3, BRD-A64173453-015-01-5","CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1, CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1, CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1","DEQANNDTNATYII-UHFFFAOYSA-N, DEQANNDTNATYII-UHFFFAOYSA-N, DEQANNDTNATYII-UHFFFAOYSA-N",Launched,
ofloxacin,bacterial DNA gyrase inhibitor,TOP2A,"infectious disease, otolaryngology, gastroenterology, endocrinology","respiratory tract infections, sinusitis, skin infections, bone and joint infections, intra-abdominal infections, diarrhea, fever, urinary tract infections","MicroSource, Selleck",98.67,"BRD-A24228527-213-01-9, BRD-A24228527-001-31-5","CC1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O, CC1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O","GSDSWSVVBLHKDQ-UHFFFAOYSA-N, GSDSWSVVBLHKDQ-UHFFFAOYSA-N",Launched,
olanzapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7",neurology/psychiatry,"schizophrenia, bipolar disorder","MicroSource, Tocris, Selleck, Selleck",95.27,"BRD-K18895904-001-16-1, BRD-K18895904-001-19-5, BRD-K18895904-001-15-3, BRD-K18895904-001-17-9","CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12, CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12, CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12, CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12","KVWDHTXUZHCGIO-UHFFFAOYSA-N, KVWDHTXUZHCGIO-UHFFFAOYSA-N, KVWDHTXUZHCGIO-UHFFFAOYSA-N, KVWDHTXUZHCGIO-UHFFFAOYSA-N",Launched,
olaparib,PARP inhibitor,"PARP1, PARP2",oncology,ovarian cancer,"Selleck, Selleck",98.64,"BRD-K02113016-001-19-6, BRD-K02113016-001-15-4","Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1, Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1","FDLYAMZZIXQODN-UHFFFAOYSA-N, FDLYAMZZIXQODN-UHFFFAOYSA-N",Launched,
olmesartan,angiotensin receptor antagonist,AGTR1,cardiology,hypertension,"Tocris, MedChemEx, MicroSource, MedChemEx",95.2,"BRD-K83144676-001-09-5, BRD-K83144676-001-08-7, BRD-K83144676-001-06-1, BRD-K83144676-001-07-9","CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O, CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O, CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O, CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)C(C)(C)O","VTRAEEWXHOVJFV-UHFFFAOYSA-N, VTRAEEWXHOVJFV-UHFFFAOYSA-N, VTRAEEWXHOVJFV-UHFFFAOYSA-N, VTRAEEWXHOVJFV-UHFFFAOYSA-N",Launched,
olmesartan-medoxomil,angiotensin receptor antagonist,AGTR1,cardiology,hypertension,"MicroSource, Tocris, Selleck",95.9,"BRD-K78485176-001-07-8, BRD-K78485176-001-09-4, BRD-K78485176-001-06-0","CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1, CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1, CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1","UQGKUQLKSCSZGY-UHFFFAOYSA-N, UQGKUQLKSCSZGY-UHFFFAOYSA-N, UQGKUQLKSCSZGY-UHFFFAOYSA-N",Launched,
olmutinib,"EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor","BTK, EGFR",,,"MedChemEx, MedChemEx",91.76,"BRD-K60421517-001-02-2, BRD-K60421517-001-01-4","CN1CCN(CC1)c1ccc(Nc2nc(Oc3cccc(NC(=O)C=C)c3)c3sccc3n2)cc1, CN1CCN(CC1)c1ccc(Nc2nc(Oc3cccc(NC(=O)C=C)c3)c3sccc3n2)cc1","FDMQDKQUTRLUBU-UHFFFAOYSA-N, FDMQDKQUTRLUBU-UHFFFAOYSA-N",Launched,
olopatadine,histamine receptor antagonist,"HRH1, S100A1, S100A12, S100A13, S100A2, S100B",ophthalmology,conjunctivitis,"Tocris, Selleck",98.6,"BRD-K67637637-003-11-8, BRD-K67637637-003-12-6","CN(C)CC\C=C1\c2ccccc2COc2ccc(CC(O)=O)cc12, CN(C)CC\C=C1\c2ccccc2COc2ccc(CC(O)=O)cc12","JBIMVDZLSHOPLA-LSCVHKIXSA-N, JBIMVDZLSHOPLA-LSCVHKIXSA-N",Launched,BRD-K06625472-003-01-6
olprinone,phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure,MedChemEx,99.86,BRD-K20745393-003-01-0,Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N,JPAWFIIYTJQOKW-UHFFFAOYSA-N,Launched,
olsalazine,cyclooxygenase inhibitor,"IFNG, TPMT",gastroenterology,ulcerative colitis,"Selleck, MicroSource",98.41,"BRD-K57853941-304-02-5, BRD-K57853941-304-03-3","OC(=O)c1cc(ccc1O)\N=N\c1ccc(O)c(c1)C(O)=O, OC(=O)c1cc(ccc1O)\N=N\c1ccc(O)c(c1)C(O)=O","QQBDLJCYGRGAKP-FOCLMDBBSA-N, QQBDLJCYGRGAKP-FOCLMDBBSA-N",Launched,
omarigliptin,dipeptidyl peptidase inhibitor,DPP4,,,"MedChemEx, MedChemEx",94.52,"BRD-K14171291-001-01-4, BRD-K14171291-001-02-2","CS(=O)(=O)n1cc2CN(Cc2n1)[C@H]1CO[C@@H]([C@@H](N)C1)c1cc(F)ccc1F, CS(=O)(=O)n1cc2CN(Cc2n1)[C@H]1CO[C@@H]([C@@H](N)C1)c1cc(F)ccc1F","MKMPWKUAHLTIBJ-ISTRZQFTSA-N, MKMPWKUAHLTIBJ-ISTRZQFTSA-N",Launched,
ombitasvir,HCV inhibitor,,infectious disease,hepatitis C,"MedChemEx, MedChemEx",96.54,"BRD-K11072003-001-02-4, BRD-K11072003-001-01-6","COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)cc1, COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)cc1","PIDFDZJZLOTZTM-KHVQSSSXSA-N, PIDFDZJZLOTZTM-KHVQSSSXSA-N",Launched,
omega-3-acid-esters,cholesterol inhibitor,,,,"MicroSource, MedChemEx, MedChemEx",71.9,"BRD-K31139048-001-02-4, BRD-K31139048-001-03-2, BRD-K31139048-001-04-0","CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC, CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC, CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC","SSQPWTVBQMWLSZ-AAQCHOMXSA-N, SSQPWTVBQMWLSZ-AAQCHOMXSA-N, SSQPWTVBQMWLSZ-AAQCHOMXSA-N",Launched,
omeprazole,ATPase inhibitor,"ATP4A, CLCN2",gastroenterology,heartburn,"Selleck, MicroSource, Tocris, Selleck",99.07,"BRD-A55962179-001-24-7, BRD-A55962179-001-23-9, BRD-A55962179-001-22-1, BRD-A55962179-001-21-3","COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C, COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C, COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C, COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C","SUBDBMMJDZJVOS-UHFFFAOYSA-N, SUBDBMMJDZJVOS-UHFFFAOYSA-N, SUBDBMMJDZJVOS-UHFFFAOYSA-N, SUBDBMMJDZJVOS-UHFFFAOYSA-N",Launched,
omeprazole-magnesium,proton pump inhibitor,"ATP4A, ATP4B",gastroenterology,"gastroesophageal reflux disease (GERD), heartburn",Vitas-M,98.99,BRD-A56892734-001-09-4,COc1ccc2n([Mg]n3c(nc4cc(OC)ccc34)S(=O)Cc3ncc(C)c(OC)c3C)c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C,KWORUUGOSLYAGD-UHFFFAOYSA-N,Launched,
ondansetron,serotonin receptor antagonist,"HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1",gastroenterology,"nausea, vomiting","Selleck, Selleck, MicroSource",99.41,"BRD-A19736161-003-14-7, BRD-A19736161-001-05-9, BRD-A19736161-001-06-7","Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C, Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C, Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C","FELGMEQIXOGIFQ-UHFFFAOYSA-N, FELGMEQIXOGIFQ-UHFFFAOYSA-N, FELGMEQIXOGIFQ-UHFFFAOYSA-N",Launched,
opipramol,sigma receptor agonist,,neurology/psychiatry,generalized anxiety disorder (GAD),Prestwick,97.22,BRD-K43786866-300-02-3,OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc23)CC1,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Launched,
orbifloxacin,bacterial DNA gyrase inhibitor,,infectious disease,urinary tract infections,"MicroSource, Selleck, Selleck",99.48,"BRD-K63001556-001-08-8, BRD-K63001556-001-10-4, BRD-K63001556-001-09-6","C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1, C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1, C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1","QIPQASLPWJVQMH-DTORHVGOSA-N, QIPQASLPWJVQMH-DTORHVGOSA-N, QIPQASLPWJVQMH-DTORHVGOSA-N",Launched,BRD-K68153448-001-01-9
oritavancin,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections,MedChemEx,92.37,BRD-A33352494-316-01-6,CNC(CC(C)C)C(=O)NC1C(O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)C(OC5CC(C)(N)C(O)C(C)O5)C5NC(=O)C(NC(=O)C4NC(=O)C(CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1C(NC5=O)C(O)=O)c3OC1OC(CO)C(O)C(O)C1OC1CC(C)(NCc3ccc(cc3)-c3ccc(Cl)cc3)C(O)C(C)O1)c(Cl)c2,VHFGEBVPHAGQPI-UHFFFAOYSA-N,Launched,
orlistat,lipase inhibitor,"CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP",endocrinology,weight-loss aid,"MicroSource, Tocris, Selleck",100,"BRD-K94062100-001-04-3, BRD-K63343048-001-13-0, BRD-K63343048-001-12-2","CCCCCCCCCCC[C@@H](C[C@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O, CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O, CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O","AHLBNYSZXLDEJQ-GWMMUDDPSA-N, AHLBNYSZXLDEJQ-FWEHEUNISA-N, AHLBNYSZXLDEJQ-FWEHEUNISA-N",Launched,
ornidazole,antiprotozoal agent,,infectious disease,protozoan infection,"MicroSource, Selleck, Selleck",92.96,"BRD-A42759514-001-20-5, BRD-A42759514-001-21-3, BRD-A42759514-001-19-7","Cc1ncc(n1CC(O)CCl)[N+]([O-])=O, Cc1ncc(n1CC(O)CCl)[N+]([O-])=O, Cc1ncc(n1CC(O)CCl)[N+]([O-])=O","IPWKIXLWTCNBKN-UHFFFAOYSA-N, IPWKIXLWTCNBKN-UHFFFAOYSA-N, IPWKIXLWTCNBKN-UHFFFAOYSA-N",Launched,
ornithine,NFkB pathway modulator,"ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4",,,MicroSource,0,BRD-A13561534-003-02-0,NCCCC(N)C(O)=O,AHLPHDHHMVZTML-UHFFFAOYSA-N,Launched,
orphenadrine,acetylcholine receptor antagonist,"GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2",neurology/psychiatry,muscle pain,"MicroSource, Selleck",98.55,"BRD-A53576514-048-14-3, BRD-A53576514-048-13-5","CN(C)CCOC(c1ccccc1)c1ccccc1C, CN(C)CCOC(c1ccccc1)c1ccccc1C","QVYRGXJJSLMXQH-UHFFFAOYSA-N, QVYRGXJJSLMXQH-UHFFFAOYSA-N",Launched,
oseltamivir-carboxylate,neuraminidase inhibitor,,infectious disease,influenza A virus infection,MedChemEx,85.81,BRD-K93767137-001-01-1,CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O,NENPYTRHICXVCS-YNEHKIRRSA-N,Launched,
oseltamivir-phosphate,neuraminidase inhibitor,"CES1, NEU1, NEU2",infectious disease,influenza A virus infection,"Selleck, Selleck, MicroSource",93.88,"BRD-K76011241-011-02-5, BRD-K76011241-001-02-6, BRD-K76011241-001-01-8","CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1, CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1, CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1","VSZGPKBBMSAYNT-RRFJBIMHSA-N, VSZGPKBBMSAYNT-RRFJBIMHSA-N, VSZGPKBBMSAYNT-RRFJBIMHSA-N",Launched,BRD-U75584406-000-01-6
osimertinib,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC),MedChemEx,87.75,BRD-K42805893-001-04-9,COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C)c2ccccc12,DUYJMQONPNNFPI-UHFFFAOYSA-N,Launched,
ospemifene,selective estrogen receptor modulator (SERM),"ESR1, ESR2","obstetrics/gynecology, endocrinology","vaginal atrophy, dyspareunia, menopause",Selleck,99.9,BRD-K44184170-001-01-7,OCCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1,LUMKNAVTFCDUIE-VHXPQNKSSA-N,Launched,
otilonium,acetylcholine receptor antagonist,CACNA1C,gastroenterology,irritable bowel syndrome,Selleck,98.47,BRD-K85337334-004-02-6,CCCCCCCCOc1ccccc1C(=O)Nc1ccc(cc1)C(=O)OCC[N+](C)(CC)CC,NQHNLNLJPDMBFN-UHFFFAOYSA-O,Launched,
ouabain,ATPase inhibitor,ATP1A1,cardiology,"hypertension, cardiac arrythmia","Tocris, MicroSource, Selleck",96.12,"BRD-K33277808-001-01-2, BRD-K33277808-331-01-3, BRD-K33277808-001-02-0","C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](O[C@@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O","LPMXVESGRSUGHW-VGFRVVOQSA-N, LPMXVESGRSUGHW-VGFRVVOQSA-N, LPMXVESGRSUGHW-VGFRVVOQSA-N",Launched,"BRD-A68930007-331-01-6, BRD-A68930007-001-04-9,BRD-K92158972-331-01-3"
oxacillin,bacterial cell wall synthesis inhibitor,,infectious disease,staphylococcal infections,"Selleck, Selleck, MicroSource",98.27,"BRD-K96786677-323-02-0, BRD-K96786677-323-03-8, BRD-K96786677-236-02-4","Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1, Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1","UWYHMGVUTGAWSP-JKIFEVAISA-N, UWYHMGVUTGAWSP-JKIFEVAISA-N, UWYHMGVUTGAWSP-JKIFEVAISA-N",Launched,"BRD-K71213463-323-01-4, BRD-A66481418-236-04-0"
oxaliplatin,DNA inhibitor,,oncology,colorectal cancer,"Selleck, Tocris, MicroSource, Selleck",98.79,"BRD-K78960041-001-05-7, BRD-K78960041-001-03-2, BRD-K78960041-001-07-3, BRD-K78960041-001-02-4","O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O, O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O, O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O, O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O","DWAFYCQODLXJNR-BNTLRKBRSA-L, DWAFYCQODLXJNR-BNTLRKBRSA-L, DWAFYCQODLXJNR-BNTLRKBRSA-L, DWAFYCQODLXJNR-BNTLRKBRSA-L",Launched,"BRD-M78823677-034-04-0, BRD-M78823677-034-03-2, BRD-A20035137-001-01-3,BRD-M43490210-001-01-9, BRD-M78823677-034-02-4"
oxandrolone,androgen receptor agonist,AR,endocrinology,weight-gain aid,MedChemEx,100,BRD-K92467929-001-01-1,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C,QSLJIVKCVHQPLV-PEMPUTJUSA-N,Launched,
oxaprozin,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"osteoarthritis, rheumatoid arthritis","MicroSource, Selleck",99.41,"BRD-K25394294-001-14-9, BRD-K25394294-001-13-1","OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1, OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1","OFPXSFXSNFPTHF-UHFFFAOYSA-N, OFPXSFXSNFPTHF-UHFFFAOYSA-N",Launched,
oxatomide,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,Vitas-M,95.48,BRD-K02079473-001-01-3,O=c1[nH]c2ccccc2n1CCCN1CCN(CC1)C(c1ccccc1)c1ccccc1,BAINIUMDFURPJM-UHFFFAOYSA-N,Launched,
oxazepam,GABA benzodiazepine site receptor agonist,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3",neurology/psychiatry,anxiety,Enzo,98.7,BRD-A50049929-001-01-9,OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Launched,
oxcarbazepine,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,"MicroSource, Selleck, Selleck",95.44,"BRD-K04196797-001-24-4, BRD-K04196797-001-23-6, BRD-K04196797-001-25-1","NC(=O)N1c2ccccc2CC(=O)c2ccccc12, NC(=O)N1c2ccccc2CC(=O)c2ccccc12, NC(=O)N1c2ccccc2CC(=O)c2ccccc12","CTRLABGOLIVAIY-UHFFFAOYSA-N, CTRLABGOLIVAIY-UHFFFAOYSA-N, CTRLABGOLIVAIY-UHFFFAOYSA-N",Launched,
oxelaidin,antitussive,,pulmonary,cough suppressant,"Selleck, MicroSource, Selleck",91.86,"BRD-K17977438-048-03-2, BRD-K17977438-048-02-4, BRD-K17977438-048-04-0","CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1, CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1, CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1","IQADUMSPOQKAAO-UHFFFAOYSA-N, IQADUMSPOQKAAO-UHFFFAOYSA-N, IQADUMSPOQKAAO-UHFFFAOYSA-N",Launched,BRD-M29157795-001-01-5
oxethazaine,local anesthetic,,neurology/psychiatry,local anesthetic,"MicroSource, Selleck",94.7,"BRD-K56940463-001-14-6, BRD-K56940463-001-13-8","CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1, CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1","FTLDJPRFCGDUFH-UHFFFAOYSA-N, FTLDJPRFCGDUFH-UHFFFAOYSA-N",Launched,
oxfendazole,anthelmintic agent,,infectious disease,"lungworms, tapeworm, gastrointestinal roundworms","MicroSource, Selleck",97.28,"BRD-A33447119-001-11-6, BRD-A33447119-001-10-8","COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c1ccccc1, COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c1ccccc1","BEZZFPOZAYTVHN-UHFFFAOYSA-N, BEZZFPOZAYTVHN-UHFFFAOYSA-N",Launched,
oxibendazole,tubulin polymerization inhibitor,"TUBB, TUBB4B",infectious disease,strongyles,"MicroSource, Selleck",96.34,"BRD-K52075715-001-07-5, BRD-K52075715-001-06-7","CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1, CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1","RAOCRURYZCVHMG-UHFFFAOYSA-N, RAOCRURYZCVHMG-UHFFFAOYSA-N",Launched,
oxiconazole,bacterial cell wall synthesis inhibitor,,infectious disease,"tinea pedis, tinea cruris, tinea corporis",MicroSource,98.63,BRD-K56104152-008-04-1,Clc1ccc(CO\N=C(/Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Launched,
oxiracetam,acetylcholine receptor agonist,,,,MedChemEx,100,BRD-K50677762-001-01-5,NC(=O)CN1C[C@H](O)CC1=O,IHLAQQPQKRMGSS-SCSAIBSYSA-N,Launched,
oxolamine,antitussive,,pulmonary,cough suppressant,MicroSource,43.12,BRD-K42596464-048-11-9,CCN(CC)CCc1nc(no1)-c1ccccc1,IDCHQQSVJAAUQQ-UHFFFAOYSA-N,Launched,
oxprenolol,adrenergic receptor antagonist,"ADRB1, ADRB2",cardiology,"angina pectoris, hypertension, cardiac arrythmia",Selleck,95.83,BRD-A43671941-003-11-9,CC(C)NCC(O)COc1ccccc1OCC=C,CEMAWMOMDPGJMB-UHFFFAOYSA-N,Launched,BRD-U77311119-000-01-0
oxtriphylline,adenosine receptor antagonist,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A",pulmonary,"asthma, chronic obstructive pulmonary disease (COPD), bronchospasm",MicroSource,60.29,BRD-K97799481-205-01-9,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,Launched,
oxybenzone,lipase inhibitor,LIPE,dermatology,sunscreen lotion,MicroSource,98.13,BRD-K59037100-001-14-7,COc1ccc(C(=O)c2ccccc2)c(O)c1,DXGLGDHPHMLXJC-UHFFFAOYSA-N,Launched,
oxybuprocaine,local anesthetic,SCN10A,neurology/psychiatry,local anesthetic,"MicroSource, Selleck, Selleck",94.35,"BRD-K04185004-003-12-7, BRD-K04185004-003-11-9, BRD-K04185004-003-13-5","CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC, CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC, CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC","CMHHMUWAYWTMGS-UHFFFAOYSA-N, CMHHMUWAYWTMGS-UHFFFAOYSA-N, CMHHMUWAYWTMGS-UHFFFAOYSA-N",Launched,
oxybutynin,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3",urology,urinary incontinence,"MicroSource, Selleck, Selleck",95.56,"BRD-A65013509-003-24-4, BRD-A65013509-001-02-4, BRD-A65013509-003-23-6","CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1, CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1, CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1","XIQVNETUBQGFHX-UHFFFAOYSA-N, XIQVNETUBQGFHX-UHFFFAOYSA-N, XIQVNETUBQGFHX-UHFFFAOYSA-N",Launched,
oxyclozanide,,,infectious disease,fascioliasis,MicroSource,95.82,BRD-K07283971-001-01-3,Oc1c(Cl)cc(Cl)cc1NC(=O)c1c(O)c(Cl)cc(Cl)c1Cl,JYWIYHUXVMAGLG-UHFFFAOYSA-N,Launched,BRD-K13017451-001-01-6
oxyfedrine,adrenergic receptor agonist,,cardiology,angina pectoris,Kemprotec,94.49,BRD-K73027814-003-01-0,COc1cccc(c1)C(=O)CCN[C@@H](C)[C@H](O)c1ccccc1,GDYUVHBMFVMBAF-LIRRHRJNSA-N,Launched,
oxymatrine,,,,,Selleck,90.8,BRD-A57833392-001-01-7,[O-][N+]12CCC[C@@H]3CN4[C@H](CCCC4=O)[C@H](CCC1)[C@@H]23,XVPBINOPNYFXID-WEFVWUPKSA-N,Launched,
oxymetazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C",otolaryngology,nasal congestion,"Tocris, MicroSource, Selleck",99.39,"BRD-K16195444-003-25-2, BRD-K16195444-003-26-0, BRD-K16195444-003-24-5","Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C, Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C, Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C","WYWIFABBXFUGLM-UHFFFAOYSA-N, WYWIFABBXFUGLM-UHFFFAOYSA-N, WYWIFABBXFUGLM-UHFFFAOYSA-N",Launched,
oxymetholone,androgen receptor agonist,AR,hematology,anemia,"Selleck, Selleck",35.22,"BRD-A93291428-001-02-0, BRD-A23637604-001-04-1","CC1(O)CCC2C3CCC4CC(=O)C(CC4(C)C3CCC12C)C=O, C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(C[C@]4(C)[C@H]3CC[C@]12C)C=O","DLZUBMGMHUNDLF-UHFFFAOYSA-N, DLZUBMGMHUNDLF-CVSXEEBHSA-N",Launched,BRD-A16767899-001-01-5
oxyphencyclimine,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3",gastroenterology,peptic ulcer disease (PUD),MicroSource,97.02,BRD-A58193911-003-18-7,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)c1ccccc1,DUDKAZCAISNGQN-UHFFFAOYSA-N,Launched,
oxyphenonium,cholinergic receptor antagonist,CHRM1,gastroenterology,peptic ulcer disease (PUD),MicroSource,92.38,BRD-A14208071-004-19-8,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c1ccccc1,GFRUPHOKLBPHTQ-UHFFFAOYSA-N,Launched,
oxyquinoline,chelating agent,METAP2,dermatology,cosmetic,MicroSource,97.72,BRD-K66808046-065-03-7,Oc1cccc2cccnc12,MCJGNVYPOGVAJF-UHFFFAOYSA-N,Launched,
oxytetracycline,bacterial 30S ribosomal subunit inhibitor,,"infectious disease, urology","chlamydia, urinary tract infections, skin infections, ear infections, gonorrhea, urethritis, Lyme disease","Selleck, MedChemEx, Selleck, Sigma, MedChemEx, Selleck, MicroSource, Selleck",51.7,"BRD-A22740840-001-09-7, BRD-A56621826-001-02-1, BRD-A22740840-001-10-5, BRD-A22740840-002-07-9, BRD-A22740840-001-11-3, BRD-A22740840-335-06-5, BRD-A22740840-003-06-9, BRD-A22740840-001-08-9","CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4C3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O","TUEWQXNXQFRUTK-NWGWHKHOSA-N, TUEWQXNXQFRUTK-PIZKLEGOSA-N, TUEWQXNXQFRUTK-NWGWHKHOSA-N, TUEWQXNXQFRUTK-NWGWHKHOSA-N, TUEWQXNXQFRUTK-NWGWHKHOSA-N, TUEWQXNXQFRUTK-NWGWHKHOSA-N, TUEWQXNXQFRUTK-NWGWHKHOSA-N, TUEWQXNXQFRUTK-NWGWHKHOSA-N",Launched,"BRD-A78694248-335-01-6, BRD-A56621826-001-01-3"
oxytocin,oxytocin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR",obstetrics/gynecology,labor induction,"Sigma, MedChemEx",84.04,"BRD-K25243230-001-01-2, BRD-K25243230-001-02-0","CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O, CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O","XNOPRXBHLZRZKH-DSZYJQQASA-N, XNOPRXBHLZRZKH-DSZYJQQASA-N",Launched,BRD-A80365673-001-01-1
ozagrel,thromboxane synthase inhibitor,TBXAS1,neurology/psychiatry,stroke,"Selleck, Selleck, Tocris",96.99,"BRD-K53061490-003-13-9, BRD-K53061490-001-02-6, BRD-K53061490-003-14-7","OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1, OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1, OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1","SHZKQBHERIJWAO-AATRIKPKSA-N, SHZKQBHERIJWAO-AATRIKPKSA-N, SHZKQBHERIJWAO-AATRIKPKSA-N",Launched,
paclitaxel,tubulin polymerization inhibitor,"BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1",oncology,"ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC)","Tocris, MicroSource, Selleck, Selleck, Tocris",98.1,"BRD-K62008436-001-25-4, BRD-K62008436-001-22-1, BRD-K62008436-001-18-9, BRD-K62008436-001-23-9, BRD-K62008436-001-24-7","CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1, CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1","RCINICONZNJXQF-MZXODVADSA-N, RCINICONZNJXQF-MZXODVADSA-N, RCINICONZNJXQF-MZXODVADSA-N, RCINICONZNJXQF-MZXODVADSA-N, RCINICONZNJXQF-MZXODVADSA-N",Launched,"BRD-A28746609-001-13-1, BRD-A28746609-001-11-5, BRD-A63610676-001-14-1, BRD-A28746609-001-10-7"
palbociclib,CDK inhibitor,"CDK4, CDK6",oncology,breast cancer,"Selleck, Selleck",94.04,"BRD-K51313569-001-07-8, BRD-K51313569-003-03-3","CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O, CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O","AHJRHEGDXFFMBM-UHFFFAOYSA-N, AHJRHEGDXFFMBM-UHFFFAOYSA-N",Launched,
paliperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C",neurology/psychiatry,schizophrenia,"Selleck, Selleck, MicroSource",96.4,"BRD-A99888680-001-05-3, BRD-A99888680-001-03-8, BRD-A99888680-001-04-6","Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12, Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12, Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12","PMXMIIMHBWHSKN-UHFFFAOYSA-N, PMXMIIMHBWHSKN-UHFFFAOYSA-N, PMXMIIMHBWHSKN-UHFFFAOYSA-N",Launched,"BRD-K00665454-001-01-4, BRD-K00665454-001-02-2"
palmitoylethanolamide,cannabinoid receptor agonist,"CNR2, GPR119, GPR55",,,"MicroSource, Tocris",96.53,"BRD-K68095457-001-11-9, BRD-K68095457-001-10-1","CCCCCCCCCCCCCCCC(=O)NCCO, CCCCCCCCCCCCCCCC(=O)NCCO","HXYVTAGFYLMHSO-UHFFFAOYSA-N, HXYVTAGFYLMHSO-UHFFFAOYSA-N",Launched,
palonosetron,serotonin receptor antagonist,HTR3A,gastroenterology,"nausea, vomiting",Selleck,97.7,BRD-K08924299-003-06-1,O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]1CN2CCC1CC2,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Launched,
pamabrom,diuretic,,gastroenterology,bloating,MicroSource,0,BRD-M67659203-001-01-9,CC(C)(N)CO.Cn1c2nc(Br)[nH]c2c(=O)n(C)c1=O,ATOTUUBRFJHZQG-UHFFFAOYSA-N,Launched,
pamidronate,bone resorption inhibitor,FDPS,"endocrinology, oncology, hematologic malignancy","hypercalcemia, Paget's disease, breast cancer, multiple myeloma","Selleck, Selleck",0,"BRD-K58513245-304-03-5, BRD-K58513245-304-02-7","NCCC(O)(P(O)(O)=O)P(O)(O)=O, NCCC(O)(P(O)(O)=O)P(O)(O)=O","WRUUGTRCQOWXEG-UHFFFAOYSA-N, WRUUGTRCQOWXEG-UHFFFAOYSA-N",Launched,
pancuronium,acetylcholine receptor antagonist,"CHRM2, CHRM3, CHRNA1, CHRNA2","critical care, neurology/psychiatry","endotracheal intubation, muscle relaxant","Selleck, Selleck",100,"BRD-K50817623-303-05-7, BRD-K50817623-303-06-5","CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1, CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1","GVEAYVLWDAFXET-XGHATYIMSA-N, GVEAYVLWDAFXET-XGHATYIMSA-N",Launched,BRD-K25166838-303-01-1
panobinostat,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9",hematologic malignancy,multiple myeloma,"Selleck, MedChemEx, MedChemEx, Selleck",81.65,"BRD-K02130563-001-12-2, BRD-K02130563-001-15-5, BRD-K02130563-001-14-8, BRD-K02130563-001-11-4","Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1, Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1, Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1, Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1","FPOHNWQLNRZRFC-ZHACJKMWSA-N, FPOHNWQLNRZRFC-ZHACJKMWSA-N, FPOHNWQLNRZRFC-ZHACJKMWSA-N, FPOHNWQLNRZRFC-ZHACJKMWSA-N",Launched,
pantethine,coenzyme A precursor,,,,"Sigma, MedChemEx, MedChemEx, MicroSource",97.01,"BRD-K68764924-001-03-2, BRD-K68764924-001-05-7, BRD-K68764924-001-04-0, BRD-A76244192-001-02-4","CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO, CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO, CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO, CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO","DJWYOLJPSHDSAL-ROUUACIJSA-N, DJWYOLJPSHDSAL-ROUUACIJSA-N, DJWYOLJPSHDSAL-ROUUACIJSA-N, DJWYOLJPSHDSAL-UHFFFAOYSA-N",Launched,
pantoprazole,ATPase inhibitor,ATP4A,gastroenterology,"gastroesophageal reflux disease (GERD), erosive esophagitis (EE), Zollinger-Ellison syndrome","MicroSource, MedChemEx, SantaCruz",99.89,"BRD-A22380646-001-05-6, BRD-A22380646-236-06-6, BRD-A22380646-236-05-8","COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC, COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC, COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC","IQPSEEYGBUAQFF-UHFFFAOYSA-N, IQPSEEYGBUAQFF-UHFFFAOYSA-N, IQPSEEYGBUAQFF-UHFFFAOYSA-N",Launched,BRD-A75848474-236-01-6
pantothenic-acid,coenzyme A precursor,,,,"Selleck, MicroSource, Selleck",86.63,"BRD-K29392254-001-02-2, BRD-K29392254-236-01-6, BRD-K29392254-001-03-0","CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O, CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O, CC(C)(CO)[C@@H](O)C(=O)NCCC(O)=O","GHOKWGTUZJEAQD-ZETCQYMHSA-N, GHOKWGTUZJEAQD-ZETCQYMHSA-N, GHOKWGTUZJEAQD-ZETCQYMHSA-N",Launched,
papaverine,phosphodiesterase inhibitor,"PDE10A, PDE4B, PDE5A","cardiology, hematology, gastroenterology","myocardial infarction, angina pectoris, pulmonary embolism (PE), colitis, vascular spasm",MicroSource,99.78,BRD-K15567136-003-27-2,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,XQYZDYMELSJDRZ-UHFFFAOYSA-N,Launched,
paracetamol,cyclooxygenase inhibitor,"FAAH, PTGS1, PTGS2, TRPV1","neurology/psychiatry, endocrinology","pain relief, fever","Tocris, MicroSource, Tocris",95,"BRD-K41524689-001-25-0, BRD-K41524689-001-23-5, BRD-K41524689-001-22-7","CC(=O)Nc1ccc(O)cc1, CC(=O)Nc1ccc(O)cc1, CC(=O)Nc1ccc(O)cc1","RZVAJINKPMORJF-UHFFFAOYSA-N, RZVAJINKPMORJF-UHFFFAOYSA-N, RZVAJINKPMORJF-UHFFFAOYSA-N",Launched,
parachlorophenol,antiinfective drug,,,,MicroSource,89.27,BRD-K40992116-001-09-7,Oc1ccc(Cl)cc1,WXNZTHHGJRFXKQ-UHFFFAOYSA-N,Launched,
paramethadione,anticonvulsant,"CACNA1G, CACNA1H, CACNA1I",neurology/psychiatry,seizures,"MicroSource, Enamine",15,"BRD-A22128695-001-02-6, BRD-A22128695-001-03-4","CCC1(C)OC(=O)N(C)C1=O, CCC1(C)OC(=O)N(C)C1=O","VQASKUSHBVDKGU-UHFFFAOYSA-N, VQASKUSHBVDKGU-UHFFFAOYSA-N",Launched,
parecoxib,cyclooxygenase inhibitor,LTF,neurology/psychiatry,pain relief,MedChemEx,99.02,BRD-K13800121-001-01-5,CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Launched,
pargyline,monoamine oxidase inhibitor,"MAOA, MAOB",cardiology,hypertension,MicroSource,99.36,BRD-K83597974-003-22-2,CN(CC#C)Cc1ccccc1,DPWPWRLQFGFJFI-UHFFFAOYSA-N,Launched,
paricalcitol,vitamin D receptor agonist,VDR,"nephrology, endocrinology","chronic kidney disease (CKD), hyperthyroidism",MedChemEx,98.6,BRD-K60585088-001-01-5,C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1C[C@@H](O)C[C@H](O)C1,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Launched,
paritaprevir,HCV inhibitor,,infectious disease,hepatitis C,MedChemEx,97.16,BRD-K89920762-001-01-4,Cc1cnc(cn1)C(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)Oc1nc2ccccc2c2ccccc12)C(=O)NS(=O)(=O)C1CC1,UAUIUKWPKRJZJV-QPLHLKROSA-N,Launched,
paromomycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,amebiasis,"MicroSource, MedChemEx, Sigma, Selleck, Selleck",97.2,"BRD-K36524108-065-06-5, BRD-K36524108-065-04-0, BRD-K36524108-065-07-3, BRD-K36524108-065-05-7, BRD-K36524108-065-03-2","NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","UOZODPSAJZTQNH-LSWIJEOBSA-N, UOZODPSAJZTQNH-LSWIJEOBSA-N, UOZODPSAJZTQNH-LSWIJEOBSA-N, UOZODPSAJZTQNH-LSWIJEOBSA-N, UOZODPSAJZTQNH-LSWIJEOBSA-N",Launched,"BRD-A20920572-065-04-7, BRD-M40700687-001-01-8, BRD-K25359791-065-01-2"
paroxetine,selective serotonin reuptake inhibitor (SSRI),"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4",neurology/psychiatry,"depression, obsessive compulsive disorder (OCD), generalized anxiety disorder (GAD), panic disorders, posttraumatic stress disorder, social anxiety disorder","MicroSource, Tocris, Selleck",94.73,"BRD-K37991163-003-14-2, BRD-K37991163-050-18-4, BRD-K37991163-003-13-4","Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1, Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1, Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1","AHOUBRCZNHFOSL-YOEHRIQHSA-N, AHOUBRCZNHFOSL-YOEHRIQHSA-N, AHOUBRCZNHFOSL-YOEHRIQHSA-N",Launched,
paroxypropione,gonadotropin inhibitor,,,,MicroSource,93.24,BRD-K07441213-001-18-9,CCC(=O)c1ccc(O)cc1,RARSHUDCJQSEFJ-UHFFFAOYSA-N,Launched,
pasiniazid,cyclooxygenase inhibitor,,infectious disease,tuberculosis,"MicroSource, Selleck",93.93,"BRD-K87202646-061-05-6, BRD-K87202646-061-04-9","NNC(=O)c1ccncc1, NNC(=O)c1ccncc1","QRXWMOHMRWLFEY-UHFFFAOYSA-N, QRXWMOHMRWLFEY-UHFFFAOYSA-N",Launched,
pasireotide,somatostatin receptor agonist,"SSTR1, SSTR2, SSTR3, SSTR5",endocrinology,"Cushing's syndrome, acromegaly",MedChemEx,87.58,BRD-K59715032-362-01-4,NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1,VMZMNAABQBOLAK-DBILLSOUSA-N,Launched,
pazopanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor","CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3",oncology,"renal cell carcinoma (RCC), soft tissue sarcoma (STS)","Selleck, Selleck",98.32,"BRD-K74514084-003-09-2, BRD-K74514084-001-03-9","CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1, CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1","CUIHSIWYWATEQL-UHFFFAOYSA-N, CUIHSIWYWATEQL-UHFFFAOYSA-N",Launched,
pazufloxacin,topoisomerase inhibitor,,infectious disease,"pneumonia, peritonitis, bacterial septicemia",MicroSource,97.79,BRD-K66412701-066-01-6,C[C@H]1COc2c(c(F)cc3c2n1cc(C(O)=O)c3=O)C1(N)CC1,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Launched,
pefloxacin,bacterial DNA gyrase inhibitor,TOP2A,"infectious disease, urology","gastrointestinal infections, urethritis, gonorrhea, urinary tract infections","MicroSource, Selleck",98.47,"BRD-K55034111-066-17-1, BRD-K55034111-066-16-3","CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCN(C)CC1, CCn1cc(C(O)=O)c(=O)c2cc(F)c(cc12)N1CCN(C)CC1","FHFYDNQZQSQIAI-UHFFFAOYSA-N, FHFYDNQZQSQIAI-UHFFFAOYSA-N",Launched,
pemetrexed,"dihydrofolate reductase inhibitor, thymidylate synthase inhibitor","ATIC, DHFR, GART, TYMS",oncology,"non-small cell lung cancer (NSCLC), mesothelioma","Key, Selleck, MedChemEx, MedChemEx, Selleck, MicroSource",87.62,"BRD-K32842773-434-01-8, BRD-K32842773-304-04-7, BRD-K32842773-304-05-4, BRD-K32842773-380-01-3, BRD-K32842773-304-06-2, BRD-K32842773-304-03-9","Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1, Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1, Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1, Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1, Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1, Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1","WBXPDJSOTKVWSJ-ZDUSSCGKSA-N, WBXPDJSOTKVWSJ-ZDUSSCGKSA-N, WBXPDJSOTKVWSJ-ZDUSSCGKSA-N, WBXPDJSOTKVWSJ-ZDUSSCGKSA-N, WBXPDJSOTKVWSJ-ZDUSSCGKSA-N, WBXPDJSOTKVWSJ-ZDUSSCGKSA-N",Launched,"BRD-M17920320-304-01-2, BRD-M18147244-437-01-2, BRD-K55395145-304-01-5"
pemirolast,mediator release inhibitor,HRH1,pulmonary,asthma,"MedChemEx, Selleck",97.42,"BRD-K31731454-237-03-3, BRD-K31731454-237-02-5","Cc1cccn2c1ncc(-c1nnn[nH]1)c2=O, Cc1cccn2c1ncc(-c1nnn[nH]1)c2=O","HIANJWSAHKJQTH-UHFFFAOYSA-N, HIANJWSAHKJQTH-UHFFFAOYSA-N",Launched,
pempidine,ganglionic blocker,,cardiology,hypertension,MicroSource,52.72,BRD-K71075093-045-14-7,CN1C(C)(C)CCCC1(C)C,XULIXFLCVXWHRF-UHFFFAOYSA-N,Launched,
penbutolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A, HTR1B",cardiology,hypertension,MicroSource,90.41,BRD-K55705469-065-01-0,CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1,KQXKVJAGOJTNJS-HNNXBMFYSA-N,Launched,
penciclovir,DNA directed DNA polymerase inhibitor,,dental,cold sore,"Selleck, MicroSource, Selleck",94.53,"BRD-K47780086-001-06-1, BRD-K47780086-001-07-9, BRD-K47780086-001-08-7","Nc1nc(O)c2ncn(CCC(CO)CO)c2n1, Nc1nc(O)c2ncn(CCC(CO)CO)c2n1, Nc1nc(O)c2ncn(CCC(CO)CO)c2n1","JNTOCHDNEULJHD-UHFFFAOYSA-N, JNTOCHDNEULJHD-UHFFFAOYSA-N, JNTOCHDNEULJHD-UHFFFAOYSA-N",Launched,
penfluridol,T-type calcium channel blocker,CACNA1G,neurology/psychiatry,schizophrenia,"MicroSource, Selleck",93.21,"BRD-K15409150-001-07-4, BRD-K15409150-001-05-8","OC1(CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccc(Cl)c(c1)C(F)(F)F, OC1(CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccc(Cl)c(c1)C(F)(F)F","MDLAAYDRRZXJIF-UHFFFAOYSA-N, MDLAAYDRRZXJIF-UHFFFAOYSA-N",Launched,
penicillamine-(D),chelating agent,,"metabolism, rheumatology, nephrology","Wilson's disease, rheumatoid arthritis, cystinuria","Selleck, Selleck",0,"BRD-K17518951-001-03-0, BRD-K17518951-001-04-8","CC(C)(S)[C@@H](N)C(O)=O, CC(C)(S)[C@@H](N)C(O)=O","VVNCNSJFMMFHPL-VKHMYHEASA-N, VVNCNSJFMMFHPL-VKHMYHEASA-N",Launched,
penicillin-v-potassium,bacterial cell wall synthesis inhibitor,,infectious disease,"pneumonia, ear infections, skin infections, throat infections, cholera, scarlet fever",MicroSource,90.16,BRD-K43966364-237-04-8,CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(O)=O,BPLBGHOLXOTWMN-MBNYWOFBSA-N,Launched,
pentagastrin,CCK receptor agonist,CCKBR,gastroenterology,"anacidity diagnostic, gastric hypersecretion diagnostic, anacidity diagnostic, gastric hypersecretion diagnostic","MicroSource, Abblis",84.88,"BRD-K78789465-001-02-4, BRD-K78789465-001-01-6","CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O, CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","NEYNJQRKHLUJRU-DZUOILHNSA-N, NEYNJQRKHLUJRU-DZUOILHNSA-N",Launched,BRD-K92045627-001-01-0
pentamidine,anti-pneumocystis agent,TRDMT1,infectious disease,pneumonia,"MicroSource, Selleck",98.99,"BRD-K13183738-317-10-2, BRD-K13183738-300-02-5","NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1, NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1","XDRYMKDFEDOLFX-UHFFFAOYSA-N, XDRYMKDFEDOLFX-UHFFFAOYSA-N",Launched,
pentolinium,cholinergic receptor antagonist,"CHRNA10, CHRNA3, CHRNA4, CHRNB4",cardiology,hypertension,"Prestwick, Acros",97.01,"BRD-K44942604-346-04-7, BRD-K44942604-346-05-4","C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1, C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1","XSBSKEQEUFOSDD-UHFFFAOYSA-N, XSBSKEQEUFOSDD-UHFFFAOYSA-N",Launched,
pentostatin,"adenosine deaminase inhibitor, ribonucleotide reductase inhibitor",ADA,hematologic malignancy,hairy cell leukemia,"MedChemEx, Enzo",86.61,"BRD-K91543828-001-02-0, BRD-A17154931-001-01-5","OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2[C@H](O)CNC=Nc12, OC[C@H]1O[C@H](CC1O)n1cnc2[C@H](O)CNC=Nc12","FPVKHBSQESCIEP-JQCXWYLXSA-N, FPVKHBSQESCIEP-FUZJYRNYSA-N",Launched,
pentoxifylline,phosphodiesterase inhibitor,"ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF",cardiology,claudication,"MicroSource, Selleck",99.53,"BRD-K57569181-001-27-5, BRD-K57569181-001-26-7","CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O, CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O","BYPFEZZEUUWMEJ-UHFFFAOYSA-N, BYPFEZZEUUWMEJ-UHFFFAOYSA-N",Launched,
peramivir,neuraminidase inhibitor,,infectious disease,influenza A virus infection,"Selleck, Selleck",85.33,"BRD-K00519864-341-02-5, BRD-K00519864-341-03-3","CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O, CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O","XRQDFNLINLXZLB-CKIKVBCHSA-N, XRQDFNLINLXZLB-CKIKVBCHSA-N",Launched,
perampanel,glutamate receptor antagonist,"GRIA1, GRIA2, GRIA3, GRIA4",neurology/psychiatry,seizures,MedChemEx,99.4,BRD-K41438959-001-01-7,O=c1c(cc(cn1-c1ccccc1)-c1ccccn1)-c1ccccc1C#N,PRMWGUBFXWROHD-UHFFFAOYSA-N,Launched,
perchlozone,,,infectious disease,tuberculosis,Vitas-M,99.35,BRD-K86435560-001-01-0,NC(=S)NN=Cc1ccncc1,QTSJJDIDTYFLFC-UHFFFAOYSA-N,Launched,
perfluamine,,,,,Oakwood,0,BRD-K16758059-001-01-8,FC(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F,JAJLKEVKNDUJBG-UHFFFAOYSA-N,Launched,
perflubron,contrast agent,,radiology,contrast agent,"Sigma, Oakwood",0,"BRD-K92988025-001-02-7, BRD-K92988025-001-01-9","FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br, FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br","WTWWXOGTJWMJHI-UHFFFAOYSA-N, WTWWXOGTJWMJHI-UHFFFAOYSA-N",Launched,
perfluorodecalin,,,dermatology,cosmetic,Sigma,0,BRD-K55401595-001-01-8,FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F,UWEYRJFJVCLAGH-UHFFFAOYSA-N,Launched,
perhexiline,carnitine palmitoyltransferase inhibitor,"CPT1A, CPT2",cardiology,angina pectoris,MicroSource,97.96,BRD-A19633847-050-32-1,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,CYXKNKQEMFBLER-UHFFFAOYSA-N,Launched,
perindopril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, myocardial infarction, coronary artery disease (CAD)","MicroSource, Selleck",95.89,"BRD-K92731339-227-04-9, BRD-K92731339-227-05-6","CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC, CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC","IPVQLZZIHOAWMC-QXKUPLGCSA-N, IPVQLZZIHOAWMC-QXKUPLGCSA-N",Launched,"BRD-A19924402-227-01-0,BRD-A47830685-227-02-1"
permethrin,,SCN1A,infectious disease,lice,"MedChemEx, MicroSource, Sigma",0,"BRD-A25366096-001-09-9, BRD-A25366096-001-07-3, BRD-A25366096-001-08-1","CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1, CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1, CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1","RLLPVAHGXHCWKJ-UHFFFAOYSA-N, RLLPVAHGXHCWKJ-UHFFFAOYSA-N, RLLPVAHGXHCWKJ-UHFFFAOYSA-N",Launched,
perospirone,"dopamine receptor antagonist, serotonin receptor antagonist","DRD2, DRD3, DRD4",neurology/psychiatry,"schizophrenia, bipolar disorder","Prestwick, AKSci",98.77,"BRD-K85503079-001-01-0, BRD-K85503079-001-02-8","O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12, O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12","FBVFZWUMDDXLLG-HDICACEKSA-N, FBVFZWUMDDXLLG-HDICACEKSA-N",Launched,
perphenazine,dopamine receptor antagonist,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7","neurology/psychiatry, gastroenterology","schizophrenia, nausea, vomiting","MicroSource, MedChemEx, Sigma",87.72,"BRD-K10995081-001-26-1, BRD-K10995081-001-28-7, BRD-K10995081-001-27-9","OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1, OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1, OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1","RGCVKNLCSQQDEP-UHFFFAOYSA-N, RGCVKNLCSQQDEP-UHFFFAOYSA-N, RGCVKNLCSQQDEP-UHFFFAOYSA-N",Launched,
phenacaine,local anesthetic,,neurology/psychiatry,local anesthetic,MPBio,99.16,BRD-K81092066-311-01-6,CCOc1ccc(NC(C)=Nc2ccc(OCC)cc2)cc1,QXDAEKSDNVPFJG-UHFFFAOYSA-N,Launched,
phenacemide,sodium channel blocker,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,"epilepsy, seizures",MicroSource,99.38,BRD-K40905133-001-04-9,NC(=O)NC(=O)Cc1ccccc1,XPFRXWCVYUEORT-UHFFFAOYSA-N,Launched,
phenazone,cyclooxygenase inhibitor,"PTGS1, PTGS2",neurology/psychiatry,pain relief,"MicroSource, Selleck",99.14,"BRD-K46937689-001-15-0, BRD-K46937689-001-14-3","Cc1cc(=O)n(-c2ccccc2)n1C, Cc1cc(=O)n(-c2ccccc2)n1C","VEQOALNAAJBPNY-UHFFFAOYSA-N, VEQOALNAAJBPNY-UHFFFAOYSA-N",Launched,
phenazopyridine,local anesthetic,SCN1A,infectious disease,urinary tract infections,"Selleck, MicroSource, Selleck",96.12,"BRD-K76304753-003-19-5, BRD-K76304753-003-20-3, BRD-K76304753-003-21-1","Nc1ccc(\N=N\c2ccccc2)c(N)n1, Nc1ccc(\N=N\c2ccccc2)c(N)n1, Nc1ccc(\N=N\c2ccccc2)c(N)n1","QPFYXYFORQJZEC-FOCLMDBBSA-N, QPFYXYFORQJZEC-FOCLMDBBSA-N, QPFYXYFORQJZEC-FOCLMDBBSA-N",Launched,
phenelzine,monoamine oxidase inhibitor,"ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,depression,"Sigma, MicroSource, Sigma",80.24,"BRD-K87024524-001-04-0, BRD-K87024524-065-17-7, BRD-K87024524-065-18-5","NNCCc1ccccc1, NNCCc1ccccc1, NNCCc1ccccc1","RMUCZJUITONUFY-UHFFFAOYSA-N, RMUCZJUITONUFY-UHFFFAOYSA-N, RMUCZJUITONUFY-UHFFFAOYSA-N",Launched,
phenethicillin,bacterial cell wall synthesis inhibitor,,,,Prestwick,55.17,BRD-A66025870-237-06-9,CC(Oc1ccccc1)C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O,NONJJLVGHLVQQM-JHXYUMNGSA-N,Launched,
phenindamine,histamine receptor antagonist,HRH1,"allergy, otolaryngology","allergic rhinitis, common cold","AMS, AMS",47.35,"BRD-A33178345-001-02-2, BRD-A33178345-001-01-4","CN1CCC2=C(C1)C(c1ccccc21)c1ccccc1, CN1CCC2=C(C1)C(c1ccccc21)c1ccccc1","ISFHAYSTHMVOJR-UHFFFAOYSA-N, ISFHAYSTHMVOJR-UHFFFAOYSA-N",Launched,
phenindione,vitamin K antagonist,VKORC1,hematology,deep vein thrombosis (DVT),"Selleck, MedChemEx, Selleck, MedChemEx, MicroSource, Sigma",95.63,"BRD-K70592963-001-29-0, BRD-K70592963-001-33-2, BRD-K70592963-001-27-4, BRD-K70592963-001-32-4, BRD-K70592963-001-28-2, BRD-K70592963-001-31-6","O=C1C(C(=O)c2ccccc12)c1ccccc1, O=C1C(C(=O)c2ccccc12)c1ccccc1, O=C1C(C(=O)c2ccccc12)c1ccccc1, O=C1C(C(=O)c2ccccc12)c1ccccc1, O=C1C(C(=O)c2ccccc12)c1ccccc1, O=C1C(C(=O)c2ccccc12)c1ccccc1","NFBAXHOPROOJAW-UHFFFAOYSA-N, NFBAXHOPROOJAW-UHFFFAOYSA-N, NFBAXHOPROOJAW-UHFFFAOYSA-N, NFBAXHOPROOJAW-UHFFFAOYSA-N, NFBAXHOPROOJAW-UHFFFAOYSA-N, NFBAXHOPROOJAW-UHFFFAOYSA-N",Launched,
pheniramine,histamine receptor antagonist,HRH1,allergy,"allergic rhinitis, urticaria","Selleck, MicroSource",98.32,"BRD-A23072235-050-17-7, BRD-A23072235-050-18-5","CN(C)CCC(c1ccccc1)c1ccccn1, CN(C)CCC(c1ccccc1)c1ccccn1","IJHNSHDBIRRJRN-UHFFFAOYSA-N, IJHNSHDBIRRJRN-UHFFFAOYSA-N",Launched,
phenolsulfonphthalein,,,,,MicroSource,91.1,BRD-K79892937-001-02-5,Oc1ccc(cc1)C1(OS(=O)(=O)c2ccccc12)c1ccc(O)cc1,BELBBZDIHDAJOR-UHFFFAOYSA-N,Launched,
phenothrin,,,infectious disease,lice,"MicroSource, Selleck",76.28,"BRD-A22106989-001-06-8, BRD-A22106989-001-05-0","CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C, CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C","SBNFWQZLDJGRLK-UHFFFAOYSA-N, SBNFWQZLDJGRLK-UHFFFAOYSA-N",Launched,
phenoxybenzamine,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB2, CALM1","cardiology, endocrinology","hypertension, pheochromocytoma","MedChemEx, Selleck, MedChemEx, Selleck",0,"BRD-A67799922-003-28-6, BRD-A67799922-003-26-0, BRD-A67799922-003-29-4, BRD-A67799922-003-27-8","CC(COc1ccccc1)N(CCCl)Cc1ccccc1, CC(COc1ccccc1)N(CCCl)Cc1ccccc1, CC(COc1ccccc1)N(CCCl)Cc1ccccc1, CC(COc1ccccc1)N(CCCl)Cc1ccccc1","QZVCTJOXCFMACW-UHFFFAOYSA-N, QZVCTJOXCFMACW-UHFFFAOYSA-N, QZVCTJOXCFMACW-UHFFFAOYSA-N, QZVCTJOXCFMACW-UHFFFAOYSA-N",Launched,
phenprobamate,muscle relaxant,,neurology/psychiatry,"anxiety, muscle relaxant",Prestwick,98.85,BRD-K22009844-001-12-5,NC(=O)OCCCc1ccccc1,CAMYKONBWHRPDD-UHFFFAOYSA-N,Launched,
phenprocoumon,vitamin K antagonist,VKORC1,hematology,"thrombosis, pulmonary embolism (PE)",Abblis,97.47,BRD-A49838158-001-01-1,CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O,DQDAYGNAKTZFIW-UHFFFAOYSA-N,Launched,
phensuximide,succinimide antiepileptic,"CACNA1G, CACNA1H, CACNA1I",neurology/psychiatry,seizures,MicroSource,98.87,BRD-A18043272-001-09-9,CN1C(=O)CC(C1=O)c1ccccc1,WLWFNJKHKGIJNW-UHFFFAOYSA-N,Launched,
phentermine,"dopamine uptake inhibitor, serotonin reuptake inhibitor","MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4",endocrinology,weight-loss aid,Prestwick,96.96,BRD-K96319534-003-03-9,CC(C)(N)Cc1ccccc1,DHHVAGZRUROJKS-UHFFFAOYSA-N,Launched,
phentolamine,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","endocrinology, cardiology","pheochromocytoma, hypertension","Selleck, MicroSource, Selleck, Enzo",99.38,"BRD-K90333595-066-17-9, BRD-K90333595-003-21-4, BRD-K90333595-066-16-1, BRD-K90333595-003-22-2","Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1, Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1, Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1, Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1","MRBDMNSDAVCSSF-UHFFFAOYSA-N, MRBDMNSDAVCSSF-UHFFFAOYSA-N, MRBDMNSDAVCSSF-UHFFFAOYSA-N, MRBDMNSDAVCSSF-UHFFFAOYSA-N",Launched,
phenyl-aminosalicylate,,,infectious disease,tuberculosis,MicroSource,99.55,BRD-K73157543-001-04-1,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,DNVVZWSVACQWJE-UHFFFAOYSA-N,Launched,
phenyl-salicylate,antiseptic,,urology,interstitial cystitis (IC),Enamine,0,BRD-K44091963-001-01-5,Oc1ccccc1C(=O)Oc1ccccc1,ZQBAKBUEJOMQEX-UHFFFAOYSA-N,Launched,
phenylbenzimidazole-sulfonic-acid,,,dermatology,sunscreen lotion,Vitas-M,92.52,BRD-K02729857-001-01-9,OS(=O)(=O)c1ccc2[nH]c(nc2c1)-c1ccccc1,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Launched,
phenylbutyrate,HDAC inhibitor,HDAC1,metabolism,urea cycle disorders,"MicroSource, Tocris, Selleck, Tocris",97.03,"BRD-K67102207-236-08-5, BRD-K67102207-236-07-7, BRD-K67102207-236-06-9, BRD-K67102207-236-10-1","OC(=O)CCCc1ccccc1, OC(=O)CCCc1ccccc1, OC(=O)CCCc1ccccc1, OC(=O)CCCc1ccccc1","OBKXEAXTFZPCHS-UHFFFAOYSA-N, OBKXEAXTFZPCHS-UHFFFAOYSA-N, OBKXEAXTFZPCHS-UHFFFAOYSA-N, OBKXEAXTFZPCHS-UHFFFAOYSA-N",Launched,
phenylephrine,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D","otolaryngology, gastroenterology, cardiology","nasal congestion, hemorrhoids, hypotension","Selleck, Selleck, MicroSource",93.38,"BRD-K73381542-003-22-6, BRD-K73381542-003-24-2, BRD-K73381542-003-23-4","CNC[C@H](O)c1cccc(O)c1, CNC[C@H](O)c1cccc(O)c1, CNC[C@H](O)c1cccc(O)c1","SONNWYBIRXJNDC-VIFPVBQESA-N, SONNWYBIRXJNDC-VIFPVBQESA-N, SONNWYBIRXJNDC-VIFPVBQESA-N",Launched,
phenylpiracetam,noradrenaline uptake inhibitor,,neurology/psychiatry,"anxiety, fatigue, depression",MedChemEx,91.32,BRD-A65683612-001-07-7,NC(=O)CN1CC(CC1=O)c1ccccc1,LYONXVJRBWWGQO-UHFFFAOYSA-N,Launched,
phenytoin,hydantoin antiepileptic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,"Selleck, MicroSource, Selleck",99.77,"BRD-K55930204-236-23-5, BRD-K55930204-236-24-3, BRD-K55930204-001-20-9","O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1, O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1, O=C1NC(=O)C(N1)(c1ccccc1)c1ccccc1","CXOFVDLJLONNDW-UHFFFAOYSA-N, CXOFVDLJLONNDW-UHFFFAOYSA-N, CXOFVDLJLONNDW-UHFFFAOYSA-N",Launched,
phloretin,sodium/glucose cotransporter inhibitor,"AQP9, CLCN3, SLC23A1",,,Selleck,95.59,BRD-K15563106-001-18-0,Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1,VGEREEWJJVICBM-UHFFFAOYSA-N,Launched,
phloroglucin,,,,,Vitas-M,98.67,BRD-K00405906-001-01-9,Oc1cc(O)cc(O)c1,QCDYQQDYXPDABM-UHFFFAOYSA-N,Launched,
phosphatidylcholine,,PCTP,"infectious disease, dermatology, gastroenterology, cardiology, obstetrics/gynecology","hepatitis B, hepatitis C, eczema, gallbladder disease, cholesterol, premenstrual syndrome","Selleck, Selleck",0,"BRD-U51753822-000-01-1, BRD-A10131665-001-02-0",", CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC",", JLPULHDHAOZNQI-ZTIMHPMXSA-O",Launched,BRD-M44205332-065-01-8
phthalylsulfathiazole,dihydropteroate synthetase inhibitor,,"infectious disease, gastroenterology","dysentry, colitis","MedChemEx, MicroSource",83.45,"BRD-K64659768-001-13-6, BRD-K64659768-001-12-8","OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1, OC(=O)c1ccccc1C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1nccs1","PBMSWVPMRUJMPE-UHFFFAOYSA-N, PBMSWVPMRUJMPE-UHFFFAOYSA-N",Launched,
physostigmine,cholinesterase inhibitor,"ACHE, BCHE","cardiology, neurology/psychiatry, ophthalmology, gastroenterology","hypotension, Alzheimer's disease, glaucoma, gastroparesis",MicroSource,86.09,BRD-K25650355-065-02-0,CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1,PIJVFDBKTWXHHD-HIFRSBDPSA-N,Launched,
phytonadione,,"BGLAP, GGCX",hematology,"vitamin K deficiency, anticoagulation reversal","MicroSource, Sigma",2.14,"BRD-K76661572-001-07-6, BRD-K76661572-001-08-4","CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O, CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O","MBWXNTAXLNYFJB-NKFFZRIASA-N, MBWXNTAXLNYFJB-NKFFZRIASA-N",Launched,
picotamide,"thromboxane receptor antagonist, thromboxane synthase inhibitor",TBXA2R,hematology,thrombosis,Prestwick,99.78,BRD-K67277431-002-10-5,COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1,KYWCWBXGRWWINE-UHFFFAOYSA-N,Launched,
pidolic-acid,,"ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA",dermatology,xerosis cutis,MicroSource,92.71,BRD-K57313110-001-06-8,OC(=O)[C@@H]1CCC(=O)N1,ODHCTXKNWHHXJC-VKHMYHEASA-N,Launched,
pidotimod,"interferon receptor agonist, interleukin receptor agonist",,infectious disease,immune adjuvant,"MicroSource, Selleck",92.63,"BRD-K44442813-001-12-9, BRD-K44442813-001-11-1","OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1, OC(=O)[C@@H]1CSCN1C(=O)[C@@H]1CCC(=O)N1","UUTKICFRNVKFRG-WDSKDSINSA-N, UUTKICFRNVKFRG-WDSKDSINSA-N",Launched,
piketoprofen,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief,Enamine,93.58,BRD-A85548292-001-01-8,CC(C(=O)Nc1cc(C)ccn1)c1cccc(c1)C(=O)c1ccccc1,ASFKKFRSMGBFRO-UHFFFAOYSA-N,Launched,
pilocarpine,acetylcholine receptor agonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5","ophthalmology, cardiology","glaucoma, hypertension","Tocris, MicroSource, Tocris, Selleck",99.14,"BRD-K85090592-003-20-2, BRD-K85090592-008-22-7, BRD-K85090592-003-19-4, BRD-K85090592-003-18-6","CC[C@H]1[C@@H](Cc2cncn2C)COC1=O, CC[C@H]1[C@@H](Cc2cncn2C)COC1=O, CC[C@H]1[C@@H](Cc2cncn2C)COC1=O, CC[C@H]1[C@@H](Cc2cncn2C)COC1=O","QCHFTSOMWOSFHM-WPRPVWTQSA-N, QCHFTSOMWOSFHM-WPRPVWTQSA-N, QCHFTSOMWOSFHM-WPRPVWTQSA-N, QCHFTSOMWOSFHM-WPRPVWTQSA-N",Launched,
pilsicainide,sodium channel blocker,SCN5A,cardiology,cardiac arrythmia,AKSci,99.35,BRD-K83245588-001-01-4,Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2,BCQTVJKBTWGHCX-UHFFFAOYSA-N,Launched,
pimavanserin,serotonin receptor inverse agonist,"DRD2, HTR2A",,,MedChemEx,88.73,BRD-K83405785-001-01-5,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Launched,
pimecrolimus,calcineurin inhibitor,"FKBP1A, MTOR",dermatology,eczema,Selleck,90.71,BRD-K92107055-001-01-9,CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC,KASDHRXLYQOAKZ-XDSKOBMDSA-N,Launched,BRD-K97729603-001-01-2
pimethixene,antihistamine,,"neurology/psychiatry, allergy","attention-deficit/hyperactivity disorder (ADHD), anxiety, sleep cycle support, allergic rhinitis",MicroSource,97.82,BRD-K88090157-050-10-8,CN1CCC(CC1)=C1c2ccccc2Sc2ccccc12,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Launched,
pimobendan,"calcium sensitizer, phosphodiesterase inhibitor",PDE3A,cardiology,congestive heart failure,Selleck,97.63,BRD-A84575140-001-02-4,COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C,GLBJJMFZWDBELO-UHFFFAOYSA-N,Launched,
pimozide,dopamine receptor antagonist,"CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2",neurology/psychiatry,Tourette's disorder,"Tocris, Selleck, Tocris, MicroSource",97.81,"BRD-K01292756-001-27-6, BRD-K01292756-001-23-5, BRD-K01292756-001-24-3, BRD-K01292756-001-25-0","Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1, Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1, Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1, Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1","YVUQSNJEYSNKRX-UHFFFAOYSA-N, YVUQSNJEYSNKRX-UHFFFAOYSA-N, YVUQSNJEYSNKRX-UHFFFAOYSA-N, YVUQSNJEYSNKRX-UHFFFAOYSA-N",Launched,
pinacidil,"ATP channel activator, potassium channel activator","ABCC8, ABCC9",cardiology,hypertension,"Selleck, MicroSource",98.87,"BRD-A43882281-001-14-8, BRD-A43882281-001-15-5","CC(N\C(Nc1ccncc1)=N\C#N)C(C)(C)C, CC(N\C(Nc1ccncc1)=N\C#N)C(C)(C)C","IVVNZDGDKPTYHK-UHFFFAOYSA-N, IVVNZDGDKPTYHK-UHFFFAOYSA-N",Launched,
pinaverium,T-type calcium channel blocker,CACNA1C,gastroenterology,irritable bowel syndrome,Prestwick,98.24,BRD-A70998768-004-01-1,COc1cc(Br)c(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)cc1OC,DDHUTBKXLWCZCO-GFUWAVFVSA-N,Launched,
pindolol,adrenergic receptor antagonist,"ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B",cardiology,hypertension,"Selleck, Tocris, MicroSource",97.25,"BRD-A97701745-001-14-5, BRD-A97701745-001-15-2, BRD-A97701745-001-16-0","CC(C)NCC(O)COc1cccc2[nH]ccc12, CC(C)NCC(O)COc1cccc2[nH]ccc12, CC(C)NCC(O)COc1cccc2[nH]ccc12","JZQKKSLKJUAGIC-UHFFFAOYSA-N, JZQKKSLKJUAGIC-UHFFFAOYSA-N, JZQKKSLKJUAGIC-UHFFFAOYSA-N",Launched,
pioglitazone,"insulin sensitizer, PPAR receptor agonist","PPARG, TRPM3",endocrinology,diabetes mellitus,"MicroSource, Tocris, Selleck, Selleck",99.54,"BRD-A48430263-003-17-2, BRD-A48430263-003-19-8, BRD-A48430263-003-16-4, BRD-A48430263-001-07-7","CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1, CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1, CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1, CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1","HYAFETHFCAUJAY-UHFFFAOYSA-N, HYAFETHFCAUJAY-UHFFFAOYSA-N, HYAFETHFCAUJAY-UHFFFAOYSA-N, HYAFETHFCAUJAY-UHFFFAOYSA-N",Launched,
pipamperone,dopamine receptor antagonist,"DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A",neurology/psychiatry,schizophrenia,MicroSource,89.65,BRD-K26801045-001-02-9,NC(=O)C1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)N1CCCCC1,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Launched,
pipecuronium,neuromuscular blocker,"CHRM2, CHRM3, CHRNA2",neurology/psychiatry,anesthetic,Kemprotec,98.54,BRD-A21544762-303-01-5,CC(=O)OC1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,OWWLUIWOFHMHOQ-XUCOTFPHSA-N,Launched,
pipemidic-acid,topoisomerase inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,90.96,BRD-K08999871-213-01-5,CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCNCC1,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Launched,
pipenzolate,cholinergic receptor antagonist,CHRM1,neurology/psychiatry,spasms,"Selleck, MicroSource",97.76,"BRD-A53561827-004-22-3, BRD-A53561827-004-23-1","CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1, CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c1ccccc1)c1ccccc1","WPUKUEMZZRVAKZ-UHFFFAOYSA-N, WPUKUEMZZRVAKZ-UHFFFAOYSA-N",Launched,
piperacetazine,dopamine receptor antagonist,,neurology/psychiatry,schizophrenia,MicroSource,94.04,BRD-K16277217-001-10-9,CC(=O)c1ccc2Sc3ccccc3N(CCCN3CCC(CCO)CC3)c2c1,BTFMCMVEUCGQDX-UHFFFAOYSA-N,Launched,
piperacillin,bacterial cell wall synthesis inhibitor,,infectious disease,"intra-abdominal infections, skin infections, pelvic inflammatory disease, pneumonia","MedChemEx, MedChemEx, Sigma, MicroSource, Selleck, Selleck",96.3,"BRD-K86873305-236-17-0, BRD-K86873305-236-16-2, BRD-K86873305-236-15-4, BRD-A99949740-236-04-6, BRD-K86873305-236-18-8, BRD-K86873305-236-14-7","CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O, CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O, CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O","IVBHGBMCVLDMKU-GXNBUGAJSA-N, IVBHGBMCVLDMKU-GXNBUGAJSA-N, IVBHGBMCVLDMKU-GXNBUGAJSA-N, IVBHGBMCVLDMKU-UVIOZBFDSA-N, IVBHGBMCVLDMKU-GXNBUGAJSA-N, IVBHGBMCVLDMKU-GXNBUGAJSA-N",Launched,BRD-K67009182-236-01-6
piperaquine-phosphate,antimalarial agent,,infectious disease,malaria,AKSci,96.15,BRD-K27382019-418-01-9,Clc1ccc2c(ccnc2c1)N1CCN(CCCN2CCN(CC2)c2ccnc3cc(Cl)ccc23)CC1,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Launched,
piperazine,benzodiazepine receptor agonist,GABRB3,infectious disease,gastrointestinal roundworms,MicroSource,100,BRD-K13249881-001-02-3,C1CNCCN1,GLUUGHFHXGJENI-UHFFFAOYSA-N,Launched,
piperidolate,acetylcholine receptor antagonist,CHRM1,neurology/psychiatry,spasms,MicroSource,98.09,BRD-A97479839-003-13-3,CCN1CCCC(C1)OC(=O)C(c1ccccc1)c1ccccc1,KTHVBAZBLKXIHZ-UHFFFAOYSA-N,Launched,
piperonyl-butoxide,cytochrome P450 inhibitor,,infectious disease,lice,MicroSource,88.86,BRD-K76452401-001-03-6,CCCCOCCOCCOCc1cc2OCOc2cc1CCC,FIPWRIJSWJWJAI-UHFFFAOYSA-N,Launched,
pipobroman,DNA alkylating agent,,hematology,"polycythemia vera, thrombocythemia","MicroSource, MedChemEx, MedChemEx",81.16,"BRD-K15656090-001-04-0, BRD-K15656090-001-06-5, BRD-K15656090-001-07-3","BrCCC(=O)N1CCN(CC1)C(=O)CCBr, BrCCC(=O)N1CCN(CC1)C(=O)CCBr, BrCCC(=O)N1CCN(CC1)C(=O)CCBr","NJBFOOCLYDNZJN-UHFFFAOYSA-N, NJBFOOCLYDNZJN-UHFFFAOYSA-N, NJBFOOCLYDNZJN-UHFFFAOYSA-N",Launched,
pipotiazine-palmitate,"dopamine receptor antagonist, serotonin receptor antagonist","DRD1, DRD2, HTR1A, HTR2A",,,Sigma,75.11,BRD-K48429278-001-01-3,CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(cc23)S(=O)(=O)N(C)C)CC1,KTOYYUONFQWSMW-UHFFFAOYSA-N,Launched,
piracetam,acetylcholine receptor agonist,"GRIA1, GRIA2, GRIA3, GRIA4",neurology/psychiatry,senile dementia,"Selleck, MicroSource",100,"BRD-K19456237-001-26-8, BRD-K19456237-001-27-6","NC(=O)CN1CCCC1=O, NC(=O)CN1CCCC1=O","GMZVRMREEHBGGF-UHFFFAOYSA-N, GMZVRMREEHBGGF-UHFFFAOYSA-N",Launched,
pirarubicin,topoisomerase inhibitor,TOP2A,oncology,breast cancer,"MedChemEx, MedChemEx, Selleck, Selleck",71.82,"BRD-K83794624-003-02-1, BRD-K83794624-003-01-3, BRD-K83794624-001-02-5, BRD-K83794624-001-03-3","COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO, COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO","KMSKQZKKOZQFFG-YXRRJAAWSA-N, KMSKQZKKOZQFFG-YXRRJAAWSA-N, KMSKQZKKOZQFFG-YXRRJAAWSA-N, KMSKQZKKOZQFFG-YXRRJAAWSA-N",Launched,
pirenoxine,AGE inhibitor,,ophthalmology,cataracts,AKSci,94.2,BRD-K65992024-001-01-5,OC(=O)c1cc(O)c2c3nc4ccccc4oc3cc(=O)c2n1,OKPNYGAWTYOBFZ-UHFFFAOYSA-N,Launched,
pirenzepine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",gastroenterology,peptic ulcer disease (PUD),MicroSource,98.27,BRD-K89375097-300-08-8,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1,RMHMFHUVIITRHF-UHFFFAOYSA-N,Launched,
piretanide,glucocorticoid receptor agonist,"SLC12A1, SLC12A2",cardiology,"hypertension, edema",Prestwick,99.31,BRD-K87990216-001-10-2,NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc1ccccc1)C(O)=O,UJEWTUDSLQGTOA-UHFFFAOYSA-N,Launched,
pirfenidone,TGF beta receptor inhibitor,"FURIN, TNF",pulmonary,idiopathic pulmonary fibrosis (IPF),"Selleck, Tocris",97.6,"BRD-K96862998-001-14-8, BRD-K96862998-001-15-5","Cc1ccc(=O)n(c1)-c1ccccc1, Cc1ccc(=O)n(c1)-c1ccccc1","ISWRGOKTTBVCFA-UHFFFAOYSA-N, ISWRGOKTTBVCFA-UHFFFAOYSA-N",Launched,
piribedil,dopamine receptor agonist,"ADRA1A, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR2B",neurology/psychiatry,"Parkinson's Disease, dizziness",Tocris,87.35,BRD-K47936004-003-11-4,C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,Launched,
pirlindole,monoamine oxidase inhibitor,MAOA,neurology/psychiatry,depression,Tocris,90,BRD-A54490543-066-11-9,Cc1ccc2n3CCNC4CCCc(c34)c2c1,IWVRVEIKCBFZNF-UHFFFAOYSA-N,Launched,
piroctone-olamine,,,infectious disease,fungal infection,MicroSource,0,BRD-A96510685-213-03-7,CC(Cc1cc(C)cc(=O)n1O)CC(C)(C)C,OIQJEQLSYJSNDS-UHFFFAOYSA-N,Launched,BRD-M95050869-001-01-2
piroxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"osteoarthritis, rheumatoid arthritis","Tocris, Selleck, MicroSource",99.2,"BRD-A57382968-001-28-2, BRD-A57382968-001-27-4, BRD-A57382968-001-29-0","CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O, CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O, CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O","MNSCVRXKDINXEY-UHFFFAOYSA-N, MNSCVRXKDINXEY-UHFFFAOYSA-N, MNSCVRXKDINXEY-UHFFFAOYSA-N",Launched,
pitavastatin,HMGCR inhibitor,HMGCR,endocrinology,hyperlipidemia,"Tocris, Selleck",96.25,"BRD-K75958547-238-02-8, BRD-K75958547-238-01-0","O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O, O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1-c1ccc(F)cc1)C1CC1)CC(O)=O","VGYFMXBACGZSIL-MCBHFWOFSA-N, VGYFMXBACGZSIL-MCBHFWOFSA-N",Launched,"BRD-M62817595-238-02-0, BRD-M62817595-238-01-2"
pivagabine,corticosteroid releasing factor receptor antagonist,"CRHR1, CRHR2",neurology/psychiatry,depression,"Enamine, Enamine",53.16,"BRD-K62264492-001-01-5, BRD-K62264492-001-02-3","CC(C)(C)C(=O)NCCCC(O)=O, CC(C)(C)C(=O)NCCCC(O)=O","SRPNQDXRVRCTNK-UHFFFAOYSA-N, SRPNQDXRVRCTNK-UHFFFAOYSA-N",Launched,
pivampicillin,bacterial cell wall synthesis inhibitor,,"pulmonary, infectious disease","bronchitis, pneumonia, gynecologic infections",Prestwick,38.24,BRD-K32791151-001-04-0,CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c1ccccc1)C2=O,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Launched,
pivmecillinam,bacterial cell wall synthesis inhibitor,,infectious disease,"urinary tract infections, gram-negative bacterial infections","Sigma, Prestwick, MedChemEx",95.37,"BRD-K67100011-001-01-8, BRD-K67100011-003-06-3, BRD-K67100011-003-07-1","CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O, CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O, CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N1CCCCCC1)C2=O","NPGNOVNWUSPMDP-UTEPHESZSA-N, NPGNOVNWUSPMDP-UTEPHESZSA-N, NPGNOVNWUSPMDP-UTEPHESZSA-N",Launched,
pixantrone,topoisomerase inhibitor,TOP2A,hematologic malignancy,non-Hodgkin lymphoma (NHL),"MedChemEx, MedChemEx",53.02,"BRD-K48304345-332-02-4, BRD-K48304345-332-01-6","NCCNc1ccc(NCCN)c2C(=O)c3cnccc3C(=O)c12, NCCNc1ccc(NCCN)c2C(=O)c3cnccc3C(=O)c12","PEZPMAYDXJQYRV-UHFFFAOYSA-N, PEZPMAYDXJQYRV-UHFFFAOYSA-N",Launched,
pizotifen,serotonin receptor antagonist,"HTR1A, HTR2A, HTR2C",neurology/psychiatry,migraine headache,"Selleck, MicroSource",98.76,"BRD-K75958195-037-08-6, BRD-K75958195-037-09-4","CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12, CN1CCC(CC1)=C1c2ccsc2CCc2ccccc12","FIADGNVRKBPQEU-UHFFFAOYSA-N, FIADGNVRKBPQEU-UHFFFAOYSA-N",Launched,
plerixafor,CC chemokine receptor antagonist,"ACKR3, CCR4, CXCR4",hematologic malignancy,"non-Hodgkin lymphoma (NHL), multiple myeloma","MedChemEx, Selleck, MedChemEx, Selleck",97.85,"BRD-K33240821-001-06-2, BRD-K33240821-001-03-9, BRD-K33240821-400-02-5, BRD-K33240821-001-05-4","C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1, C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1, C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1, C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1","YIQPUIGJQJDJOS-UHFFFAOYSA-N, YIQPUIGJQJDJOS-UHFFFAOYSA-N, YIQPUIGJQJDJOS-UHFFFAOYSA-N, YIQPUIGJQJDJOS-UHFFFAOYSA-N",Launched,
plicamycin,alcohol dehydrogenase inhibitor,,"oncology, endocrinology","testicular carcinoma, Paget's disease, hypercalcemia",Enzo,59.72,BRD-K36368047-001-01-7,CO[C@@H]([C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1)C(=O)[C@@H](O)[C@@H](C)O,CFCUWKMKBJTWLW-BGLFSJPPSA-N,Launched,
podophyllotoxin,"microtubule inhibitor, tubulin polymerization inhibitor","IGF1R, TOP2A, TUBA4A, TUBB",infectious disease,genital warts,MicroSource,94.65,BRD-K47869605-001-32-0,COc1cc(cc(OC)c1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)c2cc3OCOc3cc12,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Launched,
polidocanol,local anesthetic,,dermatology,varicose veins,Sigma,97.44,BRD-K35798650-001-01-4,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,ONJQDTZCDSESIW-UHFFFAOYSA-N,Launched,
polymyxin-b-sulfate,bacterial permeability inducer,,ophthalmology,eye infection,MicroSource,59.7,BRD-A08641215-065-04-8,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O,WQVJHHACXVLGBL-UHFFFAOYSA-N,Launched,
polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3,"cardiology, gastroenterology, rheumatology, nephrology","edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis (AGN), chronic renal failure, hypertension",Kemprotec,98.56,BRD-A15739803-001-01-0,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(cc2S1(=O)=O)S(N)(=O)=O,CYLWJCABXYDINA-UHFFFAOYSA-N,Launched,
pomalidomide,"angiogenesis inhibitor, tumor necrosis factor production inhibitor","CRBN, PTGS2, TNF",hematologic malignancy,multiple myeloma,Selleck,96.64,BRD-A12994259-001-02-1,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,UVSMNLNDYGZFPF-UHFFFAOYSA-N,Launched,
ponatinib,"Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK",hematologic malignancy,"chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)","Selleck, Selleck",90.52,"BRD-K44227013-001-08-0, BRD-K44227013-001-06-4","CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1, CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1","PHXJVRSECIGDHY-UHFFFAOYSA-N, PHXJVRSECIGDHY-UHFFFAOYSA-N",Launched,
posaconazole,sterol demethylase inhibitor,CYP3A4,infectious disease,oropharyngeal candidiasis,"Selleck, Selleck",87.29,"BRD-K06222852-001-05-7, BRD-K06222852-001-03-2","CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@@H]3CO[C@](Cn4cncn4)(C3)c3ccc(F)cc3F)cc2)c1=O, CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@@H]3CO[C@](Cn4cncn4)(C3)c3ccc(F)cc3F)cc2)c1=O","RAGOYPUPXAKGKH-XAKZXMRKSA-N, RAGOYPUPXAKGKH-XAKZXMRKSA-N",Launched,
potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2,cardiology,edema,"MicroSource, Selleck, Selleck",98.01,"BRD-K46556543-001-01-4, BRD-K46556543-237-09-7, BRD-K46556543-237-10-5","C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O, C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O, C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC(O)=O","PBKZPPIHUVSDNM-WNHSNXHDSA-N, PBKZPPIHUVSDNM-WNHSNXHDSA-N, PBKZPPIHUVSDNM-WNHSNXHDSA-N",Launched,BRD-A29322418-237-04-0
potassium-iodide,,,pulmonary,"asthma, bronchitis, emphysema","Selleck, Selleck",0,"BRD-M55321172-001-03-3, BRD-M55321172-001-02-5","[K].I, [K].I","KIRAUJWBCMCUBY-UHFFFAOYSA-N, KIRAUJWBCMCUBY-UHFFFAOYSA-N",Launched,
potassium-p-aminobenzoate,,,"rheumatology, urology","scleroderma, dermatomyositis, Peyronie's disease",MicroSource,92.96,BRD-K58497451-237-10-7,Nc1ccc(cc1)C(O)=O,ALYNCZNDIQEVRV-UHFFFAOYSA-N,Launched,
pralatrexate,dihydrofolate reductase inhibitor,"DHFR, TYMS",hematologic malignancy,peripheral T-cell lymphoma (PTCL),Selleck,94.33,BRD-A74914197-001-02-9,Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2n1,OGSBUKJUDHAQEA-WMCAAGNKSA-N,Launched,
pralidoxime,acetylcholinesterase inhibitor,"ACHE, BCHE",critical care,organophosphate poisoning,"MicroSource, MicroSource, MedChemEx",96.7,"BRD-K84281997-003-09-2, BRD-K84281997-066-03-2, BRD-K84281997-003-08-4","C[n+]1ccccc1\C=N\O, C[n+]1ccccc1\C=N\O, C[n+]1ccccc1\C=N\O","JBKPUQTUERUYQE-UHFFFAOYSA-O, JBKPUQTUERUYQE-UHFFFAOYSA-O, JBKPUQTUERUYQE-UHFFFAOYSA-O",Launched,BRD-K61327230-003-13-9
pralidoxime-chloride,acetylcholinesterase inhibitor,"ACHE, BCHE",pulmonary,respiratory depression,Sigma,97.1,BRD-K24221957-003-01-6,C[n+]1ccccc1C[N+][O-],MHOAUIZFSQGCNM-UHFFFAOYSA-N,Launched,
pramipexole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",neurology/psychiatry,Parkinson's Disease,"Tocris, Selleck, Selleck",100,"BRD-K06388322-300-01-3, BRD-K06388322-001-07-4, BRD-K06388322-312-02-6","CCCN[C@H]1CCc2nc(N)sc2C1, CCCN[C@H]1CCc2nc(N)sc2C1, CCCN[C@H]1CCc2nc(N)sc2C1","FASDKYOPVNHBLU-ZETCQYMHSA-N, FASDKYOPVNHBLU-ZETCQYMHSA-N, FASDKYOPVNHBLU-ZETCQYMHSA-N",Launched,
pramiracetam,acetylcholine receptor agonist,,,,Selleck,91.48,BRD-K21123171-001-02-9,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,ZULJGOSFKWFVRX-UHFFFAOYSA-N,Launched,
pramoxine,topical anesthetic,,dermatology,corticosteroid-responsive dermatoses,"Selleck, MicroSource",95.87,"BRD-K46523383-003-21-1, BRD-K46523383-003-22-9","CCCCOc1ccc(OCCCN2CCOCC2)cc1, CCCCOc1ccc(OCCCN2CCOCC2)cc1","DQKXQSGTHWVTAD-UHFFFAOYSA-N, DQKXQSGTHWVTAD-UHFFFAOYSA-N",Launched,
pranlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF",pulmonary,"bronchospasm, asthma, bronchospasm, asthma","MedChemEx, Selleck",99.8,"BRD-K97045029-001-02-7, BRD-K97045029-001-04-3","O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1, O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1","NBQKINXMPLXUET-UHFFFAOYSA-N, NBQKINXMPLXUET-UHFFFAOYSA-N",Launched,"BRD-K91497079-001-03-3,BRD-U02566398-000-01-1|BRD-K91497079-001-02-5"
pranoprofen,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief,"MicroSource, Selleck, Selleck",98.99,"BRD-A64610707-001-04-4, BRD-A64610707-001-03-6, BRD-A64610707-001-05-1","CC(C(O)=O)c1ccc2Oc3ncccc3Cc2c1, CC(C(O)=O)c1ccc2Oc3ncccc3Cc2c1, CC(C(O)=O)c1ccc2Oc3ncccc3Cc2c1","TVQZAMVBTVNYLA-UHFFFAOYSA-N, TVQZAMVBTVNYLA-UHFFFAOYSA-N, TVQZAMVBTVNYLA-UHFFFAOYSA-N",Launched,
prasugrel,purinergic receptor antagonist,P2RY12,cardiology,"myocardial infarction, acute coronary syndrome (ACS)","Selleck, MedChemEx, Selleck, MedChemEx",83.3,"BRD-A83029242-001-06-1, BRD-A83029242-001-08-7, BRD-A83029242-001-05-3, BRD-A83029242-001-07-9","CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F, CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F, CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F, CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C1CC1)c1ccccc1F","DTGLZDAWLRGWQN-UHFFFAOYSA-N, DTGLZDAWLRGWQN-UHFFFAOYSA-N, DTGLZDAWLRGWQN-UHFFFAOYSA-N, DTGLZDAWLRGWQN-UHFFFAOYSA-N",Launched,
pravastatin,HMGCR inhibitor,"HMGCR, SLCO1B1","endocrinology, cardiology","hypercholesterolemia, myocardial infarction, hyperlipidemia","Tocris, MicroSource, Tocris, Selleck",95.56,"BRD-K60511616-236-06-3, BRD-A71816415-236-04-3, BRD-K60511616-236-07-1, BRD-K60511616-236-08-9","CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12, CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12, CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12, CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12","TUZYXOIXSAXUGO-PZAWKZKUSA-N, TUZYXOIXSAXUGO-XYLZAPOUSA-N, TUZYXOIXSAXUGO-PZAWKZKUSA-N, TUZYXOIXSAXUGO-PZAWKZKUSA-N",Launched,BRD-K31447894-236-01-0
praziquantel,anthelmintic agent,,infectious disease,"gastrointestinal parasites, cystic hydatid disease, schistosomiasis","Selleck, MicroSource",99.62,"BRD-A21858158-001-22-7, BRD-A21858158-001-23-5","O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1, O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1","FSVJFNAIGNNGKK-UHFFFAOYSA-N, FSVJFNAIGNNGKK-UHFFFAOYSA-N",Launched,
prazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7",cardiology,hypertension,"Tocris, MicroSource, Selleck, Tocris",98.79,"BRD-K49111258-003-30-5, BRD-K49111258-003-29-7, BRD-K49111258-003-27-1, BRD-K49111258-003-28-9","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1, COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1, COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1, COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1","IENZQIKPVFGBNW-UHFFFAOYSA-N, IENZQIKPVFGBNW-UHFFFAOYSA-N, IENZQIKPVFGBNW-UHFFFAOYSA-N, IENZQIKPVFGBNW-UHFFFAOYSA-N",Launched,
prednicarbate,phospholipase activator,"NR3C1, PLA2G1B","dermatology, ophthalmology, neurology/psychiatry","eczema, contact dermatitis, itching",MicroSource,0,BRD-A93963402-001-01-6,CCOC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC,FNPXMHRZILFCKX-VZWGUQLYSA-N,Launched,
prednisolone,glucocorticoid receptor agonist,"NR3C1, NR3C2, SERPINA6","ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","MicroSource, Selleck",96.97,"BRD-A27887842-001-04-0, BRD-A27887842-001-05-7","C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO","OIGNJSKKLXVSLS-YDAVOWJHSA-N, OIGNJSKKLXVSLS-YDAVOWJHSA-N",Launched,BRD-K00645576-001-01-9
prednisolone-acetate,glucocorticoid receptor agonist,NR3C1,"ophthalmology, dermatology, infectious disease","conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis","Selleck, MicroSource, Selleck",93.2,"BRD-K45664306-001-19-6, BRD-A01643550-001-04-9, BRD-K45664306-001-20-4","CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@]12C, CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C","LRJOMUJRLNCICJ-JZYPGELDSA-N, LRJOMUJRLNCICJ-AUGMLKDDSA-N, LRJOMUJRLNCICJ-JZYPGELDSA-N",Launched,BRD-K87234558-001-01-0
prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,"allergy, pulmonary, ophthalmology, infectious disease, rheumatology, endocrinology, neurology/psychiatry, gastroenterology, hematology","allergic rhinitis, asthma, contact dermatitis, mycosis, lupus, hypercalcemia, thyroiditis, congenital adrenal hyperplasia, multiple sclerosis, ulcerative colitis, enteritis, thrombocythemia, pneumonia, asthma, meningitis, psoriatic arthritis, rheumatoid arthritis",MicroSource,84.46,BRD-A94523291-304-02-7,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)COP(O)(O)=O,JDOZJEUDSLGTLU-YDAVOWJHSA-N,Launched,
prednisolone-tebutate,anti-inflammatory agent,,,,MicroSource,96.64,BRD-A53151380-001-01-2,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@]12C,HUMXXHTVHHLNRO-VZWGUQLYSA-N,Launched,
prednisone,glucocorticoid receptor agonist,"HSD11B1, NR3C1","endocrinology, rheumatology, infectious disease, dermatology, ophthalmology, hematology, gastroenterology, neurology/psychiatry","congenital adrenal hyperplasia, hypercalcemia, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, bursitis, osteoarthritis, epicondylitis, dermatomyositis, psoriasis, mycosis, conjunctivitis, anemia, ulcerative colitis, enteritis, multiple sclerosis, meningitis","Selleck, MicroSource, Selleck",95.73,"BRD-K85883481-001-22-4, BRD-K85883481-001-25-7, BRD-K85883481-001-24-0","C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO, C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO","XOFYZVNMUHMLCC-ZPOLXVRWSA-N, XOFYZVNMUHMLCC-ZPOLXVRWSA-N, XOFYZVNMUHMLCC-ZPOLXVRWSA-N",Launched,"BRD-A62525898-001-05-2, BRD-K60679745-001-01-1"
pregabalin,voltage-gated calcium channel ligand,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8","neurology/psychiatry, rheumatology","peripheral neuropathy, seizures, fibromyalgia, postherpetic neuralgia","MicroSource, MedChemEx",97.97,"BRD-K66786476-003-01-9, BRD-K66786476-001-01-3","CC(C)C[C@H](CN)CC(O)=O, CC(C)C[C@H](CN)CC(O)=O","AYXYPKUFHZROOJ-ZETCQYMHSA-N, AYXYPKUFHZROOJ-ZETCQYMHSA-N",Launched,
pregnenolone,glutamate receptor modulator,"CYP17A1, SULT2B1",,,"MicroSource, Selleck",98.34,"BRD-K43880410-001-15-1, BRD-K43880410-001-14-4","CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","ORNBQBCIOKFOEO-QGVNFLHTSA-N, ORNBQBCIOKFOEO-QGVNFLHTSA-N",Launched,"BRD-A35054627-001-09-7, BRD-K52183142-001-01-3"
pridinol,muscle relaxant,,neurology/psychiatry,muscle relaxant,"Selleck, MicroSource",98.23,"BRD-K17565903-066-22-3, BRD-K17565903-066-23-1","OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1, OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1","RQXCLMGKHJWMOA-UHFFFAOYSA-N, RQXCLMGKHJWMOA-UHFFFAOYSA-N",Launched,
prilocaine,local anesthetic,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,anesthetic,"MicroSource, Selleck",98.67,"BRD-A53952395-003-25-1, BRD-A53952395-001-02-4","CCCNC(C)C(=O)Nc1ccccc1C, CCCNC(C)C(=O)Nc1ccccc1C","MVFGUOIZUNYYSO-UHFFFAOYSA-N, MVFGUOIZUNYYSO-UHFFFAOYSA-N",Launched,
primaquine,"antimalarial agent, DNA inhibitor","KRT7, NQO2",infectious disease,malaria,"Selleck, MicroSource",89.83,"BRD-A55913614-316-08-8, BRD-A55913614-316-09-6","COc1cc(NC(C)CCCN)c2ncccc2c1, COc1cc(NC(C)CCCN)c2ncccc2c1","INDBQLZJXZLFIT-UHFFFAOYSA-N, INDBQLZJXZLFIT-UHFFFAOYSA-N",Launched,
primidone,GABA receptor antagonist,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,"Selleck, Tocris, MicroSource",99.02,"BRD-K32247306-001-27-8, BRD-K32247306-001-28-6, BRD-K32247306-001-29-4","CCC1(C(=O)NCNC1=O)c1ccccc1, CCC1(C(=O)NCNC1=O)c1ccccc1, CCC1(C(=O)NCNC1=O)c1ccccc1","DQMZLTXERSFNPB-UHFFFAOYSA-N, DQMZLTXERSFNPB-UHFFFAOYSA-N, DQMZLTXERSFNPB-UHFFFAOYSA-N",Launched,
probenecid,uricosuric blocker,"PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1","nephrology, rheumatology","hyperuricemia, gout","Tocris, MicroSource, Selleck",98.66,"BRD-K95237249-001-27-3, BRD-K95237249-001-26-5, BRD-K95237249-001-25-7","CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O, CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O, CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O","DBABZHXKTCFAPX-UHFFFAOYSA-N, DBABZHXKTCFAPX-UHFFFAOYSA-N, DBABZHXKTCFAPX-UHFFFAOYSA-N",Launched,
probucol,atherogenesis inhibitor,"ABCA1, ABCB11, CES1",cardiology,coronary artery disease (CAD),"MicroSource, Selleck",93.74,"BRD-K72029282-001-23-8, BRD-K72029282-001-22-0","CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C, CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C","FYPMFJGVHOHGLL-UHFFFAOYSA-N, FYPMFJGVHOHGLL-UHFFFAOYSA-N",Launched,
procainamide,sodium channel blocker,"DNMT1, SCN5A",cardiology,"ventricular arrhythmias, ventricular tachycardia (VT)",MicroSource,97.98,BRD-K75089421-003-24-5,CCN(CC)CCNC(=O)c1ccc(N)cc1,REQCZEXYDRLIBE-UHFFFAOYSA-N,Launched,
procaine,HMGCR inhibitor,"CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3",neurology/psychiatry,anesthetic,"MicroSource, Selleck",99.21,"BRD-K24616672-003-20-1, BRD-K24616672-003-19-3","CCN(CC)CCOC(=O)c1ccc(N)cc1, CCN(CC)CCOC(=O)c1ccc(N)cc1","MFDFERRIHVXMIY-UHFFFAOYSA-N, MFDFERRIHVXMIY-UHFFFAOYSA-N",Launched,
procarbazine,monoamine oxidase inhibitor,,hematologic malignancy,Hodgkin's lymphoma,"Selleck, Selleck, MedChemEx, MicroSource",47.77,"BRD-K13032584-003-19-3, BRD-K13032584-003-18-5, BRD-K13032584-003-21-9, BRD-K13032584-001-01-5","CNNCc1ccc(cc1)C(=O)NC(C)C, CNNCc1ccc(cc1)C(=O)NC(C)C, CNNCc1ccc(cc1)C(=O)NC(C)C, CNNCc1ccc(cc1)C(=O)NC(C)C","CPTBDICYNRMXFX-UHFFFAOYSA-N, CPTBDICYNRMXFX-UHFFFAOYSA-N, CPTBDICYNRMXFX-UHFFFAOYSA-N, CPTBDICYNRMXFX-UHFFFAOYSA-N",Launched,
procaterol,adrenergic receptor agonist,ADRB2,pulmonary,asthma,"Tocris, Tocris",96.33,"BRD-K78666826-003-02-4, BRD-K78666826-003-01-6","CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12, CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12","FKNXQNWAXFXVNW-BLLLJJGKSA-N, FKNXQNWAXFXVNW-BLLLJJGKSA-N",Launched,
prochlorperazine,dopamine receptor antagonist,"DRD1, DRD2, DRD3, DRD4",gastroenterology,"nausea, vomiting","Tocris, Selleck, MicroSource, Selleck",93,"BRD-K19352500-332-09-4, BRD-K19352500-332-07-8, BRD-K19352500-070-12-4, BRD-K19352500-332-08-6","CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1, CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1, CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1, CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1","WIKYUJGCLQQFNW-UHFFFAOYSA-N, WIKYUJGCLQQFNW-UHFFFAOYSA-N, WIKYUJGCLQQFNW-UHFFFAOYSA-N, WIKYUJGCLQQFNW-UHFFFAOYSA-N",Launched,
procyclidine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4",neurology/psychiatry,"parkinsonism, Parkinson's Disease, akathisia, dystonia","Selleck, MicroSource",96.66,"BRD-A31800922-003-24-4, BRD-A31800922-003-25-1","OC(CCN1CCCC1)(C1CCCCC1)c1ccccc1, OC(CCN1CCCC1)(C1CCCCC1)c1ccccc1","WYDUSKDSKCASEF-UHFFFAOYSA-N, WYDUSKDSKCASEF-UHFFFAOYSA-N",Launched,
profenamine,"butyrylcholinesterase inhibitor, cholinergic receptor antagonist","CHRM1, CHRM2, GRIN3A",neurology/psychiatry,Parkinson's Disease,"MicroSource, Sigma",45.81,"BRD-A16311756-003-08-5, BRD-A16311756-003-09-3","CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12, CCN(CC)C(C)CN1c2ccccc2Sc2ccccc12","CDOZDBSBBXSXLB-UHFFFAOYSA-N, CDOZDBSBBXSXLB-UHFFFAOYSA-N",Launched,
progesterone,progesterone receptor agonist,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5","obstetrics/gynecology, endocrinology","infertility, amenorrhea","MicroSource, Selleck",97.71,"BRD-K64994968-001-32-5, BRD-K64994968-001-33-3","CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","RJKFOVLPORLFTN-LEKSSAKUSA-N, RJKFOVLPORLFTN-LEKSSAKUSA-N",Launched,"BRD-A67479912-001-03-4, BRD-K37762555-001-01-4"
proglumetacin,cyclooxygenase inhibitor,"PTGS1, PTGS2",neurology/psychiatry,pain relief,AKSci,0,BRD-A19458515-001-01-2,CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)CC1)NC(=O)c1ccccc1,PTXGHCGBYMQQIG-UHFFFAOYSA-N,Launched,
proguanil,dihydrofolate reductase inhibitor,DHFR,infectious disease,malaria,MicroSource,92.08,BRD-K28183345-003-11-4,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,SSOLNOMRVKKSON-UHFFFAOYSA-N,Launched,
promazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C",neurology/psychiatry,schizophrenia,"MedChemEx, MicroSource",94.85,"BRD-K06980535-003-26-7, BRD-K06980535-003-25-9","CN(C)CCCN1c2ccccc2Sc2ccccc12, CN(C)CCCN1c2ccccc2Sc2ccccc12","ZGUGWUXLJSTTMA-UHFFFAOYSA-N, ZGUGWUXLJSTTMA-UHFFFAOYSA-N",Launched,
promestriene,estrogen receptor agonist,ESR1,endocrinology,androgenetic alopecia,Carbosynth,0,BRD-K75097983-001-01-0,CCCOc1ccc2[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CCc2c1)OC,IUWKNLFTJBHTSD-AANPDWTMSA-N,Launched,
promethazine,histamine receptor antagonist,"ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A","neurology/psychiatry, allergy","sedative, allergic rhinitis","MedChemEx, MicroSource",88.98,"BRD-A46335897-003-27-8, BRD-A46335897-003-26-0","CC(CN1c2ccccc2Sc2ccccc12)N(C)C, CC(CN1c2ccccc2Sc2ccccc12)N(C)C","PWWVAXIEGOYWEE-UHFFFAOYSA-N, PWWVAXIEGOYWEE-UHFFFAOYSA-N",Launched,
propacetamol,cyclooxygenase inhibitor,PTGS2,"endocrinology, neurology/psychiatry","fever, pain relief",AKSci,94.37,BRD-K54496168-003-01-2,CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1,QTGAJCQTLIRCFL-UHFFFAOYSA-N,Launched,
propafenone,antiarrhythmic,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A",cardiology,"atrial fibrillation (AF), ventricular tachycardia (VT), ventricular arrhythmias","MicroSource, Selleck",96.58,"BRD-A26334849-003-23-3, BRD-A26334849-001-06-2","CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1, CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1","JWHAUXFOSRPERK-UHFFFAOYSA-N, JWHAUXFOSRPERK-UHFFFAOYSA-N",Launched,
propagermanium,"interferon receptor agonist, CCR agonist",CCR2,infectious disease,hepatitis B,Sigma,0,BRD-K53382462-001-02-0,OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O,XEABSBMNTNXEJM-UHFFFAOYSA-N,Launched,
propantheline,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4",gastroenterology,peptic ulcer disease (PUD),MicroSource,80.23,BRD-K90885812-004-24-2,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc12)C(C)C,VVWYOYDLCMFIEM-UHFFFAOYSA-N,Launched,
propatylnitrate,,,cardiology,angina pectoris,Sigma,0,BRD-K56276053-001-01-8,CCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O,YZZCJYJBCUJISI-UHFFFAOYSA-N,Launched,
propentofylline,"adenosine reuptake inhibitor, phosphodiesterase inhibitor",PDE1A,neurology/psychiatry,stroke,Enzo,95.57,BRD-K59273480-001-10-6,CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12,RBQOQRRFDPXAGN-UHFFFAOYSA-N,Launched,
propiolactone,,,,,MicroSource,1.17,BRD-K76867903-001-03-8,O=C1CCO1,VEZXCJBBBCKRPI-UHFFFAOYSA-N,Launched,
propiverine,acetylcholine receptor antagonist,CHRM1,urology,urinary incontinence,Sigma,97.84,BRD-K91244729-003-01-3,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,QPCVHQBVMYCJOM-UHFFFAOYSA-N,Launched,
propofol,benzodiazepine receptor agonist,"FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A",neurology/psychiatry,anesthetic,"MicroSource, Enamine",76.91,"BRD-K82255054-001-15-9, BRD-K82255054-001-17-5","CC(C)c1cccc(C(C)C)c1O, CC(C)c1cccc(C(C)C)c1O","OLBCVFGFOZPWHH-UHFFFAOYSA-N, OLBCVFGFOZPWHH-UHFFFAOYSA-N",Launched,
propoxur,,,,,MicroSource,93.11,BRD-K08231299-001-08-1,CNC(=O)Oc1ccccc1OC(C)C,ISRUGXGCCGIOQO-UHFFFAOYSA-N,Launched,
propoxycaine,local anesthetic,,neurology/psychiatry,anesthetic,MicroSource,98.96,BRD-K18250272-003-11-0,CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC,CAJIGINSTLKQMM-UHFFFAOYSA-N,Launched,
propranolol,adrenergic receptor antagonist,,"cardiology, neurology/psychiatry","hypertension, angina pectoris, migraine headache","MicroSource, Selleck, Tocris",97.75,"BRD-A10070317-003-30-9, BRD-A10070317-003-28-3, BRD-A10070317-003-29-1","CC(C)NCC(O)COc1cccc2ccccc12, CC(C)NCC(O)COc1cccc2ccccc12, CC(C)NCC(O)COc1cccc2ccccc12","AQHHHDLHHXJYJD-UHFFFAOYSA-N, AQHHHDLHHXJYJD-UHFFFAOYSA-N, AQHHHDLHHXJYJD-UHFFFAOYSA-N",Launched,
propyl-benzoate,,,,,Enamine,0,BRD-K15329706-001-01-6,CCCOC(=O)c1ccccc1,UDEWPOVQBGFNGE-UHFFFAOYSA-N,Launched,
propylene-glycol,,F13A1,,,Sigma,0,BRD-A19232309-001-08-6,CC(O)CO,DNIAPMSPPWPWGF-UHFFFAOYSA-N,Launched,
propylhexedrine,adrenergic receptor agonist,"SLC18A2, TAAR1","otolaryngology, endocrinology, allergy","nasal congestion, fever, allergic rhinitis",PrincetonBio,76.33,BRD-A35667010-001-01-8,CNC(C)CC1CCCCC1,JCRIVQIOJSSCQD-UHFFFAOYSA-N,Launched,
propylparaben,,,,,ChemDiv,0,BRD-K60783397-001-09-5,CCCOC(=O)c1ccc(O)cc1,QELSKZZBTMNZEB-UHFFFAOYSA-N,Launched,
propylthiouracil,thyroid peroxidase inhibitor,"DIO1, TPO",endocrinology,"hyperthyroidism, Grave's disease, goiter","MicroSource, Selleck",97.48,"BRD-K48168960-001-19-2, BRD-K48168960-001-18-4","CCCc1cc(=O)[nH]c(=S)[nH]1, CCCc1cc(=O)[nH]c(=S)[nH]1","KNAHARQHSZJURB-UHFFFAOYSA-N, KNAHARQHSZJURB-UHFFFAOYSA-N",Launched,
proquazone,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,AMS,97,BRD-K54339150-001-01-8,CC(C)n1c2cc(C)ccc2c(nc1=O)-c1ccccc1,JTIGKVIOEQASGT-UHFFFAOYSA-N,Launched,
proscillaridin-a,,,cardiology,"congestive heart failure, cardiac arrythmia",MicroSource,91.74,BRD-A11815689-001-01-1,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c2ccc(=O)oc2)C(O)C(O)[C@H]1O,MYEJFUXQJGHEQK-BACGYGAMSA-N,Launched,
protionamide,,,infectious disease,tuberculosis,"MicroSource, Selleck",94.39,"BRD-K75360161-001-18-0, BRD-K75360161-001-17-2","CCCc1cc(ccn1)C(S)=N, CCCc1cc(ccn1)C(S)=N","VRDIULHPQTYCLN-UHFFFAOYSA-N, VRDIULHPQTYCLN-UHFFFAOYSA-N",Launched,
protirelin,thyrotropin releasing hormone receptor agonist,TRHR,radiology,thyroid function diagnostic,MicroSource,96.18,BRD-A16997652-001-02-3,NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1,XNSAINXGIQZQOO-UHFFFAOYSA-N,Launched,
protriptyline,tricyclic antidepressant,"SLC6A2, SLC6A4",neurology/psychiatry,depression,MicroSource,97,BRD-K42098891-003-20-5,CNCCCC1c2ccccc2C=Cc2ccccc12,BWPIARFWQZKAIA-UHFFFAOYSA-N,Launched,
proxodolol,adrenergic receptor antagonist,,,,InterBioScreen,97.24,BRD-A29944538-003-08-3,Cc1noc(COc2ccccc2OCC(O)CNC(C)(C)C)n1,CEDZURSVVKNCSL-UHFFFAOYSA-N,Launched,
proxymetacaine,sodium channel blocker,"SCN10A, SCN5A",neurology/psychiatry,anesthetic,"MicroSource, Selleck",97.7,"BRD-K79116891-003-15-1, BRD-K79116891-003-14-4","CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC, CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC","KCLANYCVBBTKTO-UHFFFAOYSA-N, KCLANYCVBBTKTO-UHFFFAOYSA-N",Launched,
proxyphylline,,,pulmonary,asthma,MicroSource,97.93,BRD-A28887267-001-19-3,CC(O)Cn1cnc2n(C)c(=O)n(C)c(=O)c12,KYHQZNGJUGFTGR-UHFFFAOYSA-N,Launched,
prucalopride,serotonin receptor agonist,HTR4,gastroenterology,constipation,"Selleck, Selleck",97.6,"BRD-K33681278-036-01-2, BRD-K33681278-001-02-4","COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12, COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12","ZPMNHBXQOOVQJL-UHFFFAOYSA-N, ZPMNHBXQOOVQJL-UHFFFAOYSA-N",Launched,
prulifloxacin,bacterial DNA gyrase inhibitor,,"infectious disease, pulmonary, gastroenterology","urinary tract infections, bronchitis, diarrhea","MicroSource, MedChemEx",79.74,"BRD-A92341659-001-03-2, BRD-A92341659-001-04-0","CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCN(Cc2oc(=O)oc2C)CC1, CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCN(Cc2oc(=O)oc2C)CC1","PWNMXPDKBYZCOO-UHFFFAOYSA-N, PWNMXPDKBYZCOO-UHFFFAOYSA-N",Launched,BRD-A96891111-001-01-8
psoralen,,"MAOA, MAOB",dermatology,"psoriasis, eczema, vitiligo",Specs,91.19,BRD-K47264279-001-08-9,O=c1ccc2cc3ccoc3cc2o1,ZCCUUQDIBDJBTK-UHFFFAOYSA-N,Launched,
pyrantel,nicotinic receptor agonist,,infectious disease,"gastrointestinal roundworms, gastrointestinal roundworms",Sigma,97.74,BRD-K82118441-001-03-7,OC(=O)c1cc2ccccc2c(Cc2c(O)c(cc3ccccc23)C(O)=O)c1O,WLJNZVDCPSBLRP-UHFFFAOYSA-N,Launched,
pyrantel-pamoate,neuromuscular blocker,,infectious disease,"hookworm, tapeworm","MedChemEx, MedChemEx, MicroSource",94.32,"BRD-K20672254-096-06-7, BRD-K20672254-046-05-4, BRD-K20672254-096-03-4","CN1CCCN=C1\C=C\c1cccs1, CN1CCCN=C1\C=C\c1cccs1, CN1CCCN=C1\C=C\c1cccs1","YSAUAVHXTIETRK-AATRIKPKSA-N, YSAUAVHXTIETRK-AATRIKPKSA-N, YSAUAVHXTIETRK-AATRIKPKSA-N",Launched,
pyrazinamide,fatty acid synthase inhibitor,FASN,infectious disease,tuberculosis,"Selleck, MicroSource",98.54,"BRD-K28667793-001-27-3, BRD-K28667793-001-28-1","NC(=O)c1cnccn1, NC(=O)c1cnccn1","IPEHBUMCGVEMRF-UHFFFAOYSA-N, IPEHBUMCGVEMRF-UHFFFAOYSA-N",Launched,
pyrethrins,,,,,MicroSource,0,BRD-K79856453-001-01-6,CC(C)=C[C@@H]1[C@@H](C(=O)O[C@H]2CC(=O)C(C\C=C/C=C)=C2)C1(C)C,KKHJGHLRPBEIBW-NNRAVPRJSA-N,Launched,
pyridoxal,,PDXK,neurology/psychiatry,epilepsy,Vitas-M,92.3,BRD-K76204040-001-03-8,Cc1ncc(CO)c(C=O)c1O,RADKZDMFGJYCBB-UHFFFAOYSA-N,Launched,
pyridoxine,vitamin B,"DDC, PDXK",metabolism,vitamin B6 deficiency,"MicroSource, Selleck",100,"BRD-K14349461-001-04-4, BRD-K14349461-003-13-1","Cc1ncc(CO)c(CO)c1O, Cc1ncc(CO)c(CO)c1O","LXNHXLLTXMVWPM-UHFFFAOYSA-N, LXNHXLLTXMVWPM-UHFFFAOYSA-N",Launched,
pyrimethamine,dihydrofolate reductase inhibitor,"DHFR, SLC47A1",infectious disease,malaria,"Tocris, Selleck, Tocris, MicroSource",99.69,"BRD-K88429204-001-38-5, BRD-K88429204-001-33-6, BRD-K88429204-001-34-4, BRD-K88429204-001-35-1","CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1, CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1, CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1, CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1","WKSAUQYGYAYLPV-UHFFFAOYSA-N, WKSAUQYGYAYLPV-UHFFFAOYSA-N, WKSAUQYGYAYLPV-UHFFFAOYSA-N, WKSAUQYGYAYLPV-UHFFFAOYSA-N",Launched,
pyrithione-zinc,ATP synthase inhibitor,"KCNQ1, KCNQ2, KCNQ4, KCNQ5",dermatology,dandruff,"Selleck, MicroSource, Selleck",0,"BRD-K16136380-001-03-3, BRD-K16136380-001-01-7, BRD-K16136380-001-02-5","O1[n+]2ccccc2S[Zn]11O[n+]2ccccc2S1, O1[n+]2ccccc2S[Zn]11O[n+]2ccccc2S1, O1[n+]2ccccc2S[Zn]11O[n+]2ccccc2S1","KTIHEFSORPLWRR-UHFFFAOYSA-L, KTIHEFSORPLWRR-UHFFFAOYSA-L, KTIHEFSORPLWRR-UHFFFAOYSA-L",Launched,"BRD-U31911056-000-01-7, BRD-U32859412-000-01-6, BRD-U63926453-000-01-5"
pyritinol,,,"rheumatology, neurology/psychiatry","rheumatoid arthritis, senile dementia",MicroSource,96.46,BRD-K82181219-001-04-3,Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O,SIXLXDIJGIWWFU-UHFFFAOYSA-N,Launched,
pyrvinium,androgen receptor antagonist,,,,Enamine,63.11,BRD-M55114534-096-01-9,CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1,PVWVKJZCXALBAI-UHFFFAOYSA-N,Launched,
pyrvinium-pamoate,androgen receptor antagonist,AR,,,"Sigma, MicroSource",64.19,"BRD-M55114534-373-01-2, BRD-K39479472-096-04-7","CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1.CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1, CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1","PVWVKJZCXALBAI-UHFFFAOYSA-N, QMHSXPLYMTVAMK-UHFFFAOYSA-N",Launched,
quercetin,polar auxin transport inhibitor,"ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1","neurology/psychiatry, allergy","fatigue, allergic rhinitis, drowsiness","Tocris, Selleck, Selleck, Selleck, Selleck",93.07,"BRD-K97399794-001-15-3, BRD-K97399794-001-14-6, BRD-K97399794-335-05-6, BRD-K97399794-001-16-1, BRD-K97399794-335-06-4","Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O, Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O, Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O, Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O, Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O","REFJWTPEDVJJIY-UHFFFAOYSA-N, REFJWTPEDVJJIY-UHFFFAOYSA-N, REFJWTPEDVJJIY-UHFFFAOYSA-N, REFJWTPEDVJJIY-UHFFFAOYSA-N, REFJWTPEDVJJIY-UHFFFAOYSA-N",Launched,
quetiapine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2",neurology/psychiatry,"schizophrenia, bipolar disorder","MicroSource, Tocris, Selleck",98.67,"BRD-K68867920-001-11-0, BRD-K68867920-051-12-3, BRD-K68867920-051-11-5","OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12, OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12, OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12","URKOMYMAXPYINW-UHFFFAOYSA-N, URKOMYMAXPYINW-UHFFFAOYSA-N, URKOMYMAXPYINW-UHFFFAOYSA-N",Launched,"BRD-M66874015-051-04-2, BRD-M66874015-051-02-6"
quinagolide,dopamine receptor agonist,DRD2,endocrinology,hyperprolactinemia,MedChemEx,90.35,BRD-K02995728-003-01-9,CCCN1C[C@H](C[C@@H]2Cc3c(O)cccc3C[C@@H]12)NS(=O)(=O)N(CC)CC,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,Launched,
quinapril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, congestive heart failure, angioedema","MicroSource, Selleck, Selleck",93.01,"BRD-K72222507-003-16-8, BRD-K72222507-003-15-0, BRD-K72222507-003-17-6","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O","JSDRRTOADPPCHY-HSQYWUDLSA-N, JSDRRTOADPPCHY-HSQYWUDLSA-N, JSDRRTOADPPCHY-HSQYWUDLSA-N",Launched,
quinaprilat,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, angioedema",MicroSource,0,BRD-K42317111-001-01-7,C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1Cc2ccccc2C[C@H]1C(O)=O,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Launched,
quinestrol,estrogen receptor agonist,ESR1,endocrinology,menopause,MicroSource,99.34,BRD-A16439188-001-01-1,C[C@]12CCC3C(CCc4cc(OC5CCCC5)ccc34)C1CC[C@@]2(O)C#C,PWZUUYSISTUNDW-BOSQQAFTSA-N,Launched,
quinethazone,thiazide diuretic,"CA1, CA2, SLC12A1, SLC12A2, SLC12A3",cardiology,hypertension,MicroSource,98.85,BRD-A59303141-001-10-4,CCC1NC(=O)c2cc(c(Cl)cc2N1)S(N)(=O)=O,AGMMTXLNIQSRCG-UHFFFAOYSA-N,Launched,
quinidine,sodium channel blocker,"KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4","infectious disease, cardiology","malaria, atrial fibrillation (AF), ventricular arrhythmias",MicroSource,87.9,BRD-K59632282-052-03-1,COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1,LOUPRKONTZGTKE-LHHVKLHASA-N,Launched,
quinine,hemozoin biocrystallization inhibitor,"GP9, KCNB2, KCNN4, SLC29A4",infectious disease,malaria,"Selleck, MicroSource",93.42,"BRD-K07940445-310-02-9, BRD-K48278478-001-01-2","COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1, COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1","LOUPRKONTZGTKE-WZBLMQSHSA-N, LOUPRKONTZGTKE-AFHBHXEDSA-N",Launched,BRD-K99257182-310-01-6
quinine-ethyl-carbonate,,,infectious disease,malaria,MicroSource,92.37,BRD-K97028990-001-04-4,CCOC(=O)O[C@H]([C@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)c1ccnc2ccc(OC)cc12,NSBRKSWSLRQPJW-FRMGNDQPSA-N,Launched,
r(-)-apomorphine,dopamine receptor agonist,"DRD2, HTR5A",neurology/psychiatry,Parkinson's Disease,"MicroSource, Tocris, Selleck",97.34,"BRD-A35931254-003-04-3, BRD-K76022557-003-02-7, BRD-K76022557-001-03-9","CN1CCc2cccc-3c2C1Cc1ccc(O)c(O)c-31, CN1CCc2cccc-3c2[C@H]1Cc1ccc(O)c(O)c-31, CN1CCc2cccc-3c2[C@H]1Cc1ccc(O)c(O)c-31","VMWNQDUVQKEIOC-UHFFFAOYSA-N, VMWNQDUVQKEIOC-CYBMUJFWSA-N, VMWNQDUVQKEIOC-CYBMUJFWSA-N",Launched,
rabeprazole,"ATPase inhibitor, gastrin inhibitor",ATP4A,gastroenterology,"gastroesophageal reflux disease (GERD), duodenal ulcer disease, Zollinger-Ellison syndrome","MicroSource, MedChemEx, Sigma, Sigma",98.9,"BRD-A39390670-236-09-9, BRD-A39390670-236-10-7, BRD-A39390670-236-12-3, BRD-A39390670-236-11-5","COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C, COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C, COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C, COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C","YREYEVIYCVEVJK-UHFFFAOYSA-N, YREYEVIYCVEVJK-UHFFFAOYSA-N, YREYEVIYCVEVJK-UHFFFAOYSA-N, YREYEVIYCVEVJK-UHFFFAOYSA-N",Launched,
racecadotril,enkephalinase inhibitor,MME,gastroenterology,diarrhea,"MicroSource, Selleck",98,"BRD-A08187463-001-12-9, BRD-A08187463-001-11-1","CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1, CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1","ODUOJXZPIYUATO-UHFFFAOYSA-N, ODUOJXZPIYUATO-UHFFFAOYSA-N",Launched,
raclopride,dopamine receptor antagonist,"DRD2, DRD3, HTR1A",,,"Tocris, Tocris",96.6,"BRD-K04111260-001-12-6, BRD-K04111260-001-10-0","CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC, CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC","WAOQONBSWFLFPE-VIFPVBQESA-N, WAOQONBSWFLFPE-VIFPVBQESA-N",Launched,
ractopamine,adrenergic receptor agonist,,,,"Selleck, MicroSource",93.48,"BRD-A86414188-003-01-5, BRD-A86414188-003-02-3","CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1, CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1","YJQZYXCXBBCEAQ-UHFFFAOYSA-N, YJQZYXCXBBCEAQ-UHFFFAOYSA-N",Launched,
raloxifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","MicroSource, Tocris, Tocris, Selleck",98.21,"BRD-K63828191-003-34-7, BRD-K63828191-003-33-9, BRD-K63828191-003-35-4, BRD-K63828191-003-32-1","Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1, Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1, Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1, Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1","GZUITABIAKMVPG-UHFFFAOYSA-N, GZUITABIAKMVPG-UHFFFAOYSA-N, GZUITABIAKMVPG-UHFFFAOYSA-N, GZUITABIAKMVPG-UHFFFAOYSA-N",Launched,
raltegravir,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),"Selleck, Selleck",94.8,"BRD-K05658747-001-02-9, BRD-K05658747-001-03-7","Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C, Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C","CZFFBEXEKNGXKS-UHFFFAOYSA-N, CZFFBEXEKNGXKS-UHFFFAOYSA-N",Launched,
raltitrexed,thymidylate synthase inhibitor,"FPGS, TYMS",oncology,mesothelioma,"Selleck, Selleck",93.68,"BRD-K89839824-001-06-1, BRD-K89839824-001-05-3","CN(Cc1ccc2[nH]c(C)nc(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CN(Cc1ccc2[nH]c(C)nc(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O","IVTVGDXNLFLDRM-HNNXBMFYSA-N, IVTVGDXNLFLDRM-HNNXBMFYSA-N",Launched,
ramatroban,prostanoid receptor antagonist,"PTGDR2, TBXA2R","cardiology, pulmonary","coronary artery disease (CAD), asthma",MedChemEx,97.83,BRD-K08586861-001-01-1,OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Launched,
ramelteon,melatonin receptor agonist,"MTNR1A, MTNR1B",neurology/psychiatry,insomnia,"MicroSource, Selleck",98.49,"BRD-K28761891-001-10-1, BRD-K28761891-001-09-3","CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12, CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12","YLXDSYKOBKBWJQ-LBPRGKRZSA-N, YLXDSYKOBKBWJQ-LBPRGKRZSA-N",Launched,
ramifenazone,cyclooxygenase inhibitor,,"neurology/psychiatry, endocrinology","pain relief, fever","Key, MicroSource",80.52,"BRD-K85333151-001-01-3, BRD-K85333151-003-13-4","CC(C)Nc1c(C)n(C)n(-c2ccccc2)c1=O, CC(C)Nc1c(C)n(C)n(-c2ccccc2)c1=O","XOZLRRYPUKAKMU-UHFFFAOYSA-N, XOZLRRYPUKAKMU-UHFFFAOYSA-N",Launched,
ramipril,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,"MicroSource, Tocris, Selleck",98.06,"BRD-K89348303-001-14-7, BRD-K89348303-001-16-2, BRD-K89348303-001-17-0","CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O, CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O","HDACQVRGBOVJII-JBDAPHQKSA-N, HDACQVRGBOVJII-JBDAPHQKSA-N, HDACQVRGBOVJII-JBDAPHQKSA-N",Launched,BRD-K01296542-001-01-1
ramosetron,serotonin receptor antagonist,HTR3A,gastroenterology,"nausea, vomiting, irritable bowel syndrome",MedChemEx,99.58,BRD-K85046107-003-01-2,Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc12,NTHPAPBPFQJABD-LLVKDONJSA-N,Launched,
ranitidine,histamine receptor antagonist,HRH2,gastroenterology,heartburn,"Selleck, Selleck, Tocris, MicroSource",97.81,"BRD-K70505054-003-11-6, BRD-K70505054-003-13-2, BRD-K70505054-003-14-0, BRD-K70505054-003-12-4","CN\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O, CN\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O, CN\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O, CN\C(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O","VMXUWOKSQNHOCA-UKTHLTGXSA-N, VMXUWOKSQNHOCA-UKTHLTGXSA-N, VMXUWOKSQNHOCA-UKTHLTGXSA-N, VMXUWOKSQNHOCA-UKTHLTGXSA-N",Launched,BRD-K14204120-003-20-6
ranolazine,sodium channel blocker,"SCN10A, SCN4A, SCN5A, SCN9A",cardiology,chronic stable angina,"MicroSource, Tocris, Selleck, Selleck",98.48,"BRD-A97674275-001-11-8, BRD-A97674275-300-04-9, BRD-A97674275-001-10-0, BRD-A97674275-300-03-1","COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1, COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1, COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1, COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1","XKLMZUWKNUAPSZ-UHFFFAOYSA-N, XKLMZUWKNUAPSZ-UHFFFAOYSA-N, XKLMZUWKNUAPSZ-UHFFFAOYSA-N, XKLMZUWKNUAPSZ-UHFFFAOYSA-N",Launched,
rasagiline,monoamine oxidase inhibitor,"BCL2, MAOB",neurology/psychiatry,Parkinson's Disease,"Tocris, Selleck, MicroSource, Selleck",98.6,"BRD-K58114536-066-03-5, BRD-K58114536-066-04-3, BRD-K58114536-001-01-6, BRD-K58114536-066-02-7","C#CCN[C@@H]1CCc2ccccc12, C#CCN[C@@H]1CCc2ccccc12, C#CCN[C@@H]1CCc2ccccc12, C#CCN[C@@H]1CCc2ccccc12","RUOKEQAAGRXIBM-GFCCVEGCSA-N, RUOKEQAAGRXIBM-GFCCVEGCSA-N, RUOKEQAAGRXIBM-GFCCVEGCSA-N, RUOKEQAAGRXIBM-GFCCVEGCSA-N",Launched,BRD-K58826770-066-01-3
rebamipide,free radical scavenger,FPR1,gastroenterology,"peptic ulcer disease (PUD), gastritis","MicroSource, Selleck",98.72,"BRD-A15909516-001-07-4, BRD-A15909516-001-06-6","OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1, OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1","ALLWOAVDORUJLA-UHFFFAOYSA-N, ALLWOAVDORUJLA-UHFFFAOYSA-N",Launched,
reboxetine,adrenergic receptor antagonist,SLC6A2,neurology/psychiatry,depression,"Tocris, Selleck, Cayman, Tocris",98.89,"BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1","CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1, CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1, CCOc1ccccc1OC(C1CNCCO1)c1ccccc1, CCOc1ccccc1O[C@@H]([C@H]1CNCCO1)c1ccccc1.CCOc1ccccc1O[C@H]([C@@H]1CNCCO1)c1ccccc1","XGSCYTRLSDKRRZ-JQDMTEHVSA-N, CBQGYUDMJHNJBX-RTBURBONSA-N, CBQGYUDMJHNJBX-UHFFFAOYSA-N, XGSCYTRLSDKRRZ-JQDMTEHVSA-N",Launched,
regadenoson,adenosine receptor agonist,"ADORA1, ADORA2A, ADORA2B, ADORA3",radiology,myocardial perfusion imaging (MPI),Enzo,98.94,BRD-A78341343-001-01-6,CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)C(O)C3O)c2n1,LZPZPHGJDAGEJZ-SMDQVTJXSA-N,Launched,
regorafenib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK",oncology,"colorectal cancer, gastrointestinal stromal tumors (GIST)",Selleck,97.53,BRD-K16730910-001-07-3,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Launched,
repaglinide,insulin secretagogue,"ABCC8, KCNJ11, PPARG",endocrinology,diabetes mellitus,"Tocris, Tocris, MicroSource, Selleck",99.06,"BRD-K82846253-001-17-0, BRD-K82846253-001-15-4, BRD-K82846253-001-16-2, BRD-K82846253-001-14-7","CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O, CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O, CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O, CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O","FAEKWTJYAYMJKF-QHCPKHFHSA-N, FAEKWTJYAYMJKF-QHCPKHFHSA-N, FAEKWTJYAYMJKF-QHCPKHFHSA-N, FAEKWTJYAYMJKF-QHCPKHFHSA-N",Launched,
reserpine,vesicular monoamine transporter inhibitor,"SLC18A1, SLC18A2",cardiology,hypertension,"Selleck, Tocris, Selleck, MicroSource",88.29,"BRD-K95921201-001-15-3, BRD-K95921201-001-13-8, BRD-K95921201-001-12-0, BRD-K95921201-001-14-6","CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1, CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1, CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1, CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c1cc(OC)c(OC)c(OC)c1","QEVHRUUCFGRFIF-MDEJGZGSSA-N, QEVHRUUCFGRFIF-MDEJGZGSSA-N, QEVHRUUCFGRFIF-MDEJGZGSSA-N, QEVHRUUCFGRFIF-MDEJGZGSSA-N",Launched,
resorcinol,phosphodiesterase inhibitor,"CA12, CA14, CA2, PTGS1",dermatology,"acne vulgaris (AV), eczema, psoriasis, seborrheic dermatitis",MicroSource,99.52,BRD-K74190368-001-04-3,Oc1cccc(O)c1,GHMLBKRAJCXXBS-UHFFFAOYSA-N,Launched,
resorcinol-monoacetate,antiseptic,,,,"MicroSource, MedChemEx",70.52,"BRD-K85603128-001-03-5, BRD-K85603128-001-04-3","CC(=O)Oc1cccc(O)c1, CC(=O)Oc1cccc(O)c1","ZZPKZRHERLGEKA-UHFFFAOYSA-N, ZZPKZRHERLGEKA-UHFFFAOYSA-N",Launched,
resveratrol,"cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2",,,"Selleck, MedChemEx, Selleck, Tocris, Tocris",95.03,"BRD-K80738081-001-44-3, BRD-K80738081-001-46-8, BRD-K80738081-001-42-7, BRD-K80738081-001-43-5, BRD-K80738081-001-47-6","Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1, Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1, Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1, Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1, Oc1ccc(cc1)\C=C\c1cc(O)cc(O)c1","LUKBXSAWLPMMSZ-OWOJBTEDSA-N, LUKBXSAWLPMMSZ-OWOJBTEDSA-N, LUKBXSAWLPMMSZ-OWOJBTEDSA-N, LUKBXSAWLPMMSZ-OWOJBTEDSA-N, LUKBXSAWLPMMSZ-OWOJBTEDSA-N",Launched,
retapamulin,protein synthesis inhibitor,,infectious disease,impetigo,Selleck,100,BRD-K33082088-001-03-3,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C,STZYTFJPGGDRJD-NHUWBDDWSA-N,Launched,BRD-K17930269-001-01-8
retigabine,potassium channel activator,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5",neurology/psychiatry,epilepsy,MedChemEx,90.38,BRD-K89917372-001-01-2,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,PCOBBVZJEWWZFR-UHFFFAOYSA-N,Launched,
retinaldehyde,,,dermatology,cosmetic,SantaCruz,96.68,BRD-K79884267-001-01-4,CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/C=O,NCYCYZXNIZJOKI-OVSJKPMPSA-N,Launched,
retinol,retinoid receptor ligand,"ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG",dermatology,"cosmetic, acne vulgaris (AV), keratosis","Sigma, MicroSource",0,"BRD-K22429181-001-15-9, BRD-K22429181-001-14-2","CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/CO, CC(\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C)=C/CO","FPIPGXGPPPQFEQ-OVSJKPMPSA-N, FPIPGXGPPPQFEQ-OVSJKPMPSA-N",Launched,
retinyl-acetate,,,,,"MicroSource, Sigma",0,"BRD-K65331431-001-06-2, BRD-K65331431-001-08-8","CC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C, CC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C","QGNJRVVDBSJHIZ-QHLGVNSISA-N, QGNJRVVDBSJHIZ-QHLGVNSISA-N",Launched,
retinyl-palmitate,,,,,"MicroSource, Sigma",0,"BRD-K80595380-001-07-2, BRD-K80595380-001-09-8","CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C, CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C","VYGQUTWHTHXGQB-FFHKNEKCSA-N, VYGQUTWHTHXGQB-FFHKNEKCSA-N",Launched,
revaprazan,potassium-competitive acid antagonist,ATP4A,gastroenterology,gastritis,AvaChem,0,BRD-A51497544-001-01-4,CC1N(CCc2ccccc12)c1nc(Nc2ccc(F)cc2)nc(C)c1C,LECZXZOBEZITCL-UHFFFAOYSA-N,Launched,
ribavirin,antiviral,"ADK, ENPP1, IMPDH1, IMPDH2, NT5C2",infectious disease,hepatitis C,"Tocris, Selleck, MicroSource",100,"BRD-K60369935-001-17-5, BRD-K60369935-001-18-3, BRD-K60369935-001-15-9","NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O, NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O, NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","IWUCXVSUMQZMFG-AFCXAGJDSA-N, IWUCXVSUMQZMFG-AFCXAGJDSA-N, IWUCXVSUMQZMFG-AFCXAGJDSA-N",Launched,BRD-K94397152-001-01-6
ribociclib,CDK inhibitor,"CDK4, CDK6",oncology,breast cancer,"MedChemEx, Selleck, Selleck",93.42,"BRD-K36788280-001-04-6, BRD-K36788280-001-01-2, BRD-K36788280-001-03-8","CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1, CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1, CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n1C1CCCC1","RHXHGRAEPCAFML-UHFFFAOYSA-N, RHXHGRAEPCAFML-UHFFFAOYSA-N, RHXHGRAEPCAFML-UHFFFAOYSA-N",Launched,
riboflavin,vitamin B2,"BLVRB, RFK",gastroenterology,jaundice,"MicroSource, Selleck, Selleck",91.09,"BRD-K70246307-001-04-1, BRD-K92760278-001-07-3, BRD-K92760278-001-06-5","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C, Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C, Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C","AUNGANRZJHBGPY-MBNYWOFBSA-N, AUNGANRZJHBGPY-SCRDCRAPSA-N, AUNGANRZJHBGPY-SCRDCRAPSA-N",Launched,
riboflavin-5-phosphate-sodium,,"BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1",,,"MedChemEx, MicroSource, Sigma",10.28,"BRD-K09229706-236-02-6, BRD-K58734774-236-02-2, BRD-K09229706-236-01-8","Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)c2cc1C, Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@@H](O)[C@@H](O)[C@@H](O)COP(O)(O)=O)c2cc1C, Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)c2cc1C","FVTCRASFADXXNN-SCRDCRAPSA-N, FVTCRASFADXXNN-MBNYWOFBSA-N, FVTCRASFADXXNN-SCRDCRAPSA-N",Launched,
ribostamycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,"human immunodeficiency virus (HIV-1), human immunodeficiency virus (HIV-1)","MedChemEx, Bosche",73.8,"BRD-K55188888-065-01-2, BRD-A86073102-001-01-6","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O, NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(O)C2O)C(N)C(O)C1O","NSKGQURZWSPSBC-VVPCINPTSA-N, NSKGQURZWSPSBC-UHFFFAOYSA-N",Launched,
ribostamycin-sulfate,bacterial 30S ribosomal subunit inhibitor,P4HB,infectious disease,gram-negative bacterial infections,MicroSource,0,BRD-A03826781-065-03-6,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,NSKGQURZWSPSBC-VCUPSGBRSA-N,Launched,
ricinoleic-acid,prostanoid receptor agonist,PTGER3,,,TCI,51.56,BRD-K33682646-001-02-7,CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O,WBHHMMIMDMUBKC-QJWNTBNXSA-N,Launched,
rifabutin,protein synthesis inhibitor,"HSP90AA1, HSP90B1",infectious disease,human immunodeficiency virus (HIV-1),Selleck,94.51,BRD-K30563334-001-02-9,CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(c(O)c3C)c(O)c(NC(=O)\C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c1=NC3(CCN(CC(C)C)CC3)N=c21,AZFBLLCNOQPJGJ-NYGPAKPVSA-N,Launched,
rifampin,RNA polymerase inhibitor,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3",infectious disease,"tuberculosis, meningitis","Selleck, MicroSource, Selleck",89.01,"BRD-K01507359-001-23-7, BRD-A23603052-001-03-2, BRD-K01507359-001-22-9","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C, CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C, CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(C)CC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C","JQXXHWHPUNPDRT-WLSIYKJHSA-N, JQXXHWHPUNPDRT-OUBGVEFFSA-N, JQXXHWHPUNPDRT-WLSIYKJHSA-N",Launched,"BRD-K66218091-001-01-2, BRD-K56156786-001-01-6"
rifamycin,DNA directed RNA polymerase inhibitor,"SLCO1A2, SLCO1B1, SLCO1B3, SLCO2B1",infectious disease,"tuberculosis, leprosy",AvaChem,2.86,BRD-K38512030-001-01-7,CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C,HJYYPODYNSCCOU-ODRIEIDWSA-N,Launched,
rifapentine,RNA polymerase inhibitor,"CYP2C8, CYP2C9, CYP3A4",infectious disease,tuberculosis,"Selleck, MedChemEx, Selleck",71.91,"BRD-K28346421-001-08-4, BRD-K28346421-001-07-6, BRD-K28346421-001-06-8","CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(CC4)C4CCCC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C, CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(CC4)C4CCCC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C, CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)c(\C=N\N4CCN(CC4)C4CCCC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C","WDZCUPBHRAEYDL-GZAUEHORSA-N, WDZCUPBHRAEYDL-GZAUEHORSA-N, WDZCUPBHRAEYDL-GZAUEHORSA-N",Launched,"BRD-K55889443-001-03-4, BRD-K42569090-001-01-8, BRD-K62325629-001-01-0"
rifaximin,RNA synthesis inhibitor,NR1I2,gastroenterology,"diarrhea, irritable bowel syndrome, hepatic encephalopathy (HE)","MicroSource, Selleck",94.32,"BRD-K92838188-001-01-9, BRD-K92838188-001-02-7","CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C, CO[C@H]1C=CO[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C","NZCRJKRKKOLAOJ-CPJOEXDVSA-N, NZCRJKRKKOLAOJ-CPJOEXDVSA-N",Launched,"BRD-A62879835-001-04-2, BRD-K45512312-001-01-7"
rilmenidine,"adrenergic receptor agonist, imidazoline receptor agonist",ADRA2A,cardiology,hypertension,"Tocris, Selleck",88.74,"BRD-K01638814-051-16-8, BRD-K01638814-011-01-4","C1CC1C(NC1=NCCO1)C1CC1, C1CC1C(NC1=NCCO1)C1CC1","CQXADFVORZEARL-UHFFFAOYSA-N, CQXADFVORZEARL-UHFFFAOYSA-N",Launched,BRD-M62162320-051-04-6
rilpivirine,non-nucleoside reverse transcriptase inhibitor,"NR1I2, SCN10A",infectious disease,human immunodeficiency virus (HIV-1),Selleck,93.71,BRD-K06240250-001-01-6,Cc1cc(\C=C\C#N)cc(C)c1Nc1ccnc(Nc2ccc(cc2)C#N)n1,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Launched,
riluzole,glutamate inhibitor,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11",neurology/psychiatry,amyotrophic lateral sclerosis (ALS),"Tocris, MicroSource, Selleck",99.88,"BRD-K21283037-003-11-2, BRD-K21283037-001-21-5, BRD-K21283037-001-20-7","Nc1nc2ccc(OC(F)(F)F)cc2s1, Nc1nc2ccc(OC(F)(F)F)cc2s1, Nc1nc2ccc(OC(F)(F)F)cc2s1","FTALBRSUTCGOEG-UHFFFAOYSA-N, FTALBRSUTCGOEG-UHFFFAOYSA-N, FTALBRSUTCGOEG-UHFFFAOYSA-N",Launched,
rimantadine,"antiviral, RNA synthesis inhibitor",,infectious disease,influenza A virus infection,"MicroSource, Selleck",100,"BRD-A75479906-003-11-1, BRD-A75479906-001-02-4","CC(N)C12CC3CC(CC(C3)C1)C2, CC(N)C12CC3CC(CC(C3)C1)C2","UBCHPRBFMUDMNC-UHFFFAOYSA-N, UBCHPRBFMUDMNC-UHFFFAOYSA-N",Launched,
rimexolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6",ophthalmology,anterior uveitis,Prestwick,97.27,BRD-K31627533-001-09-5,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Launched,
riociguat,guanylate cyclase stimulant,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3",cardiology,hypertension,MedChemEx,99.03,BRD-K84783599-001-01-0,COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Launched,
riodoxol,other antibiotic,,,,"Vitas-M, Vitas-M",31.26,"BRD-K48963429-001-01-9, BRD-K48963429-001-02-7","Oc1c(I)cc(I)c(O)c1I, Oc1c(I)cc(I)c(O)c1I","XKFZYVWWXHCHIX-UHFFFAOYSA-N, XKFZYVWWXHCHIX-UHFFFAOYSA-N",Launched,
ripasudil,rho associated kinase inhibitor,"ROCK1, ROCK2",ophthalmology,"glaucoma, ocular hypertension",MedChemEx,98.73,BRD-K53814070-310-01-3,C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12,QSKQVZWVLOIIEV-NSHDSACASA-N,Launched,
risedronate,osteoclast inhibitor,FDPS,"orthopedics, endocrinology","osteoporosis, Paget's disease","Selleck, MicroSource, Selleck, Selleck, Selleck",0,"BRD-K05185389-236-05-1, BRD-K05185389-236-04-4, BRD-K05185389-001-02-6, BRD-K05185389-001-03-4, BRD-K05185389-236-03-6","OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O, OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O, OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O, OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O, OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O","IIDJRNMFWXDHID-UHFFFAOYSA-N, IIDJRNMFWXDHID-UHFFFAOYSA-N, IIDJRNMFWXDHID-UHFFFAOYSA-N, IIDJRNMFWXDHID-UHFFFAOYSA-N, IIDJRNMFWXDHID-UHFFFAOYSA-N",Launched,
risperidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7",neurology/psychiatry,"schizophrenia, bipolar disorder, irritability","MicroSource, Selleck",98.34,"BRD-K53857191-001-22-7, BRD-K53857191-001-21-9","Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12, Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12","RAPZEAPATHNIPO-UHFFFAOYSA-N, RAPZEAPATHNIPO-UHFFFAOYSA-N",Launched,
ritodrine,adrenergic receptor agonist,ADRB2,obstetrics/gynecology,premature labor,"Selleck, Selleck, MicroSource",98.11,"BRD-K14003026-003-09-0, BRD-K14003026-003-08-2, BRD-A59174698-003-18-5","C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1, C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c1ccc(O)cc1, CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1","IOVGROKTTNBUGK-SJKOYZFVSA-N, IOVGROKTTNBUGK-SJKOYZFVSA-N, IOVGROKTTNBUGK-UHFFFAOYSA-N",Launched,
ritonavir,HIV protease inhibitor,"CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7",infectious disease,human immunodeficiency virus (HIV-1),Selleck,98.16,BRD-K51485625-001-08-4,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,Launched,
rivaroxaban,coagulation factor inhibitor,F10,"neurology/psychiatry, hematology, cardiology","stroke, systemic embolism, atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE)","MicroSource, Selleck",96.48,"BRD-K37130656-001-03-8, BRD-K37130656-001-04-6","Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O, Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O","KGFYHTZWPPHNLQ-AWEZNQCLSA-N, KGFYHTZWPPHNLQ-AWEZNQCLSA-N",Launched,BRD-A50033377-001-02-8
rivastigmine,acetylcholinesterase inhibitor,"ACHE, BCHE",neurology/psychiatry,"Alzheimer's disease, Parkinson's Disease, senile dementia","MicroSource, Tocris, Tocris, Selleck",97.89,"BRD-K10706131-046-04-4, BRD-K10706131-046-05-1, BRD-K10706131-046-03-6, BRD-K10706131-046-02-8","CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C, CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C, CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C, CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C","XSVMFMHYUFZWBK-NSHDSACASA-N, XSVMFMHYUFZWBK-NSHDSACASA-N, XSVMFMHYUFZWBK-NSHDSACASA-N, XSVMFMHYUFZWBK-NSHDSACASA-N",Launched,
rizatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",neurology/psychiatry,migraine headache,"Selleck, Tocris, MicroSource, Selleck",93.99,"BRD-K75699339-057-09-9, BRD-K75699339-057-10-7, BRD-K75699339-057-08-1, BRD-K75699339-057-07-3","CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12, CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12, CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12, CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12","ULFRLSNUDGIQQP-UHFFFAOYSA-N, ULFRLSNUDGIQQP-UHFFFAOYSA-N, ULFRLSNUDGIQQP-UHFFFAOYSA-N, ULFRLSNUDGIQQP-UHFFFAOYSA-N",Launched,
rocuronium,acetylcholine receptor antagonist,"CHRM2, CHRNA2, HTR3A",neurology/psychiatry,anesthetic,"MicroSource, Selleck",100,"BRD-K43305603-004-03-6, BRD-K43305603-004-02-8","CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1, CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1","YXRDKMPIGHSVRX-OOJCLDBCSA-N, YXRDKMPIGHSVRX-OOJCLDBCSA-N",Launched,"BRD-A40127632-004-01-8, BRD-K58951486-004-01-5"
roflumilast,phosphodiesterase inhibitor,"PDE4A, PDE4B, PDE4C, PDE4D",pulmonary,"chronic obstructive pulmonary disease (COPD), bronchitis",Selleck,99.14,BRD-K03194791-001-04-8,FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl,MNDBXUUTURYVHR-UHFFFAOYSA-N,Launched,
rolitetracycline,bacterial 30S ribosomal subunit inhibitor,,,,"MicroSource, Selleck, Selleck",2.99,"BRD-A62336573-001-03-1, BRD-A62336573-001-04-9, BRD-A62336573-001-02-3","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCN2CCCC2)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCN2CCCC2)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(=O)NCN2CCCC2)C1=O","PLDZOHPIBZVDLQ-KOQYWDHLSA-N, PLDZOHPIBZVDLQ-KOQYWDHLSA-N, PLDZOHPIBZVDLQ-KOQYWDHLSA-N",Launched,
romidepsin,HDAC inhibitor,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",hematologic malignancy,cutaneous T-cell lymphoma (CTCL),MedChemEx,98.84,BRD-K61397605-001-03-4,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,OHRURASPPZQGQM-GCCNXGTGSA-N,Launched,
ronidazole,antiprotozoal agent,,infectious disease,"histomoniasis, dysentry","MicroSource, Selleck",99.46,"BRD-K94266545-001-24-1, BRD-K94266545-001-23-3","Cn1c(COC(N)=O)ncc1[N+]([O-])=O, Cn1c(COC(N)=O)ncc1[N+]([O-])=O","PQFRTXSWDXZRRS-UHFFFAOYSA-N, PQFRTXSWDXZRRS-UHFFFAOYSA-N",Launched,
ropinirole,dopamine receptor agonist,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",neurology/psychiatry,"Parkinson's Disease, restless leg syndrome","MicroSource, Selleck",97.67,"BRD-K15933101-003-07-9, BRD-K15933101-003-06-1","CCCN(CCC)CCc1cccc2NC(=O)Cc12, CCCN(CCC)CCc1cccc2NC(=O)Cc12","UHSKFQJFRQCDBE-UHFFFAOYSA-N, UHSKFQJFRQCDBE-UHFFFAOYSA-N",Launched,
ropivacaine,sodium channel blocker,SCN10A,neurology/psychiatry,anesthetic,Selleck,97.16,BRD-K50938786-003-11-8,CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,Launched,
rose-bengal,contrast agent,,radiology,diagnostic agent,"SantaCruz, Acros",57.93,"BRD-K33623053-304-02-5, BRD-K33623053-304-01-7","OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12, OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(O)c(I)c2oc2c(I)c(=O)c(I)cc12","VDNLFJGJEQUWRB-UHFFFAOYSA-N, VDNLFJGJEQUWRB-UHFFFAOYSA-N",Launched,BRD-K36163066-304-01-6
rose-bengal-lactone,coloring agent,,ophthalmology,staining agent,CombiBlocks,73.73,BRD-K36163066-304-02-4,Oc1c(I)cc2c(Oc3c(I)c(O)c(I)cc3C22OC(=O)c3c2c(Cl)c(Cl)c(Cl)c3Cl)c1I,IICCLYANAQEHCI-UHFFFAOYSA-N,Launched,
rosmarinic-acid,GABA transaminase inhibitor,"MCL1, TYR",,,Tocris,94.08,BRD-K20313525-001-04-6,OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c(O)c1,DOUMFZQKYFQNTF-WUTVXBCWSA-N,Launched,
rosoxacin,topoisomerase inhibitor,,infectious disease,urinary tract infections,Accela,98.05,BRD-K49841478-001-01-6,CCn1cc(C(O)=O)c(=O)c2ccc(cc12)-c1ccncc1,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Launched,
rosuvastatin,HMGCR inhibitor,HMGCR,"endocrinology, cardiology","hyperlipidemia, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, atherosclerosis","MicroSource, Selleck",93.46,"BRD-K82941592-238-03-7, BRD-K82941592-238-04-5","CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O, CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O","BPRHUIZQVSMCRT-VEUZHWNKSA-N, BPRHUIZQVSMCRT-VEUZHWNKSA-N",Launched,BRD-M41627219-238-01-7
rotigotine,dopamine receptor agonist,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A",neurology/psychiatry,"Parkinson's Disease, restless leg syndrome","Tocris, MedChemEx",98.62,"BRD-K91111634-003-01-8, BRD-K91111634-001-01-2","CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1, CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1","KFQYTPMOWPVWEJ-INIZCTEOSA-N, KFQYTPMOWPVWEJ-INIZCTEOSA-N",Launched,
rotundine,serotonin receptor agonist,"DRD1, DRD2, DRD3, HTR1A",,,Selleck,90.41,BRD-K35719256-001-02-6,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Launched,
roxarsone,antiprotozoal agent,,endocrinology,weight-gain aid,MicroSource,98.02,BRD-K22685337-001-13-4,Oc1ccc(cc1[N+]([O-])=O)[As](O)(O)=O,XMVJITFPVVRMHC-UHFFFAOYSA-N,Launched,
roxatidine-acetate,histamine receptor antagonist,HRH2,gastroenterology,"Zollinger-Ellison syndrome, erosive esophagitis (EE), gastroesophageal reflux disease (GERD), gastritis","MedChemEx, Selleck, MicroSource",97.97,"BRD-K81855038-003-14-7, BRD-K81855038-003-12-1, BRD-K81855038-003-13-9","CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1, CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1, CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1","SMTZFNFIKUPEJC-UHFFFAOYSA-N, SMTZFNFIKUPEJC-UHFFFAOYSA-N, SMTZFNFIKUPEJC-UHFFFAOYSA-N",Launched,
roxithromycin,bacterial 50S ribosomal subunit inhibitor,"ABCB1, MLNR",infectious disease,"respiratory tract infections, urinary tract infections, skin infections","MicroSource, Selleck",99.06,"BRD-K38684403-001-04-7, BRD-K38684403-001-05-4","CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O, CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O","RXZBMPWDPOLZGW-XMRMVWPWSA-N, RXZBMPWDPOLZGW-XMRMVWPWSA-N",Launched,BRD-K58211978-001-01-5
rufinamide,voltage-gated sodium channel blocker,"GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,Selleck,98.35,BRD-K20079257-001-09-6,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,POGQSBRIGCQNEG-UHFFFAOYSA-N,Launched,
rufloxacin,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,97.36,BRD-K62374253-001-07-8,CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(C(O)=O)c2=O,NJCJBUHJQLFDSW-UHFFFAOYSA-N,Launched,
rupatadine,"histamine receptor antagonist, platelet activating factor receptor antagonist","HRH1, PTAFR",allergy,"allergic rhinitis, urticaria",Selleck,91.72,BRD-K98004573-051-02-8,Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1,WUZYKBABMWJHDL-UHFFFAOYSA-N,Launched,
rutin,"antioxidant, capillary stabilizing agent, nitric oxide scavenger",AKR1C3,"rheumatology, otolaryngology, gastroenterology, neurology/psychiatry, allergy","joint pain, nasal congestion, constipation, irritability, allergic rhinitis","MicroSource, Selleck, Selleck",91.2,"BRD-K20482099-001-11-0, BRD-K20482099-001-09-4, BRD-K20482099-001-10-2","C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O","IKGXIBQEEMLURG-NVPNHPEKSA-N, IKGXIBQEEMLURG-NVPNHPEKSA-N, IKGXIBQEEMLURG-NVPNHPEKSA-N",Launched,"BRD-A76747559-001-03-1, BRD-K22924152-001-01-4"
ruxolitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2","hematologic malignancy, hematology","myelofibrosis, polycythemia vera",Selleck,96.54,BRD-K53972329-001-07-0,N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12,HFNKQEVNSGCOJV-OAHLLOKOSA-N,Launched,BRD-K19601669-001-02-7
saccharin,DNA polymerase inhibitor,"CA1, CA12, CA2, CA9",,,MicroSource,98.63,BRD-K46493214-001-06-7,O=C1NS(=O)(=O)c2ccccc12,CVHZOJJKTDOEJC-UHFFFAOYSA-N,Launched,
sacubitril,neprilysin inhibitor,MME,cardiology,congestive heart failure,"MedChemEx, MedChemEx",99.59,"BRD-K91456750-001-01-9, BRD-K91456750-238-01-7","CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O, CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O","PYNXFZCZUAOOQC-UTKZUKDTSA-N, PYNXFZCZUAOOQC-UTKZUKDTSA-N",Launched,BRD-M32063731-001-01-7
safinamide,"dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor",MAOB,neurology/psychiatry,Parkinson's Disease,Selleck,97.9,BRD-K92613113-066-02-7,C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NEMGRZFTLSKBAP-LBPRGKRZSA-N,Launched,
salicylamide,analgesic agent,,"neurology/psychiatry, endocrinology","pain relief, fever",MicroSource,98.74,BRD-K81130846-001-17-4,NC(=O)c1ccccc1O,SKZKKFZAGNVIMN-UHFFFAOYSA-N,Launched,
salicylic-acid,cyclooxygenase inhibitor,"AKR1C1, PTGS1, PTGS2",dermatology,acne vulgaris (AV),MicroSource,98.29,BRD-K93632104-001-17-2,OC(=O)c1ccccc1O,YGSDEFSMJLZEOE-UHFFFAOYSA-N,Launched,
salinomycin,,,infectious disease,coccidiosis,"MicroSource, Selleck, Selleck",94.17,"BRD-A28301258-236-01-6, BRD-A28301258-001-03-0, BRD-A28301258-001-04-8","CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O, CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O, CC[C@H](C1CC[C@H](C)C(O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)C1O[C@@]2(O[C@@]3(CC[C@](C)(O3)C3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O","KQXDHUJYNAXLNZ-DLOCPGDYSA-N, KQXDHUJYNAXLNZ-DLOCPGDYSA-N, KQXDHUJYNAXLNZ-DLOCPGDYSA-N",Launched,"BRD-A28301258-001-05-5,BRD-A32757659-236-04-2, BRD-A98605041-001-01-5, BRD-A46641338-001-02-3"
salmeterol,adrenergic receptor agonist,ADRB2,pulmonary,"asthma, chronic obstructive pulmonary disease (COPD), bronchospasm","MedChemEx, Tocris, Sigma, MedChemEx, Tocris",67.68,"BRD-A01320529-104-14-3, BRD-A01320529-104-13-5, BRD-A01320529-104-11-9, BRD-A01320529-104-12-7, BRD-A01320529-104-10-1","OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1, OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1, OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1, OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1, OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1","GIIZNNXWQWCKIB-UHFFFAOYSA-N, GIIZNNXWQWCKIB-UHFFFAOYSA-N, GIIZNNXWQWCKIB-UHFFFAOYSA-N, GIIZNNXWQWCKIB-UHFFFAOYSA-N, GIIZNNXWQWCKIB-UHFFFAOYSA-N",Launched,
sapropterin,phenylalanine 4-hydroxylase stimulant,"NOS3, PAH, TH, TPH1",metabolism,hyperphenylalaninemia (HPA),"Cayman, Cayman, Cayman",84.77,"BRD-K36859431-300-04-9, BRD-K36859431-300-03-1, BRD-K36859431-300-02-3","C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1, C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1, C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1","FNKQXYHWGSIFBK-RPDRRWSUSA-N, FNKQXYHWGSIFBK-RPDRRWSUSA-N, FNKQXYHWGSIFBK-RPDRRWSUSA-N",Launched,
saquinavir,HIV protease inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1),"Tocris, Enzo",98.75,"BRD-K09963420-066-12-5, BRD-A26690767-066-01-9","CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1, CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1","QWAXKHKRTORLEM-UGJKXSETSA-N, QWAXKHKRTORLEM-LINFGICFSA-N",Launched,
sarafloxacin,bacterial DNA gyrase inhibitor,,,,"MicroSource, Selleck",92.94,"BRD-K08525451-003-06-0, BRD-K08525451-003-05-2","OC(=O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O, OC(=O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O","XBHBWNFJWIASRO-UHFFFAOYSA-N, XBHBWNFJWIASRO-UHFFFAOYSA-N",Launched,
sarpogrelate,serotonin receptor antagonist,"HTR2A, HTR2B, HTR2C","endocrinology, cardiology, rheumatology","diabetes mellitus, angina pectoris, Raynaud's disease, atherosclerosis, Buerger's disease","Tocris, MedChemEx",93.14,"BRD-A34358106-003-02-4, BRD-A34358106-003-01-6","COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(O)=O)c1, COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(O)=O)c1","FFYNAVGJSYHHFO-UHFFFAOYSA-N, FFYNAVGJSYHHFO-UHFFFAOYSA-N",Launched,
sasapyrine,NFkB pathway inhibitor,"PTGS1, PTGS2",rheumatology,"osteoarthritis, rheumatoid arthritis","MicroSource, Selleck",97.73,"BRD-K48892307-001-05-8, BRD-K48892307-001-04-1","OC(=O)c1ccccc1OC(=O)c1ccccc1O, OC(=O)c1ccccc1OC(=O)c1ccccc1O","WVYADZUPLLSGPU-UHFFFAOYSA-N, WVYADZUPLLSGPU-UHFFFAOYSA-N",Launched,
saxagliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,Selleck,91.2,BRD-A81513827-001-03-6,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2,QGJUIPDUBHWZPV-SGTAVMJGSA-N,Launched,BRD-A82156122-001-01-9
sclareolide,other antifungal,,,,"Selleck, Selleck",83.52,"BRD-K72925150-001-10-3, BRD-K72925150-001-11-1","C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2, C[C@@]12CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CC(=O)O2","IMKJGXCIJJXALX-SHUKQUCYSA-N, IMKJGXCIJJXALX-SHUKQUCYSA-N",Launched,BRD-K35504063-001-01-7
SCMC-Lys,mucolytic agent,GSTP1,,,"ChemImpex, ChemImpex",83.3,"BRD-K33809398-001-02-6, BRD-K33809398-001-01-8","N[C@@H](CSCC(O)=O)C(O)=O, N[C@@H](CSCC(O)=O)C(O)=O","GBFLZEXEOZUWRN-VKHMYHEASA-N, GBFLZEXEOZUWRN-VKHMYHEASA-N",Launched,
scopine,,,,,"Selleck, Selleck",100,"BRD-K75923785-003-02-1, BRD-K75923785-001-02-5","CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21, CN1[C@H]2C[C@H](O)C[C@@H]1[C@H]1O[C@@H]21","FIMXSEMBHGTNKT-RZVDLVGDSA-N, FIMXSEMBHGTNKT-RZVDLVGDSA-N",Launched,
scopolamine,acetylcholine receptor antagonist,,"neurology/psychiatry, gastroenterology","motion sickness, vomiting, nausea","Selleck, MicroSource, Tocris",98.87,"BRD-K89923877-004-15-4, BRD-K64990126-004-01-1, BRD-K89923877-004-16-2","CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1, CN1[C@H]2C[C@H](C[C@@H]1[C@@H]1O[C@H]21)OC(=O)[C@H](CO)c1ccccc1, CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1","STECJAGHUSJQJN-FWXGHANASA-N, STECJAGHUSJQJN-AQGHMYMLSA-N, STECJAGHUSJQJN-FWXGHANASA-N",Launched,BRD-A62035778-004-03-6
secalciferol,vitamin D receptor agonist,VDR,critical care,bone fracture,Enzo,81.1,BRD-K02965577-001-03-4,C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C,FCKJYANJHNLEEP-XRWYNYHCSA-N,Launched,
secnidazole,"acetylcholinesterase inhibitor, microtubule inhibitor",,infectious disease,protozoan infection,"Selleck, Selleck, MicroSource",99.58,"BRD-A70083328-001-22-7, BRD-A70083328-001-24-3, BRD-A70083328-001-23-5","CC(O)Cn1c(C)ncc1[N+]([O-])=O, CC(O)Cn1c(C)ncc1[N+]([O-])=O, CC(O)Cn1c(C)ncc1[N+]([O-])=O","KPQZUUQMTUIKBP-UHFFFAOYSA-N, KPQZUUQMTUIKBP-UHFFFAOYSA-N, KPQZUUQMTUIKBP-UHFFFAOYSA-N",Launched,
selamectin,nematocide,,infectious disease,flea control,MicroSource,95.85,BRD-A58564983-001-04-6,CO[C@H]1CC(O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4C(=N/O)\C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]2(CC[C@H](C)[C@H](O2)C2CCCCC2)C5)[C@]34O)O[C@@H](C)C1O,AFJYYKSVHJGXSN-XUCDQRGXSA-N,Launched,
selegiline,monoamine oxidase inhibitor,"MAOA, MAOB",neurology/psychiatry,Parkinson's Disease,MicroSource,98.41,BRD-A28545468-003-16-6,CC(Cc1ccccc1)N(C)CC#C,MEZLKOACVSPNER-UHFFFAOYSA-N,Launched,
selenomethionine,,,,,"Sigma, Ark, MicroSource",100,"BRD-A18774709-001-01-9, BRD-K74664543-001-01-1, BRD-K74664543-213-01-2","C[Se]CCC(N)C(O)=O, C[Se]CC[C@H](N)C(O)=O, C[Se]CC[C@H](N)C(O)=O","RJFAYQIBOAGBLC-UHFFFAOYSA-N, RJFAYQIBOAGBLC-BYPYZUCNSA-N, RJFAYQIBOAGBLC-BYPYZUCNSA-N",Launched,
sennoside-a,glycoside agonist,,gastroenterology,constipation,MicroSource,98.1,BRD-A30370660-001-04-1,OC[C@H]1O[C@H](Oc2cccc3C([C@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4C(=O)c23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O,IPQVTOJGNYVQEO-FPJYKMGYSA-N,Launched,
seratrodast,prostanoid receptor antagonist,TBXA2R,pulmonary,asthma,"MedChemEx, MedChemEx, MicroSource",87.19,"BRD-A60765580-001-03-4, BRD-A60765580-001-02-6, BRD-A60765580-001-01-8","CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O, CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O, CC1=C(C)C(=O)C(C(CCCCCC(O)=O)c2ccccc2)=C(C)C1=O","ZBVKEHDGYSLCCC-UHFFFAOYSA-N, ZBVKEHDGYSLCCC-UHFFFAOYSA-N, ZBVKEHDGYSLCCC-UHFFFAOYSA-N",Launched,
serotonin,growth factor receptor activator,"DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1",neurology/psychiatry,"anxiety, depression, sleeplessness","Tocris, Selleck, Selleck",80.69,"BRD-K38580127-003-16-2, BRD-K38580127-003-15-4, BRD-K38580127-003-17-0","NCCc1c[nH]c2ccc(O)cc12, NCCc1c[nH]c2ccc(O)cc12, NCCc1c[nH]c2ccc(O)cc12","QZAYGJVTTNCVMB-UHFFFAOYSA-N, QZAYGJVTTNCVMB-UHFFFAOYSA-N, QZAYGJVTTNCVMB-UHFFFAOYSA-N",Launched,
sertaconazole,sterol demethylase inhibitor,,infectious disease,tinea pedis,Selleck,98.39,BRD-A95939040-001-01-2,Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1,JLGKQTAYUIMGRK-UHFFFAOYSA-N,Launched,BRD-U65696040-000-01-2
sertraline,selective serotonin reuptake inhibitor (SSRI),"SLC6A3, SLC6A4","neurology/psychiatry, obstetrics/gynecology","depression, obsessive compulsive disorder (OCD), panic disorders, posttraumatic stress disorder, premenstrual syndrome, social anxiety disorder","MicroSource, Tocris, Tocris, Selleck",97.77,"BRD-K82036761-003-17-9, BRD-K82036761-003-16-1, BRD-K82036761-003-19-5, BRD-K82036761-003-20-3","CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12, CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12, CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12, CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc12","VGKDLMBJGBXTGI-SJCJKPOMSA-N, VGKDLMBJGBXTGI-SJCJKPOMSA-N, VGKDLMBJGBXTGI-SJCJKPOMSA-N, VGKDLMBJGBXTGI-SJCJKPOMSA-N",Launched,BRD-K70464547-003-01-2
setiptiline,adrenergic receptor antagonist,"HRH1, HTR2A, HTR2C",neurology/psychiatry,depression,MedChemEx,96.01,BRD-K36732695-001-01-9,CN1CCC2=C(C1)c1ccccc1Cc1ccccc21,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Launched,
sevelamer,phosphate antagonist,,nephrology,chronic kidney disease (CKD),"Selleck, Selleck",0,"BRD-U45393375-000-01-6, BRD-M22581557-003-02-5",", NCC=C.ClCC1CO1",", ZNSIZMQNQCNRBW-UHFFFAOYSA-N",Launched,BRD-M22581557-003-01-7
sevoflurane,membrane integrity inhibitor,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1",neurology/psychiatry,anesthetic,"Enamine, Enamine",0,"BRD-K05638300-001-02-0, BRD-K05638300-001-01-2","FCOC(C(F)(F)F)C(F)(F)F, FCOC(C(F)(F)F)C(F)(F)F","DFEYYRMXOJXZRJ-UHFFFAOYSA-N, DFEYYRMXOJXZRJ-UHFFFAOYSA-N",Launched,
sildenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3",cardiology,hypertension,"Tocris, MicroSource, Selleck",99.19,"BRD-K79759585-048-07-1, BRD-K79759585-048-04-8, BRD-K79759585-048-03-0","CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1, CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1, CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1","BNRNXUUZRGQAQC-UHFFFAOYSA-N, BNRNXUUZRGQAQC-UHFFFAOYSA-N, BNRNXUUZRGQAQC-UHFFFAOYSA-N",Launched,
silibinin,cytochrome P450 inhibitor,ALOX5,gastroenterology,hepatic cirrhosis,"Selleck, MicroSource, Selleck",97.75,"BRD-K80353138-001-13-9, BRD-K80353138-001-12-1, BRD-K80353138-001-16-2","COc1cc(ccc1O)[C@H]1Oc2cc(ccc2O[C@@H]1CO)[C@H]1Oc2cc(O)cc(O)c2C(=O)[C@@H]1O, COc1cc(ccc1O)[C@H]1Oc2cc(ccc2O[C@@H]1CO)[C@H]1Oc2cc(O)cc(O)c2C(=O)[C@@H]1O, COc1cc(ccc1O)[C@H]1Oc2cc(ccc2O[C@@H]1CO)[C@H]1Oc2cc(O)cc(O)c2C(=O)[C@@H]1O","SEBFKMXJBCUCAI-HKTJVKLFSA-N, SEBFKMXJBCUCAI-HKTJVKLFSA-N, SEBFKMXJBCUCAI-HKTJVKLFSA-N",Launched,BRD-K47267049-001-01-6
silodosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D",urology,benign prostatic hyperplasia (BPH),"Selleck, Selleck",93.88,"BRD-K10906636-001-01-1, BRD-K10906636-001-02-9","C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc1ccccc1OCC(F)(F)F, C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc1ccccc1OCC(F)(F)F","PNCPYILNMDWPEY-QGZVFWFLSA-N, PNCPYILNMDWPEY-QGZVFWFLSA-N",Launched,
silver-sulfadiazine,PABA antagonist,,critical care,sepsis,"Sigma, Enzo",99.7,"BRD-K68379918-001-01-1, BRD-K68379918-001-02-9","Nc1ccc(cc1)S(=O)(=O)N([Ag])c1ncccn1, Nc1ccc(cc1)S(=O)(=O)N([Ag])c1ncccn1","UEJSSZHHYBHCEL-UHFFFAOYSA-N, UEJSSZHHYBHCEL-UHFFFAOYSA-N",Launched,BRD-M11664367-001-01-8
silymarin,,,,,"Selleck, Selleck",50.9,"BRD-A06629414-001-02-3, BRD-A06629414-001-03-1","COc1cc(ccc1O)C1Oc2ccc(cc2OC1CO)C1Oc2cc(O)cc(O)c2C(=O)C1O, COc1cc(ccc1O)C1Oc2ccc(cc2OC1CO)C1Oc2cc(O)cc(O)c2C(=O)C1O","FDQAOULAVFHKBX-UHFFFAOYSA-N, FDQAOULAVFHKBX-UHFFFAOYSA-N",Launched,
simeprevir,HCV inhibitor,"CYP1A2, CYP3A4",infectious disease,hepatitis C,MedChemEx,98.75,BRD-A68493689-001-01-9,COc1ccc2c(O[C@@H]3C[C@@H]4C(C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C,JTZZSQYMACOLNN-SNWGISBASA-N,Launched,
simvastatin,HMGCR inhibitor,"HMGCR, ITGB2","endocrinology, cardiology, neurology/psychiatry","hypercholesterolemia, coronary heart disease, myocardial infarction, stroke, hyperlipidemia","Tocris, Selleck, MicroSource, Tocris, Selleck",91.31,"BRD-K22134346-001-28-0, BRD-K22134346-001-24-9, BRD-K22134346-001-22-3, BRD-K22134346-001-21-5, BRD-K22134346-001-30-6","CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12, CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12","RYMZZMVNJRMUDD-HGQWONQESA-N, RYMZZMVNJRMUDD-HGQWONQESA-N, RYMZZMVNJRMUDD-HGQWONQESA-N, RYMZZMVNJRMUDD-HGQWONQESA-N, RYMZZMVNJRMUDD-HGQWONQESA-N",Launched,BRD-K94986873-001-01-4
sirolimus,mTOR inhibitor,"FGF2, FKBP1A, MTOR","transplant, pulmonary","organ rejection, lymphangioleiomyomatosis","Selleck, MedChemEx, MicroSource, Selleck",95.67,"BRD-K84937637-001-09-9, BRD-K84937637-001-13-1, BRD-A79768653-001-12-0, BRD-K84937637-001-11-5","CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O, COC1CC(CC(C)C2CC(=O)C(C)\C=C(C)\C(O)C(OC)C(=O)C(C)CC(C)\C=C\C=C\C=C(C)\C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O, CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O","QFJCIRLUMZQUOT-HPLJOQBZSA-N, QFJCIRLUMZQUOT-HPLJOQBZSA-N, QFJCIRLUMZQUOT-XWBLMERNSA-N, QFJCIRLUMZQUOT-HPLJOQBZSA-N",Launched,BRD-K79988249-001-01-6
sisomicin,protein synthesis inhibitor,,ophthalmology,"conjunctivitis, punctate keratitis, conjunctivitis, punctate keratitis","MedChemEx, MedChemEx, AvaChem",11.93,"BRD-K71772032-001-01-3, BRD-K71772032-315-02-5, BRD-K71772032-315-01-7","CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O, CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O, CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O","URWAJWIAIPFPJE-YFMIWBNJSA-N, URWAJWIAIPFPJE-YFMIWBNJSA-N, URWAJWIAIPFPJE-YFMIWBNJSA-N",Launched,"BRD-M71798497-001-01-4, BRD-M47753525-343-01-2, BRD-A29840884-001-01-2"
sisomicin-sulfate,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections,MicroSource,0,BRD-A68997559-065-04-5,CN[C@@H]1C(O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O,URWAJWIAIPFPJE-JYERGDCNSA-N,Launched,
sitafloxacin,bacterial DNA gyrase inhibitor,,infectious disease,buruli ulcer,Selleck,93.27,BRD-K10836013-001-01-3,N[C@@H]1CN(CC11CC1)c1c(F)cc2c(c1Cl)n(cc(C(O)=O)c2=O)[C@@H]1C[C@@H]1F,PNUZDKCDAWUEGK-CYZMBNFOSA-N,Launched,BRD-U60340452-000-01-3
sitagliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,"MicroSource, Selleck",92.63,"BRD-K19416115-366-02-7, BRD-K19416115-001-05-3","N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F, N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F","MFFMDFFZMYYVKS-SECBINFHSA-N, MFFMDFFZMYYVKS-SECBINFHSA-N",Launched,BRD-U27206154-000-01-9
sivelestat,elastase inhibitor,"CELA1, ELANE",pulmonary,acute lung injury,"Tocris, MedChemEx, MedChemEx",97.49,"BRD-K02152879-236-01-0, BRD-K02152879-414-02-1, BRD-K02152879-414-01-3","CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc1ccccc1C(=O)NCC(O)=O, CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc1ccccc1C(=O)NCC(O)=O, CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc1ccccc1C(=O)NCC(O)=O","BTGNGJJLZOIYID-UHFFFAOYSA-N, BTGNGJJLZOIYID-UHFFFAOYSA-N, BTGNGJJLZOIYID-UHFFFAOYSA-N",Launched,
SN-38,topoisomerase inhibitor,TOP1,oncology,colorectal cancer,"Tocris, Tocris, Selleck",98.53,"BRD-K89561498-001-02-5, BRD-K89561498-001-03-3, BRD-K89561498-001-01-7","CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12, CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc2ccc(O)cc12","FJHBVJOVLFPMQE-QFIPXVFZSA-N, FJHBVJOVLFPMQE-QFIPXVFZSA-N, FJHBVJOVLFPMQE-QFIPXVFZSA-N",Launched,
sobrepin,mucolytic agent,,pulmonary,chest congestion,TCI,0,BRD-K58262380-001-01-0,CC1=CC[C@H](C[C@@H]1O)C(C)(C)O,OMDMTHRBGUBUCO-BDAKNGLRSA-N,Launched,
sodium-ascorbate,,,,,"Selleck, Selleck",0,"BRD-A67265925-236-01-8, BRD-A67265925-236-02-6","OC[C@H](O)[C@H]1OC(=O)C(O)C1O, OC[C@H](O)[C@H]1OC(=O)C(O)C1O","SXZYCXMUPBBULW-FORAYFFESA-N, SXZYCXMUPBBULW-FORAYFFESA-N",Launched,
sodium-glucoheptonate,,,,,TCI,100,BRD-K35952844-236-01-6,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O,KWMLJOLKUYYJFJ-VFUOTHLCSA-N,Launched,
sodium-gluconate,,,,,"MicroSource, Selleck, Selleck",0,"BRD-K93201765-001-01-0, BRD-M54096567-001-01-9, BRD-M54096567-001-03-5","OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O, [Na].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O, [Na].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O","RGHNJXZEOKUKBD-SQOUGZDYSA-N, MPPJUDJABRMYJR-ZBHRUSISSA-N, MPPJUDJABRMYJR-ZBHRUSISSA-N",Launched,BRD-M54096567-001-02-7
sodium-gualenate,antacid,,,,AKSci,99.62,BRD-K80043866-236-01-1,CC(C)c1ccc(C)c2c(cc(C)c2c1)S(O)(=O)=O,VIZXMHCBZLGUET-UHFFFAOYSA-N,Launched,
sodium-monofluorophosphate,,PYGM,dental,cavities,"Selleck, MicroSource, Selleck",0,"BRD-K99308954-304-02-4, BRD-K99308954-304-03-2, BRD-K99308954-304-04-0","OP(O)(F)=O, OP(O)(F)=O, OP(O)(F)=O","DWYMPOCYEZONEA-UHFFFAOYSA-N, DWYMPOCYEZONEA-UHFFFAOYSA-N, DWYMPOCYEZONEA-UHFFFAOYSA-N",Launched,
sodium-nitrite,nitric oxide donor,,critical care,"poison antidote, cyanide poisoning","Selleck, Selleck",0,"BRD-K61230716-236-02-7, BRD-K61230716-236-03-5","[O-][N+][O-], [O-][N+][O-]","KYHRXPHIUFTLNH-UHFFFAOYSA-N, KYHRXPHIUFTLNH-UHFFFAOYSA-N",Launched,
sodium-nitroprusside,nitric oxide donor,,cardiology,"hypertension, congestive heart failure","MicroSource, Selleck, Selleck",0,"BRD-K48526231-304-02-8, BRD-K48526231-304-03-6, BRD-K48526231-236-01-4","[O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N, [O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N, [O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N","WTISQLWAPBSCSF-UHFFFAOYSA-N, WTISQLWAPBSCSF-UHFFFAOYSA-N, WTISQLWAPBSCSF-UHFFFAOYSA-N",Launched,BRD-U32870953-000-01-8
sodium-oxybate,benzodiazepine receptor agonist,"GABRB1, HCAR1, SLC52A2",neurology/psychiatry,narcolepsy,MicroSource,90.06,BRD-K82166906-236-02-8,OCCCC(O)=O,SJZRECIVHVDYJC-UHFFFAOYSA-N,Launched,
sodium-picosulfate,,,gastroenterology,constipation,Selleck,91.14,BRD-K77251551-304-02-9,OS(=O)(=O)Oc1ccc(cc1)C(c1ccc(OS(O)(=O)=O)cc1)c1ccccn1,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Launched,
sodium-salicylate,prostanoid receptor antagonist,"ASIC3, PTGS1, PTGS2","endocrinology, neurology/psychiatry","fever, pain relief","Selleck, MicroSource",98.74,"BRD-K93632104-001-19-8, BRD-K93632104-001-18-0","OC(=O)c1ccccc1O, OC(=O)c1ccccc1O","YGSDEFSMJLZEOE-UHFFFAOYSA-N, YGSDEFSMJLZEOE-UHFFFAOYSA-N",Launched,"BRD-M30512773-001-05-5, BRD-M30512773-001-06-3"
sodium-stibogluconate,tyrosine phosphatase inhibitor,"PTPN6, TOP1",infectious disease,leishmaniasis,Enzo,0,BRD-A60786380-412-01-5,OCC(O)C1O[Sb]2(O)(O[Sb]34(O)OC(C(O)CO)C(O3)C(O4)C(O)=O)OC1C(O2)C(O)=O,RPOBPHCDIPHDQL-UHFFFAOYSA-L,Launched,
sodium-tetradecyl-sulfate,,"PROC, PROS1",dermatology,"varicose veins, varicose veins","MicroSource, AlfaAesar",100,"BRD-A55664972-236-02-6, BRD-K84544951-236-01-0","CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O, CCCCCCCCCCCCCCOS(O)(=O)=O","GROJOWHVXQYQGN-UHFFFAOYSA-N, URLJMZWTXZTZRR-UHFFFAOYSA-N",Launched,
sofalcone,mucus protecting agent,CBR1,gastroenterology,peptic ulcer disease (PUD),Cayman,97.31,BRD-K01039503-001-01-2,CC(C)=CCOc1ccc(\C=C\C(=O)c2ccc(OCC=C(C)C)cc2OCC(O)=O)cc1,GFWRVVCDTLRWPK-KPKJPENVSA-N,Launched,
sofosbuvir,RNA polymerase inhibitor,,infectious disease,hepatitis C,MedChemEx,98.52,BRD-K05674516-001-02-5,CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,TTZHDVOVKQGIBA-YBSJRAAASA-N,Launched,
solifenacin-succinate,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",urology,"urinary incontinence, urinary frequency","MicroSource, Selleck",97.36,"BRD-K24723746-001-01-1, BRD-K24723746-036-02-5","O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1, O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1","FBOUYBDGKBSUES-VXKWHMMOSA-N, FBOUYBDGKBSUES-VXKWHMMOSA-N",Launched,
somatostatin,somatostatin receptor agonist,"OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5",hematology,hemorrhage,Key,82.44,BRD-K14681867-001-01-6,C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N,NHXLMOGPVYXJNR-ATOGVRKGSA-N,Launched,
sonidegib,smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC),"Selleck, Selleck",95.51,"BRD-K19796430-001-05-6, BRD-K19796430-001-09-8","C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1, C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1","VZZJRYRQSPEMTK-CALCHBBNSA-N, VZZJRYRQSPEMTK-CALCHBBNSA-N",Launched,
sorafenib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET",oncology,"renal cell carcinoma (RCC), thyroid cancer, hepatocellular carcinoma (HCC)","Selleck, Selleck",98.3,"BRD-K23984367-075-15-2, BRD-K23984367-001-07-5","CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1, CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1","MLDQJTXFUGDVEO-UHFFFAOYSA-N, MLDQJTXFUGDVEO-UHFFFAOYSA-N",Launched,
sorbitol,mucolytic agent,,,,"Selleck, MicroSource",100,"BRD-K66035042-001-10-1, BRD-K36513555-001-02-0","OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO, OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO","FBPFZTCFMRRESA-JGWLITMVSA-N, FBPFZTCFMRRESA-ZXXMMSQZSA-N",Launched,
sotalol,adrenergic receptor antagonist,"ADRB1, ADRB2, KCNH2",cardiology,"atrial fibrillation (AF), ventricular arrhythmias","MicroSource, Selleck, Tocris",98.92,"BRD-A33168282-003-18-0, BRD-A33168282-003-16-4, BRD-A33168282-003-17-2","CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1, CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1, CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1","ZBMZVLHSJCTVON-UHFFFAOYSA-N, ZBMZVLHSJCTVON-UHFFFAOYSA-N, ZBMZVLHSJCTVON-UHFFFAOYSA-N",Launched,
spaglumic-acid,glutamate receptor antagonist,GRM3,allergy,"allergic conjunctivitis, allergic rhinitis","Prestwick, Tocris",98.11,"BRD-K68405354-001-07-2, BRD-K68405354-001-06-4","CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O, CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O","OPVPGKGADVGKTG-BQBZGAKWSA-N, OPVPGKGADVGKTG-BQBZGAKWSA-N",Launched,BRD-K96659869-001-09-4
sparteine-sulfate,,,,,MicroSource,100,BRD-K32847234-065-04-6,C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1,SLRCCWJSBJZJBV-NMWPEEMBSA-N,Launched,
spectinomycin,bacterial 30S ribosomal subunit inhibitor,,pulmonary,"airsacculitis, chronic respiratory disease","MedChemEx, MedChemEx, Selleck, MicroSource, Selleck",68.33,"BRD-K11905747-300-11-3, BRD-K11905747-300-10-5, BRD-K11905747-300-09-7, BRD-K11905747-300-08-9, BRD-K11905747-300-12-1","CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O, CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O, CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O, CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O, CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O","UNFWWIHTNXNPBV-WXKVUWSESA-N, UNFWWIHTNXNPBV-WXKVUWSESA-N, UNFWWIHTNXNPBV-WXKVUWSESA-N, UNFWWIHTNXNPBV-WXKVUWSESA-N, UNFWWIHTNXNPBV-WXKVUWSESA-N",Launched,BRD-K38300715-300-01-5
spiperone,dopamine receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7",neurology/psychiatry,schizophrenia,"Tocris, MicroSource",96.07,"BRD-K55468218-003-02-8, BRD-K55468218-001-26-1","Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1, Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1","DKGZKTPJOSAWFA-UHFFFAOYSA-N, DKGZKTPJOSAWFA-UHFFFAOYSA-N",Launched,
spiramycin,bacterial 50S ribosomal subunit inhibitor,,infectious disease,"toxoplasmosis, soft tissue infection","MicroSource, Selleck, Selleck",84.38,"BRD-A67305656-001-03-1, BRD-A67305656-001-02-3, BRD-A67305656-001-01-5","CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C, CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C, CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C","ACTOXUHEUCPTEW-YJTMPVKHSA-N, ACTOXUHEUCPTEW-YJTMPVKHSA-N, ACTOXUHEUCPTEW-YJTMPVKHSA-N",Launched,"BRD-K14716343-001-04-8, BRD-K77056640-001-01-9,BRD-K14716343-001-06-3, BRD-K35824922-001-01-0"
spironolactone,mineralocorticoid receptor antagonist,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG","endocrinology, cardiology, gastroenterology, rheumatology","hyperaldosteronism, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, hypertension, hypokalemia","Tocris, MicroSource, Selleck, Selleck",98.19,"BRD-K90027355-001-16-6, BRD-K90027355-001-19-0, BRD-K90027355-001-20-8, BRD-K90027355-001-13-3","CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12, CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12, CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12, CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12","LXMSZDCAJNLERA-ZHYRCANASA-N, LXMSZDCAJNLERA-ZHYRCANASA-N, LXMSZDCAJNLERA-ZHYRCANASA-N, LXMSZDCAJNLERA-ZHYRCANASA-N",Launched,"BRD-A97808748-001-03-8, BRD-A71422083-001-15-5,BRD-K30171400-001-01-2"
stanozolol,androgen receptor agonist,AR,hematology,anemia,Prestwick,97.25,BRD-K46791647-001-01-2,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5[nH]ncc5C[C@]4(C)[C@H]3CC[C@]12C,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,Launched,
stavudine,"DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor",,infectious disease,human immunodeficiency virus (HIV-1),"Tocris, Selleck, MicroSource",98.42,"BRD-K93880783-001-27-4, BRD-K93880783-001-28-2, BRD-K93880783-001-26-6","Cc1cn([C@@H]2O[C@H](CO)C=C2)c(=O)[nH]c1=O, Cc1cn([C@@H]2O[C@H](CO)C=C2)c(=O)[nH]c1=O, Cc1cn([C@@H]2O[C@H](CO)C=C2)c(=O)[nH]c1=O","XNKLLVCARDGLGL-JGVFFNPUSA-N, XNKLLVCARDGLGL-JGVFFNPUSA-N, XNKLLVCARDGLGL-JGVFFNPUSA-N",Launched,BRD-A06317634-001-10-2
stepronin,mucolytic agent,,,,AKSci,98.87,BRD-A04506385-001-01-2,CC(SC(=O)c1cccs1)C(=O)NCC(O)=O,JNYSEDHQJCOWQU-UHFFFAOYSA-N,Launched,
stetaderm,,,,,Sigma,96.74,BRD-K93900986-001-15-0,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@]12C,BFZHCUBIASXHPK-QJSKAATBSA-N,Launched,
stiripentol,GABA uptake inhibitor,GABRA3,neurology/psychiatry,epilepsy,Sigma,0,BRD-A72441487-001-05-7,CC(C)(C)C(O)\C=C\c1ccc2OCOc2c1,IBLNKMRFIPWSOY-FNORWQNLSA-N,Launched,
streptomycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,tuberculosis,"Selleck, Selleck, MicroSource",94.3,"BRD-K07166362-330-01-0, BRD-K07166362-330-02-8, BRD-A98954669-065-04-7","CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O, CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O, CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O","UCSJYZPVAKXKNQ-HZYVHMACSA-N, UCSJYZPVAKXKNQ-HZYVHMACSA-N, UCSJYZPVAKXKNQ-HUOHZKRVSA-N",Launched,"BRD-K91768078-330-01-5,BRD-M30124979-326-01-1, BRD-K91768078-330-02-3,BRD-M87628937-326-02-2"
streptozotocin,DNA alkylating agent,SLC2A2,oncology,pancreatic cancer,"Sigma, Selleck, MedChemEx, MedChemEx, MicroSource, Selleck, Tocris",83.34,"BRD-K34411947-001-14-1, BRD-K34411947-001-13-3, BRD-A94713674-001-02-3, BRD-K34411947-001-15-8, BRD-K34411947-001-12-5, BRD-K34411947-001-11-7, BRD-K34411947-001-17-4","CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)NC1[C@@H](O)OC(CO)[C@@H](O)[C@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O, CN([N+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","ZSJLQEPLLKMAKR-GKHCUFPYSA-N, ZSJLQEPLLKMAKR-GKHCUFPYSA-N, ZSJLQEPLLKMAKR-FEQHFJGESA-N, ZSJLQEPLLKMAKR-GKHCUFPYSA-N, ZSJLQEPLLKMAKR-GKHCUFPYSA-N, ZSJLQEPLLKMAKR-GKHCUFPYSA-N, ZSJLQEPLLKMAKR-GKHCUFPYSA-N",Launched,BRD-A25576662-001-02-2
strontium-ranelate,"bone formation stimulant, bone resorption inhibitor",CASR,"orthopedics, rheumatology","osteoporosis, osteoarthritis","MedChemEx, Selleck, LKT, Selleck",0,"BRD-K83146339-001-02-4, BRD-K83146339-001-03-2, BRD-K83146339-001-04-0, BRD-K83146339-001-05-7","O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N, O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N, O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N, O=C1CN(CC(=O)O[Sr]O1)c1sc2c(CC(=O)O[Sr]OC2=O)c1C#N","XXUZFRDUEGQHOV-UHFFFAOYSA-J, XXUZFRDUEGQHOV-UHFFFAOYSA-J, XXUZFRDUEGQHOV-UHFFFAOYSA-J, XXUZFRDUEGQHOV-UHFFFAOYSA-J",Launched,"BRD-K88014802-001-01-9,BRD-M65265990-001-02-2, BRD-M65265990-001-03-0, BRD-K88014802-001-02-7,BRD-K83146339-001-01-6"
succinic-acid,,"ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE",,,Enamine,100,BRD-K45238818-001-02-6,OC(=O)CCC(O)=O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Launched,
succinylcholine-chloride,,"CHRFAM7A, CHRM1, CHRM2, CHRM3, CHRNA1, CHRNA10",neurology/psychiatry,muscle relaxant,"Sigma, DuPont, Selleck, Selleck",66.78,"BRD-K45497762-336-03-2, BRD-K45497762-300-01-2, BRD-K45497762-336-01-6, BRD-K45497762-336-02-4","C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C, C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C, C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C, C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C","AXOIZCJOOAYSMI-UHFFFAOYSA-N, AXOIZCJOOAYSMI-UHFFFAOYSA-N, AXOIZCJOOAYSMI-UHFFFAOYSA-N, AXOIZCJOOAYSMI-UHFFFAOYSA-N",Launched,
sucralfate,antacid,"EGF, FGA, FGB, FGF2, FGG",gastroenterology,duodenal ulcer disease,MicroSource,0,BRD-M71167108-001-01-3,O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,DTULOKYBGCTCFP-QRLOXDDHSA-A,Launched,
sucralose,,,,,"MicroSource, Selleck",100,"BRD-K58968598-001-02-8, BRD-K58968598-001-03-6","OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl, OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl","BAQAVOSOZGMPRM-QBMZZYIRSA-N, BAQAVOSOZGMPRM-QBMZZYIRSA-N",Launched,BRD-K23414802-001-01-9
sucrose,,"ACTA1, ATOX1, C22orf28, LYZ",,,Sigma,99.8,BRD-K74724920-001-02-4,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,CZMRCDWAGMRECN-UGDNZRGBSA-N,Launched,
sufentanil,opioid receptor modulator,"OPRD1, OPRK1, OPRM1",neurology/psychiatry,anesthetic,MedChemEx,94.14,BRD-K21547160-001-01-4,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,GGCSSNBKKAUURC-UHFFFAOYSA-N,Launched,
sulbactam,beta lactamase inhibitor,,infectious disease,"skin infections, intra-abdominal infections, gynecologic infections","Selleck, Selleck, MicroSource, Selleck",98.41,"BRD-K44133266-001-10-0, BRD-K44133266-236-03-7, BRD-A12490291-001-01-2, BRD-K44133266-236-02-9","CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O, CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O, CC1(C)C(N2[C@@H](CC2=O)S1(=O)=O)C(O)=O, CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O","FKENQMMABCRJMK-RITPCOANSA-N, FKENQMMABCRJMK-RITPCOANSA-N, FKENQMMABCRJMK-LWOQYNTDSA-N, FKENQMMABCRJMK-RITPCOANSA-N",Launched,"BRD-K85679373-001-01-1, BRD-K85679373-236-01-3"
sulbactam-pivoxil,beta lactamase inhibitor,,infectious disease,skin infections,AvaChem,85.23,BRD-A63431791-001-01-9,CC(C)(C)C(=O)OCOC(=O)C1N2C(CC2=O)S(=O)(=O)C1(C)C,OHPVYKXTRACOSQ-UHFFFAOYSA-N,Launched,
sulbutiamine,acetylcholine receptor antagonist,,neurology/psychiatry,asthenia,AKSci,97.93,BRD-K12539416-001-01-4,CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(Cc1cnc(C)nc1N)C=O)=C(\C)N(Cc1cnc(C)nc1N)C=O,CKHJPWQVLKHBIH-GPAWKIAZSA-N,Launched,
sulconazole,sterol demethylase inhibitor,,infectious disease,"tinea pedis, tinea cruris, tinea corporis","Selleck, MicroSource",99.7,"BRD-A70649075-008-29-0, BRD-A70649075-008-30-8","Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1, Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1","AFNXATANNDIXLG-UHFFFAOYSA-N, AFNXATANNDIXLG-UHFFFAOYSA-N",Launched,
sulfabenzamide,bacterial antifolate,,,,MicroSource,98.4,BRD-K59983611-001-21-9,Nc1ccc(cc1)S(=O)(=O)NC(=O)c1ccccc1,PBCZLFBEBARBBI-UHFFFAOYSA-N,Launched,
sulfacetamide,PABA antagonist,,ophthalmology,conjunctivitis,"Selleck, MicroSource",94.36,"BRD-K21520694-236-02-6, BRD-K21520694-001-21-4","CC(=O)NS(=O)(=O)c1ccc(N)cc1, CC(=O)NS(=O)(=O)c1ccc(N)cc1","SKIVFJLNDNKQPD-UHFFFAOYSA-N, SKIVFJLNDNKQPD-UHFFFAOYSA-N",Launched,
sulfachlorpyridazine,bacterial antifolate,,infectious disease,urinary tract infections,MicroSource,98.26,BRD-K32021043-001-14-3,Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)nn1,XOXHILFPRYWFOD-UHFFFAOYSA-N,Launched,
sulfadiazine,bacterial antifolate,,"infectious disease, ophthalmology","malaria, meningitis, urinary tract infections, conjunctivitis, trachoma, chancroid","Enamine, Selleck, MicroSource",99.24,"BRD-K32273377-001-17-9, BRD-K32273377-001-15-3, BRD-K32273377-001-16-1","Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1, Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1, Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1","SEEPANYCNGTZFQ-UHFFFAOYSA-N, SEEPANYCNGTZFQ-UHFFFAOYSA-N, SEEPANYCNGTZFQ-UHFFFAOYSA-N",Launched,
sulfadoxine,dihydropteroate synthase inhibitor,,infectious disease,malaria,"MicroSource, Selleck",96.8,"BRD-K55250441-001-13-0, BRD-K55250441-001-12-2","COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC, COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC","PJSFRIWCGOHTNF-UHFFFAOYSA-N, PJSFRIWCGOHTNF-UHFFFAOYSA-N",Launched,
sulfafurazole,bacterial antifolate,,infectious disease,urinary tract infections,"Tocris, MicroSource, Selleck",97.76,"BRD-K50859149-001-18-7, BRD-K50859149-001-19-5, BRD-K50859149-001-17-9","Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C, Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C, Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C","NHUHCSRWZMLRLA-UHFFFAOYSA-N, NHUHCSRWZMLRLA-UHFFFAOYSA-N, NHUHCSRWZMLRLA-UHFFFAOYSA-N",Launched,
sulfaguanidine,bacterial antifolate,,infectious disease,urinary tract infections,"MicroSource, Selleck, Selleck",100,"BRD-K45086103-001-15-5, BRD-K45086103-001-14-8, BRD-K45086103-001-16-3","NC(=N)NS(=O)(=O)c1ccc(N)cc1, NC(=N)NS(=O)(=O)c1ccc(N)cc1, NC(=N)NS(=O)(=O)c1ccc(N)cc1","BRBKOPJOKNSWSG-UHFFFAOYSA-N, BRBKOPJOKNSWSG-UHFFFAOYSA-N, BRBKOPJOKNSWSG-UHFFFAOYSA-N",Launched,
sulfamerazine,bacterial antifolate,,infectious disease,"coccidiosis, cholera","MicroSource, Selleck",98.63,"BRD-K93524252-001-24-7, BRD-K93524252-001-23-9","Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1, Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1","QPPBRPIAZZHUNT-UHFFFAOYSA-N, QPPBRPIAZZHUNT-UHFFFAOYSA-N",Launched,
sulfameter,dihydrofolate reductase inhibitor,DHFR,infectious disease,urinary tract infections,"Selleck, MicroSource",98.75,"BRD-K87492696-001-15-7, BRD-K87492696-001-16-5","COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1, COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1","GPTONYMQFTZPKC-UHFFFAOYSA-N, GPTONYMQFTZPKC-UHFFFAOYSA-N",Launched,
sulfamethazine,PABA antagonist,,gastroenterology,"enteritis, enteritis","Prestwick, MicroSource, Selleck",99.35,"BRD-K11640013-236-10-1, BRD-K11640013-001-15-8, BRD-K11640013-001-14-1","Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1, Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1, Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1","ASWVTGNCAZCNNR-UHFFFAOYSA-N, ASWVTGNCAZCNNR-UHFFFAOYSA-N, ASWVTGNCAZCNNR-UHFFFAOYSA-N",Launched,
sulfamethizole,bacterial antifolate,,infectious disease,urinary tract infections,"MicroSource, Selleck",93.08,"BRD-K31682896-001-24-0, BRD-K31682896-001-23-2","Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1, Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1","VACCAVUAMIDAGB-UHFFFAOYSA-N, VACCAVUAMIDAGB-UHFFFAOYSA-N",Launched,
sulfamethoxazole,PABA antagonist,,"infectious disease, gastroenterology","pneumonia, enteritis, urinary tract infections","MicroSource, Selleck",98.94,"BRD-K28494619-001-28-2, BRD-K28494619-001-27-4","Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1, Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1","JLKIGFTWXXRPMT-UHFFFAOYSA-N, JLKIGFTWXXRPMT-UHFFFAOYSA-N",Launched,
sulfametopyrazine,PABA antagonist,,infectious disease,"malaria, urinary tract infections, respiratory tract infections",Enamine,96.63,BRD-K17205817-001-06-1,COc1nccnc1NS(=O)(=O)c1ccc(N)cc1,KXRZBTAEDBELFD-UHFFFAOYSA-N,Launched,
sulfamonomethoxine,bacterial antifolate,,infectious disease,urinary tract infections,MicroSource,97.68,BRD-K14116214-001-09-6,COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1,WMPXPUYPYQKQCX-UHFFFAOYSA-N,Launched,
sulfamoxole,PABA antagonist,,infectious disease,urinary tract infections,"Sigma, SantaCruz",70.9,"BRD-K19742012-001-02-3, BRD-K19742012-001-01-5","Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C, Cc1nc(NS(=O)(=O)c2ccc(N)cc2)oc1C","CYFLXLSBHQBMFT-UHFFFAOYSA-N, CYFLXLSBHQBMFT-UHFFFAOYSA-N",Launched,
sulfanilamide,carbonic anhydrase inhibitor,"CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4",infectious disease,vulvovaginal candidiasis,"MicroSource, Selleck",100,"BRD-K02594908-001-16-4, BRD-K02594908-001-15-6","Nc1ccc(cc1)S(N)(=O)=O, Nc1ccc(cc1)S(N)(=O)=O","FDDDEECHVMSUSB-UHFFFAOYSA-N, FDDDEECHVMSUSB-UHFFFAOYSA-N",Launched,
sulfanitran,,,,,MicroSource,78.09,BRD-K76845197-001-05-4,CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)[N+]([O-])=O,GWBPFRGXNGPPMF-UHFFFAOYSA-N,Launched,
sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS,infectious disease,urinary tract infections,MicroSource,90.33,BRD-K10671814-001-14-8,Nc1ccc(cc1)S(=O)(=O)Nc1ccnn1-c1ccccc1,QWCJHSGMANYXCW-UHFFFAOYSA-N,Launched,
sulfapyridine,PABA antagonist,,,,"Selleck, MicroSource",98.64,"BRD-K41406082-001-15-4, BRD-K41406082-001-16-2","Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1, Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1","GECHUMIMRBOMGK-UHFFFAOYSA-N, GECHUMIMRBOMGK-UHFFFAOYSA-N",Launched,
sulfaquinoxaline,vitamin K antagonist,,infectious disease,coccidiosis,MicroSource,92.12,BRD-K71133585-236-14-4,Nc1ccc(cc1)S(=O)(=O)Nc1cnc2ccccc2n1,NHZLNPMOSADWGC-UHFFFAOYSA-N,Launched,
sulfasalazine,cyclooxygenase inhibitor,"ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1",gastroenterology,ulcerative colitis,"Tocris, MicroSource, Selleck",97.78,"BRD-K10670311-001-17-1, BRD-K10670311-001-15-5, BRD-K10670311-001-14-8","OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)S(=O)(=O)Nc1ccccn1, OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)S(=O)(=O)Nc1ccccn1, OC(=O)c1cc(ccc1O)\N=N\c1ccc(cc1)S(=O)(=O)Nc1ccccn1","NCEXYHBECQHGNR-QZQOTICOSA-N, NCEXYHBECQHGNR-QZQOTICOSA-N, NCEXYHBECQHGNR-QZQOTICOSA-N",Launched,
sulfathiazole,dihydropteroate synthase inhibitor,,,,"MicroSource, Selleck",98.28,"BRD-K14705039-001-16-4, BRD-K14705039-001-15-6","Nc1ccc(cc1)S(=O)(=O)Nc1nccs1, Nc1ccc(cc1)S(=O)(=O)Nc1nccs1","JNMRHUJNCSQMMB-UHFFFAOYSA-N, JNMRHUJNCSQMMB-UHFFFAOYSA-N",Launched,
sulfinpyrazone,uricosuric blocker,"ABCC1, ABCC2, FPR1, SLC22A12",rheumatology,gout,MicroSource,97.57,BRD-A36217750-001-16-3,O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c1ccccc1)c1ccccc1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Launched,
sulfisoxazole-acetyl,folic acid antagonist,,"infectious disease, otolaryngology","meningitis, urinary tract infections, otitis, trachoma",MicroSource,56.69,BRD-K84810336-001-01-9,CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1,JFNWFXVFBDDWCX-UHFFFAOYSA-N,Launched,BRD-K05009775-001-02-0
sulindac,cyclooxygenase inhibitor,"AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2",rheumatology,"osteoarthritis, rheumatoid arthritis, ankylosing spondylitis","Tocris, Selleck, MicroSource, Selleck",95.9,"BRD-A13946108-001-17-1, BRD-A13946108-001-16-3, BRD-A13946108-001-18-9, BRD-A13946108-001-19-7","CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O, CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O, CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O, CC1=C(CC(O)=O)c2cc(F)ccc2C\1=C/c1ccc(cc1)S(C)=O","MLKXDPUZXIRXEP-MFOYZWKCSA-N, MLKXDPUZXIRXEP-MFOYZWKCSA-N, MLKXDPUZXIRXEP-MFOYZWKCSA-N, MLKXDPUZXIRXEP-MFOYZWKCSA-N",Launched,
sulisobenzone,,,dermatology,sunscreen lotion,"MicroSource, ChemBridge",98.83,"BRD-K38602774-001-03-2, BRD-K38602774-002-01-4","COc1cc(O)c(cc1S(O)(=O)=O)C(=O)c1ccccc1, COc1cc(O)c(cc1S(O)(=O)=O)C(=O)c1ccccc1","CXVGEDCSTKKODG-UHFFFAOYSA-N, CXVGEDCSTKKODG-UHFFFAOYSA-N",Launched,BRD-K59265707-001-01-8
sulmetozine,gastrin inhibitor,GAST,gastroenterology,peptic ulcer disease (PUD),Vitas-M,96.89,BRD-K29570907-001-07-3,COc1cc(cc(OC)c1OC)C(=S)N1CCOCC1,MVOUIYUWRXPNKD-UHFFFAOYSA-N,Launched,
sulphadimethoxine,dihydropteroate synthetase inhibitor,,,,"Selleck, MicroSource",97.65,"BRD-K71125014-001-26-3, BRD-K71125014-001-27-1","COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1, COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1","ZZORFUFYDOWNEF-UHFFFAOYSA-N, ZZORFUFYDOWNEF-UHFFFAOYSA-N",Launched,
sulpiride,dopamine receptor antagonist,,neurology/psychiatry,"schizophrenia, schizophrenia","Tocris, Tocris, MicroSource",98.91,"BRD-A55272860-001-16-1, BRD-A55272860-001-14-6, BRD-A55272860-001-15-3","CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O, CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O, CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O","BGRJTUBHPOOWDU-UHFFFAOYSA-N, BGRJTUBHPOOWDU-UHFFFAOYSA-N, BGRJTUBHPOOWDU-UHFFFAOYSA-N",Launched,BRD-A10715913-001-04-6
sumatriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7",neurology/psychiatry,migraine headache,"MicroSource, Tocris, Tocris, Selleck",95.83,"BRD-K50938287-001-09-0, BRD-K50938287-036-13-8, BRD-K50938287-036-16-1, BRD-K50938287-036-12-0","CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1, CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1, CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1, CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1","KQKPFRSPSRPDEB-UHFFFAOYSA-N, KQKPFRSPSRPDEB-UHFFFAOYSA-N, KQKPFRSPSRPDEB-UHFFFAOYSA-N, KQKPFRSPSRPDEB-UHFFFAOYSA-N",Launched,
sunitinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET",oncology,"gastrointestinal stromal tumors (GIST), renal cell carcinoma (RCC), neuroendocrine tumors of pancreatic origin (PNET)","Selleck, MedChemEx, Selleck, Tocris",94.01,"BRD-K42828737-044-10-8, BRD-K42828737-001-03-3, BRD-K42828737-044-09-0, BRD-K42828737-044-12-4","CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C, CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C, CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C, CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C","WINHZLLDWRZWRT-ATVHPVEESA-N, WINHZLLDWRZWRT-ATVHPVEESA-N, WINHZLLDWRZWRT-ATVHPVEESA-N, WINHZLLDWRZWRT-ATVHPVEESA-N",Launched,
suplatast,"histamine release inhibitor, immunoglobulin inhibitor",,rheumatology,Kimura's disease,"MedChemEx, Tocris, Selleck, MedChemEx, Selleck",36.74,"BRD-A98427211-075-06-1, BRD-A98427211-075-03-8, BRD-A98427211-075-04-6, BRD-A98427211-075-05-3, BRD-A98427211-075-02-0","CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1, CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1, CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1, CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1, CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1","DYZJXZOQQRXDLE-UHFFFAOYSA-O, DYZJXZOQQRXDLE-UHFFFAOYSA-O, DYZJXZOQQRXDLE-UHFFFAOYSA-O, DYZJXZOQQRXDLE-UHFFFAOYSA-O, DYZJXZOQQRXDLE-UHFFFAOYSA-O",Launched,
suramin,DNA synthesis inhibitor,"F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5",infectious disease,"African trypanosomiasis, onchocerciasis","MicroSource, Tocris",96.4,"BRD-K70327167-348-13-4, BRD-K70327167-348-12-6","Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O, Cc1ccc(cc1NC(=O)c1cccc(NC(=O)Nc2cccc(c2)C(=O)Nc2cc(ccc2C)C(=O)Nc2ccc(c3cc(cc(c23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)c1)C(=O)Nc1ccc(c2cc(cc(c12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O","FIAFUQMPZJWCLV-UHFFFAOYSA-N, FIAFUQMPZJWCLV-UHFFFAOYSA-N",Launched,
suvorexant,orexin receptor antagonist,"HCRTR1, HCRTR2",neurology/psychiatry,insomnia,Selleck,99.04,BRD-K94293891-001-01-3,C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1,JYTNQNCOQXFQPK-MRXNPFEDSA-N,Launched,
suxibuzone,cyclooxygenase inhibitor,,"rheumatology, neurology/psychiatry","joint pain, muscle pain","Selleck, MicroSource",97.83,"BRD-K78815826-001-13-8, BRD-K78815826-001-14-6","CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1, CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1","ONWXNHPOAGOMTG-UHFFFAOYSA-N, ONWXNHPOAGOMTG-UHFFFAOYSA-N",Launched,
synephrine,adrenergic receptor agonist,ADRA1A,,,"Selleck, Selleck, Selleck, MicroSource, Selleck",100,"BRD-A04327189-003-02-5, BRD-A04327189-003-03-3, BRD-A04327189-001-16-9, BRD-A04327189-001-15-1, BRD-A04327189-001-14-4","CNCC(O)c1ccc(O)cc1, CNCC(O)c1ccc(O)cc1, CNCC(O)c1ccc(O)cc1, CNCC(O)c1ccc(O)cc1, CNCC(O)c1ccc(O)cc1","YRCWQPVGYLYSOX-UHFFFAOYSA-N, YRCWQPVGYLYSOX-UHFFFAOYSA-N, YRCWQPVGYLYSOX-UHFFFAOYSA-N, YRCWQPVGYLYSOX-UHFFFAOYSA-N, YRCWQPVGYLYSOX-UHFFFAOYSA-N",Launched,
tacalcitol,vitamin D receptor agonist,VDR,dermatology,"psoriasis, chapped lips",MedChemEx,93.56,BRD-K73237276-001-01-0,CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Launched,
tacrine,acetylcholinesterase inhibitor,"ACHE, BCHE",neurology/psychiatry,Alzheimer's disease,"Selleck, Tocris, MicroSource",99.35,"BRD-K81473089-003-24-6, BRD-K81473089-003-25-3, BRD-K81473089-003-26-1","Nc1c2CCCCc2nc2ccccc12, Nc1c2CCCCc2nc2ccccc12, Nc1c2CCCCc2nc2ccccc12","YLJREFDVOIBQDA-UHFFFAOYSA-N, YLJREFDVOIBQDA-UHFFFAOYSA-N, YLJREFDVOIBQDA-UHFFFAOYSA-N",Launched,
tacrolimus,calcineurin inhibitor,FKBP1A,transplant,organ rejection,"MedChemEx, MicroSource, Selleck",97.24,"BRD-K69608737-001-08-6, BRD-K69608737-001-10-2, BRD-K69608737-001-09-4","CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC, CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC, CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC","QJJXYPPXXYFBGM-LFZNUXCKSA-N, QJJXYPPXXYFBGM-LFZNUXCKSA-N, QJJXYPPXXYFBGM-LFZNUXCKSA-N",Launched,"BRD-A96754982-001-01-4, BRD-K54509797-001-01-5"
tadalafil,phosphodiesterase inhibitor,"PDE11A, PDE5A",cardiology,hypertension,"MicroSource, Selleck",98.74,"BRD-K93645900-001-12-1, BRD-K93645900-001-11-3","CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O, CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O","WOXKDUGGOYFFRN-IIBYNOLFSA-N, WOXKDUGGOYFFRN-IIBYNOLFSA-N",Launched,
tafamidis-meglumine,transthyretin amyloid inhibitor,TTR,neurology/psychiatry,familial amyloid polyneuropathy (FAP),MedChemEx,99.69,BRD-K23728141-001-01-2,OC(=O)c1ccc2nc(oc2c1)-c1cc(Cl)cc(Cl)c1,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Launched,
talc,,,,,"Selleck, Selleck",0,"BRD-M92352362-002-02-3, BRD-M92352362-002-03-1","O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O, O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O","XBPUDTAATCFDRE-UHFFFAOYSA-N, XBPUDTAATCFDRE-UHFFFAOYSA-N",Launched,
talinolol,adrenergic receptor antagonist,ADRB1,cardiology,hypertension,Cayman,90.03,BRD-A94276798-001-01-4,CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1,MXFWWQICDIZSOA-UHFFFAOYSA-N,Launched,
talipexole,"adrenergic receptor agonist, dopamine receptor agonist","ADRA2A, DRD2, HTR3A",infectious disease,genitial herpes,"MedChemEx, MedChemEx, MedChemEx, Enzo",84.52,"BRD-K75615183-300-04-7, BRD-K75615183-300-05-4, BRD-K75615183-300-06-2, BRD-K75615183-300-03-9","Nc1nc2CCN(CC=C)CCc2s1, Nc1nc2CCN(CC=C)CCc2s1, Nc1nc2CCN(CC=C)CCc2s1, Nc1nc2CCN(CC=C)CCc2s1","DHSSDEDRBUKTQY-UHFFFAOYSA-N, DHSSDEDRBUKTQY-UHFFFAOYSA-N, DHSSDEDRBUKTQY-UHFFFAOYSA-N, DHSSDEDRBUKTQY-UHFFFAOYSA-N",Launched,
talniflumate,cyclooxygenase inhibitor,CLCA1,neurology/psychiatry,pain relief,"Tocris, Tocris",93.24,"BRD-A98378129-001-02-2, BRD-A98378129-001-03-0","FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1, FC(F)(F)c1cccc(Nc2ncccc2C(=O)OC2OC(=O)c3ccccc23)c1","ANMLJLFWUCQGKZ-UHFFFAOYSA-N, ANMLJLFWUCQGKZ-UHFFFAOYSA-N",Launched,
taltirelin,thyrotropin releasing hormone receptor agonist,TRHR,neurology/psychiatry,spinocerebellar ataxia,MedChemEx,86.52,BRD-K93869735-001-01-1,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(N)=O,LQZAIAZUDWIVPM-SRVKXCTJSA-N,Launched,
tamibarotene,retinoid receptor agonist,"RARA, RARB",hematologic malignancy,acute promyelocytic leukemia (APL),Selleck,97.33,BRD-K36627727-001-05-4,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Launched,
tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ",oncology,breast cancer,"Tocris, Selleck, Tocris, MicroSource, Selleck",97.31,"BRD-K93754473-048-23-6, BRD-K93754473-048-18-6, BRD-K93754473-048-19-4, BRD-K93754473-048-20-2, BRD-K93754473-048-21-0","CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1, CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1, CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1, CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1, CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1","NKANXQFJJICGDU-QPLCGJKRSA-N, NKANXQFJJICGDU-QPLCGJKRSA-N, NKANXQFJJICGDU-QPLCGJKRSA-N, NKANXQFJJICGDU-QPLCGJKRSA-N, NKANXQFJJICGDU-QPLCGJKRSA-N",Launched,
tamsulosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D",urology,benign prostatic hyperplasia (BPH),"Tocris, Enzo",99.03,"BRD-K74339692-003-03-1, BRD-K74339692-001-01-9","CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O, CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O","DRHKJLXJIQTDTD-OAHLLOKOSA-N, DRHKJLXJIQTDTD-OAHLLOKOSA-N",Launched,
tandospirone,serotonin receptor agonist,HTR1A,neurology/psychiatry,"generalized anxiety disorder (GAD), dysthymic disorder","Tocris, MedChemEx",98.71,"BRD-K65904673-003-01-0, BRD-K65904673-001-01-4","O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)c1ncccn1, O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(CC1)c1ncccn1","CEIJFEGBUDEYSX-FZDBZEDMSA-N, CEIJFEGBUDEYSX-FZDBZEDMSA-N",Launched,
tannic-acid,PARG inhibitor,ANO1,gastroenterology,constipation,MicroSource,0,BRD-K67392463-001-04-8,Oc1cc(cc(O)c1O)C(=O)Oc1cc(cc(O)c1O)C(=O)OC[C@H]1O[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,LRBQNJMCXXYXIU-NRMVVENXSA-N,Launched,
tapentadol,opioid receptor agonist,"HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4",neurology/psychiatry,"acute pain, muscle pain","MicroSource, MedChemEx, MedChemEx",91.75,"BRD-K25699529-003-01-1, BRD-K04283354-003-01-9, BRD-K04283354-003-02-7","CC[C@@H]([C@@H](C)CN(C)C)c1cccc(O)c1, CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1, CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1","KWTWDQCKEHXFFR-FZMZJTMJSA-N, KWTWDQCKEHXFFR-SMDDNHRTSA-N, KWTWDQCKEHXFFR-SMDDNHRTSA-N",Launched,
tartaric-acid,antioxidant,"ATP6V1C1, B3GAT1, DDX6, HIF1AN, TREM1",,,MicroSource,0,BRD-K36474365-001-06-6,O[C@H]([C@@H](O)C(O)=O)C(O)=O,FEWJPZIEWOKRBE-JCYAYHJZSA-N,Launched,
tasimelteon,melatonin receptor agonist,"MTNR1A, MTNR1B",neurology/psychiatry,Non-24-Hour Sleep-Wake Disorder,Synnovator,98.42,BRD-K62971431-001-01-9,CCC(=O)NC[C@@H]1C[C@H]1c1cccc2OCCc12,PTOIAAWZLUQTIO-GXFFZTMASA-N,Launched,
taurine,antioxidant,,neurology/psychiatry,"anxiety, irritability, sleeplessness","MicroSource, Selleck",100,"BRD-K51474575-001-11-2, BRD-K51474575-001-10-4","NCCS(O)(=O)=O, NCCS(O)(=O)=O","XOAAWQZATWQOTB-UHFFFAOYSA-N, XOAAWQZATWQOTB-UHFFFAOYSA-N",Launched,
taurolidine,apoptosis stimulant,,infectious disease,catheter-related bloodstream infection,Sigma,0,BRD-K98765504-001-01-5,O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,AJKIRUJIDFJUKJ-UHFFFAOYSA-N,Launched,
tavaborole,leucyl-tRNA synthetase inhibitor,,infectious disease,onychomycosis,"MedChemEx, MedChemEx",91.53,"BRD-K76713213-001-02-1, BRD-K76713213-001-01-3","OB1OCc2cc(F)ccc12, OB1OCc2cc(F)ccc12","LFQDNHWZDQTITF-UHFFFAOYSA-N, LFQDNHWZDQTITF-UHFFFAOYSA-N",Launched,
tazarotene,retinoid receptor agonist,"RARA, RARB, RARG, RXRB",dermatology,"cosmetic, sunscreen lotion",Selleck,97.04,BRD-K76841105-001-04-7,CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1,OGQICQVSFDPSEI-UHFFFAOYSA-N,Launched,
tazobactam,beta lactamase inhibitor,,infectious disease,pneumonia,MicroSource,96.32,BRD-A18611368-001-01-5,C[C@]1(Cn2ccnn2)C(N2C(CC2=O)S1(=O)=O)C(O)=O,LPQZKKCYTLCDGQ-KTOWXAHTSA-N,Launched,
tebipenem,bacterial cell wall synthesis inhibitor,CNR1,"infectious disease, otolaryngology","pneumonia, otitis",Selleck,94.38,BRD-K06900071-001-01-2,C[C@@H](O)[C@@H]1[C@@H]2[C@H](C)C(SC3CN(C3)C3=NCCS3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C,SNUDIPVBUUXCDG-MXYBEHONSA-N,Launched,
tedizolid,bacterial 50S ribosomal subunit inhibitor,,infectious disease,skin infections,MedChemEx,98.73,BRD-K59436580-001-01-7,Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](CO)OC1=O,XFALPSLJIHVRKE-GFCCVEGCSA-N,Launched,
tedizolid-phosphate,protein synthesis inhibitor,,infectious disease,skin infections,"MedChemEx, Annova, MedChemEx",94.69,"BRD-K89121095-001-02-5, BRD-K89121095-304-01-5, BRD-K89121095-001-01-7","Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](COP(O)(O)=O)OC1=O, Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](COP(O)(O)=O)OC1=O, Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](COP(O)(O)=O)OC1=O","QCGUSIANLFXSGE-GFCCVEGCSA-N, QCGUSIANLFXSGE-GFCCVEGCSA-N, QCGUSIANLFXSGE-GFCCVEGCSA-N",Launched,
teicoplanin,bacterial cell wall synthesis inhibitor,,,,MedChemEx,56.59,BRD-K07712545-001-01-8,CCCCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl,BJNLLBUOHPVGFT-VPMXZCLFSA-N,Launched,
teicoplanin-A2-1,bacterial cell wall synthesis inhibitor,,,,MicroSource,46.55,BRD-A09761158-001-02-1,CCCCC\C=C\CCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(CC4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@H](NC1=O)C(O)=O)c5)cc3Cl,YMWQIYMUNZBOOV-AQQDCCNYSA-N,Launched,
teicoplanin-a2-3,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections,"Selleck, Selleck",9.36,"BRD-K96571715-001-01-4, BRD-U59360347-000-01-3","CC(C)CCCCCCCC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H]1NC(=O)[C@@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl, ","FHBQKTSCJKPYIO-UBGUEUOASA-N, ",Launched,
telaprevir,HCV inhibitor,"CTSA, PGR",infectious disease,hepatitis C,"Selleck, Selleck",85.93,"BRD-K72912098-001-03-1, BRD-K72912098-001-02-3","CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1, CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1","BBAWEDCPNXPBQM-GDEBMMAJSA-N, BBAWEDCPNXPBQM-GDEBMMAJSA-N",Launched,BRD-K83470352-001-01-2
telbivudine,DNA polymerase inhibitor,TK2,infectious disease,hepatitis B,Selleck,93.99,BRD-K15976406-001-03-3,Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O,IQFYYKKMVGJFEH-CSMHCCOUSA-N,Launched,
telithromycin,"bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor","CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7",infectious disease,pneumonia,"MicroSource, Cayman",81.67,"BRD-A94008949-001-01-9, BRD-K82240271-001-01-8","CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC, CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC","LJVAJPDWBABPEJ-FXVGUYRBSA-N, LJVAJPDWBABPEJ-PNUFFHFMSA-N",Launched,
telmesteine,mucolytic agent,,,,TCI,96.9,BRD-A05523972-001-01-5,CCOC(=O)N1CSCC1C(O)=O,XBJWOGLKABXFJE-UHFFFAOYSA-N,Launched,
telmisartan,angiotensin receptor antagonist,"AGTR1, PPARG",cardiology,hypertension,"MicroSource, Tocris, Selleck",99.08,"BRD-K73999723-001-11-3, BRD-K73999723-001-13-9, BRD-K73999723-001-10-5","CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C, CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C, CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C","RMMXLENWKUUMAY-UHFFFAOYSA-N, RMMXLENWKUUMAY-UHFFFAOYSA-N, RMMXLENWKUUMAY-UHFFFAOYSA-N",Launched,
telotristat,tryptophan hydroxylase inhibitor,TPH1,,,MedChemEx,94.93,BRD-K63178091-001-01-1,Cc1ccn(n1)-c1cc(Cl)ccc1[C@@H](Oc1cc(nc(N)n1)-c1ccc(C[C@H](N)C(O)=O)cc1)C(F)(F)F,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Launched,
telotristat-ethyl,tryptophan hydroxylase inhibitor,TPH1,gastroenterology,diarrhea,"MedChemEx, MedChemEx, Selleck",99.27,"BRD-K94559059-091-03-2, BRD-K94559059-091-01-6, BRD-K94559059-091-02-4","CCOC(=O)[C@@H](N)Cc1ccc(cc1)-c1cc(O[C@H](c2ccc(Cl)cc2-n2ccc(C)n2)C(F)(F)F)nc(N)n1, CCOC(=O)[C@@H](N)Cc1ccc(cc1)-c1cc(O[C@H](c2ccc(Cl)cc2-n2ccc(C)n2)C(F)(F)F)nc(N)n1, CCOC(=O)[C@@H](N)Cc1ccc(cc1)-c1cc(O[C@H](c2ccc(Cl)cc2-n2ccc(C)n2)C(F)(F)F)nc(N)n1","MDSQOJYHHZBZKA-GBXCKJPGSA-N, MDSQOJYHHZBZKA-GBXCKJPGSA-N, MDSQOJYHHZBZKA-GBXCKJPGSA-N",Launched,
temefos,cholinesterase inhibitor,,,,MicroSource,46.31,BRD-K51805276-001-09-3,COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1,WWJZWCUNLNYYAU-UHFFFAOYSA-N,Launched,
temocapril,angiotensin converting enzyme inhibitor,ACE,"cardiology, nephrology","hypertension, congestive heart failure, diabetic nephropathy, coronary artery disease (CAD)",Selleck,97.25,BRD-K10784860-003-02-3,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)c1cccs1,FIQOFIRCTOWDOW-BJLQDIEVSA-N,Launched,
temoporfin,radical formation stimulant,,oncology,head and neck squamous cell carcinoma (HNSCC),MedChemEx,85.6,BRD-K63712959-001-01-8,Oc1cccc(c1)-c1c2CCc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2,LYPFDBRUNKHDGX-UHFFFAOYSA-N,Launched,
temozolomide,DNA alkylating agent,MGMT,oncology,"glioblastoma, astrocytoma","Tocris, Tocris, Selleck, MicroSource",97.56,"BRD-K32107296-001-20-1, BRD-K32107296-001-15-1, BRD-K32107296-001-14-4, BRD-K32107296-001-16-9","Cn1nnc2c(ncn2c1=O)C(N)=O, Cn1nnc2c(ncn2c1=O)C(N)=O, Cn1nnc2c(ncn2c1=O)C(N)=O, Cn1nnc2c(ncn2c1=O)C(N)=O","BPEGJWRSRHCHSN-UHFFFAOYSA-N, BPEGJWRSRHCHSN-UHFFFAOYSA-N, BPEGJWRSRHCHSN-UHFFFAOYSA-N, BPEGJWRSRHCHSN-UHFFFAOYSA-N",Launched,
temsirolimus,mTOR inhibitor,MTOR,oncology,renal cell carcinoma (RCC),Selleck,90.63,BRD-K42898655-001-01-8,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1OC(=O)C(C)(CO)CO,CBPNZQVSJQDFBE-SREVRWKESA-N,Launched,
teneligliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,MedChemEx,96.62,BRD-K48068743-001-01-6,Cc1cc(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)n(n1)-c1ccccc1,WGRQANOPCQRCME-PMACEKPBSA-N,Launched,
teniposide,topoisomerase inhibitor,"TOP2A, TOP2B",hematologic malignancy,acute lymphoblastic leukemia (ALL),"Selleck, MicroSource, Selleck",91.09,"BRD-K10362825-001-03-4, BRD-A35588707-001-05-5, BRD-K10362825-001-04-2","COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12, COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@H](O[C@H]3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12","NRUKOCRGYNPUPR-QBPJDGROSA-N, NRUKOCRGYNPUPR-OQMCATNJSA-N, NRUKOCRGYNPUPR-QBPJDGROSA-N",Launched,BRD-K94631066-001-01-3
tenofovir,"HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor",,infectious disease,"human immunodeficiency virus (HIV-1), hepatitis B","Selleck, MicroSource, Selleck",100,"BRD-K15891719-001-05-1, BRD-K15891719-213-01-1, BRD-K15891719-001-04-4","C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O, C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O, C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O","SGOIRFVFHAKUTI-ZCFIWIBFSA-N, SGOIRFVFHAKUTI-ZCFIWIBFSA-N, SGOIRFVFHAKUTI-ZCFIWIBFSA-N",Launched,
tenofovir-disoproxil,nucleoside reverse transcriptase inhibitor,CYP1A2,infectious disease,"human immunodeficiency virus (HIV-1), hepatitis B","Selleck, Selleck",95.24,"BRD-K61868322-051-06-4, BRD-K61868322-050-01-7","CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C, CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C","JFVZFKDSXNQEJW-CQSZACIVSA-N, JFVZFKDSXNQEJW-CQSZACIVSA-N",Launched,
tenoxicam,cyclooxygenase inhibitor,"PTGS1, PTGS2","rheumatology, orthopedics","rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, periarthritis","MicroSource, Selleck",98.19,"BRD-A22844106-001-26-0, BRD-A22844106-001-25-2","CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O, CN1C(C(=O)Nc2ccccn2)C(=O)c2sccc2S1(=O)=O","OTGJPAOGHQFBMI-UHFFFAOYSA-N, OTGJPAOGHQFBMI-UHFFFAOYSA-N",Launched,
tepoxalin,"cyclooxygenase inhibitor, lipoxygenase inhibitor",ALOX5,"rheumatology, orthopedics","rheumatoid arthritis, hip dysplasia","MicroSource, Toronto",97.32,"BRD-K89714990-001-01-5, BRD-K89714990-001-02-3","COc1ccc(cc1)-n1nc(CCC(=O)N(C)O)cc1-c1ccc(Cl)cc1, COc1ccc(cc1)-n1nc(CCC(=O)N(C)O)cc1-c1ccc(Cl)cc1","XYKWNRUXCOIMFZ-UHFFFAOYSA-N, XYKWNRUXCOIMFZ-UHFFFAOYSA-N",Launched,
teprenone,mucus protecting agent,,dermatology,cosmetic,"MedChemEx, MedChemEx, SantaCruz, SantaCruz",82.34,"BRD-K11510141-001-04-2, BRD-K11510141-001-03-4, BRD-K11510141-001-02-6, BRD-K11510141-001-01-8","CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C, CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C, CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C, CC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C","HUCXKZBETONXFO-NJFMWZAGSA-N, HUCXKZBETONXFO-NJFMWZAGSA-N, HUCXKZBETONXFO-NJFMWZAGSA-N, HUCXKZBETONXFO-NJFMWZAGSA-N",Launched,
terazosin,adrenergic receptor antagonist,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7","urology, cardiology","benign prostatic hyperplasia (BPH), hypertension","Selleck, Tocris",98.12,"BRD-A22256192-310-02-8, BRD-A22256192-003-22-7","COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1, COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1","VCKUSRYTPJJLNI-UHFFFAOYSA-N, VCKUSRYTPJJLNI-UHFFFAOYSA-N",Launched,
terbinafine,fungal squalene epoxidase inhibitor,SQLE,infectious disease,"tinea pedis, tinea cruris, tinea corporis","MicroSource, Selleck, Selleck",98.49,"BRD-K68132782-003-14-6, BRD-K68132782-003-13-8, BRD-K68132782-001-03-3","CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12, CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12, CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12","DOMXUEMWDBAQBQ-WEVVVXLNSA-N, DOMXUEMWDBAQBQ-WEVVVXLNSA-N, DOMXUEMWDBAQBQ-WEVVVXLNSA-N",Launched,
terbutaline,adrenergic receptor agonist,ADRB2,pulmonary,"bronchospasm, bronchitis, emphysema","MedChemEx, MicroSource",93.35,"BRD-A50157456-065-21-4, BRD-A50157456-065-20-6","CC(C)(C)NCC(O)c1cc(O)cc(O)c1, CC(C)(C)NCC(O)c1cc(O)cc(O)c1","XWTYSIMOBUGWOL-UHFFFAOYSA-N, XWTYSIMOBUGWOL-UHFFFAOYSA-N",Launched,BRD-M79902621-065-06-7
terconazole,sterol demethylase inhibitor,,infectious disease,vulvovaginal candidiasis,"MicroSource, Kemprotec",94.91,"BRD-K86204871-001-16-2, BRD-K07400595-001-02-7","CC(C)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1, CC(C)N1CCN(CC1)c1ccc(OC[C@@H]2CO[C@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1","BLSQLHNBWJLIBQ-OZXSUGGESA-N, BLSQLHNBWJLIBQ-ZEQKJWHPSA-N",Launched,
terguride,"dopamine receptor agonist, serotonin receptor antagonist","ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",,,Kemprotec,94.68,BRD-A89207210-001-01-6,CCN(CC)C(=O)N[C@H]1CC2C(Cc3c[nH]c4cccc2c34)N(C)C1,JOAHPSVPXZTVEP-NXVRBGIVSA-N,Launched,
teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH,neurology/psychiatry,multiple sclerosis,"Selleck, Tocris, Selleck",99.84,"BRD-A42699921-001-02-8, BRD-A42699921-001-04-4, BRD-A42699921-001-03-6","CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F, CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F, CC(=O)C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F","NABQBYDEMLGCEO-UHFFFAOYSA-N, NABQBYDEMLGCEO-UHFFFAOYSA-N, NABQBYDEMLGCEO-UHFFFAOYSA-N",Launched,
terlipressin,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2",cardiology,hypotension,Key,86.38,BRD-K73451719-001-01-2,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,BENFXAYNYRLAIU-QSVFAHTRSA-N,Launched,
testolactone,aromatase inhibitor,CYP19A1,oncology,breast cancer,MedChemEx,90.38,BRD-K69636617-001-01-7,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2,BPEWUONYVDABNZ-DZBHQSCQSA-N,Launched,
testosterone,androgen receptor agonist,AR,endocrinology,hypogonadism,MicroSource,86.8,BRD-A55393291-001-09-9,C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O,MUMGGOZAMZWBJJ-PPORCNLBSA-N,Launched,
testosterone-enanthate,androgen receptor agonist,AR,endocrinology,hypogonadism,Enzo,84.92,BRD-K89657519-001-01-8,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,Launched,
testosterone-propionate,androgen receptor agonist,AR,,,MicroSource,96.91,BRD-A48720949-001-04-0,CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,PDMMFKSKQVNJMI-PPRDLICTSA-N,Launched,
testosterone-undecanoate,androgen receptor agonist,AR,endocrinology,hypogonadism,MedChemEx,88.78,BRD-K70650177-001-01-7,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,UDSFVOAUHKGBEK-CNQKSJKFSA-N,Launched,
tetrabenazine,vesicular monoamine transporter inhibitor,"DRD2, SLC18A1, SLC18A2","infectious disease, neurology/psychiatry","cholera, Huntington's disease","Tocris, Tocris",93.02,"BRD-K95739795-001-04-5, BRD-K95739795-001-03-7","COc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC, COc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC","MKJIEFSOBYUXJB-HOCLYGCPSA-N, MKJIEFSOBYUXJB-HOCLYGCPSA-N",Launched,
tetracaine,membrane integrity inhibitor,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,anesthetic,"Selleck, MicroSource",98.82,"BRD-K45071273-003-24-9, BRD-K45071273-003-25-6","CCCCNc1ccc(cc1)C(=O)OCCN(C)C, CCCCNc1ccc(cc1)C(=O)OCCN(C)C","GKCBAIGFKIBETG-UHFFFAOYSA-N, GKCBAIGFKIBETG-UHFFFAOYSA-N",Launched,
tetracycline,bacterial 30S ribosomal subunit inhibitor,PRNP,"infectious disease, dermatology","respiratory tract infections, pneumonia, skin infections, urinary tract infections, acne vulgaris (AV), plague, psittacosis","MedChemEx, Selleck, Selleck, MedChemEx, MicroSource, Sigma",76.62,"BRD-A34788695-003-13-6, BRD-A34788695-003-08-6, BRD-A34788695-003-10-2, BRD-A34788695-003-14-4, BRD-A34788695-003-09-4, BRD-A34788695-003-12-8","CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O, CN(C)[C@H]1[C@@H]2C[C@H]3C(C(=O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O","MUHBBHLZPHKTTR-GWFFGYACSA-N, MUHBBHLZPHKTTR-GWFFGYACSA-N, MUHBBHLZPHKTTR-GWFFGYACSA-N, MUHBBHLZPHKTTR-GWFFGYACSA-N, MUHBBHLZPHKTTR-GWFFGYACSA-N, MUHBBHLZPHKTTR-GWFFGYACSA-N",Launched,BRD-A78253580-003-01-1
tetrahydrofolic-acid,,"ALDH1L1, AMT, ATIC, FOLR2, FTCD, MTFMT, MTHFD1, MTHFD2, MTHFR, MTR, SHMT1, SHMT2",,,Sigma,0,BRD-A36978621-001-01-9,Nc1nc(O)c2NC(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNc2n1,MSTNYGQPCMXVAQ-KIYNQFGBSA-N,Launched,
tetrahydrozoline,adrenergic receptor agonist,,ophthalmology,eye irritation,"Selleck, MicroSource",97.32,"BRD-A28856712-003-25-2, BRD-A28856712-003-26-0","C1CN=C(N1)C1CCCc2ccccc12, C1CN=C(N1)C1CCCc2ccccc12","BYJAVTDNIXVSPW-UHFFFAOYSA-N, BYJAVTDNIXVSPW-UHFFFAOYSA-N",Launched,
tetramisole,immunostimulant,,infectious disease,gastrointestinal parasites,"MicroSource, Selleck",99.58,"BRD-A46393198-003-16-6, BRD-A46393198-003-15-8","C1CN2CC(N=C2S1)c1ccccc1, C1CN2CC(N=C2S1)c1ccccc1","HLFSDGLLUJUHTE-UHFFFAOYSA-N, HLFSDGLLUJUHTE-UHFFFAOYSA-N",Launched,
tezacaftor,CFTR channel agonist,,pulmonary,cystic fibrosis,Selleck,96.27,BRD-K97101532-001-02-8,CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c3ccc4OC(F)(F)Oc4c3)c(F)cc2n1C[C@@H](O)CO,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Launched,
thalidomide,tumor necrosis factor production inhibitor,"CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF",,,"Tocris, Selleck",99,"BRD-A93255169-001-28-3, BRD-A93255169-001-27-5","O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12, O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12","UEJJHQNACJXSKW-UHFFFAOYSA-N, UEJJHQNACJXSKW-UHFFFAOYSA-N",Launched,
theobromine,phosphodiesterase inhibitor,"ADORA1, ADORA2A, PDE4B",,,"Selleck, MicroSource",98.78,"BRD-K34888156-001-11-2, BRD-K34888156-213-01-4","Cn1cnc2n(C)c(=O)[nH]c(=O)c12, Cn1cnc2n(C)c(=O)[nH]c(=O)c12","YAPQBXQYLJRXSA-UHFFFAOYSA-N, YAPQBXQYLJRXSA-UHFFFAOYSA-N",Launched,
theophylline,adenosine receptor antagonist,,pulmonary,"asthma, emphysema, bronchitis",MicroSource,98.81,BRD-K97799481-001-16-0,Cn1c2nc[nH]c2c(=O)n(C)c1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,Launched,
thiamine,vitamin B,"SLC19A2, SLC19A3, TPK1",metabolism,thiamine deficiency,"Selleck, MicroSource",96.41,"BRD-K95785345-300-14-8, BRD-K95785345-300-15-5","Cc1c(CCO)sc[n+]1Cc1cnc(C)nc1N, Cc1c(CCO)sc[n+]1Cc1cnc(C)nc1N","JZRWCGZRTZMZEH-UHFFFAOYSA-N, JZRWCGZRTZMZEH-UHFFFAOYSA-N",Launched,
thiamine-pyrophosphate,,,,,ChemImpex,0,BRD-A09994331-003-02-4,Cc1c(CCOP(O)(=O)OP(O)(O)=O)sc[n+]1Cc1cnc(C)nc1N,AYEKOFBPNLCAJY-UHFFFAOYSA-O,Launched,
thiamphenicol,bacterial 50S ribosomal subunit inhibitor,,infectious disease,pelvic inflammatory disease,"MicroSource, Selleck",98.69,"BRD-K79711234-001-18-3, BRD-K79711234-001-17-5","CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl, CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl","OTVAEFIXJLOWRX-NXEZZACHSA-N, OTVAEFIXJLOWRX-NXEZZACHSA-N",Launched,
thiamylal,glutamate receptor antagonist,"GABRA1, KCNJ11, KCNJ8",neurology/psychiatry,sedative,MicroSource,52.77,BRD-A23970436-236-04-2,CCCC(C)C1(CC=C)C(=O)NC(S)=NC1=O,XLOMZPUITCYLMJ-UHFFFAOYSA-N,Launched,
thiethylperazine,dopamine receptor antagonist,"DRD1, DRD2, DRD4",gastroenterology,nausea,Prestwick,91.84,BRD-K69600043-328-05-5,CCSc1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1,XCTYLCDETUVOIP-UHFFFAOYSA-N,Launched,
thiocolchicoside,GABA receptor antagonist,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB",neurology/psychiatry,muscle relaxant,Prestwick,96.58,BRD-K26619122-001-02-1,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2CC[C@H](NC(C)=O)c3cc(=O)c(SC)ccc3-c2c1OC,LEQAKWQJCITZNK-AXHKHJLKSA-N,Launched,
thioctic-acid,reducing agent,"ACHE, LIAS, LIPT1, PTGS2, SLC5A6",,,MicroSource,94.83,BRD-A16347691-001-13-1,OC(=O)CCCCC1CCSS1,AGBQKNBQESQNJD-UHFFFAOYSA-N,Launched,
thioguanine,purine antagonist,"IMPDH1, IMPDH2",hematologic malignancy,acute myeloid leukemia (AML),"Selleck, MicroSource, MicroSource",100,"BRD-K49350383-001-13-7, BRD-K49350383-001-14-5, BRD-K49350383-001-15-2","Nc1nc2nc[nH]c2c(=S)[nH]1, Nc1nc2nc[nH]c2c(=S)[nH]1, Nc1nc2nc[nH]c2c(=S)[nH]1","WYWHKKSPHMUBEB-UHFFFAOYSA-N, WYWHKKSPHMUBEB-UHFFFAOYSA-N, WYWHKKSPHMUBEB-UHFFFAOYSA-N",Launched,
thiomersal,other antibiotic,OXCT1,,,MicroSource,95.81,BRD-K61443650-236-13-1,CC[Hg]Sc1ccccc1C(O)=O,HXQVQGWHFRNKMS-UHFFFAOYSA-M,Launched,
thiopental,GABA receptor antagonist,"CHRNA4, CHRNA7, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2",neurology/psychiatry,anesthetic,"Key, MicroSource",63.17,"BRD-A72603112-236-05-7, BRD-A72603112-236-04-0","CCCC(C)C1(CC)C(=O)NC(S)=NC1=O, CCCC(C)C1(CC)C(=O)NC(S)=NC1=O","IUJDSEJGGMCXSG-UHFFFAOYSA-N, IUJDSEJGGMCXSG-UHFFFAOYSA-N",Launched,
thioproperazine,dopamine receptor antagonist,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A",neurology/psychiatry,schizophrenia,Prestwick,77.82,BRD-K08619574-334-05-4,CN(C)S(=O)(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1,VZYCZNZBPPHOFY-UHFFFAOYSA-N,Launched,
thiostrepton,"FOXM1 inhibitor, protein synthesis inhibitor",FOXM1,obstetrics/gynecology,mastitis,"MicroSource, MedChemEx, MedChemEx, Selleck, Selleck",96.6,"BRD-A20697603-001-07-2, BRD-K58049875-001-03-9, BRD-K58049875-001-01-3, BRD-K58049875-001-02-1, BRD-K58049875-001-04-7","CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C2NC(=O)c3csc(n3)C(NC(=O)C3CSC(=N3)\C(NC(=O)C(NC(=O)c3csc(n3)C3(CCC(=NC3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)=C/C)C(C)(O)C(C)O)C(C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O, CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O","NSFFHOGKXHRQEW-DVRIZHICSA-N, NSFFHOGKXHRQEW-AIHSUZKVSA-N, NSFFHOGKXHRQEW-AIHSUZKVSA-N, NSFFHOGKXHRQEW-AIHSUZKVSA-N, NSFFHOGKXHRQEW-AIHSUZKVSA-N",Launched,"BRD-A89819812-001-02-8, BRD-A86083681-001-01-4, BRD-A91347104-001-01-5, BRD-A89819812-001-01-0,BRD-A51799737-001-01-0"
thiotepa,cytochrome P450 inhibitor,"CYP2B6, CYP3A4",oncology,"breast cancer, ovarian cancer, bladder cancer","MedChemEx, MicroSource, MedChemEx",77.41,"BRD-K09631521-001-12-3, BRD-K09631521-001-09-9, BRD-K09631521-001-11-5","S=P(N1CC1)(N1CC1)N1CC1, S=P(N1CC1)(N1CC1)N1CC1, S=P(N1CC1)(N1CC1)N1CC1","FOCVUCIESVLUNU-UHFFFAOYSA-N, FOCVUCIESVLUNU-UHFFFAOYSA-N, FOCVUCIESVLUNU-UHFFFAOYSA-N",Launched,
thiothixene,dopamine receptor antagonist,"DRD1, DRD2, HRH1, HTR2A",neurology/psychiatry,schizophrenia,MicroSource,92.31,BRD-K97309399-001-09-4,CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C/CCN3CCN(C)CC3)c2c1,GFBKORZTTCHDGY-UFWORHAWSA-N,Launched,
thiram,,JAK2,ophthalmology,contact dermatitis,MicroSource,97.98,BRD-K29254801-001-14-7,CN(C)C(=S)SSC(=S)N(C)C,KUAZQDVKQLNFPE-UHFFFAOYSA-N,Launched,
thonzonium,ATPase inhibitor,,,,"MicroSource, Selleck",94.95,"BRD-K13387373-004-15-2, BRD-K13387373-004-14-5","CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1, CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1","IOYZYMQFUSNATM-UHFFFAOYSA-N, IOYZYMQFUSNATM-UHFFFAOYSA-N",Launched,
thonzylamine,antihistamine,,neurology/psychiatry,itching,MicroSource,91.69,BRD-K88405679-003-03-1,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,GULNIHOSWFYMRN-UHFFFAOYSA-N,Launched,
thymol,GABA receptor positive allosteric modulator,TRPA1,,,Enamine,0,BRD-K17458574-001-07-7,CC(C)c1ccc(C)cc1O,MGSRCZKZVOBKFT-UHFFFAOYSA-N,Launched,
tiabendazole,angiogenesis inhibitor,,infectious disease,"gastrointestinal roundworms, hookworm","Selleck, MicroSource",99.12,"BRD-K77695569-001-29-2, BRD-K77695569-001-30-0","c1nc(cs1)-c1nc2ccccc2[nH]1, c1nc(cs1)-c1nc2ccccc2[nH]1","WJCNZQLZVWNLKY-UHFFFAOYSA-N, WJCNZQLZVWNLKY-UHFFFAOYSA-N",Launched,
tiagabine,GABA uptake inhibitor,SLC6A1,neurology/psychiatry,seizures,"Tocris, Enzo",95.06,"BRD-K60160658-003-12-0, BRD-K60160658-003-11-2","Cc1ccsc1C(=CCCN1CCC[C@H](C1)C(O)=O)c1sccc1C, Cc1ccsc1C(=CCCN1CCC[C@H](C1)C(O)=O)c1sccc1C","PBJUNZJWGZTSKL-MRXNPFEDSA-N, PBJUNZJWGZTSKL-MRXNPFEDSA-N",Launched,
tianeptine,selective serotonin reuptake enhancer (SSRE),"OPRD1, OPRK1, OPRM1","neurology/psychiatry, pulmonary, gastroenterology","depression, asthma, irritable bowel syndrome","Selleck, MedChemEx, MedChemEx, MedChemEx, Selleck, Tocris",98.15,"BRD-A53077924-236-07-1, BRD-A53077924-001-02-0, BRD-A53077924-236-09-7, BRD-A53077924-001-01-2, BRD-A53077924-236-05-5, BRD-A53077924-236-06-3","CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O, CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O, CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O, CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O, CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O, CN1c2ccccc2C(NCCCCCCC(O)=O)c2ccc(Cl)cc2S1(=O)=O","JICJBGPOMZQUBB-UHFFFAOYSA-N, JICJBGPOMZQUBB-UHFFFAOYSA-N, JICJBGPOMZQUBB-UHFFFAOYSA-N, JICJBGPOMZQUBB-UHFFFAOYSA-N, JICJBGPOMZQUBB-UHFFFAOYSA-N, JICJBGPOMZQUBB-UHFFFAOYSA-N",Launched,
tiapride,dopamine receptor antagonist,"DRD2, DRD3",neurology/psychiatry,"dyskinesia, abstinence from alcohol, psychosis",MicroSource,98.27,BRD-K57432881-003-21-8,CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O,JTVPZMFULRWINT-UHFFFAOYSA-N,Launched,
tiaprofenic-acid,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,rheumatoid arthritis,"Prestwick, Sigma",94.01,"BRD-A72988804-001-10-3, BRD-A72988804-001-11-1","CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1, CC(C(O)=O)c1ccc(s1)C(=O)c1ccccc1","GUHPRPJDBZHYCJ-UHFFFAOYSA-N, GUHPRPJDBZHYCJ-UHFFFAOYSA-N",Launched,
tiaramide,anti-inflammatory agent,,pulmonary,asthma,Sigma,99.54,BRD-K27293958-001-01-5,OCCN1CCN(CC1)C(=O)Cn1c2cc(Cl)ccc2sc1=O,HTJXMOGUGMSZOG-UHFFFAOYSA-N,Launched,
tibolone,"androgen receptor agonist, estrogen receptor agonist, progesterone receptor agonist",ESR1,obstetrics/gynecology,endometriosis,MicroSource,85,BRD-A82522119-001-01-7,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,WZDGZWOAQTVYBX-MLWZVTOESA-N,Launched,
ticagrelor,purinergic receptor antagonist,P2RY12,cardiology,"acute coronary syndrome (ACS), myocardial infarction",Selleck,97.56,BRD-K44974079-001-01-3,CCCSc1nc(N[C@@H]2C[C@@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)c2n1,OEKWJQXRCDYSHL-MGXMICMRSA-N,Launched,
ticarcillin,lactamase inhibitor,,infectious disease,gram-negative bacterial infections,"Selleck, Selleck, MedChemEx, MicroSource",0,"BRD-K29229654-304-02-0, BRD-K29229654-304-03-8, BRD-A55051145-304-03-2, BRD-K29229654-304-04-6","CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O, CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(O)=O)c3ccsc3)C(=O)N2[C@H]1C(O)=O","OHKOGUYZJXTSFX-KZFFXBSXSA-N, OHKOGUYZJXTSFX-KZFFXBSXSA-N, OHKOGUYZJXTSFX-IRHHVTTKSA-N, OHKOGUYZJXTSFX-KZFFXBSXSA-N",Launched,"BRD-A91757199-304-01-9, BRD-A91757199-304-02-7, BRD-A91757199-001-01-1"
ticlopidine,purinergic receptor antagonist,P2RY12,"hematology, neurology/psychiatry","thrombosis, stroke","MicroSource, Selleck",98.54,"BRD-K00603606-003-24-0, BRD-K00603606-003-23-2","Clc1ccccc1CN1CCc2sccc2C1, Clc1ccccc1CN1CCc2sccc2C1","PHWBOXQYWZNQIN-UHFFFAOYSA-N, PHWBOXQYWZNQIN-UHFFFAOYSA-N",Launched,
tigecycline,bacterial 30S ribosomal subunit inhibitor,,infectious disease,"skin infections, pneumonia, intra-abdominal infections","Selleck, MedChemEx, MedChemEx, Selleck, Sigma, MedChemEx, MicroSource",26.42,"BRD-A34462049-001-09-3, BRD-A34462049-001-14-3, BRD-A34462049-001-13-5, BRD-A34462049-001-15-0, BRD-A34462049-001-11-9, BRD-A34462049-001-12-7, BRD-A34462049-001-08-5","CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C, CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C","CGZOGNUFXMNYEI-UDUHKTKDSA-N, CGZOGNUFXMNYEI-UDUHKTKDSA-N, CGZOGNUFXMNYEI-UDUHKTKDSA-N, CGZOGNUFXMNYEI-UDUHKTKDSA-N, CGZOGNUFXMNYEI-UDUHKTKDSA-N, CGZOGNUFXMNYEI-UDUHKTKDSA-N, CGZOGNUFXMNYEI-UDUHKTKDSA-N",Launched,BRD-A08915912-001-01-3
tiletamine,glutamate receptor antagonist,,neurology/psychiatry,anesthetic,MicroSource,96.29,BRD-A30582499-003-05-1,CCNC1(CCCCC1=O)c1cccs1,QAXBVGVYDCAVLV-UHFFFAOYSA-N,Launched,
tilmicosin,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bovine respiratory disease (BRD),"MicroSource, Selleck",98.67,"BRD-K26634012-001-03-1, BRD-K26634012-001-04-9","CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC, CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)\C=C\C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","JTSDBFGMPLKDCD-NXYWBGGVSA-N, JTSDBFGMPLKDCD-NXYWBGGVSA-N",Launched,BRD-K12921935-001-01-6
tilorone,interferon inducer,,"infectious disease, gastroenterology, neurology/psychiatry","influenza A virus infection, diarrhea, hepatitis B, multiple sclerosis, urinary tract infections, virus herpes simplex (HSV), hepatitis C",MicroSource,86.28,BRD-K34568562-001-04-3,CCN(CC)CCOc1ccc2-c3ccc(OCCN(CC)CC)cc3C(=O)c2c1,MPMFCABZENCRHV-UHFFFAOYSA-N,Launched,
tiludronate,"bone resorption inhibitor, osteoclast inhibitor","ATP6V1A, MMP2, PTPN1",orthopedics,navicular syndrome,Enzo,100,BRD-K10845183-304-01-6,OP(O)(=O)C(Sc1ccc(Cl)cc1)P(O)(O)=O,DKJJVAGXPKPDRL-UHFFFAOYSA-N,Launched,
timolol,adrenergic receptor antagonist,"ADRB1, ADRB2",ophthalmology,"ocular hypertension, glaucoma","MicroSource, Tocris, Selleck",97.45,"BRD-K30421593-050-04-9, BRD-K08806317-050-29-1, BRD-K08806317-051-01-8","CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1, CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1, CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1","BLJRIMJGRPQVNF-SNVBAGLBSA-N, BLJRIMJGRPQVNF-JTQLQIEISA-N, BLJRIMJGRPQVNF-JTQLQIEISA-N",Launched,
timonacic,antioxidant,ANXA5,,,MicroSource,100,BRD-A38592941-001-02-7,OC(=O)C1CSCN1,DZLNHFMRPBPULJ-UHFFFAOYSA-N,Launched,
tinidazole,antiprotozoal agent,,"infectious disease, obstetrics/gynecology","giardiasis, amebiasis, bacterial vaginosis, trichomoniasis","Selleck, MicroSource, Selleck",98.57,"BRD-K89125793-001-25-2, BRD-K89125793-001-26-0, BRD-K89125793-001-27-8","CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O, CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O, CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O","HJLSLZFTEKNLFI-UHFFFAOYSA-N, HJLSLZFTEKNLFI-UHFFFAOYSA-N, HJLSLZFTEKNLFI-UHFFFAOYSA-N",Launched,
tioconazole,sterol demethylase inhibitor,CYP51A1,infectious disease,yeast infection,"MicroSource, Selleck",98.01,"BRD-A33084557-001-07-4, BRD-A33084557-001-06-6","Clc1sccc1COC(Cn1ccnc1)c1ccc(Cl)cc1Cl, Clc1sccc1COC(Cn1ccnc1)c1ccc(Cl)cc1Cl","QXHHHPZILQDDPS-UHFFFAOYSA-N, QXHHHPZILQDDPS-UHFFFAOYSA-N",Launched,
tiopronin,"chelating agent, reducing agent",,urology,kidney stones,"MedChemEx, Sigma, Selleck, MicroSource, Selleck",91.45,"BRD-A85295731-001-06-4, BRD-A85295731-001-05-6, BRD-A85295731-001-02-3, BRD-A85295731-001-03-1, BRD-A85295731-001-04-9","CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O, CC(S)C(=O)NCC(O)=O","YTGJWQPHMWSCST-UHFFFAOYSA-N, YTGJWQPHMWSCST-UHFFFAOYSA-N, YTGJWQPHMWSCST-UHFFFAOYSA-N, YTGJWQPHMWSCST-UHFFFAOYSA-N, YTGJWQPHMWSCST-UHFFFAOYSA-N",Launched,
tiotropium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3",pulmonary,"chronic obstructive pulmonary disease (COPD), bronchitis, emphysema",Selleck,90.47,BRD-K62782754-337-02-5,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1,LERNTVKEWCAPOY-DZZGSBJMSA-N,Launched,
tipiracil,thymidine phosphorylase inhibitor,TYMP,oncology,colorectal cancer,MedChemEx,92.57,BRD-K11973162-003-01-8,Clc1c(CN2CCCC2=N)[nH]c(=O)[nH]c1=O,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,Launched,
tipranavir,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),"MedChemEx, MedChemEx",88.06,"BRD-A10039652-001-02-0, BRD-A10039652-001-01-2","CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1, CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1","MYXACKZCYFKMTE-JETRDCLMSA-N, MYXACKZCYFKMTE-JETRDCLMSA-N",Launched,
tiquizium,acetylcholine receptor antagonist,,neurology/psychiatry,spasms,AKSci,97.14,BRD-K77552740-004-01-0,C[N@+]12CCCC[C@@H]1CCC(C2)=C(c1cccs1)c1cccs1,ZGSDGGRVFIYKKE-OXQOHEQNSA-N,Launched,
tiratricol,thyroid hormone stimulant,"THRA, THRB",endocrinology,Refetoff syndrome,"Selleck, MicroSource",92.5,"BRD-K61236135-001-08-2, BRD-K61236135-001-09-0","OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1, OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1","UOWZUVNAGUAEQC-UHFFFAOYSA-N, UOWZUVNAGUAEQC-UHFFFAOYSA-N",Launched,
tirofiban,"platelet aggregation inhibitor, structural glycoprotein antagonist","ITGA2B, ITGB3",cardiology,"myocardial infarction, refactory angina",Enzo,97.97,BRD-K37872686-003-01-9,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O,COKMIXFXJJXBQG-NRFANRHFSA-N,Launched,
tizanidine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C, NISCH",neurology/psychiatry,spasms,"Tocris, Tocris, Selleck",98.81,"BRD-K06335600-003-20-7, BRD-K06335600-003-22-3, BRD-K06335600-003-19-9","Clc1ccc2nsnc2c1NC1=NCCN1, Clc1ccc2nsnc2c1NC1=NCCN1, Clc1ccc2nsnc2c1NC1=NCCN1","XFYDIVBRZNQMJC-UHFFFAOYSA-N, XFYDIVBRZNQMJC-UHFFFAOYSA-N, XFYDIVBRZNQMJC-UHFFFAOYSA-N",Launched,
tobramycin,bacterial 30S ribosomal subunit inhibitor,,infectious disease,"bacterial septicemia, respiratory tract infections, meningitis, skin infections, urinary tract infections","MicroSource, Selleck",100,"BRD-K05619559-001-10-1, BRD-K05619559-001-12-7","NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O, NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O","NLVFBUXFDBBNBW-PBSUHMDJSA-N, NLVFBUXFDBBNBW-PBSUHMDJSA-N",Launched,BRD-K96342952-001-01-2
tocainide,sodium channel blocker,SCN5A,cardiology,cardiac arrythmia,MicroSource,96.83,BRD-A92670106-003-05-4,CC(N)C(=O)Nc1c(C)cccc1C,BUJAGSGYPOAWEI-UHFFFAOYSA-N,Launched,
toceranib,protein tyrosine kinase inhibitor,"FLT1, FLT3, KDR, PDGFRA, PDGFRB",oncology,"cutaneous mast cell tumors, cutaneous mast cell tumors","MedChemEx, MedChemEx, MedChemEx",92.31,"BRD-K62040061-001-01-0, BRD-K62040061-011-02-7, BRD-K62040061-011-01-9","Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1, Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1, Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN1CCCC1","SRSGVKWWVXWSJT-ATVHPVEESA-N, SRSGVKWWVXWSJT-ATVHPVEESA-N, SRSGVKWWVXWSJT-ATVHPVEESA-N",Launched,
tocofersolan,antioxidant,,cardiology,cerebral cholesterosis,"MedChemEx, MedChemEx",0,"BRD-A39830855-001-01-6, BRD-K57305459-001-01-4","CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1, CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(OC(=O)CCC(=O)OCCO)c(C)c(C)c2O1","AOBORMOPSGHCAX-UHFFFAOYSA-N, AOBORMOPSGHCAX-AZAGJHQNSA-N",Launched,BRD-U58371969-000-01-8
todralazine,antihypertensive agent,,,,MicroSource,89.59,BRD-K68553471-003-12-3,CCOC(=O)NNc1nncc2ccccc12,WGZDBVOTUVNQFP-UHFFFAOYSA-N,Launched,
tofacitinib,JAK inhibitor,"JAK1, JAK2, JAK3, TYK2",rheumatology,rheumatoid arthritis,"Selleck, Selleck, Tocris",98.2,"BRD-K31283835-001-08-4, BRD-K31283835-048-04-4, BRD-K31283835-048-03-6","C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N, C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N, C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N","UJLAWZDWDVHWOW-YPMHNXCESA-N, UJLAWZDWDVHWOW-YPMHNXCESA-N, UJLAWZDWDVHWOW-YPMHNXCESA-N",Launched,"BRD-K36280065-001-01-1, BRD-K36280065-048-01-2"
tofisopam,"phosphodiesterase inhibitor, cytochrome P450 inhibitor","CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A",neurology/psychiatry,"anxiety, abstinence from alcohol",Sigma,80.14,BRD-K94830213-001-01-3,CCC1=C(C)NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc12,LOUZDJSQOFXLAP-UHFFFAOYSA-N,Launched,
tofogliflozin,sodium/glucose cotransporter inhibitor,GCK,endocrinology,"diabetes mellitus, diabetes mellitus","MedChemEx, MedChemEx",95.64,"BRD-K96344439-002-02-7, BRD-K96344439-002-01-9","CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1, CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1","VWVKUNOPTJGDOB-BDHVOXNPSA-N, VWVKUNOPTJGDOB-BDHVOXNPSA-N",Launched,
tolazamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ10, KCNJ11",endocrinology,diabetes mellitus,"Selleck, Selleck, MicroSource",97.65,"BRD-K32164935-001-29-0, BRD-K32164935-001-31-6, BRD-K32164935-001-30-8","Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1, Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1, Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1","OUDSBRTVNLOZBN-UHFFFAOYSA-N, OUDSBRTVNLOZBN-UHFFFAOYSA-N, OUDSBRTVNLOZBN-UHFFFAOYSA-N",Launched,
tolazoline,adrenergic receptor antagonist,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2",neurology/psychiatry,reverse sedative,"MicroSource, Selleck",98.11,"BRD-K46211610-003-26-7, BRD-K46211610-003-25-9","C(C1=NCCN1)c1ccccc1, C(C1=NCCN1)c1ccccc1","JIVZKJJQOZQXQB-UHFFFAOYSA-N, JIVZKJJQOZQXQB-UHFFFAOYSA-N",Launched,
tolbutamide,ATP channel blocker,"ABCC8, KCNJ1, KCNJ11, KCNJ8",endocrinology,diabetes mellitus,"MicroSource, Selleck",98.93,"BRD-K85119730-001-28-9, BRD-K85119730-001-27-1","CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1, CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1","JLRGJRBPOGGCBT-UHFFFAOYSA-N, JLRGJRBPOGGCBT-UHFFFAOYSA-N",Launched,
tolfenamic-acid,"cyclooxygenase inhibitor, prostanoid receptor antagonist",,neurology/psychiatry,migraine headache,"MicroSource, Selleck",98.71,"BRD-K50133271-001-18-7, BRD-K50133271-001-17-9","Cc1c(Cl)cccc1Nc1ccccc1C(O)=O, Cc1c(Cl)cccc1Nc1ccccc1C(O)=O","YEZNLOUZAIOMLT-UHFFFAOYSA-N, YEZNLOUZAIOMLT-UHFFFAOYSA-N",Launched,
tolmetin,cyclooxygenase inhibitor,"PTGS1, PTGS2",rheumatology,"rheumatoid arthritis, osteoarthritis","Selleck, MicroSource",98.68,"BRD-K82562631-325-04-7, BRD-K82562631-236-04-6","Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C, Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C","UPSPUYADGBWSHF-UHFFFAOYSA-N, UPSPUYADGBWSHF-UHFFFAOYSA-N",Launched,
tolnaftate,fungal squalene epoxidase inhibitor,,infectious disease,"tinea pedis, tinea corporis","MicroSource, Selleck",99.91,"BRD-K44273375-001-25-0, BRD-K44273375-001-24-3","CN(C(=S)Oc1ccc2ccccc2c1)c1cccc(C)c1, CN(C(=S)Oc1ccc2ccccc2c1)c1cccc(C)c1","FUSNMLFNXJSCDI-UHFFFAOYSA-N, FUSNMLFNXJSCDI-UHFFFAOYSA-N",Launched,
tolonidine,adrenergic receptor antagonist,ADRA2A,,,Enamine,98.87,BRD-K82687598-001-01-6,Cc1ccc(NC2=NCCN2)c(Cl)c1,KWBTZIFLQYYPTH-UHFFFAOYSA-N,Launched,
tolonium,,,hematology,methemoglobinemia,MicroSource,48.61,BRD-K94882685-003-09-2,CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1,RQNADZJRELIICT-UHFFFAOYSA-N,Launched,
toloxatone,monoamine oxidase inhibitor,"MAOA, MAOB",neurology/psychiatry,depression,Sigma,99.02,BRD-A67182178-001-01-7,Cc1cccc(c1)N1CC(CO)OC1=O,MXUNKHLAEDCYJL-UHFFFAOYSA-N,Launched,
tolperisone,voltage-gated sodium channel blocker,"CYP2C19, CYP2D6","neurology/psychiatry, infectious disease, rheumatology, cardiology","muscle relaxant, multiple sclerosis, encephalomyelitis, ankylosing spondylitis, atherosclerosis, Raynaud's disease","MicroSource, Selleck",97.96,"BRD-A27732521-003-08-3, BRD-A27732521-003-07-5","CC(CN1CCCCC1)C(=O)c1ccc(C)cc1, CC(CN1CCCCC1)C(=O)c1ccc(C)cc1","FSKFPVLPFLJRQB-UHFFFAOYSA-N, FSKFPVLPFLJRQB-UHFFFAOYSA-N",Launched,
tolterodine,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",urology,"urinary incontinence, urinary frequency","Tocris, Selleck, Selleck",90.63,"BRD-K54316499-046-06-0, BRD-K54316499-046-05-2, BRD-K54316499-046-04-5","CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C, CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C, CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C","OOGJQPCLVADCPB-HXUWFJFHSA-N, OOGJQPCLVADCPB-HXUWFJFHSA-N, OOGJQPCLVADCPB-HXUWFJFHSA-N",Launched,
toltrazuril,antiprotozoal agent,,infectious disease,coccidiosis,"MicroSource, Selleck",99.46,"BRD-K64514229-001-05-2, BRD-K64514229-001-04-5","Cc1cc(ccc1Oc1ccc(SC(F)(F)F)cc1)-n1c(=O)[nH]c(=O)n(C)c1=O, Cc1cc(ccc1Oc1ccc(SC(F)(F)F)cc1)-n1c(=O)[nH]c(=O)n(C)c1=O","OCINXEZVIIVXFU-UHFFFAOYSA-N, OCINXEZVIIVXFU-UHFFFAOYSA-N",Launched,
tolvaptan,vasopressin receptor antagonist,"AVPR1A, AVPR2","endocrinology, cardiology, gastroenterology","hyponatremia, congestive heart failure, hepatic cirrhosis","Tocris, Selleck",98.54,"BRD-A82035391-001-03-5, BRD-A82035391-001-02-7","Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1, Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1","GYHCTFXIZSNGJT-UHFFFAOYSA-N, GYHCTFXIZSNGJT-UHFFFAOYSA-N",Launched,
topiramate,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist","CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,"epilepsy, migraine headache","Tocris, Tocris, MicroSource, Selleck",100,"BRD-K29653726-001-16-7, BRD-K29653726-001-14-2, BRD-K29653726-001-15-9, BRD-K29653726-001-13-4","CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1, CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1, CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1, CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1","KJADKKWYZYXHBB-XBWDGYHZSA-N, KJADKKWYZYXHBB-XBWDGYHZSA-N, KJADKKWYZYXHBB-XBWDGYHZSA-N, KJADKKWYZYXHBB-XBWDGYHZSA-N",Launched,
topiroxostat,xanthine oxidase inhibitor,XDH,"rheumatology, nephrology","gout, hyperuricemia",MedChemEx,99.78,BRD-K77561571-001-01-1,N#Cc1cc(ccn1)-c1n[nH]c(n1)-c1ccncc1,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Launched,
topotecan,topoisomerase inhibitor,"TOP1, TOP1MT",oncology,"small cell lung cancer, cervical cancer","Selleck, MedChemEx, MicroSource, Key, MedChemEx, Selleck",76.92,"BRD-K55696337-003-22-8, BRD-K55696337-003-25-1, BRD-K55696337-003-21-0, BRD-K55696337-003-23-6, BRD-K55696337-003-24-4, BRD-K55696337-003-20-2","CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O, CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O, CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O, CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O, CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O, CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O","UCFGDBYHRUNTLO-QHCPKHFHSA-N, UCFGDBYHRUNTLO-QHCPKHFHSA-N, UCFGDBYHRUNTLO-QHCPKHFHSA-N, UCFGDBYHRUNTLO-QHCPKHFHSA-N, UCFGDBYHRUNTLO-QHCPKHFHSA-N, UCFGDBYHRUNTLO-QHCPKHFHSA-N",Launched,
torasemide,"electrolyte reabsorption inhibitor, thromboxane receptor antagonist",SLC12A1,cardiology,"edema, congestive heart failure, hypertension","MicroSource, Selleck",99.36,"BRD-K30480208-001-18-5, BRD-K30480208-001-17-7","CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1, CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(C)c1","NGBFQHCMQULJNZ-UHFFFAOYSA-N, NGBFQHCMQULJNZ-UHFFFAOYSA-N",Launched,
toremifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",ESR1,oncology,breast cancer,"MicroSource, Selleck, Selleck",97.25,"BRD-K51350053-048-16-5, BRD-K51350053-048-17-3, BRD-K51350053-048-15-7","CN(C)CCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1, CN(C)CCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1, CN(C)CCOc1ccc(cc1)C(\c1ccccc1)=C(\CCCl)c1ccccc1","XFCLJVABOIYOMF-QPLCGJKRSA-N, XFCLJVABOIYOMF-QPLCGJKRSA-N, XFCLJVABOIYOMF-QPLCGJKRSA-N",Launched,
tosufloxacin,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections,"Prestwick, TCI",98.13,"BRD-A41450521-003-02-7, BRD-A41450521-075-10-8","NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F, NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F","WUWFMDMBOJLQIV-UHFFFAOYSA-N, WUWFMDMBOJLQIV-UHFFFAOYSA-N",Launched,
tramadol,"norepinephrine reputake inhibitor, opioid receptor agonist, serotonin reuptake inhibitor","CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4",neurology/psychiatry,"acute pain, chronic pain",MicroSource,96.17,BRD-K51033547-003-02-6,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,TVYLLZQTGLZFBW-GOEBONIOSA-N,Launched,
trametinib,MEK inhibitor,"MAP2K1, MAP2K2",oncology,melanoma,"Selleck, MedChemEx, Selleck, Selleck",94.67,"BRD-K12343256-001-18-8, BRD-K12343256-001-14-7, BRD-K12343256-001-11-3, BRD-K12343256-001-08-9","CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O, CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O, CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O, CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O","LIRYPHYGHXZJBZ-UHFFFAOYSA-N, LIRYPHYGHXZJBZ-UHFFFAOYSA-N, LIRYPHYGHXZJBZ-UHFFFAOYSA-N, LIRYPHYGHXZJBZ-UHFFFAOYSA-N",Launched,
trandolapril,angiotensin converting enzyme inhibitor,ACE,cardiology,"hypertension, myocardial infarction",MicroSource,96.92,BRD-A32505112-001-04-4,CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N1C2CCCCC2C[C@H]1C(O)=O,VXFJYXUZANRPDJ-UPUXWEDPSA-N,Launched,
tranexamic-acid,"antifibrinolytic, plasminogen activator inhibitor",PLG,hematology,hemophilia,"MedChemEx, MedChemEx, MicroSource, Selleck, Selleck",97,"BRD-K15014948-001-11-1, BRD-K15014948-001-10-3, BRD-K15014948-213-01-3, BRD-K15014948-001-09-5, BRD-K15014948-001-12-9","NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O, NC[C@H]1CC[C@@H](CC1)C(O)=O","GYDJEQRTZSCIOI-LJGSYFOKSA-N, GYDJEQRTZSCIOI-LJGSYFOKSA-N, GYDJEQRTZSCIOI-LJGSYFOKSA-N, GYDJEQRTZSCIOI-LJGSYFOKSA-N, GYDJEQRTZSCIOI-LJGSYFOKSA-N",Launched,BRD-K79165417-001-01-7
tranilast,angiogenesis inhibitor,"HPGDS, HRH1",pulmonary,asthma,"Selleck, Tocris, MicroSource, Selleck, Tocris",99.75,"BRD-K17849083-001-32-9, BRD-K17849083-001-34-5, BRD-K17849083-001-31-1, BRD-K17849083-001-29-5, BRD-K17849083-001-30-3","COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC, COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC, COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC, COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC, COc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC","NZHGWWWHIYHZNX-CSKARUKUSA-N, NZHGWWWHIYHZNX-CSKARUKUSA-N, NZHGWWWHIYHZNX-CSKARUKUSA-N, NZHGWWWHIYHZNX-CSKARUKUSA-N, NZHGWWWHIYHZNX-CSKARUKUSA-N",Launched,
"trans-10,cis-12-Conjugated-linoleic-acid",,,,,Cayman,95.61,BRD-K26222048-001-01-7,CCCCC\C=C/C=C/CCCCCCCCC(O)=O,GKJZMAHZJGSBKD-NMMTYZSQSA-N,Launched,
tranylcypromine,monoamine oxidase inhibitor,"KDM1A, MAOA, MAOB",neurology/psychiatry,depression,"Selleck, Tocris, MicroSource, Tocris, Selleck",95.92,"BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7","N[C@H]1C[C@@H]1c1ccccc1, N[C@@H]1C[C@H]1c1ccccc1, NC1C[C@H]1c1ccccc1, N[C@@H]1C[C@H]1c1ccccc1, N[C@@H]1C[C@H]1c1ccccc1","AELCINSCMGFISI-BDAKNGLRSA-N, AELCINSCMGFISI-DTWKUNHWSA-N, AELCINSCMGFISI-IENPIDJESA-N, AELCINSCMGFISI-DTWKUNHWSA-N, AELCINSCMGFISI-DTWKUNHWSA-N",Launched,BRD-M46777692-003-01-9
trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,cardiology,coronary artery disease (CAD),Prestwick,97.83,BRD-K95763993-001-19-3,CCN(CC)c1cc(C)nc2ncnn12,GSNOZLZNQMLSKJ-UHFFFAOYSA-N,Launched,
travoprost,prostanoid receptor agonist,PTGFR,ophthalmology,"ocular hypertension, glaucoma",Enzo,95.41,BRD-K23976833-001-01-0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc1cccc(c1)C(F)(F)F,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Launched,
trazodone,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor","ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4",neurology/psychiatry,depression,"MicroSource, Selleck",97.98,"BRD-K70778732-003-27-5, BRD-K70778732-003-26-7","Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1, Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1","PHLBKPHSAVXXEF-UHFFFAOYSA-N, PHLBKPHSAVXXEF-UHFFFAOYSA-N",Launched,
trelagliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,Selleck,94.03,BRD-A88369366-001-01-7,Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O,IWYJYHUNXVAVAA-UHFFFAOYSA-N,Launched,
treosulfan,DNA synthesis inhibitor,,oncology,ovarian cancer,"MedChemEx, MedChemEx",0,"BRD-K20902145-001-01-2, BRD-K20902145-001-02-0","CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O, CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O","YCPOZVAOBBQLRI-WDSKDSINSA-N, YCPOZVAOBBQLRI-WDSKDSINSA-N",Launched,
trepibutone,cholinergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4",gastroenterology,irritable bowel syndrome,AvaChem,97.79,BRD-K37543758-001-01-3,CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(O)=O,YPTFHLJNWSJXKG-UHFFFAOYSA-N,Launched,
tretinoin,"retinoid receptor agonist, retinoid receptor ligand","ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARG, RARRES1, RORB, RORC, RXRB, RXRG",hematologic malignancy,acute promyelocytic leukemia (APL),"MedChemEx, Selleck, Sigma, MedChemEx, Tocris, Selleck, MicroSource",64.55,"BRD-K71879491-001-51-5, BRD-K71879491-001-44-0, BRD-K71879491-001-47-3, BRD-K71879491-001-48-1, BRD-K71879491-001-38-2, BRD-K71879491-001-37-4, BRD-K71879491-001-39-0","CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O, CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O","SHGAZHPCJJPHSC-YCNIQYBTSA-N, SHGAZHPCJJPHSC-YCNIQYBTSA-N, SHGAZHPCJJPHSC-YCNIQYBTSA-N, SHGAZHPCJJPHSC-YCNIQYBTSA-N, SHGAZHPCJJPHSC-YCNIQYBTSA-N, SHGAZHPCJJPHSC-YCNIQYBTSA-N, SHGAZHPCJJPHSC-YCNIQYBTSA-N",Launched,
triacetin,,,,,MicroSource,85.32,BRD-K92844263-001-09-8,CC(=O)OCC(COC(C)=O)OC(C)=O,URAYPUMNDPQOKB-UHFFFAOYSA-N,Launched,
triamcinolone,glucocorticoid receptor agonist,"NR3C1, SERPINA6",dermatology,corticosteroid-responsive dermatoses,"Selleck, MicroSource, Selleck",94.01,"BRD-K77554836-001-11-6, BRD-K77554836-001-14-0, BRD-K77554836-001-13-2","C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO, C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","GFNANZIMVAIWHM-OBYCQNJPSA-N, GFNANZIMVAIWHM-OBYCQNJPSA-N, GFNANZIMVAIWHM-OBYCQNJPSA-N",Launched,"BRD-A37780065-001-04-5, BRD-K97780336-001-01-9"
triamcinolone-acetonide,"glucocorticoid receptor agonist, immunosuppressant",NR3C1,dermatology,corticosteroid-responsive dermatoses,"MicroSource, Selleck",95.27,"BRD-A92439610-001-04-0, BRD-A92439610-001-05-7","CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO, CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO","YNDXUCZADRHECN-BPHAHLGOSA-N, YNDXUCZADRHECN-BPHAHLGOSA-N",Launched,BRD-K41708980-001-01-6
triamterene,sodium channel blocker,"SCNN1A, SCNN1B, SCNN1D, SCNN1G","endocrinology, cardiology","hypokalemia, hypertension, edema","MicroSource, Selleck",99.47,"BRD-K92049597-001-20-8, BRD-K92049597-001-19-0","Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1, Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1","FNYLWPVRPXGIIP-UHFFFAOYSA-N, FNYLWPVRPXGIIP-UHFFFAOYSA-N",Launched,
tribenoside,"anti-inflammatory agent, capillary stabilizing agent",,,,Prestwick,63.93,BRD-A60294240-001-03-7,CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O,ULLNJSBQMBKOJH-VIVFLBMVSA-N,Launched,
tricaprylin,,,dermatology,cosmetic,MicroSource,85.71,BRD-K24790130-001-07-1,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,VLPFTAMPNXLGLX-UHFFFAOYSA-N,Launched,
trichlormethiazide,chloride channel blocker,"ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3",cardiology,"hypertension, edema","Selleck, MicroSource, Selleck",100,"BRD-A28940325-001-23-2, BRD-A28940325-001-24-0, BRD-A28940325-001-25-7","NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl, NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl, NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl","LMJSLTNSBFUCMU-UHFFFAOYSA-N, LMJSLTNSBFUCMU-UHFFFAOYSA-N, LMJSLTNSBFUCMU-UHFFFAOYSA-N",Launched,
trichloroacetic-acid,,,dermatology,warts,"Enamine, Enamine",0,"BRD-K42090719-001-07-3, BRD-K42090719-001-06-5","OC(=O)C(Cl)(Cl)Cl, OC(=O)C(Cl)(Cl)Cl","YNJBWRMUSHSURL-UHFFFAOYSA-N, YNJBWRMUSHSURL-UHFFFAOYSA-N",Launched,
triclabendazole,microtubule inhibitor,DNMT1,infectious disease,tapeworm,"MicroSource, Selleck",97.58,"BRD-K81916719-001-14-7, BRD-K81916719-001-13-9","CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1, CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1","NQPDXQQQCQDHHW-UHFFFAOYSA-N, NQPDXQQQCQDHHW-UHFFFAOYSA-N",Launched,
triclocarban,other antibiotic,,,,ChemDiv,97.9,BRD-K25029121-001-05-8,Clc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1,ICUTUKXCWQYESQ-UHFFFAOYSA-N,Launched,
triclosan,antibacterial agent,DNMT1,,,MicroSource,99.42,BRD-K41731458-001-15-1,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,XEFQLINVKFYRCS-UHFFFAOYSA-N,Launched,
tridihexethyl,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3","gastroenterology, ophthalmology","peptic ulcer disease (PUD), nystagmus",Prestwick,94,BRD-A22152765-003-10-0,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c1ccccc1,NPRHVSBSZMAEIN-UHFFFAOYSA-N,Launched,
trientine,chelating agent,CA14,metabolism,Wilson's disease,MicroSource,100,BRD-K37111771-300-02-6,NCCNCCNCCN,VILCJCGEZXAXTO-UHFFFAOYSA-N,Launched,
trifluoperazine,dopamine receptor antagonist,"ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1",neurology/psychiatry,schizophrenia,"Selleck, MicroSource, Selleck",96.64,"BRD-K89732114-300-15-4, BRD-K89732114-300-14-7, BRD-K89732114-300-13-9","CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1, CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1, CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1","ZEWQUBUPAILYHI-UHFFFAOYSA-N, ZEWQUBUPAILYHI-UHFFFAOYSA-N, ZEWQUBUPAILYHI-UHFFFAOYSA-N",Launched,
triflupromazine,dopamine receptor antagonist,"CHRM1, CHRM2, DRD1, DRD2, HTR2B","neurology/psychiatry, gastroenterology","psychosis, nausea, vomiting","MicroSource, Selleck",96.33,"BRD-K63675182-003-23-6, BRD-K63675182-003-22-8","CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F, CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F","XSCGXQMFQXDFCW-UHFFFAOYSA-N, XSCGXQMFQXDFCW-UHFFFAOYSA-N",Launched,
trifluridine,"DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor",TYMS,infectious disease,virus herpes simplex (HSV),"Selleck, Tocris, MicroSource, Selleck",96.52,"BRD-K03243820-001-23-8, BRD-K03243820-001-24-6, BRD-K03243820-001-25-3, BRD-K03243820-001-22-0","OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(c(=O)[nH]c1=O)C(F)(F)F","VSQQQLOSPVPRAZ-RRKCRQDMSA-N, VSQQQLOSPVPRAZ-RRKCRQDMSA-N, VSQQQLOSPVPRAZ-RRKCRQDMSA-N, VSQQQLOSPVPRAZ-RRKCRQDMSA-N",Launched,"BRD-A64485570-001-12-8, BRD-A64485570-001-11-0"
triflusal,"cyclooxygenase inhibitor, platelet aggregation inhibitor, thromboxane synthase inhibitor","NFKB1, NOS2, PDE10A, PTGS1","neurology/psychiatry, cardiology","stroke, myocardial infarction, atrial fibrillation (AF)","MedChemEx, MedChemEx, Selleck, MedChemEx, Selleck",94.75,"BRD-K71696703-001-08-7, BRD-K71696703-001-11-1, BRD-K71696703-001-07-9, BRD-K71696703-001-09-5, BRD-K71696703-001-06-1","CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F, CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F, CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F, CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F, CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F","RMWVZGDJPAKBDE-UHFFFAOYSA-N, RMWVZGDJPAKBDE-UHFFFAOYSA-N, RMWVZGDJPAKBDE-UHFFFAOYSA-N, RMWVZGDJPAKBDE-UHFFFAOYSA-N, RMWVZGDJPAKBDE-UHFFFAOYSA-N",Launched,
trihexyphenidyl,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",neurology/psychiatry,parkinsonism,MicroSource,96.17,BRD-A48180038-003-24-3,OC(CCN1CCCCC1)(C1CCCCC1)c1ccccc1,HWHLPVGTWGOCJO-UHFFFAOYSA-N,Launched,
trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,"ESR1, ESR2, HSD3B1, HSD3B2",endocrinology,Cushing's syndrome,"MicroSource, MedChemEx, Selleck",99.44,"BRD-A04497688-001-05-9, BRD-A04497688-001-03-4, BRD-A04497688-001-04-2","C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O, C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@@H]2O","RLQVKDVIBJCQGE-WDUCDQOOSA-N, RLQVKDVIBJCQGE-WDUCDQOOSA-N, RLQVKDVIBJCQGE-WDUCDQOOSA-N",Launched,"BRD-A99644790-001-02-4, BRD-A66155091-001-01-8"
trimebutine,opioid receptor agonist,"OPRD1, OPRK1, OPRM1",gastroenterology,irritable bowel syndrome,"MicroSource, Selleck",93.92,"BRD-A92630576-050-24-1, BRD-A92630576-001-02-0","CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1, CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1","LORDFXWUHHSAQU-UHFFFAOYSA-N, LORDFXWUHHSAQU-UHFFFAOYSA-N",Launched,
trimeprazine,"histamine receptor ligand, histamine receptor antagonist",HRH1,"allergy, neurology/psychiatry, pulmonary","urticaria, itching, cough suppressant",Sigma,0,BRD-M58473998-046-01-0,CC(CN(C)C)CN1c2ccccc2Sc2ccccc12.CC(CN(C)C)CN1c2ccccc2Sc2ccccc12,QVKSGMJGGSXIQM-UHFFFAOYSA-N,Launched,
trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2,cardiology,angina pectoris,MicroSource,93.14,BRD-K88366685-300-06-0,COc1ccc(CN2CCNCC2)c(OC)c1OC,UHWVSEOVJBQKBE-UHFFFAOYSA-N,Launched,
trimethadione,oxazolidine antiepileptic,"CACNA1G, CACNA1H, CACNA1I",neurology/psychiatry,seizures,"MicroSource, MedChemEx, MedChemEx, Sigma",12.34,"BRD-K16606819-001-10-1, BRD-K16606819-001-13-5, BRD-K16606819-001-12-7, BRD-K16606819-001-11-9","CN1C(=O)OC(C)(C)C1=O, CN1C(=O)OC(C)(C)C1=O, CN1C(=O)OC(C)(C)C1=O, CN1C(=O)OC(C)(C)C1=O","IRYJRGCIQBGHIV-UHFFFAOYSA-N, IRYJRGCIQBGHIV-UHFFFAOYSA-N, IRYJRGCIQBGHIV-UHFFFAOYSA-N, IRYJRGCIQBGHIV-UHFFFAOYSA-N",Launched,
trimethobenzamide,histamine receptor antagonist,DRD2,gastroenterology,"vomiting, nausea, gastroenteritis",MicroSource,98.53,BRD-K34415467-003-13-0,COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,FEZBIKUBAYAZIU-UHFFFAOYSA-N,Launched,
trimethoprim,dihydrofolate reductase inhibitor,"DHFR, TYMS","infectious disease, gastroenterology","urinary tract infections, ear infections, diarrhea","MicroSource, Selleck",98.69,"BRD-K07208025-001-31-3, BRD-K07208025-001-29-7","COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC, COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC","IEDVJHCEMCRBQM-UHFFFAOYSA-N, IEDVJHCEMCRBQM-UHFFFAOYSA-N",Launched,
trimethoquinol,adrenergic receptor antagonist,"ADRB2, ADRB3",,,Sigma,85.22,BRD-A56241705-003-01-2,COc1cc(CC2NCCc3cc(O)c(O)cc23)cc(OC)c1OC,RGVPOXRFEPSFGH-UHFFFAOYSA-N,Launched,
trimetozine,sedative,,neurology/psychiatry,sedative,MicroSource,99.51,BRD-K53220666-001-02-6,COc1cc(cc(OC)c1OC)C(=O)N1CCOCC1,XWVOEFLBOSSYGM-UHFFFAOYSA-N,Launched,
trimipramine,"norepinephrine reputake inhibitor, tricyclic antidepressant","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,depression,"MicroSource, Selleck",98.04,"BRD-A19195498-050-14-1, BRD-A19195498-050-13-3","CC(CN(C)C)CN1c2ccccc2CCc2ccccc12, CC(CN(C)C)CN1c2ccccc2CCc2ccccc12","ZSCDBOWYZJWBIY-UHFFFAOYSA-N, ZSCDBOWYZJWBIY-UHFFFAOYSA-N",Launched,
trioxsalen,DNA synthesis inhibitor,,dermatology,"vitiligo, eczema",MicroSource,97.99,BRD-K54790157-001-15-5,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1,FMHHVULEAZTJMA-UHFFFAOYSA-N,Launched,
tripelennamine,histamine receptor antagonist,HRH1,"pulmonary, allergy","asthma, allergic rhinitis, urticaria","MicroSource, Selleck",96.93,"BRD-K57033106-048-04-4, BRD-K57033106-003-19-7","CN(C)CCN(Cc1ccccc1)c1ccccn1, CN(C)CCN(Cc1ccccc1)c1ccccn1","UFLGIAIHIAPJJC-UHFFFAOYSA-N, UFLGIAIHIAPJJC-UHFFFAOYSA-N",Launched,
triprolidine,histamine receptor antagonist,HRH1,allergy,allergic rhinitis,"MicroSource, Tocris",98.84,"BRD-K11742128-003-23-4, BRD-K11742128-003-22-6","Cc1ccc(cc1)C(=C/CN1CCCC1)\c1ccccn1, Cc1ccc(cc1)C(=C/CN1CCCC1)\c1ccccn1","CBEQULMOCCWAQT-WOJGMQOQSA-N, CBEQULMOCCWAQT-WOJGMQOQSA-N",Launched,
triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR,"oncology, endocrinology, obstetrics/gynecology","prostate cancer, breast cancer, precocious puberty, endometriosis, myoma, gender dysphoria",Enzo,93.55,BRD-K62685538-001-01-7,CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,VXKHXGOKWPXYNA-PGBVPBMZSA-N,Launched,
troclosene,,,,,MicroSource,0,BRD-K76375510-237-01-1,Cln1c(=O)[nH]c(=O)n(Cl)c1=O,CEJLBZWIKQJOAT-UHFFFAOYSA-N,Launched,
troleandomycin,protein synthesis inhibitor,,"infectious disease, pulmonary, otolaryngology","pneumonia, bronchitis, tonsillitis, sinusitis",MicroSource,100,BRD-A24297246-001-03-9,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O,LQCLVBQBTUVCEQ-RFHKDOLOSA-N,Launched,
trolox,antioxidant,,,,Enzo,76.18,BRD-A17846016-001-13-9,Cc1c(C)c2OC(C)(CCc2c(C)c1O)C(O)=O,GLEVLJDDWXEYCO-UHFFFAOYSA-N,Launched,
tromaril,prostanoid receptor antagonist,,,,Enamine,99.33,BRD-K91422571-001-01-8,OC(=O)c1ccccc1NCCc1ccccc1,HLNLBEFKHHCAMV-UHFFFAOYSA-N,Launched,
trometamol,,"AMD1, CANT1, DCN, NEIL1, VEGFA",,,"MicroSource, Selleck",100,"BRD-K47978074-001-03-2, BRD-K47978074-001-02-4","NC(CO)(CO)CO, NC(CO)(CO)CO","LENZDBCJOHFCAS-UHFFFAOYSA-N, LENZDBCJOHFCAS-UHFFFAOYSA-N",Launched,
tropesin,cyclooxygenase inhibitor,"PTGS1, PTGS2",,,Sigma,99.27,BRD-A34603619-001-01-9,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(C(O)=O)c3ccccc3)c2c1,UCCJWNPWWPJKGL-UHFFFAOYSA-N,Launched,
tropicamide,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4",ophthalmology,"mydriasis diagnostic, cycloplegia diagnostic","Tocris, Tocris, MicroSource, Selleck",99.63,"BRD-A79672927-001-22-3, BRD-A79672927-001-19-9, BRD-A79672927-001-20-7, BRD-A79672927-001-18-1","CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1, CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1, CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1, CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1","BGDKAVGWHJFAGW-UHFFFAOYSA-N, BGDKAVGWHJFAGW-UHFFFAOYSA-N, BGDKAVGWHJFAGW-UHFFFAOYSA-N, BGDKAVGWHJFAGW-UHFFFAOYSA-N",Launched,
tropisetron,serotonin receptor antagonist,"GLRA1, GLRA2, GLRB, HTR3A, HTR4",gastroenterology,"nausea, vomiting, nausea, vomiting","Tocris, Selleck",98.6,"BRD-K50866992-003-09-5, BRD-K50866992-003-10-3","CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)c1c[nH]c2ccccc12, CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)c1c[nH]c2ccccc12","ZNRGQMMCGHDTEI-ITGUQSILSA-N, ZNRGQMMCGHDTEI-ITGUQSILSA-N",Launched,"BRD-M19407551-300-01-6, BRD-A79226577-003-19-3"
trospium,acetylcholine receptor antagonist,CHRM1,urology,"urinary incontinence, urinary frequency",Selleck,97.42,BRD-K69469734-003-02-5,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)(c1ccccc1)c1ccccc1,OYYDSUSKLWTMMQ-JKHIJQBDSA-N,Launched,
troxerutin,antioxidant,,,,"Selleck, MicroSource, Selleck",90.3,"BRD-K73529671-001-02-9, BRD-K73529671-001-04-5, BRD-K73529671-001-03-7","C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(OCCO)cc(O)c4c3=O)-c3ccc(OCCO)c(OCCO)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(OCCO)cc(O)c4c3=O)-c3ccc(OCCO)c(OCCO)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O, C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(OCCO)cc(O)c4c3=O)-c3ccc(OCCO)c(OCCO)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O","IYVFNTXFRYQLRP-VVSTWUKXSA-N, IYVFNTXFRYQLRP-VVSTWUKXSA-N, IYVFNTXFRYQLRP-VVSTWUKXSA-N",Launched,"BRD-A74160776-001-04-4, BRD-K03928833-001-01-5"
troxipide,glucosamine synthetase stimulant,,gastroenterology,gastroesophageal reflux disease (GERD),"Selleck, Selleck",91.33,"BRD-A68589262-001-04-3, BRD-A68589262-001-05-0","COc1cc(cc(OC)c1OC)C(=O)NC1CCCNC1, COc1cc(cc(OC)c1OC)C(=O)NC1CCCNC1","YSIITVVESCNIPR-UHFFFAOYSA-N, YSIITVVESCNIPR-UHFFFAOYSA-N",Launched,
tryptophan,serotonin receptor partial agonist,"CASR, IDO1, SLC36A1, WARS, WARS2","neurology/psychiatry, gastroenterology","anxiety, bloating, constipation, fatigue, sleeplessness","MicroSource, Sigma",98.59,"BRD-K83776863-001-05-5, BRD-K83776863-001-08-9","N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O, N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O","QIVBCDIJIAJPQS-VIFPVBQESA-N, QIVBCDIJIAJPQS-VIFPVBQESA-N",Launched,
tuaminoheptane,,,otolaryngology,nasal congestion,MicroSource,100,BRD-A19958636-065-04-4,CCCCCC(C)N,VSRBKQFNFZQRBM-UHFFFAOYSA-N,Launched,
tubocurarine,acetylcholine receptor antagonist,"ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN",neurology/psychiatry,anesthetic,MicroSource,93.49,BRD-K99621550-300-01-8,COc1cc2CCN(C)[C@H]3Cc4ccc(Oc5c(O)c(OC)cc6CC[N+](C)(C)[C@H](Cc7ccc(O)c(Oc1cc23)c7)c56)cc4,JFJZZMVDLULRGK-URLMMPGGSA-O,Launched,
tulobuterol,adrenergic receptor agonist,ADRB2,pulmonary,asthma,MicroSource,97.79,BRD-A37441042-003-04-8,CC(C)(C)NCC(O)c1ccccc1Cl,YREYLAVBNPACJM-UHFFFAOYSA-N,Launched,
tylosin,protein synthesis inhibitor,,"infectious disease, gastroenterology","gram-positive bacterial infections, colitis","MicroSource, Selleck",94.95,"BRD-K37753391-046-02-4, BRD-K37753391-046-03-2","CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC, CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","WBPYTXDJUQJLPQ-VMXQISHHSA-N, WBPYTXDJUQJLPQ-VMXQISHHSA-N",Launched,BRD-K90749417-046-01-8
tyloxapol,NFkB pathway inhibitor,"LPL, NFKB2",,,"MedChemEx, Prestwick, MicroSource, MedChemEx",0,"BRD-M08959712-001-02-7, BRD-U25960968-000-01-9, BRD-U48018661-000-01-9, BRD-M08959712-001-01-9","C=O.C1CO1.CC(C)(C)CC(C)(C)c1ccc(O)cc1, , , C=O.C1CO1.CC(C)(C)CC(C)(C)c1ccc(O)cc1","MDYZKJNTKZIUSK-UHFFFAOYSA-N, , , MDYZKJNTKZIUSK-UHFFFAOYSA-N",Launched,"BRD-K46156294-001-05-5, BRD-M13714491-001-01-8"
tymazoline,,,allergy,allergic rhinitis,Sigma,53.77,BRD-K64414150-001-01-7,CC(C)c1ccc(C)cc1OC=C1NCCN1,AFQQVNXTHGUXEQ-UHFFFAOYSA-N,Launched,
ubenimex,leukotriene synthesis inhibitor,"LTA4H, RNPEP",hematologic malignancy,acute myeloid leukemia (AML),"Selleck, Tocris",91.72,"BRD-K59574735-001-11-8, BRD-K59574735-001-12-6","CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O, CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O","VGGGPCQERPFHOB-RDBSUJKOSA-N, VGGGPCQERPFHOB-RDBSUJKOSA-N",Launched,
ufenamate,cyclooxygenase inhibitor,"PTGS1, PTGS2",dermatology,"eczema, dermatitis",AvaChem,98.96,BRD-K84173274-001-01-6,CCCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,JDLSRXWHEBFHNC-UHFFFAOYSA-N,Launched,
ulifloxacin,,,,,"AKSci, Ark",79.96,"BRD-A61633223-001-01-0, BRD-A61633223-001-02-8","CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCNCC1, CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCNCC1","SUXQDLLXIBLQHW-UHFFFAOYSA-N, SUXQDLLXIBLQHW-UHFFFAOYSA-N",Launched,
ulipristal,progesterone receptor antagonist,PGR,endocrinology,contraceptive,"Selleck, Selleck",91,"BRD-K64381438-001-02-0, BRD-K64381438-001-03-8","CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12, CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12","OOLLAFOLCSJHRE-ZHAKMVSLSA-N, OOLLAFOLCSJHRE-ZHAKMVSLSA-N",Launched,"BRD-K55641198-001-01-0, BRD-K76197012-001-01-2"
umeclidinium,acetylcholine receptor antagonist,"CHRM1, CHRM2, CHRM3",pulmonary,"chronic obstructive pulmonary disease (COPD), bronchitis, emphysema",MedChemEx,98.3,BRD-K46692793-004-01-8,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Launched,
undecylenic-acid,other antifungal,,infectious disease,"tinea pedis, tinea corporis","MicroSource, MedChemEx",25.82,"BRD-K19189338-001-03-2, BRD-K19189338-001-05-7","OC(=O)CCCCCCCCC=C, OC(=O)CCCCCCCCC=C","FRPZMMHWLSIFAZ-UHFFFAOYSA-N, FRPZMMHWLSIFAZ-UHFFFAOYSA-N",Launched,
uracil,,"DPYD, UCKL1",,,"Selleck, MicroSource",100,"BRD-K80129304-001-08-1, BRD-K80129304-001-09-9","Oc1ccnc(O)n1, Oc1ccnc(O)n1","ISAKRJDGNUQOIC-UHFFFAOYSA-N, ISAKRJDGNUQOIC-UHFFFAOYSA-N",Launched,
uracil-mustard,DNA synthesis inhibitor,,hematologic malignancy,non-Hodgkin lymphoma (NHL),"MedChemEx, MedChemEx, Sigma",69.59,"BRD-K10180294-001-07-3, BRD-K10180294-001-06-5, BRD-K10180294-001-04-0","Oc1ncc(N(CCCl)CCCl)c(O)n1, Oc1ncc(N(CCCl)CCCl)c(O)n1, Oc1ncc(N(CCCl)CCCl)c(O)n1","IDPUKCWIGUEADI-UHFFFAOYSA-N, IDPUKCWIGUEADI-UHFFFAOYSA-N, IDPUKCWIGUEADI-UHFFFAOYSA-N",Launched,
urapidil,adrenergic receptor antagonist,HTR1A,cardiology,hypertension,"MicroSource, Selleck, Tocris",97.01,"BRD-K73196317-003-15-5, BRD-K73196317-003-13-0, BRD-K73196317-003-14-8","COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1, COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1, COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1","ICMGLRUYEQNHPF-UHFFFAOYSA-N, ICMGLRUYEQNHPF-UHFFFAOYSA-N, ICMGLRUYEQNHPF-UHFFFAOYSA-N",Launched,
urea,hydroxy radical formation stimulant,"ARG1, CA2, CTNNB1",dermatology,"psoriasis, xerosis cutis, ichthyosis vulgaris, eczema, keratosis, dermatitis",MicroSource,97.73,BRD-K88052444-001-08-8,NC(N)=O,XSQUKJJJFZCRTK-UHFFFAOYSA-N,Launched,
uridine-triacetate,,,nephrology,orotic aciduria,Bepharm,96.02,BRD-K18323388-001-01-1,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)n1ccc(=O)[nH]c1=O,AUFUWRKPQLGTGF-FMKGYKFTSA-N,Launched,
uridine-5'-triphosphate,purinergic receptor activator,"P2RY11, P2RY2, P2RY4, P2RY6, UCK2",,,Sigma,0,BRD-A89637065-001-01-0,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O,PGAVKCOVUIYSFO-XVFCMESISA-N,Launched,
ursodiol,"nuclear factor erythroid derived, like (NRF2) activator",NR1H4,gastroenterology,gallstones,"MicroSource, Selleck",100,"BRD-K15697815-001-15-4, BRD-K15697815-001-16-2","C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C, C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","RUDATBOHQWOJDD-UZVSRGJWSA-N, RUDATBOHQWOJDD-UZVSRGJWSA-N",Launched,BRD-K87300616-001-01-9
valaciclovir,DNA polymerase inhibitor,,infectious disease,"shingles, virus herpes simplex (HSV)","MicroSource, Selleck",97.83,"BRD-K46435977-003-12-9, BRD-K46435977-003-11-1","CC(C)[C@H](N)C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O, CC(C)[C@H](N)C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O","HDOVUKNUBWVHOX-QMMMGPOBSA-N, HDOVUKNUBWVHOX-QMMMGPOBSA-N",Launched,
valethamate,acetylcholine receptor antagonist,"CHRM1, CHRM4, CHRM5",obstetrics/gynecology,labor induction,Sigma,90.39,BRD-A56613951-004-01-1,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1,UPPMZCXMQRVMME-UHFFFAOYSA-N,Launched,
valganciclovir,DNA synthesis inhibitor,,infectious disease,cytomegalovirus (CMV),"MicroSource, Selleck",100,"BRD-A50922295-003-05-0, BRD-A50922295-001-01-3","CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c1nc(N)[nH]c2=O, CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c1nc(N)[nH]c2=O","WPVFJKSGQUFQAP-GKAPJAKFSA-N, WPVFJKSGQUFQAP-GKAPJAKFSA-N",Launched,BRD-A08013053-003-01-2
valnemulin,bacterial 50S ribosomal subunit inhibitor,,"infectious disease, gastroenterology","dysentry, colitis, pneumonia",Selleck,100,BRD-K33813875-003-01-8,CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@]23CCC(=O)[C@H]2[C@]1(C)[C@H](C)CC3,LLYYNOVSVPBRGV-LWVOSLLHSA-N,Launched,
valproic-acid,HDAC inhibitor,"ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,seizures,"Selleck, EMDBio, MicroSource, Enzo, Tocris",96.83,"BRD-K41260949-236-15-0, BRD-K41260949-236-18-4, BRD-K41260949-236-16-8, BRD-K41260949-236-17-6, BRD-K41260949-236-21-8","CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O, CCCC(CCC)C(O)=O","NIJJYAXOARWZEE-UHFFFAOYSA-N, NIJJYAXOARWZEE-UHFFFAOYSA-N, NIJJYAXOARWZEE-UHFFFAOYSA-N, NIJJYAXOARWZEE-UHFFFAOYSA-N, NIJJYAXOARWZEE-UHFFFAOYSA-N",Launched,
valpromide,epoxide hydolase inhibitor,,neurology/psychiatry,epilepsy,Sigma,60.96,BRD-K54698528-001-01-2,CCCC(CCC)C(N)=O,OMOMUFTZPTXCHP-UHFFFAOYSA-N,Launched,
valrubicin,"DNA inhibitor, topoisomerase inhibitor",TOP2A,oncology,bladder cancer,MedChemEx,97.11,BRD-K72951360-001-01-4,CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,Launched,
valsartan,angiotensin receptor antagonist,AGTR1,cardiology,"hypertension, congestive heart failure","MicroSource, Tocris, Selleck",99.42,"BRD-K45158365-001-11-4, BRD-K45158365-001-12-2, BRD-K45158365-001-10-6","CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O, CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O, CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O","ACWBQPMHZXGDFX-QFIPXVFZSA-N, ACWBQPMHZXGDFX-QFIPXVFZSA-N, ACWBQPMHZXGDFX-QFIPXVFZSA-N",Launched,
vancomycin,bacterial cell wall synthesis inhibitor,,infectious disease,endocarditis,"MicroSource, Selleck, Selleck",88.61,"BRD-K91065602-001-01-8, BRD-K91065602-003-05-5, BRD-K91065602-003-04-8","CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2, CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2, CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2","MYPYJXKWCTUITO-LYRMYLQWSA-N, MYPYJXKWCTUITO-LYRMYLQWSA-N, MYPYJXKWCTUITO-LYRMYLQWSA-N",Launched,BRD-K60071190-003-01-7
vandetanib,"EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor","EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA",oncology,medullary thyroid cancer (MTC),Selleck,97.69,BRD-K77625799-001-07-7,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,UHTHHESEBZOYNR-UHFFFAOYSA-N,Launched,
vardenafil,phosphodiesterase inhibitor,"PDE5A, PDE6G, PDE6H",urology,erectile dysfunction,"MicroSource, Selleck",99.24,"BRD-K13926615-003-03-3, BRD-K13926615-394-02-8","CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1, CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1","SECKRCOLJRRGGV-UHFFFAOYSA-N, SECKRCOLJRRGGV-UHFFFAOYSA-N",Launched,
varenicline,acetylcholine receptor agonist,"CHRNA3, CHRNA4, CHRNA6, CHRNA7",neurology/psychiatry,smoking cessation,Selleck,91.17,BRD-A86216746-046-02-6,C1C2CNCC1c1cc3nccnc3cc21,JQSHBVHOMNKWFT-UHFFFAOYSA-N,Launched,
vasopressin,vasopressin receptor agonist,"AVPR1A, AVPR1B, AVPR2, OXTR",gastroenterology,abdominal distension,Sigma,85.73,BRD-K73028949-001-02-8,N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,KBZOIRJILGZLEJ-LGYYRGKSSA-N,Launched,
vecuronium,acetylcholine receptor antagonist,CHRNA2,neurology/psychiatry,muscle relaxant,"MicroSource, Selleck",96.73,"BRD-K20168442-004-07-1, BRD-K20168442-004-06-3","CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1, CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1","BGSZAXLLHYERSY-XQIGCQGXSA-N, BGSZAXLLHYERSY-XQIGCQGXSA-N",Launched,"BRD-A82463680-004-02-5, BRD-K07365190-004-01-7"
vemurafenib,RAF inhibitor,"BRAF, RAF1",oncology,melanoma,"Selleck, MedChemEx, Selleck",98.74,"BRD-K56343971-001-14-8, BRD-K56343971-001-12-2, BRD-K56343971-001-10-6","CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F, CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F, CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F","GPXBXXGIAQBQNI-UHFFFAOYSA-N, GPXBXXGIAQBQNI-UHFFFAOYSA-N, GPXBXXGIAQBQNI-UHFFFAOYSA-N",Launched,
venetoclax,BCL inhibitor,BCL2,hematologic malignancy,chronic lymphocytic leukemia (CLL),"Selleck, Adooq, Selleck",97.4,"BRD-K62391742-001-08-9, BRD-K62391742-001-09-7, BRD-K62391742-001-03-0","CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1, CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1, CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1","LQBVNQSMGBZMKD-UHFFFAOYSA-N, LQBVNQSMGBZMKD-UHFFFAOYSA-N, LQBVNQSMGBZMKD-UHFFFAOYSA-N",Launched,
venlafaxine,"adrenergic inhibitor, norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)","SLC6A2, SLC6A3, SLC6A4",neurology/psychiatry,"depression, generalized anxiety disorder (GAD), panic disorders, social anxiety disorder","Tocris, MicroSource, Selleck",96.92,"BRD-A51714012-003-14-4, BRD-A51714012-003-13-6, BRD-A51714012-003-12-8","COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1, COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1, COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1","PNVNVHUZROJLTJ-UHFFFAOYSA-N, PNVNVHUZROJLTJ-UHFFFAOYSA-N, PNVNVHUZROJLTJ-UHFFFAOYSA-N",Launched,
verapamil,calcium channel blocker,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4",cardiology,hypertension,"Selleck, MicroSource",97.04,"BRD-A09533288-003-29-6, BRD-A09533288-003-31-2","COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC, COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC","SGTNSNPWRIOYBX-UHFFFAOYSA-N, SGTNSNPWRIOYBX-UHFFFAOYSA-N",Launched,
vernakalant,potassium channel blocker,KCNA5,cardiology,atrial fibrillation (AF),MedChemEx,97.82,BRD-K19741547-003-01-7,COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC,VBHQKCBVWWUUKN-KZNAEPCWSA-N,Launched,
verteporfin,photosensitizing agent,,ophthalmology,macular degeneration,"MedChemEx, Tocris, Selleck, Cayman, Selleck",69.27,"BRD-K81849500-001-07-7, BRD-K81849500-001-06-9, BRD-K81849500-001-02-8, BRD-K81849500-001-05-1, BRD-K81849500-001-01-0","COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC, COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC, COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC, COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC, COC(=O)CCc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(O)=O)c5C)c(C=C)c4C)C1=CC=C([C@@H](C(=O)OC)[C@@]31C)C(=O)OC","YTZALCGQUPRCGW-ZSFNYQMMSA-N, YTZALCGQUPRCGW-ZSFNYQMMSA-N, YTZALCGQUPRCGW-ZSFNYQMMSA-N, YTZALCGQUPRCGW-ZSFNYQMMSA-N, YTZALCGQUPRCGW-ZSFNYQMMSA-N",Launched,
vesnarinone,phosphodiesterase inhibitor,"KCNH2, PDE3A",cardiology,congestive heart failure,MedChemEx,88.52,BRD-K13414800-001-01-3,COc1ccc(cc1OC)C(=O)N1CCN(CC1)c1ccc2NC(=O)CCc2c1,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Launched,
vidarabine,antiviral,ADA,infectious disease,"virus herpes simplex (HSV), varicella-zoster virus (VZV)","MicroSource, Selleck",98.16,"BRD-K72093121-001-17-1, BRD-K72093121-001-16-3","Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O, Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","OIRDTQYFTABQOQ-UHTZMRCNSA-N, OIRDTQYFTABQOQ-UHTZMRCNSA-N",Launched,
vigabatrin,GABA aminotransferase inhibitor,"ABAT, GABBR1, SLC32A1",neurology/psychiatry,"seizures, spasms",MicroSource,0,BRD-A07893380-213-01-7,NC(CCC(O)=O)C=C,PJDFLNIOAUIZSL-UHFFFAOYSA-N,Launched,
vilanterol,adrenergic receptor agonist,ADRB2,pulmonary,chronic obstructive pulmonary disease (COPD),"MedChemEx, MedChemEx, MedChemEx, MedChemEx",54.71,"BRD-M36487418-001-05-5, BRD-M36487418-001-03-0, BRD-M36487418-001-01-4, BRD-M36487418-001-02-2","OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl, OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl, OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl, OC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc1c(Cl)cccc1Cl","KLOLZALDXGTNQE-JIDHJSLPSA-N, KLOLZALDXGTNQE-JIDHJSLPSA-N, KLOLZALDXGTNQE-JIDHJSLPSA-N, KLOLZALDXGTNQE-JIDHJSLPSA-N",Launched,"BRD-U26240578-000-01-7,BRD-M36487418-001-04-8"
vilazodone,serotonin reuptake inhibitor,"DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4",neurology/psychiatry,depression,"MicroSource, Selleck, Selleck",98.4,"BRD-K58010567-003-02-2, BRD-K58010567-003-01-4, BRD-K58010567-003-03-0","NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1, NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1, NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1","SGEGOXDYSFKCPT-UHFFFAOYSA-N, SGEGOXDYSFKCPT-UHFFFAOYSA-N, SGEGOXDYSFKCPT-UHFFFAOYSA-N",Launched,
vildagliptin,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus,"Selleck, Selleck",99.32,"BRD-A94993966-001-04-4, BRD-A94993966-001-05-1","OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N, OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N","SYOKIDBDQMKNDQ-XWTIBIIYSA-N, SYOKIDBDQMKNDQ-XWTIBIIYSA-N",Launched,
viloxazine,norepinephrine reuptake inhibitor,SLC6A2,neurology/psychiatry,depression,Prestwick,98.75,BRD-A59198242-003-02-9,CCOc1ccccc1OCC1CNCCO1,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,Launched,
vinblastine,"microtubule inhibitor, tubulin polymerization inhibitor","JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1","hematologic malignancy, infectious disease, oncology","Hodgkin's lymphoma, true histiocytic lymphoma (THL), mycosis, small lymphocytic lymphoma (SLL), testicular carcinoma, Kaposi sarcoma","MedChemEx, MedChemEx, MedChemEx, MicroSource, Selleck, Selleck, Tocris",96.33,"BRD-K06519765-065-01-6, BRD-K06519765-065-02-4, BRD-K06519765-001-03-7, BRD-K06519765-065-04-0, BRD-K06519765-001-02-9, BRD-K06519765-001-01-1, BRD-K06519765-065-03-2","CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC","JXLYSJRDGCGARV-CFWMRBGOSA-N, JXLYSJRDGCGARV-CFWMRBGOSA-N, JXLYSJRDGCGARV-CFWMRBGOSA-N, JXLYSJRDGCGARV-CFWMRBGOSA-N, JXLYSJRDGCGARV-CFWMRBGOSA-N, JXLYSJRDGCGARV-CFWMRBGOSA-N, JXLYSJRDGCGARV-CFWMRBGOSA-N",Launched,"BRD-K01188359-065-23-1, BRD-K01188359-001-03-8, BRD-A55594068-065-04-9, BRD-K01188359-001-04-6,BRD-A39708826-001-01-0, BRD-A66484359-001-01-9, BRD-K12515392-065-01-7"
vinburnine,adrenergic receptor antagonist,"CHRM1, CHRM2, CHRM3, CHRM4",neurology/psychiatry,stroke,Enzo,98.61,BRD-K40227168-001-12-9,CC[C@@]12CCCN3CCc4c([C@H]13)n(C(=O)C2)c1ccccc41,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Launched,
vincristine,tubulin polymerization inhibitor,"TUBA4A, TUBB",hematologic malignancy,acute lymphoblastic leukemia (ALL),"MicroSource, MedChemEx, Tocris, Selleck, MedChemEx, Selleck",90.52,"BRD-K12251893-065-06-2, BRD-K12251893-065-01-3, BRD-K12251893-065-04-7, BRD-K12251893-065-05-4, BRD-K12251893-065-02-1, BRD-K12251893-065-03-9","CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC","OGWKCGZFUXNPDA-CFWMRBGOSA-N, OGWKCGZFUXNPDA-CFWMRBGOSA-N, OGWKCGZFUXNPDA-CFWMRBGOSA-N, OGWKCGZFUXNPDA-CFWMRBGOSA-N, OGWKCGZFUXNPDA-CFWMRBGOSA-N, OGWKCGZFUXNPDA-CFWMRBGOSA-N",Launched,"BRD-A60414806-065-02-4, BRD-K49229349-065-01-6, BRD-K98953900-065-01-2, BRD-K49229349-065-02-4, BRD-A60578817-065-01-5"
vindesine,tubulin polymerization inhibitor,"TUBB, TUBB1",oncology,"breast cancer, non-small cell lung cancer (NSCLC), melanoma",AvaChem,78.54,BRD-K59753975-001-02-6,CC[C@]1(O)C[C@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](O)[C@]1(O)C(N)=O,HHJUWIANJFBDHT-KOTLKJBCSA-N,Launched,
vinflunine,microtubule inhibitor,,oncology,bladder cancer,"AvaChem, Selleck",95.66,"BRD-K64120610-001-01-4, BRD-K64120610-046-01-9","CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c1cc(OC)c(cc41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCc3c1[nH]c1ccccc31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC, CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c1cc(OC)c(cc41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCc3c1[nH]c1ccccc31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC","NOSAJPUYIASWEH-USRBKURZSA-N, NOSAJPUYIASWEH-USRBKURZSA-N",Launched,"BRD-K10549975-001-01-8, BRD-A52946717-045-01-7"
vinorelbine,tubulin polymerization inhibitor,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",oncology,non-small cell lung cancer (NSCLC),"MedChemEx, MedChemEx, Enzo",77.38,"BRD-K04269837-346-01-8, BRD-K69280563-346-01-7, BRD-K69280563-001-01-8","CCC1=C[C@@H]2C[N@](C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC, CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC","GBABOYUKABKIAF-IELIFDKJSA-N, GBABOYUKABKIAF-IELIFDKJSA-N, GBABOYUKABKIAF-IELIFDKJSA-N",Launched,
vinpocetine,"phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C",,,"MicroSource, Tocris, Selleck",98.68,"BRD-K53318339-001-24-9, BRD-K53318339-001-23-1, BRD-K53318339-001-26-4","CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41, CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41, CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41","DDNCQMVWWZOMLN-IRLDBZIGSA-N, DDNCQMVWWZOMLN-IRLDBZIGSA-N, DDNCQMVWWZOMLN-IRLDBZIGSA-N",Launched,BRD-K25429851-001-01-5
viomycin,protein synthesis inhibitor,,infectious disease,tuberculosis,Prestwick,39.8,BRD-A42379279-065-03-8,NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)C1C[C@H](O)N=C(N)N1,GXFAIFRPOKBQRV-IKZNKTFNSA-N,Launched,
vismodegib,"hedgehog pathway inhibitor, smoothened receptor antagonist",SMO,oncology,basal cell carcinoma (BCC),Selleck,98.12,BRD-K44827188-001-06-0,Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Launched,
vitamin-b12,,,hematology,megaloblastic anemia,AKSci,97.81,BRD-A75369945-001-01-2,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2[N+]3=C1C(C)=C1[C@@H](CCC(N)=O)C(C)(C)C4=[N+]1[Co]31(C#N)N3C([C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@]23C)=C(C)C2=[N+]1C(=C4)[C@@H](CCC(N)=O)[C@]2(C)CC(N)=O)OP(O)(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12,FMCRMSOQAVOHRD-WZHZPDAFSA-M,Launched,BRD-M28180999-001-01-2
voglibose,glucosidase inhibitor,MGAM,endocrinology,"diabetes mellitus, hyperglycemia","Tocris, Tocris, Selleck",100,"BRD-K66850609-001-05-8, BRD-K66850609-001-06-6, BRD-K66850609-001-07-4","OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O, OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O, OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O","FZNCGRZWXLXZSZ-CIQUZCHMSA-N, FZNCGRZWXLXZSZ-CIQUZCHMSA-N, FZNCGRZWXLXZSZ-CIQUZCHMSA-N",Launched,BRD-K59331299-001-01-2
vonoprazan,potassium-competitive acid antagonist,ATP4A,gastroenterology,peptic ulcer disease (PUD),"Selleck, Selleck",88.52,"BRD-K32768103-051-02-6, BRD-K32768103-051-03-4","CNCc1cc(-c2ccccc2F)n(c1)S(=O)(=O)c1cccnc1, CNCc1cc(-c2ccccc2F)n(c1)S(=O)(=O)c1cccnc1","BFDBKMOZYNOTPK-UHFFFAOYSA-N, BFDBKMOZYNOTPK-UHFFFAOYSA-N",Launched,
vorapaxar,thrombin receptor antagonist,F2R,cardiology,"myocardial infarction, peripheral artery disease (PAD)",Adooq,98.32,BRD-K93442924-001-03-4,CCOC(=O)N[C@@H]1CC[C@@H]2[C@H](C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c2ccc(cn2)-c2cccc(F)c2)C1,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Launched,
voriconazole,cytochrome P450 inhibitor,"CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1",infectious disease,"esophageal candidiasis, aspergillosis, skin infections","Selleck, MicroSource, Selleck",99.42,"BRD-K06557128-001-08-8, BRD-K06557128-001-07-0, BRD-K06557128-001-06-2","C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F, C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F, C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F","BCEHBSKCWLPMDN-MGPLVRAMSA-N, BCEHBSKCWLPMDN-MGPLVRAMSA-N, BCEHBSKCWLPMDN-MGPLVRAMSA-N",Launched,
vorinostat,HDAC inhibitor,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9",hematologic malignancy,cutaneous T-cell lymphoma (CTCL),"Selleck, Selleck, Tocris",99.7,"BRD-K81418486-001-47-5, BRD-K81418486-001-44-2, BRD-K81418486-001-51-7","ONC(=O)CCCCCCC(=O)Nc1ccccc1, ONC(=O)CCCCCCC(=O)Nc1ccccc1, ONC(=O)CCCCCCC(=O)Nc1ccccc1","WAEXFXRVDQXREF-UHFFFAOYSA-N, WAEXFXRVDQXREF-UHFFFAOYSA-N, WAEXFXRVDQXREF-UHFFFAOYSA-N",Launched,
vortioxetine,"serotonin receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4",neurology/psychiatry,depression,"MicroSource, Selleck",95.12,"BRD-K53963539-001-01-8, BRD-K53963539-004-02-0","Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1, Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1","YQNWZWMKLDQSAC-UHFFFAOYSA-N, YQNWZWMKLDQSAC-UHFFFAOYSA-N",Launched,
warfarin,vitamin K antagonist,VKORC1,"hematology, cardiology","deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), myocardial infarction",MicroSource,99.85,BRD-A24514565-001-09-7,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,Launched,
xipamide,carbonic anhydrase inhibitor,SLC12A3,cardiology,"edema, hypertension",OxChem,99.61,BRD-K27393415-001-01-0,Cc1cccc(C)c1NC(=O)c1cc(c(Cl)cc1O)S(N)(=O)=O,MTZBBNMLMNBNJL-UHFFFAOYSA-N,Launched,
xylazine,adrenergic receptor agonist,"ADRA2A, ADRA2B, ADRA2C",neurology/psychiatry,anesthetic,"Selleck, MicroSource",99.59,"BRD-K21565985-003-02-3, BRD-K21565985-001-22-5","Cc1cccc(C)c1NC1=NCCCS1, Cc1cccc(C)c1NC1=NCCCS1","BPICBUSOMSTKRF-UHFFFAOYSA-N, BPICBUSOMSTKRF-UHFFFAOYSA-N",Launched,
xylometazoline,adrenergic receptor agonist,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","otolaryngology, allergy","nasal congestion, allergic rhinitis","MicroSource, Selleck",98.38,"BRD-K08356259-003-24-7, BRD-K08356259-003-23-9","Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C, Cc1cc(cc(C)c1CC1=NCCN1)C(C)(C)C","HUCJFAOMUPXHDK-UHFFFAOYSA-N, HUCJFAOMUPXHDK-UHFFFAOYSA-N",Launched,
xylose,,,,,"Selleck, Selleck",100,"BRD-K10759144-001-03-5, BRD-K10759144-001-04-3","OC[C@@H](O)[C@H](O)[C@@H](O)C=O, OC[C@@H](O)[C@H](O)[C@@H](O)C=O","PYMYPHUHKUWMLA-VPENINKCSA-N, PYMYPHUHKUWMLA-VPENINKCSA-N",Launched,
yohimbine,adrenergic receptor antagonist,"ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8",cardiology,"cardiac arrythmia, bradycardia","Tocris, Selleck, MicroSource",97.72,"BRD-K35586044-003-15-4, BRD-K35586044-003-14-7, BRD-K35586044-003-16-2","COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12, COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12, COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12","BLGXFZZNTVWLAY-SCYLSFHTSA-N, BLGXFZZNTVWLAY-SCYLSFHTSA-N, BLGXFZZNTVWLAY-SCYLSFHTSA-N",Launched,BRD-A87445400-003-04-4
zafirlukast,leukotriene receptor antagonist,"CYSLTR1, CYSLTR2",pulmonary,asthma,Selleck,95.1,BRD-K71289571-001-11-4,COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Launched,
zalcitabine,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1),"Selleck, MicroSource",100,"BRD-K85925969-001-16-6, BRD-K85925969-001-17-4","Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1, Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1","WREGKURFCTUGRC-POYBYMJQSA-N, WREGKURFCTUGRC-POYBYMJQSA-N",Launched,
zaleplon,benzodiazepine receptor agonist,"GABRA1, GABRB1, GABRG2, TSPO",neurology/psychiatry,insomnia,MicroSource,99.85,BRD-K92657060-001-05-7,CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N,HUNXMJYCHXQEGX-UHFFFAOYSA-N,Launched,
zaltoprofen,cyclooxygenase inhibitor,,"endocrinology, neurology/psychiatry","fever, pain relief",Selleck,97.2,BRD-A00578795-001-04-3,CC(C(O)=O)c1ccc2Sc3ccccc3C(=O)Cc2c1,MUXFZBHBYYYLTH-UHFFFAOYSA-N,Launched,
zanamivir,neuraminidase inhibitor,NEU2,infectious disease,influenza A virus infection,"Selleck, Selleck",100,"BRD-K23067689-001-03-9, BRD-K23067689-001-02-1","CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O, CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O","ARAIBEBZBOPLMB-UFGQHTETSA-N, ARAIBEBZBOPLMB-UFGQHTETSA-N",Launched,BRD-K75153898-001-01-5
zidovudine,nucleoside reverse transcriptase inhibitor,TERT,infectious disease,"human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS)","Selleck, MicroSource",99.36,"BRD-K72903603-001-24-4, BRD-A33692381-001-01-9","Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O, Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O","HBOMLICNUCNMMY-XLPZGREQSA-N, HBOMLICNUCNMMY-UHFFFAOYSA-N",Launched,
zileuton,"leukotriene synthesis inhibitor, lipoxygenase inhibitor",ALOX5,pulmonary,asthma,"Selleck, Tocris, MicroSource, Selleck",92.71,"BRD-A56359832-001-13-7, BRD-A56359832-001-15-2, BRD-A56359832-001-12-9, BRD-A56359832-001-11-1","CC(N(O)C(N)=O)c1cc2ccccc2s1, CC(N(O)C(N)=O)c1cc2ccccc2s1, CC(N(O)C(N)=O)c1cc2ccccc2s1, CC(N(O)C(N)=O)c1cc2ccccc2s1","MWLSOWXNZPKENC-UHFFFAOYSA-N, MWLSOWXNZPKENC-UHFFFAOYSA-N, MWLSOWXNZPKENC-UHFFFAOYSA-N, MWLSOWXNZPKENC-UHFFFAOYSA-N",Launched,
zilpaterol,adrenergic receptor agonist,ADRB2,endocrinology,weight-gain aid,Cayman,97.26,BRD-K42816473-001-01-0,CC(C)N[C@H]1CCn2c(O)nc3cccc([C@@H]1O)c23,ZSTCZWJCLIRCOJ-AAEUAGOBSA-N,Launched,
zinc-undecylenate,other antifungal,,infectious disease,tinea pedis,MicroSource,0,BRD-K13330768-001-01-1,C=CCCCCCCCCC(=O)O[Zn]OC(=O)CCCCCCCCC=C,YMCOHQVWOBMDCZ-UHFFFAOYSA-L,Launched,BRD-K86452172-410-01-8
ziprasidone,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4",neurology/psychiatry,"schizophrenia, bipolar disorder","MicroSource, Selleck",94.98,"BRD-K29582115-066-01-2, BRD-K29582115-003-03-1","Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12, Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12","MVWVFYHBGMAFLY-UHFFFAOYSA-N, MVWVFYHBGMAFLY-UHFFFAOYSA-N",Launched,
zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension,MedChemEx,99.29,BRD-K46654563-238-01-0,C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@H](C[C@H]1C(O)=O)Sc1ccccc1,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Launched,BRD-M85357167-001-01-2
zoledronic-acid,bone resorption inhibitor,"FDPS, GGPS1",endocrinology,Paget's disease,"Selleck, Selleck",0,"BRD-K84253429-001-04-4, BRD-K84253429-001-03-6","OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O, OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O","XRASPMIURGNCCH-UHFFFAOYSA-N, XRASPMIURGNCCH-UHFFFAOYSA-N",Launched,
zolimidine,mucus protecting agent,,,,Enamine,89.09,BRD-K45125084-001-01-4,CS(=O)(=O)c1ccc(cc1)-c1cn2ccccc2n1,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Launched,
zolmitriptan,serotonin receptor agonist,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",neurology/psychiatry,migraine headache,"Tocris, MicroSource, Selleck",95.65,"BRD-K54314721-001-11-0, BRD-K54314721-001-10-2, BRD-K54314721-001-09-4","CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12, CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12, CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12","ULSDMUVEXKOYBU-ZDUSSCGKSA-N, ULSDMUVEXKOYBU-ZDUSSCGKSA-N, ULSDMUVEXKOYBU-ZDUSSCGKSA-N",Launched,
zolpidem,benzodiazepine receptor agonist,"GABRA1, GABRA2, GABRA3",neurology/psychiatry,insomnia,MicroSource,98.52,BRD-K44876623-001-03-7,CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Launched,
zonisamide,"sodium channel blocker, T-type calcium channel blocker","CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A",neurology/psychiatry,"seizures, epilepsy","Tocris, Tocris, Selleck",98.12,"BRD-K48300629-001-17-8, BRD-K48300629-001-14-5, BRD-K48300629-001-13-7","NS(=O)(=O)Cc1noc2ccccc12, NS(=O)(=O)Cc1noc2ccccc12, NS(=O)(=O)Cc1noc2ccccc12","UBQNRHZMVUUOMG-UHFFFAOYSA-N, UBQNRHZMVUUOMG-UHFFFAOYSA-N, UBQNRHZMVUUOMG-UHFFFAOYSA-N",Launched,
zotarolimus,mTOR inhibitor,FKBP1A,cardiology,coronary artery restenosis,Adooq,87.25,BRD-K46843573-001-01-9,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@@H]1n1cnnn1,CGTADGCBEXYWNE-JUKNQOCSSA-N,Launched,
zotepine,"dopamine receptor antagonist, serotonin receptor antagonist","ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4",neurology/psychiatry,schizophrenia,Prestwick,97.88,BRD-K64557645-001-02-4,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc12,HDOZVRUNCMBHFH-UHFFFAOYSA-N,Launched,
zuclopenthixol,dopamine receptor antagonist,"ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A",neurology/psychiatry,"schizophrenia, bipolar disorder",Prestwick,97.19,BRD-K28761384-300-01-0,OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1,WFPIAZLQTJBIFN-DVZOWYKESA-N,Launched,
1-hexadecanol,,,dermatology,cosmetic,"Selleck, Selleck",0,"BRD-K37203094-001-02-5, BRD-K37203094-001-03-3","CCCCCCCCCCCCCCCCO, CCCCCCCCCCCCCCCCO","BXWNKGSJHAJOGX-UHFFFAOYSA-N, BXWNKGSJHAJOGX-UHFFFAOYSA-N",Launched,
17-alpha-methyltestosterone,aromatase inhibitor,AR,,,"MedChemEx, MedChemEx",88.24,"BRD-K84036904-001-08-8, BRD-K84036904-001-09-6","C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C, C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","GCKMFJBGXUYNAG-HLXURNFRSA-N, GCKMFJBGXUYNAG-HLXURNFRSA-N",Launched,
17-hydroxyprogesterone-caproate,progesterone receptor agonist,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR",,,MicroSource,97.31,BRD-A29731977-001-04-5,CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)=O,DOMWKUIIPQCAJU-JKPPDDDBSA-N,Launched,
2-hydroxyethyl-salicylate,,,,,Acros,97.62,BRD-K41866823-001-01-3,OCCOC(=O)c1ccccc1O,LVYLCBNXHHHPSB-UHFFFAOYSA-N,Launched,
3-(4-methylbenzylidene)camphor,endocrine disruptor,,dermatology,sunscreen lotion,AlfaAesar,98.91,BRD-A55464252-001-01-2,Cc1ccc(cc1)\C=C1\C2CCC(C)(C1=O)C2(C)C,HEOCBCNFKCOKBX-KAMYIIQDSA-N,Launched,
3-bromocamphor,,,,,Vitas-M,0,BRD-A62841832-001-01-1,CC1(C)C2CCC1(C)C(=O)C2Br,NJQADTYRAYFBJN-UHFFFAOYSA-N,Launched,
4-aminohippuric-acid,,SLC22A6,,,"MicroSource, Selleck, MedChemEx, Selleck, Selleck",100,"BRD-K65544384-001-15-8, BRD-K65544384-236-01-0, BRD-K65544384-236-03-6, BRD-K65544384-001-14-1, BRD-K65544384-236-02-8","Nc1ccc(cc1)C(=O)NCC(O)=O, Nc1ccc(cc1)C(=O)NCC(O)=O, Nc1ccc(cc1)C(=O)NCC(O)=O, Nc1ccc(cc1)C(=O)NCC(O)=O, Nc1ccc(cc1)C(=O)NCC(O)=O","HSMNQINEKMPTIC-UHFFFAOYSA-N, HSMNQINEKMPTIC-UHFFFAOYSA-N, HSMNQINEKMPTIC-UHFFFAOYSA-N, HSMNQINEKMPTIC-UHFFFAOYSA-N, HSMNQINEKMPTIC-UHFFFAOYSA-N",Launched,
5-aminolevulinic-acid,oxidizing agent,ALAD,,,"MicroSource, Selleck",100,"BRD-K57631554-003-07-0, BRD-K57631554-003-06-2","NCC(=O)CCC(O)=O, NCC(=O)CCC(O)=O","ZGXJTSGNIOSYLO-UHFFFAOYSA-N, ZGXJTSGNIOSYLO-UHFFFAOYSA-N",Launched,
5-fluorouracil,thymidylate synthase inhibitor,"DPYD, TYMS",oncology,"colorectal cancer, breast cancer, pancreatic cancer, gastric adenocarcinoma","MicroSource, Selleck",100,"BRD-K24844714-001-25-2, BRD-K24844714-001-24-5","Fc1c[nH]c(=O)[nH]c1=O, Fc1c[nH]c(=O)[nH]c1=O","GHASVSINZRGABV-UHFFFAOYSA-N, GHASVSINZRGABV-UHFFFAOYSA-N",Launched,
5-hydroxytryptophan,neurotransmitter,"SLC36A1, SLC36A2",neurology/psychiatry,insomnia,"Selleck, Selleck",97.09,"BRD-A73930134-001-02-2, BRD-A73930134-001-03-0","NC(Cc1c[nH]c2ccc(O)cc12)C(O)=O, NC(Cc1c[nH]c2ccc(O)cc12)C(O)=O","LDCYZAJDBXYCGN-UHFFFAOYSA-N, LDCYZAJDBXYCGN-UHFFFAOYSA-N",Launched,
7-keto-DHEA,steroid,,,,ChemImpex,98.83,BRD-K07785030-001-01-6,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3C(=O)C=C2C1,VVSMJVQHDZUPIL-XFKPDKBWSA-N,Launched,
